<?xml version="1.0" encoding="UTF-8" standalone="no"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
      <channel>
        <atom:link href="https://feeds.soundcloud.com/users/soundcloud:users:20761437/sounds.rss" rel="self" type="application/rss+xml"/>
        <atom:link href="https://feeds.soundcloud.com/users/soundcloud:users:20761437/sounds.rss?before=1196487001" rel="next" type="application/rss+xml"/>
        <title>BMJ talk medicine</title>
        <link>http://www.bmj.com</link>
        <pubDate>Sun, 08 Mar 2026 11:22:26 +0000</pubDate>
        <lastBuildDate>Sun, 08 Mar 2026 11:22:26 +0000</lastBuildDate>
        <ttl>60</ttl>
        <language>en</language>
        <copyright>BMJ Publishing Group Ltd</copyright>
        <webMaster>feeds@soundcloud.com (SoundCloud Feeds)</webMaster>
        <description>Podcast by BMJ Group</description>
        <itunes:subtitle>talk medicine</itunes:subtitle>
        
        <itunes:author>BMJ Group</itunes:author>
        <itunes:explicit>yes</itunes:explicit>
        <itunes:image href="https://i1.sndcdn.com/avatars-000218918125-v7268h-original.jpg"/>
        <image>
          <url>https://i1.sndcdn.com/avatars-000218918125-v7268h-original.jpg</url>
          <title>BMJ talk medicine</title>
          <link>http://www.bmj.com</link>
        </image>
        
        <itunes:category text="Science &amp; Medicine"><itunes:category text="Medicine"/></itunes:category><itunes:category text="Health"/><itunes:owner><itunes:email>podcasts.admin@bmj.com</itunes:email><itunes:name>BMJ Group</itunes:name></itunes:owner><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/2279669270</guid>
      <title>Episode 1: The present: Backlash to women’s health</title>
      <pubDate>Sun, 08 Mar 2026 11:22:26 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-1-the-present-backlash-to-womens-health-1</link>
      <itunes:duration>00:39:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Episode 1: The present: Backlash to women’s health by BMJ Group</itunes:summary>
      <itunes:subtitle>Episode 1: The present: Backlash to women’s healt…</itunes:subtitle>
      <description>Episode 1: The present: Backlash to women’s health by BMJ Group</description>
      <enclosure length="56802998" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/2279669270-bmjpodcasts-episode-1-the-present-backlash-to-womens-health-1.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-F4FW5T9U7KQ3Wvkk-tMOydg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/2279669267</guid>
      <title>Episode 3: The future: Gender equality as a foundation for socially just health systems</title>
      <pubDate>Sun, 08 Mar 2026 11:22:26 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-3-the-future-gender-equality-as-a-foundation-for-socially-just-health-systems-3</link>
      <itunes:duration>00:43:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Episode 3: The future: Gender equality as a foundation for socially just health systems by BMJ Group</itunes:summary>
      <itunes:subtitle>Episode 3: The future: Gender equality as a found…</itunes:subtitle>
      <description>Episode 3: The future: Gender equality as a foundation for socially just health systems by BMJ Group</description>
      <enclosure length="62969074" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/2279669267-bmjpodcasts-episode-3-the-future-gender-equality-as-a-foundation-for-socially-just-health-systems-3.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-F4FW5T9U7KQ3Wvkk-tMOydg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/2279669264</guid>
      <title>Episode 2: The past: How Covid-19 exposed the cracks</title>
      <pubDate>Sun, 08 Mar 2026 11:22:26 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-2-the-past-how-covid-19-exposed-the-cracks-2</link>
      <itunes:duration>00:42:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Episode 2: The past: How Covid-19 exposed the cracks by BMJ Group</itunes:summary>
      <itunes:subtitle>Episode 2: The past: How Covid-19 exposed the cra…</itunes:subtitle>
      <description>Episode 2: The past: How Covid-19 exposed the cracks by BMJ Group</description>
      <enclosure length="61733266" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/2279669264-bmjpodcasts-episode-2-the-past-how-covid-19-exposed-the-cracks-2.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-F4FW5T9U7KQ3Wvkk-tMOydg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1528660639</guid>
      <title>Predictors of SLN Mapping Failure with Diego Raimondo and Giulia Rovero</title>
      <pubDate>Mon, 05 Jun 2023 10:00:14 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ijgc-predictors-of-sln-mapping-failure-with-diego-raimondo-and-giulia-rovero</link>
      <itunes:duration>00:25:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Diego Raimondo and Giulia Rovero. 

Dr. Raimondo works as medical director and assistant researcher at the Division of Gynecology and Pathophysiology of Human Reproduction, Bologna, Italy, directed by Prof. Renato Seracchioli. He received his PhD on new technologies for endometriosis surgical removal from the University of Bologna in 2021. He is an Advisory Board Member of the ESGE (European Society for Gynaecological Endoscopy) and member of the Special Interest Group in Robotics. His research interests are focused on minimally invasive surgery (laparoscopic, robotic and hysteroscopic) for endometriosis and endometrial cancer. 

Dr. Giulia Rovero graduated in Medicine in 2017 at the University of Florence. She is currently a fifth-year resident at the Division of Gynecology and Pathophysiology of Human Reproduction, Bologna, Italy, directed by Prof. Renato Seracchioli. In 2022/23 she spent twelve months at the Lariboisiere Hospital in Paris focusing on gynecologic oncology. She is developing her research activity in collaboration with Dr. Raimondo in the field of minimally invasive surgery for endometrial cancer. 

Highlights:

* In endometrial carcinoma (EC) patients, the rate of sentinel lymph node (SLN) mapping failure ranges from 20% to 25%.
* Pooled data assessing predictive factors of SLN mapping failure in EC patients undergoing SLN biopsy through the cervical injection of indocyanine green (ICG) are lacking.
* ICG dose &lt;3mL, advanced FIGO stage, lymph node involvement and bulky lymph node are predictive factors of SLN mapping failure in EC patients.
* Neither clinical features (i.e., BMI &gt;30 kg/m2, menopausal status, adenomyosis) nor surgical history is significantly associated with SLN mapping failure in EC patients.
* Deep myometrial invasion, FIGO grade 3, non-endometrioid histotype, and lymphovascular space invasion are not significantly associated with SLN mapping failure in EC patients.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Diego Raimondo and Giulia Rovero. 

Dr. Raimondo works as medical director and assistant researcher at the Division of Gynecology and Pathophysiology of Human Reproduction, Bologna, Italy, directed by Prof. Renato Seracchioli. He received his PhD on new technologies for endometriosis surgical removal from the University of Bologna in 2021. He is an Advisory Board Member of the ESGE (European Society for Gynaecological Endoscopy) and member of the Special Interest Group in Robotics. His research interests are focused on minimally invasive surgery (laparoscopic, robotic and hysteroscopic) for endometriosis and endometrial cancer. 

Dr. Giulia Rovero graduated in Medicine in 2017 at the University of Florence. She is currently a fifth-year resident at the Division of Gynecology and Pathophysiology of Human Reproduction, Bologna, Italy, directed by Prof. Renato Seracchioli. In 2022/23 she spent twelve months at the Lariboisiere Hospital in Paris focusing on gynecologic oncology. She is developing her research activity in collaboration with Dr. Raimondo in the field of minimally invasive surgery for endometrial cancer. 

Highlights:

* In endometrial carcinoma (EC) patients, the rate of sentinel lymph node (SLN) mapping failure ranges from 20% to 25%.
* Pooled data assessing predictive factors of SLN mapping failure in EC patients undergoing SLN biopsy through the cervical injection of indocyanine green (ICG) are lacking.
* ICG dose &lt;3mL, advanced FIGO stage, lymph node involvement and bulky lymph node are predictive factors of SLN mapping failure in EC patients.
* Neither clinical features (i.e., BMI &gt;30 kg/m2, menopausal status, adenomyosis) nor surgical history is significantly associated with SLN mapping failure in EC patients.
* Deep myometrial invasion, FIGO grade 3, non-endometrioid histotype, and lymphovascular space invasion are not significantly associated with SLN mapping failure in EC patients.</description>
      <enclosure length="24391271" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1528660639-bmjpodcasts-ijgc-predictors-of-sln-mapping-failure-with-diego-raimondo-and-giulia-rovero.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OllkYpFS3U1qGWWC-HM0hYQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1526149006</guid>
      <title>Primary Survey - the highlights of June 2023</title>
      <pubDate>Fri, 02 Jun 2023 12:55:23 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-june-2023</link>
      <itunes:duration>00:30:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A summary of some of the best paper we published in the June 2023 issue of the Emergency Medicine Journal. Rick and Sarah talk through topics including home pulse oximetry, out of hospital cardiac arrest, the perils of correctly calculating respiratory rate in the ED and even cross-cultural adaptation of patient communication material.

Read the highlights: https://emj.bmj.com/content/40/6/393

You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>A summary of some of the best paper we published …</itunes:subtitle>
      <description>A summary of some of the best paper we published in the June 2023 issue of the Emergency Medicine Journal. Rick and Sarah talk through topics including home pulse oximetry, out of hospital cardiac arrest, the perils of correctly calculating respiratory rate in the ED and even cross-cultural adaptation of patient communication material.

Read the highlights: https://emj.bmj.com/content/40/6/393

You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="29707776" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1526149006-bmjpodcasts-emj-june-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1525847221</guid>
      <title>Single-cell transcriptomics sheds new light on pancreas biology and disease</title>
      <pubDate>Thu, 01 Jun 2023 07:23:01 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/single-cell-transcriptomics-sheds-new-light-on-pancreas-biology-and-disease</link>
      <itunes:duration>00:09:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Kathy DelGiorno, from the Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA, on the paper 'It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease' published in paper copy in Gut in June 2023 and available online: https://gut.bmj.com/content/72/6/1211

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Kathy DelGiorno, from the Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA, on the paper 'It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease' published in paper copy in Gut in June 2023 and available online: https://gut.bmj.com/content/72/6/1211

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="9533952" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1525847221-bmjpodcasts-single-cell-transcriptomics-sheds-new-light-on-pancreas-biology-and-disease.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1523331934</guid>
      <title>Aciclovir PEP after VZ exposure in pregnancy, falls and fractures with aspirin, an inclisiran rant</title>
      <pubDate>Wed, 31 May 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-june-2023</link>
      <itunes:duration>00:33:49</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the June 2023 issue of DTB. They discuss new guidelines on post-exposure prophylaxis
for varicella or shingles during pregnancy (https://dtb.bmj.com/content/61/6/82). They review the effect of low-dose aspirin on fractures and falls (https://dtb.bmj.com/content/61/6/85), and talk about a study that does not provide meaningful cardiovascular outcome data for inclisiran (https://dtb.bmj.com/content/61/6/86). The main review article explores hospitalisation as a consequence of medication-related harm and the need to reduce the burden of harm caused by medication (https://dtb.bmj.com/content/61/6/87). They begin by discussing an announcement from NHS England that antibiotics will be provided without the need for a prescription from community pharmacies to free up GP time.

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the June 2023 issue of DTB. They discuss new guidelines on post-exposure prophylaxis
for varicella or shingles during pregnancy (https://dtb.bmj.com/content/61/6/82). They review the effect of low-dose aspirin on fractures and falls (https://dtb.bmj.com/content/61/6/85), and talk about a study that does not provide meaningful cardiovascular outcome data for inclisiran (https://dtb.bmj.com/content/61/6/86). The main review article explores hospitalisation as a consequence of medication-related harm and the need to reduce the burden of harm caused by medication (https://dtb.bmj.com/content/61/6/87). They begin by discussing an announcement from NHS England that antibiotics will be provided without the need for a prescription from community pharmacies to free up GP time.

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="81146586" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1523331934-bmjpodcasts-dtb-june-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-cu976gE5p3f2Nwrn-liAj8g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1522218451</guid>
      <title>NRG-018 Pembrolizumab and Chemotherapy in Uterine Cancer with Ramez Eskander</title>
      <pubDate>Mon, 29 May 2023 10:00:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/nrg-018-pembrolizumab-and-chemotherapy-in-uterine-cancer-with-ramez-eskander</link>
      <itunes:duration>00:41:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ramez N. Eskander to discuss NRG-018 pembrolizumab and chemotherapy in uterine cancer. Dr. Eskander is a gynecologic oncologist who specializes in the comprehensive management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes diagnostic and therapeutic procedures, including minimally invasive (robotic) surgery, chemotherapy and novel drugs.

Highlights:

• NRG-GY018 showed that the addition of pembrolizumab to chemotherapy, followed by maintenance pembrolizumab, resulted in a 70% lower risk of disease progression or death in patients in the dMMR cohort and a 46% lower risk in the pMMR cohort than in the placebo group.

• These data suggest that the incorporation of immunotherapy into the first-line treatment of advanced or recurrent endometrial cancer improves oncologic outcomes, regardless of MMR status or histologic findings.

• Previous monotherapy drugs against PD-1 and PD-L1 in recurrent or metastatic pMMR endometrial cancer resulted in only modest improvement.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ramez N. Eskander to discuss NRG-018 pembrolizumab and chemotherapy in uterine cancer. Dr. Eskander is a gynecologic oncologist who specializes in the comprehensive management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes diagnostic and therapeutic procedures, including minimally invasive (robotic) surgery, chemotherapy and novel drugs.

Highlights:

• NRG-GY018 showed that the addition of pembrolizumab to chemotherapy, followed by maintenance pembrolizumab, resulted in a 70% lower risk of disease progression or death in patients in the dMMR cohort and a 46% lower risk in the pMMR cohort than in the placebo group.

• These data suggest that the incorporation of immunotherapy into the first-line treatment of advanced or recurrent endometrial cancer improves oncologic outcomes, regardless of MMR status or histologic findings.

• Previous monotherapy drugs against PD-1 and PD-L1 in recurrent or metastatic pMMR endometrial cancer resulted in only modest improvement.</description>
      <enclosure length="39969229" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1522218451-bmjpodcasts-nrg-018-pembrolizumab-and-chemotherapy-in-uterine-cancer-with-ramez-eskander.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OllkYpFS3U1qGWWC-HM0hYQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1522180366</guid>
      <title>Predictors for large vessel recanalization before stroke thrombectomy: the HALT score</title>
      <pubDate>Fri, 26 May 2023 16:18:06 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/predictors-for-large-vessel-recanalization-before-stroke-thrombectomy-the-halt-score</link>
      <itunes:duration>00:18:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Marco Colasurdo (1) and Prof. Dheeraj Gandhi (2), authors of the original research article, "Predictors for large vessel recanalization before stroke thrombectomy: the HALT score" - https://jnis.bmj.com/content/early/2023/04/25/jnis-2023-020220

This paper is free-to-access for a month following the publication of this podcast. 

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767 

Thank you for listening! This episode was edited by Brian O'Toole. 

(1) Interventional Neuroradiology, Dept. of Diagnostic Radiology, Uni. of Maryland Medical Center, Baltimore, Maryland, USA 
(2) Dept. of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut, USA</itunes:summary>
      <itunes:subtitle>In this podcast, JNIS Editor-in-Chief, Dr. Felipe…</itunes:subtitle>
      <description>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Marco Colasurdo (1) and Prof. Dheeraj Gandhi (2), authors of the original research article, "Predictors for large vessel recanalization before stroke thrombectomy: the HALT score" - https://jnis.bmj.com/content/early/2023/04/25/jnis-2023-020220

This paper is free-to-access for a month following the publication of this podcast. 

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767 

Thank you for listening! This episode was edited by Brian O'Toole. 

(1) Interventional Neuroradiology, Dept. of Diagnostic Radiology, Uni. of Maryland Medical Center, Baltimore, Maryland, USA 
(2) Dept. of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut, USA</description>
      <enclosure length="17614848" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1522180366-bmjpodcasts-predictors-for-large-vessel-recanalization-before-stroke-thrombectomy-the-halt-score.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-LvQE4ly1LNIkzpWl-Kaq3lw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1523275168</guid>
      <title>Atoms: the highlights from the ADC June 2023</title>
      <pubDate>Fri, 26 May 2023 14:39:42 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-june-2023</link>
      <itunes:duration>00:13:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the June 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/6/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the June 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/6/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="18744084" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1523275168-bmjpodcasts-atoms-the-highlights-from-the-adc-june-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-kLlv8zTGLsUJHKA6-oCDiuQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1523149597</guid>
      <title>Quantity AND Quality Is Key For People With Knee OA – Dr Kerry Costello And Dr Deepak Kumar. EP#531</title>
      <pubDate>Fri, 26 May 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/quantity-and-quality-is-key-for-people-with-knee-oa-dr-kerry-costello-and-dr-deepak-kumar-ep531</link>
      <itunes:duration>00:26:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Kerry Costello and Dr Deepak Kumar discuss a BSJM paper that investigated gait and physical activity predictors of cartilage worsening in people with knee osteoarthritis from the MOST study, using a machine learning model. Kerry and Deepak do a brilliant job of explaining the biomechanical variables, and the advantages of machine learning, and what these findings might mean for clinicians treating people with knee osteoarthritis. 

Link to paper: https://bjsm.bmj.com/content/early/2023/03/02/bjsports-2022-106142
Connect with Kerry: https://mae.ufl.edu/people/faculty/primary/profiles/kerry-costello/</itunes:summary>
      <itunes:subtitle>Dr Kerry Costello and Dr Deepak Kumar discuss a B…</itunes:subtitle>
      <description>Dr Kerry Costello and Dr Deepak Kumar discuss a BSJM paper that investigated gait and physical activity predictors of cartilage worsening in people with knee osteoarthritis from the MOST study, using a machine learning model. Kerry and Deepak do a brilliant job of explaining the biomechanical variables, and the advantages of machine learning, and what these findings might mean for clinicians treating people with knee osteoarthritis. 

Link to paper: https://bjsm.bmj.com/content/early/2023/03/02/bjsports-2022-106142
Connect with Kerry: https://mae.ufl.edu/people/faculty/primary/profiles/kerry-costello/</description>
      <enclosure length="62975999" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1523149597-bmjpodcasts-quantity-and-quality-is-key-for-people-with-knee-oa-dr-kerry-costello-and-dr-deepak-kumar-ep531.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-eZ2wsyFXvC9BIO1y-5MTmkw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1520706682</guid>
      <title>Editors Highlights of the June 2023 issue</title>
      <pubDate>Thu, 25 May 2023 12:38:40 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-june-2023-issue</link>
      <itunes:duration>00:45:39</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the June 2023 issue of the journal (https://pn.bmj.com/content/23/3/189).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</itunes:summary>
      <itunes:subtitle>Practical Neurology Editors Phil Smith and Gerain…</itunes:subtitle>
      <description>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the June 2023 issue of the journal (https://pn.bmj.com/content/23/3/189).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</description>
      <enclosure length="43826363" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1520706682-bmjpodcasts-editors-highlights-of-the-june-2023-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1520425726</guid>
      <title>How to model safe clinical practice</title>
      <pubDate>Tue, 23 May 2023 09:41:39 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/how-to-model-safe-clinical-practice</link>
      <itunes:duration>00:26:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>There are concerns that junior healthcare professionals do not use decision support as they don’t see senior staff using it. There are concerns that seniors don't use clinical decision support as they worry about looking things up people in front of people. So a complex issue to discuss. 

To find out more about this, listen to this interview with  Dr Tom Foley, Consultant Child and Adolescent Psychiatrist with expertise in digital health.</itunes:summary>
      <itunes:subtitle>There are concerns that junior healthcare profess…</itunes:subtitle>
      <description>There are concerns that junior healthcare professionals do not use decision support as they don’t see senior staff using it. There are concerns that seniors don't use clinical decision support as they worry about looking things up people in front of people. So a complex issue to discuss. 

To find out more about this, listen to this interview with  Dr Tom Foley, Consultant Child and Adolescent Psychiatrist with expertise in digital health.</description>
      <enclosure length="25133734" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1520425726-bmjpodcasts-how-to-model-safe-clinical-practice.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-r49z0272Ud3bPxfD-Fthcjw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1515079243</guid>
      <title>Improving GDMT Implementation in HFrEF with Dr. Nancy Albert of the Cleveland Clinic</title>
      <pubDate>Tue, 23 May 2023 05:00:08 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/improving-gdmt-implementation-in-hfref-with-dr-nancy-albert-of-the-cleveland-clinic</link>
      <itunes:duration>00:19:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the podcast, Andrew Perry discusses with Dr. Albert the barriers to implementing guideline-directed medical therapy in heart failure with reduced ejection fraction and how to improve matters.

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2</itunes:summary>
      <itunes:subtitle>In this episode of the podcast, Andrew Perry disc…</itunes:subtitle>
      <description>In this episode of the podcast, Andrew Perry discusses with Dr. Albert the barriers to implementing guideline-directed medical therapy in heart failure with reduced ejection fraction and how to improve matters.

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2</description>
      <enclosure length="45653512" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1515079243-bmjpodcasts-improving-gdmt-implementation-in-hfref-with-dr-nancy-albert-of-the-cleveland-clinic.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-AixmH23o82oKUNNM-m1MPbg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1517576581</guid>
      <title>RAINBO Trials with Carien Creutzberg, Nanda Horeweg, and Alexandra Leary</title>
      <pubDate>Mon, 22 May 2023 05:00:28 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/rainbo-trials</link>
      <itunes:duration>00:33:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Carien Creutzberg, Nanda Horeweg, and Alexandra Leary to discuss the RAINBO trials. Carien Creutzberg is Professor of Radiation Oncology at Leiden University Medical Center, the Netherlands. She specializes in research and treatment of gynecological cancers and has been the initiator and principal investigator of the four PORTEC trials and the TransPORTEC consortium. She is current chair of the GCIG Endometrial Cancer Committee and past Council member of ESGO and IGCS. Nanda Horeweg is senior researcher at the department of Radiation Oncology of Leiden University Medical Center, the Netherlands. She is one of the principal investigators of the PORTEC team and the international coordinator of the RAINBO program of clinical trials. Alexandra Leary, MD, PhD, is a medical oncologist specializing in gynecological cancers at Gustave Roussy Cancer Center in France. She is the CI for the RAINBO-RED trial and member of the TransPORTEC Consortium. She is current chair of the GCIG Phase II committee, gyne track chair for ESMO Asia, and past gyne track chair for ESMO.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Carien Creutzberg, Nanda Horeweg, and Alexandra Leary to discuss the RAINBO trials. Carien Creutzberg is Professor of Radiation Oncology at Leiden University Medical Center, the Netherlands. She specializes in research and treatment of gynecological cancers and has been the initiator and principal investigator of the four PORTEC trials and the TransPORTEC consortium. She is current chair of the GCIG Endometrial Cancer Committee and past Council member of ESGO and IGCS. Nanda Horeweg is senior researcher at the department of Radiation Oncology of Leiden University Medical Center, the Netherlands. She is one of the principal investigators of the PORTEC team and the international coordinator of the RAINBO program of clinical trials. Alexandra Leary, MD, PhD, is a medical oncologist specializing in gynecological cancers at Gustave Roussy Cancer Center in France. She is the CI for the RAINBO-RED trial and member of the TransPORTEC Consortium. She is current chair of the GCIG Phase II committee, gyne track chair for ESMO Asia, and past gyne track chair for ESMO.</description>
      <enclosure length="32198582" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1517576581-bmjpodcasts-rainbo-trials.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-WDyd6S8vNupNYj2y-ATv9Ww-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1516996426</guid>
      <title>Biomarker reduction indicates treatment response to Belimumab</title>
      <pubDate>Mon, 22 May 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reduction-in-urinary-cd163-associated-with-treatment-response-in-the-belimumab-lupus-nephritis-trial</link>
      <itunes:duration>00:14:36</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in urinary CD163 levels and the response to Belimumab treatment in Lupus Nephritis trials. The conversation provides important insights into the efficacy of this treatment option and potential biomarker use for personalized and precision medicine in the future.
Read the article: http://dx.doi.org/10.1136/lupus-2022-000763</itunes:summary>
      <itunes:subtitle>Dr. Anna Wolska from the Lupus Foundation of Amer…</itunes:subtitle>
      <description>Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in urinary CD163 levels and the response to Belimumab treatment in Lupus Nephritis trials. The conversation provides important insights into the efficacy of this treatment option and potential biomarker use for personalized and precision medicine in the future.
Read the article: http://dx.doi.org/10.1136/lupus-2022-000763</description>
      <enclosure length="21089428" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1516996426-bmjpodcasts-reduction-in-urinary-cd163-associated-with-treatment-response-in-the-belimumab-lupus-nephritis-trial.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-5PaNLLjOUkytbrXG-WsAztg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1511807395</guid>
      <title>Not all vaping is the same: CBD vs nicotine</title>
      <pubDate>Wed, 17 May 2023 10:01:34 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/not-all-vaping-is-the-same-cbd-vs-nicotine</link>
      <itunes:duration>00:28:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Kate Diomede, social media editor at Thorax, is joined by Dr. Yasmin Thanavala (1) to discuss her group's recent research paper, "Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine". Their study used a using a mouse model of vaping and in vitro experiments with human cells. The paper is available online: https://thorax.bmj.com/content/early/2023/04/02/thorax-2022-218743

Hear the previous discussion with Prof. Nick Hopkinson on policy relating to vaping and smoking: https://on.soundcloud.com/cjFhd

(1) Prof. Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.</itunes:summary>
      <itunes:subtitle>Dr. Kate Diomede, social media editor at Thorax, …</itunes:subtitle>
      <description>Dr. Kate Diomede, social media editor at Thorax, is joined by Dr. Yasmin Thanavala (1) to discuss her group's recent research paper, "Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine". Their study used a using a mouse model of vaping and in vitro experiments with human cells. The paper is available online: https://thorax.bmj.com/content/early/2023/04/02/thorax-2022-218743

Hear the previous discussion with Prof. Nick Hopkinson on policy relating to vaping and smoking: https://on.soundcloud.com/cjFhd

(1) Prof. Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.</description>
      <enclosure length="26945827" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1511807395-bmjpodcasts-not-all-vaping-is-the-same-cbd-vs-nicotine.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wlCv5ebW8LVKp9iQ-m8ifTQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1514620846</guid>
      <title>The first generation medical students</title>
      <pubDate>Mon, 15 May 2023 13:24:39 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-first-generation-medical-students</link>
      <itunes:duration>00:47:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Starting university or medical school can be a daunting experience for anyone, but when you’re the first person in your family to study medicine, it can feel even scarier. 

In today’s episode, we’re going to be talking all about what it’s like to be a first-generation medical student. We’ll start from the very beginning and talk about when we first realised we wanted to study medicine and what it was like to apply. We’ll then move on to discussing our time at medical school, and whether we experienced any kind of culture shock when we arrived. We’ll finish up by talking about positive changes we’d like to see in medicine, and how our feelings have changed with time. 

Expert guests:
Dr Enam-Ul Haque is a GP Partner in Manchester, as well as a Clinical Senior Lecturer at the University of Manchester. He has a passion for widening participation and equality, diversity and inclusion (EDI) and is the Founder of the National Medical Schools Widening Participation Forum and Co-Chair of the MSC EDI Alliance. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Starting university or medical school can be a da…</itunes:subtitle>
      <description>Starting university or medical school can be a daunting experience for anyone, but when you’re the first person in your family to study medicine, it can feel even scarier. 

In today’s episode, we’re going to be talking all about what it’s like to be a first-generation medical student. We’ll start from the very beginning and talk about when we first realised we wanted to study medicine and what it was like to apply. We’ll then move on to discussing our time at medical school, and whether we experienced any kind of culture shock when we arrived. We’ll finish up by talking about positive changes we’d like to see in medicine, and how our feelings have changed with time. 

Expert guests:
Dr Enam-Ul Haque is a GP Partner in Manchester, as well as a Clinical Senior Lecturer at the University of Manchester. He has a passion for widening participation and equality, diversity and inclusion (EDI) and is the Founder of the National Medical Schools Widening Participation Forum and Co-Chair of the MSC EDI Alliance. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="45343616" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1514620846-bmjpodcasts-the-first-generation-medical-students.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-mC2vNor3DUtjCLzG-ZzBeAg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1506157867</guid>
      <title>Case Reports of the month: aciclovir neurotoxicity, and a rare posterior spinal artery infarct</title>
      <pubDate>Mon, 15 May 2023 12:59:02 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/case-reports-explained-aciclovir-neurotoxicity-and-a-rare-posterior-spinal-artery-infarct</link>
      <itunes:duration>00:45:03</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this new series of the Practical Neurology podcast, Professor Martin Turner (1) invites Dr Ruth Wood (2) and Dr Xin You Tai (3) to discuss the nitty-gritty details of two Case Reports from the latest issue of the Practical Neurology journal.

This month, they start by commenting on a case of a woman in her 70s with renal failure who developed confusion and seizures after receiving aciclovir, and was subsequently diagnosed with aciclovir-induced neurotoxicity (Aciclovir-induced neurotoxicity - https://pn.bmj.com/content/23/2/157).
They also talk (starting at 23:05) about an unusual case of an acute posterior spinal artery syndrome in a man in his 60s with vascular risk factors (Posterior spinal artery infarct - https://pn.bmj.com/content/23/2/160).

(1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital.
(2) Neurology Registrar, University Hospitals Sussex.
(3) Clinical Academic Fellow, Nuffield Department of Clinical Neurosciences, Oxford University, and Neurology Specialty registrar, Oxford University Hospital.

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this new series of the Practical Neurology pod…</itunes:subtitle>
      <description>In this new series of the Practical Neurology podcast, Professor Martin Turner (1) invites Dr Ruth Wood (2) and Dr Xin You Tai (3) to discuss the nitty-gritty details of two Case Reports from the latest issue of the Practical Neurology journal.

This month, they start by commenting on a case of a woman in her 70s with renal failure who developed confusion and seizures after receiving aciclovir, and was subsequently diagnosed with aciclovir-induced neurotoxicity (Aciclovir-induced neurotoxicity - https://pn.bmj.com/content/23/2/157).
They also talk (starting at 23:05) about an unusual case of an acute posterior spinal artery syndrome in a man in his 60s with vascular risk factors (Posterior spinal artery infarct - https://pn.bmj.com/content/23/2/160).

(1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital.
(2) Neurology Registrar, University Hospitals Sussex.
(3) Clinical Academic Fellow, Nuffield Department of Clinical Neurosciences, Oxford University, and Neurology Specialty registrar, Oxford University Hospital.

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</description>
      <enclosure length="43253759" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1506157867-bmjpodcasts-case-reports-explained-aciclovir-neurotoxicity-and-a-rare-posterior-spinal-artery-infarct.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-SndhyG01JN4l7Ret-oq9mrA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1514494804</guid>
      <title>MOGAD: Definition, diagnosis and treatment</title>
      <pubDate>Mon, 15 May 2023 11:15:11 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mogad-definition-diagnosis-and-treatment</link>
      <itunes:duration>00:21:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Matteo Gastaldi (2) about Myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD for short. A multi-centre retrospective study, "Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD", was recently published in JNNP, and Dr. Gastaldi is its first author. Listen to this podcast to learn what MOGAD is, its differential diagnosis and the potential pathogenesis. Plus some discussion of the use of MOG titres in predicting relapse of the disease. You can read the paper at the following link: https://jnnp.bmj.com/content/94/3/201

(1) Warren Alpert Medical School, Brown University, Rhode Island, USA
(2) Neuroimmunology Research Unit, IRCCS Mondino Foundation, Pavia, Italy 

Please subscribe to the show on Apple Podcasts (https://podcasts.apple.com/gb/podcast/jnnp-podcast/id426391174), Spotify (https://open.spotify.com/show/3VHlgiFD3LRw395wBB167T) or find it on your platform of choice. Your feedback and reviews are very appreciated.

Follow JNNP on twitter: https://twitter.com/jnnp_bmj</itunes:summary>
      <itunes:subtitle>In this episode, JNNP's new podcast host Dr. Saim…</itunes:subtitle>
      <description>In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Matteo Gastaldi (2) about Myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD for short. A multi-centre retrospective study, "Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD", was recently published in JNNP, and Dr. Gastaldi is its first author. Listen to this podcast to learn what MOGAD is, its differential diagnosis and the potential pathogenesis. Plus some discussion of the use of MOG titres in predicting relapse of the disease. You can read the paper at the following link: https://jnnp.bmj.com/content/94/3/201

(1) Warren Alpert Medical School, Brown University, Rhode Island, USA
(2) Neuroimmunology Research Unit, IRCCS Mondino Foundation, Pavia, Italy 

Please subscribe to the show on Apple Podcasts (https://podcasts.apple.com/gb/podcast/jnnp-podcast/id426391174), Spotify (https://open.spotify.com/show/3VHlgiFD3LRw395wBB167T) or find it on your platform of choice. Your feedback and reviews are very appreciated.

Follow JNNP on twitter: https://twitter.com/jnnp_bmj</description>
      <enclosure length="20424410" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1514494804-bmjpodcasts-mogad-definition-diagnosis-and-treatment.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-9pz06t2ByxonNrHD-1RSWWw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1484106469</guid>
      <title>Snoring</title>
      <pubDate>Tue, 09 May 2023 13:40:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/snoring</link>
      <itunes:duration>00:23:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Snoring is common. In the 30- to 35-year-old age group, 20% of men and 5% of women snore. By 60, 60% of men and 40% of women will snore habitually.

And snoring can affect the quality of life - of both the patient and their partner.

In this BMJ Best Practice podcast on snoring, Kieran Walsh talks with Dr Showkat Mirza, Consultant in Otorhinolaryngology and Head &amp; Neck Surgery, Sheffield Teaching Hospitals NHS Trust.

For more on snoring, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/1035

Competing interests: SM has no competing interests</itunes:summary>
      <itunes:subtitle>Snoring is common. In the 30- to 35-year-old age …</itunes:subtitle>
      <description>Snoring is common. In the 30- to 35-year-old age group, 20% of men and 5% of women snore. By 60, 60% of men and 40% of women will snore habitually.

And snoring can affect the quality of life - of both the patient and their partner.

In this BMJ Best Practice podcast on snoring, Kieran Walsh talks with Dr Showkat Mirza, Consultant in Otorhinolaryngology and Head &amp; Neck Surgery, Sheffield Teaching Hospitals NHS Trust.

For more on snoring, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/1035

Competing interests: SM has no competing interests</description>
      <enclosure length="22362860" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1484106469-bmjpodcasts-snoring.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-n60PM2czl9YNmony-9rnmoA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1510187110</guid>
      <title>Clots and complications - ADC Archimedes May 2023</title>
      <pubDate>Tue, 09 May 2023 12:31:07 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/clots-and-complications-adc-archimedes-may-2023</link>
      <itunes:duration>00:10:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>If you’ve ever wondered why tests sometimes don’t really work when you start using them then you’ll really want to listen to this episode .. or read this instead - https://adc.bmj.com/content/108/5/411.2 

Or maybe you’ve lain awake at night worrying about how common portal vein thrombosis is in neonates and what that might mean for the baby … again, you’ll really want to get your ears attached to this podcast and take a few minutes to admire the search strategy here - https://adc.bmj.com/content/108/5/411.1

We would love for you to be involved in Archi [adc.bmj.com/pages/authors/#archimedes] - just ask the questions that your patients are offering you.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>If you’ve ever wondered why tests sometimes don’t…</itunes:subtitle>
      <description>If you’ve ever wondered why tests sometimes don’t really work when you start using them then you’ll really want to listen to this episode .. or read this instead - https://adc.bmj.com/content/108/5/411.2 

Or maybe you’ve lain awake at night worrying about how common portal vein thrombosis is in neonates and what that might mean for the baby … again, you’ll really want to get your ears attached to this podcast and take a few minutes to admire the search strategy here - https://adc.bmj.com/content/108/5/411.1

We would love for you to be involved in Archi [adc.bmj.com/pages/authors/#archimedes] - just ask the questions that your patients are offering you.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="9928619" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1510187110-bmjpodcasts-clots-and-complications-adc-archimedes-may-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-lrX2nQhulEEywzcV-4qzg7w-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1505954626</guid>
      <title>Primary Prevention of Cardiovascular Disease in Women with a Mediterranean Diet</title>
      <pubDate>Tue, 09 May 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/primary-prevention-of-cardiovascular-disease-in-women-with-a-mediterranean-diet</link>
      <itunes:duration>00:15:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Sarah Zaman from the University of Sydney, Australia. They discuss her systematic review and meta-analysis of the effect of this diet specifically in women, something not previously studied. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2023/02/14/heartjnl-2022-321930</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Sarah Zaman from the University of Sydney, Australia. They discuss her systematic review and meta-analysis of the effect of this diet specifically in women, something not previously studied. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2023/02/14/heartjnl-2022-321930</description>
      <enclosure length="37351844" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1505954626-bmjpodcasts-primary-prevention-of-cardiovascular-disease-in-women-with-a-mediterranean-diet.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-AixmH23o82oKUNNM-m1MPbg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1509309796</guid>
      <title>Post-PARP Myeloid Neoplasms with Giuseppe Caruso</title>
      <pubDate>Mon, 08 May 2023 14:26:22 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/post-parp-myeloid-neoplasms-with-giuseppe-caruso</link>
      <itunes:duration>00:28:30</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso discuss post-PARP myeloid neoplasms. Dr. Caruso is a fifth-year resident in Obstetrics and Gynecology and a first-year fellow of the PhD in “Network Oncology and Precision Medicine” at Sapienza University of Rome in Italy. Over the past year, he has been attending the Department of Gynecologic Oncology at the European Institution of Oncology (Milan) under the mentorship of Professor Nicoletta Colombo and has now started his research fellowship period at Mayo Clinic (Rochester) under the supervision of Professor William Cliby. His main interest areas are gynecologic oncology, personalized oncology, and clinical research.

Highlights:

- Myeloid neoplasms post PARPi in patients with ovarian cancer are gradually emerging as life-threatening late toxicities and should not be underestimated.

- The first two years of PARPi exposure are the critical window of onset and persistent cytopenia has been recognized as an early warning sign.

- Active surveillance, differential diagnosis, and prompt hematological referral are crucial.

- PARPi are recommended in the first line also to improve the risk-benefit ratio.

- PARPi should be used cautiously in patients with a higher baseline risk and/or those who are less likely to have a significant benefit.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso discuss post-PARP myeloid neoplasms. Dr. Caruso is a fifth-year resident in Obstetrics and Gynecology and a first-year fellow of the PhD in “Network Oncology and Precision Medicine” at Sapienza University of Rome in Italy. Over the past year, he has been attending the Department of Gynecologic Oncology at the European Institution of Oncology (Milan) under the mentorship of Professor Nicoletta Colombo and has now started his research fellowship period at Mayo Clinic (Rochester) under the supervision of Professor William Cliby. His main interest areas are gynecologic oncology, personalized oncology, and clinical research.

Highlights:

- Myeloid neoplasms post PARPi in patients with ovarian cancer are gradually emerging as life-threatening late toxicities and should not be underestimated.

- The first two years of PARPi exposure are the critical window of onset and persistent cytopenia has been recognized as an early warning sign.

- Active surveillance, differential diagnosis, and prompt hematological referral are crucial.

- PARPi are recommended in the first line also to improve the risk-benefit ratio.

- PARPi should be used cautiously in patients with a higher baseline risk and/or those who are less likely to have a significant benefit.</description>
      <enclosure length="27217104" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1509309796-bmjpodcasts-post-parp-myeloid-neoplasms-with-giuseppe-caruso.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OllkYpFS3U1qGWWC-HM0hYQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1507371109</guid>
      <title>Talk Evidence - cloning, reporting, and disseminating</title>
      <pubDate>Fri, 05 May 2023 18:11:28 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-cloning-reporting-and-diseminating</link>
      <itunes:duration>00:47:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Helen Macdonald, Juan Franco, and Joe Ross are back with our monthly update on the world of evidence based medicine.

This episode delves into new methodologies which can use observational data to emulate trial data.  We discuss a new systematic review and meta-analysis of RCTs for surgical treatment of sciatica.  There is elaboration and explanation of the CONSORT Harms 2022 statement - and we'll be asking if it goes far enough. Finally, the old chestnut of surrogate endpoints in cancer treatment trials - are benefits communicated to patients accurately?

Reading list;
Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records - https://www.bmj.com/content/381/bmj-2022-073312

Surgical versus non-surgical treatment for sciatica
https://www.bmj.com/content/381/bmj-2022-070730


CONSORT Harms 2022 statement, explanation, and elaboration
https://www.bmj.com/content/381/bmj-2022-073725

Funders crack down on unpublished clinical trials—but is it enough?
https://www.bmj.com/content/381/bmj.p840

Communication of anticancer drug benefits and related uncertainties to patients and clinicians
https://www.bmj.com/content/380/bmj-2022-073711</itunes:summary>
      <itunes:subtitle>Helen Macdonald, Juan Franco, and Joe Ross are ba…</itunes:subtitle>
      <description>Helen Macdonald, Juan Franco, and Joe Ross are back with our monthly update on the world of evidence based medicine.

This episode delves into new methodologies which can use observational data to emulate trial data.  We discuss a new systematic review and meta-analysis of RCTs for surgical treatment of sciatica.  There is elaboration and explanation of the CONSORT Harms 2022 statement - and we'll be asking if it goes far enough. Finally, the old chestnut of surrogate endpoints in cancer treatment trials - are benefits communicated to patients accurately?

Reading list;
Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records - https://www.bmj.com/content/381/bmj-2022-073312

Surgical versus non-surgical treatment for sciatica
https://www.bmj.com/content/381/bmj-2022-070730


CONSORT Harms 2022 statement, explanation, and elaboration
https://www.bmj.com/content/381/bmj-2022-073725

Funders crack down on unpublished clinical trials—but is it enough?
https://www.bmj.com/content/381/bmj.p840

Communication of anticancer drug benefits and related uncertainties to patients and clinicians
https://www.bmj.com/content/380/bmj-2022-073711</description>
      <enclosure length="67637240" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1507371109-bmjpodcasts-talk-evidence-cloning-reporting-and-diseminating.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-G1o2BdD4ylHaKc6a-nny65g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1501554823</guid>
      <title>Counteracting the harm of dietary emulsifiers with Akkermansia muciniphila</title>
      <pubDate>Tue, 02 May 2023 04:00:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dietary-emulsifiers-and-akkermansia-muciniphila</link>
      <itunes:duration>00:15:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Benoit Chassaing, group leader from the “Mucosal microbiota in chronic inflammatory diseases” Team at INSERM and the Université Paris Cité, Paris, France, on the paper 'Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism' published in paper copy in Gut in May 2023 and available online: https://gut.bmj.com/content/72/5/906

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Benoit Chassaing, group leader from the “Mucosal microbiota in chronic inflammatory diseases” Team at INSERM and the Université Paris Cité, Paris, France, on the paper 'Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism' published in paper copy in Gut in May 2023 and available online: https://gut.bmj.com/content/72/5/906

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="14952070" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1501554823-bmjpodcasts-dietary-emulsifiers-and-akkermansia-muciniphila.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-6ZtYVmBPoEz7YPVq-JQErpA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1502109394</guid>
      <title>Minimally invasive endoscopic therapies for GORD</title>
      <pubDate>Tue, 02 May 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/minimally-invasive-endoscopic-therapies-for-gord</link>
      <itunes:duration>00:15:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this co-interview, both Dr Philip Smith, Deputy Editor of FG and Social Media Associate Editor and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, and Dr Vivek Goodoory, Frontline Gastroenterology trainee editor, Clinical Research Fellow and Registrar in Gastroenterology at Leeds Teaching Hospitals NHS Trust, interview Dr Nasar Aslam, Endoscopy Research fellow at University College London Hospitals NHS Foundation Trust, on the paper 'Minimally invasive endoscopic therapies for gastro-oesophageal reflux disease’, published in Frontline Gastroenterology: https://fg.bmj.com/content/14/3/249.

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>In this co-interview, both Dr Philip Smith, Deput…</itunes:subtitle>
      <description>In this co-interview, both Dr Philip Smith, Deputy Editor of FG and Social Media Associate Editor and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, and Dr Vivek Goodoory, Frontline Gastroenterology trainee editor, Clinical Research Fellow and Registrar in Gastroenterology at Leeds Teaching Hospitals NHS Trust, interview Dr Nasar Aslam, Endoscopy Research fellow at University College London Hospitals NHS Foundation Trust, on the paper 'Minimally invasive endoscopic therapies for gastro-oesophageal reflux disease’, published in Frontline Gastroenterology: https://fg.bmj.com/content/14/3/249.

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="14513631" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1502109394-bmjpodcasts-minimally-invasive-endoscopic-therapies-for-gord.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-LnNI4fr2B4Abf84I-OBjDRg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1500932509</guid>
      <title>Primary Survey - the highlights of May 2023</title>
      <pubDate>Tue, 02 May 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-may-2023</link>
      <itunes:duration>00:28:59</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Rick Body, University of Manchester and Manchester University NHS Foundation Trust, and Sarah Edwards, University Hospitals of Derby NHS Foundation Trust, cover the pick of the papers from EMJ's May 2023 issue. In this edition, we cover papers on shoulder dislocation, blunt chest trauma, uterine bleeding, medical errors, benign paroxysmal position vertigo, and calcium and QTc interval.

Read the highlights: https://emj.bmj.com/content/40/5/317

You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>Rick Body, University of Manchester and Mancheste…</itunes:subtitle>
      <description>Rick Body, University of Manchester and Manchester University NHS Foundation Trust, and Sarah Edwards, University Hospitals of Derby NHS Foundation Trust, cover the pick of the papers from EMJ's May 2023 issue. In this edition, we cover papers on shoulder dislocation, blunt chest trauma, uterine bleeding, medical errors, benign paroxysmal position vertigo, and calcium and QTc interval.

Read the highlights: https://emj.bmj.com/content/40/5/317

You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="27825213" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1500932509-bmjpodcasts-emj-may-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1501593889</guid>
      <title>ESGO-ESTRO-ESP Guidelines for Cervical Cancer 2023 with David Cibula</title>
      <pubDate>Mon, 01 May 2023 10:00:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/esgo-estro-esp-guidelines-for-cervical-cancer-2023-with-david-cibula</link>
      <itunes:duration>00:49:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. David Cibula to discuss the 2023 ESGO-ESTRO-ESP Guidelines for Cervical Cancer. Dr. Cibula is the Chair of the Department of Obstetrics and Gynecology at the General Faculty Hospital in Prague, Professor at the First Medical Faculty of the Charles University, Chair of the Central and Eastern European Gynaecologic Oncology Group (CEEGOG), member of the Strategic group of the ENGOT (European Network for Gynaecological Oncological Trial Groups) as well as a Former ESGO president.

 Highlights:

- Multidisciplinary clinical practice guidelines developed jointly by ESGO/ESTRO/ESP in the field of gynaecological oncology, radiation oncology and pathology.

- Guidelines cover the management of all stages of cervical cancer, including separate sections dedicated to pathology reporting and management in pregnancy.

- The guidelines include recommendations, algorithms, and summaries of recent evidence published as supplements.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. David Cibula to discuss the 2023 ESGO-ESTRO-ESP Guidelines for Cervical Cancer. Dr. Cibula is the Chair of the Department of Obstetrics and Gynecology at the General Faculty Hospital in Prague, Professor at the First Medical Faculty of the Charles University, Chair of the Central and Eastern European Gynaecologic Oncology Group (CEEGOG), member of the Strategic group of the ENGOT (European Network for Gynaecological Oncological Trial Groups) as well as a Former ESGO president.

 Highlights:

- Multidisciplinary clinical practice guidelines developed jointly by ESGO/ESTRO/ESP in the field of gynaecological oncology, radiation oncology and pathology.

- Guidelines cover the management of all stages of cervical cancer, including separate sections dedicated to pathology reporting and management in pregnancy.

- The guidelines include recommendations, algorithms, and summaries of recent evidence published as supplements.</description>
      <enclosure length="47202617" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1501593889-bmjpodcasts-esgo-estro-esp-guidelines-for-cervical-cancer-2023-with-david-cibula.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OllkYpFS3U1qGWWC-HM0hYQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1502155903</guid>
      <title>Using Nutrition to Optimize Performance with Dr. Stacy Sims. EP#530</title>
      <pubDate>Fri, 28 Apr 2023 13:17:38 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/using-nutrition-to-optimize-performance-with-dr-stacy-sims-ep530</link>
      <itunes:duration>00:16:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM (T: @TheAMSSM) Sports Medcast, host Dr. Jake Wessels, MD, is joined by Dr. Stacy Sims, MSc, PhD (Insta: @drstacysims), to discuss her upcoming lectures on how nutrition affects performance during the 2023 AMSSM Annual Meeting.

Dr. Sims is an international exercise physiologist and nutrition scientist. She has directed research programs at Stanford, AUT University, and the University of Waikato, focusing on female athlete health and performance and pushed to improve research on all women. Her contributions to the international research environment and the sports nutrition industry has established a new niche in sports nutrition; and established her reputation as the expert in sex differences in training, nutrition and health. Dr. Sims has published over 70 peer-reviewed papers and several books.

In this conversation, Dr. Sims addresses the following topics:
* How her athletic background impacted her journey into the field of nutrition and performance
* Sharing a starting point for medical professionals to think about optimizing nutrition for athletes
* Ways to encourage athletes to be aware of their nutrition and how to effectively structure training sessions and nutritional plans
* Her standard approach on supplementation and why less can often be more

Learn more about her work and publications on her website (drstacysims.com), and register to attend the 2023 AMSSM Annual Meeting in-person or virtually at annualmeeting.amssm.org.</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM (T: @TheAMSSM) Sport…</itunes:subtitle>
      <description>On this episode of the AMSSM (T: @TheAMSSM) Sports Medcast, host Dr. Jake Wessels, MD, is joined by Dr. Stacy Sims, MSc, PhD (Insta: @drstacysims), to discuss her upcoming lectures on how nutrition affects performance during the 2023 AMSSM Annual Meeting.

Dr. Sims is an international exercise physiologist and nutrition scientist. She has directed research programs at Stanford, AUT University, and the University of Waikato, focusing on female athlete health and performance and pushed to improve research on all women. Her contributions to the international research environment and the sports nutrition industry has established a new niche in sports nutrition; and established her reputation as the expert in sex differences in training, nutrition and health. Dr. Sims has published over 70 peer-reviewed papers and several books.

In this conversation, Dr. Sims addresses the following topics:
* How her athletic background impacted her journey into the field of nutrition and performance
* Sharing a starting point for medical professionals to think about optimizing nutrition for athletes
* Ways to encourage athletes to be aware of their nutrition and how to effectively structure training sessions and nutritional plans
* Her standard approach on supplementation and why less can often be more

Learn more about her work and publications on her website (drstacysims.com), and register to attend the 2023 AMSSM Annual Meeting in-person or virtually at annualmeeting.amssm.org.</description>
      <enclosure length="11418391" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1502155903-bmjpodcasts-using-nutrition-to-optimize-performance-with-dr-stacy-sims-ep530.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-eZ2wsyFXvC9BIO1y-5MTmkw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1496617885</guid>
      <title>May 2023 - another DTB celebration (or two), OACs and NSAIDs, and siRNA-based therapeutics</title>
      <pubDate>Fri, 28 Apr 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-may-2023</link>
      <itunes:duration>00:25:42</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the May 2023 issue of DTB. They celebrate 60 years since DTB became independent from The Medical Letter and discuss what DTB stands for (https://dtb.bmj.com/content/61/5/66). They review a retrospective cohort study involving people taking oral anticoagulants that compared the risk of bleeding and embolic events in new users of NSAIDs with those not prescribed NSAIDs (https://dtb.bmj.com/content/61/5/67). They also talk about the main review article that explores the therapeutics of siRNA medicines (https://dtb.bmj.com/content/61/5/72). They begin by discussing the UK Government’s recent Budget statement that the MHRA will introduce a new approval process for medicines that have been licensed elsewhere.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the May 2023 issue of DTB. They celebrate 60 years since DTB became independent from The Medical Letter and discuss what DTB stands for (https://dtb.bmj.com/content/61/5/66). They review a retrospective cohort study involving people taking oral anticoagulants that compared the risk of bleeding and embolic events in new users of NSAIDs with those not prescribed NSAIDs (https://dtb.bmj.com/content/61/5/67). They also talk about the main review article that explores the therapeutics of siRNA medicines (https://dtb.bmj.com/content/61/5/72). They begin by discussing the UK Government’s recent Budget statement that the MHRA will introduce a new approval process for medicines that have been licensed elsewhere.</description>
      <enclosure length="61690602" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1496617885-bmjpodcasts-dtb-may-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-cu976gE5p3f2Nwrn-liAj8g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1500789304</guid>
      <title>How good is a good enough doctor?</title>
      <pubDate>Thu, 27 Apr 2023 06:00:07 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/how-good-is-a-good-enough-doctor</link>
      <itunes:duration>00:41:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>When we think of being a ‘good enough’ medical student, our thoughts might go straight to exams. Have we passed them all? What about merits, or even distinctions? It’s easy to prioritise exam scores above all else as it is one of the only times we get clear, concrete feedback - or a number that tells us how ‘good’ we really are. 

But can exam results capture everything or is something missing here when we talk about being a ‘good enough’ medical student or doctor? Can written papers or practical exams like OSCEs ever really sum up whether we’ll be ‘good doctors’? And despite so much pressure to excel, do we really need doctors to be the best or do we need them to be good enough?

Expert guests:
Abi Rimmer is a news reporter and careers editor at The BMJ. She is responsible for the careers content and reports on workforce-related and NHS policy issues. She was also recently treated as a patient for stage III rectal cancer.  

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>When we think of being a ‘good enough’ medical st…</itunes:subtitle>
      <description>When we think of being a ‘good enough’ medical student, our thoughts might go straight to exams. Have we passed them all? What about merits, or even distinctions? It’s easy to prioritise exam scores above all else as it is one of the only times we get clear, concrete feedback - or a number that tells us how ‘good’ we really are. 

But can exam results capture everything or is something missing here when we talk about being a ‘good enough’ medical student or doctor? Can written papers or practical exams like OSCEs ever really sum up whether we’ll be ‘good doctors’? And despite so much pressure to excel, do we really need doctors to be the best or do we need them to be good enough?

Expert guests:
Abi Rimmer is a news reporter and careers editor at The BMJ. She is responsible for the careers content and reports on workforce-related and NHS policy issues. She was also recently treated as a patient for stage III rectal cancer.  

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="39866240" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1500789304-bmjpodcasts-how-good-is-a-good-enough-doctor.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-mC2vNor3DUtjCLzG-ZzBeAg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1500049990</guid>
      <title>Atoms: the highlights from the ADC May 2023</title>
      <pubDate>Tue, 25 Apr 2023 15:28:49 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-may-2023</link>
      <itunes:duration>00:11:59</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the May 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/5/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the May 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/5/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="11510594" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1500049990-bmjpodcasts-atoms-the-highlights-from-the-adc-may-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-kLlv8zTGLsUJHKA6-oCDiuQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1496565541</guid>
      <title>Percutaneous management of acute ischaemic stroke</title>
      <pubDate>Tue, 25 Apr 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/percutaneous-management-of-acute-ischaemic-stroke</link>
      <itunes:duration>00:27:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Helen Routledge from Worcester Royal Hospital, UK. They discuss all aspects of intervention for ischaemic stroke, including the workforce challenges in delivering this lifesaving therapy. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://heart.bmj.com/content/109/10/794</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Helen Routledge from Worcester Royal Hospital, UK. They discuss all aspects of intervention for ischaemic stroke, including the workforce challenges in delivering this lifesaving therapy. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://heart.bmj.com/content/109/10/794</description>
      <enclosure length="66191862" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1496565541-bmjpodcasts-percutaneous-management-of-acute-ischaemic-stroke.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-AixmH23o82oKUNNM-m1MPbg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1499104492</guid>
      <title>Adhesive capsulitis</title>
      <pubDate>Mon, 24 Apr 2023 10:23:11 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adhesive-capsulitis</link>
      <itunes:duration>00:17:53</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Adhesive capsulitis affects 2% to 5% of the population. It is slightly more common in women than in men, and is most common in people between the ages of 40 and 70.

And it can cause a range of problems - including pain, stiffness, and loss of function. So it is important that we get the diagnosis and management of this condition right.

To give us more details about this problem and what we can do about it, Kieran Walsh, Clinical Director at BMJ, speaks with Professor Lance LeClerc, Associate Professor of Orthopedic Surgery at Vanderbilt University Medical Centre in Nashville.  

For more on adhesive capsulitis, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/1043

Competing interests: None</itunes:summary>
      <itunes:subtitle>Adhesive capsulitis affects 2% to 5% of the popul…</itunes:subtitle>
      <description>Adhesive capsulitis affects 2% to 5% of the population. It is slightly more common in women than in men, and is most common in people between the ages of 40 and 70.

And it can cause a range of problems - including pain, stiffness, and loss of function. So it is important that we get the diagnosis and management of this condition right.

To give us more details about this problem and what we can do about it, Kieran Walsh, Clinical Director at BMJ, speaks with Professor Lance LeClerc, Associate Professor of Orthopedic Surgery at Vanderbilt University Medical Centre in Nashville.  

For more on adhesive capsulitis, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/1043

Competing interests: None</description>
      <enclosure length="21508322" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1499104492-bmjpodcasts-adhesive-capsulitis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-dl6QChK26uNnQ5Cz-2xHl4Q-t3000x3000.png"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1495683745</guid>
      <title>Back by Demand: Updates on PARPi Ovarian Cancer</title>
      <pubDate>Mon, 24 Apr 2023 10:00:16 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/back-by-demand-updates-on-parpi-ovarian-cancer</link>
      <itunes:duration>00:43:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso and Prof. Nicoletta Colombo to discuss updates on PARPi in ovarian cancer. Dr. Caruso is a fifth-year resident in Obstetrics and Gynecology and a first-year fellow of the PhD in “Network Oncology and Precision Medicine” at the Sapienza University of Rome in Italy. Over the past year, he has been attending the Department of Gynecologic Oncology at the European Institution of Oncology (Milan) and had the huge opportunity to follow the clinical, surgical and research activities of an international center of excellence, under the mentorship of Prof. Nicoletta Colombo and Prof. Giovanni D. Aletti. His main interest areas are gynecologic oncology, personalized oncology, clinical research, and medical writing. Prof. Nicoletta Colombo is Chair of Gynecology Program and Director of the Ovarian Cancer Centre at the European Institute of Oncology in Milan. Principal investigators of several international clinical trials and author of several publications, she was President of ESGO and Chair of the ESMO-ESGO-ESTRO Consensus Conference in endometrial cancer (2015) and the ESMO-ESGO Consensus Conference in ovarian Cancer (2018). In 2020, Prof. Colombo received the IGCS Lifetime Achievement Award in recognition of her work in gynecological oncology. 

Highlights:

- PARPi should be preferred in the upfront setting for both efficacy and safety reasons.

- Mutational status and platinum response are key factors for personalizing the maintenance treatment.

- Identifying better predictors of resistance to platinum and PARPi is an unmet need.

- PARPi combinations could become a strategy for overcoming PARPi resistance.

- The best treatment algorithm after PARPi progression needs prospective validation.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso and Prof. Nicoletta Colombo to discuss updates on PARPi in ovarian cancer. Dr. Caruso is a fifth-year resident in Obstetrics and Gynecology and a first-year fellow of the PhD in “Network Oncology and Precision Medicine” at the Sapienza University of Rome in Italy. Over the past year, he has been attending the Department of Gynecologic Oncology at the European Institution of Oncology (Milan) and had the huge opportunity to follow the clinical, surgical and research activities of an international center of excellence, under the mentorship of Prof. Nicoletta Colombo and Prof. Giovanni D. Aletti. His main interest areas are gynecologic oncology, personalized oncology, clinical research, and medical writing. Prof. Nicoletta Colombo is Chair of Gynecology Program and Director of the Ovarian Cancer Centre at the European Institute of Oncology in Milan. Principal investigators of several international clinical trials and author of several publications, she was President of ESGO and Chair of the ESMO-ESGO-ESTRO Consensus Conference in endometrial cancer (2015) and the ESMO-ESGO Consensus Conference in ovarian Cancer (2018). In 2020, Prof. Colombo received the IGCS Lifetime Achievement Award in recognition of her work in gynecological oncology. 

Highlights:

- PARPi should be preferred in the upfront setting for both efficacy and safety reasons.

- Mutational status and platinum response are key factors for personalizing the maintenance treatment.

- Identifying better predictors of resistance to platinum and PARPi is an unmet need.

- PARPi combinations could become a strategy for overcoming PARPi resistance.

- The best treatment algorithm after PARPi progression needs prospective validation.</description>
      <enclosure length="41421609" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1495683745-bmjpodcasts-back-by-demand-updates-on-parpi-ovarian-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1497699652</guid>
      <title>Addiction in doctors</title>
      <pubDate>Fri, 21 Apr 2023 16:46:29 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/addiction-in-doctors</link>
      <itunes:duration>00:59:11</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Everyone has coping mechanisms, but sometimes those ways of coping become problem behaviours - addictions.

In this episode of Doctor Informed, we're focussing on how to spot the signs that you may be sliding into addiction, how to have conversations with friends and colleagues if you worry about their behaviour, and how seeking treatment is the best way to avoid GMC scrutiny.

Joining Clara Munro are Liz Croton and Zaid Al-Najjar, GPs who work for NHS Practitioner health - a mental health and addiction service specifically for health professionals. They are also joined by Ruth Mayall, a retired consultant anaesthetist who has experienced addiction herself, and has contributed to the Association of Anaesthetists guidance on drug and alcohol abuse.

Some resources mentioned in the podcast;

NHS Practitioner Health
https://www.practitionerhealth.nhs.uk/

The Sick Doctor's Trust
http://sick-doctors-trust.co.uk/

British Doctors &amp; Dentists Group
https://www.bddg.org/

Substance use disorder in the anaesthetist
https://anaesthetists.org/Home/Resources-publications/Guidelines/Substance-use-disorder-in-the-anaesthetist

Substance abuse in anaesthetists
https://academic.oup.com/bjaed/article/16/7/236/2196385?login=false</itunes:summary>
      <itunes:subtitle>Everyone has coping mechanisms, but sometimes tho…</itunes:subtitle>
      <description>Everyone has coping mechanisms, but sometimes those ways of coping become problem behaviours - addictions.

In this episode of Doctor Informed, we're focussing on how to spot the signs that you may be sliding into addiction, how to have conversations with friends and colleagues if you worry about their behaviour, and how seeking treatment is the best way to avoid GMC scrutiny.

Joining Clara Munro are Liz Croton and Zaid Al-Najjar, GPs who work for NHS Practitioner health - a mental health and addiction service specifically for health professionals. They are also joined by Ruth Mayall, a retired consultant anaesthetist who has experienced addiction herself, and has contributed to the Association of Anaesthetists guidance on drug and alcohol abuse.

Some resources mentioned in the podcast;

NHS Practitioner Health
https://www.practitionerhealth.nhs.uk/

The Sick Doctor's Trust
http://sick-doctors-trust.co.uk/

British Doctors &amp; Dentists Group
https://www.bddg.org/

Substance use disorder in the anaesthetist
https://anaesthetists.org/Home/Resources-publications/Guidelines/Substance-use-disorder-in-the-anaesthetist

Substance abuse in anaesthetists
https://academic.oup.com/bjaed/article/16/7/236/2196385?login=false</description>
      <enclosure length="56827520" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1497699652-bmjpodcasts-addiction-in-doctors.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-83ATKykJ5trKalLu-Kyj0IQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1497594040</guid>
      <title>Examining Health Disparities in SEM with Drs. Megan Burleson and Katie Rizzone. EP#529</title>
      <pubDate>Fri, 21 Apr 2023 13:10:14 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/examining-health-disparities-in-sem-with-drs-megan-burleson-and-katie-rizzone-ep529</link>
      <itunes:duration>00:16:24</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM Sports Medcast, host Dr. Jake Wessels, MD, is joined by Dr. Katie Rizzone, MD, MPH, and Dr. Megan Burleson, DO, to discuss the upcoming 2023 Collaborative Research Network (CRN) Research Summit on Justice, Equity and Inclusion.

Dr. Burleson and Dr. Rizzone are members of Summit Planning Committee for the one-day conference, which takes place Friday, April 28, in Phoenix, AZ. This conference, will emphasize specific areas within sports and exercise medicine where health disparities have been previously identified or where they need to be further investigated. It will also highlight best practices for conducting meaningful research in the field of sports and exercise medicine through an equity lens.

In this conversation, they address the following topics and questions:
* Origin and mission of the Collaborative Research Network
* The primary aims of the 2023 CRN Research Summit
* The current lack of available research regarding health disparities and how this conference seeks to explore those topics
* Some of the potential outcomes and future research directions of the Summit, and why they will be based on the conversations that happen during the conference
* The inclusive nature and applicability of the Research Summit, especially for clinicians who are not heavily involved in research
* Some of the biggest surprises the organizers have experienced while preparing for the Research Summit and the biggest highlights to look forward to

In-person and virtual attendance options are still available for the summit. Find complete details about the Research Summit and register here: https://annualmeeting.amssm.org/researchsummit.php</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM Sports Medcast, host…</itunes:subtitle>
      <description>On this episode of the AMSSM Sports Medcast, host Dr. Jake Wessels, MD, is joined by Dr. Katie Rizzone, MD, MPH, and Dr. Megan Burleson, DO, to discuss the upcoming 2023 Collaborative Research Network (CRN) Research Summit on Justice, Equity and Inclusion.

Dr. Burleson and Dr. Rizzone are members of Summit Planning Committee for the one-day conference, which takes place Friday, April 28, in Phoenix, AZ. This conference, will emphasize specific areas within sports and exercise medicine where health disparities have been previously identified or where they need to be further investigated. It will also highlight best practices for conducting meaningful research in the field of sports and exercise medicine through an equity lens.

In this conversation, they address the following topics and questions:
* Origin and mission of the Collaborative Research Network
* The primary aims of the 2023 CRN Research Summit
* The current lack of available research regarding health disparities and how this conference seeks to explore those topics
* Some of the potential outcomes and future research directions of the Summit, and why they will be based on the conversations that happen during the conference
* The inclusive nature and applicability of the Research Summit, especially for clinicians who are not heavily involved in research
* Some of the biggest surprises the organizers have experienced while preparing for the Research Summit and the biggest highlights to look forward to

In-person and virtual attendance options are still available for the summit. Find complete details about the Research Summit and register here: https://annualmeeting.amssm.org/researchsummit.php</description>
      <enclosure length="10915120" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1497594040-bmjpodcasts-examining-health-disparities-in-sem-with-drs-megan-burleson-and-katie-rizzone-ep529.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-eZ2wsyFXvC9BIO1y-5MTmkw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1494851527</guid>
      <title>Smoking and vaping: policy and challenges with Nick Hopkinson</title>
      <pubDate>Wed, 19 Apr 2023 10:41:34 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/smoking-and-vaping-policy-and-challenges-with-nick-hopkinson</link>
      <itunes:duration>00:25:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Kate Diomede, social media editor at Thorax, is joined by Prof. Nick Hopkinson(1) to delve into the history of smoking policy in the UK, as well as detailing the lay of the land in current smoking-cessation practices, especially pertaining to vaping. 

Hear the previous discussion with Prof. Andrew Bush on recent developments in paediatric therapy: https://on.soundcloud.com/PY9Nz

(1) Prof. of Respiratory Medicine, Imperial College London,
Respiratory Consultant, Royal Brompton Hospital,
Associate Editor of Thorax,
Chair of ASH (Action on Smoking in Health) UK Charity
https://twitter.com/COPDdoc

Relevant papers and references:

Millennium cohort – child smoking uptake related to parents and peers smoking https://pubmed.ncbi.nlm.nih.gov/30442657/

Confirming the impact of standardised packaging
https://pubmed.ncbi.nlm.nih.gov/33093164/

Effectiveness of ban on smoking in cars with children
https://pubmed.ncbi.nlm.nih.gov/31988266/

Smoking and increased risk from COVID 
https://pubmed.ncbi.nlm.nih.gov/33402392/
https://pubmed.ncbi.nlm.nih.gov/34580193/

Javed Khan’s independent report commissioned by UK Govt: Making Smoking Obsolete
https://www.gov.uk/government/publications/the-khan-review-making-smoking-obsolete/making-smoking-obsolete-summary

Cochrane systematic review suggests vaping is more effective for smoking cessation than NRT
https://www.cochrane.org/CD010216/TOBACCO_can-electronic-cigarettes-help-people-stop-smoking-and-do-they-have-any-unwanted-effects-when-used

Recent evidence update on risk of vaping for OHID concludes, “vaping poses only a small fraction of the risks of smoking.” 
https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update/nicotine-vaping-in-england-2022-evidence-update-summary

NICE guidance on nicotine vapes to help smokers quit https://www.nice.org.uk/guidance/ng209/chapter/recommendations-on-treating-tobacco-dependence#stop-smoking-interventions

British Thoracic Society guidance on tobacco harm reduction
https://www.brit-thoracic.org.uk/document-library/governance-and-policy-documents/position-statements/tobacco-and-smoking-march-2020/

National Centre for Smoking Cessation Training
https://www.ncsct.co.uk/publication_Support_stop_vaping.php 

Cigarette Smoking: An Assessment of Tobacco's Global Environmental Footprint Across Its Entire Supply Chain
https://pubs.acs.org/doi/10.1021/acs.est.8b01533 

ASH: Use of e-cigarettes (vapes) among young people in Great Britain
https://ash.org.uk/uploads/Use-of-e-cigarettes-among-young-people-in-Great-Britain-2022.pdf

Competing interests: None declared.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.</itunes:summary>
      <itunes:subtitle>Dr. Kate Diomede, social media editor at Thorax, …</itunes:subtitle>
      <description>Dr. Kate Diomede, social media editor at Thorax, is joined by Prof. Nick Hopkinson(1) to delve into the history of smoking policy in the UK, as well as detailing the lay of the land in current smoking-cessation practices, especially pertaining to vaping. 

Hear the previous discussion with Prof. Andrew Bush on recent developments in paediatric therapy: https://on.soundcloud.com/PY9Nz

(1) Prof. of Respiratory Medicine, Imperial College London,
Respiratory Consultant, Royal Brompton Hospital,
Associate Editor of Thorax,
Chair of ASH (Action on Smoking in Health) UK Charity
https://twitter.com/COPDdoc

Relevant papers and references:

Millennium cohort – child smoking uptake related to parents and peers smoking https://pubmed.ncbi.nlm.nih.gov/30442657/

Confirming the impact of standardised packaging
https://pubmed.ncbi.nlm.nih.gov/33093164/

Effectiveness of ban on smoking in cars with children
https://pubmed.ncbi.nlm.nih.gov/31988266/

Smoking and increased risk from COVID 
https://pubmed.ncbi.nlm.nih.gov/33402392/
https://pubmed.ncbi.nlm.nih.gov/34580193/

Javed Khan’s independent report commissioned by UK Govt: Making Smoking Obsolete
https://www.gov.uk/government/publications/the-khan-review-making-smoking-obsolete/making-smoking-obsolete-summary

Cochrane systematic review suggests vaping is more effective for smoking cessation than NRT
https://www.cochrane.org/CD010216/TOBACCO_can-electronic-cigarettes-help-people-stop-smoking-and-do-they-have-any-unwanted-effects-when-used

Recent evidence update on risk of vaping for OHID concludes, “vaping poses only a small fraction of the risks of smoking.” 
https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update/nicotine-vaping-in-england-2022-evidence-update-summary

NICE guidance on nicotine vapes to help smokers quit https://www.nice.org.uk/guidance/ng209/chapter/recommendations-on-treating-tobacco-dependence#stop-smoking-interventions

British Thoracic Society guidance on tobacco harm reduction
https://www.brit-thoracic.org.uk/document-library/governance-and-policy-documents/position-statements/tobacco-and-smoking-march-2020/

National Centre for Smoking Cessation Training
https://www.ncsct.co.uk/publication_Support_stop_vaping.php 

Cigarette Smoking: An Assessment of Tobacco's Global Environmental Footprint Across Its Entire Supply Chain
https://pubs.acs.org/doi/10.1021/acs.est.8b01533 

ASH: Use of e-cigarettes (vapes) among young people in Great Britain
https://ash.org.uk/uploads/Use-of-e-cigarettes-among-young-people-in-Great-Britain-2022.pdf

Competing interests: None declared.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.</description>
      <enclosure length="24423443" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1494851527-bmjpodcasts-smoking-and-vaping-policy-and-challenges-with-nick-hopkinson.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OrdixQ8Emj6if3z1-OcSPLw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1495478830</guid>
      <title>Getting the joy back - With Claire Kaye</title>
      <pubDate>Tue, 18 Apr 2023 16:20:12 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/getting-the-joy-back-with-clare-kay</link>
      <itunes:duration>00:58:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This week, we're going to be returning to a guest we heard from a while ago - Claire Kaye. 

Claire was a GP before deciding to become a coach, and we found her way of thinking through our wants and needs so useful, we decided to invite her back. 

This week we're going to be talking about that holding onto that feeling of excitement you had at the beginning of your career, a feeling that's difficult to hold onto, as the pressures on general practice mount.

Our guest:
Claire Kaye, formerly a GP, is an executive coach. She specialises in career development.
Instagram: @drclairekayecoaching
LinkedIn: @drclairekaye
Website: www.drclairekaye.com</itunes:summary>
      <itunes:subtitle>This week, we're going to be returning to a guest…</itunes:subtitle>
      <description>This week, we're going to be returning to a guest we heard from a while ago - Claire Kaye. 

Claire was a GP before deciding to become a coach, and we found her way of thinking through our wants and needs so useful, we decided to invite her back. 

This week we're going to be talking about that holding onto that feeling of excitement you had at the beginning of your career, a feeling that's difficult to hold onto, as the pressures on general practice mount.

Our guest:
Claire Kaye, formerly a GP, is an executive coach. She specialises in career development.
Instagram: @drclairekayecoaching
LinkedIn: @drclairekaye
Website: www.drclairekaye.com</description>
      <enclosure length="84623638" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1495478830-bmjpodcasts-getting-the-joy-back-with-clare-kay.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-HEyCKuzc0vjfGQVF-laMLiQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1491477793</guid>
      <title>Toxic neuropathies: a practical approach</title>
      <pubDate>Tue, 18 Apr 2023 04:00:26 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/toxic-neuropathies-a-practical-approach</link>
      <itunes:duration>00:47:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Amy Ross Russell(1) is joined by a selection of the authors of "Toxic neuropathies; a practical approach", a review recently published in Practical Neurology. The guests, Dr. Duncan Smyth(2), Dr. Aisling Carr(3) and Prof. Michael Lunn(3), explain the background to these conditions and describe approaches to treatment and care of toxic neuropathy patients.

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/23/2/120) and the April print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-april-2023-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Dept. of Neurology, Wellington Hospital, Wellington, NZ
(3) MRC Centre for Neuromuscular Diseases, National Hospital for Neurology, University College London Hospitals, UK

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</itunes:summary>
      <itunes:subtitle>Dr. Amy Ross Russell(1) is joined by a selection …</itunes:subtitle>
      <description>Dr. Amy Ross Russell(1) is joined by a selection of the authors of "Toxic neuropathies; a practical approach", a review recently published in Practical Neurology. The guests, Dr. Duncan Smyth(2), Dr. Aisling Carr(3) and Prof. Michael Lunn(3), explain the background to these conditions and describe approaches to treatment and care of toxic neuropathy patients.

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/23/2/120) and the April print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-april-2023-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Dept. of Neurology, Wellington Hospital, Wellington, NZ
(3) MRC Centre for Neuromuscular Diseases, National Hospital for Neurology, University College London Hospitals, UK

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</description>
      <enclosure length="45691714" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1491477793-bmjpodcasts-toxic-neuropathies-a-practical-approach.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Qe4zpvM6eEObbHqB-ZnrPzg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1491836881</guid>
      <title>Intraoperative Imaging with OTL38 in Ovarian Cancer</title>
      <pubDate>Mon, 17 Apr 2023 10:00:16 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/intraoperative-imaging-with-otl38-in-ovarian-cancer</link>
      <itunes:duration>00:35:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Janos L. Tanyi to discuss intraoperative imaging with OTL38 in ovarian cancer. Dr. Tanyi is an associate professor in the Department of Obstetrics and Gynecology at The University of Pennsylvania. He developed an advanced immunotherapy program that allows patients’ own immune cells to recognize and kill their tumor; a gene-engineered T cell approach. Dr. Tanyi has a broad background in immunotherapy, cancer immunology, molecular genetics and clinical expertise in gynecologic oncology. He has the frontline experience in ovarian cancer immunotherapy as he is the primary PI for both the ovarian cancer vaccine and adoptive T cell transfer trials at University of Pennsylvania. At Penn, he has fostered the establishment of a rich translational research environment focused on ovarian cancer. Furthermore, Dr. Tanyi led the Phase 2 and 3 trials evaluating the efficacy and safety of Pafolacianine Sodium combined with intraoperative molecular imaging during cytoreductive surgery of ovarian cancer.

 Highlights:

- It is well known that the extent of residual disease after surgery is negatively correlated with patient survival in ovarian cancer. To achieve R0 complete cytoreduction remains the goal of surgery. In this phase III study, it was evaluated whether Cytalux, would identify cancer lesions not identified by the surgeon by white light visual inspection or palpation.

- During this phase 3 trial, one or more additional cancer lesions were identified in approximately 33% of patients using of Cytalux with near-infrared imaging which was not detected by white light visual inspection and manual palpation.

- The intraoperative use of Cytalux with near-infrared imaging can be a good adjunct to current surgical approaches in identifying additional cancer lesions during cytoreductive surgery.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Janos L. Tanyi to discuss intraoperative imaging with OTL38 in ovarian cancer. Dr. Tanyi is an associate professor in the Department of Obstetrics and Gynecology at The University of Pennsylvania. He developed an advanced immunotherapy program that allows patients’ own immune cells to recognize and kill their tumor; a gene-engineered T cell approach. Dr. Tanyi has a broad background in immunotherapy, cancer immunology, molecular genetics and clinical expertise in gynecologic oncology. He has the frontline experience in ovarian cancer immunotherapy as he is the primary PI for both the ovarian cancer vaccine and adoptive T cell transfer trials at University of Pennsylvania. At Penn, he has fostered the establishment of a rich translational research environment focused on ovarian cancer. Furthermore, Dr. Tanyi led the Phase 2 and 3 trials evaluating the efficacy and safety of Pafolacianine Sodium combined with intraoperative molecular imaging during cytoreductive surgery of ovarian cancer.

 Highlights:

- It is well known that the extent of residual disease after surgery is negatively correlated with patient survival in ovarian cancer. To achieve R0 complete cytoreduction remains the goal of surgery. In this phase III study, it was evaluated whether Cytalux, would identify cancer lesions not identified by the surgeon by white light visual inspection or palpation.

- During this phase 3 trial, one or more additional cancer lesions were identified in approximately 33% of patients using of Cytalux with near-infrared imaging which was not detected by white light visual inspection and manual palpation.

- The intraoperative use of Cytalux with near-infrared imaging can be a good adjunct to current surgical approaches in identifying additional cancer lesions during cytoreductive surgery.</description>
      <enclosure length="22242456" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1491836881-bmjpodcasts-intraoperative-imaging-with-otl38-in-ovarian-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1492525288</guid>
      <title>Carrot or Stick? Driving change to create safe sport spaces with Dr Erik Denison and Neil Hay EP#528</title>
      <pubDate>Fri, 14 Apr 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/carrot-or-stick-driving-change-to-create-safe-sport-spaces-with-dr-erik-denison-and-neil-hay-ep528</link>
      <itunes:duration>00:33:36</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, Brooke Patterson hosts Dr Erik Denison (PhD, Research Fellow Monash University) and Neil Hay (Rugby Victoria President) about a trial published in the BJSM which tested the effectiveness of an education program delivered by professional rugby players designed to stop homophobic language. They discuss openly and honestly the challenges in changing behaviour in community sport. It is not too often we get to chat to sports administrators more broadly about what is needed to drive change – whether it be related to health, safety, inclusion, or diversity. Should we be using the carrot or stick? What other strategies might work? What is your role as a clinician in creating a safe environment? 

https://bjsm.bmj.com/content/early/2023/02/09/bjsports-2022-105916
https://bjsm.bmj.com/content/early/2023/02/07/bjsports-2022-105917</itunes:summary>
      <itunes:subtitle>In this podcast, Brooke Patterson hosts Dr Erik D…</itunes:subtitle>
      <description>In this podcast, Brooke Patterson hosts Dr Erik Denison (PhD, Research Fellow Monash University) and Neil Hay (Rugby Victoria President) about a trial published in the BJSM which tested the effectiveness of an education program delivered by professional rugby players designed to stop homophobic language. They discuss openly and honestly the challenges in changing behaviour in community sport. It is not too often we get to chat to sports administrators more broadly about what is needed to drive change – whether it be related to health, safety, inclusion, or diversity. Should we be using the carrot or stick? What other strategies might work? What is your role as a clinician in creating a safe environment? 

https://bjsm.bmj.com/content/early/2023/02/09/bjsports-2022-105916
https://bjsm.bmj.com/content/early/2023/02/07/bjsports-2022-105917</description>
      <enclosure length="80639999" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1492525288-bmjpodcasts-carrot-or-stick-driving-change-to-create-safe-sport-spaces-with-dr-erik-denison-and-neil-hay-ep528.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1488155014</guid>
      <title>Is the grass greener elsewhere?</title>
      <pubDate>Thu, 13 Apr 2023 07:00:06 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/is-the-grass-greener-elsewhere</link>
      <itunes:duration>00:47:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Given the current working conditions in the UK, we’re hearing more and more stories of doctors moving abroad to practise medicine. However, this isn’t necessarily unusual. Doctors and other healthcare professionals from many different countries do often decide to get a taste for healthcare systems elsewhere either through short, temporary placements, or through a more permanent move! 

In today’s episode we’re going to be talking all about why students or junior doctors might be considering working abroad. We’ll also talk about the pros and cons of moving to a different country to work, and whether the grass really is greener on the other side. We’ll finish off by talking about the logistics of making such a move, and hear some top tips from our expert guest! 

Expert guests:
Dr Matt Morgan is an intensive care consultant, researcher, and author. He currently works in Perth, Western Australia. He is also a columnist for The BMJ and works with BMJ OnExamination.  

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Given the current working conditions in the UK, w…</itunes:subtitle>
      <description>Given the current working conditions in the UK, we’re hearing more and more stories of doctors moving abroad to practise medicine. However, this isn’t necessarily unusual. Doctors and other healthcare professionals from many different countries do often decide to get a taste for healthcare systems elsewhere either through short, temporary placements, or through a more permanent move! 

In today’s episode we’re going to be talking all about why students or junior doctors might be considering working abroad. We’ll also talk about the pros and cons of moving to a different country to work, and whether the grass really is greener on the other side. We’ll finish off by talking about the logistics of making such a move, and hear some top tips from our expert guest! 

Expert guests:
Dr Matt Morgan is an intensive care consultant, researcher, and author. He currently works in Perth, Western Australia. He is also a columnist for The BMJ and works with BMJ OnExamination.  

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="45617024" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1488155014-bmjpodcasts-is-the-grass-greener-elsewhere.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1489840786</guid>
      <title>ADC Fetal and Neonatal’s Fantoms. Highlights from the March 2023 issue</title>
      <pubDate>Tue, 11 Apr 2023 12:35:24 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adc-fantoms-march-2023</link>
      <itunes:duration>00:22:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the March 2023 issue. The Fantoms article: https://fn.bmj.com/content/108/2/95 

Additional links:
Caffeine Therapy for Apnea of Prematurity
https://www.nejm.org/doi/full/10.1056/nejmoa054065 

Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
https://jamanetwork.com/journals/jama/fullarticle/1104870 

Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
https://jamanetwork.com/journals/jama/fullarticle/1104865 

Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2617993

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>ADC Fetal and Neonatal’s Associate Editor, Jonath…</itunes:subtitle>
      <description>ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the March 2023 issue. The Fantoms article: https://fn.bmj.com/content/108/2/95 

Additional links:
Caffeine Therapy for Apnea of Prematurity
https://www.nejm.org/doi/full/10.1056/nejmoa054065 

Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
https://jamanetwork.com/journals/jama/fullarticle/1104870 

Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
https://jamanetwork.com/journals/jama/fullarticle/1104865 

Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2617993

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="21582575" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1489840786-bmjpodcasts-adc-fantoms-march-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-PDk0heSRM2lHslN5-fy94mA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1489722256</guid>
      <title>Gastro-oesophageal reflux disease (GORD)</title>
      <pubDate>Tue, 11 Apr 2023 08:44:19 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/gastro-oesophageal-reflux-disease-gord</link>
      <itunes:duration>00:29:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Gastro-oesophageal reflux disease (GORD) is a common condition that affects between 10% and 30% of people in developed countries.

There can be a range of complications from haemorrhage to stricture to Barrett's oesophagus. So it is important that we get the diagnosis and management of this condition right.

In this BMJ Best Practice podcast on GORD, Kieran Walsh talks with Dr Andres Carrion, Associate Professor of Clinical Medicine at The Division of Digestive Health and Liver Diseases in University of Miami Miller School of Medicine.

For more on GORD, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/82

Competing interests: None</itunes:summary>
      <itunes:subtitle>Gastro-oesophageal reflux disease (GORD) is a com…</itunes:subtitle>
      <description>Gastro-oesophageal reflux disease (GORD) is a common condition that affects between 10% and 30% of people in developed countries.

There can be a range of complications from haemorrhage to stricture to Barrett's oesophagus. So it is important that we get the diagnosis and management of this condition right.

In this BMJ Best Practice podcast on GORD, Kieran Walsh talks with Dr Andres Carrion, Associate Professor of Clinical Medicine at The Division of Digestive Health and Liver Diseases in University of Miami Miller School of Medicine.

For more on GORD, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/82

Competing interests: None</description>
      <enclosure length="35103597" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1489722256-bmjpodcasts-gastro-oesophageal-reflux-disease-gord.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-dl6QChK26uNnQ5Cz-2xHl4Q-t3000x3000.png"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1487067580</guid>
      <title>Remote detection of AF - what's acceptable to patients?</title>
      <pubDate>Tue, 11 Apr 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/remote-detection-of-af-whats-acceptable-to-patients</link>
      <itunes:duration>00:17:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Rachel M J van der Velden from Maastricht in The Netherlands. They discuss the use of mobile devices for detecting recurrences of AF in high-risk subjects and how acceptable this is to patients. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:

https://heart.bmj.com/content/109/1/26</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Rachel M J van der Velden from Maastricht in The Netherlands. They discuss the use of mobile devices for detecting recurrences of AF in high-risk subjects and how acceptable this is to patients. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:

https://heart.bmj.com/content/109/1/26</description>
      <enclosure length="41202668" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1487067580-bmjpodcasts-remote-detection-of-af-whats-acceptable-to-patients.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Xy3y1e3ydlFjQYaY-vPcZPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1485016537</guid>
      <title>Laura Chambers - Low-risk Population in Advanced Ovarian Cancer</title>
      <pubDate>Mon, 10 Apr 2023 10:00:06 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/laura-chambers-low-risk-pop-in-adv-ovarian-cancer-audio</link>
      <itunes:duration>00:46:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Laura Chambers to discuss the low-risk population in advanced ovarian cancer. Laura Chambers, DO is an Assistant Professor in the Division of Gynecologic Oncology at The James Cancer Center at The Ohio State University.

Highlights:

- Discuss historical perspectives of low and high-risk ovarian cancer, and how this has been analyzed in contemporary trials

- Review of contemporary trials for PARPi and Bevacizumab maintenance in women with advanced ovarian cancer

- Data obtained through un-powered sub-analysis from randomized clinical trials is hypothesis generating and care must be exercised in applying this to patient cohorts</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Laura Chambers to discuss the low-risk population in advanced ovarian cancer. Laura Chambers, DO is an Assistant Professor in the Division of Gynecologic Oncology at The James Cancer Center at The Ohio State University.

Highlights:

- Discuss historical perspectives of low and high-risk ovarian cancer, and how this has been analyzed in contemporary trials

- Review of contemporary trials for PARPi and Bevacizumab maintenance in women with advanced ovarian cancer

- Data obtained through un-powered sub-analysis from randomized clinical trials is hypothesis generating and care must be exercised in applying this to patient cohorts</description>
      <enclosure length="44286142" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1485016537-bmjpodcasts-laura-chambers-low-risk-pop-in-adv-ovarian-cancer-audio.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1484350831</guid>
      <title>Reviewing the March Special Issue with Giulio Bonaldo and Jennifer  Davies-Oliveira</title>
      <pubDate>Thu, 06 Apr 2023 10:00:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reviewing-the-march-special-issue-with-giulio-bonaldo-and-jennifer-davies-oliveira</link>
      <itunes:duration>00:22:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC Podcast, Editorial Fellows, Giulio Bonaldo and Jennifer Davies-Oliveira, discuss the contents of the March Special issue of IJGC.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC Podcast, Editorial Fe…</itunes:subtitle>
      <description>In this episode of the IJGC Podcast, Editorial Fellows, Giulio Bonaldo and Jennifer Davies-Oliveira, discuss the contents of the March Special issue of IJGC.</description>
      <enclosure length="36201552" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1484350831-bmjpodcasts-reviewing-the-march-special-issue-with-giulio-bonaldo-and-jennifer-davies-oliveira.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1484348485</guid>
      <title>Reviewing the February Issue with Núria Agustí and Ryan Kahn</title>
      <pubDate>Tue, 04 Apr 2023 10:00:27 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reviewing-the-february-issue-with-nuria-agusti-and-ryan-kahn</link>
      <itunes:duration>00:16:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC Podcast, Editorial Fellows, Núria Agustí and Ryan Kahn, discuss the contents of the February issue of IJGC.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC Podcast, Editorial Fe…</itunes:subtitle>
      <description>In this episode of the IJGC Podcast, Editorial Fellows, Núria Agustí and Ryan Kahn, discuss the contents of the February issue of IJGC.</description>
      <enclosure length="21666536" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1484348485-bmjpodcasts-reviewing-the-february-issue-with-nuria-agusti-and-ryan-kahn.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1474578352</guid>
      <title>When should you take antihypertensive medication. Prescribing for skin conditions in pregnancy</title>
      <pubDate>Tue, 04 Apr 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-april-2023</link>
      <itunes:duration>00:21:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the April 2023 issue of DTB. They discuss evidence around morning and evening doses of antihypertensive medication (https://dtb.bmj.com/content/61/4/50). They review a study that analysed health technology assessment decisions made in Australia, Canada and England (https://dtb.bmj.com/content/61/4/51) and also talk about managing skin conditions in women who are planning pregnancy or who are pregnant (https://dtb.bmj.com/content/61/4/55). They begin by responding to a listener's letter about last month's podcast.

The Prescribing for pregnancy series of articles can be found here: https://dtb.bmj.com/pages/prescribing-for-pregnancy-series/</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the April 2023 issue of DTB. They discuss evidence around morning and evening doses of antihypertensive medication (https://dtb.bmj.com/content/61/4/50). They review a study that analysed health technology assessment decisions made in Australia, Canada and England (https://dtb.bmj.com/content/61/4/51) and also talk about managing skin conditions in women who are planning pregnancy or who are pregnant (https://dtb.bmj.com/content/61/4/55). They begin by responding to a listener's letter about last month's podcast.

The Prescribing for pregnancy series of articles can be found here: https://dtb.bmj.com/pages/prescribing-for-pregnancy-series/</description>
      <enclosure length="50781292" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1474578352-bmjpodcasts-dtb-april-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Cl3ATBXNl3Qnbrqh-zfdELQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1482044800</guid>
      <title>Updates on PARPi in Ovarian Cancer</title>
      <pubDate>Mon, 03 Apr 2023 10:00:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/updates-on-parpi-in-ovarian-cancer</link>
      <itunes:duration>00:43:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso and Prof. Nicoletta Colombo to discuss updates on PARPi in ovarian cancer. Dr. Caruso is a fifth-year resident in Obstetrics and Gynecology and a first-year fellow of the PhD in “Network Oncology and Precision Medicine” at the Sapienza University of Rome in Italy. Over the past year, he has been attending the Department of Gynecologic Oncology at the European Institution of Oncology (Milan) and had the huge opportunity to follow the clinical, surgical and research activities of an international center of excellence, under the mentorship of Prof. Nicoletta Colombo and Prof. Giovanni D. Aletti. His main interest areas are gynecologic oncology, personalized oncology, clinical research, and medical writing. 

 Prof. Nicoletta Colombo is Chair of Gynecology Program and Director of the Ovarian Cancer Centre at the European Institute of Oncology in Milan. Principal investigators of several international clinical trials and author of several publications, she was President of ESGO and Chair of the ESMO-ESGO-ESTRO Consensus Conference in endometrial cancer (2015) and the ESMO-ESGO Consensus Conference in ovarian Cancer (2018). In 2020, Prof. Colombo received the IGCS Lifetime Achievement Award in recognition of her work in gynecological oncology.

Highlights:

- PARPi should be preferred in the upfront setting for both efficacy and safety reasons.

- Mutational status and platinum response are key factors for personalizing the maintenance treatment.

- Identifying better predictors of resistance to platinum and PARPi is an unmet need.

- PARPi combinations could become a strategy for overcoming PARPi resistance.

- The best treatment algorithm after PARPi progression needs prospective validation.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso and Prof. Nicoletta Colombo to discuss updates on PARPi in ovarian cancer. Dr. Caruso is a fifth-year resident in Obstetrics and Gynecology and a first-year fellow of the PhD in “Network Oncology and Precision Medicine” at the Sapienza University of Rome in Italy. Over the past year, he has been attending the Department of Gynecologic Oncology at the European Institution of Oncology (Milan) and had the huge opportunity to follow the clinical, surgical and research activities of an international center of excellence, under the mentorship of Prof. Nicoletta Colombo and Prof. Giovanni D. Aletti. His main interest areas are gynecologic oncology, personalized oncology, clinical research, and medical writing. 

 Prof. Nicoletta Colombo is Chair of Gynecology Program and Director of the Ovarian Cancer Centre at the European Institute of Oncology in Milan. Principal investigators of several international clinical trials and author of several publications, she was President of ESGO and Chair of the ESMO-ESGO-ESTRO Consensus Conference in endometrial cancer (2015) and the ESMO-ESGO Consensus Conference in ovarian Cancer (2018). In 2020, Prof. Colombo received the IGCS Lifetime Achievement Award in recognition of her work in gynecological oncology.

Highlights:

- PARPi should be preferred in the upfront setting for both efficacy and safety reasons.

- Mutational status and platinum response are key factors for personalizing the maintenance treatment.

- Identifying better predictors of resistance to platinum and PARPi is an unmet need.

- PARPi combinations could become a strategy for overcoming PARPi resistance.

- The best treatment algorithm after PARPi progression needs prospective validation.</description>
      <enclosure length="41421609" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1482044800-bmjpodcasts-updates-on-parpi-in-ovarian-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1484216029</guid>
      <title>Straightening the curves - ADC Archimedes April 2023</title>
      <pubDate>Mon, 03 Apr 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/straightening-the-curves-adc-archimedes-april-2023</link>
      <itunes:duration>00:10:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A patient and their family will often ask the most sensible, thoughtful questions and we’ll head to the evidence to find that research doesn’t quite fit the bill. We discuss this in both the abstract ‘what’s the methodological issues here’ bit of Achimedes (https://adc.bmj.com/content/108/4/323.2) and bring it to life via our case of the specialist core exercises system (https://adc.bmj.com/content/108/4/323.1). Have a listen and find out more.

We would love for you to be involved in Archi [adc.bmj.com/pages/authors/#archimedes] - just ask the questions that your patients are offering you.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>A patient and their family will often ask the mos…</itunes:subtitle>
      <description>A patient and their family will often ask the most sensible, thoughtful questions and we’ll head to the evidence to find that research doesn’t quite fit the bill. We discuss this in both the abstract ‘what’s the methodological issues here’ bit of Achimedes (https://adc.bmj.com/content/108/4/323.2) and bring it to life via our case of the specialist core exercises system (https://adc.bmj.com/content/108/4/323.1). Have a listen and find out more.

We would love for you to be involved in Archi [adc.bmj.com/pages/authors/#archimedes] - just ask the questions that your patients are offering you.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="9608462" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1484216029-bmjpodcasts-straightening-the-curves-adc-archimedes-april-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-oQU0PHynaPo6xAa8-yS3S9w-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1481000683</guid>
      <title>Talk Evidence - automatic approval, evidence apps, and pay for performance data</title>
      <pubDate>Fri, 31 Mar 2023 21:00:07 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-automatic-approval-evidence-apps-and-pay-for-performance-data</link>
      <itunes:duration>00:39:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this month’s Talk Evidence, Helen Macdonald, Juan Franco and Joseph Ross are back to talk us through some of the latest research, 

They’ll talk about pay-for-perfomance schemes, and whether the data they routinely collect is measuring outcomes or  tickboxes. They’ll also talk about a new analysis published on bmj.com which suggests ways in which that data could be better.


We’re also by Huseyin Naci, associate professor of health policy at the London School of Economics and Political Science, who will tell us about proposed changes to drug regulation in the UK - and we discuss research which has linked speedier regulatory approval to more adverse advents in post marketing studies.

Finally, we talk about point of care apps. The availability of medical information in the clinic has changed practice, but how good is that information? We hear about research which has evaluated those point of care apps (including BMJ’s Best Practice app) and rates them against different criteria.


Reading list

Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland 
https://www.bmj.com/content/380/bmj-2022-072098
How can we improve the quality of data collected in general practice?
https://www.bmj.com/content/380/bmj-2022-071950#


UK to give “near automatic sign off” for treatments approved by “trusted” regulators
https://www.bmj.com/content/380/bmj.p633


Smartphone apps for point-of-care information summaries
https://ebm.bmj.com/content/early/2023/03/14/bmjebm-2022-112146</itunes:summary>
      <itunes:subtitle>In this month’s Talk Evidence, Helen Macdonald, J…</itunes:subtitle>
      <description>In this month’s Talk Evidence, Helen Macdonald, Juan Franco and Joseph Ross are back to talk us through some of the latest research, 

They’ll talk about pay-for-perfomance schemes, and whether the data they routinely collect is measuring outcomes or  tickboxes. They’ll also talk about a new analysis published on bmj.com which suggests ways in which that data could be better.


We’re also by Huseyin Naci, associate professor of health policy at the London School of Economics and Political Science, who will tell us about proposed changes to drug regulation in the UK - and we discuss research which has linked speedier regulatory approval to more adverse advents in post marketing studies.

Finally, we talk about point of care apps. The availability of medical information in the clinic has changed practice, but how good is that information? We hear about research which has evaluated those point of care apps (including BMJ’s Best Practice app) and rates them against different criteria.


Reading list

Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland 
https://www.bmj.com/content/380/bmj-2022-072098
How can we improve the quality of data collected in general practice?
https://www.bmj.com/content/380/bmj-2022-071950#


UK to give “near automatic sign off” for treatments approved by “trusted” regulators
https://www.bmj.com/content/380/bmj.p633


Smartphone apps for point-of-care information summaries
https://ebm.bmj.com/content/early/2023/03/14/bmjebm-2022-112146</description>
      <enclosure length="56844994" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1481000683-bmjpodcasts-talk-evidence-automatic-approval-evidence-apps-and-pay-for-performance-data.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-CSg4F6Zi1aMOEbTy-tgfxkw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1480654396</guid>
      <title>Primary Survey - the highlights of April 2023</title>
      <pubDate>Fri, 31 Mar 2023 15:02:11 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-april-2023</link>
      <itunes:duration>00:32:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A summary of some of the best paper we published in the April 2023 issue of the Emergency Medicine Journal. Rick and Sarah talk through topics including the impact of emergency physician gender on the outcomes of patients with early pregnancy loss; major trauma centre care for patients with low velocity trauma; the development of a new checklist for emergency paediatric intubation; the effect of head-up position on intubation success in the Emergency Department; and spiking by injection in the ED. One great feature of this month's papers is that there is so much that's immediately relevant to our clinical practice.
Read the highlights: https://emj.bmj.com/content/40/4/239
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>A summary of some of the best paper we published …</itunes:subtitle>
      <description>A summary of some of the best paper we published in the April 2023 issue of the Emergency Medicine Journal. Rick and Sarah talk through topics including the impact of emergency physician gender on the outcomes of patients with early pregnancy loss; major trauma centre care for patients with low velocity trauma; the development of a new checklist for emergency paediatric intubation; the effect of head-up position on intubation success in the Emergency Department; and spiking by injection in the ED. One great feature of this month's papers is that there is so much that's immediately relevant to our clinical practice.
Read the highlights: https://emj.bmj.com/content/40/4/239
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="30730030" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1480654396-bmjpodcasts-emj-april-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1480645531</guid>
      <title>Gender disparities in industry compensation and research payments</title>
      <pubDate>Fri, 31 Mar 2023 11:39:15 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/gender-disparities-in-industry-compensation-and-research-payments</link>
      <itunes:duration>00:16:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Mariam Kyarunts(1) and Charlotte Michaelcheck(2), contributing authors to the recently published article "Gender disparities in industry compensation and research payments among neurointerventional surgeons in the USA" - https://jnis.bmj.com/content/early/2023/01/23/jnis-2022-019921

This paper is free-to-access for a month following the publication of this podcast. 

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was edited by Brian O'Toole.

(1)Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
(2)Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA</itunes:summary>
      <itunes:subtitle>In this podcast, JNIS Editor-in-Chief, Dr. Felipe…</itunes:subtitle>
      <description>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Mariam Kyarunts(1) and Charlotte Michaelcheck(2), contributing authors to the recently published article "Gender disparities in industry compensation and research payments among neurointerventional surgeons in the USA" - https://jnis.bmj.com/content/early/2023/01/23/jnis-2022-019921

This paper is free-to-access for a month following the publication of this podcast. 

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was edited by Brian O'Toole.

(1)Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
(2)Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA</description>
      <enclosure length="15426036" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1480645531-bmjpodcasts-gender-disparities-in-industry-compensation-and-research-payments.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1480257265</guid>
      <title>How do I choose a specialty?</title>
      <pubDate>Thu, 30 Mar 2023 06:30:08 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/how-do-i-choose-a-specialty</link>
      <itunes:duration>00:44:42</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>From the moment you start medical school, you’re asked the same question - ‘what kind of doctor are you going to be?’. Whilst some know from the very beginning that they’re going to be a surgeon or a paediatrician or a GP, others have no idea. 

The reality of choosing a specialty can be really difficult. In this episode, we talk about the common worries that medical students or junior doctors might have when it comes to choosing a specialty. We’ll also discuss some steps we can take to make that process a little easier. 

Expert guests:
Heather Samuel is a professionally qualified careers adviser with over 30 years experience, spending the last 15 years specialising in working with doctors from F1 to CCT and beyond. She now works on a freelance basis for the NHS and with schools.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>From the moment you start medical school, you’re …</itunes:subtitle>
      <description>From the moment you start medical school, you’re asked the same question - ‘what kind of doctor are you going to be?’. Whilst some know from the very beginning that they’re going to be a surgeon or a paediatrician or a GP, others have no idea. 

The reality of choosing a specialty can be really difficult. In this episode, we talk about the common worries that medical students or junior doctors might have when it comes to choosing a specialty. We’ll also discuss some steps we can take to make that process a little easier. 

Expert guests:
Heather Samuel is a professionally qualified careers adviser with over 30 years experience, spending the last 15 years specialising in working with doctors from F1 to CCT and beyond. She now works on a freelance basis for the NHS and with schools.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="42924416" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1480257265-bmjpodcasts-how-do-i-choose-a-specialty.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1475903425</guid>
      <title>Individualised consent for endoscopy: update on the 2016 BSG guidelines</title>
      <pubDate>Thu, 30 Mar 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/individualised-consent-for-endoscopy-update-on-the-2016-bsg-guidelines</link>
      <itunes:duration>00:30:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Deputy Editor of FG and Social Media Associate Editor and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Simon Everett, Consultant Gastroenterologist at Leeds Teaching Hospitals NHS Trust, Leeds, UK and BSG ERCP and EUS Quality improvement Lead, on the paper 'Individualised consent for endoscopy: update on the 2016 BSG guidelines’ published online in Frontline Gastroenterology in February 2023: https://fg.bmj.com/content/early/2023/02/07/flgastro-2022-102353

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Deputy Editor of FG and Social M…</itunes:subtitle>
      <description>Dr Philip Smith, Deputy Editor of FG and Social Media Associate Editor and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Simon Everett, Consultant Gastroenterologist at Leeds Teaching Hospitals NHS Trust, Leeds, UK and BSG ERCP and EUS Quality improvement Lead, on the paper 'Individualised consent for endoscopy: update on the 2016 BSG guidelines’ published online in Frontline Gastroenterology in February 2023: https://fg.bmj.com/content/early/2023/02/07/flgastro-2022-102353

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="29715643" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1475903425-bmjpodcasts-individualised-consent-for-endoscopy-update-on-the-2016-bsg-guidelines.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1475087575</guid>
      <title>Antibiotic use as a risk factor for IBD</title>
      <pubDate>Thu, 30 Mar 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/antibiotic-use-as-a-risk-factor-for-ibd</link>
      <itunes:duration>00:17:48</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Tine Jess, from the Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, and Department of Gastroenterology and Hepatology, Aalborg University, Aalborg, Denmark, and Dr Adam S Faye, from the Department of Medicine and Population Health, New York University Langone Health, New York, USA, on the paper 'Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study' published in paper copy in Gut in April 2023 and published online: https://gut.bmj.com/content/72/4/663

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Tine Jess, from the Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, and Department of Gastroenterology and Hepatology, Aalborg University, Aalborg, Denmark, and Dr Adam S Faye, from the Department of Medicine and Population Health, New York University Langone Health, New York, USA, on the paper 'Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study' published in paper copy in Gut in April 2023 and published online: https://gut.bmj.com/content/72/4/663

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="17095783" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1475087575-bmjpodcasts-antibiotic-use-as-a-risk-factor-for-ibd.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1479588700</guid>
      <title>Age-related macular degeneration: an update on diagnosis and management</title>
      <pubDate>Tue, 28 Mar 2023 15:35:27 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/age-related-macular-degeneration-an-update-on-diagnosis-and-management</link>
      <itunes:duration>00:25:37</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Age-related macular degeneration is the third most common cause of visual impairment worldwide. The main risk is advanced disease and resultant visual loss.

Prompt diagnosis and treatment can make a big difference to the outcome - so it is vital that we get the diagnosis and management of this condition right.

In this BMJ Best Practice podcast on macular degeneration, Kieran Walsh talks with Dr. Sajjad Mahmood, Consultant Ophthalmic Surgeon, Medical Retina Specialist, and Honorary Clinical Lecturer at the University of Manchester.

For more on age-related macular degeneration, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/554

Competing interests: SM has done consultancy work and received honoraria for lecturing and travel from Bayer Pharmaceuticals and Novartis. He has also been a principal investigator for clinical trials on behalf of Bayer, Novartis, and Roche.</itunes:summary>
      <itunes:subtitle>Age-related macular degeneration is the third mos…</itunes:subtitle>
      <description>Age-related macular degeneration is the third most common cause of visual impairment worldwide. The main risk is advanced disease and resultant visual loss.

Prompt diagnosis and treatment can make a big difference to the outcome - so it is vital that we get the diagnosis and management of this condition right.

In this BMJ Best Practice podcast on macular degeneration, Kieran Walsh talks with Dr. Sajjad Mahmood, Consultant Ophthalmic Surgeon, Medical Retina Specialist, and Honorary Clinical Lecturer at the University of Manchester.

For more on age-related macular degeneration, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/554

Competing interests: SM has done consultancy work and received honoraria for lecturing and travel from Bayer Pharmaceuticals and Novartis. He has also been a principal investigator for clinical trials on behalf of Bayer, Novartis, and Roche.</description>
      <enclosure length="30743776" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1479588700-bmjpodcasts-age-related-macular-degeneration-an-update-on-diagnosis-and-management.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-n60PM2czl9YNmony-9rnmoA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1476272647</guid>
      <title>INOCA and MINOCA with Dr. C Noel Bairey Merz</title>
      <pubDate>Tue, 28 Mar 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/inoca-and-minoca-with-dr-c-noel-bairey-merz</link>
      <itunes:duration>00:15:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Andrew Perry visits Dr. Bairey Merz to discuss the diagnosis and management of INOCA and MINOCA. Dr. Bairey Merz spoke on this topic at the American College of Cardiology Scientific Sessions in March 2023. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/104/4/284</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Andrew Perr…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Andrew Perry visits Dr. Bairey Merz to discuss the diagnosis and management of INOCA and MINOCA. Dr. Bairey Merz spoke on this topic at the American College of Cardiology Scientific Sessions in March 2023. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/104/4/284</description>
      <enclosure length="36894504" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1476272647-bmjpodcasts-inoca-and-minoca-with-dr-c-noel-bairey-merz.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Xy3y1e3ydlFjQYaY-vPcZPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1478609128</guid>
      <title>Antidepressant withdrawal with Tony Kendrick and Mark Horowitz</title>
      <pubDate>Mon, 27 Mar 2023 13:38:45 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/antidepressant-withdrawal-with-tony-kendrick-and-mark-horowitz</link>
      <itunes:duration>00:51:36</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The theory that depression is caused by serotonin deficiency has become embedded in our practice over the years, and can be a persuasive explanation of the condition for patients considering starting antidepressants. We talk to Tony Kendrick about the evidence (or lack thereof) to support this hypothesis, and what that means for the efficacy of antidepressants, particularly SSRIs. Later on, we speak to Mark Horowitz to discuss how to come off antidepressants safely, and manage withdrawal symptoms, and how to advise and support our patients as they gradually reduce, then stop, their medication. 


Our guests:

Tony Kendrick is a retired GP, and NICE committee member for the 2022 guideline update on depression in adults. He is also a professor of Primary Medical Care at the University of Southampton.

Mark Horowitz is a training psychiatrist, working as a clinical research fellow at North East NHS Trust, and as an honorary clinical research fellow at UCL, he is also the co-founder of outro.com.


Further reading:

‘Antidepressants and the serotonin hypothesis of depression’. BMJ 2022;378:o1993 https://www.bmj.com/content/378/bmj.o1993

‘Stopping antidepressants’. Royal College of Psychiatrists. 2020. https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants</itunes:summary>
      <itunes:subtitle>The theory that depression is caused by serotonin…</itunes:subtitle>
      <description>The theory that depression is caused by serotonin deficiency has become embedded in our practice over the years, and can be a persuasive explanation of the condition for patients considering starting antidepressants. We talk to Tony Kendrick about the evidence (or lack thereof) to support this hypothesis, and what that means for the efficacy of antidepressants, particularly SSRIs. Later on, we speak to Mark Horowitz to discuss how to come off antidepressants safely, and manage withdrawal symptoms, and how to advise and support our patients as they gradually reduce, then stop, their medication. 


Our guests:

Tony Kendrick is a retired GP, and NICE committee member for the 2022 guideline update on depression in adults. He is also a professor of Primary Medical Care at the University of Southampton.

Mark Horowitz is a training psychiatrist, working as a clinical research fellow at North East NHS Trust, and as an honorary clinical research fellow at UCL, he is also the co-founder of outro.com.


Further reading:

‘Antidepressants and the serotonin hypothesis of depression’. BMJ 2022;378:o1993 https://www.bmj.com/content/378/bmj.o1993

‘Stopping antidepressants’. Royal College of Psychiatrists. 2020. https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants</description>
      <enclosure length="61930495" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1478609128-bmjpodcasts-antidepressant-withdrawal-with-tony-kendrick-and-mark-horowitz.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8i9LTpkaLEKQ3DNF-EFzLHw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1475909608</guid>
      <title>KELIM Validation: GOG 218 with Benoit You</title>
      <pubDate>Mon, 27 Mar 2023 10:00:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/kelim-validation-gog-218-with-benoit-you</link>
      <itunes:duration>00:32:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Benoit You to discuss KELIM validation. Dr. You is a French medical oncologist at Lyon University Hospital, specialized in gynecological cancers, and the head of the drug development program of his institution (CITOHL-EPSILYON). Morever, he is the Director of a university research team involved in pharmacokinetics, and modeling analyses of the kinetics of serum tumor markers (EA 3738 CICLY). He is an active member of the French GINECO group, of the European ENGOT group, and of the international GCIG group.

 

Highlights:

- KELIM is the modeled CA-125 decline rate during the first 3 cycles of adjuvant or neo-adjuvant chemotherapy in first-line setting

- It is a pragmatic indicator of the tumor intrinsic chemosensitivity, easily calculable online on  https://www.biomarker-kinetics.org

- KELIM is helpful to surgeons to anticipate the feasibility/complexity of complete interval debulking surgery after neo-adjuvant chemotherapy 

- The analyses of ICON-7 and GOG-0218 trial datasets reproducibly showed that only the patients with unfavorable KELIM score &lt; 1.0 had a survival benefit from bevacizumab among those with a high-risk disease

- KELIM may be a complementary tool to HRD status to select the best maintenance treatment in first-line setting, especially in patients with HRP cancer :  PARP inhibitor expected to be effective in the case of favorable KELIM score ≥ 1.0 ; bevacizumab expected to be effective in the case of unfavorable KELIM score &lt; 1.0</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Benoit You to discuss KELIM validation. Dr. You is a French medical oncologist at Lyon University Hospital, specialized in gynecological cancers, and the head of the drug development program of his institution (CITOHL-EPSILYON). Morever, he is the Director of a university research team involved in pharmacokinetics, and modeling analyses of the kinetics of serum tumor markers (EA 3738 CICLY). He is an active member of the French GINECO group, of the European ENGOT group, and of the international GCIG group.

 

Highlights:

- KELIM is the modeled CA-125 decline rate during the first 3 cycles of adjuvant or neo-adjuvant chemotherapy in first-line setting

- It is a pragmatic indicator of the tumor intrinsic chemosensitivity, easily calculable online on  https://www.biomarker-kinetics.org

- KELIM is helpful to surgeons to anticipate the feasibility/complexity of complete interval debulking surgery after neo-adjuvant chemotherapy 

- The analyses of ICON-7 and GOG-0218 trial datasets reproducibly showed that only the patients with unfavorable KELIM score &lt; 1.0 had a survival benefit from bevacizumab among those with a high-risk disease

- KELIM may be a complementary tool to HRD status to select the best maintenance treatment in first-line setting, especially in patients with HRP cancer :  PARP inhibitor expected to be effective in the case of favorable KELIM score ≥ 1.0 ; bevacizumab expected to be effective in the case of unfavorable KELIM score &lt; 1.0</description>
      <enclosure length="31479013" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1475909608-bmjpodcasts-kelim-validation-gog-218-with-benoit-you.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1478480608</guid>
      <title>Atoms: the highlights from the ADC April 2023</title>
      <pubDate>Mon, 27 Mar 2023 09:23:26 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-april-2023</link>
      <itunes:duration>00:12:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the April 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/4/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the April 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/4/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="11753847" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1478480608-bmjpodcasts-atoms-the-highlights-from-the-adc-april-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-kLlv8zTGLsUJHKA6-oCDiuQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1475881273</guid>
      <title>Episode 13: Lumbar Medial Branch Blocks: How Does The Second Block Influence Progression?</title>
      <pubDate>Mon, 27 Mar 2023 09:00:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-13-lumbar-medial-branch-blocks-how-does-the-second-block-influence-progression</link>
      <itunes:duration>00:36:15</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>For interventional procedures that involve implanting devices or ablating tissues, it is common for patients to undergo prognostic tests to determine if they are responders prior to moving on to permanent procedures. However, definitions of responders and the number of prognostic tests necessary has caused some confusion. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins David Provenzano, MD, and Jozef Leech, to discuss their study “Evaluation of lumbar medial branch blocks: how does the second block influence progression to radiofrequency ablation?,” first published in July 2022 (https://rapm.bmj.com/content/47/12/719). In a single-center retrospective review, 224 patients with two consecutive local anesthetic-only blocks were examined for pain relief. 

Dr. David Provenzano is president-elect of the American Society of Regional Anesthesia and Pain Medicine. He is currently an adjunct associate professor at the University of Pittsburgh, is on the executive committee of the Western PA Surgery Center, and is a critical member of the editorial board at Regional Anesthesia &amp; Pain Medicine.

Jozef Leech is a native of Johnstown, PA, and graduated from Washington &amp; Jefferson College in 2020 with his Bachelor of Arts in biology. He completed 2 years of internship work with Dr. Provenzano at Pain Diagnostics and Interventional Care located in Pennsylvania. In August of 2022, Jozef started Kent State University College of Podiatric Medicine in Independence, OH. He is an active member with the American College of Foot and Ankle Surgeons. 

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>For interventional procedures that involve implan…</itunes:subtitle>
      <description>For interventional procedures that involve implanting devices or ablating tissues, it is common for patients to undergo prognostic tests to determine if they are responders prior to moving on to permanent procedures. However, definitions of responders and the number of prognostic tests necessary has caused some confusion. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins David Provenzano, MD, and Jozef Leech, to discuss their study “Evaluation of lumbar medial branch blocks: how does the second block influence progression to radiofrequency ablation?,” first published in July 2022 (https://rapm.bmj.com/content/47/12/719). In a single-center retrospective review, 224 patients with two consecutive local anesthetic-only blocks were examined for pain relief. 

Dr. David Provenzano is president-elect of the American Society of Regional Anesthesia and Pain Medicine. He is currently an adjunct associate professor at the University of Pittsburgh, is on the executive committee of the Western PA Surgery Center, and is a critical member of the editorial board at Regional Anesthesia &amp; Pain Medicine.

Jozef Leech is a native of Johnstown, PA, and graduated from Washington &amp; Jefferson College in 2020 with his Bachelor of Arts in biology. He completed 2 years of internship work with Dr. Provenzano at Pain Diagnostics and Interventional Care located in Pennsylvania. In August of 2022, Jozef started Kent State University College of Podiatric Medicine in Independence, OH. He is an active member with the American College of Foot and Ankle Surgeons. 

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="43505056" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1475881273-bmjpodcasts-episode-13-lumbar-medial-branch-blocks-how-does-the-second-block-influence-progression.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-rpvV8DL9MQyMH46S-5bhdwg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1476749296</guid>
      <title>Nappuccinos and circadian rhythms</title>
      <pubDate>Fri, 24 Mar 2023 18:41:37 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/nappuccinos-and-circadian-rhythms</link>
      <itunes:duration>00:52:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Fatigue can have as much of an affect in your ability to function as alcohol, and yet while you would be chastised for drinking before appearing on the ward, hospitals have systematically removed the spaces where tired clinicians can rest and recover.

The Royal College of Anaesthetists have been campaigning to raise awareness of the dangers of fatigue, and it seems that anaesthetic trainees have benefitted from that, with sleep pods and flexible schedules - but other specialties are lagging behind.

In this podcast, Roo McCrossan, a consultant anaesthetist joins our host Clara Munro, a surgical trainee, and Ayesha Ashmore, obstetric trainee, to talk about how to fight fatigue. They discuss circadian rhythms, what to eat, nappuccinos, and why trusts should make more sleeping spaces.

For more information about fighting fatigue;
https://anaesthetists.org/Home/Wellbeing-support/Fatigue/-Fight-Fatigue-download-our-information-packs</itunes:summary>
      <itunes:subtitle>Fatigue can have as much of an affect in your abi…</itunes:subtitle>
      <description>Fatigue can have as much of an affect in your ability to function as alcohol, and yet while you would be chastised for drinking before appearing on the ward, hospitals have systematically removed the spaces where tired clinicians can rest and recover.

The Royal College of Anaesthetists have been campaigning to raise awareness of the dangers of fatigue, and it seems that anaesthetic trainees have benefitted from that, with sleep pods and flexible schedules - but other specialties are lagging behind.

In this podcast, Roo McCrossan, a consultant anaesthetist joins our host Clara Munro, a surgical trainee, and Ayesha Ashmore, obstetric trainee, to talk about how to fight fatigue. They discuss circadian rhythms, what to eat, nappuccinos, and why trusts should make more sleeping spaces.

For more information about fighting fatigue;
https://anaesthetists.org/Home/Wellbeing-support/Fatigue/-Fight-Fatigue-download-our-information-packs</description>
      <enclosure length="76123304" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1476749296-bmjpodcasts-nappuccinos-and-circadian-rhythms.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-o9X3NxDz5qvalN5Q-0EjxEQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1468502626</guid>
      <title>Editors Highlights of the April 2023 issue</title>
      <pubDate>Mon, 20 Mar 2023 14:55:43 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-april-2023-issue</link>
      <itunes:duration>00:44:49</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the April 2023 issue of the journal (https://pn.bmj.com/content/23/2/103).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</itunes:summary>
      <itunes:subtitle>Practical Neurology Editors Phil Smith and Gerain…</itunes:subtitle>
      <description>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the April 2023 issue of the journal (https://pn.bmj.com/content/23/2/103).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</description>
      <enclosure length="43035166" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1468502626-bmjpodcasts-editors-highlights-of-the-april-2023-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-GsbcZTRkDA30v0cO-pyPLuw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1471214800</guid>
      <title>LESSER Trial With Vandré Carneiro And Glauco Baiocchi</title>
      <pubDate>Mon, 20 Mar 2023 10:00:10 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/lesser-trial-with-vandre-carneiro-and-glauco-baiocchi</link>
      <itunes:duration>00:34:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Drs. Vandré Carneiro and Glauco Baiocchi to discuss the LESSER trial. Dr. Carneiro is the head of the Department of Gynecologic Oncology at the Instituto de Medicina Integral Professor Fernando Figueira (IMIP). He is also Director of the Department of the Hereditary Cancer Program of Hospital de Cancer de Pernambuco. Dr.  Baiocchi is the head of the Department of Gynecologic Oncology at the AC Camargo Cancer Center. He is also the president of the Brazilian Gynecologic Oncology Group – EVA Group. 

Highlights:

- Hysterectomy is safe and potentially non-inferior to modified radical hysterectomy in early-stage cervical cancer.

- The LESSER supports simple hysterectomy as a substitute for radical hysterectomy in patients with cervical cancer ≤2 cm.

- The SHAPE trial will provide more concrete data on the role of simple hysterectomy for early-stage cervical cancer.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Drs. Vandré Carneiro and Glauco Baiocchi to discuss the LESSER trial. Dr. Carneiro is the head of the Department of Gynecologic Oncology at the Instituto de Medicina Integral Professor Fernando Figueira (IMIP). He is also Director of the Department of the Hereditary Cancer Program of Hospital de Cancer de Pernambuco. Dr.  Baiocchi is the head of the Department of Gynecologic Oncology at the AC Camargo Cancer Center. He is also the president of the Brazilian Gynecologic Oncology Group – EVA Group. 

Highlights:

- Hysterectomy is safe and potentially non-inferior to modified radical hysterectomy in early-stage cervical cancer.

- The LESSER supports simple hysterectomy as a substitute for radical hysterectomy in patients with cervical cancer ≤2 cm.

- The SHAPE trial will provide more concrete data on the role of simple hysterectomy for early-stage cervical cancer.</description>
      <enclosure length="21104388" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1471214800-bmjpodcasts-lesser-trial-with-vandre-carneiro-and-glauco-baiocchi.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1465526224</guid>
      <title>Recent developments in paediatric therapy with Prof. Andrew Bush</title>
      <pubDate>Thu, 16 Mar 2023 13:10:10 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/recent-developments-in-paediatric-therapy</link>
      <itunes:duration>00:19:06</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode Dr. Kate Diomede, social media editor at Thorax, speaks with Prof. Andrew Bush(1) about the state of paediatric treatment for thoracic issues, including discussion of cystic fibrosis and asthma.

Hear the previous discussion with Prof. Ian Hall on the future of respiratory medicine: https://on.soundcloud.com/yb7pJ

(1) Consultant paediatric chest physician at Royal Brompton Hospital;
Professor of paediatric respirology, National Heart and Lung Institute, Imperial College London.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</itunes:summary>
      <itunes:subtitle>In this episode Dr. Kate Diomede, social media ed…</itunes:subtitle>
      <description>In this episode Dr. Kate Diomede, social media editor at Thorax, speaks with Prof. Andrew Bush(1) about the state of paediatric treatment for thoracic issues, including discussion of cystic fibrosis and asthma.

Hear the previous discussion with Prof. Ian Hall on the future of respiratory medicine: https://on.soundcloud.com/yb7pJ

(1) Consultant paediatric chest physician at Royal Brompton Hospital;
Professor of paediatric respirology, National Heart and Lung Institute, Imperial College London.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</description>
      <enclosure length="18347989" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1465526224-bmjpodcasts-recent-developments-in-paediatric-therapy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OrdixQ8Emj6if3z1-OcSPLw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1470185572</guid>
      <title>Baptism of fire: starting in the NHS</title>
      <pubDate>Thu, 16 Mar 2023 12:40:06 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/baptism-of-fire-starting-in-the-nhs</link>
      <itunes:duration>00:44:54</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>From the lingering effects of the pandemic to ongoing industrial action, it is a turbulent time to be working in healthcare. As medical students about to start working in this profession, it can feel really overwhelming and daunting to think about our future careers in the NHS. 

Today we’re going to be talking about all the things we’re worried about when it comes to the current NHS crisis. Our expert guest, Elisabeth, will pull in evidence from interviews with junior doctors and healthcare leaders to get a broader sense of the current situation. We also reached out to the rest of the panel, and other medical students on social media, to hear more about their concerns too. 

Expert guests:
Elisabeth Mahase is the clinical news reporter for the journalism team at The BMJ. She previously worked at GP magazine Pulse and has a background in Science Communication and Biomedical Science.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>From the lingering effects of the pandemic to ong…</itunes:subtitle>
      <description>From the lingering effects of the pandemic to ongoing industrial action, it is a turbulent time to be working in healthcare. As medical students about to start working in this profession, it can feel really overwhelming and daunting to think about our future careers in the NHS. 

Today we’re going to be talking about all the things we’re worried about when it comes to the current NHS crisis. Our expert guest, Elisabeth, will pull in evidence from interviews with junior doctors and healthcare leaders to get a broader sense of the current situation. We also reached out to the rest of the panel, and other medical students on social media, to hear more about their concerns too. 

Expert guests:
Elisabeth Mahase is the clinical news reporter for the journalism team at The BMJ. She previously worked at GP magazine Pulse and has a background in Science Communication and Biomedical Science.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="43112960" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1470185572-bmjpodcasts-baptism-of-fire-starting-in-the-nhs.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1463871745</guid>
      <title>Frailty, and why it’s important in cardiology</title>
      <pubDate>Tue, 14 Mar 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/frailty-and-why-its-important-in-cardiology</link>
      <itunes:duration>00:17:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Chris Wilkinson from Hull York Medical School and the James Cook hospital, UK. They discuss the concept of frailty and why it's an important concept in cardiology. 
If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2  or in your favourite podcast app!

Link to published paper:
https://heart.bmj.com/content/108/24/1991</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Chris Wilkinson from Hull York Medical School and the James Cook hospital, UK. They discuss the concept of frailty and why it's an important concept in cardiology. 
If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2  or in your favourite podcast app!

Link to published paper:
https://heart.bmj.com/content/108/24/1991</description>
      <enclosure length="40857528" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1463871745-bmjpodcasts-frailty-and-why-its-important-in-cardiology.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Xy3y1e3ydlFjQYaY-vPcZPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1467890626</guid>
      <title>Cluster headache: an update on diagnosis and management</title>
      <pubDate>Mon, 13 Mar 2023 13:44:28 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/cluster-headache-an-update-on-diagnosis-and-management</link>
      <itunes:duration>00:18:59</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The prevalence of cluster headache is about one in 500. In people coming to a headache clinic, the prevalence is about 10%.

Cluster headaches are excruciating and incapacitating, and affect quality of life. Prompt diagnosis and treatment can make a big difference to the outcome - so it is vital that we get the diagnosis and management of this condition right.

In this BMJ Best Practice podcast on cluster headache, Kieran Walsh talks with Professor Amaal Starling, Associate Professor of Neurology at the Department of Neurology in the Mayo Clinic.

Further resources: clusterbusters.org/.

Competing interests: AS has received consulting fees from AbbVie, Allergan, Amgen, Axsome Therapeutics, Everyday Health, Lundbeck, Med-IQ, Medscape, Neurolief, Satsuma, and WebMD.

We release episodes fortnightly.</itunes:summary>
      <itunes:subtitle>The prevalence of cluster headache is about one i…</itunes:subtitle>
      <description>The prevalence of cluster headache is about one in 500. In people coming to a headache clinic, the prevalence is about 10%.

Cluster headaches are excruciating and incapacitating, and affect quality of life. Prompt diagnosis and treatment can make a big difference to the outcome - so it is vital that we get the diagnosis and management of this condition right.

In this BMJ Best Practice podcast on cluster headache, Kieran Walsh talks with Professor Amaal Starling, Associate Professor of Neurology at the Department of Neurology in the Mayo Clinic.

Further resources: clusterbusters.org/.

Competing interests: AS has received consulting fees from AbbVie, Allergan, Amgen, Axsome Therapeutics, Everyday Health, Lundbeck, Med-IQ, Medscape, Neurolief, Satsuma, and WebMD.

We release episodes fortnightly.</description>
      <enclosure length="22792096" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1467890626-bmjpodcasts-cluster-headache-an-update-on-diagnosis-and-management.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-n60PM2czl9YNmony-9rnmoA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1467854977</guid>
      <title>The climate crisis is also a child rights crisis</title>
      <pubDate>Mon, 13 Mar 2023 12:58:37 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adc-spotlight-climate-crisis-is-also-a-child-rights-crisis</link>
      <itunes:duration>00:23:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month, Dr. Rachel Agbeko, Senior Editor of ADC, is joined by Dr. Bernadette O'Hare(1), to discuss the impact of the climate crisis on children's health and healthcare worldwide. She is a senior lecturer in Global Health at both St. Andrews, Scotland and the Kamuzu University of Health Sciences in Malawi, and a consultant paediatrician. With the Government Revenue and Development Estimations (GRADE) team, she studies the impact of global policies on government revenue and therefore on public services and children’s right to their determinants of health. 

Related editorial: https://adc.bmj.com/content/107/5/417

The ADC Spotlight podcast is the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. This series is produced by Letícia Amorim and edited by Brian O'Toole.

Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>This month, Dr. Rachel Agbeko, Senior Editor of A…</itunes:subtitle>
      <description>This month, Dr. Rachel Agbeko, Senior Editor of ADC, is joined by Dr. Bernadette O'Hare(1), to discuss the impact of the climate crisis on children's health and healthcare worldwide. She is a senior lecturer in Global Health at both St. Andrews, Scotland and the Kamuzu University of Health Sciences in Malawi, and a consultant paediatrician. With the Government Revenue and Development Estimations (GRADE) team, she studies the impact of global policies on government revenue and therefore on public services and children’s right to their determinants of health. 

Related editorial: https://adc.bmj.com/content/107/5/417

The ADC Spotlight podcast is the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. This series is produced by Letícia Amorim and edited by Brian O'Toole.

Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="22315257" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1467854977-bmjpodcasts-adc-spotlight-climate-crisis-is-also-a-child-rights-crisis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-MRWRroZ1Uz3oKq7p-pEKt2w-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1466332870</guid>
      <title>SCCAN Study: Hospital Volume and Radical Hysterectomy</title>
      <pubDate>Mon, 13 Mar 2023 10:00:38 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sccan-study-hospital-volume-and-radical-hysterectomy</link>
      <itunes:duration>00:34:37</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Nicolò Bizzarri to discuss the SCCAN study. Dr. Bizzarri is a former IJGC Editorial Fellow under the mentorship of Prof. Pedro Ramirez. He is a Gynecologic Oncologist at Policlinico Agostino Gemelli in Rome, president of the European Network of Young Gynecologic Oncologists (ENYGO), and he happily serves on the IJGC Early Career Editorial Board.

Highlights: 

- Women with early-stage cervical cancer treated with primary radical hysterectomy had improved disease free survival if treated in hospitals with a higher number of radical hysterectomies per year. 

- Surgical volume of centers represented an independent prognostic factor affecting disease-free survival.

- Increasing number of radical hysterectomies performed in each center every year was associated with improved disease-free survival.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Nicolò Bizzarri to discuss the SCCAN study. Dr. Bizzarri is a former IJGC Editorial Fellow under the mentorship of Prof. Pedro Ramirez. He is a Gynecologic Oncologist at Policlinico Agostino Gemelli in Rome, president of the European Network of Young Gynecologic Oncologists (ENYGO), and he happily serves on the IJGC Early Career Editorial Board.

Highlights: 

- Women with early-stage cervical cancer treated with primary radical hysterectomy had improved disease free survival if treated in hospitals with a higher number of radical hysterectomies per year. 

- Surgical volume of centers represented an independent prognostic factor affecting disease-free survival.

- Increasing number of radical hysterectomies performed in each center every year was associated with improved disease-free survival.</description>
      <enclosure length="33062270" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1466332870-bmjpodcasts-sccan-study-hospital-volume-and-radical-hysterectomy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1466114920</guid>
      <title>Time needed to treat, with Minna Johansson</title>
      <pubDate>Fri, 10 Mar 2023 18:27:35 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/time-needed-to-treat-with-minna-johansson-1</link>
      <itunes:duration>00:43:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>How long would it take GPs to enact all of the guideline recommendations that they might be expected too? Far more GP hours than exist in any healthcare system, but as medicine has turned its attention to primary prevention, and expanded the populations whose health we seek to improve, those guidelines are taking up more and more time.

A recent analysis in The BMJ has proposed the concept of “Time Needed to Treat” and implores guideline makers to take account consultation time as a precious, finite, resource when thinking about their recommendations.

In this episode of Deep Breath In, we’re joined by Minna Johansson, family doctor and director Global Center for Sustainable Healthcare, who co-authored that analysis to talk about how the concept has gone down, and what it might mean for rethinking what primary care is supposed to do.

Reading list:
Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953</itunes:summary>
      <itunes:subtitle>How long would it take GPs to enact all of the gu…</itunes:subtitle>
      <description>How long would it take GPs to enact all of the guideline recommendations that they might be expected too? Far more GP hours than exist in any healthcare system, but as medicine has turned its attention to primary prevention, and expanded the populations whose health we seek to improve, those guidelines are taking up more and more time.

A recent analysis in The BMJ has proposed the concept of “Time Needed to Treat” and implores guideline makers to take account consultation time as a precious, finite, resource when thinking about their recommendations.

In this episode of Deep Breath In, we’re joined by Minna Johansson, family doctor and director Global Center for Sustainable Healthcare, who co-authored that analysis to talk about how the concept has gone down, and what it might mean for rethinking what primary care is supposed to do.

Reading list:
Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953</description>
      <enclosure length="62562095" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1466114920-bmjpodcasts-time-needed-to-treat-with-minna-johansson-1.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8i9LTpkaLEKQ3DNF-EFzLHw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1466113720</guid>
      <title>Why guideline authors need to pay attention to doctor's time</title>
      <pubDate>Fri, 10 Mar 2023 18:25:46 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/time-needed-to-treat-with-minna-johansson</link>
      <itunes:duration>00:44:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We're bringing you an episode of the BMJ's podcast for primary care, Deep Breath In, which we think you'll enjoy.

How long would it take GPs to enact all of the guideline recommendations that they might be expected too? Far more GP hours than exist in any healthcare system; but as medicine has turned its attention to primary prevention, and expanded the populations whose health we seek to improve, those guidelines are taking up more and more time.

A recent analysis in The BMJ has proposed the concept of “Time Needed to Treat” - and implores guideline makers to take account consultation time as a precious, finite, resource when thinking about their recommendations.

In this episode of Deep Breath In, we’re joined by Minna Johansson, family doctor and director Global Center for Sustainable Healthcare, who co-authored that analysis to talk about how the concept has gone down, and what it might mean for rethinking what primary care is supposed to do.

Reading list:
Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953</itunes:summary>
      <itunes:subtitle>We're bringing you an episode of the BMJ's podcas…</itunes:subtitle>
      <description>We're bringing you an episode of the BMJ's podcast for primary care, Deep Breath In, which we think you'll enjoy.

How long would it take GPs to enact all of the guideline recommendations that they might be expected too? Far more GP hours than exist in any healthcare system; but as medicine has turned its attention to primary prevention, and expanded the populations whose health we seek to improve, those guidelines are taking up more and more time.

A recent analysis in The BMJ has proposed the concept of “Time Needed to Treat” - and implores guideline makers to take account consultation time as a precious, finite, resource when thinking about their recommendations.

In this episode of Deep Breath In, we’re joined by Minna Johansson, family doctor and director Global Center for Sustainable Healthcare, who co-authored that analysis to talk about how the concept has gone down, and what it might mean for rethinking what primary care is supposed to do.

Reading list:
Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953</description>
      <enclosure length="64113943" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1466113720-bmjpodcasts-time-needed-to-treat-with-minna-johansson.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8i9LTpkaLEKQ3DNF-EFzLHw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1465881172</guid>
      <title>BJSM Real World Injury Prevention In Amateur Soccer With Hanna Lindblom. EP#527</title>
      <pubDate>Fri, 10 Mar 2023 12:42:42 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/bjsm-real-world-injury-prevention-in-amateur-soccer-with-hanna-lindblom-ep527</link>
      <itunes:duration>00:18:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this BJSM Podcast, we host Associate Professor Hanna Lindblom, who is a physiotherapist, researcher, and lecturer at Linkoping University in Sweden. 

We discuss Hanna’s paper, which evaluated the preventive efficacy of an extended version of the Knee Control injury prevention exercise program compared with an adductor strength program in amateur adolescent and adult male and female football (soccer) players. 

Coaches and player representatives received a printed and digital program material, and a practical workshop to show them how to use the programs. 

The novelty of this trial is they also compared the extended Knee Control to a second comparison group; where the teams were where the teams already used a self-selected program and did not receive workshop or program material. Many of these comparison teams (50%) said they were self-using the old Knee Control program, providing a “real world” comparison and proven benefits of the Extended Knee Control program. 

Hanna has hands-on experience designing and delivering injury prevention in a range of sports and has some great advice for clinicians looking to implement Knee Control and similar programs in amateur sports settings. 

Paper link: https://bjsm.bmj.com/content/57/2/83.abstract</itunes:summary>
      <itunes:subtitle>In this BJSM Podcast, we host Associate Professor…</itunes:subtitle>
      <description>In this BJSM Podcast, we host Associate Professor Hanna Lindblom, who is a physiotherapist, researcher, and lecturer at Linkoping University in Sweden. 

We discuss Hanna’s paper, which evaluated the preventive efficacy of an extended version of the Knee Control injury prevention exercise program compared with an adductor strength program in amateur adolescent and adult male and female football (soccer) players. 

Coaches and player representatives received a printed and digital program material, and a practical workshop to show them how to use the programs. 

The novelty of this trial is they also compared the extended Knee Control to a second comparison group; where the teams were where the teams already used a self-selected program and did not receive workshop or program material. Many of these comparison teams (50%) said they were self-using the old Knee Control program, providing a “real world” comparison and proven benefits of the Extended Knee Control program. 

Hanna has hands-on experience designing and delivering injury prevention in a range of sports and has some great advice for clinicians looking to implement Knee Control and similar programs in amateur sports settings. 

Paper link: https://bjsm.bmj.com/content/57/2/83.abstract</description>
      <enclosure length="44543999" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1465881172-bmjpodcasts-bjsm-real-world-injury-prevention-in-amateur-soccer-with-hanna-lindblom-ep527.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1464028693</guid>
      <title>DTB 60th anniversary podcast interview - Joanna Girling</title>
      <pubDate>Thu, 09 Mar 2023 17:50:36 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-60th-anniversary-podcast-interview-joanna-girling</link>
      <itunes:duration>00:36:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB. In this podcast, recorded May 2022, David Phizackerley (DTB's deputy editor) talks to Joanna Girling who is a consultant in obstetric medicine in north London and has been involved with DTB since 2006. Joanna talks about her clinical work, her role with establishing the local maternity network and her involvement in research. She also talks about supporting women who have pre-existing medical conditions and who are pregnant or who are planning pregnancy and the importance of checking that they are on the most appropriate medicines.

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listenin</itunes:summary>
      <itunes:subtitle>In a series of podcasts to mark the 60th annivers…</itunes:subtitle>
      <description>In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB. In this podcast, recorded May 2022, David Phizackerley (DTB's deputy editor) talks to Joanna Girling who is a consultant in obstetric medicine in north London and has been involved with DTB since 2006. Joanna talks about her clinical work, her role with establishing the local maternity network and her involvement in research. She also talks about supporting women who have pre-existing medical conditions and who are pregnant or who are planning pregnancy and the importance of checking that they are on the most appropriate medicines.

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listenin</description>
      <enclosure length="34964374" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1464028693-bmjpodcasts-dtb-60th-anniversary-podcast-interview-joanna-girling.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-FP57DzxjuFW419bc-cqcWHA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1460734486</guid>
      <title>Special Issue: Novel Therapies Leading to a New Landscape in Gynecologic Tumors</title>
      <pubDate>Mon, 06 Mar 2023 11:00:20 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/special-issue-novel-therapies-leading-to-a-new-landscape-in-gynecologic-tumors</link>
      <itunes:duration>00:35:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Drs. Ainhoa Madariaga and Robert Coleman, two of the Guest Editors for this month’s special issue entitled “Novel Therapies Leading to a New Landscape in Gynecologic Tumors”. Dr. Madariaga is a Medical Oncologist in the Gynecologic Cancer Unit at 12 de Octubre University Hospital in Madrid, Spain. She is the chair of the Young and Early Career Investigator - EORTC Gynecological Cancer Group. Her research interests include patient reported outcomes and drug development. Dr. Coleman is a Gynecologic Oncologist and Chief Medical Officer at Sarah Cannon Research Institute (SCRI) in Nashville, TN. His research interests include drug development, clinical trial design and global medical education in gynecologic oncology.

 Highlights:

- The alignment of cancer biology and novel treatment approaches are significantly extending the lives of patients with gynecologic malignancies, particularly with agents such as antibody drug conjugates, immunotherapy, and targeted agents.

- The evolving therapeutic landscape is escalating the need for a clearer understanding of how precision medicine can most efficiently be implemented.

- Emergence of drug resistance provides new challenges and opportunities through creative and strategic investigation of novel treatment and combinations.

- Advances in testing platforms in bringing genomic testing to the global audience.

- Clinical trial interpretation requires critical evaluation of analytical primary and hypothesis-generating secondary endpoints – strategies to make appropriate inference is key to clinical trial design.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Drs. Ainhoa Madariaga and Robert Coleman, two of the Guest Editors for this month’s special issue entitled “Novel Therapies Leading to a New Landscape in Gynecologic Tumors”. Dr. Madariaga is a Medical Oncologist in the Gynecologic Cancer Unit at 12 de Octubre University Hospital in Madrid, Spain. She is the chair of the Young and Early Career Investigator - EORTC Gynecological Cancer Group. Her research interests include patient reported outcomes and drug development. Dr. Coleman is a Gynecologic Oncologist and Chief Medical Officer at Sarah Cannon Research Institute (SCRI) in Nashville, TN. His research interests include drug development, clinical trial design and global medical education in gynecologic oncology.

 Highlights:

- The alignment of cancer biology and novel treatment approaches are significantly extending the lives of patients with gynecologic malignancies, particularly with agents such as antibody drug conjugates, immunotherapy, and targeted agents.

- The evolving therapeutic landscape is escalating the need for a clearer understanding of how precision medicine can most efficiently be implemented.

- Emergence of drug resistance provides new challenges and opportunities through creative and strategic investigation of novel treatment and combinations.

- Advances in testing platforms in bringing genomic testing to the global audience.

- Clinical trial interpretation requires critical evaluation of analytical primary and hypothesis-generating secondary endpoints – strategies to make appropriate inference is key to clinical trial design.</description>
      <enclosure length="33589349" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1460734486-bmjpodcasts-special-issue-novel-therapies-leading-to-a-new-landscape-in-gynecologic-tumors.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1460675560</guid>
      <title>Nuffield Summit 2023 - healthcare needs flexible working</title>
      <pubDate>Fri, 03 Mar 2023 18:14:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/nuffield-summit-2023-healthcare-needs-flexible-working</link>
      <itunes:duration>00:44:21</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>As workforce gaps in the NHS, and other healthcare systems around the world widen, the need to improve staff retention has become an ever more pressing concern. Yet work-life balance issues continue to drive staff away from the service.

What is the imperative to get flexible working right, and what can be done to remove the barriers facing healthcare workers seeking to change the way they work?

Joining us in the discussion are;
Kamran Abbasi, editor in chief of The BMJ
Rachel Hutchings, fellow at the Nuffield Trust
Sarah Sweeney, interim chief executive, National Voices
Farzana Hussain, a GP in Newham, London
Thea Stein, chief executive of Leeds Community Healthcare NHS Trust

The report that Rachel Hutchings has authors is summaried in a BMJ feature -  Challenges of combining a career in surgery with parenting https://www.bmj.com/content/380/bmj.p449</itunes:summary>
      <itunes:subtitle>As workforce gaps in the NHS, and other healthcar…</itunes:subtitle>
      <description>As workforce gaps in the NHS, and other healthcare systems around the world widen, the need to improve staff retention has become an ever more pressing concern. Yet work-life balance issues continue to drive staff away from the service.

What is the imperative to get flexible working right, and what can be done to remove the barriers facing healthcare workers seeking to change the way they work?

Joining us in the discussion are;
Kamran Abbasi, editor in chief of The BMJ
Rachel Hutchings, fellow at the Nuffield Trust
Sarah Sweeney, interim chief executive, National Voices
Farzana Hussain, a GP in Newham, London
Thea Stein, chief executive of Leeds Community Healthcare NHS Trust

The report that Rachel Hutchings has authors is summaried in a BMJ feature -  Challenges of combining a career in surgery with parenting https://www.bmj.com/content/380/bmj.p449</description>
      <enclosure length="63815201" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1460675560-bmjpodcasts-nuffield-summit-2023-healthcare-needs-flexible-working.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-P3zbxLO5QrUap1dM-VDkM3Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1460388154</guid>
      <title>Potential Bone Stress Injuries in Runners Using Carbon Fiber Plate Footwear. EP# 526</title>
      <pubDate>Fri, 03 Mar 2023 09:59:31 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/potential-bone-stress-injuries-in-runners-using-carbon-fiber-plate-footwear-ep-526</link>
      <itunes:duration>00:18:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM (T: @TheAMSSM) Sports Medcast, host Dr. Devin McFadden, MD (T: @ArmySportsDoc), is joined by Dr. Adam Tenforde, MD (T: @AdamTenfordeMD), to discuss the a recently published manuscript titled “Bone Stress Injuries in Runners Using Carbon Fiber Plate Footwear.”

In this conversation, Dr. Tenforde addresses the following topics related to the article:

●	Explanation of the use of Carbon Fiber Plate (CFP) technology in footwear and why it’s become so popular
●	Addressing the rapid changes and progression of record-breaking performance in the running community as a result of this footwear
●	Discussing his article featuring a case series of navicular bone stress injuries in runners using CFP footwear
●	Providing some general recommendations for safely using CFP footwear, as well as raising awareness on the possible health concerns of this new technology

Additional Resources:

Bone Stress Injuries in Runners Using Carbon Fiber Plate Footwear https://link.springer.com/article/10.1007/s40279-023-01818-z

Return to Sport Following Low-Risk and High-Risk Bone Stress Injuries: A Systematic Review and Meta-Analysis
https://bjsm.bmj.com/content/early/2023/01/24/bjsports-2022-106328</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM (T: @TheAMSSM) Sport…</itunes:subtitle>
      <description>On this episode of the AMSSM (T: @TheAMSSM) Sports Medcast, host Dr. Devin McFadden, MD (T: @ArmySportsDoc), is joined by Dr. Adam Tenforde, MD (T: @AdamTenfordeMD), to discuss the a recently published manuscript titled “Bone Stress Injuries in Runners Using Carbon Fiber Plate Footwear.”

In this conversation, Dr. Tenforde addresses the following topics related to the article:

●	Explanation of the use of Carbon Fiber Plate (CFP) technology in footwear and why it’s become so popular
●	Addressing the rapid changes and progression of record-breaking performance in the running community as a result of this footwear
●	Discussing his article featuring a case series of navicular bone stress injuries in runners using CFP footwear
●	Providing some general recommendations for safely using CFP footwear, as well as raising awareness on the possible health concerns of this new technology

Additional Resources:

Bone Stress Injuries in Runners Using Carbon Fiber Plate Footwear https://link.springer.com/article/10.1007/s40279-023-01818-z

Return to Sport Following Low-Risk and High-Risk Bone Stress Injuries: A Systematic Review and Meta-Analysis
https://bjsm.bmj.com/content/early/2023/01/24/bjsports-2022-106328</description>
      <enclosure length="12171883" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1460388154-bmjpodcasts-potential-bone-stress-injuries-in-runners-using-carbon-fiber-plate-footwear-ep-526.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1458917044</guid>
      <title>JAG consensus statements for training and certification in colonoscopy</title>
      <pubDate>Fri, 03 Mar 2023 05:02:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/jag-consensus-statements-for-training-and-certification-in-colonoscopy</link>
      <itunes:duration>00:32:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Deputy Editor and Associate Editor of FG and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Keith Siau, Consultant Gastroenterologist at the Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, UK and Dr Aravinth Murugananthan, Consultant Gastroenterologist at The Royal Wolverhampton NHS Trust, Wolverhampton, UK and Director of the Midlands Endoscopy Training Academy on the paper 'JAG consensus statements for training and certification in colonoscopy’ published online in Frontline Gastroenterology in January 2023 and available online: https://fg.bmj.com/content/early/2023/01/26/flgastro-2022-102260

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Deputy Editor and Associate Edit…</itunes:subtitle>
      <description>Dr Philip Smith, Deputy Editor and Associate Editor of FG and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Keith Siau, Consultant Gastroenterologist at the Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, UK and Dr Aravinth Murugananthan, Consultant Gastroenterologist at The Royal Wolverhampton NHS Trust, Wolverhampton, UK and Director of the Midlands Endoscopy Training Academy on the paper 'JAG consensus statements for training and certification in colonoscopy’ published online in Frontline Gastroenterology in January 2023 and available online: https://fg.bmj.com/content/early/2023/01/26/flgastro-2022-102260

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="31234506" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1458917044-bmjpodcasts-jag-consensus-statements-for-training-and-certification-in-colonoscopy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1458110494</guid>
      <title>Being yourself at work</title>
      <pubDate>Thu, 02 Mar 2023 08:00:10 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/being-yourself-at-work</link>
      <itunes:duration>00:42:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Every consultation we have with a patient reveals something about us - sometimes we do that deliberately, sometimes it's just incidental - but we always bring something of ourselves to the consultation.

In a recent episode, we talked all about self disclosure; when it is and isn’t appropriate to share things with your patients. In that episode, we focused on health and illness but today, we’re going to be talking about things that are outside of the sphere of medicine. For example, the way that we consider our identity and other aspects of our personal life. This might be through outright self-disclosure or it might be more linked to all of the nonverbal and visual cues you get and give in a consultation. 

Expert guests:
Dr Brendan J Dunlop is a principal clinical psychologist and clinical lecturer in clinical psychology. He is also the author of The Queer Mental Health Workbook. He delivers training and teaching which covers elements of self-disclosure. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Every consultation we have with a patient reveals…</itunes:subtitle>
      <description>Every consultation we have with a patient reveals something about us - sometimes we do that deliberately, sometimes it's just incidental - but we always bring something of ourselves to the consultation.

In a recent episode, we talked all about self disclosure; when it is and isn’t appropriate to share things with your patients. In that episode, we focused on health and illness but today, we’re going to be talking about things that are outside of the sphere of medicine. For example, the way that we consider our identity and other aspects of our personal life. This might be through outright self-disclosure or it might be more linked to all of the nonverbal and visual cues you get and give in a consultation. 

Expert guests:
Dr Brendan J Dunlop is a principal clinical psychologist and clinical lecturer in clinical psychology. He is also the author of The Queer Mental Health Workbook. He delivers training and teaching which covers elements of self-disclosure. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="40336763" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1458110494-bmjpodcasts-being-yourself-at-work.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1458951133</guid>
      <title>Investigating the use of lung ultrasound: author discussion</title>
      <pubDate>Thu, 02 Mar 2023 05:00:30 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/investigating-the-use-of-lung-ultrasound-author-discussion</link>
      <itunes:duration>00:27:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Jonathan Davis, ADC associate editor, is joined by Arun Sett(1), Dr. Sheryle Rogerson(2), and Dr. Peter Davis(3) to discuss the paper "Lung ultrasound of the dependent lung detects real-time changes in lung volume in the preterm lamb", as well as the lung ultrasound method's applicability to neonatal treatment.

Related links:
https://fn.bmj.com/content/108/1/51
http://www.ncbi.nlm.nih.gov/pubmed/27596161
https://thorax.bmj.com/content/72/1/83
https://www.asum.com.au/education/ccpu-course/ccpu-neonatal/

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

(1) Joan Kirner Women's and Children's Hospital, Melbourne, Australia  &amp; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia 
(2) The Royal Women's Hospital, Melbourne, Australia 
(3) Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia</itunes:summary>
      <itunes:subtitle>Jonathan Davis, ADC associate editor, is joined b…</itunes:subtitle>
      <description>Jonathan Davis, ADC associate editor, is joined by Arun Sett(1), Dr. Sheryle Rogerson(2), and Dr. Peter Davis(3) to discuss the paper "Lung ultrasound of the dependent lung detects real-time changes in lung volume in the preterm lamb", as well as the lung ultrasound method's applicability to neonatal treatment.

Related links:
https://fn.bmj.com/content/108/1/51
http://www.ncbi.nlm.nih.gov/pubmed/27596161
https://thorax.bmj.com/content/72/1/83
https://www.asum.com.au/education/ccpu-course/ccpu-neonatal/

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

(1) Joan Kirner Women's and Children's Hospital, Melbourne, Australia  &amp; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia 
(2) The Royal Women's Hospital, Melbourne, Australia 
(3) Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia</description>
      <enclosure length="26081488" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1458951133-bmjpodcasts-investigating-the-use-of-lung-ultrasound-author-discussion.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-PDk0heSRM2lHslN5-fy94mA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1458775513</guid>
      <title>Featuring the Nocturnist's SHAME IN MEDICINE: The Lost Forest</title>
      <pubDate>Thu, 02 Mar 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/featuring-the-nocturnists-shame-in-medicine-the-lost-forest</link>
      <itunes:duration>00:28:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Medical Humanities, editor-in-chief Brandy Schillace speaks to Emily Silverman, MD, the University of California San Francisco (UCSF)creator of The Nocturnist podcast, and Luna Dolezal, Associate Professor in Philosophy and Medical Humanities based in the Wellcome Centre for Cultures and Environments of Health. They both published a 10-part podcast series called 'Shame in Medicine: The Lost Forest'.
Blog link with the transcription of this podcast: 
https://blogs.bmj.com/medical-humanities/2023/03/02/shame-in-medicine-the-lost-forest

Related links: 
https://shameandmedicine.org/ 
https://thenocturnists.com/ 
https://www.thenocturnists-shame.org/

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>Medical Humanities, editor-in-chief Brandy Schill…</itunes:subtitle>
      <description>Medical Humanities, editor-in-chief Brandy Schillace speaks to Emily Silverman, MD, the University of California San Francisco (UCSF)creator of The Nocturnist podcast, and Luna Dolezal, Associate Professor in Philosophy and Medical Humanities based in the Wellcome Centre for Cultures and Environments of Health. They both published a 10-part podcast series called 'Shame in Medicine: The Lost Forest'.
Blog link with the transcription of this podcast: 
https://blogs.bmj.com/medical-humanities/2023/03/02/shame-in-medicine-the-lost-forest

Related links: 
https://shameandmedicine.org/ 
https://thenocturnists.com/ 
https://www.thenocturnists-shame.org/

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="40620970" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1458775513-bmjpodcasts-featuring-the-nocturnists-shame-in-medicine-the-lost-forest.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-V4qUvkGk2Mhz6SzG-4jzoUA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1456913818</guid>
      <title>Primary Survey - the highlights of March 2023</title>
      <pubDate>Wed, 01 Mar 2023 16:31:50 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-march-2023</link>
      <itunes:duration>00:29:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A summary of some of the best papers we published in the March 2023 issue of the Emergency Medicine Journal. EMJ's deputy editor Rick Body and social media editor Sarah Edwards talk through topics including biomarkers of traumatic brain injury, the limping child, hypothermia and sepsis in infants and the importance of avoiding secondary insults in patients intubated for traumatic brain injury in the prehospital environment.
Read the highlights: https://emj.bmj.com/content/40/3/157
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>A summary of some of the best papers we published…</itunes:subtitle>
      <description>A summary of some of the best papers we published in the March 2023 issue of the Emergency Medicine Journal. EMJ's deputy editor Rick Body and social media editor Sarah Edwards talk through topics including biomarkers of traumatic brain injury, the limping child, hypothermia and sepsis in infants and the importance of avoiding secondary insults in patients intubated for traumatic brain injury in the prehospital environment.
Read the highlights: https://emj.bmj.com/content/40/3/157
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="27933047" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1456913818-bmjpodcasts-emj-march-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1458227836</guid>
      <title>Idiopathic normal pressure hydrocephalus: a contemporary guide</title>
      <pubDate>Wed, 01 Mar 2023 15:21:04 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/idiopathic-normal-pressure-hydrocephalus-a-contemporary-guide</link>
      <itunes:duration>00:46:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Amy Ross Russell(1) discusses a recently published review by Dr. Christopher Carswell(2) on the historical context of normal pressure hydrocephalus, the challenges faced when dealing with patients, and the current state of clinical evidence for diagnosis and treatment.

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/23/1/15) and the February print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-february-2023-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Imperial College Healthcare NHS Trust, London, UK

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</itunes:summary>
      <itunes:subtitle>Dr. Amy Ross Russell(1) discusses a recently publ…</itunes:subtitle>
      <description>Dr. Amy Ross Russell(1) discusses a recently published review by Dr. Christopher Carswell(2) on the historical context of normal pressure hydrocephalus, the challenges faced when dealing with patients, and the current state of clinical evidence for diagnosis and treatment.

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/23/1/15) and the February print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-february-2023-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Imperial College Healthcare NHS Trust, London, UK

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</description>
      <enclosure length="45054745" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1458227836-bmjpodcasts-idiopathic-normal-pressure-hydrocephalus-a-contemporary-guide.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1456960588</guid>
      <title>Predicting disease progression in bridging fibrosis and cirrhosis with liver stiffness</title>
      <pubDate>Tue, 28 Feb 2023 05:00:20 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/predicting-disease-progression-in-bridging-fibrosis-and-cirrhosis-with-liver-stiffness</link>
      <itunes:duration>00:09:12</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Rohit Loomba, Professor of Medicine in the Division of Gastroenterology, and Adjunct Professor in the Division of Epidemiology at the University of California San Diego, La Jolla, California, USA on the paper 'Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis' published in paper copy in Gut in March 2023 and available online: https://gut.bmj.com/content/72/3/581

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Rohit Loomba, Professor of Medicine in the Division of Gastroenterology, and Adjunct Professor in the Division of Epidemiology at the University of California San Diego, La Jolla, California, USA on the paper 'Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis' published in paper copy in Gut in March 2023 and available online: https://gut.bmj.com/content/72/3/581

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="8833566" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1456960588-bmjpodcasts-predicting-disease-progression-in-bridging-fibrosis-and-cirrhosis-with-liver-stiffness.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1457090023</guid>
      <title>Spinal cord compression: an update on diagnosis and management</title>
      <pubDate>Mon, 27 Feb 2023 16:31:59 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/spinal-cord-compression-an-update-on-diagnosis-and-management</link>
      <itunes:duration>00:27:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Spinal cord compression is an extremely serious disorder that can have devastating consequences. These include weakness of the legs, bladder and bowel dysfunction, and loss of sensation.

Rapid diagnosis and treatment can make a big difference to the outcome - so it is vital that we get the diagnosis and management of this condition right. 

In this BMJ Best Practice podcast on spinal cord compression, Kieran Walsh talks with Professor Kenneth Casey, Clinical Associate Professor in Neurosurgery at Michigan State University and Clinical Associate Professor in Physical Medicine and Rehabilitation at Wayne State University School of Medicine.

Competing interests: none declared

We release episodes fortnightly.</itunes:summary>
      <itunes:subtitle>Spinal cord compression is an extremely serious d…</itunes:subtitle>
      <description>Spinal cord compression is an extremely serious disorder that can have devastating consequences. These include weakness of the legs, bladder and bowel dysfunction, and loss of sensation.

Rapid diagnosis and treatment can make a big difference to the outcome - so it is vital that we get the diagnosis and management of this condition right. 

In this BMJ Best Practice podcast on spinal cord compression, Kieran Walsh talks with Professor Kenneth Casey, Clinical Associate Professor in Neurosurgery at Michigan State University and Clinical Associate Professor in Physical Medicine and Rehabilitation at Wayne State University School of Medicine.

Competing interests: none declared

We release episodes fortnightly.</description>
      <enclosure length="33420736" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1457090023-bmjpodcasts-spinal-cord-compression-an-update-on-diagnosis-and-management.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-n60PM2czl9YNmony-9rnmoA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1455036820</guid>
      <title>Mentor’s Podcast: Robert Coleman</title>
      <pubDate>Mon, 27 Feb 2023 11:00:10 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mentors-podcast-robert-coleman</link>
      <itunes:duration>00:22:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman. Dr. Coleman is a Gynecologic Oncologist and Chief Medical Officer at Sarah Cannon Research Institute (SCRI) in Nashville, TN. His research interests include drug development, clinical trial design and global medical education in gynecologic oncology.

 Highlights:

- Strong mentorship is vital to personal and academic development. However, it is a two-way street. True synergy will come from bilateral engagement.

- Remember your clinic is your “laboratory” – keep a keen eye for clinical relationships, build hypotheses, and practice the exercise of how to best test it. Even in resource-constrained situations, the process of discovery and hypothesis testing will arm one to be a better investigator and to most appropriately interrogate the literature.

- A strong balance between personal and professional responsibilities will provide the environment for sustainability – this is the long game!</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman. Dr. Coleman is a Gynecologic Oncologist and Chief Medical Officer at Sarah Cannon Research Institute (SCRI) in Nashville, TN. His research interests include drug development, clinical trial design and global medical education in gynecologic oncology.

 Highlights:

- Strong mentorship is vital to personal and academic development. However, it is a two-way street. True synergy will come from bilateral engagement.

- Remember your clinic is your “laboratory” – keep a keen eye for clinical relationships, build hypotheses, and practice the exercise of how to best test it. Even in resource-constrained situations, the process of discovery and hypothesis testing will arm one to be a better investigator and to most appropriately interrogate the literature.

- A strong balance between personal and professional responsibilities will provide the environment for sustainability – this is the long game!</description>
      <enclosure length="22031463" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1455036820-bmjpodcasts-mentors-podcast-robert-coleman.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1455029731</guid>
      <title>Episode 12: Association of Perioperative Anxiety and Postoperative Opioid-Related Outcomes</title>
      <pubDate>Mon, 27 Feb 2023 11:00:10 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-12-association-of-perioperative-anxiety-and-postoperative-opioid-related-outcomes</link>
      <itunes:duration>00:37:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The International Association for the Study of Pain defines pain as: “An unpleasant sensory or emotional experience associated with, or resembling that associated with, actual or potential tissue damage.”
Among many other variables, mental health conditions play a critical role in determining the emotional experience. Thus, it is very reasonable to hypothesize that baseline anxiety, for instance, may influence pain and opioid prescribing. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins Shay Nguyen and Jennifer Waljee, MD, authors on “Prospective cohort study on the trajectory and association of perioperative anxiety and postoperative opioid-related outcomes,” first published in August 2022 (https://rapm.bmj.com/content/47/10/637). In this fascinating study, 1,771 patients were prospectively followed; self-reported opioid use, pain, and anxiety were recorded on the day of surgery and at 1-, 3-, and 6-months post-surgery to examine whether or not anxiety was a mediator between pain and opioid use.

Shay N. Nguyen is a fourth-year medical student at the University of Michigan who is applying into classic surgery. She studied biochemistry in the University of California, Santa Barba, where she did research in chemistry and material science. Currently, her research interests include understanding risk factors for opioid use in the context of surgery and perioperative anxiety management.

Dr. Jennifer F. Waljee is a plastic surgeon in academic practice at the University of Michigan. She completed her medical school training at Emory University and completed clinical residencies in general
surgery and plastic surgery at the University of Michigan, followed by a hand surgery fellowship. Dr. Waljee is a co-founder and co-director of the Michigan Opioid Prescribing Engagement Network (OPEN),
a statewide collaborative program dedicated to enhancing opioid stewardship and developing best practices for the management of acute pain during procedural care.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this
podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical
treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>The International Association for the Study of Pa…</itunes:subtitle>
      <description>The International Association for the Study of Pain defines pain as: “An unpleasant sensory or emotional experience associated with, or resembling that associated with, actual or potential tissue damage.”
Among many other variables, mental health conditions play a critical role in determining the emotional experience. Thus, it is very reasonable to hypothesize that baseline anxiety, for instance, may influence pain and opioid prescribing. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins Shay Nguyen and Jennifer Waljee, MD, authors on “Prospective cohort study on the trajectory and association of perioperative anxiety and postoperative opioid-related outcomes,” first published in August 2022 (https://rapm.bmj.com/content/47/10/637). In this fascinating study, 1,771 patients were prospectively followed; self-reported opioid use, pain, and anxiety were recorded on the day of surgery and at 1-, 3-, and 6-months post-surgery to examine whether or not anxiety was a mediator between pain and opioid use.

Shay N. Nguyen is a fourth-year medical student at the University of Michigan who is applying into classic surgery. She studied biochemistry in the University of California, Santa Barba, where she did research in chemistry and material science. Currently, her research interests include understanding risk factors for opioid use in the context of surgery and perioperative anxiety management.

Dr. Jennifer F. Waljee is a plastic surgeon in academic practice at the University of Michigan. She completed her medical school training at Emory University and completed clinical residencies in general
surgery and plastic surgery at the University of Michigan, followed by a hand surgery fellowship. Dr. Waljee is a co-founder and co-director of the Michigan Opioid Prescribing Engagement Network (OPEN),
a statewide collaborative program dedicated to enhancing opioid stewardship and developing best practices for the management of acute pain during procedural care.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this
podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical
treatment or for the medical treatment of others.</description>
      <enclosure length="45543616" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1455029731-bmjpodcasts-episode-12-association-of-perioperative-anxiety-and-postoperative-opioid-related-outcomes.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-rpvV8DL9MQyMH46S-5bhdwg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1452220744</guid>
      <title>Promoting gender equity in academic rheumatology</title>
      <pubDate>Mon, 27 Feb 2023 10:56:36 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/gender-equity-eular-task-force</link>
      <itunes:duration>00:29:03</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, Dr. Javier Rodríguez-Carrio talks to Dr. Pavel Ovseiko and Prof. Laura Coates about the recent paper on gender equity in academic rheumatology which emerged from a EULAR task force. They discuss the current situation of gender equity in academic rheumatology across Europe, the pros and cons of potential interventions to accelerate gender-equitable career advancement in this field and how and these be applied in the short- and long-term. Link to the viewpoint: https://rmdopen.bmj.com/content/8/2/e002518.long
Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864</itunes:summary>
      <itunes:subtitle>In this podcast, Dr. Javier Rodríguez-Carrio talk…</itunes:subtitle>
      <description>In this podcast, Dr. Javier Rodríguez-Carrio talks to Dr. Pavel Ovseiko and Prof. Laura Coates about the recent paper on gender equity in academic rheumatology which emerged from a EULAR task force. They discuss the current situation of gender equity in academic rheumatology across Europe, the pros and cons of potential interventions to accelerate gender-equitable career advancement in this field and how and these be applied in the short- and long-term. Link to the viewpoint: https://rmdopen.bmj.com/content/8/2/e002518.long
Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864</description>
      <enclosure length="27897520" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1452220744-bmjpodcasts-gender-equity-eular-task-force.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-RBy4yW4w2fQwHxFA-MLRZdA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1456880497</guid>
      <title>Atoms: the highlights from the ADC March 2023</title>
      <pubDate>Mon, 27 Feb 2023 10:55:02 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-march-2023</link>
      <itunes:duration>00:14:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the March 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/3/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the March 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/3/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="14269543" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1456880497-bmjpodcasts-atoms-the-highlights-from-the-adc-march-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-kLlv8zTGLsUJHKA6-oCDiuQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1453699051</guid>
      <title>Women and non-ST elevation ACS - what's the evidence base?</title>
      <pubDate>Mon, 27 Feb 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/women-and-non-st-elevation-acs-whats-the-evidence-base</link>
      <itunes:duration>00:22:36</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Vijay Kunadian from Newcastle, UK. They discuss all aspects of NSTEACS in women - from risk factors to management and outcomes, plus what we all need to do to improve matters. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://heart.bmj.com/content/108/21/1682
https://www.thelancet.com/commissions/women-cardiovascular-disease</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Vijay Kunadian from Newcastle, UK. They discuss all aspects of NSTEACS in women - from risk factors to management and outcomes, plus what we all need to do to improve matters. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://heart.bmj.com/content/108/21/1682
https://www.thelancet.com/commissions/women-cardiovascular-disease</description>
      <enclosure length="54254764" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1453699051-bmjpodcasts-women-and-non-st-elevation-acs-whats-the-evidence-base.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Xy3y1e3ydlFjQYaY-vPcZPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1455254077</guid>
      <title>Talk Evidence - masks, chronic pain, and baby milk formulae claims</title>
      <pubDate>Fri, 24 Feb 2023 23:46:20 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-masks-chronic-pain-and-baby-milk-formulae-claims</link>
      <itunes:duration>00:38:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of Talk Evidence, Helen Macdonald is joined by Juan Franco and Joe Ross, to bring you the newest evidence in The BMJ.

First, chronic pain. As prescribers move away from opioids, Juan finds an overview of systematic reviews asking whether anti-depressants might help. 

Joe finds new research on the link between six healthy lifestyle markers and cognitive decline. 

Helen looks at a trial to reduce prescribing among older people with suspected urinary tract infection or UTI.

Juan has a nuanced take on the updated evidence on masks to reduce the spread of respiratory viruses. 

Finally, an international group of researchers traced the health claims made about infant formula milk back to the evidence or lack of it 

Reading list:
Efficacy, safety, and tolerability of antidepressants for pain in adults
https://www.bmj.com/content/380/bmj-2022-072415

Association between healthy lifestyle and memory decline in older adults
https://www.bmj.com/content/380/bmj-2022-072691

Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults 
https://www.bmj.com/content/380/bmj-2022-072319

Physical interventions to interrupt or reduce the spread of respiratory viruses
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006207.pub6/full

Health and nutrition claims for infant formula
https://www.bmj.com/content/380/bmj-2022-071075</itunes:summary>
      <itunes:subtitle>In this episode of Talk Evidence, Helen Macdonald…</itunes:subtitle>
      <description>In this episode of Talk Evidence, Helen Macdonald is joined by Juan Franco and Joe Ross, to bring you the newest evidence in The BMJ.

First, chronic pain. As prescribers move away from opioids, Juan finds an overview of systematic reviews asking whether anti-depressants might help. 

Joe finds new research on the link between six healthy lifestyle markers and cognitive decline. 

Helen looks at a trial to reduce prescribing among older people with suspected urinary tract infection or UTI.

Juan has a nuanced take on the updated evidence on masks to reduce the spread of respiratory viruses. 

Finally, an international group of researchers traced the health claims made about infant formula milk back to the evidence or lack of it 

Reading list:
Efficacy, safety, and tolerability of antidepressants for pain in adults
https://www.bmj.com/content/380/bmj-2022-072415

Association between healthy lifestyle and memory decline in older adults
https://www.bmj.com/content/380/bmj-2022-072691

Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults 
https://www.bmj.com/content/380/bmj-2022-072319

Physical interventions to interrupt or reduce the spread of respiratory viruses
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006207.pub6/full

Health and nutrition claims for infant formula
https://www.bmj.com/content/380/bmj-2022-071075</description>
      <enclosure length="54652618" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1455254077-bmjpodcasts-talk-evidence-masks-chronic-pain-and-baby-milk-formulae-claims.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-CSg4F6Zi1aMOEbTy-tgfxkw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1451087551</guid>
      <title>Penicillin allergy, lecanemab and Alzeimer's disease, a new oral contraceptive and statins for all</title>
      <pubDate>Wed, 22 Feb 2023 10:45:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-march-2023</link>
      <itunes:duration>00:30:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the March 2023 issue of DTB. They discuss incorrect penicillin allergy labels and ways that these can be corrected (https://dtb.bmj.com/content/61/3/34). They review clinical trial results for lecanameb in early Alzheimer's disease (https://dtb.bmj.com/content/61/3/37) and also talk about a new combined oral contraceptive that contains estetrol and drospirenone (https://dtb.bmj.com/content/61/3/39). They begin by discussing a proposal from the National Institute for Health and Care Excellence to lower the threshold for offering statins for primary prevention.

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the March 2023 issue of DTB. They discuss incorrect penicillin allergy labels and ways that these can be corrected (https://dtb.bmj.com/content/61/3/34). They review clinical trial results for lecanameb in early Alzheimer's disease (https://dtb.bmj.com/content/61/3/37) and also talk about a new combined oral contraceptive that contains estetrol and drospirenone (https://dtb.bmj.com/content/61/3/39). They begin by discussing a proposal from the National Institute for Health and Care Excellence to lower the threshold for offering statins for primary prevention.

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="72186774" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1451087551-bmjpodcasts-dtb-march-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Cl3ATBXNl3Qnbrqh-zfdELQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1451379478</guid>
      <title>BJSM Concussion through my eyes, Dr Richard Weiler on blind football and concussion. ep #525</title>
      <pubDate>Mon, 20 Feb 2023 17:06:40 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/bjsm-concussion-through-my-eyes-with-dr-richard-weiler-20-feb-2023</link>
      <itunes:duration>00:18:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>BJSM’s Liam West talks to Dr. Richard Weiler about concussion in Para Sport. Dr. Weiler and colleagues have investigated concussion experiences of blind male footballers turning up some very interesting results. To ensure that these findings are accessible to visually impaired individuals, they have gone down the novel route of creating an audio file of the entire paper – the link for this can be found below.

Links -

"Concussion through my eyes" audio paper
https://on.soundcloud.com/XQb2T

Concussion in para sport: the first position statement of the Concussion in Para Sport (CIPS) Group - https://bjsm.bmj.com/content/55/21/1187

https://bjsm.bmj.com/content/early/2023/02/14/bjsports-2022-106256</itunes:summary>
      <itunes:subtitle>BJSM’s Liam West talks to Dr. Richard Weiler abou…</itunes:subtitle>
      <description>BJSM’s Liam West talks to Dr. Richard Weiler about concussion in Para Sport. Dr. Weiler and colleagues have investigated concussion experiences of blind male footballers turning up some very interesting results. To ensure that these findings are accessible to visually impaired individuals, they have gone down the novel route of creating an audio file of the entire paper – the link for this can be found below.

Links -

"Concussion through my eyes" audio paper
https://on.soundcloud.com/XQb2T

Concussion in para sport: the first position statement of the Concussion in Para Sport (CIPS) Group - https://bjsm.bmj.com/content/55/21/1187

https://bjsm.bmj.com/content/early/2023/02/14/bjsports-2022-106256</description>
      <enclosure length="44543999" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1451379478-bmjpodcasts-bjsm-concussion-through-my-eyes-with-dr-richard-weiler-20-feb-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1447001299</guid>
      <title>Updates on Germ Cell Tumors with David Gershenson</title>
      <pubDate>Mon, 20 Feb 2023 11:00:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/updates-on-germ-cell-tumors-with-david-gershenson</link>
      <itunes:duration>00:44:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. David M. Gershenson to discuss updates on germ cell tumors. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research or rare ovarian cancers.

 Highlights:
- The treatment of malignant ovarian germ cell tumor has evolved over the last 5 decades to represent one of our most remarkable success stories, with cure in 95+% of patients with stage I/II and approximately 75% of patients with stage III/IV.

- AGCT1531 is a very important trial, which, if positive, will reduce toxicity by extending surveillance to patients with stage IA or IB malignant ovarian germ cell tumors, including grade 2 and 3 immature teratomas, yolk sac tumors, and non-gestational choriocarcinomas and will result in the substitution of carboplatin for cisplatin in the regimen for treatment of stage IC-III.

- Fertility-sparing surgery is possible in the majority of young patients with malignant ovarian germ cell tumor, related to the following: a) 95% are confined to one ovary ; b) approximately 2/3s are stage I; and c) most patients are in their teenage years, 20s, and 30s and have not completed childbearing.

- Major controversies differentiating the treatment of children and adults by pediatric oncologists/pediatric surgeons and gynecologic oncologists, respectively, include the extent of surgical staging and the role of postoperative chemotherapy in patients with pure immature teratoma.

- For patients with malignant ovarian germ cell tumors who recur following primary therapy, BEP is recommended for those who have been treated with surgery alone. For those who have previously received BEP, standard management generally includes high-dose chemotherapy with stem cell rescue.

- Aspects of management of malignant ovarian germ cell tumors that require further study include the role of neoadjuvant chemotherapy and the role of secondary cytoreductive surgery.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. David M. Gershenson to discuss updates on germ cell tumors. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research or rare ovarian cancers.

 Highlights:
- The treatment of malignant ovarian germ cell tumor has evolved over the last 5 decades to represent one of our most remarkable success stories, with cure in 95+% of patients with stage I/II and approximately 75% of patients with stage III/IV.

- AGCT1531 is a very important trial, which, if positive, will reduce toxicity by extending surveillance to patients with stage IA or IB malignant ovarian germ cell tumors, including grade 2 and 3 immature teratomas, yolk sac tumors, and non-gestational choriocarcinomas and will result in the substitution of carboplatin for cisplatin in the regimen for treatment of stage IC-III.

- Fertility-sparing surgery is possible in the majority of young patients with malignant ovarian germ cell tumor, related to the following: a) 95% are confined to one ovary ; b) approximately 2/3s are stage I; and c) most patients are in their teenage years, 20s, and 30s and have not completed childbearing.

- Major controversies differentiating the treatment of children and adults by pediatric oncologists/pediatric surgeons and gynecologic oncologists, respectively, include the extent of surgical staging and the role of postoperative chemotherapy in patients with pure immature teratoma.

- For patients with malignant ovarian germ cell tumors who recur following primary therapy, BEP is recommended for those who have been treated with surgery alone. For those who have previously received BEP, standard management generally includes high-dose chemotherapy with stem cell rescue.

- Aspects of management of malignant ovarian germ cell tumors that require further study include the role of neoadjuvant chemotherapy and the role of secondary cytoreductive surgery.</description>
      <enclosure length="42182431" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1447001299-bmjpodcasts-updates-on-germ-cell-tumors-with-david-gershenson.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1449049915</guid>
      <title>Collapses, guidelines, and how to go forwards - Archimedes March 2023</title>
      <pubDate>Fri, 17 Feb 2023 10:33:57 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/archimedes-march-2023</link>
      <itunes:duration>00:13:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Sudden Unexpected Postnatal Collapse can be a really disturbing event, and one where the whole team need to pull together. A trio of international neonatologists considered if therapeutic hypothermia might be an option for the baby - while we summarise in this podcast their full thoughts are seriously worth a read: https://adc.bmj.com/content/108/3/236.1

We would love for you to be involved in Archi [adc.bmj.com/pages/authors/#archimedes] - and your index problem can be far more mundane, and doesn’t have to be neonatal.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Sudden Unexpected Postnatal Collapse can be a rea…</itunes:subtitle>
      <description>Sudden Unexpected Postnatal Collapse can be a really disturbing event, and one where the whole team need to pull together. A trio of international neonatologists considered if therapeutic hypothermia might be an option for the baby - while we summarise in this podcast their full thoughts are seriously worth a read: https://adc.bmj.com/content/108/3/236.1

We would love for you to be involved in Archi [adc.bmj.com/pages/authors/#archimedes] - and your index problem can be far more mundane, and doesn’t have to be neonatal.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="20102516" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1449049915-bmjpodcasts-archimedes-march-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-kLlv8zTGLsUJHKA6-oCDiuQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1448251537</guid>
      <title>Behind the scenes at The BMJ</title>
      <pubDate>Thu, 16 Feb 2023 13:56:01 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/behind-the-scenes-at-the-bmj</link>
      <itunes:duration>00:48:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Maybe you’ve been following BMJ Student for a really long time, or maybe you’re new to following us. Perhaps you only know about Sharp Scratch, or you’ve written and worked with us before. However much you know about BMJ Student, we hope today’s episode will be a look behind the scenes at what it means to work at The BMJ.

Today we’ve got four current/former Editorial Scholars ready to talk all about our experiences working at The BMJ, as well as how you can get involved via the Clegg Scholarship, the Editorial Scholarship, Sharp Scratch, and writing articles! We’ll dive into any worries we had before joining, and unpick our experiences to hopefully allow you to get a better insight into the inner workings of a medical journal! 

With thanks to Marina Politis and Nicholas Phillips (Clegg Scholars, 2022).

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Maybe you’ve been following BMJ Student for a rea…</itunes:subtitle>
      <description>Maybe you’ve been following BMJ Student for a really long time, or maybe you’re new to following us. Perhaps you only know about Sharp Scratch, or you’ve written and worked with us before. However much you know about BMJ Student, we hope today’s episode will be a look behind the scenes at what it means to work at The BMJ.

Today we’ve got four current/former Editorial Scholars ready to talk all about our experiences working at The BMJ, as well as how you can get involved via the Clegg Scholarship, the Editorial Scholarship, Sharp Scratch, and writing articles! We’ll dive into any worries we had before joining, and unpick our experiences to hopefully allow you to get a better insight into the inner workings of a medical journal! 

With thanks to Marina Politis and Nicholas Phillips (Clegg Scholars, 2022).

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="46160384" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1448251537-bmjpodcasts-behind-the-scenes-at-the-bmj.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1446969712</guid>
      <title>Mark Beattie's UpFront January 2023</title>
      <pubDate>Wed, 15 Feb 2023 10:39:05 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mark-beatties-upfront-january-2023</link>
      <itunes:duration>00:09:37</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The highlights of this edition brought to you by the Editor-in-Chief of Frontline Gastroenterology Mark Beattie.
Read the UpFront of the January 2023 issue of Frontline Gastroenterology:
https://fg.bmj.com/content/14/1/1
The full issue is now online: https://fg.bmj.com/content/14/1
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</itunes:summary>
      <itunes:subtitle>The highlights of this edition brought to you by …</itunes:subtitle>
      <description>The highlights of this edition brought to you by the Editor-in-Chief of Frontline Gastroenterology Mark Beattie.
Read the UpFront of the January 2023 issue of Frontline Gastroenterology:
https://fg.bmj.com/content/14/1/1
The full issue is now online: https://fg.bmj.com/content/14/1
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</description>
      <enclosure length="9242748" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1446969712-bmjpodcasts-mark-beatties-upfront-january-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-CfcjyL6xtyPQKyBz-fmAzIw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1447008085</guid>
      <title>Episode 11: Effects of Hypnosis on Postoperative Opioid Use After Total Knee Arthroplasty</title>
      <pubDate>Tue, 14 Feb 2023 20:48:40 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/effects-of-hypnosis-on-postoperative-opioid-use-after-total-knee-arthroplasty</link>
      <itunes:duration>00:33:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The International Association for the Study of Pain defines pain as: “An unpleasant sensory or emotional experience associated with, or resembling that associated with, actual or potential tissue damage. Pain is both a disease and a symptom.” The inclusion of the word emotional in the definition alludes to the fact that consciousness is part of the pain pathway. Despite the knowledge that neurocognitive aspects of human psychology are intimately related to pain, very little research exists examining behavioral interventions. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins Jessie Markovits, MD, the lead author of “Effects of hypnosis versus enhanced standard of care on postoperative opioid use after total knee arthroplasty: the HYPNO-TKA randomized clinical trial,” first published in June 2022
(https://rapm.bmj.com/content/47/9/534). In this provocative study, 64 patients got either a 10-minute hypnosis session or an enhanced control during a hospital medicine pre-op visit before total knee
arthroplasty.

Dr. Jessie Markovits completed medical school at Tulane School of Medicine in New Orleans, followed by an internal medicine residency at Stanford. Her current appointment is associate professor of
medicine, with a courtesy appointment to psychiatry and behavioral sciences at Stanford University. She is board-certified in internal medicine and has developed a perioperative specialization over the past 6 years in her clinical role as surgical co-management hospitalist, primarily for orthopedic surgery.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this
podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical
treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>The International Association for the Study of Pa…</itunes:subtitle>
      <description>The International Association for the Study of Pain defines pain as: “An unpleasant sensory or emotional experience associated with, or resembling that associated with, actual or potential tissue damage. Pain is both a disease and a symptom.” The inclusion of the word emotional in the definition alludes to the fact that consciousness is part of the pain pathway. Despite the knowledge that neurocognitive aspects of human psychology are intimately related to pain, very little research exists examining behavioral interventions. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins Jessie Markovits, MD, the lead author of “Effects of hypnosis versus enhanced standard of care on postoperative opioid use after total knee arthroplasty: the HYPNO-TKA randomized clinical trial,” first published in June 2022
(https://rapm.bmj.com/content/47/9/534). In this provocative study, 64 patients got either a 10-minute hypnosis session or an enhanced control during a hospital medicine pre-op visit before total knee
arthroplasty.

Dr. Jessie Markovits completed medical school at Tulane School of Medicine in New Orleans, followed by an internal medicine residency at Stanford. Her current appointment is associate professor of
medicine, with a courtesy appointment to psychiatry and behavioral sciences at Stanford University. She is board-certified in internal medicine and has developed a perioperative specialization over the past 6 years in her clinical role as surgical co-management hospitalist, primarily for orthopedic surgery.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this
podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical
treatment or for the medical treatment of others.</description>
      <enclosure length="80917436" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1447008085-bmjpodcasts-effects-of-hypnosis-on-postoperative-opioid-use-after-total-knee-arthroplasty.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-rpvV8DL9MQyMH46S-5bhdwg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1446917392</guid>
      <title>Halitosis: an update on diagnosis and management</title>
      <pubDate>Tue, 14 Feb 2023 18:15:49 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/halitosis-an-update-on-diagnosis-and-management</link>
      <itunes:duration>00:14:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Halitosis is common and can affect people of all ages. Severe halitosis is less common but it can affect confidence and quality of life. It can even result in social isolation. So it is important that we get the diagnosis and management of this condition right.

In this BMJ Best Practice podcast on halitosis, Kieran Walsh talks with Professor Stephen Porter, Director of the UCL Eastman Dental Institute in London.

Competing interests: none declared</itunes:summary>
      <itunes:subtitle>Halitosis is common and can affect people of all …</itunes:subtitle>
      <description>Halitosis is common and can affect people of all ages. Severe halitosis is less common but it can affect confidence and quality of life. It can even result in social isolation. So it is important that we get the diagnosis and management of this condition right.

In this BMJ Best Practice podcast on halitosis, Kieran Walsh talks with Professor Stephen Porter, Director of the UCL Eastman Dental Institute in London.

Competing interests: none declared</description>
      <enclosure length="17912896" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1446917392-bmjpodcasts-halitosis-an-update-on-diagnosis-and-management.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-n60PM2czl9YNmony-9rnmoA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1444214929</guid>
      <title>MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study</title>
      <pubDate>Tue, 14 Feb 2023 10:03:06 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/muc5b-telomere-length-and-longitudinal-quantitative-interstitial-lung-changes-the-mesa-lung-study</link>
      <itunes:duration>00:15:27</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Kate Diomede, social media editor at Thorax, speaks with Dr. Anna Podolanczuk(1) and Dr. John Kim(2) about their article, "MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study", published in Thorax:
https://thorax.bmj.com/content/early/2022/08/04/thorax-2021-218139

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

(1) Division of Pulmonary and Critical Care, Weill Cornell Medical College, New York, New York, USA
(2) Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA
Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA

This episode was produced by Letícia Amorim and edited by Brian O'Toole.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</itunes:summary>
      <itunes:subtitle>Dr. Kate Diomede, social media editor at Thorax, …</itunes:subtitle>
      <description>Dr. Kate Diomede, social media editor at Thorax, speaks with Dr. Anna Podolanczuk(1) and Dr. John Kim(2) about their article, "MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study", published in Thorax:
https://thorax.bmj.com/content/early/2022/08/04/thorax-2021-218139

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

(1) Division of Pulmonary and Critical Care, Weill Cornell Medical College, New York, New York, USA
(2) Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA
Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA

This episode was produced by Letícia Amorim and edited by Brian O'Toole.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</description>
      <enclosure length="14840057" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1444214929-bmjpodcasts-muc5b-telomere-length-and-longitudinal-quantitative-interstitial-lung-changes-the-mesa-lung-study.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OrdixQ8Emj6if3z1-OcSPLw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1441479271</guid>
      <title>The Ironman Study with Professor Paul Kalra</title>
      <pubDate>Tue, 14 Feb 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-ironman-study-with-professor-paul-kalra</link>
      <itunes:duration>00:22:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Paul Kalra from Portsmouth, UK, the CI of the Ironman study. They discuss the trial in depth and the implications for future management of heart failure patients.

This episode is sponsored by an educational grant from the Boehringer Ingelheim-Lilly Alliance. The sponsor has no influence over podcast content, the selection of speakers or any associated educational material. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02083-9/fulltext</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Paul Kalra from Portsmouth, UK, the CI of the Ironman study. They discuss the trial in depth and the implications for future management of heart failure patients.

This episode is sponsored by an educational grant from the Boehringer Ingelheim-Lilly Alliance. The sponsor has no influence over podcast content, the selection of speakers or any associated educational material. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02083-9/fulltext</description>
      <enclosure length="55018414" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1441479271-bmjpodcasts-the-ironman-study-with-professor-paul-kalra.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Xy3y1e3ydlFjQYaY-vPcZPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1441322776</guid>
      <title>Molecular Classification and Risk Stratification Endometrial Cancer</title>
      <pubDate>Mon, 13 Feb 2023 11:00:05 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/molecular-classification-and-risk-stratification-endometrial-cancer-with-jenny-mueller-and-bill-zammarrelli</link>
      <itunes:duration>00:36:06</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Jenny Mueller and Bill Zammarrelli to discuss molecular classification and risk stratification in endometrial cancer. Jenny Mueller, MD, is a gynecologic oncologist and assistant attending in the department of surgery at Memorial Sloan Kettering Cancer Center. She leads the endometrial cancer research team at MSKCC with an emphasis on prospective, translational, and collaborative efforts within and across institutions. Bill Zammarrelli, MD, currently works as a gynecologic oncology fellow at Memorial Sloan Kettering Cancer Center. He is a commissioned officer in the US Army and completed his residency at Walter Reed National Military Medical Center. His current research focuses on the genetics of endometrial cancer. 

Highlights:

- PORTEC-1 and GOG-99 risk classifications are discordant for stage I grade 3 endometrioid endometrial carcinoma (EEC).

- Stage I grade 3 EECs of CN-high molecular subtype have a worse 3-year progression-free survival compared to non-CN-high molecular subtypes.

- Molecular classification in combination with clinicopathologic factors may provide improved prognostic information.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Jenny Mueller and Bill Zammarrelli to discuss molecular classification and risk stratification in endometrial cancer. Jenny Mueller, MD, is a gynecologic oncologist and assistant attending in the department of surgery at Memorial Sloan Kettering Cancer Center. She leads the endometrial cancer research team at MSKCC with an emphasis on prospective, translational, and collaborative efforts within and across institutions. Bill Zammarrelli, MD, currently works as a gynecologic oncology fellow at Memorial Sloan Kettering Cancer Center. He is a commissioned officer in the US Army and completed his residency at Walter Reed National Military Medical Center. His current research focuses on the genetics of endometrial cancer. 

Highlights:

- PORTEC-1 and GOG-99 risk classifications are discordant for stage I grade 3 endometrioid endometrial carcinoma (EEC).

- Stage I grade 3 EECs of CN-high molecular subtype have a worse 3-year progression-free survival compared to non-CN-high molecular subtypes.

- Molecular classification in combination with clinicopathologic factors may provide improved prognostic information.</description>
      <enclosure length="34479004" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1441322776-bmjpodcasts-molecular-classification-and-risk-stratification-endometrial-cancer-with-jenny-mueller-and-bill-zammarrelli.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1444182604</guid>
      <title>Got grit?</title>
      <pubDate>Fri, 10 Feb 2023 17:26:33 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/got-grit</link>
      <itunes:duration>00:53:30</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Grit is one of those concepts (like the dreaded resilience) that has a specific meaning, but has become a buzzword in healthcare.
It’s the ability to persevere in the pursuit of a goal, in the face of obstacles - and it’s something all doctors have. 

However that trait has benefits and drawbacks. It’s not necessarily fixed, but will depend on context, and it is measurable but not a very helpful measure in isolation.

In this episode, Clara Munro is joined by Declan Murphy and Ayisha Ashmore - and they sit down with neurourgeon and researcher Simone Betchen, who has measured grit in women surgeons, and helps them understand their grit scores.

Reading list
Grit in surgeons
https://pubmed.ncbi.nlm.nih.gov/34218313/</itunes:summary>
      <itunes:subtitle>Grit is one of those concepts (like the dreaded r…</itunes:subtitle>
      <description>Grit is one of those concepts (like the dreaded resilience) that has a specific meaning, but has become a buzzword in healthcare.
It’s the ability to persevere in the pursuit of a goal, in the face of obstacles - and it’s something all doctors have. 

However that trait has benefits and drawbacks. It’s not necessarily fixed, but will depend on context, and it is measurable but not a very helpful measure in isolation.

In this episode, Clara Munro is joined by Declan Murphy and Ayisha Ashmore - and they sit down with neurourgeon and researcher Simone Betchen, who has measured grit in women surgeons, and helps them understand their grit scores.

Reading list
Grit in surgeons
https://pubmed.ncbi.nlm.nih.gov/34218313/</description>
      <enclosure length="51368960" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1444182604-bmjpodcasts-got-grit.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-o9X3NxDz5qvalN5Q-0EjxEQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1444096144</guid>
      <title>Let's Get Physical Activity Messaging Right With Dr Chloë Williamson EP# 524</title>
      <pubDate>Fri, 10 Feb 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/lets-get-physical-activity-messaging-right-with-dr-chloe-williamson-ep-524</link>
      <itunes:duration>00:22:48</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, we host Dr Chloë Williamson (Twitter @Chlobobs). Chloë is a Postdoctoral Fellow in Physical Activity for Health based in the Physical Activity for Health Research Centre at the University of Edinburgh.  Her research (including PhD) over the past 4 years or so has focused on physical activity communication and messaging. We all know that physical activity is important but it is equally important to consider how PA messaging is delivered. Chloë  provides a great overview on the findings of her research to date and her work on the development of a translational tool to bring PA messaging research into practice. In this podcast, we discuss on:
The framework of PA messaging and how to use it
Key points to focus on and consider when delivering PA messages
How we can use the framework findings to engage different partners and organisations 
How we can make PA attractive to our target audience

Get the Message? A scoping review of physical activity messaging. https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-020-00954-3

A modified Delphi study to enhance and gain international consensus on the Physical Activity Messaging Framework (PAMF) and Checklist (PAMC): https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-021-01182-z

Physical Activity Messaging Framework (PAMF) and Checklist (PAMC): International consensus statement and user guide. https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-021-01230-8

How can we better promote physical activity to the public through messaging? https://blogs.bmj.com/bjsm/2020/11/10/how-can-we-better-promote-physical-activity-to-the-public-through-messaging/

Infographic: Walking on sunshine: scoping review of the evidence for walking and mental health: https://bjsm.bmj.com/content/53/14/903</itunes:summary>
      <itunes:subtitle>In this podcast, we host Dr Chloë Williamson (Twi…</itunes:subtitle>
      <description>In this podcast, we host Dr Chloë Williamson (Twitter @Chlobobs). Chloë is a Postdoctoral Fellow in Physical Activity for Health based in the Physical Activity for Health Research Centre at the University of Edinburgh.  Her research (including PhD) over the past 4 years or so has focused on physical activity communication and messaging. We all know that physical activity is important but it is equally important to consider how PA messaging is delivered. Chloë  provides a great overview on the findings of her research to date and her work on the development of a translational tool to bring PA messaging research into practice. In this podcast, we discuss on:
The framework of PA messaging and how to use it
Key points to focus on and consider when delivering PA messages
How we can use the framework findings to engage different partners and organisations 
How we can make PA attractive to our target audience

Get the Message? A scoping review of physical activity messaging. https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-020-00954-3

A modified Delphi study to enhance and gain international consensus on the Physical Activity Messaging Framework (PAMF) and Checklist (PAMC): https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-021-01182-z

Physical Activity Messaging Framework (PAMF) and Checklist (PAMC): International consensus statement and user guide. https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-021-01230-8

How can we better promote physical activity to the public through messaging? https://blogs.bmj.com/bjsm/2020/11/10/how-can-we-better-promote-physical-activity-to-the-public-through-messaging/

Infographic: Walking on sunshine: scoping review of the evidence for walking and mental health: https://bjsm.bmj.com/content/53/14/903</description>
      <enclosure length="54720260" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1444096144-bmjpodcasts-lets-get-physical-activity-messaging-right-with-dr-chloe-williamson-ep-524.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1442564386</guid>
      <title>Mechanical thrombectomy decision making and prognostication: SATIN study</title>
      <pubDate>Thu, 09 Feb 2023 09:42:53 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mechanical-thrombectomy-decision-making-and-prognostication-satin-study</link>
      <itunes:duration>00:28:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Kyle Fargen(1) about the recently published study "Mechanical thrombectomy decision making and prognostication: Stroke treatment Assessments prior to Thrombectomy In Neurointervention (SATIN) study" - https://jnis.bmj.com/content/early/2023/01/05/jnis-2022-019741.long

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was produced and edited by Brian O'Toole.

(1) Neurological Surgery and Radiology, Wake Forest University, Winston-Salem, North Carolina, USA</itunes:summary>
      <itunes:subtitle>In this podcast, JNIS Editor-in-Chief, Dr. Felipe…</itunes:subtitle>
      <description>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Kyle Fargen(1) about the recently published study "Mechanical thrombectomy decision making and prognostication: Stroke treatment Assessments prior to Thrombectomy In Neurointervention (SATIN) study" - https://jnis.bmj.com/content/early/2023/01/05/jnis-2022-019741.long

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was produced and edited by Brian O'Toole.

(1) Neurological Surgery and Radiology, Wake Forest University, Winston-Salem, North Carolina, USA</description>
      <enclosure length="27142268" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1442564386-bmjpodcasts-mechanical-thrombectomy-decision-making-and-prognostication-satin-study.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1439213467</guid>
      <title>MIS in Recurrent Ovarian Cancer</title>
      <pubDate>Mon, 06 Feb 2023 11:00:20 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mis-in-recurrent-ovarian-cancer</link>
      <itunes:duration>00:36:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Professor Giovanni Scambia and Dr. Carmine Conte to discuss mildly invasive surgery in ovarian cancer. Prof. Scambia is the Director of the Gynecologic Oncology Unit and the Scientific Director of Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, Italy. He is Full Professor of Obstetrics and Gynaecology, at Catholic University in Rome, and Member of Consiglio Superiore di Sanità, Ministry of Health Italy and Vice President 1st Section of Consiglio Superiore di Sanità. He is President Elect of E.S.G.E. (European Society for Gynaecological Endoscopy), and Past President of the Italian Society of Obstetrics and Gynecology (S.I.G.O.). Prof. Scambia is specialized in gynaecological cancer treatment and research. He has studied and developed innovative surgical approaches for the cure of gynecological cancers and has been invited professor in several academic hospitals both in Europe and outside Europe, and he is considered an opinion leader in the field of gynecologic oncology. Dr. Carmine Conte works at the Gynecologic Oncology Unit at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, Italy. He got the ESGO Fellowship diploma and is recognized as a certified European Gynaecological Oncologist. Dr. Conte is a surgeon and researcher with special interest in minimally invasive surgery (laparoscopy and robotic) to treat cancerous and noncancerous diseases of the female reproductive system.

 Highlights:

- The patients with oligometastatic recurrent disease had a higher likelihood of minimally invasive secondary cytoreductive surgery.

- Lymphnodal recurrences can be easily approached by MIS.

- Propensity-matched analysis showed no differences in survival between the MIS and open groups, with a higher rate of overall and severe early complications in the open group.

- Diagnostic laparoscopy and PET/CT scan should be considered complementary because of the potential of each one to identify a different disease setting.

- A diagnostic laparoscopy before secondary cytoreductive surgery may prevent unnecessary laparotomies.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Professor Giovanni Scambia and Dr. Carmine Conte to discuss mildly invasive surgery in ovarian cancer. Prof. Scambia is the Director of the Gynecologic Oncology Unit and the Scientific Director of Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, Italy. He is Full Professor of Obstetrics and Gynaecology, at Catholic University in Rome, and Member of Consiglio Superiore di Sanità, Ministry of Health Italy and Vice President 1st Section of Consiglio Superiore di Sanità. He is President Elect of E.S.G.E. (European Society for Gynaecological Endoscopy), and Past President of the Italian Society of Obstetrics and Gynecology (S.I.G.O.). Prof. Scambia is specialized in gynaecological cancer treatment and research. He has studied and developed innovative surgical approaches for the cure of gynecological cancers and has been invited professor in several academic hospitals both in Europe and outside Europe, and he is considered an opinion leader in the field of gynecologic oncology. Dr. Carmine Conte works at the Gynecologic Oncology Unit at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, Italy. He got the ESGO Fellowship diploma and is recognized as a certified European Gynaecological Oncologist. Dr. Conte is a surgeon and researcher with special interest in minimally invasive surgery (laparoscopy and robotic) to treat cancerous and noncancerous diseases of the female reproductive system.

 Highlights:

- The patients with oligometastatic recurrent disease had a higher likelihood of minimally invasive secondary cytoreductive surgery.

- Lymphnodal recurrences can be easily approached by MIS.

- Propensity-matched analysis showed no differences in survival between the MIS and open groups, with a higher rate of overall and severe early complications in the open group.

- Diagnostic laparoscopy and PET/CT scan should be considered complementary because of the potential of each one to identify a different disease setting.

- A diagnostic laparoscopy before secondary cytoreductive surgery may prevent unnecessary laparotomies.</description>
      <enclosure length="34650905" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1439213467-bmjpodcasts-mis-in-recurrent-ovarian-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1439574679</guid>
      <title>Is it time for the Beano to drop the junk food brands?</title>
      <pubDate>Sat, 04 Feb 2023 10:20:50 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/is-it-time-for-the-beano-to-drop-the-junk-food-brands</link>
      <itunes:duration>00:17:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Claire Mulrenan, specialist registrar in public health, and Mark Petticrew, professor of public health evaluation, both working at the London School of Hygiene and Tropical medicine were surprised to see high-fat, high-salt fast food brands being featured heavily on the website of one of the UK's most beloved children's comics.
In this podcast, they describe why they think that is harmful, and why the Beano should think again about its editorial policies, to protect children's health.
To read the full investigation: www.bmj.com/content/380/bmj.p197</itunes:summary>
      <itunes:subtitle>Claire Mulrenan, specialist registrar in public h…</itunes:subtitle>
      <description>Claire Mulrenan, specialist registrar in public health, and Mark Petticrew, professor of public health evaluation, both working at the London School of Hygiene and Tropical medicine were surprised to see high-fat, high-salt fast food brands being featured heavily on the website of one of the UK's most beloved children's comics.
In this podcast, they describe why they think that is harmful, and why the Beano should think again about its editorial policies, to protect children's health.
To read the full investigation: www.bmj.com/content/380/bmj.p197</description>
      <enclosure length="25285360" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1439574679-bmjpodcasts-is-it-time-for-the-beano-to-drop-the-junk-food-brands.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-P3zbxLO5QrUap1dM-VDkM3Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1439573518</guid>
      <title>Reproductive coercion and narrative medicine with Annabel Sowemimo and John Launer</title>
      <pubDate>Sat, 04 Feb 2023 10:17:24 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reproductive-coercion-and-narrative-medicine-with-annabel-sowemimo-and-john-launer</link>
      <itunes:duration>00:46:36</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Reproductive coercion may feel like something that we don’t see very often in general practice, but a 2022 poll carried out for BBC Radio 4 of 1,060 UK women between the ages of 18 and 44 found that half of them had experienced some form of reproductive coercion. This week, we speak to returning guest Annabel Sowemimo about the various forms that reproductive coercion can take, and who might be at risk of experiencing it. We discuss how we, as GPs, can identify these patients, and, once we’ve done so, how we might be able to help them. Later on, we talk to our BMJ columnist, John Launer, about how narrative medicine approaches can help to reach a better &amp; more satisfying resolution to a consultation “puzzle” for you and for the patient.


Our guests:

Annabel Sowemimo is a community sexual health registrar, based in Leicester. She is also a PhD candidate at King’s College London, and is the co-founder of the charity Reproductive Justice Initiative.

John Launer is a GP educator, working for Health Education England. He is also a freelance educator and writer, as well as being a columnist for ‘The BMJ’.


Further reading:

‘How to recognise and respond to reproductive coercion’. BMJ 2022;378:e069043. https://www.bmj.com/content/378/bmj-2021-069043

‘John Launer: The art of paying attention’. BMJ 2022;378:o2294. https://www.bmj.com/content/378/bmj.o2294

‘Careful, kind care is our compass out of the pandemic fog’. BMJ 2022;379:e073444. https://www.bmj.com/content/379/bmj-2022-073444</itunes:summary>
      <itunes:subtitle>Reproductive coercion may feel like something tha…</itunes:subtitle>
      <description>Reproductive coercion may feel like something that we don’t see very often in general practice, but a 2022 poll carried out for BBC Radio 4 of 1,060 UK women between the ages of 18 and 44 found that half of them had experienced some form of reproductive coercion. This week, we speak to returning guest Annabel Sowemimo about the various forms that reproductive coercion can take, and who might be at risk of experiencing it. We discuss how we, as GPs, can identify these patients, and, once we’ve done so, how we might be able to help them. Later on, we talk to our BMJ columnist, John Launer, about how narrative medicine approaches can help to reach a better &amp; more satisfying resolution to a consultation “puzzle” for you and for the patient.


Our guests:

Annabel Sowemimo is a community sexual health registrar, based in Leicester. She is also a PhD candidate at King’s College London, and is the co-founder of the charity Reproductive Justice Initiative.

John Launer is a GP educator, working for Health Education England. He is also a freelance educator and writer, as well as being a columnist for ‘The BMJ’.


Further reading:

‘How to recognise and respond to reproductive coercion’. BMJ 2022;378:e069043. https://www.bmj.com/content/378/bmj-2021-069043

‘John Launer: The art of paying attention’. BMJ 2022;378:o2294. https://www.bmj.com/content/378/bmj.o2294

‘Careful, kind care is our compass out of the pandemic fog’. BMJ 2022;379:e073444. https://www.bmj.com/content/379/bmj-2022-073444</description>
      <enclosure length="67030492" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1439573518-bmjpodcasts-reproductive-coercion-and-narrative-medicine-with-annabel-sowemimo-and-john-launer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8i9LTpkaLEKQ3DNF-EFzLHw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1438079911</guid>
      <title>Sharing is caring</title>
      <pubDate>Thu, 02 Feb 2023 10:14:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sharing-is-caring</link>
      <itunes:duration>00:44:21</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We’ve talked before about how one's own experience of illness can affect their practice, but does it also influence how much you share with your patients?

In today’s episode we’re going to be talking all about physician self-disclosure - that is, all the things we, as future doctors, might share with our patients. We’ll be asking how appropriate it is to share your own stories with a patient and how you know when the timing is right to do this. This week, we’re going to be focusing on stories of illness and health, but we’ll come on to talking about other aspects of our identity in a future episode. 

Expert guests:
Dr John Launer is a medical educator and writer. His background is in general practice and family therapy, and he also has a degree in English literature. He now devotes his time to medical education and he specialises in interactional skills.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>We’ve talked before about how one's own experienc…</itunes:subtitle>
      <description>We’ve talked before about how one's own experience of illness can affect their practice, but does it also influence how much you share with your patients?

In today’s episode we’re going to be talking all about physician self-disclosure - that is, all the things we, as future doctors, might share with our patients. We’ll be asking how appropriate it is to share your own stories with a patient and how you know when the timing is right to do this. This week, we’re going to be focusing on stories of illness and health, but we’ll come on to talking about other aspects of our identity in a future episode. 

Expert guests:
Dr John Launer is a medical educator and writer. His background is in general practice and family therapy, and he also has a degree in English literature. He now devotes his time to medical education and he specialises in interactional skills.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="42577664" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1438079911-bmjpodcasts-sharing-is-caring.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1436533462</guid>
      <title>Primary Survey - the highlights of February 2023</title>
      <pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-february-23</link>
      <itunes:duration>00:29:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The best of the papers from our February 2023 issue, covered by Sarah Edwards and Rick Body. This month we cover great papers on COVID-19 and wellbeing, domestic violence and the diagnosis of testicular torsion.
Read the highlights: https://emj.bmj.com/content/40/2/83.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>The best of the papers from our February 2023 iss…</itunes:subtitle>
      <description>The best of the papers from our February 2023 issue, covered by Sarah Edwards and Rick Body. This month we cover great papers on COVID-19 and wellbeing, domestic violence and the diagnosis of testicular torsion.
Read the highlights: https://emj.bmj.com/content/40/2/83.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="27956870" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1436533462-bmjpodcasts-emj-february-23.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1428551800</guid>
      <title>ADC Fetal and Neonatal’s Fantoms. Highlights from the January 2023 issue</title>
      <pubDate>Thu, 02 Feb 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adc-fantoms-january-2023</link>
      <itunes:duration>00:22:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the January 2023 issue. The Fantoms article: https://fn.bmj.com/content/108/1/1
Additional links:
Helix trial: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00264-3/fulltext 
Premiloc study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)00202-6/fulltext 
SToP BPD study: https://jamanetwork.com/journals/jama/fullarticle/2722773
Early amino acids in preterm infants and neurodisability at 2 years: https://www.nejm.org/doi/full/10.1056/NEJMoa2204886?query=recirc_curatedRelated_article 
Commentary on early amino acid study: https://www.nejm.org/doi/full/10.1056/NEJMe2212522 
Commentary on steroids and risk modification: https://fn.bmj.com/content/103/6/F500
Neoprom metaanalysis - https://pubmed.ncbi.nlm.nih.gov/29872859/
Boost II trial - https://www.nejm.org/doi/full/10.1056/nejmoa1514212

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>ADC Fetal and Neonatal’s Associate Editor, Jonath…</itunes:subtitle>
      <description>ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the January 2023 issue. The Fantoms article: https://fn.bmj.com/content/108/1/1
Additional links:
Helix trial: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00264-3/fulltext 
Premiloc study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)00202-6/fulltext 
SToP BPD study: https://jamanetwork.com/journals/jama/fullarticle/2722773
Early amino acids in preterm infants and neurodisability at 2 years: https://www.nejm.org/doi/full/10.1056/NEJMoa2204886?query=recirc_curatedRelated_article 
Commentary on early amino acid study: https://www.nejm.org/doi/full/10.1056/NEJMe2212522 
Commentary on steroids and risk modification: https://fn.bmj.com/content/103/6/F500
Neoprom metaanalysis - https://pubmed.ncbi.nlm.nih.gov/29872859/
Boost II trial - https://www.nejm.org/doi/full/10.1056/nejmoa1514212

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="21127417" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1428551800-bmjpodcasts-adc-fantoms-january-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-rUdNSW2WrRz68y0N-3UpxXg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1426388473</guid>
      <title>Editors Highlights of the February 2023 issue</title>
      <pubDate>Tue, 31 Jan 2023 11:04:53 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-february-2023-issue</link>
      <itunes:duration>00:42:39</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the February 2023 issue of the journal (https://pn.bmj.com/content/23/1/1).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</itunes:summary>
      <itunes:subtitle>Practical Neurology Editors Phil Smith and Gerain…</itunes:subtitle>
      <description>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the February 2023 issue of the journal (https://pn.bmj.com/content/23/1/1).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</description>
      <enclosure length="40948296" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1426388473-bmjpodcasts-editors-highlights-of-the-february-2023-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1430225158</guid>
      <title>Swapping to edoxaban, DOACs in renal impairment, inflammatory rheumatic diseases in pregnancy</title>
      <pubDate>Tue, 31 Jan 2023 09:44:15 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-february-2023</link>
      <itunes:duration>00:25:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the February 2023 issue of DTB. They discuss concerns over a national initiative in England to transfer people with atrial fibrillation to edoxaban from other DOACs (https://dtb.bmj.com/content/61/2/18). They review a study that examined whether the correct dose of DOAC was used in people with renal impairment (https://dtb.bmj.com/content/61/2/21). They talk about the use of empagliflozin in people with heart failure (https://dtb.bmj.com/content/61/2/22) and finish with an overview of an article that discusses prescribing for pregnancy for those with inflammatory rheumatic disease (https://dtb.bmj.com/content/61/2/24).

60th anniversary interview with Dr John Dowden: https://soundcloud.com/bmjpodcasts/dtb-60th-anniversary-podcast-interview-john-dowden

Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014–2019): https://heart.bmj.com/content/109/3/195

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the February 2023 issue of DTB. They discuss concerns over a national initiative in England to transfer people with atrial fibrillation to edoxaban from other DOACs (https://dtb.bmj.com/content/61/2/18). They review a study that examined whether the correct dose of DOAC was used in people with renal impairment (https://dtb.bmj.com/content/61/2/21). They talk about the use of empagliflozin in people with heart failure (https://dtb.bmj.com/content/61/2/22) and finish with an overview of an article that discusses prescribing for pregnancy for those with inflammatory rheumatic disease (https://dtb.bmj.com/content/61/2/24).

60th anniversary interview with Dr John Dowden: https://soundcloud.com/bmjpodcasts/dtb-60th-anniversary-podcast-interview-john-dowden

Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014–2019): https://heart.bmj.com/content/109/3/195

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="60829091" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1430225158-bmjpodcasts-dtb-february-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Cl3ATBXNl3Qnbrqh-zfdELQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1433649043</guid>
      <title>Assessing the impact of dietary fibre on bile acid transformation by gut bacteria in mice</title>
      <pubDate>Tue, 31 Jan 2023 05:00:28 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/impact-of-dietary-fibre-on-bile-acid-transformation</link>
      <itunes:duration>00:10:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Fredrik Bäckhed, The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden on the paper '6α-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice' published in paper copy in Gut in February 2023, and available online: https://gut.bmj.com/content/72/2/314

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Fredrik Bäckhed, The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden on the paper '6α-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice' published in paper copy in Gut in February 2023, and available online: https://gut.bmj.com/content/72/2/314

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="9808665" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1433649043-bmjpodcasts-impact-of-dietary-fibre-on-bile-acid-transformation.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-6HXcviXXzJAzykGu-yf1bhg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1432637980</guid>
      <title>Diagnosis, Risk Stratification and Management of Myocarditis</title>
      <pubDate>Tue, 31 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/diagnosis-risk-stratification-and-management-of-myocarditis</link>
      <itunes:duration>00:23:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Bettina Heidecker from Berlin to discuss all aspects of myocarditis. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/108/18/1486.full</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Bettina Heidecker from Berlin to discuss all aspects of myocarditis. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/108/18/1486.full</description>
      <enclosure length="55394812" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1432637980-bmjpodcasts-diagnosis-risk-stratification-and-management-of-myocarditis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Xy3y1e3ydlFjQYaY-vPcZPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1431808333</guid>
      <title>Prolonged Maintenance with Bevacizumab (BOOST Trial) with Jacobus Pfisterer and Philipp Harter</title>
      <pubDate>Mon, 30 Jan 2023 11:00:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/prolonged-maintenance-with-bevacizumab-boost-trial-with-jacobus-pfisterer-and-philipp-harter</link>
      <itunes:duration>00:32:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Professors Jacobus Pfisterer and Philipp Harter to discuss prolonged maintenance with bevacizumab. Prof. Philipp Harter is the director of the Department of Gynecology &amp; Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany and the chair of the AGO Study Group. Prof. Jacobus Pfisterer is Director of the Gynecologic Oncology Center in Kiel Germany and former chair of the AGO Study Group. 

 Highlights:

- 30-month bevacizumb maintenance does not improve progression-free survival nor overall survival in advanced ovarian cancer. 

- 30-month bevacizumb maintenance is associated with more adverse events compared to 15 months. 

- 15-month bevacizumb maintenance remains standard of care.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Professors Jacobus Pfisterer and Philipp Harter to discuss prolonged maintenance with bevacizumab. Prof. Philipp Harter is the director of the Department of Gynecology &amp; Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany and the chair of the AGO Study Group. Prof. Jacobus Pfisterer is Director of the Gynecologic Oncology Center in Kiel Germany and former chair of the AGO Study Group. 

 Highlights:

- 30-month bevacizumb maintenance does not improve progression-free survival nor overall survival in advanced ovarian cancer. 

- 30-month bevacizumb maintenance is associated with more adverse events compared to 15 months. 

- 15-month bevacizumb maintenance remains standard of care.</description>
      <enclosure length="30966202" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1431808333-bmjpodcasts-prolonged-maintenance-with-bevacizumab-boost-trial-with-jacobus-pfisterer-and-philipp-harter.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1435620268</guid>
      <title>Osteoarthritis</title>
      <pubDate>Mon, 30 Jan 2023 09:11:05 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/osteoarthritis-1</link>
      <itunes:duration>00:24:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We release episodes fortnightly. Osteoarthritis is the most common form of arthritis. It is more common in women than in men, with incidence increasing sharply around the age of 50. And it can cause complications - including the inability to perform activities of daily living and spinal stenosis in cervical and lumbar osteoarthritis. So it is vital that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast on osteoarthritis, Kieran Walsh talks to Fadi Badlissi, Assistant Professor at Harvard Medical School and Director of the Musculoskeletal Medicine Unit at Beth Israel Deaconess Medical Center in Boston. Competing interests: None</itunes:summary>
      <itunes:subtitle>We release episodes fortnightly. Osteoarthritis i…</itunes:subtitle>
      <description>We release episodes fortnightly. Osteoarthritis is the most common form of arthritis. It is more common in women than in men, with incidence increasing sharply around the age of 50. And it can cause complications - including the inability to perform activities of daily living and spinal stenosis in cervical and lumbar osteoarthritis. So it is vital that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast on osteoarthritis, Kieran Walsh talks to Fadi Badlissi, Assistant Professor at Harvard Medical School and Director of the Musculoskeletal Medicine Unit at Beth Israel Deaconess Medical Center in Boston. Competing interests: None</description>
      <enclosure length="29444896" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1435620268-bmjpodcasts-osteoarthritis-1.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-n60PM2czl9YNmony-9rnmoA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1433867491</guid>
      <title>Talk Evidence - excess deaths, the ONS, and the healthcare crisis</title>
      <pubDate>Fri, 27 Jan 2023 16:37:37 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-excess-deaths-the-ons-and-the-healthcare-crisis</link>
      <itunes:duration>00:52:06</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this week's episode, we're focusing on covid and the ongoing crisis in the NHS.

Helen Macdonald, Juan Franco and Joseph Ross cast their evidence seeking eyes over research into outcomes as well as the workload of doctors.

Firstly, Joe tells us about a new big data study into longer term outcomes after mild covid-19, how those ongoing symptoms relate to long covid, and how often they resolve themselves.

Juan looks back to his homeland to see what Argentina which was very early to offer children vaccinations against covid-19. He tells us how a new study design can help understand how effective different combinations of vaccines were.

Joe has a Danish registry paper, which links people's employment status after a MI, explains how that gives us an insight into morbidity following that event.

Helen looks at a new analysis which outlines the concept of "time needed to treat" - a measure of how much time it would take a clinician to actually carry out a guideline - and you'd be surprised how much GP time would be swallowed by a "brief" intervention to reduce inactivity in their patients.

Finally, the data on excess mortality in the UK has been up for debate recently - our health minister calling into question the Office of National Statistic's data. We hear from Nazrul Islam, Associate professor of medical statistics, advisor to the ONS and BMJ research editor, who has some bad news for him.

Reading list:
Long covid outcomes at one year after mild SARS-CoV-2 infection
https://www.bmj.com/content/380/bmj-2022-072529

Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants
https://www.bmj.com/content/379/bmj-2022-073070


Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953

Expanding the measurement of overdiagnosis in the context of disease precursors and risk factors
https://ebm.bmj.com/content/early/2023/01/10/bmjebm-2022-112117

Excess deaths associated with covid-19 pandemic in 2020
https://www.bmj.com/content/373/bmj.n1137.abstract</itunes:summary>
      <itunes:subtitle>In this week's episode, we're focusing on covid a…</itunes:subtitle>
      <description>In this week's episode, we're focusing on covid and the ongoing crisis in the NHS.

Helen Macdonald, Juan Franco and Joseph Ross cast their evidence seeking eyes over research into outcomes as well as the workload of doctors.

Firstly, Joe tells us about a new big data study into longer term outcomes after mild covid-19, how those ongoing symptoms relate to long covid, and how often they resolve themselves.

Juan looks back to his homeland to see what Argentina which was very early to offer children vaccinations against covid-19. He tells us how a new study design can help understand how effective different combinations of vaccines were.

Joe has a Danish registry paper, which links people's employment status after a MI, explains how that gives us an insight into morbidity following that event.

Helen looks at a new analysis which outlines the concept of "time needed to treat" - a measure of how much time it would take a clinician to actually carry out a guideline - and you'd be surprised how much GP time would be swallowed by a "brief" intervention to reduce inactivity in their patients.

Finally, the data on excess mortality in the UK has been up for debate recently - our health minister calling into question the Office of National Statistic's data. We hear from Nazrul Islam, Associate professor of medical statistics, advisor to the ONS and BMJ research editor, who has some bad news for him.

Reading list:
Long covid outcomes at one year after mild SARS-CoV-2 infection
https://www.bmj.com/content/380/bmj-2022-072529

Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants
https://www.bmj.com/content/379/bmj-2022-073070


Guidelines should consider clinicians’ time needed to treat
https://www.bmj.com/content/380/bmj-2022-072953

Expanding the measurement of overdiagnosis in the context of disease precursors and risk factors
https://ebm.bmj.com/content/early/2023/01/10/bmjebm-2022-112117

Excess deaths associated with covid-19 pandemic in 2020
https://www.bmj.com/content/373/bmj.n1137.abstract</description>
      <enclosure length="50026369" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1433867491-bmjpodcasts-talk-evidence-excess-deaths-the-ons-and-the-healthcare-crisis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-CSg4F6Zi1aMOEbTy-tgfxkw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1433885491</guid>
      <title>Exercise Physiology with Polly de Mille. EP #523</title>
      <pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/exercise-physiology-with-polly-de-mille-ep-523</link>
      <itunes:duration>00:21:45</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Jacob Wessels, MD is joined by Polly de Mille, RN, MA, RCEP, CSCS, USAT, to discuss the topic of Exercise Physiology and how it can help figure out the missing links in training programs.
Polly de Mille is an exercise physiologist and the Director of Performance Services at Hospital for Special Surgery in New York. She will provide the American College of Sports Medicine (T: @ACSMNews) Exchange Lecture titled, “Inside the Running Lab:How to Evaluate Optimal Run Mechanics and Physiology” during the 2023 AMSSM Annual Meeting in Phoenix, AZ.

In this 20-minute conversation, she addresses the following topics:
·	Sharing more information about her work as a certified exercise 
 physiologist at HSS
·	How she and her team can help identify the causes of injuries and help athletes stay healthy in order to reach their goals
·	How her background as a critical care nurse and an avid marathoner led her into the field of exercise physiology
·	The ways she and her colleagues can help improve runner’s outcomes and how many different disciplines come together to play important roles to make that happen
·	The different types of tests used by exercise physiologists and how they use that information to improve performance
·	The possibilities of using nutrition to enhance physiologic training sessions

HSS Sports Rehabilitation and Performance Center: https://www.hss.edu/sports-rehabilitation-and-performance-center.asp</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM Sports Medcast (T: @…</itunes:subtitle>
      <description>On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Jacob Wessels, MD is joined by Polly de Mille, RN, MA, RCEP, CSCS, USAT, to discuss the topic of Exercise Physiology and how it can help figure out the missing links in training programs.
Polly de Mille is an exercise physiologist and the Director of Performance Services at Hospital for Special Surgery in New York. She will provide the American College of Sports Medicine (T: @ACSMNews) Exchange Lecture titled, “Inside the Running Lab:How to Evaluate Optimal Run Mechanics and Physiology” during the 2023 AMSSM Annual Meeting in Phoenix, AZ.

In this 20-minute conversation, she addresses the following topics:
·	Sharing more information about her work as a certified exercise 
 physiologist at HSS
·	How she and her team can help identify the causes of injuries and help athletes stay healthy in order to reach their goals
·	How her background as a critical care nurse and an avid marathoner led her into the field of exercise physiology
·	The ways she and her colleagues can help improve runner’s outcomes and how many different disciplines come together to play important roles to make that happen
·	The different types of tests used by exercise physiologists and how they use that information to improve performance
·	The possibilities of using nutrition to enhance physiologic training sessions

HSS Sports Rehabilitation and Performance Center: https://www.hss.edu/sports-rehabilitation-and-performance-center.asp</description>
      <enclosure length="14852375" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1433885491-bmjpodcasts-exercise-physiology-with-polly-de-mille-ep-523.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1432779376</guid>
      <title>Lower distress or more breathing? - Archimedes February 2023</title>
      <pubDate>Thu, 26 Jan 2023 11:50:31 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/archimedes-february-2023</link>
      <itunes:duration>00:09:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Neonates are a breadth of … well… actually breathing is one of the big issues they have. Adding a squirt of finely curated surfactant we know can help them out, and LISA (less invasive surfactant administration) is probably the best at the job. But it’s pretty stressful having things splashed into your lungs, so should we be giving premedication? Listen on for a short answer, or read the full paper here: https://adc.bmj.com/content/108/2/141.1

We would love for you to be involved and submit your very own Archi [https://adc.bmj.com/pages/authors/#archimedes] - and you’ll be doing the world a favour as we explain in detail too.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Neonates are a breadth of … well… actually breath…</itunes:subtitle>
      <description>Neonates are a breadth of … well… actually breathing is one of the big issues they have. Adding a squirt of finely curated surfactant we know can help them out, and LISA (less invasive surfactant administration) is probably the best at the job. But it’s pretty stressful having things splashed into your lungs, so should we be giving premedication? Listen on for a short answer, or read the full paper here: https://adc.bmj.com/content/108/2/141.1

We would love for you to be involved and submit your very own Archi [https://adc.bmj.com/pages/authors/#archimedes] - and you’ll be doing the world a favour as we explain in detail too.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="8808070" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1432779376-bmjpodcasts-archimedes-february-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Pp2GfzOU4gfJ2wCy-oHl7wQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1432179436</guid>
      <title>Reviewing the January Issue with Andrea Rosati and Anisa Mburu</title>
      <pubDate>Wed, 25 Jan 2023 16:47:23 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reviewing-the-january-issue-with-andrea-rosati-and-anisa-mburu</link>
      <itunes:duration>00:24:46</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC Podcast, Editorial Fellows Andrea Rosati and Anisa Mburu discuss the contents of the January issue of IJGC.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC Podcast, Editorial Fe…</itunes:subtitle>
      <description>In this episode of the IJGC Podcast, Editorial Fellows Andrea Rosati and Anisa Mburu discuss the contents of the January issue of IJGC.</description>
      <enclosure length="23787310" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1432179436-bmjpodcasts-reviewing-the-january-issue-with-andrea-rosati-and-anisa-mburu.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1427092648</guid>
      <title>Precursors of Ovarian Cancer with Elvio Silva</title>
      <pubDate>Mon, 23 Jan 2023 11:00:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/precursors-of-ovarian-cancer-with-elvio-silva</link>
      <itunes:duration>00:38:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Elvio Silva to discuss precursors of ovarian cancer. Dr. Silva received a medical degree from the Universidad de La Plata and has been a faculty member at M.D. Anderson Cancer Center since 1980. He had pathology residences in Buenos Aires, Argentina, and University of Toronto, Canada and is the former President of the International Society of Gynecological Pathologists.

Highlights:

- Most ovarian serous tumors originate in the ovarian stroma.

- Ovarian serous tumors originate in the epithelium of inclusion cysts or in epithelial areas that appear in the stroma due to mesenchymal-epithelial transition.

- Mesenchymal-epithelial transition in serous tumors mimics the development of the Mullerian duct from the celomic mesenchyma.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Elvio Silva to discuss precursors of ovarian cancer. Dr. Silva received a medical degree from the Universidad de La Plata and has been a faculty member at M.D. Anderson Cancer Center since 1980. He had pathology residences in Buenos Aires, Argentina, and University of Toronto, Canada and is the former President of the International Society of Gynecological Pathologists.

Highlights:

- Most ovarian serous tumors originate in the ovarian stroma.

- Ovarian serous tumors originate in the epithelium of inclusion cysts or in epithelial areas that appear in the stroma due to mesenchymal-epithelial transition.

- Mesenchymal-epithelial transition in serous tumors mimics the development of the Mullerian duct from the celomic mesenchyma.</description>
      <enclosure length="36705491" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1427092648-bmjpodcasts-precursors-of-ovarian-cancer-with-elvio-silva.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1426833451</guid>
      <title>What's in a name?</title>
      <pubDate>Thu, 19 Jan 2023 07:00:13 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/whats-in-a-name</link>
      <itunes:duration>00:43:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Some supervisors say "call me Bob'' but others insist on "Doctor Jones". In this episode we're reflecting on what types of supervisors fall into each camp and why sometimes using professional titles feels like honouring someone's hard work, but other times it feels like a way of putting you in your place.

In today’s episode, we’re thinking all about the title “doctor”. We’ll talk about when and how it should be used and discuss our own experiences with this. We’ll also discuss why some people get called ‘doctor’ far less than others, and how titles can sometimes create strange power dynamics and unhealthy hierarchies in medicine.

Expert guests:
Dr Anna Baverstock is a paediatric consultant in Somerset. She has a wellbeing role within the trust and is passionate about kindness, civility and inclusion.
Miss Evelyn Mensah, otherwise known as Evie, is a consultant ophthalmic surgeon in a large acute trust in north west London. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Some supervisors say "call me Bob'' but others in…</itunes:subtitle>
      <description>Some supervisors say "call me Bob'' but others insist on "Doctor Jones". In this episode we're reflecting on what types of supervisors fall into each camp and why sometimes using professional titles feels like honouring someone's hard work, but other times it feels like a way of putting you in your place.

In today’s episode, we’re thinking all about the title “doctor”. We’ll talk about when and how it should be used and discuss our own experiences with this. We’ll also discuss why some people get called ‘doctor’ far less than others, and how titles can sometimes create strange power dynamics and unhealthy hierarchies in medicine.

Expert guests:
Dr Anna Baverstock is a paediatric consultant in Somerset. She has a wellbeing role within the trust and is passionate about kindness, civility and inclusion.
Miss Evelyn Mensah, otherwise known as Evie, is a consultant ophthalmic surgeon in a large acute trust in north west London. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="41540096" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1426833451-bmjpodcasts-whats-in-a-name.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1427606275</guid>
      <title>Atoms: the highlights from the ADC February 2023</title>
      <pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-february-2023</link>
      <itunes:duration>00:14:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the February 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/2/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the February 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/2/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="13671861" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1427606275-bmjpodcasts-atoms-the-highlights-from-the-adc-february-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1426308715</guid>
      <title>Live from the British Thoracic Society (BTS) Winter Meeting 2022</title>
      <pubDate>Wed, 18 Jan 2023 05:00:23 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/live-from-bts-winter-meeting-2022</link>
      <itunes:duration>00:09:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Thorax social media editor, Dr. Puja Mehta, caught up with several Respiratory consultants from across the UK at the British Thoracic Society (BTS) Winter Meeting 2022, and asked them the question, 'What makes the Winter BTS meeting special?'

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</itunes:summary>
      <itunes:subtitle>Thorax social media editor, Dr. Puja Mehta, caugh…</itunes:subtitle>
      <description>Thorax social media editor, Dr. Puja Mehta, caught up with several Respiratory consultants from across the UK at the British Thoracic Society (BTS) Winter Meeting 2022, and asked them the question, 'What makes the Winter BTS meeting special?'

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</description>
      <enclosure length="9051323" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1426308715-bmjpodcasts-live-from-bts-winter-meeting-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OrdixQ8Emj6if3z1-OcSPLw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1422583198</guid>
      <title>Primary Survey - the highlights of January 2023</title>
      <pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-january-23</link>
      <itunes:duration>00:25:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A rundown of some of the best papers we published in the January 2023 edition of the journal. We cover an excellent practice review on the management of pulmonary embolism, going through some of the great pearls of wisdom relevant to our practice. How do you risk stratify patients with PE? What do you treat them with and how do you decide, especially when there are special considerations? When should you use thrombolysis? We cover a national survey of practice for prophyalxis of venous thromboembolism in patients who need lower limb immobilisation, we look at ambulance service configuration (should we have more rapid response vehicles?), we look at the outcomes of children who received 999 ambulance responses but weren't transported to hospital, and we look at whether vitamin D deficiency predicts outcome for patients with severe sepsis.
Read the highlights: https://emj.bmj.com/content/40/1/1.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>A rundown of some of the best papers we published…</itunes:subtitle>
      <description>A rundown of some of the best papers we published in the January 2023 edition of the journal. We cover an excellent practice review on the management of pulmonary embolism, going through some of the great pearls of wisdom relevant to our practice. How do you risk stratify patients with PE? What do you treat them with and how do you decide, especially when there are special considerations? When should you use thrombolysis? We cover a national survey of practice for prophyalxis of venous thromboembolism in patients who need lower limb immobilisation, we look at ambulance service configuration (should we have more rapid response vehicles?), we look at the outcomes of children who received 999 ambulance responses but weren't transported to hospital, and we look at whether vitamin D deficiency predicts outcome for patients with severe sepsis.
Read the highlights: https://emj.bmj.com/content/40/1/1.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="24908276" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1422583198-bmjpodcasts-emj-january-23.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1422024847</guid>
      <title>Transitioning from medicine to industry: general considerations</title>
      <pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/transitioning-from-medicine-to-industry-general-considerations</link>
      <itunes:duration>00:26:37</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast James Rudd is joined by Dr Jennifer Franke, Chief Medical Officer at Philips, and Dr Matthew Daniels from Sana Biotechnology in Seattle. They discuss career pathways outside of clinical medicine. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/10/17/heartjnl-2022-321700</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast James Rudd i…</itunes:subtitle>
      <description>In this episode of the Heart podcast James Rudd is joined by Dr Jennifer Franke, Chief Medical Officer at Philips, and Dr Matthew Daniels from Sana Biotechnology in Seattle. They discuss career pathways outside of clinical medicine. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/10/17/heartjnl-2022-321700</description>
      <enclosure length="63868190" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1422024847-bmjpodcasts-transitioning-from-medicine-to-industry-general-considerations.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Xy3y1e3ydlFjQYaY-vPcZPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1421641741</guid>
      <title>Hormone Replacement Therapy after Cervical Cancer with Jason Wright</title>
      <pubDate>Mon, 16 Jan 2023 11:00:03 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/hormone-replacement-therapy-after-cervical-cancer-with-jason-wright</link>
      <itunes:duration>00:25:18</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Jason Wright to discuss hormone replacement therapy after cervical cancer. Dr. Wright is the Sol Goldman Associate Professor and Chief of the Division of Gynecologic Oncology at Columbia University.

Highlights:

- Among cervical cancer patients &lt;50 years of age who underwent surgery including oophorectomy or primary radiation, only 39% received estrogen replacement therapy.

- In patients who did receive estrogen replacement therapy the duration of use was short, with a median of only 60 days.

- Black patients were significantly less likely to receive estrogen replacement therapy than White patients.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Jason Wright to discuss hormone replacement therapy after cervical cancer. Dr. Wright is the Sol Goldman Associate Professor and Chief of the Division of Gynecologic Oncology at Columbia University.

Highlights:

- Among cervical cancer patients &lt;50 years of age who underwent surgery including oophorectomy or primary radiation, only 39% received estrogen replacement therapy.

- In patients who did receive estrogen replacement therapy the duration of use was short, with a median of only 60 days.

- Black patients were significantly less likely to receive estrogen replacement therapy than White patients.</description>
      <enclosure length="24157528" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1421641741-bmjpodcasts-hormone-replacement-therapy-after-cervical-cancer-with-jason-wright.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1380962797</guid>
      <title>Carotid artery stenosis: an update on diagnosis and management</title>
      <pubDate>Mon, 16 Jan 2023 09:30:03 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/carotid-a-sten</link>
      <itunes:duration>00:32:46</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We release episodes fortnightly. Stroke is the fourth and fifth leading cause of death in the UK and US, respectively. There are more than 100,000 strokes in the UK every year. And approximately 10% to 15% of all ischaemic strokes are associated with carotid artery stenosis. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast on carotid artery stenosis, Kieran Walsh talks to Brajesh Lal, Professor of Vascular Surgery, University of Maryland School of Medicine and Professor of Neurology, Mayo Clinic. 

Competing interests: None</itunes:summary>
      <itunes:subtitle>We release episodes fortnightly. Stroke is the fo…</itunes:subtitle>
      <description>We release episodes fortnightly. Stroke is the fourth and fifth leading cause of death in the UK and US, respectively. There are more than 100,000 strokes in the UK every year. And approximately 10% to 15% of all ischaemic strokes are associated with carotid artery stenosis. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast on carotid artery stenosis, Kieran Walsh talks to Brajesh Lal, Professor of Vascular Surgery, University of Maryland School of Medicine and Professor of Neurology, Mayo Clinic. 

Competing interests: None</description>
      <enclosure length="39328576" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1380962797-bmjpodcasts-carotid-a-sten.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-mxgGilBQ4xPDFULu-IRcQJA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1423186372</guid>
      <title>ACL MYTH BUSTING Part 2 with Prof Jackie Whittaker and Dr Stephanie Filbay. EP #522</title>
      <pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/acl-myth-busting-part-2-with-prof-jackie-whittaker-and-dr-stephanie-filbay-ep-522</link>
      <itunes:duration>00:25:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, Dr Brooke Patterson hosts ACL injury and post-traumatic osteoarthritis leading experts Ass. Prof Jackie Whittaker and Dr Stephanie Filbay in part 2 of an ACL myth busting series. Jackie and Steph provide tips about how you can integrate new evidence into daily practice that may challenge existing beliefs and practices. In today’s episode you will find out if the following statements are TRUE or FALSE….
• ACL tears can heal 
• ACL tears only heal if patients are braced immediately 
• Open chain knee extension exercises are safe to perform in the first 4 weeks after ACLR
• Returning to high impact sports increases the risk of PTOA after ACL injury
• Having an early ACL reconstruction will reduce the risk of future structural OA

Whittaker et al 2022 OPTIKNEE consensus statement https://www.ncbi.nlm.nih.gov/pubmed/36379676
Whittaker et al 2022 OPTIKNEE review of risk factors http://bjsm.bmj.com/content/early/2022/10/05/bjsports-2022-105496.abstract
Filbay et al 2022 ACL healing paper http://dx.doi.org/10.1136/bjsports-2022-105473
OPTIKNEE website OPTIKNEE bit.ly https://bit.ly/OPTIKNEE</itunes:summary>
      <itunes:subtitle>In this podcast, Dr Brooke Patterson hosts ACL in…</itunes:subtitle>
      <description>In this podcast, Dr Brooke Patterson hosts ACL injury and post-traumatic osteoarthritis leading experts Ass. Prof Jackie Whittaker and Dr Stephanie Filbay in part 2 of an ACL myth busting series. Jackie and Steph provide tips about how you can integrate new evidence into daily practice that may challenge existing beliefs and practices. In today’s episode you will find out if the following statements are TRUE or FALSE….
• ACL tears can heal 
• ACL tears only heal if patients are braced immediately 
• Open chain knee extension exercises are safe to perform in the first 4 weeks after ACLR
• Returning to high impact sports increases the risk of PTOA after ACL injury
• Having an early ACL reconstruction will reduce the risk of future structural OA

Whittaker et al 2022 OPTIKNEE consensus statement https://www.ncbi.nlm.nih.gov/pubmed/36379676
Whittaker et al 2022 OPTIKNEE review of risk factors http://bjsm.bmj.com/content/early/2022/10/05/bjsports-2022-105496.abstract
Filbay et al 2022 ACL healing paper http://dx.doi.org/10.1136/bjsports-2022-105473
OPTIKNEE website OPTIKNEE bit.ly https://bit.ly/OPTIKNEE</description>
      <enclosure length="60432717" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1423186372-bmjpodcasts-acl-myth-busting-part-2-with-prof-jackie-whittaker-and-dr-stephanie-filbay-ep-522.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1422562543</guid>
      <title>DTB 60th anniversary podcast interview - John Dowden</title>
      <pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-60th-anniversary-podcast-interview-john-dowden</link>
      <itunes:duration>00:35:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB.

In this podcast, David Phizackerley (DTB's deputy editor) talks to Dr John Dowden, the editor of Australian Prescriber since 1990. Australian Prescriber (https://www.nps.org.au/australian-prescriber) is an independent peer-reviewed journal providing critical commentary on drugs and therapeutics for health professionals, and like DTB, Australian Prescriber was a founder member of the International Society of Drug Bulletins. At the time of recording, John highlighted that public funding for NPS Medicinewise (https://www.nps.org.au/), the organisation that publishes Australian Prescriber, was under threat and unfortunately the Australian Government withdrew funding and the organisation closed at the end of December. John and his team were made redundant, and the future of Australian Prescriber is uncertain.

We wrote an editorial that criticises the decision to remove funding from NPS Medicinewise and you can find this in the January 2023 issue of DTB (https://dtb.bmj.com/content/61/1/2).

This special series of the DTB Podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In a series of podcasts to mark the 60th annivers…</itunes:subtitle>
      <description>In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB.

In this podcast, David Phizackerley (DTB's deputy editor) talks to Dr John Dowden, the editor of Australian Prescriber since 1990. Australian Prescriber (https://www.nps.org.au/australian-prescriber) is an independent peer-reviewed journal providing critical commentary on drugs and therapeutics for health professionals, and like DTB, Australian Prescriber was a founder member of the International Society of Drug Bulletins. At the time of recording, John highlighted that public funding for NPS Medicinewise (https://www.nps.org.au/), the organisation that publishes Australian Prescriber, was under threat and unfortunately the Australian Government withdrew funding and the organisation closed at the end of December. John and his team were made redundant, and the future of Australian Prescriber is uncertain.

We wrote an editorial that criticises the decision to remove funding from NPS Medicinewise and you can find this in the January 2023 issue of DTB (https://dtb.bmj.com/content/61/1/2).

This special series of the DTB Podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="34492080" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1422562543-bmjpodcasts-dtb-60th-anniversary-podcast-interview-john-dowden.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ZhHhdSJ2iCM3BJau-Mb17sg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1423038289</guid>
      <title>Autoantibodies against PTM proteins as biomarkers for lupus</title>
      <pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/autoantibodies-against-ptm-proteins-as-biomarkers-for-lupus</link>
      <itunes:duration>00:09:45</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Autoantibodies against post-translationally modified proteins (PTM) are described in various rheumatic diseases and facilitate diagnosis and patient stratification. Researchers from the Leiden University Medical Center analysed the presence of autoantibodies against six different post-translational modifications in a cohort of patients with neuropsychiatric lupus. In this podcast, Leendert Trouw, Rory Monahan and Michelle van den Beukel discuss the results of their study with the ARD/RMDopen social media advisor Caroline Ospelt.
Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002079
Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864</itunes:summary>
      <itunes:subtitle>Autoantibodies against post-translationally modif…</itunes:subtitle>
      <description>Autoantibodies against post-translationally modified proteins (PTM) are described in various rheumatic diseases and facilitate diagnosis and patient stratification. Researchers from the Leiden University Medical Center analysed the presence of autoantibodies against six different post-translational modifications in a cohort of patients with neuropsychiatric lupus. In this podcast, Leendert Trouw, Rory Monahan and Michelle van den Beukel discuss the results of their study with the ARD/RMDopen social media advisor Caroline Ospelt.
Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002079
Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864</description>
      <enclosure length="9371479" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1423038289-bmjpodcasts-autoantibodies-against-ptm-proteins-as-biomarkers-for-lupus.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-xsyoYtEZKvN4aP9w-fnLRPA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1420563202</guid>
      <title>Immersive and Interactive: Accessibility Theatre and LivingBodiesObjects</title>
      <pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/immersive-and-interactive-accessibility-theatre-and-livingbodiesobjects</link>
      <itunes:duration>00:23:53</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor's in Chief of Medical Humanities, Brandy Schillace, interviews Amelia DeFalco, University of Leeds and Steve Byrne Director/Chief exec of the Interplay Theatre about the Interplay Theatre's work with disabled students and the role of immersive experience for the LivingBodiedObjects project.

Related blog including the transcription of the podcast: 
https://blogs.bmj.com/medical-humanities/2023/01/12/immersive-and-interactive-accessibility-theatre-and-livingbodiesobjects

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>Editor's in Chief of Medical Humanities, Brandy S…</itunes:subtitle>
      <description>Editor's in Chief of Medical Humanities, Brandy Schillace, interviews Amelia DeFalco, University of Leeds and Steve Byrne Director/Chief exec of the Interplay Theatre about the Interplay Theatre's work with disabled students and the role of immersive experience for the LivingBodiedObjects project.

Related blog including the transcription of the podcast: 
https://blogs.bmj.com/medical-humanities/2023/01/12/immersive-and-interactive-accessibility-theatre-and-livingbodiesobjects

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="34357190" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1420563202-bmjpodcasts-immersive-and-interactive-accessibility-theatre-and-livingbodiesobjects.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-JorgovIia1xsfVxi-L3KHrg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1418106253</guid>
      <title>Novel High-Grade Serous Ovarian Morphologic Classification with Anil K. Sood</title>
      <pubDate>Mon, 09 Jan 2023 11:00:21 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/novel-high-grade-serous-ovarian-morphologic-classification-with-anil-k-sood</link>
      <itunes:duration>00:36:40</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Anil K. Sood to discuss novel high-grade serous ovarian morphologic classification. Dr. Sood is a Professor in the Department of Gynecologic Oncology and Reproductive Medicine at the UT MD Anderson Cancer Center. He is Co-Director of the multi-disciplinary Blanton-Davis Ovarian Cancer Research Program and co-leads the Ovarian Cancer Moonshot Program. He is an elected member of the American Society for Clinical Investigation (ASCI), the Association of American Physicians (AAP), and the National Academy of Medicine (NAM).

Highlights:

- High grade serous ovarian cancer (HGSOC) could be classified into two gross morphologic subtypes.
- Type I and type II morphologic subtypes differed with respect to clinical outcomes.
- The two morphologic subtypes also differed with regard to transcriptomic, proteomic, and metabolomic profiles.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Anil K. Sood to discuss novel high-grade serous ovarian morphologic classification. Dr. Sood is a Professor in the Department of Gynecologic Oncology and Reproductive Medicine at the UT MD Anderson Cancer Center. He is Co-Director of the multi-disciplinary Blanton-Davis Ovarian Cancer Research Program and co-leads the Ovarian Cancer Moonshot Program. He is an elected member of the American Society for Clinical Investigation (ASCI), the Association of American Physicians (AAP), and the National Academy of Medicine (NAM).

Highlights:

- High grade serous ovarian cancer (HGSOC) could be classified into two gross morphologic subtypes.
- Type I and type II morphologic subtypes differed with respect to clinical outcomes.
- The two morphologic subtypes also differed with regard to transcriptomic, proteomic, and metabolomic profiles.</description>
      <enclosure length="35013209" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1418106253-bmjpodcasts-novel-high-grade-serous-ovarian-morphologic-classification-with-anil-k-sood.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1418124427</guid>
      <title>Formal Training Pathways, are they really all that?</title>
      <pubDate>Fri, 06 Jan 2023 17:59:09 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/formal-training-pathways-are-they-really-all-that</link>
      <itunes:duration>00:59:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>One size doesn’t fit all - so what are the alternative career paths of doctors in the NHS? The treadmill of medical school, to foundation training, to specialist training, to a consultant position takes years and is not very trainee-centric in it’s design.

So are there other ways for doctors to be able to work in the NHS, still progress their career, but also tailor the job to themselves? And what are the drawbacks of trying to do that?

In this podcast, Clara Munro is joined by Flo Wedmore and new panelist Jason Ramsingh, a surgical trainee in Newcastle. They speak to Rob Fleming an SAS (speciality and associate specialist) doctor in anaesthetics.</itunes:summary>
      <itunes:subtitle>One size doesn’t fit all - so what are the altern…</itunes:subtitle>
      <description>One size doesn’t fit all - so what are the alternative career paths of doctors in the NHS? The treadmill of medical school, to foundation training, to specialist training, to a consultant position takes years and is not very trainee-centric in it’s design.

So are there other ways for doctors to be able to work in the NHS, still progress their career, but also tailor the job to themselves? And what are the drawbacks of trying to do that?

In this podcast, Clara Munro is joined by Flo Wedmore and new panelist Jason Ramsingh, a surgical trainee in Newcastle. They speak to Rob Fleming an SAS (speciality and associate specialist) doctor in anaesthetics.</description>
      <enclosure length="56848256" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1418124427-bmjpodcasts-formal-training-pathways-are-they-really-all-that.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-o9X3NxDz5qvalN5Q-0EjxEQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1417242265</guid>
      <title>Pregnancy and parental leave for neurointerventional surgeons</title>
      <pubDate>Fri, 06 Jan 2023 11:43:14 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/pregnancy-and-parental-leave-for-neurointerventional-surgeons</link>
      <itunes:duration>00:21:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Amanda Baker(1) and Dr. Sandra Narayanan(2) about their recently published standard "Society of NeuroInterventional Surgery: position statement on pregnancy and parental leave for physicians practicing neurointerventional surgery" - https://jnis.bmj.com/content/15/1/5.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was edited by Brian O'Toole.

(1)  Radiology and Biomedical Imaging, UCSF, San Francisco
(2) Neurointerventional Program and Comprehensive Stroke Program, Pacific Neuroscience Institute, Santa Monica</itunes:summary>
      <itunes:subtitle>In this podcast, JNIS Editor-in-Chief, Dr. Felipe…</itunes:subtitle>
      <description>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Amanda Baker(1) and Dr. Sandra Narayanan(2) about their recently published standard "Society of NeuroInterventional Surgery: position statement on pregnancy and parental leave for physicians practicing neurointerventional surgery" - https://jnis.bmj.com/content/15/1/5.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was edited by Brian O'Toole.

(1)  Radiology and Biomedical Imaging, UCSF, San Francisco
(2) Neurointerventional Program and Comprehensive Stroke Program, Pacific Neuroscience Institute, Santa Monica</description>
      <enclosure length="20330369" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1417242265-bmjpodcasts-pregnancy-and-parental-leave-for-neurointerventional-surgeons.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1416372526</guid>
      <title>Artificial intelligence in inflammatory bowel disease</title>
      <pubDate>Fri, 06 Jan 2023 06:00:41 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/artificial-intelligence-in-ibd</link>
      <itunes:duration>00:12:49</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith(1) interviews Dr James Ashton(2) on the papers, "The importance of high quality ‘big data’ in the application of artificial intelligence in inflammatory bowel disease" and "Artificial intelligence and inflammatory bowel disease: practicalities and future prospects" published online in Frontline Gastroenterology in 2022. Read the articles in Frontline Gastroenterology here: 
https://fg.bmj.com/content/early/2022/11/17/flgastro-2022-102342
https://fg.bmj.com/content/13/4/325

(1) Social Media and Associate Editor of FG and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK.
(2) Paediatric Gastroenterology trainee at the Southampton Children’s Hospital, Southampton, UK, and Clinical Lecturer in Human Genetics and Genomic Medicine at the University of Southampton

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>Dr Philip Smith(1) interviews Dr James Ashton(2) …</itunes:subtitle>
      <description>Dr Philip Smith(1) interviews Dr James Ashton(2) on the papers, "The importance of high quality ‘big data’ in the application of artificial intelligence in inflammatory bowel disease" and "Artificial intelligence and inflammatory bowel disease: practicalities and future prospects" published online in Frontline Gastroenterology in 2022. Read the articles in Frontline Gastroenterology here: 
https://fg.bmj.com/content/early/2022/11/17/flgastro-2022-102342
https://fg.bmj.com/content/13/4/325

(1) Social Media and Associate Editor of FG and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK.
(2) Paediatric Gastroenterology trainee at the Southampton Children’s Hospital, Southampton, UK, and Clinical Lecturer in Human Genetics and Genomic Medicine at the University of Southampton

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="12314330" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1416372526-bmjpodcasts-artificial-intelligence-in-ibd.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1417939120</guid>
      <title>ACL MYTH BUSTING Part 1 with Prof Jackie Whittaker and Dr Stephanie Filbay EP# 521</title>
      <pubDate>Fri, 06 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/acl-myth-busting-part-1-with-prof-jackie-whittaker-and-dr-stephanie-filbay-ep-521</link>
      <itunes:duration>00:18:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, Dr Brooke Patterson hosts ACL injury and post-traumatic osteoarthritis leading experts Ass. Prof Jackie Whittaker and Dr Stephanie Filbay in part 1 of an ACL myth busting series. In today’s episode you will find out if the following statements are TRUE or FALSE….
●	ACL reconstruction reduces the risk of osteoarthritis compared to non-surgical management 
●	Only patella tendon grafts get patellofemoral osteoarthritis after ACL reconstruction
●	Non-surgical management of an ACL injury increases the risk of future meniscal tears
●	Meniscal lesions at the time of ACL injury/surgery increases the risk osteoarthritis after ACL injury  
●	Higher BMI increases the risk of osteoarthritis after ACL injury
●	People can return to sport without having an ACL reconstruction for their ACL tear
●	Increased laxity increases the risk of osteoarthritis after ACL injury/surgery

Whittaker et al 2022 OPTIKNEE consensus statement https://www.ncbi.nlm.nih.gov/pubmed/36379676
Whittaker et al 2022 OPTIKNEE review of risk factors http://bjsm.bmj.com/content/early/2022/10/05/bjsports-2022-105496.abstract
OPTIKNEE website OPTIKNEE bit.ly https://bit.ly/OPTIKNEE</itunes:summary>
      <itunes:subtitle>In this podcast, Dr Brooke Patterson hosts ACL in…</itunes:subtitle>
      <description>In this podcast, Dr Brooke Patterson hosts ACL injury and post-traumatic osteoarthritis leading experts Ass. Prof Jackie Whittaker and Dr Stephanie Filbay in part 1 of an ACL myth busting series. In today’s episode you will find out if the following statements are TRUE or FALSE….
●	ACL reconstruction reduces the risk of osteoarthritis compared to non-surgical management 
●	Only patella tendon grafts get patellofemoral osteoarthritis after ACL reconstruction
●	Non-surgical management of an ACL injury increases the risk of future meniscal tears
●	Meniscal lesions at the time of ACL injury/surgery increases the risk osteoarthritis after ACL injury  
●	Higher BMI increases the risk of osteoarthritis after ACL injury
●	People can return to sport without having an ACL reconstruction for their ACL tear
●	Increased laxity increases the risk of osteoarthritis after ACL injury/surgery

Whittaker et al 2022 OPTIKNEE consensus statement https://www.ncbi.nlm.nih.gov/pubmed/36379676
Whittaker et al 2022 OPTIKNEE review of risk factors http://bjsm.bmj.com/content/early/2022/10/05/bjsports-2022-105496.abstract
OPTIKNEE website OPTIKNEE bit.ly https://bit.ly/OPTIKNEE</description>
      <enclosure length="44543999" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1417939120-bmjpodcasts-acl-myth-busting-part-1-with-prof-jackie-whittaker-and-dr-stephanie-filbay-ep-521.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1416340819</guid>
      <title>Radiation and the nervous system</title>
      <pubDate>Thu, 05 Jan 2023 09:59:50 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/radiation-and-the-nervous-system</link>
      <itunes:duration>00:42:48</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Amy Ross Russell(1) discusses a recently published review by Dr. Jeremy Rees(2) and Dr. Michael Kosmin(3) on the subject of radiation therapy on the brain, the history and motivation of its use, and its benefits and limitations.

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/6/450) and the December print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-december-2022-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Neurology, National Hospital for Neurology and Neurosurgery, London, UK 
(3) Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, UK 

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</itunes:summary>
      <itunes:subtitle>Dr. Amy Ross Russell(1) discusses a recently publ…</itunes:subtitle>
      <description>Dr. Amy Ross Russell(1) discusses a recently published review by Dr. Jeremy Rees(2) and Dr. Michael Kosmin(3) on the subject of radiation therapy on the brain, the history and motivation of its use, and its benefits and limitations.

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/6/450) and the December print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-december-2022-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Neurology, National Hospital for Neurology and Neurosurgery, London, UK 
(3) Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, UK 

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</description>
      <enclosure length="41092492" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1416340819-bmjpodcasts-radiation-and-the-nervous-system.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1416388495</guid>
      <title>Nothing like Grey's Anatomy</title>
      <pubDate>Thu, 05 Jan 2023 08:00:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/nothing-like-greys-anatomy</link>
      <itunes:duration>00:47:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>From Casualty, Holby City, and Cardiac Arrest to Grey’s Anatomy, Scrubs and House, medical TV dramas are part of the fabric of growing up interested in a career in medicine. So today we’re discussing all things medical TV dramas and talking about whether these shows prepared us for medical school and life as a doctor!

Join us for this episode as we play some of our favourite clips from popular medical TV programmes and talk more about how our experiences as medical students and new doctors compare. We’ll be discussing the heartbreak, the friendships, the drama, and the romance, as well as unpicking just how realistic (or unrealistic) these shows really are. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>From Casualty, Holby City, and Cardiac Arrest to …</itunes:subtitle>
      <description>From Casualty, Holby City, and Cardiac Arrest to Grey’s Anatomy, Scrubs and House, medical TV dramas are part of the fabric of growing up interested in a career in medicine. So today we’re discussing all things medical TV dramas and talking about whether these shows prepared us for medical school and life as a doctor!

Join us for this episode as we play some of our favourite clips from popular medical TV programmes and talk more about how our experiences as medical students and new doctors compare. We’ll be discussing the heartbreak, the friendships, the drama, and the romance, as well as unpicking just how realistic (or unrealistic) these shows really are. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="45205376" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1416388495-bmjpodcasts-nothing-like-greys-anatomy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1416329059</guid>
      <title>Autoimmune gastritis: cancer risk in consistently tested H. pylori-negative patients</title>
      <pubDate>Thu, 05 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/autoimmune-gastritis-cancer-risk-in-consistently-tested-h-pylori-negative-patients</link>
      <itunes:duration>00:14:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut, and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Professor Massimo Rugge, Pathologist at Padova University, Italy, and Adjunct Professor of Medicine at the Baylor College of Medicine in Houston, Texas, USA; and Ms Ludovica Bricca, a student at Padova University, and the youngest researcher involved in the study. They are interviewed on the paper 'Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients' published in paper copy in Gut in January 2023.


Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut, and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Professor Massimo Rugge, Pathologist at Padova University, Italy, and Adjunct Professor of Medicine at the Baylor College of Medicine in Houston, Texas, USA; and Ms Ludovica Bricca, a student at Padova University, and the youngest researcher involved in the study. They are interviewed on the paper 'Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients' published in paper copy in Gut in January 2023.


Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="14276230" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1416329059-bmjpodcasts-autoimmune-gastritis-cancer-risk-in-consistently-tested-h-pylori-negative-patients.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-aEhbznxsdXsvJzZG-YRdVmw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1412841013</guid>
      <title>Shared decision making in cardiology</title>
      <pubDate>Tue, 03 Jan 2023 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/shared-decision-making-in-cardiology</link>
      <itunes:duration>00:14:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Panagiota Mitropoulou from Southampton, UK. They discuss the idea of shared decision-making with patients and the benefits it can bring. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published papers:
Paper : https://heart.bmj.com/content/109/1/34
Editorial : https://heart.bmj.com/content/109/1/4</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Panagiota Mitropoulou from Southampton, UK. They discuss the idea of shared decision-making with patients and the benefits it can bring. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published papers:
Paper : https://heart.bmj.com/content/109/1/34
Editorial : https://heart.bmj.com/content/109/1/4</description>
      <enclosure length="35689238" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1412841013-bmjpodcasts-shared-decision-making-in-cardiology.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1412729065</guid>
      <title>“Impact of Transfusions on Outcomes in Ovarian Cancer” with Lauren Prescott</title>
      <pubDate>Mon, 02 Jan 2023 11:00:27 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/impact-of-transfusions-on-outcomes-in-ovarian-cancer-with-lauren-prescott</link>
      <itunes:duration>00:19:27</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Lauren Prescott to discuss the impact of transfusions on outcomes in ovarian cancer. Dr. Prescott received her undergraduate degree from Georgetown University and went on study at the National Institutes of Health for two years. She then completed medical school at Georgetown University, residency in Obstetrics and Gynecology at Dartmouth Hitchcock Medical Center, and fellowship in Gynecologic Oncology at MD Anderson Cancer Center. She has been at Vanderbilt University since 2017. Dr. Prescott's research interests include measuring and evaluating surgical and oncologic outcomes and improving the quality of health care delivery through implementation of evidence-based medicine. Dr. Prescott leads the Vanderbilt Enhanced Recovery After Surgery Program for patients undergoing gynecologic surgery.

Highlights:

- Perioperative blood transfusions in ovarian cancer is common with 53% of patients in our study having received a transfusion

- Blood transfusions were not associated with negative impact on progression-free survival or overall survival

- However, blood transfusions were associated with increased peri-operative morbidity without improvements in quality of life</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Lauren Prescott to discuss the impact of transfusions on outcomes in ovarian cancer. Dr. Prescott received her undergraduate degree from Georgetown University and went on study at the National Institutes of Health for two years. She then completed medical school at Georgetown University, residency in Obstetrics and Gynecology at Dartmouth Hitchcock Medical Center, and fellowship in Gynecologic Oncology at MD Anderson Cancer Center. She has been at Vanderbilt University since 2017. Dr. Prescott's research interests include measuring and evaluating surgical and oncologic outcomes and improving the quality of health care delivery through implementation of evidence-based medicine. Dr. Prescott leads the Vanderbilt Enhanced Recovery After Surgery Program for patients undergoing gynecologic surgery.

Highlights:

- Perioperative blood transfusions in ovarian cancer is common with 53% of patients in our study having received a transfusion

- Blood transfusions were not associated with negative impact on progression-free survival or overall survival

- However, blood transfusions were associated with increased peri-operative morbidity without improvements in quality of life</description>
      <enclosure length="18574617" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1412729065-bmjpodcasts-impact-of-transfusions-on-outcomes-in-ovarian-cancer-with-lauren-prescott.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hBF55STAiexAsTHd-mtkd5A-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1376582983</guid>
      <title>Bell's palsy: an update on diagnosis and management</title>
      <pubDate>Mon, 02 Jan 2023 09:30:07 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/bells-palsy</link>
      <itunes:duration>00:21:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We release episodes fortnightly. Bell's palsy is the most common unilateral facial palsy in adults. It is most prevalent in people between 15 and 45 years of age. And it can cause a range of complications - including ongoing facial weakness, keratoconjunctivitis sicca, exposure keratopathy, and ectropion. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast, Kieran Walsh talks with Professor Matthew Miller about Bell's palsy. Matt is Assistant Professor Otolaryngology and Head and Neck Surgery, University of North Carolina Chapel Hill. 

Competing interests: none declared</itunes:summary>
      <itunes:subtitle>We release episodes fortnightly. Bell's palsy is …</itunes:subtitle>
      <description>We release episodes fortnightly. Bell's palsy is the most common unilateral facial palsy in adults. It is most prevalent in people between 15 and 45 years of age. And it can cause a range of complications - including ongoing facial weakness, keratoconjunctivitis sicca, exposure keratopathy, and ectropion. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast, Kieran Walsh talks with Professor Matthew Miller about Bell's palsy. Matt is Assistant Professor Otolaryngology and Head and Neck Surgery, University of North Carolina Chapel Hill. 

Competing interests: none declared</description>
      <enclosure length="26207296" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1376582983-bmjpodcasts-bells-palsy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1413804322</guid>
      <title>Conflict and food global food insecurity</title>
      <pubDate>Sat, 31 Dec 2022 16:47:23 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/conflict-and-food-global-food-insecurity</link>
      <itunes:duration>00:44:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>As we gear up for the winter in the northern hemisphere, the need to stay warm and eat well is pressing - but in 2022, there are global pressures working against us. 

Russia invaded Ukraine, and the subsequent restrictions on exports from both of those countries is being felt in terms of fuel costs - but also food costs. At the same time, this year has seen droughts and flooding which have affected global food production, as well as continuing restrictions around covid and economic activity. 

All of these factors are working together to increase food insecurity.

Our Guests;
Sheryl Hendricks, professor of food security at the University of Pretoria
Renzo Guinto, chief planetary doctor at PH Lab
Tim Benton, director of the Environment and Society Programme at Chatham House.</itunes:summary>
      <itunes:subtitle>As we gear up for the winter in the northern hemi…</itunes:subtitle>
      <description>As we gear up for the winter in the northern hemisphere, the need to stay warm and eat well is pressing - but in 2022, there are global pressures working against us. 

Russia invaded Ukraine, and the subsequent restrictions on exports from both of those countries is being felt in terms of fuel costs - but also food costs. At the same time, this year has seen droughts and flooding which have affected global food production, as well as continuing restrictions around covid and economic activity. 

All of these factors are working together to increase food insecurity.

Our Guests;
Sheryl Hendricks, professor of food security at the University of Pretoria
Renzo Guinto, chief planetary doctor at PH Lab
Tim Benton, director of the Environment and Society Programme at Chatham House.</description>
      <enclosure length="43041017" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1413804322-bmjpodcasts-conflict-and-food-global-food-insecurity.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-P3zbxLO5QrUap1dM-VDkM3Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1413786508</guid>
      <title>Coaching with Claire Kaye</title>
      <pubDate>Sat, 31 Dec 2022 16:10:35 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/coaching-with-claire-kaye</link>
      <itunes:duration>00:53:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In general practice, it can often feel like a lot is changing beyond our grasp. On top of this, the pandemic has left many healthcare professionals self-reflecting on their careers and lives, and trying to work out what they really want going forward. 

This week, we speak to Claire Kaye about her role as a coach for doctors. Claire talks to us about the benefits of coaching, including helping to get rid of internal &amp; external noise, shaping the mindset, and coping better with change. She also offers advice on the best ways to approach coaching in order to achieve a positive outcome. 

Our guest:
Claire Kaye, formerly a GP, is an executive coach. She specialises in career development. 
Instagram: @drclairekayecoaching 
LinkedIn: @drclairekaye 
Website: www.drclairekaye.com</itunes:summary>
      <itunes:subtitle>In general practice, it can often feel like a lot…</itunes:subtitle>
      <description>In general practice, it can often feel like a lot is changing beyond our grasp. On top of this, the pandemic has left many healthcare professionals self-reflecting on their careers and lives, and trying to work out what they really want going forward. 

This week, we speak to Claire Kaye about her role as a coach for doctors. Claire talks to us about the benefits of coaching, including helping to get rid of internal &amp; external noise, shaping the mindset, and coping better with change. She also offers advice on the best ways to approach coaching in order to achieve a positive outcome. 

Our guest:
Claire Kaye, formerly a GP, is an executive coach. She specialises in career development. 
Instagram: @drclairekayecoaching 
LinkedIn: @drclairekaye 
Website: www.drclairekaye.com</description>
      <enclosure length="51096345" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1413786508-bmjpodcasts-coaching-with-claire-kaye.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8i9LTpkaLEKQ3DNF-EFzLHw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1412978533</guid>
      <title>Episode 10: Quality of Meta-Analyses of Perioperative Interventions for Chronic Postsurgical Pain</title>
      <pubDate>Fri, 30 Dec 2022 11:06:26 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/rapm-focus-episode-10-quality-of-meta-analyses-of-perioperative-interventions-for-chronic-postsurgical-pain</link>
      <itunes:duration>00:34:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Systematic reviews and meta-analyses are the main drivers of policy, evidence-based guidelines, and funding decisions, but many of them are fraught with errors, and the resources needed to peer-review
them are massive. A recent systematic review examined the quality of the current published meta-analyses in order to inform the design and reporting of future studies. In this month’s RAPM Focus,
Editor-in-Chief Brian Sites, MD, joins John Kramer MSc, PhD, the senior author of “Quality of meta-analyses of non-opioid, pharmacological, perioperative interventions for chronic postsurgical pain: a systematic review,” first published in January 2022 (https://rapm.bmj.com/content/47/4/263).   The systematic review explored the idea that surgery may represent an environment, known as a transitional pain state, that could result in a patient developing chronic pain following surgery.

 Dr. John Kramer is an associate professor in the faculty of medicine, department of anesthesiology, pharmacology and therapeutics, and principal investigator at ICORD at the University of British Columbia
in Vancouver, Canada. His lab is focused on improving outcomes for individuals with spinal cord injury and neuropathic pain.

 *The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this
podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical
treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</itunes:summary>
      <itunes:subtitle>Systematic reviews and meta-analyses are the main…</itunes:subtitle>
      <description>Systematic reviews and meta-analyses are the main drivers of policy, evidence-based guidelines, and funding decisions, but many of them are fraught with errors, and the resources needed to peer-review
them are massive. A recent systematic review examined the quality of the current published meta-analyses in order to inform the design and reporting of future studies. In this month’s RAPM Focus,
Editor-in-Chief Brian Sites, MD, joins John Kramer MSc, PhD, the senior author of “Quality of meta-analyses of non-opioid, pharmacological, perioperative interventions for chronic postsurgical pain: a systematic review,” first published in January 2022 (https://rapm.bmj.com/content/47/4/263).   The systematic review explored the idea that surgery may represent an environment, known as a transitional pain state, that could result in a patient developing chronic pain following surgery.

 Dr. John Kramer is an associate professor in the faculty of medicine, department of anesthesiology, pharmacology and therapeutics, and principal investigator at ICORD at the University of British Columbia
in Vancouver, Canada. His lab is focused on improving outcomes for individuals with spinal cord injury and neuropathic pain.

 *The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this
podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical
treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</description>
      <enclosure length="83543096" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1412978533-bmjpodcasts-rapm-focus-episode-10-quality-of-meta-analyses-of-perioperative-interventions-for-chronic-postsurgical-pain.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-rpvV8DL9MQyMH46S-5bhdwg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1402730776</guid>
      <title>Revisited: "Featured Mentor’s Podcast: Christina Fotopoulou"</title>
      <pubDate>Mon, 26 Dec 2022 11:00:02 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/revisited-featured-mentors-podcast-with-christina-fotopoulou</link>
      <itunes:duration>00:38:49</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Christina Fotopoulou. Professor Fotopoulou works at the Department of Surgery and Cancer at Imperial College London, UK. She is an elected ESGO council member and Chair of the ESGO guidelines committee.    

Highlights:

- Early support from mentors and "giants" in the field, national and international networking and early focusing/specialization in the field of interest are keys to success

- Try to turn your weaknesses and failures to learning points and opportunities to make you stronger

- Hard work, kindness and caring for patients, team spirit, professionalism and dedication are the main keys of success next to any talent and luck that anyone might be fortunate enough to have</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Christina Fotopoulou. Professor Fotopoulou works at the Department of Surgery and Cancer at Imperial College London, UK. She is an elected ESGO council member and Chair of the ESGO guidelines committee.    

Highlights:

- Early support from mentors and "giants" in the field, national and international networking and early focusing/specialization in the field of interest are keys to success

- Try to turn your weaknesses and failures to learning points and opportunities to make you stronger

- Hard work, kindness and caring for patients, team spirit, professionalism and dedication are the main keys of success next to any talent and luck that anyone might be fortunate enough to have</description>
      <enclosure length="957127043" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1402730776-bmjpodcasts-revisited-featured-mentors-podcast-with-christina-fotopoulou.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1407325957</guid>
      <title>Talking evidence at Christmas</title>
      <pubDate>Fri, 23 Dec 2022 05:01:32 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talking-evidence-at-christmas</link>
      <itunes:duration>00:34:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>It's almost time for the Christmas edition of the BMJ to hit your doormats, and in this festive edition of Talk Evidence we're going to be talking Christmas research.

Joining Helen and Juan, we have Tim Feeney, BMJ research editor and researcher into Surgical outcomes at Boston University.

In this episode we'll be hearing about the health of footballers, and if a career in the sport predisposes Swedish players to substance use disorders. We'll hear about the performance of BMJ’s editors, when it comes to assessing the impact of a paper. We'll find out if AI algorithms can pass UK radiology exams, misinformation and a belief that everything causes cancer, and finally, some tips from BMJ’s statisticians to set the world right</itunes:summary>
      <itunes:subtitle>It's almost time for the Christmas edition of the…</itunes:subtitle>
      <description>It's almost time for the Christmas edition of the BMJ to hit your doormats, and in this festive edition of Talk Evidence we're going to be talking Christmas research.

Joining Helen and Juan, we have Tim Feeney, BMJ research editor and researcher into Surgical outcomes at Boston University.

In this episode we'll be hearing about the health of footballers, and if a career in the sport predisposes Swedish players to substance use disorders. We'll hear about the performance of BMJ’s editors, when it comes to assessing the impact of a paper. We'll find out if AI algorithms can pass UK radiology exams, misinformation and a belief that everything causes cancer, and finally, some tips from BMJ’s statisticians to set the world right</description>
      <enclosure length="33096514" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1407325957-bmjpodcasts-talking-evidence-at-christmas.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-CSg4F6Zi1aMOEbTy-tgfxkw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1406404675</guid>
      <title>EVT for acute ischemic stroke in patients with cancer</title>
      <pubDate>Wed, 21 Dec 2022 14:10:36 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/evt-for-acute-ischemic-stroke-in-patients-with-cancer</link>
      <itunes:duration>00:16:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Krishna C. Joshi(1) and Dr. Michael Chen(2) about their paper "Endovascular thrombectomy for acute ischemic stroke in patients with cancer: a propensity-matched analysis" - https://jnis.bmj.com/content/14/12/1161.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was edited by Brian O'Toole.
(1) Neurological Surgery, Rush University Medical Center, Chicago
(2) Neurological Surgery, Rush University Medical Center, Chicago</itunes:summary>
      <itunes:subtitle>In this podcast, JNIS Editor-in-Chief, Dr. Felipe…</itunes:subtitle>
      <description>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Krishna C. Joshi(1) and Dr. Michael Chen(2) about their paper "Endovascular thrombectomy for acute ischemic stroke in patients with cancer: a propensity-matched analysis" - https://jnis.bmj.com/content/14/12/1161.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was edited by Brian O'Toole.
(1) Neurological Surgery, Rush University Medical Center, Chicago
(2) Neurological Surgery, Rush University Medical Center, Chicago</description>
      <enclosure length="16055483" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1406404675-bmjpodcasts-evt-for-acute-ischemic-stroke-in-patients-with-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1406272744</guid>
      <title>Happy New Year, sad news from Australia, toxocarosis in humans and yet more on valproate safety</title>
      <pubDate>Wed, 21 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-january-2023</link>
      <itunes:duration>00:21:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the January 2023 issue of DTB. They begin with another reminder of the concerns over the use of sodium valproate. They talk about the closure of NPS MedicineWise in Australia and the uncertainty over the future of Australian Prescriber - https://dtb.bmj.com/content/61/1/2. They highlight the risk of eye problems with dupilumab  - https://dtb.bmj.com/content/61/1/6 (see more links below) and the challenge of making sure that primary care clinical systems record drugs prescribed by specialists. They discuss toxocarosis in humans and the risk of environmental contamination from parasiticides used for deworming cats and dogs (https://dtb.bmj.com/content/61/1/3 and https://dtb.bmj.com/content/61/1/7).

Dupilumab links:
1. Reji MA, Haque A, Goyal S, et al. Dupilumab-induced ocular surface disease: a primer. BMJ Case Reports CP 2022;15:e249019. https://casereports.bmj.com/content/15/4/e249019

2. Nahum Y, Mimouni M, Livny E, et al. Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment. British Journal of Ophthalmology 2020;104:776-9. https://bjo.bmj.com/content/104/6/776

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the January 2023 issue of DTB. They begin with another reminder of the concerns over the use of sodium valproate. They talk about the closure of NPS MedicineWise in Australia and the uncertainty over the future of Australian Prescriber - https://dtb.bmj.com/content/61/1/2. They highlight the risk of eye problems with dupilumab  - https://dtb.bmj.com/content/61/1/6 (see more links below) and the challenge of making sure that primary care clinical systems record drugs prescribed by specialists. They discuss toxocarosis in humans and the risk of environmental contamination from parasiticides used for deworming cats and dogs (https://dtb.bmj.com/content/61/1/3 and https://dtb.bmj.com/content/61/1/7).

Dupilumab links:
1. Reji MA, Haque A, Goyal S, et al. Dupilumab-induced ocular surface disease: a primer. BMJ Case Reports CP 2022;15:e249019. https://casereports.bmj.com/content/15/4/e249019

2. Nahum Y, Mimouni M, Livny E, et al. Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment. British Journal of Ophthalmology 2020;104:776-9. https://bjo.bmj.com/content/104/6/776

The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="50630462" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1406272744-bmjpodcasts-dtb-january-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-4UYNPol1a3WqZp54-5fI5ug-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1401409405</guid>
      <title>MPox 101, Community and Global response</title>
      <pubDate>Wed, 21 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mpx-101-and-community-global-response</link>
      <itunes:duration>00:21:47</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Today we talk about transmission, diagnosis and management of MPox. We will also review the UK community and the World Health’s Organization's perspective on this virus. Please note that after the recording of this podcast the WHO implemented a change of the name of the virus to MPox.

Dr Fabiola Martin, STI's Podcast editor, interviews Dr Liesbeth Van Gestel, ID physician and clinical researcher at the Tropical Institute of Antwerp, Belgium; Mr Simon Collins, director and co-founder of HIV iBase London, UK; as well as Dr Meg Doherty, the World Health Organisation’s Director of Global HIV, Hepatitis and STIs Programmes.

For more information, please read the STI recently published articles: one from Vanhamel and co-authors tracking the transmission of the virus in the early phases of the outbreak in Belgium (https://sti.bmj.com/content/early/2022/11/17/sextrans-2022-055601), and a second from Heskin and colleagues reporting on the rapid response of sexual health services to the outbreak in the UK (https://sti.bmj.com/content/early/2022/12/14/sextrans-2022-055558?rss=1).</itunes:summary>
      <itunes:subtitle>Today we talk about transmission, diagnosis and m…</itunes:subtitle>
      <description>Today we talk about transmission, diagnosis and management of MPox. We will also review the UK community and the World Health’s Organization's perspective on this virus. Please note that after the recording of this podcast the WHO implemented a change of the name of the virus to MPox.

Dr Fabiola Martin, STI's Podcast editor, interviews Dr Liesbeth Van Gestel, ID physician and clinical researcher at the Tropical Institute of Antwerp, Belgium; Mr Simon Collins, director and co-founder of HIV iBase London, UK; as well as Dr Meg Doherty, the World Health Organisation’s Director of Global HIV, Hepatitis and STIs Programmes.

For more information, please read the STI recently published articles: one from Vanhamel and co-authors tracking the transmission of the virus in the early phases of the outbreak in Belgium (https://sti.bmj.com/content/early/2022/11/17/sextrans-2022-055601), and a second from Heskin and colleagues reporting on the rapid response of sexual health services to the outbreak in the UK (https://sti.bmj.com/content/early/2022/12/14/sextrans-2022-055558?rss=1).</description>
      <enclosure length="20928051" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1401409405-bmjpodcasts-mpx-101-and-community-global-response.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-pAPNWIdcqzhbf4vB-70N7zw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1406421559</guid>
      <title>Atoms: the highlights from the ADC January 2023</title>
      <pubDate>Tue, 20 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-january-2023</link>
      <itunes:duration>00:07:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the January 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/1/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the January 2023 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/108/1/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="7546252" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1406421559-bmjpodcasts-atoms-the-highlights-from-the-adc-january-2023.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1402687174</guid>
      <title>Revisited: "Featured Mentor’s Podcast: Andrea du Bois"</title>
      <pubDate>Mon, 19 Dec 2022 11:00:17 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/revisited-featured-mentors-podcast-andrea-du-bois</link>
      <itunes:duration>00:40:02</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Andrea du Bois. Prof du Bois completed his medical degree in 1987 at the University of Freiburg, Germany. He subsequently trained in general surgery at Krankenhaus Wolfach Personalwohnheim and gynaecology and obstetrics at the University of Freiburg, leading to his registration as Fellow for Gynaecology and Obstetrics in 1993.

In 1993, Prof. du Bois became a Consultant in the Department of Gynaecology and Obstetrics at St. Vincentius-Kliniken, Karlsruhe. He then served as Director of the Department of Gynaecology and Gynaecologic Oncology, Horst-Schmidt-Kliniken, Wiesbaden (1999-2010) before taking up his current roles as Director of the Department of Gynaecology and Gynaecologic Oncology at Kliniken Essen-Mitte, and Associate Professor at Johannes Gutenberg University of Mainz, Germany.

Prof. du Bois has been the Principal Investigator of several pivotal and practice-changing international clinical trials in gynaecological oncology. He founded the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group in 1993 and co-founded the European Network of Gynaecological Oncological Trial groups (ENGOT) in 2007. He has previously been a member of the German Guideline Committee for guidelines in breast, cervical, and ovarian cancer, Chairman of the German quality assurance programme for ovarian cancer (QS-OVAR), and member of the Gynecological Cancer InterGroup (GCIG) executive board and European Society of Gynaecological Oncology (ESGO) council. Prof. du Bois has been Chairman and a member of the Scientific Committee of the Ovarian Cancer Consensus Conference of the GCIG, and served as a member of the Scientific Committee of the 1st European Society of Medical Oncology (ESMO)-ESGO Ovarian Cancer Consensus Conference 2018. Prof. du Bois is a member of the American Society of Clinical Oncology (ASCO), ESGO, International Gynecologic Cancer Society (ISGC), German Cancer Society, and AGO. He has authored more than 500 publications with more than 33,500 citations, and has a Google Scholar h index of 86.

Prof. du Bois has received multiple honours and awards in recognition for his work, including the Arthur Walpole Award (German Cancer Society, 2006), Ernst Wertheim Award (Austrian Society of Gynecologic Oncology, 2006), MD Anderson Madrid Lifetime Award (2016), Wilhelm-Warner Prize for Cancer Research (2019), German Cancer Prize (Deutsche Krebsgesellschaft, 2020) and honorary membership of the German Society for Gynecology and Obstetrics (2020); 2021 he received the ESGO Lifetime Achievement Award (European Society of Gynaecological Oncology).</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Andrea du Bois. Prof du Bois completed his medical degree in 1987 at the University of Freiburg, Germany. He subsequently trained in general surgery at Krankenhaus Wolfach Personalwohnheim and gynaecology and obstetrics at the University of Freiburg, leading to his registration as Fellow for Gynaecology and Obstetrics in 1993.

In 1993, Prof. du Bois became a Consultant in the Department of Gynaecology and Obstetrics at St. Vincentius-Kliniken, Karlsruhe. He then served as Director of the Department of Gynaecology and Gynaecologic Oncology, Horst-Schmidt-Kliniken, Wiesbaden (1999-2010) before taking up his current roles as Director of the Department of Gynaecology and Gynaecologic Oncology at Kliniken Essen-Mitte, and Associate Professor at Johannes Gutenberg University of Mainz, Germany.

Prof. du Bois has been the Principal Investigator of several pivotal and practice-changing international clinical trials in gynaecological oncology. He founded the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group in 1993 and co-founded the European Network of Gynaecological Oncological Trial groups (ENGOT) in 2007. He has previously been a member of the German Guideline Committee for guidelines in breast, cervical, and ovarian cancer, Chairman of the German quality assurance programme for ovarian cancer (QS-OVAR), and member of the Gynecological Cancer InterGroup (GCIG) executive board and European Society of Gynaecological Oncology (ESGO) council. Prof. du Bois has been Chairman and a member of the Scientific Committee of the Ovarian Cancer Consensus Conference of the GCIG, and served as a member of the Scientific Committee of the 1st European Society of Medical Oncology (ESMO)-ESGO Ovarian Cancer Consensus Conference 2018. Prof. du Bois is a member of the American Society of Clinical Oncology (ASCO), ESGO, International Gynecologic Cancer Society (ISGC), German Cancer Society, and AGO. He has authored more than 500 publications with more than 33,500 citations, and has a Google Scholar h index of 86.

Prof. du Bois has received multiple honours and awards in recognition for his work, including the Arthur Walpole Award (German Cancer Society, 2006), Ernst Wertheim Award (Austrian Society of Gynecologic Oncology, 2006), MD Anderson Madrid Lifetime Award (2016), Wilhelm-Warner Prize for Cancer Research (2019), German Cancer Prize (Deutsche Krebsgesellschaft, 2020) and honorary membership of the German Society for Gynecology and Obstetrics (2020); 2021 he received the ESGO Lifetime Achievement Award (European Society of Gynaecological Oncology).</description>
      <enclosure length="23334120" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1402687174-bmjpodcasts-revisited-featured-mentors-podcast-andrea-du-bois.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1382990479</guid>
      <title>Data, AI, oncology and patients</title>
      <pubDate>Mon, 19 Dec 2022 09:30:07 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/data-ai-oncology-and-patients</link>
      <itunes:duration>00:27:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We release episodes fortnightly. Data, AI, oncology, and patients are a wide range of subjects to be addressed in one podcast. Individually they are big topics and when you put them together you really get to high levels of complexity. In this BMJ Best Practice podcast, Kieran Walsh delves into all these topics with Dr Arun Sujenthiran, Senior Medical Director and UK Clinical Lead at Flatiron Health. Flatiron Health is a healthtech company that specialises in data science and oncology. Competing interests: AS is an employee of Flatiron Health Inc, an independent subsidiary of Roche, and holds stock in Roche.</itunes:summary>
      <itunes:subtitle>We release episodes fortnightly. Data, AI, oncolo…</itunes:subtitle>
      <description>We release episodes fortnightly. Data, AI, oncology, and patients are a wide range of subjects to be addressed in one podcast. Individually they are big topics and when you put them together you really get to high levels of complexity. In this BMJ Best Practice podcast, Kieran Walsh delves into all these topics with Dr Arun Sujenthiran, Senior Medical Director and UK Clinical Lead at Flatiron Health. Flatiron Health is a healthtech company that specialises in data science and oncology. Competing interests: AS is an employee of Flatiron Health Inc, an independent subsidiary of Roche, and holds stock in Roche.</description>
      <enclosure length="32425216" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1382990479-bmjpodcasts-data-ai-oncology-and-patients.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-mxgGilBQ4xPDFULu-IRcQJA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1404189349</guid>
      <title>Patient access to notes with Charlotte Blease, Brian Macmillan and Gail Davidge</title>
      <pubDate>Fri, 16 Dec 2022 18:21:19 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/patient-access-to-notes-with-charlotte-blease-brian-macmillan-and-gail-davidge</link>
      <itunes:duration>01:00:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The possibility that patients will suddenly have access to their notes has caused some anxiety for GPs in England. The department of health's plans to allow patients to prospectively access their medical record lead to fears about increased workloads, misunderstandings, and safety - and the plans have now been pushed back.

In this podcast the Deep Breath In team are joined by the authors of a recent article in The BMJ to explore those fears, hear about the potential benefits, and understand the evidence behind open notes.

Our guests;
Charlotte Blease, and interdisciplinary health researcher at OpenNotes, Beth Israel Deaconess Medical Center/Harvard Medical School.
Brian McMillan, a GP and senior clinical lecturer at the University of Manchester
Gail Davidge, research associate at the University of Manchester

The article they're discussing is a practice pointer on Adapting to transparent medical records: international experience with “open notes”
https://www.bmj.com/content/379/bmj-2021-069861</itunes:summary>
      <itunes:subtitle>The possibility that patients will suddenly have …</itunes:subtitle>
      <description>The possibility that patients will suddenly have access to their notes has caused some anxiety for GPs in England. The department of health's plans to allow patients to prospectively access their medical record lead to fears about increased workloads, misunderstandings, and safety - and the plans have now been pushed back.

In this podcast the Deep Breath In team are joined by the authors of a recent article in The BMJ to explore those fears, hear about the potential benefits, and understand the evidence behind open notes.

Our guests;
Charlotte Blease, and interdisciplinary health researcher at OpenNotes, Beth Israel Deaconess Medical Center/Harvard Medical School.
Brian McMillan, a GP and senior clinical lecturer at the University of Manchester
Gail Davidge, research associate at the University of Manchester

The article they're discussing is a practice pointer on Adapting to transparent medical records: international experience with “open notes”
https://www.bmj.com/content/379/bmj-2021-069861</description>
      <enclosure length="58027362" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1404189349-bmjpodcasts-patient-access-to-notes-with-charlotte-blease-brian-macmillan-and-gail-davidge.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8i9LTpkaLEKQ3DNF-EFzLHw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1402631785</guid>
      <title>From Voiceless to a Voice Representing the Deaf Community and British Sign Language (BSL)</title>
      <pubDate>Thu, 15 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/from-voiceless-to-a-voice-representing-the-deaf-community-and-british-sign-language-bsl</link>
      <itunes:duration>00:41:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Khalid Ali, film and media correspondent, interviews British documentary filmmaker, Edward Lovelace. They discuss his film ‘’Name me Lawand’’, a rapturous portrait of a deaf Kurdish boy’s emotional journey towards discovering how to express himself. A love letter to the power of communication and community. Edward describes how he bonded with Lawand and how together they created a poignant film amplifying the voices of the Deaf community and their fight for passing the BSL act in 2022. 
Related blog with the transcript of this podcast: https://blogs.bmj.com/medical-humanities/2022/12/15/lawand-from-voiceless-to-a-voice-representing-the-deaf-community-and-british-sign-language-bsl
Other related links:
https://blogs.bmj.com/medical-humanities/2021/10/27/listen-without-prejudice/ 
https://blogs.bmj.com/medical-humanities/2016/04/08/the-reading-room-deaf-gain/ https://blogs.bmj.com/medical-humanities/2018/08/09/deafhearing-family-life-in-the-silent-child-an-unsympathetic-portrayal/ 
https://blogs.bmj.com/medical-humanities/2021/01/05/hearing-happiness-jaipreet-virdi-on-deafness-accessibility-and-her-latest-book/ 
https://blogs.bmj.com/medical-humanities/2021/01/21/book-review-hearing-happiness-deafness-cures-in-history/

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>Dr Khalid Ali, film and media correspondent, inte…</itunes:subtitle>
      <description>Dr Khalid Ali, film and media correspondent, interviews British documentary filmmaker, Edward Lovelace. They discuss his film ‘’Name me Lawand’’, a rapturous portrait of a deaf Kurdish boy’s emotional journey towards discovering how to express himself. A love letter to the power of communication and community. Edward describes how he bonded with Lawand and how together they created a poignant film amplifying the voices of the Deaf community and their fight for passing the BSL act in 2022. 
Related blog with the transcript of this podcast: https://blogs.bmj.com/medical-humanities/2022/12/15/lawand-from-voiceless-to-a-voice-representing-the-deaf-community-and-british-sign-language-bsl
Other related links:
https://blogs.bmj.com/medical-humanities/2021/10/27/listen-without-prejudice/ 
https://blogs.bmj.com/medical-humanities/2016/04/08/the-reading-room-deaf-gain/ https://blogs.bmj.com/medical-humanities/2018/08/09/deafhearing-family-life-in-the-silent-child-an-unsympathetic-portrayal/ 
https://blogs.bmj.com/medical-humanities/2021/01/05/hearing-happiness-jaipreet-virdi-on-deafness-accessibility-and-her-latest-book/ 
https://blogs.bmj.com/medical-humanities/2021/01/21/book-review-hearing-happiness-deafness-cures-in-history/

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="58977142" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1402631785-bmjpodcasts-from-voiceless-to-a-voice-representing-the-deaf-community-and-british-sign-language-bsl.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-35rzDteJIBP6iGmy-ch0M3g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1401413917</guid>
      <title>Respiratory research in the UK: investing for the next 10 years</title>
      <pubDate>Thu, 15 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/respiratory-research-in-the-uk-investing-for-the-next-10-years</link>
      <itunes:duration>00:26:49</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode, Thorax social media editor Dr. Puja Mehta speaks with Professor Ian Hall, Director of the Nottingham Biomedical Research Centre and the University of Nottingham about his paper "Respiratory Research in the UK: investing for the next 10 years". They discuss some of the biggest challenges facing respiratory research in the UK, and why respiratory diseases need more investment. Read the paper here:
https://thorax.bmj.com/content/77/9/851

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</itunes:summary>
      <itunes:subtitle>In this episode, Thorax social media editor Dr. P…</itunes:subtitle>
      <description>In this episode, Thorax social media editor Dr. Puja Mehta speaks with Professor Ian Hall, Director of the Nottingham Biomedical Research Centre and the University of Nottingham about his paper "Respiratory Research in the UK: investing for the next 10 years". They discuss some of the biggest challenges facing respiratory research in the UK, and why respiratory diseases need more investment. Read the paper here:
https://thorax.bmj.com/content/77/9/851

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</description>
      <enclosure length="25749210" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1401413917-bmjpodcasts-respiratory-research-in-the-uk-investing-for-the-next-10-years.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-OrdixQ8Emj6if3z1-OcSPLw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1402516930</guid>
      <title>DNACPR</title>
      <pubDate>Wed, 14 Dec 2022 12:28:57 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dnacpr</link>
      <itunes:duration>01:00:47</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Dr. Informed podcast, the topic of discussion is death and dying, and how to involve patients in DNACPR decisions.

The panel discuss the importance of doctors having discussions with patients about end-of-life care as a way of creating the best possible death for patients. The conversation also touches on the challenges that doctors may face when having these difficult discussions and they give some advice on how they to overcome them.

Joining Clara are;
Mark Taubert, palliative care consultant, and national chair of future care planning for the Welsh Government
Kat Shelley, an anaesthetics trainee, who has stage four breast cancer, and is receiving palliative care
Lucy-Anne Frank, an elderly care consultant.

The article "Do not resuscitate me in Barbados" is published by BMJ Supportive and Palliative Care, and is free to access at;
https://spcare.bmj.com/content/11/3/310</itunes:summary>
      <itunes:subtitle>In this episode of the Dr. Informed podcast, the …</itunes:subtitle>
      <description>In this episode of the Dr. Informed podcast, the topic of discussion is death and dying, and how to involve patients in DNACPR decisions.

The panel discuss the importance of doctors having discussions with patients about end-of-life care as a way of creating the best possible death for patients. The conversation also touches on the challenges that doctors may face when having these difficult discussions and they give some advice on how they to overcome them.

Joining Clara are;
Mark Taubert, palliative care consultant, and national chair of future care planning for the Welsh Government
Kat Shelley, an anaesthetics trainee, who has stage four breast cancer, and is receiving palliative care
Lucy-Anne Frank, an elderly care consultant.

The article "Do not resuscitate me in Barbados" is published by BMJ Supportive and Palliative Care, and is free to access at;
https://spcare.bmj.com/content/11/3/310</description>
      <enclosure length="58365056" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1402516930-bmjpodcasts-dnacpr.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iv1zjTJkVfROtFcB-2RBqcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1398028681</guid>
      <title>The ESC guidelines on heart failure - what are the important takeaways?</title>
      <pubDate>Tue, 13 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-esc-guidelines-on-heart-failure-what-are-the-important-takeaways</link>
      <itunes:duration>00:31:23</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Patricia Campbell the Southern Trust, Northern Ireland. They discuss the important takeaways from the 2021 ESC heart failure guidelines, including the diagnosis of HFpEF, revised BNP cut-offs, cardiac amyloidosis and much more. 

This episode is sponsored by an educational grant from the Boehringer Ingelheim-Lilly Alliance. The sponsor has no influence over podcast content, the selection of speakers or any associated educational material. 

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://bjcardio.co.uk/2022/07/new-developments-in-the-investigations-and-diagnosis-of-heart-failure/</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Patricia Campbell the Southern Trust, Northern Ireland. They discuss the important takeaways from the 2021 ESC heart failure guidelines, including the diagnosis of HFpEF, revised BNP cut-offs, cardiac amyloidosis and much more. 

This episode is sponsored by an educational grant from the Boehringer Ingelheim-Lilly Alliance. The sponsor has no influence over podcast content, the selection of speakers or any associated educational material. 

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://bjcardio.co.uk/2022/07/new-developments-in-the-investigations-and-diagnosis-of-heart-failure/</description>
      <enclosure length="75315448" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1398028681-bmjpodcasts-the-esc-guidelines-on-heart-failure-what-are-the-important-takeaways.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1401130801</guid>
      <title>Mentor’s Podcast: Anna Fagotti</title>
      <pubDate>Mon, 12 Dec 2022 15:03:37 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mentors-podcast-anna-fagotti</link>
      <itunes:duration>00:24:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti. Dr. Fagotti is the director of the ovarian cancer unit at the A. Gemelli IRCCS University Hospital Foundation, ESGO President Elect and member of the ESGO Executive Committee, and Editor of the International Journal of Gynecological Cancer.

 Highlights:

-Always practice your skills if you want to excel in minimally invasive surgery: Practice makes perfect.

-The journey is long for a gynecologic oncologist. We can’t foresee the future and plans might have to be adjusted along the way, so try to be flexible on what you have beside you. Try to answer the relevant clinical questions. Don’t create a question just to answer.

-There can be difficulties along the way, but look forward and focus on your aim and don’t get stopped by obstacles. Remember to try to enjoy everything.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti. Dr. Fagotti is the director of the ovarian cancer unit at the A. Gemelli IRCCS University Hospital Foundation, ESGO President Elect and member of the ESGO Executive Committee, and Editor of the International Journal of Gynecological Cancer.

 Highlights:

-Always practice your skills if you want to excel in minimally invasive surgery: Practice makes perfect.

-The journey is long for a gynecologic oncologist. We can’t foresee the future and plans might have to be adjusted along the way, so try to be flexible on what you have beside you. Try to answer the relevant clinical questions. Don’t create a question just to answer.

-There can be difficulties along the way, but look forward and focus on your aim and don’t get stopped by obstacles. Remember to try to enjoy everything.</description>
      <enclosure length="23528601" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1401130801-bmjpodcasts-mentors-podcast-anna-fagotti.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1399426075</guid>
      <title>Don’t forget the long game after knee injury – OPTIKNEE consensus with Jackie Whittaker EP #520</title>
      <pubDate>Fri, 09 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dont-forget-the-long-game-after-knee-injury-optiknee-consensus-with-jackie-whittaker-ep-520</link>
      <itunes:duration>00:28:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this BJSM podcast Jackie Whittaker discusses the OPTIKNEE consensus clinical and research recommendations. Jackie is an Associate Professor in the Department of Physical Therapy, at the University of British Columbia. The OPTIKNEE initiative aims to shine the light on post-traumatic osteoarthritis after traumatic knee injury – who is most at risk, what should we be measuring and how, and what interventions should we be using? Jackie encourages clinicians to think about knee and overall health beyond the short-game of injury rehab and return to sport. There are some great tips on how you can set up patients at risk of post-traumatic osteoarthritis with the knowledge, skills, and motivation to self-manage in the long-term. 

OPTIKNEE Consensus Statement https://www.ncbi.nlm.nih.gov/pubmed/36379676
OPTIKNEE website and links to systematic reviews: bit.ly/OPTIKNEE</itunes:summary>
      <itunes:subtitle>In this BJSM podcast Jackie Whittaker discusses t…</itunes:subtitle>
      <description>In this BJSM podcast Jackie Whittaker discusses the OPTIKNEE consensus clinical and research recommendations. Jackie is an Associate Professor in the Department of Physical Therapy, at the University of British Columbia. The OPTIKNEE initiative aims to shine the light on post-traumatic osteoarthritis after traumatic knee injury – who is most at risk, what should we be measuring and how, and what interventions should we be using? Jackie encourages clinicians to think about knee and overall health beyond the short-game of injury rehab and return to sport. There are some great tips on how you can set up patients at risk of post-traumatic osteoarthritis with the knowledge, skills, and motivation to self-manage in the long-term. 

OPTIKNEE Consensus Statement https://www.ncbi.nlm.nih.gov/pubmed/36379676
OPTIKNEE website and links to systematic reviews: bit.ly/OPTIKNEE</description>
      <enclosure length="69312260" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1399426075-bmjpodcasts-dont-forget-the-long-game-after-knee-injury-optiknee-consensus-with-jackie-whittaker-ep-520.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7ViFSDCC6mfXG5cn-ykYM9Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1398573625</guid>
      <title>It’s not just you, medicine is weird</title>
      <pubDate>Thu, 08 Dec 2022 11:24:32 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/its-not-just-you-medicine-is-weird</link>
      <itunes:duration>00:39:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Medicine is a career unlike almost any other. As medical students and junior doctors, we’ve had a lot of experience with strange, surreal moments. The first time you ask a super invasive question to someone you’ve known for all of five minutes, the first time you make an incision in surgery, the first time you do an intimate examination - all of these things can be really strange as they go against our social norms. 

Getting used to this is important but no one ever teaches us this in medical school. In everyday life, there are lots of rules that we follow that aren’t written down anywhere. But when we start placements, we have to unlearn years of following those rules and start doing things that conflict with how we would normally act. Join us in this episode as we talk about how strange medicine can be and how best to cope with moments that can sometimes be uncomfortable or awkward. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Medicine is a career unlike almost any other. As …</itunes:subtitle>
      <description>Medicine is a career unlike almost any other. As medical students and junior doctors, we’ve had a lot of experience with strange, surreal moments. The first time you ask a super invasive question to someone you’ve known for all of five minutes, the first time you make an incision in surgery, the first time you do an intimate examination - all of these things can be really strange as they go against our social norms. 

Getting used to this is important but no one ever teaches us this in medical school. In everyday life, there are lots of rules that we follow that aren’t written down anywhere. But when we start placements, we have to unlearn years of following those rules and start doing things that conflict with how we would normally act. Join us in this episode as we talk about how strange medicine can be and how best to cope with moments that can sometimes be uncomfortable or awkward. 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="37859072" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1398573625-bmjpodcasts-its-not-just-you-medicine-is-weird.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zZvQ5Z5lini22Jbq-GHPOQA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1387559536</guid>
      <title>Role of endoscopy in patients with familial adenomatous polyposis</title>
      <pubDate>Wed, 07 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/endoscopy-in-patients-with-fap</link>
      <itunes:duration>00:21:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Aditi Kumar(1) is joined by Professor Andrew Hopper(2) to discuss the role and importance of endoscopy in patients diagnosed with familial adenomatous polyposis (FAP). Read the article in Frontline Gastroenterology here: https://fg.bmj.com/content/13/e1/e72

(1) Trainee associate editor for Frontline Gastroenterology and gastroenterology trainee in the West Midlands.
(2) Consultant Gastroenterologist at the Royal Hallamshire Hospital, Sheffield, UK

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>Dr Aditi Kumar(1) is joined by Professor Andrew H…</itunes:subtitle>
      <description>Dr Aditi Kumar(1) is joined by Professor Andrew Hopper(2) to discuss the role and importance of endoscopy in patients diagnosed with familial adenomatous polyposis (FAP). Read the article in Frontline Gastroenterology here: https://fg.bmj.com/content/13/e1/e72

(1) Trainee associate editor for Frontline Gastroenterology and gastroenterology trainee in the West Midlands.
(2) Consultant Gastroenterologist at the Royal Hallamshire Hospital, Sheffield, UK

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="21068903" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1387559536-bmjpodcasts-endoscopy-in-patients-with-fap.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1392209704</guid>
      <title>Peritoneal Carcinomatosis after MIS in Cervical Cancer with Dr. Jorge Hoegl</title>
      <pubDate>Mon, 05 Dec 2022 11:00:14 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/peritoneal-carcinomatosis-after-mis-in-cervical-cancer-with-dr-jorge-hoegl</link>
      <itunes:duration>00:23:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Jorge Hoegl to discuss peritoneal carcinomatosis after minimally invasive surgery in cervical cancer. Dr. Jorge Hoegl is an early career gynecologic oncologist at the Department of Obstetrics and Gynecology at the General Hospital of the East “Dr. Domingo Luciani” in Caracas, Venezuela.  

Highlights:

-Peritoneal carcinomatosis represented more than 15% of all recurrences, with a recurrence rate of 22.2% in minimally invasive surgery compared to 8.8%.

-Peritoneal carcinomatosis has been frequently grouped within distant recurrences and perhaps this made it not such a notorious fact.

-Peritoneal carcinomatosis does not appear to be an unusual recurrence pattern associated with cervical cancer and it should be reported separately.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Jorge Hoegl to discuss peritoneal carcinomatosis after minimally invasive surgery in cervical cancer. Dr. Jorge Hoegl is an early career gynecologic oncologist at the Department of Obstetrics and Gynecology at the General Hospital of the East “Dr. Domingo Luciani” in Caracas, Venezuela.  

Highlights:

-Peritoneal carcinomatosis represented more than 15% of all recurrences, with a recurrence rate of 22.2% in minimally invasive surgery compared to 8.8%.

-Peritoneal carcinomatosis has been frequently grouped within distant recurrences and perhaps this made it not such a notorious fact.

-Peritoneal carcinomatosis does not appear to be an unusual recurrence pattern associated with cervical cancer and it should be reported separately.</description>
      <enclosure length="22075203" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1392209704-bmjpodcasts-peritoneal-carcinomatosis-after-mis-in-cervical-cancer-with-dr-jorge-hoegl.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1366918750</guid>
      <title>Rosacea: an update on diagnosis and management</title>
      <pubDate>Mon, 05 Dec 2022 09:30:04 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/rosacea</link>
      <itunes:duration>00:16:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We release episodes fortnightly. Rosacea is  a common disorder. Studies suggest a prevalence of 5% for women and 4% for men. And rosacea can cause a range of problems including papules and pustules, telangiectasias, and eye problems. So it is important that we get the diagnosis and management of this condition right.  
In this BMJ Best Practice podcast on rosacea, Kieran Walsh talks to Dr Abel Jarell, Dermatologist and Dermatopathologist, Northeast Dermatology Associates, Portsmouth, New Hampshire. Competing interests: none declared</itunes:summary>
      <itunes:subtitle>We release episodes fortnightly. Rosacea is  a co…</itunes:subtitle>
      <description>We release episodes fortnightly. Rosacea is  a common disorder. Studies suggest a prevalence of 5% for women and 4% for men. And rosacea can cause a range of problems including papules and pustules, telangiectasias, and eye problems. So it is important that we get the diagnosis and management of this condition right.  
In this BMJ Best Practice podcast on rosacea, Kieran Walsh talks to Dr Abel Jarell, Dermatologist and Dermatopathologist, Northeast Dermatology Associates, Portsmouth, New Hampshire. Competing interests: none declared</description>
      <enclosure length="20365696" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1366918750-bmjpodcasts-rosacea.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1394794615</guid>
      <title>Talk Evidence - endometriosis, falling, and better EBM</title>
      <pubDate>Fri, 02 Dec 2022 14:11:45 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-endometriosis-falling-and-better-ebm</link>
      <itunes:duration>00:47:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this month's episode, Helen Juan and Joe delve into the clinical - with a new review of endometriosis, and why the difficulty in diagnosis has lead to a dearth of evidence and attention on the condition.

Joe tells us about a risk prediction tool that could be useful in helping to mitigate some of the problems of antihypertensive treatments.

We're also having a geek out about a group of papers we've published lately, on how well evidence is created, maintained, and diseminated.

Reading list;


Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
https://www.bmj.com/content/379/bmj-2022-070918

Pathophysiology, diagnosis, and management of endometriosis
https://www.bmj.com/content/379/bmj-2022-070750


Effective knowledge mobilisation: creating environments for quick generation, dissemination, and use of evidence
https://www.bmj.com/content/379/bmj-2022-070195

Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review 
https://bmjmedicine.bmj.com/content/1/1/e000309

Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: a meta-research study from the REPRISE project
https://www.medrxiv.org/content/10.1101/2022.04.11.22273688v2</itunes:summary>
      <itunes:subtitle>In this month's episode, Helen Juan and Joe delve…</itunes:subtitle>
      <description>In this month's episode, Helen Juan and Joe delve into the clinical - with a new review of endometriosis, and why the difficulty in diagnosis has lead to a dearth of evidence and attention on the condition.

Joe tells us about a risk prediction tool that could be useful in helping to mitigate some of the problems of antihypertensive treatments.

We're also having a geek out about a group of papers we've published lately, on how well evidence is created, maintained, and diseminated.

Reading list;


Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study
https://www.bmj.com/content/379/bmj-2022-070918

Pathophysiology, diagnosis, and management of endometriosis
https://www.bmj.com/content/379/bmj-2022-070750


Effective knowledge mobilisation: creating environments for quick generation, dissemination, and use of evidence
https://www.bmj.com/content/379/bmj-2022-070195

Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review 
https://bmjmedicine.bmj.com/content/1/1/e000309

Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: a meta-research study from the REPRISE project
https://www.medrxiv.org/content/10.1101/2022.04.11.22273688v2</description>
      <enclosure length="45732257" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1394794615-bmjpodcasts-talk-evidence-endometriosis-falling-and-better-ebm.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2yobq1Hjl6r87WmD-zdjn1Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1391972710</guid>
      <title>Primary Survey - the highlights of December 2022</title>
      <pubDate>Fri, 02 Dec 2022 11:51:49 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-december-22</link>
      <itunes:duration>00:27:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A selection of the best papers from our December 2022, picked apart and distilled for you by Rick Body and Sarah Edwards. In this festive issue we cover anaesthesia for paediatric forearm fractures, ultrasound diagnosis of acute appendicitis, a deep dive into the predictive value of vital signs, clinical judgement versus early warning scores, pulmonary embolism and... Do you know what calibration drift is? If not, listen and you'll find out!
Read the highlights: https://emj.bmj.com/content/39/12/881.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>A selection of the best papers from our December …</itunes:subtitle>
      <description>A selection of the best papers from our December 2022, picked apart and distilled for you by Rick Body and Sarah Edwards. In this festive issue we cover anaesthesia for paediatric forearm fractures, ultrasound diagnosis of acute appendicitis, a deep dive into the predictive value of vital signs, clinical judgement versus early warning scores, pulmonary embolism and... Do you know what calibration drift is? If not, listen and you'll find out!
Read the highlights: https://emj.bmj.com/content/39/12/881.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="26815424" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1391972710-bmjpodcasts-emj-december-22.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1392020917</guid>
      <title>FMT-AID trial shows effectiveness in inducing remission of ulcerative colitis</title>
      <pubDate>Thu, 01 Dec 2022 02:00:03 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/fmt-aid-trial-for-ulcerative-colitis</link>
      <itunes:duration>00:13:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Vineet Ahuja who is from the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India, on the paper 'Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial' published in paper copy in Gut in December 2022 and available online: https://gut.bmj.com/content/71/12/2401

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Vineet Ahuja who is from the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India, on the paper 'Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial' published in paper copy in Gut in December 2022 and available online: https://gut.bmj.com/content/71/12/2401

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="13176998" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1392020917-bmjpodcasts-fmt-aid-trial-for-ulcerative-colitis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1392681379</guid>
      <title>When. What. How long must this carry on? - Archimedes December 2022</title>
      <pubDate>Thu, 01 Dec 2022 01:00:03 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/archimedes-december-2022</link>
      <itunes:duration>00:11:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The joy of Archimedes is the breadth of what it covers. For instance, have you ever considered the management of NTM lymphedenits with MAC? (That’s not a sneaky way of getting a cosmetics company to sponsor our EBM slot.) If you’ve no idea what that last but one sentence means … listen on! If you have, listen on anyway! And if you’re struggling with the bit in parentheses, then wander down to your local department store and glance around the make-up counters. The full paper can be read here [ https://adc.bmj.com/content/107/12/1131.1 ]
We would love for you to be involved and submit your very own Archi [adc.bmj.com/pages/authors/#archimedes] - it’s more fun than tidying up the messy kitchen.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>The joy of Archimedes is the breadth of what it c…</itunes:subtitle>
      <description>The joy of Archimedes is the breadth of what it covers. For instance, have you ever considered the management of NTM lymphedenits with MAC? (That’s not a sneaky way of getting a cosmetics company to sponsor our EBM slot.) If you’ve no idea what that last but one sentence means … listen on! If you have, listen on anyway! And if you’re struggling with the bit in parentheses, then wander down to your local department store and glance around the make-up counters. The full paper can be read here [ https://adc.bmj.com/content/107/12/1131.1 ]
We would love for you to be involved and submit your very own Archi [adc.bmj.com/pages/authors/#archimedes] - it’s more fun than tidying up the messy kitchen.

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="10707695" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1392681379-bmjpodcasts-archimedes-december-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-kLlv8zTGLsUJHKA6-oCDiuQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1393491223</guid>
      <title>Reporting at Safety 2022: all shades of Injury Prevention represented</title>
      <pubDate>Thu, 01 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/safety-2022-all-shades-of-injury-prevention-represented</link>
      <itunes:duration>00:14:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Ever wondered what it would be like to help design and run a world injury conference? Come visit Safety 2022, in a conversation with a member of the Australian Organising Committee. Editor-in-Chief of Injury Prevention, Rod McLure, talks with Dr Amy Peden* at the Safety 2022 Conference, in Adelaide, Australia.

*Bachelor of Arts (Government and International Relations, Social Policy), Master of Public Policy, PhD (Health); School of Population Health, Faculty of Medicine &amp; Health, University of NSW

Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>Ever wondered what it would be like to help desig…</itunes:subtitle>
      <description>Ever wondered what it would be like to help design and run a world injury conference? Come visit Safety 2022, in a conversation with a member of the Australian Organising Committee. Editor-in-Chief of Injury Prevention, Rod McLure, talks with Dr Amy Peden* at the Safety 2022 Conference, in Adelaide, Australia.

*Bachelor of Arts (Government and International Relations, Social Policy), Master of Public Policy, PhD (Health); School of Population Health, Faculty of Medicine &amp; Health, University of NSW

Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="14280410" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1393491223-bmjpodcasts-safety-2022-all-shades-of-injury-prevention-represented.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-97PYlC3idubTCbxz-1rv9FQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1392586303</guid>
      <title>HIV and STI prevention, plus HIV in Ukraine</title>
      <pubDate>Thu, 01 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/hiv-glasgow-2022-highlights</link>
      <itunes:duration>00:31:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this double-interview podcast, the Editor-in-Chief of the STI journal, Professor Anna Maria Geretti, brings you some of the highlights from the HIV Glasgow 2022 conference.
In the first interview (starting at 1:00), Professor Geretti interviews Jean-Michel Molina*, who discusses HIV and STI prevention.
The second interview (starting at 12:30) is with Professor Miłosz Parczewski**. They discuss the effects of the war in Ukraine on the country’s healthcare system, in particular on the prevalence of STIs. 
 
*Professor of Infectious Diseases University of Paris, France and Head of the Infectious Diseases Department, Saint-Louis Hospital and Lariboisière Hospital Paris, France.
 
**Clinical specialist and Professor of Infectious Diseases Pomeranian Medical University, Szczecin, Poland. Associate Editor on STI and newly elected Vice President of the European AIDS Clinical Society.
 
To hear more episodes of the STI Podcast, please subscribe: 
https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980</itunes:summary>
      <itunes:subtitle>In this double-interview podcast, the Editor-in-C…</itunes:subtitle>
      <description>In this double-interview podcast, the Editor-in-Chief of the STI journal, Professor Anna Maria Geretti, brings you some of the highlights from the HIV Glasgow 2022 conference.
In the first interview (starting at 1:00), Professor Geretti interviews Jean-Michel Molina*, who discusses HIV and STI prevention.
The second interview (starting at 12:30) is with Professor Miłosz Parczewski**. They discuss the effects of the war in Ukraine on the country’s healthcare system, in particular on the prevalence of STIs. 
 
*Professor of Infectious Diseases University of Paris, France and Head of the Infectious Diseases Department, Saint-Louis Hospital and Lariboisière Hospital Paris, France.
 
**Clinical specialist and Professor of Infectious Diseases Pomeranian Medical University, Szczecin, Poland. Associate Editor on STI and newly elected Vice President of the European AIDS Clinical Society.
 
To hear more episodes of the STI Podcast, please subscribe: 
https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980</description>
      <enclosure length="30377690" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1392586303-bmjpodcasts-hiv-glasgow-2022-highlights.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QsRTwnBAaqDmx3t3-PmDMzA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1373588551</guid>
      <title>Primary Survey - the highlights of November 2022</title>
      <pubDate>Thu, 01 Dec 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-november-22</link>
      <itunes:duration>00:29:54</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A selection of the best papers from our November 2022 edition. Rick and Sarah take you through five great papers discussing headache, subarachnoid haemorrhage, pre-hospital births, how to mitigate emergency physician stress in resuscitation and pathways for the early diagnosis of acute myocardial infarction.
Read the highlights: https://emj.bmj.com/content/39/11/799.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>A selection of the best papers from our November …</itunes:subtitle>
      <description>A selection of the best papers from our November 2022 edition. Rick and Sarah take you through five great papers discussing headache, subarachnoid haemorrhage, pre-hospital births, how to mitigate emergency physician stress in resuscitation and pathways for the early diagnosis of acute myocardial infarction.
Read the highlights: https://emj.bmj.com/content/39/11/799.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="28706689" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1373588551-bmjpodcasts-emj-november-22.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1388031493</guid>
      <title>December 2022 - MHT and 'brain fog', risks from sodium-containing paracetamol and 2022 revisited</title>
      <pubDate>Wed, 30 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-december-2022</link>
      <itunes:duration>00:25:53</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the December 2022 issue of DTB. They discuss cognitive changes that have been reported during the menopause and whether there is a role for MHT (https://dtb.bmj.com/content/60/12/178). They highlight an observational study that found an association between the use of sodium-containing paracetamol and cardiovascular events (https://dtb.bmj.com/content/60/12/181), and talk about the evidence for increasing the dose of vedolizumab in IBD (https://dtb.bmj.com/content/60/12/183). They begin the podcast by talking about their top three highlights from 2022.

The contact address for the DTB team is dtb@bmj.com.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the December 2022 issue of DTB. They discuss cognitive changes that have been reported during the menopause and whether there is a role for MHT (https://dtb.bmj.com/content/60/12/178). They highlight an observational study that found an association between the use of sodium-containing paracetamol and cardiovascular events (https://dtb.bmj.com/content/60/12/181), and talk about the evidence for increasing the dose of vedolizumab in IBD (https://dtb.bmj.com/content/60/12/183). They begin the podcast by talking about their top three highlights from 2022.

The contact address for the DTB team is dtb@bmj.com.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="62139028" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1388031493-bmjpodcasts-dtb-december-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1382986849</guid>
      <title>Editors Highlights of the December 2022 issue</title>
      <pubDate>Wed, 30 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-december-2022-issue</link>
      <itunes:duration>00:38:18</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the December 2022 issue of the journal (https://pn.bmj.com/content/22/6/445).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</itunes:summary>
      <itunes:subtitle>Practical Neurology Editors Phil Smith and Gerain…</itunes:subtitle>
      <description>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the December 2022 issue of the journal (https://pn.bmj.com/content/22/6/445).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</description>
      <enclosure length="36775391" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1382986849-bmjpodcasts-editors-highlights-of-the-december-2022-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1390125634</guid>
      <title>What's new in heart failure? An update from Professor Carolyn Lam</title>
      <pubDate>Tue, 29 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/whats-new-in-heart-failure-an-update-from-professor-carolyn-lam</link>
      <itunes:duration>00:25:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Professor Carolyn Lam, a world expert in heart failure from the University of Singapore and the National Heart Centre, also in Singapore. They discuss updates in the diagnosis and management of heart failure, including wearables, biomarkers, the 4 pillars of therapy, and how and why there has historically been an under-representation of women in heart failure trials. 

This episode is sponsored by an educational grant from the Boehringer Ingelheim-Lilly Alliance. The sponsor has no influence over podcast content, the selection of speakers or any associated educational material. 

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Circulation on the Run podcast - https://www.ahajournals.org/circ/podcasts</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Professor Carolyn Lam, a world expert in heart failure from the University of Singapore and the National Heart Centre, also in Singapore. They discuss updates in the diagnosis and management of heart failure, including wearables, biomarkers, the 4 pillars of therapy, and how and why there has historically been an under-representation of women in heart failure trials. 

This episode is sponsored by an educational grant from the Boehringer Ingelheim-Lilly Alliance. The sponsor has no influence over podcast content, the selection of speakers or any associated educational material. 

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Circulation on the Run podcast - https://www.ahajournals.org/circ/podcasts</description>
      <enclosure length="60285466" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1390125634-bmjpodcasts-whats-new-in-heart-failure-an-update-from-professor-carolyn-lam.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1391977852</guid>
      <title>Episode 9: Role of Regional Anesthesia and Analgesia in Enhanced Recovery After Colorectal Surgery</title>
      <pubDate>Mon, 28 Nov 2022 14:55:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-9-role-of-regional-anesthesia-and-analgesia-in-enhanced-recovery-after-colorectal-surgery</link>
      <itunes:duration>00:33:41</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In surgical care worldwide, there has been a growing trend towards enhanced recovery with the emphasis on early mobility, avoidance of unnecessary procedures and drug-induced side effects, and
faster return of normal gastrointestinal function, with the end result of shorter hospital stay. It’s natural to assume that regional anesthesiology and acute pain medicine would play a central role in enhanced recovery protocols for all of the well-described benefits. However, the base evidence is continually evolving as both anesthetic and surgical practices change.

In this month’s RAPM Focus, Associate Editor Edward Mariano, MD, joins Kariem El-Boghdadly, MBBS, BSc, FRCA, EDRA, lead author of an international collaboration in the regional anesthesiology and
enhanced recovery world, “Role of regional anesthesia and analgesia in enhanced recovery after colorectal surgery: a systematic review of randomized controlled trials,” first published in March 2022
(https://rapm.bmj.com/content/47/5/282). Investigators carefully evaluated thirteen published randomized controlled trial studies involving 1,170 participants and concluded that regional analgesia
may only have modest evidence to support its inclusion in enhanced recovery protocols involving colorectal surgery patients.

Dr. Kariem El-Boghdadly is a consultant anesthetist at Guy’s and St. Thomas’ NHS Trust in London, and an editor of the journal Anesthesia. Dr. El-Boghdadly completed his undergraduate training at University College of London in 2007 and proceeded to undertake his anesthetic training in Southeast School of Anesthesia. He was awarded the Nuffield Prize for the fellowship of the Royal College of Anaesthetists and completed fellowships in prehospital medicine in Australia, followed by regional anesthesia in Toronto, Canada. Dr. El-Boghdadly is an honorary senior lecturer at King’s College London, and his research interests include regional anesthesia, airway management, and research delivery. He is a brilliant researcher and writer and is well-known for his work in the COVIDSurg Collaborative during the ongoing pandemic, and the ASRA-ESRA regional anesthesia nomenclature project.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical
treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</itunes:summary>
      <itunes:subtitle>In surgical care worldwide, there has been a grow…</itunes:subtitle>
      <description>In surgical care worldwide, there has been a growing trend towards enhanced recovery with the emphasis on early mobility, avoidance of unnecessary procedures and drug-induced side effects, and
faster return of normal gastrointestinal function, with the end result of shorter hospital stay. It’s natural to assume that regional anesthesiology and acute pain medicine would play a central role in enhanced recovery protocols for all of the well-described benefits. However, the base evidence is continually evolving as both anesthetic and surgical practices change.

In this month’s RAPM Focus, Associate Editor Edward Mariano, MD, joins Kariem El-Boghdadly, MBBS, BSc, FRCA, EDRA, lead author of an international collaboration in the regional anesthesiology and
enhanced recovery world, “Role of regional anesthesia and analgesia in enhanced recovery after colorectal surgery: a systematic review of randomized controlled trials,” first published in March 2022
(https://rapm.bmj.com/content/47/5/282). Investigators carefully evaluated thirteen published randomized controlled trial studies involving 1,170 participants and concluded that regional analgesia
may only have modest evidence to support its inclusion in enhanced recovery protocols involving colorectal surgery patients.

Dr. Kariem El-Boghdadly is a consultant anesthetist at Guy’s and St. Thomas’ NHS Trust in London, and an editor of the journal Anesthesia. Dr. El-Boghdadly completed his undergraduate training at University College of London in 2007 and proceeded to undertake his anesthetic training in Southeast School of Anesthesia. He was awarded the Nuffield Prize for the fellowship of the Royal College of Anaesthetists and completed fellowships in prehospital medicine in Australia, followed by regional anesthesia in Toronto, Canada. Dr. El-Boghdadly is an honorary senior lecturer at King’s College London, and his research interests include regional anesthesia, airway management, and research delivery. He is a brilliant researcher and writer and is well-known for his work in the COVIDSurg Collaborative during the ongoing pandemic, and the ASRA-ESRA regional anesthesia nomenclature project.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical
treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</description>
      <enclosure length="80797376" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1391977852-bmjpodcasts-episode-9-role-of-regional-anesthesia-and-analgesia-in-enhanced-recovery-after-colorectal-surgery.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-36rEAsdbqSkJRswY-u6sWGg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1387621324</guid>
      <title>SUCCOR: Validation of ESGO Quality Indicators Cervical Cancer with Félix Boria</title>
      <pubDate>Sun, 27 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/succor-validation-of-esgo-quality-indicators-cervical-cancer-with-felix-boria</link>
      <itunes:duration>00:19:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Félix Boria to discuss the validation of ESGO quality indicators for cervical cancer. Mr. Boria is an attending physician of the gynecologic oncology division at the University of Navarra (Madrid, Spain) under the mentorship of Dr. Luis Chiva. He is currently finishing his PhD at Universidad Autonoma de Madrid about PET/CT and advanced ovarian cancer.

Highlights:

- Women who were operated on centers with high compliance of quality indicators had significant lower risk of relapse (HR, 0.39; 95% CI, 0.25 to 0.61; p&lt;0.001). The association remained significant after further adjustment for conization, surgical approach and use of manipulator and for adjuvant therapy.

- High compliance centers performed more open surgeries (58.4% vs 36.7%, p&lt;0.01), more cone biopsies (45.4% vs 30.0%, p&lt;0.01), lower use of a uterine manipulator (15.5% vs 31.7%, p&lt;0.01), lower use of adjuvant treatment (40.2% vs 48.4%, p=0.01).

- The rate of adjuvant treatment in Europe is surprisingly high, especially in low compliance centers (48%). Future investigations should try to address if we are overtreating patients with cervical cancer.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Félix Boria to discuss the validation of ESGO quality indicators for cervical cancer. Mr. Boria is an attending physician of the gynecologic oncology division at the University of Navarra (Madrid, Spain) under the mentorship of Dr. Luis Chiva. He is currently finishing his PhD at Universidad Autonoma de Madrid about PET/CT and advanced ovarian cancer.

Highlights:

- Women who were operated on centers with high compliance of quality indicators had significant lower risk of relapse (HR, 0.39; 95% CI, 0.25 to 0.61; p&lt;0.001). The association remained significant after further adjustment for conization, surgical approach and use of manipulator and for adjuvant therapy.

- High compliance centers performed more open surgeries (58.4% vs 36.7%, p&lt;0.01), more cone biopsies (45.4% vs 30.0%, p&lt;0.01), lower use of a uterine manipulator (15.5% vs 31.7%, p&lt;0.01), lower use of adjuvant treatment (40.2% vs 48.4%, p=0.01).

- The rate of adjuvant treatment in Europe is surprisingly high, especially in low compliance centers (48%). Future investigations should try to address if we are overtreating patients with cervical cancer.</description>
      <enclosure length="18310827" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1387621324-bmjpodcasts-succor-validation-of-esgo-quality-indicators-cervical-cancer-with-felix-boria.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1389810559</guid>
      <title>I’m a (Phobic) Medical Student… Get Me Out of Here!</title>
      <pubDate>Thu, 24 Nov 2022 17:09:04 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/im-a-phobic-medical-student-get-me-out-of-here</link>
      <itunes:duration>00:44:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Medicine is occasionally like the reality TV show I’m a Celebrity… Get Me Out of Here! in that some of the things we have to do are just unpleasant, whereas other parts may be phobia-inducing. But how might having a phobia as a medical student affect the ways you are able to work on placement?

In today’s episode, we’re going to be talking all about phobias. We’ll discuss what happens when you have a phobic response to something, the ways that this can impact you whilst studying medicine, and how to tell whether something is just dislike or an actual phobia. 

Expert guests:
Dr Digby Quested is a general adult psychiatrist working in Oxford. He works in the community, and has covered many of the GP practices which serve the student population. He self managed blood phobia whilst at medical school 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Medicine is occasionally like the reality TV show…</itunes:subtitle>
      <description>Medicine is occasionally like the reality TV show I’m a Celebrity… Get Me Out of Here! in that some of the things we have to do are just unpleasant, whereas other parts may be phobia-inducing. But how might having a phobia as a medical student affect the ways you are able to work on placement?

In today’s episode, we’re going to be talking all about phobias. We’ll discuss what happens when you have a phobic response to something, the ways that this can impact you whilst studying medicine, and how to tell whether something is just dislike or an actual phobia. 

Expert guests:
Dr Digby Quested is a general adult psychiatrist working in Oxford. He works in the community, and has covered many of the GP practices which serve the student population. He self managed blood phobia whilst at medical school 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="63964358" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1389810559-bmjpodcasts-im-a-phobic-medical-student-get-me-out-of-here.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1388155543</guid>
      <title>#MedTwitter - a force for good or evil?</title>
      <pubDate>Tue, 22 Nov 2022 10:43:41 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/med-twitter-a-force-for-good-or-evil</link>
      <itunes:duration>00:53:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>#MedTwitter consists of an online community of researchers, health practitioners and students who have created an open source decentralised forum for information sharing, medical education and professional networking. #MedTwitter also provides a space for publications to be shared and promoted. While many will credit Twitter with giving a voice to clinicians, it also comes with challenges, the potential for abuse, or the spread of misinformation.

Joining Clara to discuss are;

Jonathan Guckian, a dermatology registrar in Leeds, and director of social media and communications at the Association for the Study of Medical Education (ASMI).

Flo Wedmore, a medical registrar and NHS sustainability fellow

Declan Murphy, an academic medical fellow S2 in ophthalmology in Newcastle, and former Sharp Scratch panelist.</itunes:summary>
      <itunes:subtitle>#MedTwitter consists of an online community of re…</itunes:subtitle>
      <description>#MedTwitter consists of an online community of researchers, health practitioners and students who have created an open source decentralised forum for information sharing, medical education and professional networking. #MedTwitter also provides a space for publications to be shared and promoted. While many will credit Twitter with giving a voice to clinicians, it also comes with challenges, the potential for abuse, or the spread of misinformation.

Joining Clara to discuss are;

Jonathan Guckian, a dermatology registrar in Leeds, and director of social media and communications at the Association for the Study of Medical Education (ASMI).

Flo Wedmore, a medical registrar and NHS sustainability fellow

Declan Murphy, an academic medical fellow S2 in ophthalmology in Newcastle, and former Sharp Scratch panelist.</description>
      <enclosure length="50944256" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1388155543-bmjpodcasts-med-twitter-a-force-for-good-or-evil.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iv1zjTJkVfROtFcB-2RBqcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1385768632</guid>
      <title>A Discussion of Cystic Fibrosis from the Patient Perspective</title>
      <pubDate>Mon, 21 Nov 2022 20:47:42 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/jim-podcast-nick-bell-cf-experience-november-18-2022</link>
      <itunes:duration>00:28:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this month’s podcast, Journal of Investigative Medicine Social Media Editor John Dickinson, MD, PhD, University of Nebraska Medical Center, welcomes guest Nick Bell for a discussion of cystic fibrosis from the patient perspective. Nick has lived his entire life under the shadow of CF. However, thanks to new advances in CF treatment based on our understanding of the fundamental biology of the CF protein, Nick has been able to emerge from the shadow of CF. He is a successful business owner and community philanthropist who has used his talent with poetry and creative writing to enrich the lives of the less fortunate in the community. In this episode, we explore how science and medical research make lasting impacts on people’s lives.</itunes:summary>
      <itunes:subtitle>In this month’s podcast, Journal of Investigative…</itunes:subtitle>
      <description>In this month’s podcast, Journal of Investigative Medicine Social Media Editor John Dickinson, MD, PhD, University of Nebraska Medical Center, welcomes guest Nick Bell for a discussion of cystic fibrosis from the patient perspective. Nick has lived his entire life under the shadow of CF. However, thanks to new advances in CF treatment based on our understanding of the fundamental biology of the CF protein, Nick has been able to emerge from the shadow of CF. He is a successful business owner and community philanthropist who has used his talent with poetry and creative writing to enrich the lives of the less fortunate in the community. In this episode, we explore how science and medical research make lasting impacts on people’s lives.</description>
      <enclosure length="52097722" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1385768632-bmjpodcasts-jim-podcast-nick-bell-cf-experience-november-18-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iaEWqSKNrU0eR4co-05ELtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1375530439</guid>
      <title>Hypothermia: an update on diagnosis and management</title>
      <pubDate>Mon, 21 Nov 2022 14:51:19 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/hypothermia</link>
      <itunes:duration>00:17:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We release episodes fortnightly. Hypothermia is a serious condition - it can cause rhabdomyolysis, electrolyte disturbances, and cardiac arrhythmias. It can also kill. In the UK, the annual number of hypothermia-related deaths is about 300. And in countries with colder climates, the numbers are far higher. 

So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast, Kieran Walsh talks to Dr Alexander Alexiou, Emergency Medicine Consultant, Barts Health NHS Trust about hypothermia. 

Competing interests: none declared</itunes:summary>
      <itunes:subtitle>We release episodes fortnightly. Hypothermia is a…</itunes:subtitle>
      <description>We release episodes fortnightly. Hypothermia is a serious condition - it can cause rhabdomyolysis, electrolyte disturbances, and cardiac arrhythmias. It can also kill. In the UK, the annual number of hypothermia-related deaths is about 300. And in countries with colder climates, the numbers are far higher. 

So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast, Kieran Walsh talks to Dr Alexander Alexiou, Emergency Medicine Consultant, Barts Health NHS Trust about hypothermia. 

Competing interests: none declared</description>
      <enclosure length="21565696" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1375530439-bmjpodcasts-hypothermia.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1385765728</guid>
      <title>Molecular Classification of Endometrial Cancer with Drs. Ilaria Betella and Francesco Multinu</title>
      <pubDate>Mon, 21 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/molecular-classification-of-endometrial-cancer-with-drs-ilaria-betella-and-francesco-multinu</link>
      <itunes:duration>00:45:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Ilaria Betella and Francesco Multinu. Dr. Betella is an attending in the Department of Gynecologic Surgery at the European Institute of Oncology (IEO) in Milan. Her research focuses on molecular classification of endometrial cancer and on hereditary gynecologic cancer syndromes. Dr. Multinu is a gynecologic oncologist at the European Institute of Oncology (IEO) in Milan as well as a research collaborator in the Department of Obstetrics and Gynecology, Division of Gynecologic Surgery at the Mayo Clinic in Rochester, Minnesota. His special research interests include surgical and postoperative treatment of endometrial cancer.

Highlights:

- There is evidence that the new molecular classification will be the future in the management of endometrial cancer.

- The implementation of molecular analysis allows oncologists to reallocate to a different risk class 6.8% of endometrial cancers that otherwise would have been misclassified and consequently undertreated or overtreated.

- The interpretation of molecular classification requires a validated hierarchical algorithm, for which POLE analysis is essential: Even though POLE testing has not been implemented in many institutions, there is no way to use part of the molecular analysis and completely escape POLE analysis.

- According to the new algorithm proposed by Dr. Betella et al., POLE analysis could be spared in 67% of patients and reserved only for those in whom the incorporation of the molecular classification could change the risk class attribution and post-operative management.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Ilaria Betella and Francesco Multinu. Dr. Betella is an attending in the Department of Gynecologic Surgery at the European Institute of Oncology (IEO) in Milan. Her research focuses on molecular classification of endometrial cancer and on hereditary gynecologic cancer syndromes. Dr. Multinu is a gynecologic oncologist at the European Institute of Oncology (IEO) in Milan as well as a research collaborator in the Department of Obstetrics and Gynecology, Division of Gynecologic Surgery at the Mayo Clinic in Rochester, Minnesota. His special research interests include surgical and postoperative treatment of endometrial cancer.

Highlights:

- There is evidence that the new molecular classification will be the future in the management of endometrial cancer.

- The implementation of molecular analysis allows oncologists to reallocate to a different risk class 6.8% of endometrial cancers that otherwise would have been misclassified and consequently undertreated or overtreated.

- The interpretation of molecular classification requires a validated hierarchical algorithm, for which POLE analysis is essential: Even though POLE testing has not been implemented in many institutions, there is no way to use part of the molecular analysis and completely escape POLE analysis.

- According to the new algorithm proposed by Dr. Betella et al., POLE analysis could be spared in 67% of patients and reserved only for those in whom the incorporation of the molecular classification could change the risk class attribution and post-operative management.</description>
      <enclosure length="43910790" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1385765728-bmjpodcasts-molecular-classification-of-endometrial-cancer-with-drs-ilaria-betella-and-francesco-multinu.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1385140684</guid>
      <title>WISH Innovation Award 2022 - how to succeed in competitions</title>
      <pubDate>Thu, 17 Nov 2022 16:03:58 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/wish-innovations-award-2022-how-to-succeed-in-competitions</link>
      <itunes:duration>00:21:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>One way that start-ups can help accelerate their growth is by entering (and winning!) competitions – like the WISH 2022 Innovation Award. BMJ Innovations was in Doha and spoke to the organisers and some of the winners of this year’s award to get their insight on what makes for a successful entry. Joining us are –

Mahmoud El Achi, Head of Innovation at the World Innovation Summit for Health (WISH)
Nicolas Vachicouras, CEO &amp; Co-founder at Neurosoft Bioelectronics
Yashar Faranjani, CEO &amp; Co-founder at Smiletronix</itunes:summary>
      <itunes:subtitle>One way that start-ups can help accelerate their …</itunes:subtitle>
      <description>One way that start-ups can help accelerate their growth is by entering (and winning!) competitions – like the WISH 2022 Innovation Award. BMJ Innovations was in Doha and spoke to the organisers and some of the winners of this year’s award to get their insight on what makes for a successful entry. Joining us are –

Mahmoud El Achi, Head of Innovation at the World Innovation Summit for Health (WISH)
Nicolas Vachicouras, CEO &amp; Co-founder at Neurosoft Bioelectronics
Yashar Faranjani, CEO &amp; Co-founder at Smiletronix</description>
      <enclosure length="30967914" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1385140684-bmjpodcasts-wish-innovations-award-2022-how-to-succeed-in-competitions.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-9OMfcCJV8cYyM83e-d24rYg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1384953946</guid>
      <title>Atoms: the highlights from the ADC December 2022</title>
      <pubDate>Thu, 17 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-adc-december-2022</link>
      <itunes:duration>00:07:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of ADC Nick Brown brings you the monthly Atoms - the highlights of the December 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/12/i

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of ADC Nick Brown brings you the …</itunes:subtitle>
      <description>Editor-in-Chief of ADC Nick Brown brings you the monthly Atoms - the highlights of the December 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/12/i

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="6987858" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1384953946-bmjpodcasts-atoms-adc-december-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1379942980</guid>
      <title>Salt substitutes - do they reduce cardiovascular events?</title>
      <pubDate>Tue, 15 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/salt-substitutes-do-they-reduce-cardiovascular-events</link>
      <itunes:duration>00:17:49</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Maoyi Tian, from Harbin Medical University in China. They discuss his paper entitled "Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis". 

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/07/21/heartjnl-2022-321332</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Maoyi Tian, from Harbin Medical University in China. They discuss his paper entitled "Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis". 

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/07/21/heartjnl-2022-321332</description>
      <enclosure length="42749448" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1379942980-bmjpodcasts-salt-substitutes-do-they-reduce-cardiovascular-events.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1374418651</guid>
      <title>The Thorax Podcast is back! Meet the new Editors</title>
      <pubDate>Tue, 15 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-thorax-podcast-is-back-meet-the-new-editors</link>
      <itunes:duration>00:07:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Welcome back to the Thorax Podcast, home to the discussion of new research and hot topics in respiratory research and clinical practice. In this first episode, we introduce you to the three new Editors of the Thorax journal: Dr. Mark Griffiths and Dr. Jennifer Quint, both from Imperial College London, and Dr. Cecilia O'Kane, from Queen's University Belfast. They outline plans for the Thorax journal, including the social media strategy and engaging readers and trainees. 

You'll also get to know a bit more about the two new social media editors of the journal, Dr. Puja Mehta, from University College London and Dr. Kate Diomede from Imperial College London, whose voices you'll get very familiar with over the coming months, as they are our two new podcast hosts.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</itunes:summary>
      <itunes:subtitle>Welcome back to the Thorax Podcast, home to the d…</itunes:subtitle>
      <description>Welcome back to the Thorax Podcast, home to the discussion of new research and hot topics in respiratory research and clinical practice. In this first episode, we introduce you to the three new Editors of the Thorax journal: Dr. Mark Griffiths and Dr. Jennifer Quint, both from Imperial College London, and Dr. Cecilia O'Kane, from Queen's University Belfast. They outline plans for the Thorax journal, including the social media strategy and engaging readers and trainees. 

You'll also get to know a bit more about the two new social media editors of the journal, Dr. Puja Mehta, from University College London and Dr. Kate Diomede from Imperial College London, whose voices you'll get very familiar with over the coming months, as they are our two new podcast hosts.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.</description>
      <enclosure length="7637367" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1374418651-bmjpodcasts-the-thorax-podcast-is-back-meet-the-new-editors.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-mheS8iihgySIVMX0-q9UGJQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1380449338</guid>
      <title>TOTEM Trial with Paolo Zola</title>
      <pubDate>Sun, 13 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ijgc-podcast-paolo-zola-november-14-2022</link>
      <itunes:duration>00:33:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Paolo Zola to discuss the TOTEM trial. For 20 years, Dr. Zola has been Chair of Gynaecological Oncology in the Department of Surgical Sciences of the University of Turin (Italy). Dr. Zola has conducted a large number of national and international randomized clinical trials in order to optimize the treatments for women diagnosed with gynaecological cancers. He has served as a member of the board of the EORTC Gynaecological Cancer Group and of the ESGO. Dr. Zola chairs the gynaecological cooperative group within the Oncological Network in Piedmont Region, and his research has been reported in more than 400 manuscripts published in peer reviewed literature.

 

Highlights:

- To perform the follow up in patients treated for endometrial cancer, the cornerstone is the clinical control.
- In low-risk patients, surveillance every 6 months is appropriate.
- In high-risk patients a clinical examination every 4 months for 2 years and then every 6 is recommended.
- In addition, our data suggest taking a CT after 12 and 20 months after the primary treatment.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Paolo Zola to discuss the TOTEM trial. For 20 years, Dr. Zola has been Chair of Gynaecological Oncology in the Department of Surgical Sciences of the University of Turin (Italy). Dr. Zola has conducted a large number of national and international randomized clinical trials in order to optimize the treatments for women diagnosed with gynaecological cancers. He has served as a member of the board of the EORTC Gynaecological Cancer Group and of the ESGO. Dr. Zola chairs the gynaecological cooperative group within the Oncological Network in Piedmont Region, and his research has been reported in more than 400 manuscripts published in peer reviewed literature.

 

Highlights:

- To perform the follow up in patients treated for endometrial cancer, the cornerstone is the clinical control.
- In low-risk patients, surveillance every 6 months is appropriate.
- In high-risk patients a clinical examination every 4 months for 2 years and then every 6 is recommended.
- In addition, our data suggest taking a CT after 12 and 20 months after the primary treatment.</description>
      <enclosure length="32325387" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1380449338-bmjpodcasts-ijgc-podcast-paolo-zola-november-14-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1381099222</guid>
      <title>WISH 2022 - Antimicrobial resistance, and workforce wellbeing</title>
      <pubDate>Fri, 11 Nov 2022 19:07:59 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/wish-2022-antimicrobial-resistance-and-workforce-wellbeing</link>
      <itunes:duration>00:43:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Last month, saw the WISH 2022 - the World Innovation Summit for Health, where experts from around the world came and presented their ideas.

In this podcast we'll hear from Dame Sally Davies, the UK’s Special Envoy on Antimicrobial Resistance - she explains how covid, and treatment uncertainty, put paid to conservative prescribing; and what innovations in microbial treatment are on the horizon.

Following that, James Campbell, director of the health workforce department at the WHO, who joins us to talk about new data they have on the wellbeing, and why the international market for healthcare staff is no longer the simple solution for vacancies.

The BMJ's collections we mentioned are on empowering and engaging patients (https://www.bmj.com/empowering-and-engaging-patients) and food security and health in a changing environment (https://www.bmj.com/food-security-and-health-in-a-changing-environment)</itunes:summary>
      <itunes:subtitle>Last month, saw the WISH 2022 - the World Innovat…</itunes:subtitle>
      <description>Last month, saw the WISH 2022 - the World Innovation Summit for Health, where experts from around the world came and presented their ideas.

In this podcast we'll hear from Dame Sally Davies, the UK’s Special Envoy on Antimicrobial Resistance - she explains how covid, and treatment uncertainty, put paid to conservative prescribing; and what innovations in microbial treatment are on the horizon.

Following that, James Campbell, director of the health workforce department at the WHO, who joins us to talk about new data they have on the wellbeing, and why the international market for healthcare staff is no longer the simple solution for vacancies.

The BMJ's collections we mentioned are on empowering and engaging patients (https://www.bmj.com/empowering-and-engaging-patients) and food security and health in a changing environment (https://www.bmj.com/food-security-and-health-in-a-changing-environment)</description>
      <enclosure length="41441070" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1381099222-bmjpodcasts-wish-2022-antimicrobial-resistance-and-workforce-wellbeing.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XDKA1oGZA6yXXCn9-WYgrrw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1380872353</guid>
      <title>Surrogate endpoints with Huseyin Naci</title>
      <pubDate>Fri, 11 Nov 2022 12:28:54 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/surrogate-endpoints-with-huseyin-naci</link>
      <itunes:duration>00:47:12</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This week, we’re joined by Huseyin Naci to discuss the recent press release from Eisai and Biogen announcing the Phase III trial results for lecanemab for use in Alzheimer’s disease, and the FDA’s decision to accept the drug onto its accelerated approval pathway. We talk about the pros and cons of using surrogate endpoints to predict clinical outcomes. How can we strike a better balance in clinical trials between generating high-quality and trustworthy evidence, and the urgent needs of patients with life-limiting conditions and very few available treatment options?


Our guest:

Huseyin Naci is an associate professor of Health Policy at the London School of Economics and Political Science (LSE). He is also an advisor to the Analysis section of The BMJ.</itunes:summary>
      <itunes:subtitle>This week, we’re joined by Huseyin Naci to discus…</itunes:subtitle>
      <description>This week, we’re joined by Huseyin Naci to discuss the recent press release from Eisai and Biogen announcing the Phase III trial results for lecanemab for use in Alzheimer’s disease, and the FDA’s decision to accept the drug onto its accelerated approval pathway. We talk about the pros and cons of using surrogate endpoints to predict clinical outcomes. How can we strike a better balance in clinical trials between generating high-quality and trustworthy evidence, and the urgent needs of patients with life-limiting conditions and very few available treatment options?


Our guest:

Huseyin Naci is an associate professor of Health Policy at the London School of Economics and Political Science (LSE). He is also an advisor to the Analysis section of The BMJ.</description>
      <enclosure length="45321403" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1380872353-bmjpodcasts-surrogate-endpoints-with-huseyin-naci.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1380924424</guid>
      <title>Exercise Medicine and Physical Activity Promotion with Dr. Irfan Asif EP# 519</title>
      <pubDate>Fri, 11 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/exercise-medicine-and-physical-activity-promotion-with-dr-irfan-asif-ep-519</link>
      <itunes:duration>00:19:48</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Exercise Medicine and Physical Activity Promotion with Dr. Irfan Asif EP# 519
On this episode of the AMSSM Sports Medcast, host Dr. Devin McFadden, MD, is joined by Dr. Irfan Asif, MD, to discuss the topic of Exercise Medicine and Physical Activity Promotion.
 
Dr. Asif, who is the Chair of the AMSSM Collaborative Research Network, helped lead the 2021 Research Summit, which produced several publications and educational resources related to Exercise Medicine and Physical Activity Promotion. In this conversation, he addresses the following topics and questions:
•	A refresher on the 2021 Research Summit and the significant outcomes from that event
•	How the Exercise Medicine and Physical Activity Promotion Core Curricula originated
•	More details about the interactive and freely available Exercise Medicine &amp; Physical Activity Promotion Modules
•	How can physicians and other medical faculty integrate these resources into their clinical practices?
•	Providing information about the upcoming 2023 Research Summit on Justice, Equity and Inclusion, which takes place in April 2023
•	Future publications, deliverables and other opportunities stemming from the 2021 Research Summit
 
Additional Resources
Exercise Medicine &amp; Physical Activity Promotion Modules tinyurl.com/exercisemodules

Exercise Medicine and Physical Activity Promotion: Core Curricula for US Medical Schools, Residencies and Sports Medicine Fellowships https://bjsm.bmj.com/content/bjsports/56/7/369.full.pdf</itunes:summary>
      <itunes:subtitle>Exercise Medicine and Physical Activity Promotion…</itunes:subtitle>
      <description>Exercise Medicine and Physical Activity Promotion with Dr. Irfan Asif EP# 519
On this episode of the AMSSM Sports Medcast, host Dr. Devin McFadden, MD, is joined by Dr. Irfan Asif, MD, to discuss the topic of Exercise Medicine and Physical Activity Promotion.
 
Dr. Asif, who is the Chair of the AMSSM Collaborative Research Network, helped lead the 2021 Research Summit, which produced several publications and educational resources related to Exercise Medicine and Physical Activity Promotion. In this conversation, he addresses the following topics and questions:
•	A refresher on the 2021 Research Summit and the significant outcomes from that event
•	How the Exercise Medicine and Physical Activity Promotion Core Curricula originated
•	More details about the interactive and freely available Exercise Medicine &amp; Physical Activity Promotion Modules
•	How can physicians and other medical faculty integrate these resources into their clinical practices?
•	Providing information about the upcoming 2023 Research Summit on Justice, Equity and Inclusion, which takes place in April 2023
•	Future publications, deliverables and other opportunities stemming from the 2021 Research Summit
 
Additional Resources
Exercise Medicine &amp; Physical Activity Promotion Modules tinyurl.com/exercisemodules

Exercise Medicine and Physical Activity Promotion: Core Curricula for US Medical Schools, Residencies and Sports Medicine Fellowships https://bjsm.bmj.com/content/bjsports/56/7/369.full.pdf</description>
      <enclosure length="13448097" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1380924424-bmjpodcasts-exercise-medicine-and-physical-activity-promotion-with-dr-irfan-asif-ep-519.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1375881946</guid>
      <title>DTB 60th anniversary podcast interview - Jo Congleton</title>
      <pubDate>Fri, 11 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-60th-anniversary-podcast-interview-jo-congleton</link>
      <itunes:duration>00:18:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB. 

In this podcast, David Phizackerley (DTB's deputy editor) talks to Dr Jo Congleton, who is a consultant in Integrated Respiratory Care in Brighton and Hove. She is also clinical lead for the Kent, Surrey, Sussex Academic Health and Science Network (AHSN) Respiratory Programme. Her interests are in chronic respiratory conditions (particularly COPD) and reducing both variation, and inequalities, in care.

This special series of the DTB Podcast is produced by Leticia Amorim.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In a series of podcasts to mark the 60th annivers…</itunes:subtitle>
      <description>In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB. 

In this podcast, David Phizackerley (DTB's deputy editor) talks to Dr Jo Congleton, who is a consultant in Integrated Respiratory Care in Brighton and Hove. She is also clinical lead for the Kent, Surrey, Sussex Academic Health and Science Network (AHSN) Respiratory Programme. Her interests are in chronic respiratory conditions (particularly COPD) and reducing both variation, and inequalities, in care.

This special series of the DTB Podcast is produced by Leticia Amorim.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="17971826" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1375881946-bmjpodcasts-dtb-60th-anniversary-podcast-interview-jo-congleton.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-mNh8eanG9PUKYy9R-ZImCJA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1380240778</guid>
      <title>Everyone has an accent</title>
      <pubDate>Thu, 10 Nov 2022 16:16:55 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/everyone-has-an-accent</link>
      <itunes:duration>00:45:27</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Accents and dialects are influenced by so many different things including race, gender, and class. They change frequently depending on where we are, who we are with, and even what we are trying to get out of any given interaction. But why does this happen? Do we gravitate towards a certain accent in order to fit in?

In this episode, we'll find out what an accent actually is, we'll discuss how our accents have changed whilst we've been at university, and we'll also examine the judgement that can arise when you speak in a ‘different’ accent to what someone else is used to. 

Expert guests:
Lisa Casey is an Assistant Principal in a secondary school in London with a background in English and literacy. She is one of the hosts of Lexis, a podcast about language and linguistics for A Level students, teachers and anyone else who's interested in language.  

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Accents and dialects are influenced by so many di…</itunes:subtitle>
      <description>Accents and dialects are influenced by so many different things including race, gender, and class. They change frequently depending on where we are, who we are with, and even what we are trying to get out of any given interaction. But why does this happen? Do we gravitate towards a certain accent in order to fit in?

In this episode, we'll find out what an accent actually is, we'll discuss how our accents have changed whilst we've been at university, and we'll also examine the judgement that can arise when you speak in a ‘different’ accent to what someone else is used to. 

Expert guests:
Lisa Casey is an Assistant Principal in a secondary school in London with a background in English and literacy. She is one of the hosts of Lexis, a podcast about language and linguistics for A Level students, teachers and anyone else who's interested in language.  

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="43642496" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1380240778-bmjpodcasts-everyone-has-an-accent.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1378193743</guid>
      <title>Finding the Right Words, a book on Grief, Dementia, and Literature</title>
      <pubDate>Tue, 08 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/finding-the-right-words-a-book-on-grief-dementia-and-literature</link>
      <itunes:duration>00:23:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The moving story of an English professor studying neurology in order to understand and come to terms with her father's death from Alzheimer's. Brandy Schillace (Medical Humanities' Editor-in-Chief) interviews Cindy Weinstein, Vice Provost and Professor of English at California Institute of Technology.

Related blog including the transcription of the podcast: 
https://blogs.bmj.com/medical-humanities/2022/11/08/cindy-weinstein/

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>The moving story of an English professor studying…</itunes:subtitle>
      <description>The moving story of an English professor studying neurology in order to understand and come to terms with her father's death from Alzheimer's. Brandy Schillace (Medical Humanities' Editor-in-Chief) interviews Cindy Weinstein, Vice Provost and Professor of English at California Institute of Technology.

Related blog including the transcription of the podcast: 
https://blogs.bmj.com/medical-humanities/2022/11/08/cindy-weinstein/

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="33694880" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1378193743-bmjpodcasts-finding-the-right-words-a-book-on-grief-dementia-and-literature.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-35rzDteJIBP6iGmy-ch0M3g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1358727715</guid>
      <title>Parkinson's disease</title>
      <pubDate>Mon, 07 Nov 2022 10:30:35 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/parksinsons</link>
      <itunes:duration>00:24:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We release episodes fortnightly. Parkinson's disease is a common and serious condition. It is the second most common neurodegenerative disorder in the world - only Alzheimer's disease is more common. And Parkinson's disease can cause a range of complications - from dyskinesias to depression to dementia. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast, Kieran Walsh talks to Delaram Safarpour, Assistant Professor of Neurology at Oregon Health &amp; Science University.

Competing interests: DS has received honoraria for participation in advisory boards for Boston Scientific (the manufacturer of Deep Brain Stimulation devices) and Abbvie (the manufacturer of Duopa). She has received consultation fees from Abbott (the manufacturer of Deep Brain Stimulation devices). DS has received an institutional grant and has received an honorarium for lectures from the Parkinson’s Study Group.</itunes:summary>
      <itunes:subtitle>We release episodes fortnightly. Parkinson's dise…</itunes:subtitle>
      <description>We release episodes fortnightly. Parkinson's disease is a common and serious condition. It is the second most common neurodegenerative disorder in the world - only Alzheimer's disease is more common. And Parkinson's disease can cause a range of complications - from dyskinesias to depression to dementia. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast, Kieran Walsh talks to Delaram Safarpour, Assistant Professor of Neurology at Oregon Health &amp; Science University.

Competing interests: DS has received honoraria for participation in advisory boards for Boston Scientific (the manufacturer of Deep Brain Stimulation devices) and Abbvie (the manufacturer of Duopa). She has received consultation fees from Abbott (the manufacturer of Deep Brain Stimulation devices). DS has received an institutional grant and has received an honorarium for lectures from the Parkinson’s Study Group.</description>
      <enclosure length="29979136" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1358727715-bmjpodcasts-parksinsons.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1373499760</guid>
      <title>Cerebrovascular pulsatile tinnitus: causes, treatments, and outcomes</title>
      <pubDate>Thu, 03 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/cerebrovascular-pulsatile-tinnitus-causes-treatments-and-outcomes</link>
      <itunes:duration>00:30:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Matthew Amans(1) and Daniel Cummins(2) about their paper "Cerebrovascular pulsatile tinnitus: causes, treatments, and outcomes in 164 patients with neuroangiographic correlation" - https://jnis.bmj.com/content/early/2022/09/08/jnis-2022-019259.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was edited by Brian O'Toole.
(1) School of Medicine, University of California, San Francisco, USA
(2) Radiology and Biomedical Imaging, University of California, San Francisco, USA</itunes:summary>
      <itunes:subtitle>In this podcast, JNIS Editor-in-Chief, Dr. Felipe…</itunes:subtitle>
      <description>In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Matthew Amans(1) and Daniel Cummins(2) about their paper "Cerebrovascular pulsatile tinnitus: causes, treatments, and outcomes in 164 patients with neuroangiographic correlation" - https://jnis.bmj.com/content/early/2022/09/08/jnis-2022-019259.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!

This episode was edited by Brian O'Toole.
(1) School of Medicine, University of California, San Francisco, USA
(2) Radiology and Biomedical Imaging, University of California, San Francisco, USA</description>
      <enclosure length="29225794" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1373499760-bmjpodcasts-cerebrovascular-pulsatile-tinnitus-causes-treatments-and-outcomes.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1375111243</guid>
      <title>Leadership in injury prevention, with Professor Fred Rivara</title>
      <pubDate>Thu, 03 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/leadership-in-injury-prevention-with-professor-fred-rivara</link>
      <itunes:duration>00:26:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this month's podcast, Editor-in-Chief of Injury Prevention, Dr Rod McClure​, talks with Professor Fred Rivara, Professor of Pediatrics, University of Washington, School of Medicine. They explore what is unique about Injury Prevention as a field, and where this field integrates with the more general world of public health. They  also discuss leadership in injury prevention and the major challenges ahead.

Some of Professor Fred Rivara's latest papers:
 - A Qualitative study on diverse perspectives and identities of firearm owners - https://injuryprevention.bmj.com/content/28/5/434
 - Concussion education for youth athletes using Pre-Game Safety Huddles: a cluster-randomised controlled trial - https://injuryprevention.bmj.com/content/early/2022/09/16/ip-2022-044665
 - Predictors of health-related quality of life following injury in childhood and adolescence: a pooled analysis - https://injuryprevention.bmj.com/content/28/4/301
 - Association of state-level intoxicated driving laws with firearm homicide and suicide - https://injuryprevention.bmj.com/content/28/1/32
 - Age, period and cohort effects in firearm homicide and suicide in the USA, 1983–2017 - https://injuryprevention.bmj.com/content/27/4/344

Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>In this month's podcast, Editor-in-Chief of Injur…</itunes:subtitle>
      <description>In this month's podcast, Editor-in-Chief of Injury Prevention, Dr Rod McClure​, talks with Professor Fred Rivara, Professor of Pediatrics, University of Washington, School of Medicine. They explore what is unique about Injury Prevention as a field, and where this field integrates with the more general world of public health. They  also discuss leadership in injury prevention and the major challenges ahead.

Some of Professor Fred Rivara's latest papers:
 - A Qualitative study on diverse perspectives and identities of firearm owners - https://injuryprevention.bmj.com/content/28/5/434
 - Concussion education for youth athletes using Pre-Game Safety Huddles: a cluster-randomised controlled trial - https://injuryprevention.bmj.com/content/early/2022/09/16/ip-2022-044665
 - Predictors of health-related quality of life following injury in childhood and adolescence: a pooled analysis - https://injuryprevention.bmj.com/content/28/4/301
 - Association of state-level intoxicated driving laws with firearm homicide and suicide - https://injuryprevention.bmj.com/content/28/1/32
 - Age, period and cohort effects in firearm homicide and suicide in the USA, 1983–2017 - https://injuryprevention.bmj.com/content/27/4/344

Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="25769272" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1375111243-bmjpodcasts-leadership-in-injury-prevention-with-professor-fred-rivara.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-97PYlC3idubTCbxz-1rv9FQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1374851470</guid>
      <title>Talk Evidence - Diabetes data, colonoscopies, and researchers behaving badly</title>
      <pubDate>Wed, 02 Nov 2022 10:44:11 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/diabetes-data-colonoscopies-and-researchers-behaving-badly</link>
      <itunes:duration>00:46:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this month's Talk Evidence, Helen Macdonald, The BMJ's research integrity editor, is joined again by Juan Franco, editor in chief of BMJ EBM, and Joe Ross, US research editor. 

They're straying beyond the pages of The BMJ, and discussing an NEJM paper about colonoscopy for colorectal cancer screening. 

We have a listener request, asking about evidence for England's " NHS Diabetes Prevention Programme" - what do we know about how lifestyle interventions work at a population level? Juan puts on his Cochrane hat to answer the query.

We stay with diabetes, and Joe tells us about his research trying to see if routinely collected observational data could be used to match the outcomes of an RCT into drug treatments. 

Finally, Helen updates us about what she's been doing about a case of plagiarism in one of BMJ's journals - and what that means for researchers who are writing in multiple journals about their work.

Reading list

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
https://www.nejm.org/doi/full/10.1056/NEJMoa2208375

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
https://www.bmj.com/content/379/bmj-2022-070717

Expression of concern about content of which Dr Paul McCrory is a single author
https://bjsm.bmj.com/content/early/2022/10/11/bjsports-2022-106408eoc</itunes:summary>
      <itunes:subtitle>In this month's Talk Evidence, Helen Macdonald, T…</itunes:subtitle>
      <description>In this month's Talk Evidence, Helen Macdonald, The BMJ's research integrity editor, is joined again by Juan Franco, editor in chief of BMJ EBM, and Joe Ross, US research editor. 

They're straying beyond the pages of The BMJ, and discussing an NEJM paper about colonoscopy for colorectal cancer screening. 

We have a listener request, asking about evidence for England's " NHS Diabetes Prevention Programme" - what do we know about how lifestyle interventions work at a population level? Juan puts on his Cochrane hat to answer the query.

We stay with diabetes, and Joe tells us about his research trying to see if routinely collected observational data could be used to match the outcomes of an RCT into drug treatments. 

Finally, Helen updates us about what she's been doing about a case of plagiarism in one of BMJ's journals - and what that means for researchers who are writing in multiple journals about their work.

Reading list

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
https://www.nejm.org/doi/full/10.1056/NEJMoa2208375

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
https://www.bmj.com/content/379/bmj-2022-070717

Expression of concern about content of which Dr Paul McCrory is a single author
https://bjsm.bmj.com/content/early/2022/10/11/bjsports-2022-106408eoc</description>
      <enclosure length="44397295" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1374851470-bmjpodcasts-diabetes-data-colonoscopies-and-researchers-behaving-badly.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2yobq1Hjl6r87WmD-zdjn1Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1376419126</guid>
      <title>Ovarian Preservation in Grade 2 or 3 Endometrial Cancer with Dimitrios Nasioudis</title>
      <pubDate>Wed, 02 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ovarian-preservation-in-grade-2-or-3-endometrial-cancer-with-dimitrios-nasioudis</link>
      <itunes:duration>00:26:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Dimitrios Nasioudis to discuss ovarian preservation in grade 2 or 3 endometrial cancer. Dr. Nasioudis is a Gynecologic Oncology Fellow at the University of Pennsylvania. His current research focuses on translational therapeutics and population-based research.

 Highlights:

- For premenopausal patients with endometrial cancer, ovarian preservation is not associated with worse oncologic outcomes for those with grade 1 tumors. However, safety of ovarian preservation for grade 2 or 3 tumors is not established.

- Ovarian preservation was not associated with worse overall survival for patients with grade 2 or 3 endometrioid tumors.

-Ovarian preservation may be considered for carefully selected patients with grade 2 tumors.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Dimitrios Nasioudis to discuss ovarian preservation in grade 2 or 3 endometrial cancer. Dr. Nasioudis is a Gynecologic Oncology Fellow at the University of Pennsylvania. His current research focuses on translational therapeutics and population-based research.

 Highlights:

- For premenopausal patients with endometrial cancer, ovarian preservation is not associated with worse oncologic outcomes for those with grade 1 tumors. However, safety of ovarian preservation for grade 2 or 3 tumors is not established.

- Ovarian preservation was not associated with worse overall survival for patients with grade 2 or 3 endometrioid tumors.

-Ovarian preservation may be considered for carefully selected patients with grade 2 tumors.</description>
      <enclosure length="25083346" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1376419126-bmjpodcasts-ovarian-preservation-in-grade-2-or-3-endometrial-cancer-with-dimitrios-nasioudis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1374414313</guid>
      <title>Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis</title>
      <pubDate>Wed, 02 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/endoscopic-pyloromyotomy-for-gastroparesis</link>
      <itunes:duration>00:16:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Endoscopic pyloromyotomy (G-POEM) is a minimally invasive treatment option with promising uncontrolled outcome results in patients with gastroparesis.
Dr Philip Smith, Digital and Education Editor of Gut, interviews Professor Jan Martinek, from the Department of Hepatogastroenterology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic, about his paper on this topic. The article titled 'Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial' is published in paper copy in Gut in November 2022 and available online at: https://gut.bmj.com/content/71/11/2170

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Endoscopic pyloromyotomy (G-POEM) is a minimally …</itunes:subtitle>
      <description>Endoscopic pyloromyotomy (G-POEM) is a minimally invasive treatment option with promising uncontrolled outcome results in patients with gastroparesis.
Dr Philip Smith, Digital and Education Editor of Gut, interviews Professor Jan Martinek, from the Department of Hepatogastroenterology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic, about his paper on this topic. The article titled 'Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial' is published in paper copy in Gut in November 2022 and available online at: https://gut.bmj.com/content/71/11/2170

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="15367940" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1374414313-bmjpodcasts-endoscopic-pyloromyotomy-for-gastroparesis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1365988795</guid>
      <title>Diagnosis and Management of Lynch Syndrome</title>
      <pubDate>Wed, 02 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/diagnosis-and-management-of-lynch-syndrome</link>
      <itunes:duration>00:20:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Kevin Monahan(1) explains what the general gastroenterologist needs to know about the diagnosis and management of patients with Lynch syndrome, including considerations for endoscopy surveillance and changes to the BCS programme.

Read the article in Frontline Gastroenterology here: https://fg.bmj.com/content/13/e1/e80

(1) Consultant Gastroenterologist, Family Cancer Clinic and Wolfson Endoscopy Unit, St Mark's Hospital

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>Dr Kevin Monahan(1) explains what the general gas…</itunes:subtitle>
      <description>Dr Kevin Monahan(1) explains what the general gastroenterologist needs to know about the diagnosis and management of patients with Lynch syndrome, including considerations for endoscopy surveillance and changes to the BCS programme.

Read the article in Frontline Gastroenterology here: https://fg.bmj.com/content/13/e1/e80

(1) Consultant Gastroenterologist, Family Cancer Clinic and Wolfson Endoscopy Unit, St Mark's Hospital

Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="19554219" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1365988795-bmjpodcasts-diagnosis-and-management-of-lynch-syndrome.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1371595093</guid>
      <title>Long working hours and risk of ischemic heart disease</title>
      <pubDate>Tue, 01 Nov 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/long-working-hours-and-risk-of-ischemic-heart-disease</link>
      <itunes:duration>00:19:41</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the podcast, Andrew Perry chats with Dr. Amanda Eng to discuss the paper “Long working hours, sedentary work, noise, night shifts and risk of ischaemic heart disease.”

If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:  https://heart.bmj.com/content/early/2022/08/24/heartjnl-2022-320999</itunes:summary>
      <itunes:subtitle>In this episode of the podcast, Andrew Perry chat…</itunes:subtitle>
      <description>In this episode of the podcast, Andrew Perry chats with Dr. Amanda Eng to discuss the paper “Long working hours, sedentary work, noise, night shifts and risk of ischaemic heart disease.”

If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:  https://heart.bmj.com/content/early/2022/08/24/heartjnl-2022-320999</description>
      <enclosure length="47258482" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1371595093-bmjpodcasts-long-working-hours-and-risk-of-ischemic-heart-disease.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1371989683</guid>
      <title>ICON8-Overall Survival with Jonathan Ledermann</title>
      <pubDate>Sun, 30 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/icon8-overall-survival-with-jonathan-ledermann</link>
      <itunes:duration>00:21:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jonathan Ledermann to discuss ICON8-Overall Survival. Jonathan Ledermann is a professor of medical oncology and Clinical Director at UCL Cancer Institute specializing in the treatment and research of gynaecological malignancies. He has led several national and international trials on the treatment of ovarian cancer and has played a key role in developing trials of PARP inhibitors in ovarian cancer. He is the ESMO Gynaecological Cancer Practice Guidelines Editor and past Vice President of ESGO. He is a Fellow of the Academy of Medical Sciences and a Senior Investigator for the National Institute of Health Research in the UK.

Highlights:

- Weekly first-line chemotherapy for ovarian cancer does not improve progression-free or overall survival.

- ICON8 was the largest randomized trial exploring weekly paclitaxel or weekly carboplatin and paclitaxel compared to tri-weekly chemotherapy.

- There is no evidence to suggest that weekly first-line chemotherapy should be used as part of multimodal treatment of newly diagnosed ovarian cancer.

- The results in a predominately European population differ from a similar Japanese trial, raising the possibility that genetic or pharmacogenomic differences need to be considered when comparing the results of trials in ovarian cancer.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jonathan Ledermann to discuss ICON8-Overall Survival. Jonathan Ledermann is a professor of medical oncology and Clinical Director at UCL Cancer Institute specializing in the treatment and research of gynaecological malignancies. He has led several national and international trials on the treatment of ovarian cancer and has played a key role in developing trials of PARP inhibitors in ovarian cancer. He is the ESMO Gynaecological Cancer Practice Guidelines Editor and past Vice President of ESGO. He is a Fellow of the Academy of Medical Sciences and a Senior Investigator for the National Institute of Health Research in the UK.

Highlights:

- Weekly first-line chemotherapy for ovarian cancer does not improve progression-free or overall survival.

- ICON8 was the largest randomized trial exploring weekly paclitaxel or weekly carboplatin and paclitaxel compared to tri-weekly chemotherapy.

- There is no evidence to suggest that weekly first-line chemotherapy should be used as part of multimodal treatment of newly diagnosed ovarian cancer.

- The results in a predominately European population differ from a similar Japanese trial, raising the possibility that genetic or pharmacogenomic differences need to be considered when comparing the results of trials in ovarian cancer.</description>
      <enclosure length="20317830" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1371989683-bmjpodcasts-icon8-overall-survival-with-jonathan-ledermann.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1371866695</guid>
      <title>Sickle Cell Disease with Dr. Gregory Vercellotti</title>
      <pubDate>Fri, 28 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sickle-cell-disease-with-dr-gregory-vercellotti</link>
      <itunes:duration>00:29:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this conversation with Journal of Investigative Medicine Social Media Editor John Dickinson, MD, PhD, University of Nebraska Medical Center, Gregory Vercellotti, MD, from the University of Minnesota provides an overview of the symptoms, diagnosis and management of sickle cell disease. Dr. Vercellotti is a national leader in the field of vascular biology and cares for adult patients with sickle cell disease. This podcast is especially relevant for primary care physicians, hospitalists, ER physicians, and other subspecialists who may not frequently encounter patients with sickle cell disease.



We discuss many of the common features for symptoms, including pain crises, and complications including stroke, pulmonary hypertension, and avascular necrosis. We also discuss some of the social, economic, and racial factors that are often barriers to effective care. Finally, we discuss some of the promising new options including stem cell transplantation and CRISPR-based cures.</itunes:summary>
      <itunes:subtitle>In this conversation with Journal of Investigativ…</itunes:subtitle>
      <description>In this conversation with Journal of Investigative Medicine Social Media Editor John Dickinson, MD, PhD, University of Nebraska Medical Center, Gregory Vercellotti, MD, from the University of Minnesota provides an overview of the symptoms, diagnosis and management of sickle cell disease. Dr. Vercellotti is a national leader in the field of vascular biology and cares for adult patients with sickle cell disease. This podcast is especially relevant for primary care physicians, hospitalists, ER physicians, and other subspecialists who may not frequently encounter patients with sickle cell disease.



We discuss many of the common features for symptoms, including pain crises, and complications including stroke, pulmonary hypertension, and avascular necrosis. We also discuss some of the social, economic, and racial factors that are often barriers to effective care. Finally, we discuss some of the promising new options including stem cell transplantation and CRISPR-based cures.</description>
      <enclosure length="27834825" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1371866695-bmjpodcasts-sickle-cell-disease-with-dr-gregory-vercellotti.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iaEWqSKNrU0eR4co-05ELtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1371894070</guid>
      <title>Episode 8: Postoperative Lidocaine Infusion Safety on Wards Without Continuous Cardiac Monitoring</title>
      <pubDate>Fri, 28 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-8-postoperative-lidocaine-infusion-safety-on-wards-without-continuous-cardiac-monitoring</link>
      <itunes:duration>00:38:03</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Establishing new clinical pathways and accomplishing change often takes a super-human effort in a complex health system. In terms of systemic lidocaine, the analgesic effects of systemic lidocaine are well recognized, but what is novel is the application of this therapy in an environment once thought to be inappropriate, that is, in the general inpatient units. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins Meagan Miller, APRN, MSN, AGACNP-BC, and Brian Allen, MD, to discuss their university-based study, “Safety of postoperative lidocaine infusions on general care wards without continuous cardiac monitoring in an established enhanced recovery program,” first published in January 2022 (https://rapm.bmj.com/content/47/5/320).

Meagan Miller graduated from the University of Alabama with her bachelor’s in nursing in 2012. She was then accepted into Vanderbilt University Medical Center Nurse Residency Program and joined the colorectal and general surgery floor, which sparked her interest in enhanced recovery after surgery, as it was the first floor to initiate lidocaine infusions outside of the ICU. She has her master’s in nursing science in adult gerontology acute care nurse practitioner and first assist.

Dr. Brian Allen is an associate professor at Vanderbilt University Medical Center, where he directs the fellowship in regional anesthesiology and acute pain medicine. He completed undergraduate in medical school at Washington University. He was a resident at Vanderbilt and did his regional fellowship at Oregon Health &amp; Science University (OHSU) before returning to join the Vanderbilt faculty. His clinical focus is on regional and multimodal analgesia in ERAS pathways. His research interests include educational assessment, evaluating ERAS efficiency, efficacy and compliance, and opioid minimization. 

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</itunes:summary>
      <itunes:subtitle>Establishing new clinical pathways and accomplish…</itunes:subtitle>
      <description>Establishing new clinical pathways and accomplishing change often takes a super-human effort in a complex health system. In terms of systemic lidocaine, the analgesic effects of systemic lidocaine are well recognized, but what is novel is the application of this therapy in an environment once thought to be inappropriate, that is, in the general inpatient units. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins Meagan Miller, APRN, MSN, AGACNP-BC, and Brian Allen, MD, to discuss their university-based study, “Safety of postoperative lidocaine infusions on general care wards without continuous cardiac monitoring in an established enhanced recovery program,” first published in January 2022 (https://rapm.bmj.com/content/47/5/320).

Meagan Miller graduated from the University of Alabama with her bachelor’s in nursing in 2012. She was then accepted into Vanderbilt University Medical Center Nurse Residency Program and joined the colorectal and general surgery floor, which sparked her interest in enhanced recovery after surgery, as it was the first floor to initiate lidocaine infusions outside of the ICU. She has her master’s in nursing science in adult gerontology acute care nurse practitioner and first assist.

Dr. Brian Allen is an associate professor at Vanderbilt University Medical Center, where he directs the fellowship in regional anesthesiology and acute pain medicine. He completed undergraduate in medical school at Washington University. He was a resident at Vanderbilt and did his regional fellowship at Oregon Health &amp; Science University (OHSU) before returning to join the Vanderbilt faculty. His clinical focus is on regional and multimodal analgesia in ERAS pathways. His research interests include educational assessment, evaluating ERAS efficiency, efficacy and compliance, and opioid minimization. 

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</description>
      <enclosure length="91262432" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1371894070-bmjpodcasts-episode-8-postoperative-lidocaine-infusion-safety-on-wards-without-continuous-cardiac-monitoring.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-36rEAsdbqSkJRswY-u6sWGg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1369266844</guid>
      <title>Bacterial STIs: The DoxyPEP Trial</title>
      <pubDate>Fri, 28 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-doxypep-trial</link>
      <itunes:duration>00:08:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Today we talk with the principal investigators of the DoxyPEP trial which was prematurely terminated due to its amazing success: participants receiving a stat dose of Doxycycline 200mg in less than 72 hours after condom-less sex were 63% less likely to develop a bacterial STI compared to participants in the control arm. 
Prof Annie Leutkemeyer based in San Francisco (UCSF) and Prof Connie Celum, based in Seattle (WA)join Dr Fabiola Martin, STI's Podcast editor, in this short interview.

Please listen to a recent podcast on the wider subject of Bacterial STIs: https://soundcloud.com/bmjpodcasts/management-of-bacterial-stis?in=bmjpodcasts/sets/sti

Related links:
https://www.aidsmap.com/news/jul-2022/taking-antibiotic-after-sex-cuts-stis-two-thirds-doxypep-study-finds
academic.oup.com/cid/article/70/6/1247/5557867
www.ncbi.nlm.nih.gov/pmc/articles/PMC8360665/

To hear more episodes of the STI Podcast, please subscribe: https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980</itunes:summary>
      <itunes:subtitle>Today we talk with the principal investigators of…</itunes:subtitle>
      <description>Today we talk with the principal investigators of the DoxyPEP trial which was prematurely terminated due to its amazing success: participants receiving a stat dose of Doxycycline 200mg in less than 72 hours after condom-less sex were 63% less likely to develop a bacterial STI compared to participants in the control arm. 
Prof Annie Leutkemeyer based in San Francisco (UCSF) and Prof Connie Celum, based in Seattle (WA)join Dr Fabiola Martin, STI's Podcast editor, in this short interview.

Please listen to a recent podcast on the wider subject of Bacterial STIs: https://soundcloud.com/bmjpodcasts/management-of-bacterial-stis?in=bmjpodcasts/sets/sti

Related links:
https://www.aidsmap.com/news/jul-2022/taking-antibiotic-after-sex-cuts-stis-two-thirds-doxypep-study-finds
academic.oup.com/cid/article/70/6/1247/5557867
www.ncbi.nlm.nih.gov/pmc/articles/PMC8360665/

To hear more episodes of the STI Podcast, please subscribe: https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980</description>
      <enclosure length="7902048" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1369266844-bmjpodcasts-the-doxypep-trial.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QsRTwnBAaqDmx3t3-PmDMzA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1370950216</guid>
      <title>Compassionate medical schools</title>
      <pubDate>Thu, 27 Oct 2022 08:26:22 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/compassionate-medical-schools</link>
      <itunes:duration>00:42:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Any medical student knows that medical school can be tough. The hours are long, the work is hard, and stress can build quickly. Throughout all of this, we’re taught about compassion - how to be a compassionate medical student, and eventually a compassionate doctor. But do our own medical schools show compassion towards us? 

In this episode, the Sharp Scratch team talks about compassionate organisations and the impact that compassion (or a lack of it) can have on students. We also talk more about the struggle that ensues when you have compassionate individuals but not compassionate systems, and what needs to change within our medical schools.

Expert guests:
Dr Rob Jarvis is a senior lecturer and lead for the gateway programme at the University of Dundee. He is a GP by background. For the last ten years he has been lead for student support at Dundee Medical School and also for the ScotGEM (graduate entry) programme.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Any medical student knows that medical school can…</itunes:subtitle>
      <description>Any medical student knows that medical school can be tough. The hours are long, the work is hard, and stress can build quickly. Throughout all of this, we’re taught about compassion - how to be a compassionate medical student, and eventually a compassionate doctor. But do our own medical schools show compassion towards us? 

In this episode, the Sharp Scratch team talks about compassionate organisations and the impact that compassion (or a lack of it) can have on students. We also talk more about the struggle that ensues when you have compassionate individuals but not compassionate systems, and what needs to change within our medical schools.

Expert guests:
Dr Rob Jarvis is a senior lecturer and lead for the gateway programme at the University of Dundee. He is a GP by background. For the last ten years he has been lead for student support at Dundee Medical School and also for the ScotGEM (graduate entry) programme.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent 
Instagram: https://www.instagram.com/bmj_student/ 
Facebook: https://www.facebook.com/BMJStudent/  

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="41033600" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1370950216-bmjpodcasts-compassionate-medical-schools.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1370218423</guid>
      <title>November 2022 - FMT, methotrexate and COVID vaccine boosters, and Palforzia for peanut allergy</title>
      <pubDate>Thu, 27 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-november-2022</link>
      <itunes:duration>00:30:02</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the November 2022 issue of DTB. They discuss the use of faecal microbiota transplantation to treat gastrointestinal infections and in particular its role in managing Clostridioides difficile infection (https://dtb.bmj.com/content/60/11/162). They highlight a study that assessed the effect of interrupting methotrexate treatment on COVID-19 booster vaccine response (https://dtb.bmj.com/content/60/11/163) and review a new drug that is licensed for treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy (https://dtb.bmj.com/content/60/11/166). The podcast begins with the editors talking about the response to October's editorial "Stop advertising".
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the November 2022 issue of DTB. They discuss the use of faecal microbiota transplantation to treat gastrointestinal infections and in particular its role in managing Clostridioides difficile infection (https://dtb.bmj.com/content/60/11/162). They highlight a study that assessed the effect of interrupting methotrexate treatment on COVID-19 booster vaccine response (https://dtb.bmj.com/content/60/11/163) and review a new drug that is licensed for treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy (https://dtb.bmj.com/content/60/11/166). The podcast begins with the editors talking about the response to October's editorial "Stop advertising".
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="72071644" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1370218423-bmjpodcasts-dtb-november-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1370450218</guid>
      <title>Doctor informed - sustainability isn't just waste management</title>
      <pubDate>Wed, 26 Oct 2022 13:44:13 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/doctor-informed-sustainability-isnt-just-waste-management</link>
      <itunes:duration>00:55:48</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of Doctor Informed, we're talking sustainability. The BMJ has a special edition on the climate crisis, and finding hope amid dispair - and we want to help our listeners with some of that. Clara is joined by three of the NHS's sustainability fellows, Florence, Who is a medical registrar, Emily a paedatrics trainee, and Li, an anaesthetics trainee

For more on the climate crisis, read The BMJ's special edition
https://www.bmj.com/content/379/8356</itunes:summary>
      <itunes:subtitle>In this episode of Doctor Informed, we're talking…</itunes:subtitle>
      <description>In this episode of Doctor Informed, we're talking sustainability. The BMJ has a special edition on the climate crisis, and finding hope amid dispair - and we want to help our listeners with some of that. Clara is joined by three of the NHS's sustainability fellows, Florence, Who is a medical registrar, Emily a paedatrics trainee, and Li, an anaesthetics trainee

For more on the climate crisis, read The BMJ's special edition
https://www.bmj.com/content/379/8356</description>
      <enclosure length="53573888" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1370450218-bmjpodcasts-doctor-informed-sustainability-isnt-just-waste-management.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iv1zjTJkVfROtFcB-2RBqcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1368997846</guid>
      <title>Cervical Conization Dimensions: 2022 Consensus Recommendations</title>
      <pubDate>Mon, 24 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/cervical-conization-dimensions-2022-consensus-recommendations</link>
      <itunes:duration>00:36:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor María Kyrgiou to discuss Cervical Conization Dimensions: 2022 Consensus Recommendations. Professor Mara Kyrgiou is a Professor at Imperial College London and a Consultant Surgeon in Gynaecology and Gynaecological Oncology at the West London Gynaecological Cancer Centre, Imperial Healthcare NHS Trust. She is the Head of Section of Gynaecological Oncology at Imperial College London. Her main clinical interest is minimal access and complex gynaecological cancer surgery.  

Highlights:    
 - Local treatment techniques for cervical pre-invasive and early invasive disease were previously thought to be interchangeable with regards to treatment failure rates and associated with minor and infrequent complications. 
 - The findings of a network metaanalysis (Athanasiou Lancet Oncology 2022) suggest that more aggressive treatments (i.e., CKC, laser conisation) are associated with lower recurrence rates but higher risk for subsequent preterm birth. 
 - The risk of reproductive morbidity is directly associated with the length of the cone. 
 - This paper by ESGO/EFC/IFCPC describes a consensus terminology of the cone dimensions to make studies addressing effectiveness and safety of SIL/CIN treatment comparable and facilitate their use to tailor surveillance and antenatal management. 
 - The 2022 terminology should replace all previous terminologies, which will facilitate communication between clinicians and foster tailored treatment guidelines that balance obstetrical harm against therapeutic effectiveness. 
 - Universal agreed reporting will further facilitate communications among clinicians and pathologists, promote audit of practice and future research, and improve the quality of future meta-analyses.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor María Kyrgiou to discuss Cervical Conization Dimensions: 2022 Consensus Recommendations. Professor Mara Kyrgiou is a Professor at Imperial College London and a Consultant Surgeon in Gynaecology and Gynaecological Oncology at the West London Gynaecological Cancer Centre, Imperial Healthcare NHS Trust. She is the Head of Section of Gynaecological Oncology at Imperial College London. Her main clinical interest is minimal access and complex gynaecological cancer surgery.  

Highlights:    
 - Local treatment techniques for cervical pre-invasive and early invasive disease were previously thought to be interchangeable with regards to treatment failure rates and associated with minor and infrequent complications. 
 - The findings of a network metaanalysis (Athanasiou Lancet Oncology 2022) suggest that more aggressive treatments (i.e., CKC, laser conisation) are associated with lower recurrence rates but higher risk for subsequent preterm birth. 
 - The risk of reproductive morbidity is directly associated with the length of the cone. 
 - This paper by ESGO/EFC/IFCPC describes a consensus terminology of the cone dimensions to make studies addressing effectiveness and safety of SIL/CIN treatment comparable and facilitate their use to tailor surveillance and antenatal management. 
 - The 2022 terminology should replace all previous terminologies, which will facilitate communication between clinicians and foster tailored treatment guidelines that balance obstetrical harm against therapeutic effectiveness. 
 - Universal agreed reporting will further facilitate communications among clinicians and pathologists, promote audit of practice and future research, and improve the quality of future meta-analyses.</description>
      <enclosure length="35498108" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1368997846-bmjpodcasts-cervical-conization-dimensions-2022-consensus-recommendations.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1367439286</guid>
      <title>Running repairs with James Alexander, get up to speed with the latest research. EP#518</title>
      <pubDate>Fri, 21 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/running-repairs-with-james-alexander-get-up-to-speed-with-the-latest-research-ep518</link>
      <itunes:duration>00:17:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>BJSM’s Dr. Liam West talks to James Alexander about running related knee injuries and what options the current published literature support for managing &amp; preventing these injuries. James &amp; his colleagues have just published a systematic review in the area, and he gives the clinical relevance of his findings within the podcast. You can access their paper using the link below, in addition to other related content.

Review. Strategies to prevent and manage running-related knee injuries: a systematic review of randomised controlled trials: https://bjsm.bmj.com/content/early/2022/09/23/bjsports-2022-105553.abstract

Infographic. Running Myth: recreational running causes knee osteoarthritis:https://bjsm.bmj.com/content/56/6/357

Infographic. Running myth: switching to a non-rearfoot strike reduces injury risk and improves running economy:https://bjsm.bmj.com/content/55/3/175

Infographic running myth: static stretching reduces injury risk in runners:https://bjsm.bmj.com/content/54/17/1058

Infographic. Running myth: strength training should be high repetition low load to improve running performance:https://bjsm.bmj.com/content/54/13/813</itunes:summary>
      <itunes:subtitle>BJSM’s Dr. Liam West talks to James Alexander abo…</itunes:subtitle>
      <description>BJSM’s Dr. Liam West talks to James Alexander about running related knee injuries and what options the current published literature support for managing &amp; preventing these injuries. James &amp; his colleagues have just published a systematic review in the area, and he gives the clinical relevance of his findings within the podcast. You can access their paper using the link below, in addition to other related content.

Review. Strategies to prevent and manage running-related knee injuries: a systematic review of randomised controlled trials: https://bjsm.bmj.com/content/early/2022/09/23/bjsports-2022-105553.abstract

Infographic. Running Myth: recreational running causes knee osteoarthritis:https://bjsm.bmj.com/content/56/6/357

Infographic. Running myth: switching to a non-rearfoot strike reduces injury risk and improves running economy:https://bjsm.bmj.com/content/55/3/175

Infographic running myth: static stretching reduces injury risk in runners:https://bjsm.bmj.com/content/54/17/1058

Infographic. Running myth: strength training should be high repetition low load to improve running performance:https://bjsm.bmj.com/content/54/13/813</description>
      <enclosure length="41856521" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1367439286-bmjpodcasts-running-repairs-with-james-alexander-get-up-to-speed-with-the-latest-research-ep518.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1367068063</guid>
      <title>GP Crisis with Rebecca Rosen</title>
      <pubDate>Thu, 20 Oct 2022 22:01:01 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/gp-crisis-with-rebecca-rosen</link>
      <itunes:duration>00:55:15</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The GP crisis with Rebecca Rosen


This week, we discuss the ongoing GP crisis, an ever-topical subject, in light of recent UK governmental changes. In early September, Thérèse Coffey laid out her plans for the NHS in the House of Commons, but, with general practice struggling so much as it is, is she proposing practical and feasible solutions, or will her initiatives be merely papering over the cracks? We’re joined by Rebecca Rosen to discuss whether or not there’s any real substance behind the proposed changes, how to manage patients’ expectations around access to care, and how primary care practitioners might be best supported in order to help ease the strain on them.


Our guest:

Rebecca Rosen is a GP in South East London, and a senior fellow in Health Policy at the Nuffield Trust.</itunes:summary>
      <itunes:subtitle>The GP crisis with Rebecca Rosen


This week, we …</itunes:subtitle>
      <description>The GP crisis with Rebecca Rosen


This week, we discuss the ongoing GP crisis, an ever-topical subject, in light of recent UK governmental changes. In early September, Thérèse Coffey laid out her plans for the NHS in the House of Commons, but, with general practice struggling so much as it is, is she proposing practical and feasible solutions, or will her initiatives be merely papering over the cracks? We’re joined by Rebecca Rosen to discuss whether or not there’s any real substance behind the proposed changes, how to manage patients’ expectations around access to care, and how primary care practitioners might be best supported in order to help ease the strain on them.


Our guest:

Rebecca Rosen is a GP in South East London, and a senior fellow in Health Policy at the Nuffield Trust.</description>
      <enclosure length="66304438" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1367068063-bmjpodcasts-gp-crisis-with-rebecca-rosen.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-P9MTr3MwX0SV6Bml-lZWjAw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1366201072</guid>
      <title>Atoms: the highlights from the ADC November 2022</title>
      <pubDate>Wed, 19 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-november-2022</link>
      <itunes:duration>00:16:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the November 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/11/i

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the November 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/11/i

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="15972727" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1366201072-bmjpodcasts-atoms-the-highlights-from-the-adc-november-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1361450605</guid>
      <title>Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults</title>
      <pubDate>Tue, 18 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/aspirin-and-statin-therapy-for-primary-prevention-of-cardiovascular-disease-in-older-adults</link>
      <itunes:duration>00:17:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Miedema from the Nolan Center For Cardiovascular Health, Minneapolis, Minnesota. They discuss the role of both aspirin and statins, for primary prevention, in older patients and the risks and benefits relevant to that group. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://heart.bmj.com/content/108/14/1090</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Miedema from the Nolan Center For Cardiovascular Health, Minneapolis, Minnesota. They discuss the role of both aspirin and statins, for primary prevention, in older patients and the risks and benefits relevant to that group. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper:
https://heart.bmj.com/content/108/14/1090</description>
      <enclosure length="41386538" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1361450605-bmjpodcasts-aspirin-and-statin-therapy-for-primary-prevention-of-cardiovascular-disease-in-older-adults.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1364452456</guid>
      <title>Mentor’s Podcast: Nadeem Abu-Rustum</title>
      <pubDate>Mon, 17 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mentors-podcast-nadeem-abu-rustum</link>
      <itunes:duration>00:47:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Nadeem Abu-Rustum. Dr. Abu-Rustum is a board-certified gynecologic oncologist who specializes in the surgical treatment of gynecologic cancers at Memorial Sloan Kettering Cancer Center. He is also a professor of obstetrics and gynecology at Weill Cornell Medical College. Dr. Abu-Rustum has a special interest in minimally invasive surgery (laparoscopy) for the treatment of cancerous and noncancerous diseases of the female reproductive system, and his clinical research focuses on surgical therapy for gynecologic cancers and innovative surgical approaches to treating gynecologic disorders. 

 

Highlights:

- The journey of being a gynecologic oncologist is incredibly rewarding.
- Focus your research on areas that are meaningful to you.
- Question traditional surgical principles that you believe can be improved upon.
- Be grateful to all the people who worked with you and helped make you the person you have become.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Nadeem Abu-Rustum. Dr. Abu-Rustum is a board-certified gynecologic oncologist who specializes in the surgical treatment of gynecologic cancers at Memorial Sloan Kettering Cancer Center. He is also a professor of obstetrics and gynecology at Weill Cornell Medical College. Dr. Abu-Rustum has a special interest in minimally invasive surgery (laparoscopy) for the treatment of cancerous and noncancerous diseases of the female reproductive system, and his clinical research focuses on surgical therapy for gynecologic cancers and innovative surgical approaches to treating gynecologic disorders. 

 

Highlights:

- The journey of being a gynecologic oncologist is incredibly rewarding.
- Focus your research on areas that are meaningful to you.
- Question traditional surgical principles that you believe can be improved upon.
- Be grateful to all the people who worked with you and helped make you the person you have become.</description>
      <enclosure length="45497645" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1364452456-bmjpodcasts-mentors-podcast-nadeem-abu-rustum.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-JZ2jYmCyDLqEXWgi-GazJMQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1361608549</guid>
      <title>Weakness in the ICU</title>
      <pubDate>Fri, 14 Oct 2022 05:00:56 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/weakness-in-the-icu</link>
      <itunes:duration>00:49:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Amy Ross Russell(1), interviews Dr. Jon Walters(2) about his recent review of approaches to weakness in the Intensive Care Unit (ICU).

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/5/358) and the October print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-october-2022-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Consultant Neurologist, Morriston Hospital, Swansea, UK

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</itunes:summary>
      <itunes:subtitle>Dr. Amy Ross Russell(1), interviews Dr. Jon Walte…</itunes:subtitle>
      <description>Dr. Amy Ross Russell(1), interviews Dr. Jon Walters(2) about his recent review of approaches to weakness in the Intensive Care Unit (ICU).

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/5/358) and the October print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-october-2022-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Consultant Neurologist, Morriston Hospital, Swansea, UK

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</description>
      <enclosure length="47514434" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1361608549-bmjpodcasts-weakness-in-the-icu.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1362955696</guid>
      <title>Less Pain. Better performance using contemporary science to improve both in all athletes EP#517</title>
      <pubDate>Fri, 14 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/less-pain-better-performance-using-contemporary-science-to-improve-both-in-all-athletes-ep517</link>
      <itunes:duration>00:36:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this BJSM podcast Brooke Patterson hosts Prof Lorimer Moseley AO and Dr Ebonie Rio, physiotherapists and international leaders in pain science. This is a fascinating discussion about how we increase our ability as clinicians and to “own the modern science” and explain pain to patients. We discuss the “warm-up phenomena” with painful tendons, the competing demands of self-protection and performance, and how we can help change the internal conversations that patients have about their pain.</itunes:summary>
      <itunes:subtitle>In this BJSM podcast Brooke Patterson hosts Prof …</itunes:subtitle>
      <description>In this BJSM podcast Brooke Patterson hosts Prof Lorimer Moseley AO and Dr Ebonie Rio, physiotherapists and international leaders in pain science. This is a fascinating discussion about how we increase our ability as clinicians and to “own the modern science” and explain pain to patients. We discuss the “warm-up phenomena” with painful tendons, the competing demands of self-protection and performance, and how we can help change the internal conversations that patients have about their pain.</description>
      <enclosure length="88704521" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1362955696-bmjpodcasts-less-pain-better-performance-using-contemporary-science-to-improve-both-in-all-athletes-ep517.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1362200422</guid>
      <title>Students, sex work, and stigma</title>
      <pubDate>Thu, 13 Oct 2022 12:03:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/students-sex-work-stigma</link>
      <itunes:duration>00:39:42</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The relationship between our personal and professional identity has always been an important part of the conversations we have here on Sharp Scratch. What doctors and medical students do in their own personal lives is often brought into debates on professionalism. 

The Student Sex Work Project (2015) reported that around 5% of students have, at some point, been involved in the sex industry. In this episode, the panel talk to Dr Jessica Simpson about the attitudes towards student sex workers, the GMC’s stance on this, and the concept of the personal-professional identity.

Expert guests:
Dr Jessica Simpson is a lecturer in sociology at the University of Greenwich. Her research area is the sex industry and her doctoral thesis was specifically on the topic of student sex work. She has recently contributed to this book on student sex work: https://link.springer.com/book/10.1007/978-3-031-07777-7.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>The relationship between our personal and profess…</itunes:subtitle>
      <description>The relationship between our personal and professional identity has always been an important part of the conversations we have here on Sharp Scratch. What doctors and medical students do in their own personal lives is often brought into debates on professionalism. 

The Student Sex Work Project (2015) reported that around 5% of students have, at some point, been involved in the sex industry. In this episode, the panel talk to Dr Jessica Simpson about the attitudes towards student sex workers, the GMC’s stance on this, and the concept of the personal-professional identity.

Expert guests:
Dr Jessica Simpson is a lecturer in sociology at the University of Greenwich. Her research area is the sex industry and her doctoral thesis was specifically on the topic of student sex work. She has recently contributed to this book on student sex work: https://link.springer.com/book/10.1007/978-3-031-07777-7.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="38116204" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1362200422-bmjpodcasts-students-sex-work-stigma.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1361774377</guid>
      <title>Talk Evidence - Inquiring about covid, burnout, and marginal data</title>
      <pubDate>Wed, 12 Oct 2022 17:40:09 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/inquiring-about-covid-burnout-and-marginal-data</link>
      <itunes:duration>00:36:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>It's October's Talk Evidence, and  that means the autumn is upon us including those autumnal viruses. Here in the UK covid is on the rise, and Joe Ross is looking at some research on how good those elusive lateral flows are at detecting infection among people with symptoms of covid.

Juan will give us an update on the covid inquiry, the collection of analysis articles The BMJ is publishing looking at the interface of evidence and policy in our decisions about how to handle the pandemic.

Since the pandemic moral among clinicians in many health systems has fallen even further, workloads have spiralled. Coupled with other problems with workforce planning and investment in health and healthcare, this is increasing burnout -  with a consequential impact on patient care. Helen will tell us about new research which is trying to put some numbers to how much clinican burnout effects patient outcomes

Finally, we're turning to a very clinical topic that we don't often cover in Talk Evidence - oncology, and some interesting insights into clearance margins in cancer surgery.


Reading list

Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period
https://www.bmj.com/content/378/bmj-2022-071215

Guided by the science? Questions for the UK’s covid-19 public inquiry
https://www.bmj.com/content/378/bmj.o2066

 
Associations of physician burnout with career engagement and quality of patient care
https://www.bmj.com/content/378/bmj-2022-070442

Margin status and survival outcomes after breast cancer conservation surgery
https://www.bmj.com/content/378/bmj-2022-070346</itunes:summary>
      <itunes:subtitle>It's October's Talk Evidence, and  that means the…</itunes:subtitle>
      <description>It's October's Talk Evidence, and  that means the autumn is upon us including those autumnal viruses. Here in the UK covid is on the rise, and Joe Ross is looking at some research on how good those elusive lateral flows are at detecting infection among people with symptoms of covid.

Juan will give us an update on the covid inquiry, the collection of analysis articles The BMJ is publishing looking at the interface of evidence and policy in our decisions about how to handle the pandemic.

Since the pandemic moral among clinicians in many health systems has fallen even further, workloads have spiralled. Coupled with other problems with workforce planning and investment in health and healthcare, this is increasing burnout -  with a consequential impact on patient care. Helen will tell us about new research which is trying to put some numbers to how much clinican burnout effects patient outcomes

Finally, we're turning to a very clinical topic that we don't often cover in Talk Evidence - oncology, and some interesting insights into clearance margins in cancer surgery.


Reading list

Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period
https://www.bmj.com/content/378/bmj-2022-071215

Guided by the science? Questions for the UK’s covid-19 public inquiry
https://www.bmj.com/content/378/bmj.o2066

 
Associations of physician burnout with career engagement and quality of patient care
https://www.bmj.com/content/378/bmj-2022-070442

Margin status and survival outcomes after breast cancer conservation surgery
https://www.bmj.com/content/378/bmj-2022-070346</description>
      <enclosure length="35060923" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1361774377-bmjpodcasts-inquiring-about-covid-burnout-and-marginal-data.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2yobq1Hjl6r87WmD-zdjn1Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1361587144</guid>
      <title>Physician experience, and gout with Katherine Hall and Alastair Dickson</title>
      <pubDate>Wed, 12 Oct 2022 11:49:16 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/30sep-gout</link>
      <itunes:duration>00:50:21</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of Deep Breath In, we'll be considering how a physicians personal experience of illness - either themselves, or as a parent or carer, might affect their approach to management of it in a patient. 

We'll also have an update on the NICE guideline for treatment of Gout - particularly highlighting changes around uses of urate lowering therapy, and how often we should be testing patient's serum urate levels when they're experiencing flare-ups.

Our Guests.

Katherine Hall is the associate dean of medical admissions at the university of Otago, and has researched how physician experience affects their practice.

Alastair Dickson is a GP, and lecturer at Hull York Medical School. He co-authored The BMJ article on management of gout.

Reading
Gout: diagnosis and management—summary of NICE guidance
https://www.bmj.com/content/378/bmj.o1754</itunes:summary>
      <itunes:subtitle>In this episode of Deep Breath In, we'll be consi…</itunes:subtitle>
      <description>In this episode of Deep Breath In, we'll be considering how a physicians personal experience of illness - either themselves, or as a parent or carer, might affect their approach to management of it in a patient. 

We'll also have an update on the NICE guideline for treatment of Gout - particularly highlighting changes around uses of urate lowering therapy, and how often we should be testing patient's serum urate levels when they're experiencing flare-ups.

Our Guests.

Katherine Hall is the associate dean of medical admissions at the university of Otago, and has researched how physician experience affects their practice.

Alastair Dickson is a GP, and lecturer at Hull York Medical School. He co-authored The BMJ article on management of gout.

Reading
Gout: diagnosis and management—summary of NICE guidance
https://www.bmj.com/content/378/bmj.o1754</description>
      <enclosure length="48347845" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1361587144-bmjpodcasts-30sep-gout.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1360948516</guid>
      <title>Sickle cell disease in children: an update of the evidence in low- and middle-income settings</title>
      <pubDate>Wed, 12 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sickle-cell-disease-in-children</link>
      <itunes:duration>00:33:17</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month, Dr Rachel Agbeko, Senior Editor of ADC, is joined by paediatric oncologist Dr Isaac Odame(1) to discuss the origin and spread of sickle cell disease, its diagnosis and treatment, and the wide difference in outcomes for those of varying economic backgrounds. 
Related article: https://adc.bmj.com/content/early/2022/09/07/archdischild-2021-323633

The ADC Spotlight podcast is the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. This series is produced by Letícia Amorim and edited by Brian O'Toole.

Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

(1) Haematology Section Head in the Division of Haematology/Oncology and Medical Director of the Global Sickle Cell Disease Network at the Centre for Global Child Health at The Hospital for Sick Children (SickKids), Professor and Director of the Division of Adult and Paediatric Haematology in the Departments of Medicine and Paediatrics at the University of Toronto (U of T).</itunes:summary>
      <itunes:subtitle>This month, Dr Rachel Agbeko, Senior Editor of AD…</itunes:subtitle>
      <description>This month, Dr Rachel Agbeko, Senior Editor of ADC, is joined by paediatric oncologist Dr Isaac Odame(1) to discuss the origin and spread of sickle cell disease, its diagnosis and treatment, and the wide difference in outcomes for those of varying economic backgrounds. 
Related article: https://adc.bmj.com/content/early/2022/09/07/archdischild-2021-323633

The ADC Spotlight podcast is the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. This series is produced by Letícia Amorim and edited by Brian O'Toole.

Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

(1) Haematology Section Head in the Division of Haematology/Oncology and Medical Director of the Global Sickle Cell Disease Network at the Centre for Global Child Health at The Hospital for Sick Children (SickKids), Professor and Director of the Division of Adult and Paediatric Haematology in the Departments of Medicine and Paediatrics at the University of Toronto (U of T).</description>
      <enclosure length="31956322" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1360948516-bmjpodcasts-sickle-cell-disease-in-children.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-MRWRroZ1Uz3oKq7p-pEKt2w-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1360177393</guid>
      <title>Climate change: a survey of global gastroenterology society leadership</title>
      <pubDate>Mon, 10 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/climate-change-global-gastroenterology-survey</link>
      <itunes:duration>00:16:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Desmond Leddin, who is from the Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada, on the paper 'Climate change: a survey of global gastroenterology society leadership' published in paper copy in Gut in October 2022 and available online at: https://gut.bmj.com/content/71/10/1929

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Desmond Leddin, who is from the Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada, on the paper 'Climate change: a survey of global gastroenterology society leadership' published in paper copy in Gut in October 2022 and available online at: https://gut.bmj.com/content/71/10/1929

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="15822261" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1360177393-bmjpodcasts-climate-change-global-gastroenterology-survey.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1360103047</guid>
      <title>The CHRONO Trial with Drs. Jean-Marc Classe and Florence Joly</title>
      <pubDate>Mon, 10 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-chrono-trial-with-drs-jean-marc-classe-and-florence-joly</link>
      <itunes:duration>00:37:47</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Jean-Marc Classe and Florence Joly to discuss the CHRONO trial. Dr. Classe is a surgeon and former head of the surgical department of the Institute of Surgical Oncology of Nantes, France. He is a professor in oncology and president of the French Society of Surgical Oncology. Dr. Joly is a medical oncologist and coordinator of gynecological and genito-urinary medical oncology. She is also the head of the clinical research department of Francois Baclesse Comprehensive Cancer Center in Caen, France. She is a professor in medical oncology and a member of both the scientific board of the GINECO intergroup and the GCIG.

 

Highlights:

-In patients treated for an advanced ovarian cancer not suitable to primary surgery, the timing of surgery after neoadjuvant chemotherapy (NAC) could depend on chemosensitivity.
-When more cycles of NAC are discussed, do not confuse more cycles in order to make the disease suitable to a complete surgery with more cycles in order to perform less surgery.
-In cases of patients with a highly chemosensitive advanced ovarian cancer, delaying surgery could reduce surgical morbidity and improve quality of life.
-More cycles of NAC to treat a chemosensitive disease could improve the rate of complete surgery and improve the rate of pathological complete response.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Jean-Marc Classe and Florence Joly to discuss the CHRONO trial. Dr. Classe is a surgeon and former head of the surgical department of the Institute of Surgical Oncology of Nantes, France. He is a professor in oncology and president of the French Society of Surgical Oncology. Dr. Joly is a medical oncologist and coordinator of gynecological and genito-urinary medical oncology. She is also the head of the clinical research department of Francois Baclesse Comprehensive Cancer Center in Caen, France. She is a professor in medical oncology and a member of both the scientific board of the GINECO intergroup and the GCIG.

 

Highlights:

-In patients treated for an advanced ovarian cancer not suitable to primary surgery, the timing of surgery after neoadjuvant chemotherapy (NAC) could depend on chemosensitivity.
-When more cycles of NAC are discussed, do not confuse more cycles in order to make the disease suitable to a complete surgery with more cycles in order to perform less surgery.
-In cases of patients with a highly chemosensitive advanced ovarian cancer, delaying surgery could reduce surgical morbidity and improve quality of life.
-More cycles of NAC to treat a chemosensitive disease could improve the rate of complete surgery and improve the rate of pathological complete response.</description>
      <enclosure length="36080601" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1360103047-bmjpodcasts-the-chrono-trial-with-drs-jean-marc-classe-and-florence-joly.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-JZ2jYmCyDLqEXWgi-GazJMQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1353868258</guid>
      <title>Collaboration in Injury Prevention, with Pamela Fuselli</title>
      <pubDate>Thu, 06 Oct 2022 00:30:08 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/collaboration-in-injury-prevention-with-pamela-fuselli</link>
      <itunes:duration>00:27:47</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast we talk about national collaboration across the field of injury prevention through the eyes of Pamela Fuselli, president and CEO of a national injury prevention charity, in Canada, Parachute.
We also discuss the upcoming 2022 Canadian Injury Prevention Conference.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>In this podcast we talk about national collaborat…</itunes:subtitle>
      <description>In this podcast we talk about national collaboration across the field of injury prevention through the eyes of Pamela Fuselli, president and CEO of a national injury prevention charity, in Canada, Parachute.
We also discuss the upcoming 2022 Canadian Injury Prevention Conference.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="39956342" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1353868258-bmjpodcasts-collaboration-in-injury-prevention-with-pamela-fuselli.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-lBNYPWMk19NnXlDd-TWVzcQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1353221320</guid>
      <title>What causes the progression of paroxysmal atrial fibrillation?</title>
      <pubDate>Tue, 04 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/what-causes-the-progression-of-paroxysmal-atrial-fibrillation</link>
      <itunes:duration>00:15:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the podcast, Dr Andrew Perry is joined by Professor Michiel Rienstra of the University Medical Center Groningen in the Netherlands. They discuss his paper “Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation” recently published in Heart. It is an interesting piece in the investigation to understand the pathobiology of atrial fibrillation.

If you enjoy the show, please subscribe. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 

Link to published paper:

https://heart.bmj.com/content/early/2022/07/20/heartjnl-2022-321027</itunes:summary>
      <itunes:subtitle>In this episode of the podcast, Dr Andrew Perry i…</itunes:subtitle>
      <description>In this episode of the podcast, Dr Andrew Perry is joined by Professor Michiel Rienstra of the University Medical Center Groningen in the Netherlands. They discuss his paper “Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation” recently published in Heart. It is an interesting piece in the investigation to understand the pathobiology of atrial fibrillation.

If you enjoy the show, please subscribe. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 

Link to published paper:

https://heart.bmj.com/content/early/2022/07/20/heartjnl-2022-321027</description>
      <enclosure length="36394123" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1353221320-bmjpodcasts-what-causes-the-progression-of-paroxysmal-atrial-fibrillation.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1355743960</guid>
      <title>Sedlis Criteria: A reanalysis of risk assessment with David Viveros-Carreño and Rene Pareja</title>
      <pubDate>Mon, 03 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sedlis-criteria-a-reanalysis-of-risk-assessment-with-david-viveros-carreno-and-rene-pareja</link>
      <itunes:duration>00:36:46</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. David Viveros-Carreño and Rene Pareja to discuss Sedlis criteria. Dr. Viveros-Carreño is a Gynecologic Oncologist at Instituto Nacional de Cancerología, Clínica Universitaria Colombia and Clínica Los Nogales in Bogotá, Colombia. Dr. Pareja is a gynecologist oncologist at Astorga Oncology Clinic in Medellín and the National Cancer Institute in Bogotá, Colombia. Dr. Pareja is a reviewer for more than 20 specialty journals, an Associate Editor for IJGC, and a member of the board of directors of the International Gynecological Cancer Society (IGCS). He is the author of nine book chapters and more than 70 publications in peer-reviewed journals, and at IGCS 2021 he received an award for Community Advancement in Resource-Limited Settings.

 

Highlights:

-There is currently a debate regarding the role of adjuvant therapy for intermediate-risk cervical cancer.
-Adjuvant pelvic radiotherapy showed lower risk of recurrence for intermediate-risk cervical cancer in a randomized controlled trial more than 20 years ago.
-Preoperative imaging, surgery, pathology, and radiotherapy techniques have changed since the evidence for intermediate risk adjuvant treatments was described.
-The risk of recurrence for intermediate risk cervical cancer is probably lower now, and observation could be an option.  
-New evidence from two randomized controlled trials (GOG 263 and CERVANTES trials) is expected to change definitions of intermediate risk and adjuvant algorithms.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. David Viveros-Carreño and Rene Pareja to discuss Sedlis criteria. Dr. Viveros-Carreño is a Gynecologic Oncologist at Instituto Nacional de Cancerología, Clínica Universitaria Colombia and Clínica Los Nogales in Bogotá, Colombia. Dr. Pareja is a gynecologist oncologist at Astorga Oncology Clinic in Medellín and the National Cancer Institute in Bogotá, Colombia. Dr. Pareja is a reviewer for more than 20 specialty journals, an Associate Editor for IJGC, and a member of the board of directors of the International Gynecological Cancer Society (IGCS). He is the author of nine book chapters and more than 70 publications in peer-reviewed journals, and at IGCS 2021 he received an award for Community Advancement in Resource-Limited Settings.

 

Highlights:

-There is currently a debate regarding the role of adjuvant therapy for intermediate-risk cervical cancer.
-Adjuvant pelvic radiotherapy showed lower risk of recurrence for intermediate-risk cervical cancer in a randomized controlled trial more than 20 years ago.
-Preoperative imaging, surgery, pathology, and radiotherapy techniques have changed since the evidence for intermediate risk adjuvant treatments was described.
-The risk of recurrence for intermediate risk cervical cancer is probably lower now, and observation could be an option.  
-New evidence from two randomized controlled trials (GOG 263 and CERVANTES trials) is expected to change definitions of intermediate risk and adjuvant algorithms.</description>
      <enclosure length="35303757" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1355743960-bmjpodcasts-sedlis-criteria-a-reanalysis-of-risk-assessment-with-david-viveros-carreno-and-rene-pareja.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-JZ2jYmCyDLqEXWgi-GazJMQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1340147533</guid>
      <title>Hospital quality of care linked to racial disparities in unexpected newborn complications</title>
      <pubDate>Mon, 03 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/hospital-quality-of-care-racial-disparities-newborn-complications</link>
      <itunes:duration>00:17:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Today we discuss a study that describes associations between race/ethnicity, hospital of birth and ‘unexpected newborn complications’ in low-risk term neonates in New York City.
Kristine Schmitz (1) and Lawrence Charles Kleinman (2) are the authors of a commentary published by EBN on that study. They tell Evidence-Based Nursing Associate Editor, Kerry Gaskin, how the quality of care in the hospital of delivery has a direct relation with more unexpected neonatal complications in black and hispanic infants.
Read the commentary:
Hospital Quality of Care and Racial and Ethnic Disparities in Unexpected Newborn Complications (https://ebn.bmj.com/content/25/3/89)
Commentary on: Glazer KB, Zeitlin J, Egorova NN, et al. Hospital quality of care and racial and ethnic disparities in unexpected newborn complications. Pediatrics 2021;148:e2020024091. doi:10.1542/peds.2020-024091.
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.
(1) Pediatrics, Rutgers Robert Wood Johnson Medical School Department of Pediatrics, New Brunswick, New Jersey, USA
(2) Urban-Global Public Health, Rutgers School of Public Health, Piscataway, NJ, USA</itunes:summary>
      <itunes:subtitle>Today we discuss a study that describes associati…</itunes:subtitle>
      <description>Today we discuss a study that describes associations between race/ethnicity, hospital of birth and ‘unexpected newborn complications’ in low-risk term neonates in New York City.
Kristine Schmitz (1) and Lawrence Charles Kleinman (2) are the authors of a commentary published by EBN on that study. They tell Evidence-Based Nursing Associate Editor, Kerry Gaskin, how the quality of care in the hospital of delivery has a direct relation with more unexpected neonatal complications in black and hispanic infants.
Read the commentary:
Hospital Quality of Care and Racial and Ethnic Disparities in Unexpected Newborn Complications (https://ebn.bmj.com/content/25/3/89)
Commentary on: Glazer KB, Zeitlin J, Egorova NN, et al. Hospital quality of care and racial and ethnic disparities in unexpected newborn complications. Pediatrics 2021;148:e2020024091. doi:10.1542/peds.2020-024091.
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.
(1) Pediatrics, Rutgers Robert Wood Johnson Medical School Department of Pediatrics, New Brunswick, New Jersey, USA
(2) Urban-Global Public Health, Rutgers School of Public Health, Piscataway, NJ, USA</description>
      <enclosure length="17154715" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1340147533-bmjpodcasts-hospital-quality-of-care-racial-disparities-newborn-complications.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XWHwP663TNF7c5jR-ys6wWw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1352734393</guid>
      <title>Primary Survey - the highlights of October 2022</title>
      <pubDate>Mon, 03 Oct 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-october-2022</link>
      <itunes:duration>00:30:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The best of our October 2022 issue, covering a superb qualitative study exploring the experience of older adults in the Emergency Medicine Journal with a wonderful accompanying editorial; a look at variation in practice for treating pre-orbital and orbital cellulitis in children; the association between anticoagulation and mortality in major trauma; point of care testing for tetanus immunity and more.
Read the highlights: https://emj.bmj.com/content/39/10/723
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>The best of our October 2022 issue, covering a su…</itunes:subtitle>
      <description>The best of our October 2022 issue, covering a superb qualitative study exploring the experience of older adults in the Emergency Medicine Journal with a wonderful accompanying editorial; a look at variation in practice for treating pre-orbital and orbital cellulitis in children; the association between anticoagulation and mortality in major trauma; point of care testing for tetanus immunity and more.
Read the highlights: https://emj.bmj.com/content/39/10/723
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="29158085" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1352734393-bmjpodcasts-emj-october-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1354217374</guid>
      <title>Extracorporeal Shockwave Therapy in MSK Medicine with Dr. Adam Tenforde EP #516</title>
      <pubDate>Fri, 30 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/extracorporeal-shockwave-therapy-in-msk-medicine-with-dr-adam-tenforde-ep-516</link>
      <itunes:duration>00:24:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Jacob Wessels, MD is joined by Dr. Adam Tenforde, MD to discuss the topic of Exercise for Extracorporeal Shockwave Therapy (ESWT) in Musculoskeletal Medicine.
 
Dr. Tenforde recently published a research about best practices for ESWT, which is used in a variety of clinical applications including the management of musculoskeletal conditions. In this conversation, he addresses the following topics and questions about shockwave therapy:
·        What is ESWT?
·        The origins of shockwave therapy use and some of its additional applications
·        Describing the process of shockwave therapy and its effects
·        Some of the factors to consider when performing ESWT, especially to clinicians who have never used this treatment option before
·        Understanding the different types of shockwave therapy and how they can be used to treat injuries
·        What types of providers can administer ESWT, and what are the recommended treatment protocols for medical teams?
·        What is the reimbursement status of shockwave therapy for providers?
·        What are some of the medical conditions that are best treated by ESWT, in both the lower and upper extremities?
 
Additional Resources
Best practices for extracorporeal shockwave therapy in musculoskeletal medicine: Clinical application and training consideration. PM&amp;R 2022 May;14(5):611-619. doi: 10.1002/pmrj.12790. https://doi.org/10.1002/pmrj.12790
Bone stress injuries. Nat Rev Dis Primers. 2022 Apr 28;8(1):26. doi: 10.1038/s41572-022-00352-y. PMID: 3548413
A Systematic Review of Systematic Reviews on the Epidemiology, Evaluation, and Treatment of Plantar Fasciitis. Life (Basel). 2021 Nov 24;11(12):1287. doi: 10.3390/life11121287.</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM Sports Medcast (T: @…</itunes:subtitle>
      <description>On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Jacob Wessels, MD is joined by Dr. Adam Tenforde, MD to discuss the topic of Exercise for Extracorporeal Shockwave Therapy (ESWT) in Musculoskeletal Medicine.
 
Dr. Tenforde recently published a research about best practices for ESWT, which is used in a variety of clinical applications including the management of musculoskeletal conditions. In this conversation, he addresses the following topics and questions about shockwave therapy:
·        What is ESWT?
·        The origins of shockwave therapy use and some of its additional applications
·        Describing the process of shockwave therapy and its effects
·        Some of the factors to consider when performing ESWT, especially to clinicians who have never used this treatment option before
·        Understanding the different types of shockwave therapy and how they can be used to treat injuries
·        What types of providers can administer ESWT, and what are the recommended treatment protocols for medical teams?
·        What is the reimbursement status of shockwave therapy for providers?
·        What are some of the medical conditions that are best treated by ESWT, in both the lower and upper extremities?
 
Additional Resources
Best practices for extracorporeal shockwave therapy in musculoskeletal medicine: Clinical application and training consideration. PM&amp;R 2022 May;14(5):611-619. doi: 10.1002/pmrj.12790. https://doi.org/10.1002/pmrj.12790
Bone stress injuries. Nat Rev Dis Primers. 2022 Apr 28;8(1):26. doi: 10.1038/s41572-022-00352-y. PMID: 3548413
A Systematic Review of Systematic Reviews on the Epidemiology, Evaluation, and Treatment of Plantar Fasciitis. Life (Basel). 2021 Nov 24;11(12):1287. doi: 10.3390/life11121287.</description>
      <enclosure length="18294035" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1354217374-bmjpodcasts-extracorporeal-shockwave-therapy-in-msk-medicine-with-dr-adam-tenforde-ep-516.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1347558274</guid>
      <title>Presumptive and Prophylactic management of Bacterial STIs</title>
      <pubDate>Fri, 30 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/management-of-bacterial-stis</link>
      <itunes:duration>00:14:24</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Today we focus on presumptive and prophylactic management of bacterial STIs, talking with Dr Manoji Gunathilake, Head of sexual health services in Darwin, Australia, and Assistant Prof Will Nutland, the director of the NGO, the Love Tank, in London, UK.
Related links:
STI Guidelines Australia: https://sti.guidelines.org.au/
The Love Tank: http://thelovetank.info/
GRASP report: data to June 2021 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1033882/GRASP_2020_Report.pdf
Taking antibiotic after sex cuts STIs by two-thirds, ‘DoxyPEP’ study finds - www.aidsmap.com/news/jul-2022/tak…xypep-study-finds
Doxycycline PEP significantly reduces STIs in people at high risk of infections - i-base.info/htb/43528</itunes:summary>
      <itunes:subtitle>Today we focus on presumptive and prophylactic ma…</itunes:subtitle>
      <description>Today we focus on presumptive and prophylactic management of bacterial STIs, talking with Dr Manoji Gunathilake, Head of sexual health services in Darwin, Australia, and Assistant Prof Will Nutland, the director of the NGO, the Love Tank, in London, UK.
Related links:
STI Guidelines Australia: https://sti.guidelines.org.au/
The Love Tank: http://thelovetank.info/
GRASP report: data to June 2021 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1033882/GRASP_2020_Report.pdf
Taking antibiotic after sex cuts STIs by two-thirds, ‘DoxyPEP’ study finds - www.aidsmap.com/news/jul-2022/tak…xypep-study-finds
Doxycycline PEP significantly reduces STIs in people at high risk of infections - i-base.info/htb/43528</description>
      <enclosure length="13827342" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1347558274-bmjpodcasts-management-of-bacterial-stis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-pAPNWIdcqzhbf4vB-70N7zw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1347563209</guid>
      <title>How to manage a high-output stoma</title>
      <pubDate>Thu, 29 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/how-to-manage-a-high-output-stoma</link>
      <itunes:duration>00:19:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Associate and Social Media Editor of FG and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Dr Jeremy Nightingale, Honorary Consultant Gastroenterologist and Intestinal Failure specialist from St Mark’s Hospital, London, UK, on the paper 'How to manage a high output stoma' published in Frontline Gastroenterology in 2021 and on the website: https://fg.bmj.com/content/13/2/140.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Associate and Social Media Edito…</itunes:subtitle>
      <description>Dr Philip Smith, Associate and Social Media Editor of FG and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Dr Jeremy Nightingale, Honorary Consultant Gastroenterologist and Intestinal Failure specialist from St Mark’s Hospital, London, UK, on the paper 'How to manage a high output stoma' published in Frontline Gastroenterology in 2021 and on the website: https://fg.bmj.com/content/13/2/140.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="18951940" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1347563209-bmjpodcasts-how-to-manage-a-high-output-stoma.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1351263319</guid>
      <title>October 2022 - two freebies, advertising woes, paracetamol (again) and standing up to Pharma</title>
      <pubDate>Wed, 28 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-october-2022</link>
      <itunes:duration>00:32:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the October 2022 issue of DTB. They discuss whether the language used in announcements from organisations such as NHS England, NICE and the MHRA regarding new medicines is appropriate and highlight concerns that some press releases are at risk of promoting POMs to the public (https://dtb.bmj.com/content/60/10/146). They review a study that assessed the effect that regular doses of paracetamol had on blood pressure (https://dtb.bmj.com/content/60/10/147) and talk about an article that discusses the role played over the past 20 years by groups, organisations and individuals that have been critical of the pharmaceutical industry (https://dtb.bmj.com/content/60/10/151).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the October 2022 issue of DTB. They discuss whether the language used in announcements from organisations such as NHS England, NICE and the MHRA regarding new medicines is appropriate and highlight concerns that some press releases are at risk of promoting POMs to the public (https://dtb.bmj.com/content/60/10/146). They review a study that assessed the effect that regular doses of paracetamol had on blood pressure (https://dtb.bmj.com/content/60/10/147) and talk about an article that discusses the role played over the past 20 years by groups, organisations and individuals that have been critical of the pharmaceutical industry (https://dtb.bmj.com/content/60/10/151).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="30890944" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1351263319-bmjpodcasts-dtb-october-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-LsRQxLxC3BRWBuSF-90mrcQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1352015992</guid>
      <title>Doctor Informed - the generational divide</title>
      <pubDate>Tue, 27 Sep 2022 16:29:22 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/doctor-informed-the-generational-divide</link>
      <itunes:duration>00:54:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>It's zoomers vs boomers on this week's Doctor Informed, as we assemble a multigenerational team to talk about the "good old days" and if the youth of today are really snowflakes.

Clara Munro is joined by Nikki Nabavi, a medical student at Manchester University and a regular on Sharp Scratch (The BMJ's student podcast); Ayisha Ashmoore, an trainee in obstetrics and gynaecology, in the East Midlands; and Alastair Munro, a retired professor of oncology (and Clara's dad).</itunes:summary>
      <itunes:subtitle>It's zoomers vs boomers on this week's Doctor Inf…</itunes:subtitle>
      <description>It's zoomers vs boomers on this week's Doctor Informed, as we assemble a multigenerational team to talk about the "good old days" and if the youth of today are really snowflakes.

Clara Munro is joined by Nikki Nabavi, a medical student at Manchester University and a regular on Sharp Scratch (The BMJ's student podcast); Ayisha Ashmoore, an trainee in obstetrics and gynaecology, in the East Midlands; and Alastair Munro, a retired professor of oncology (and Clara's dad).</description>
      <enclosure length="51868733" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1352015992-bmjpodcasts-doctor-informed-the-generational-divide.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iv1zjTJkVfROtFcB-2RBqcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1311943282</guid>
      <title>Herpes zoster infection</title>
      <pubDate>Mon, 26 Sep 2022 08:30:02 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/herpes-zoster-infection-1</link>
      <itunes:duration>00:18:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Herpes zoster: an update on diagnosis and management
The annual incidence of herpes zoster in the UK is between 2 and 4 patients per thousand population. It can cause a range of complications including post-herpetic neuralgia, herpes zoster of the eye, and disseminated zoster. So it is important that we get the diagnosis and management of this condition right.  In this BMJ Best Practice podcast on herpes zoster, Kieran Walsh talks to Professor  Michael Rothberg, Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio.  MR declares that he has no competing interests.-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Herpes zoster: an update on diagnosis and managem…</itunes:subtitle>
      <description>Herpes zoster: an update on diagnosis and management
The annual incidence of herpes zoster in the UK is between 2 and 4 patients per thousand population. It can cause a range of complications including post-herpetic neuralgia, herpes zoster of the eye, and disseminated zoster. So it is important that we get the diagnosis and management of this condition right.  In this BMJ Best Practice podcast on herpes zoster, Kieran Walsh talks to Professor  Michael Rothberg, Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio.  MR declares that he has no competing interests.-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="22647136" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1311943282-bmjpodcasts-herpes-zoster-infection-1.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1343662642</guid>
      <title>Editors Highlights of the October 2022 issue</title>
      <pubDate>Mon, 26 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-october-2022-issue</link>
      <itunes:duration>00:36:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the October 2022 issue of the journal.
Read the highlights: https://pn.bmj.com/content/22/5/341.
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</itunes:summary>
      <itunes:subtitle>Practical Neurology Editors Phil Smith and Gerain…</itunes:subtitle>
      <description>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the October 2022 issue of the journal.
Read the highlights: https://pn.bmj.com/content/22/5/341.
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</description>
      <enclosure length="35012021" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1343662642-bmjpodcasts-editors-highlights-of-the-october-2022-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1351083079</guid>
      <title>Immune Checkpoint Inhibitors in Ovarian Cancer with Dmitriy Zamarin</title>
      <pubDate>Mon, 26 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/immune-checkpoint-inhibitors-in-ovarian-cancer-with-dmitriy-zamarin</link>
      <itunes:duration>00:32:41</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Dmitriy Zamarin to discuss immune checkpoint inhibitors in ovarian cancer. Dr. Zamarin is a medical oncologist and a translational research director in gynecologic medical oncology at the Memorial Sloan Kettering Cancer Center. His research focuses on development of novel immune therapeutics in gynecologic malignancies and on the mechanisms of immune response to immunotherapy. 

 

Highlights:

-Immune checkpoint blockade benefits a subset of patients with ovarian cancer, but predictors of such benefit remain unknown.

-Patients with ovarian clear cell carcinoma appear to be more likely to derive benefit from immunotherapy, particularly from combined immune checkpoint blockade; however, these patients still constitute only a minority of those with ovarian clear cell carcinoma.

-Larger prospective trials of immune checkpoint blockade, including combined immune checkpoint blockade in ovarian clear cell carcinoma, are needed to validate these early observations.

-Biomarkers of response to immunotherapy like PD-L1 expression and tumor mutation burden are of limited value in ovarian cancer, and other molecular and microenvironment biomarkers are needed.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Dmitriy Zamarin to discuss immune checkpoint inhibitors in ovarian cancer. Dr. Zamarin is a medical oncologist and a translational research director in gynecologic medical oncology at the Memorial Sloan Kettering Cancer Center. His research focuses on development of novel immune therapeutics in gynecologic malignancies and on the mechanisms of immune response to immunotherapy. 

 

Highlights:

-Immune checkpoint blockade benefits a subset of patients with ovarian cancer, but predictors of such benefit remain unknown.

-Patients with ovarian clear cell carcinoma appear to be more likely to derive benefit from immunotherapy, particularly from combined immune checkpoint blockade; however, these patients still constitute only a minority of those with ovarian clear cell carcinoma.

-Larger prospective trials of immune checkpoint blockade, including combined immune checkpoint blockade in ovarian clear cell carcinoma, are needed to validate these early observations.

-Biomarkers of response to immunotherapy like PD-L1 expression and tumor mutation burden are of limited value in ovarian cancer, and other molecular and microenvironment biomarkers are needed.</description>
      <enclosure length="31386643" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1351083079-bmjpodcasts-immune-checkpoint-inhibitors-in-ovarian-cancer-with-dmitriy-zamarin.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-JZ2jYmCyDLqEXWgi-GazJMQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1329634444</guid>
      <title>Episode 7: Language Analysis: A Comparison to Traditional Meta-Analysis in Hip and Knee Surgery</title>
      <pubDate>Mon, 26 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-7-language-analysis-a-comparison-to-traditional-meta-analysis-in-hip-and-knee-surgery</link>
      <itunes:duration>00:33:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Systematic reviews and meta-analyses are incredibly important; they drive clinical practice, policy, and reimbursement, but unfortunately, take a team of people and a significant amount of time. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins Joshua Myszewski and Kristopher Schroder, MD, to discuss their exploratory study, “Evaluation of language analysis to summarize the literature: a comparison to traditional meta-analysis in primary hip and knee surgery,” first published in December 2021 (https://rapm.bmj.com/content/47/3/151). The study used something known as “sentiment analysis,” a computer-based tool, to evaluate 115 article abstracts from studies that were included in a recent systematic review and meta-analysis on total joint arthroplasty. The idea of the study was to evaluate if a sentiment analysis could come to similar conclusions as a full meta-analysis.

Joshua Myszewski is a second-year medical student at the University of Wisconsin School of Medicine. Since starting medical school, he’s been working on applying his previous engineering research experience to the clinical domain. He has an undergraduate background in engineering, and first began working with machine learning and artificial intelligence as an undergraduate. He has worked on the development of EEG-based brain computer interfaces for disabled patients.

Dr. Kristopher Schroeder is vice-chair of faculty development at the University of Wisconsin. Within ASRA Pain Medicine, he has served as the Editor for the ASRA Pain Medicine News from 2018-2021 and was honored to be one of the founding members of the Physician Mentorship and Leadership Development Special Interest Group. He assisted his wife, veterinarian Carrie Schroeder, in performing the first-ever recorded transversus abdominis plane (TAP) block on a lynx.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</itunes:summary>
      <itunes:subtitle>Systematic reviews and meta-analyses are incredib…</itunes:subtitle>
      <description>Systematic reviews and meta-analyses are incredibly important; they drive clinical practice, policy, and reimbursement, but unfortunately, take a team of people and a significant amount of time. In this month’s RAPM Focus, Editor-in-Chief Brian Sites, MD, joins Joshua Myszewski and Kristopher Schroder, MD, to discuss their exploratory study, “Evaluation of language analysis to summarize the literature: a comparison to traditional meta-analysis in primary hip and knee surgery,” first published in December 2021 (https://rapm.bmj.com/content/47/3/151). The study used something known as “sentiment analysis,” a computer-based tool, to evaluate 115 article abstracts from studies that were included in a recent systematic review and meta-analysis on total joint arthroplasty. The idea of the study was to evaluate if a sentiment analysis could come to similar conclusions as a full meta-analysis.

Joshua Myszewski is a second-year medical student at the University of Wisconsin School of Medicine. Since starting medical school, he’s been working on applying his previous engineering research experience to the clinical domain. He has an undergraduate background in engineering, and first began working with machine learning and artificial intelligence as an undergraduate. He has worked on the development of EEG-based brain computer interfaces for disabled patients.

Dr. Kristopher Schroeder is vice-chair of faculty development at the University of Wisconsin. Within ASRA Pain Medicine, he has served as the Editor for the ASRA Pain Medicine News from 2018-2021 and was honored to be one of the founding members of the Physician Mentorship and Leadership Development Special Interest Group. He assisted his wife, veterinarian Carrie Schroeder, in performing the first-ever recorded transversus abdominis plane (TAP) block on a lynx.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</description>
      <enclosure length="80453900" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1329634444-bmjpodcasts-episode-7-language-analysis-a-comparison-to-traditional-meta-analysis-in-hip-and-knee-surgery.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zz7gWPu5CVbo7hEl-LPlCNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1348701679</guid>
      <title>Being out of your depth</title>
      <pubDate>Thu, 22 Sep 2022 08:38:50 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/being-out-of-your-depth</link>
      <itunes:duration>00:40:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A career in medicine can sometimes mean stepping outside of your comfort zone. No matter what stage of your career you are in, it is likely that you will have to manage uncertainty, and will occasionally feel out of your depth. 


In this episode, the Sharp Scratch panel talks about the reality of never being able to know everything in medicine, and the benefits of acknowledging your strengths and limitations. We also talk about how to recognise that something is beyond the limit of your capabilities, and the importance of asking for help if you need it.


Expert guests:
Dr Jennifer Rasanathan is a primary care physician and clinical editor at the BMJ. She is also a podcaster on Deep Breath In, a podcast for GPs.


Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/


Thank you to Louise Griffin, final year med student at the University of Birmingham and Clegg Scholar 2022, who proposed this idea to be a Sharp Scratch episode.


This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>A career in medicine can sometimes mean stepping …</itunes:subtitle>
      <description>A career in medicine can sometimes mean stepping outside of your comfort zone. No matter what stage of your career you are in, it is likely that you will have to manage uncertainty, and will occasionally feel out of your depth. 


In this episode, the Sharp Scratch panel talks about the reality of never being able to know everything in medicine, and the benefits of acknowledging your strengths and limitations. We also talk about how to recognise that something is beyond the limit of your capabilities, and the importance of asking for help if you need it.


Expert guests:
Dr Jennifer Rasanathan is a primary care physician and clinical editor at the BMJ. She is also a podcaster on Deep Breath In, a podcast for GPs.


Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/


Thank you to Louise Griffin, final year med student at the University of Birmingham and Clegg Scholar 2022, who proposed this idea to be a Sharp Scratch episode.


This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="38945792" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1348701679-bmjpodcasts-being-out-of-your-depth.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1340129317</guid>
      <title>Data and healthcare</title>
      <pubDate>Tue, 20 Sep 2022 15:15:15 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/data-and-healthcare</link>
      <itunes:duration>00:32:08</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Data and big data in healthcare are both important and topical. Big data has the potential to transform how we provide healthcare but can also be problematic. There can be problems with how data is captured, cleaned, and corrected or with how we update data. BMJ is playing an increasing role in this field. We have our own BMJ Data Set which provides AI healthcare technologies with current, credible, and AI-ready content. In this BMJ Best Practice podcast on healthcare and data, Kieran Walsh talks to Professor Dipak Kalra, President of The European Institute for Innovation through Health Data.</itunes:summary>
      <itunes:subtitle>Data and big data in healthcare are both importan…</itunes:subtitle>
      <description>Data and big data in healthcare are both important and topical. Big data has the potential to transform how we provide healthcare but can also be problematic. There can be problems with how data is captured, cleaned, and corrected or with how we update data. BMJ is playing an increasing role in this field. We have our own BMJ Data Set which provides AI healthcare technologies with current, credible, and AI-ready content. In this BMJ Best Practice podcast on healthcare and data, Kieran Walsh talks to Professor Dipak Kalra, President of The European Institute for Innovation through Health Data.</description>
      <enclosure length="38563456" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1340129317-bmjpodcasts-data-and-healthcare.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1347418375</guid>
      <title>Atoms: the highlights from the ADC October 2022</title>
      <pubDate>Tue, 20 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-october-2022</link>
      <itunes:duration>00:14:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the October 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/10/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the October 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/10/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="14253661" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1347418375-bmjpodcasts-atoms-the-highlights-from-the-adc-october-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1342910359</guid>
      <title>Social media for cardiologists</title>
      <pubDate>Tue, 20 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/social-media-for-cardiologists</link>
      <itunes:duration>00:25:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Purvi Parwani from Loma Linda, California. They discuss her Cardiology in Focus paper about the use of social media in education. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/108/15/1240</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Purvi Parwani from Loma Linda, California. They discuss her Cardiology in Focus paper about the use of social media in education. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/108/15/1240</description>
      <enclosure length="61110895" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1342910359-bmjpodcasts-social-media-for-cardiologists.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1342992739</guid>
      <title>Outcomes of Low-Grade Endometrial Stromal Sarcoma with Mario Leitao and Evan Smith</title>
      <pubDate>Mon, 19 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/outcomes-of-low-grade-endometrial-stromal-sarcoma-with-mario-leitao-and-evan-smith</link>
      <itunes:duration>00:35:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Mario Leitao and Evan Smith to discuss outcomes of low-grade endometrial stromal sarcoma. Dr. Leitao is an attending surgeon and member at Memorial Sloan Kettering Cancer Center as well as a Professor at Weill Cornell Medical College. He serves as the fellowship director at MSKCC as well as the Director of the Minimally Invasive and Robotic Surgery Program. Dr. Smith is a gynecologic oncologist at Woman’s Hospital in Baton Rouge, Louisiana. He also serves as an Assistant Clinical Professor of Gynecologic Oncology with the LSU Health Obstetrics and Gynecology residency program in Baton Rouge.

 

Highlights:

-Lymphadenectomy is unnecessary in patients with low-grade endometrial stromal sarcoma (ESS) and clinically normal nodes.
-Postoperative therapies do not improve progression-free survival (PFS) or overall survival in low-grade ESS that is completely resected.
-FIGO stage is associated with PFS but not disease-specific survival.
-Next generation sequencing is standard for soft tissue sarcomas and should be offered to patients with low-grade ESS.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Mario Leitao and Evan Smith to discuss outcomes of low-grade endometrial stromal sarcoma. Dr. Leitao is an attending surgeon and member at Memorial Sloan Kettering Cancer Center as well as a Professor at Weill Cornell Medical College. He serves as the fellowship director at MSKCC as well as the Director of the Minimally Invasive and Robotic Surgery Program. Dr. Smith is a gynecologic oncologist at Woman’s Hospital in Baton Rouge, Louisiana. He also serves as an Assistant Clinical Professor of Gynecologic Oncology with the LSU Health Obstetrics and Gynecology residency program in Baton Rouge.

 

Highlights:

-Lymphadenectomy is unnecessary in patients with low-grade endometrial stromal sarcoma (ESS) and clinically normal nodes.
-Postoperative therapies do not improve progression-free survival (PFS) or overall survival in low-grade ESS that is completely resected.
-FIGO stage is associated with PFS but not disease-specific survival.
-Next generation sequencing is standard for soft tissue sarcomas and should be offered to patients with low-grade ESS.</description>
      <enclosure length="33745605" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1342992739-bmjpodcasts-outcomes-of-low-grade-endometrial-stromal-sarcoma-with-mario-leitao-and-evan-smith.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-JZ2jYmCyDLqEXWgi-GazJMQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1345009276</guid>
      <title>Tackling the big issues and training smarter in female collision sports with Kathryn Dane. EP#515</title>
      <pubDate>Fri, 16 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/tackling-the-big-issues-and-training-smarter-in-female-collision-sports-with-kathryn-dane-ep515</link>
      <itunes:duration>00:32:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Kathryn Dane is a physiotherapist and is a professional Irish rugby union player, and PhD candidate at Trinity College Dublin. We discuss her first PhD publication on the physical, technical, tactical demands and preparatory strategies in female field collision sports. Kathryn draws on her experience as an athlete, clinician, and researcher, and what practitioners should consider when designing training programs for female field collision sports.  

Physical and Technical Demands and Preparatory Strategies in Female Field Collision Sports: A Scoping Review: https://pubmed.ncbi.nlm.nih.gov/35767989/</itunes:summary>
      <itunes:subtitle>Kathryn Dane is a physiotherapist and is a profes…</itunes:subtitle>
      <description>Kathryn Dane is a physiotherapist and is a professional Irish rugby union player, and PhD candidate at Trinity College Dublin. We discuss her first PhD publication on the physical, technical, tactical demands and preparatory strategies in female field collision sports. Kathryn draws on her experience as an athlete, clinician, and researcher, and what practitioners should consider when designing training programs for female field collision sports.  

Physical and Technical Demands and Preparatory Strategies in Female Field Collision Sports: A Scoping Review: https://pubmed.ncbi.nlm.nih.gov/35767989/</description>
      <enclosure length="77952521" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1345009276-bmjpodcasts-tackling-the-big-issues-and-training-smarter-in-female-collision-sports-with-kathryn-dane-ep515.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1343858896</guid>
      <title>Primary Survey - the highlights of September 2022</title>
      <pubDate>Thu, 15 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-september22</link>
      <itunes:duration>00:27:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Sarah Edwards, Social Media Editor of EMJ, and Rick Body, Deputy Editor of EMJ, give an overview of the best of the September issue of the Emergency Medicine Journal. They cover a plethora of clinically relevant papers. There's a terrific non-inferiority trial looking at the use of non-sterile gloves to repair traumatic wounds in the Emergency Department, two great papers that look at whether we might avoid x-ray for patients with suspected shoulder dislocation (one involving ultrasound), a fascinating paper involving the pre-hospital use of echocardiography and point of care troponin testing for patients with chest pain and more.
Read the highlights: https://emj.bmj.com/content/39/9/647, and the complete issue: https://emj.bmj.com/content/39/9.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</itunes:summary>
      <itunes:subtitle>Sarah Edwards, Social Media Editor of EMJ, and Ri…</itunes:subtitle>
      <description>Sarah Edwards, Social Media Editor of EMJ, and Rick Body, Deputy Editor of EMJ, give an overview of the best of the September issue of the Emergency Medicine Journal. They cover a plethora of clinically relevant papers. There's a terrific non-inferiority trial looking at the use of non-sterile gloves to repair traumatic wounds in the Emergency Department, two great papers that look at whether we might avoid x-ray for patients with suspected shoulder dislocation (one involving ultrasound), a fascinating paper involving the pre-hospital use of echocardiography and point of care troponin testing for patients with chest pain and more.
Read the highlights: https://emj.bmj.com/content/39/9/647, and the complete issue: https://emj.bmj.com/content/39/9.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</description>
      <enclosure length="26278764" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1343858896-bmjpodcasts-emj-september22.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1343180266</guid>
      <title>Infectious Disease Epidemics and Inequality</title>
      <pubDate>Thu, 15 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/infectious-disease-epidemics-and-inequality</link>
      <itunes:duration>00:25:41</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Join us for a fascinating discussion about the ethics of care, and most especially the way structural racism and impediments to access heightened existing inequalities during both outbreak and lockdown.
Brandy Schillace speaks to epidemiologist Professor John Wright, Bradford Institute for Health Research and Wolfson Centre for Applied Health Research.
A blog post containing the transcript of this podcast is available here:
https://blogs.bmj.com/medical-humanities/2022/09/15/infectious-disease-epidemics-and-inequality
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>Join us for a fascinating discussion about the et…</itunes:subtitle>
      <description>Join us for a fascinating discussion about the ethics of care, and most especially the way structural racism and impediments to access heightened existing inequalities during both outbreak and lockdown.
Brandy Schillace speaks to epidemiologist Professor John Wright, Bradford Institute for Health Research and Wolfson Centre for Applied Health Research.
A blog post containing the transcript of this podcast is available here:
https://blogs.bmj.com/medical-humanities/2022/09/15/infectious-disease-epidemics-and-inequality
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="49756086" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1343180266-bmjpodcasts-infectious-disease-epidemics-and-inequality.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-gzXKa0HAjZaDvezc-iWRQnA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1343941012</guid>
      <title>Musculoskeletal pain and osteoarthritis with Imran Sajid</title>
      <pubDate>Wed, 14 Sep 2022 20:45:27 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/musculoskeletal-pain-and-osteoarthritis-with-imran-sajid</link>
      <itunes:duration>00:52:54</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Musculoskeletal (MSK) pain and osteoarthritis are clinically common in general practice, but with the new draft NICE guideline on osteoarthritis (published in April 2022) recommending a move away from pharmacological treatments and instead promoting self-management, some GPs have been left wondering how best to manage MSK pain going forwards . In this week’s episode, Dr. Imran Sajid talks to us about the importance of educating patients on what arthritis really is – moving away from the term “wear and tear” – and of taking a thorough history of a patient’s pain journey in consultations. He also gives practical advice on how we might approach non-pharmacological management of MSK pain with our patients. 


Our guest:

Imran Sajid is a GP with a special interest in MSK medicine. He is the clinical lead in MSK &amp; Diagnostics for NHS North West London, an adjunct lecturer in Health Policy  at the University of Global Health Equity, as well as being a qualified personal trainer.


Further reading:

‘Osteoarthritis: assessment and management, draft for consultation, April 2022’. NICE. 2022. https://www.nice.org.uk/guidance/gid-ng10127/documents/draft-guideline

‘The tear, flare, and repair model of osteoarthritis’. BMJ 2022;377:o1028. https://www.bmj.com/content/377/bmj.o1028</itunes:summary>
      <itunes:subtitle>Musculoskeletal (MSK) pain and osteoarthritis are…</itunes:subtitle>
      <description>Musculoskeletal (MSK) pain and osteoarthritis are clinically common in general practice, but with the new draft NICE guideline on osteoarthritis (published in April 2022) recommending a move away from pharmacological treatments and instead promoting self-management, some GPs have been left wondering how best to manage MSK pain going forwards . In this week’s episode, Dr. Imran Sajid talks to us about the importance of educating patients on what arthritis really is – moving away from the term “wear and tear” – and of taking a thorough history of a patient’s pain journey in consultations. He also gives practical advice on how we might approach non-pharmacological management of MSK pain with our patients. 


Our guest:

Imran Sajid is a GP with a special interest in MSK medicine. He is the clinical lead in MSK &amp; Diagnostics for NHS North West London, an adjunct lecturer in Health Policy  at the University of Global Health Equity, as well as being a qualified personal trainer.


Further reading:

‘Osteoarthritis: assessment and management, draft for consultation, April 2022’. NICE. 2022. https://www.nice.org.uk/guidance/gid-ng10127/documents/draft-guideline

‘The tear, flare, and repair model of osteoarthritis’. BMJ 2022;377:o1028. https://www.bmj.com/content/377/bmj.o1028</description>
      <enclosure length="50789145" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1343941012-bmjpodcasts-musculoskeletal-pain-and-osteoarthritis-with-imran-sajid.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1342525120</guid>
      <title>Doctor Informed - what to expect from an inquest</title>
      <pubDate>Mon, 12 Sep 2022 16:27:30 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/doctor-informed-what-to-expect-from-an-inquest</link>
      <itunes:duration>00:55:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In our new season of Doctor Important, we'll be discussing topics that are not always talked about, and today, by popular request of our listners, we're talking about Coroner's Court and inquests - two things that strike terror into doctors, but are often not as bad as you may fear.

Our panel;
Clara Munro is a surgical trainee in the North East Deanery.
She's joined by her colleage Katie Strong, another surgical trainee. We also have returning to Doctor Informed Ayisha Ashmore, an Obs and Gynae registrar in the East Midlands.

Our Expert guest this week is Beth Walker, a former palliative care registrar who now works as an advisor for Medical Protection.</itunes:summary>
      <itunes:subtitle>In our new season of Doctor Important, we'll be d…</itunes:subtitle>
      <description>In our new season of Doctor Important, we'll be discussing topics that are not always talked about, and today, by popular request of our listners, we're talking about Coroner's Court and inquests - two things that strike terror into doctors, but are often not as bad as you may fear.

Our panel;
Clara Munro is a surgical trainee in the North East Deanery.
She's joined by her colleage Katie Strong, another surgical trainee. We also have returning to Doctor Informed Ayisha Ashmore, an Obs and Gynae registrar in the East Midlands.

Our Expert guest this week is Beth Walker, a former palliative care registrar who now works as an advisor for Medical Protection.</description>
      <enclosure length="79938040" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1342525120-bmjpodcasts-doctor-informed-what-to-expect-from-an-inquest.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iv1zjTJkVfROtFcB-2RBqcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1342285408</guid>
      <title>Starting university</title>
      <pubDate>Mon, 12 Sep 2022 10:39:33 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/startinguniversity</link>
      <itunes:duration>00:46:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Starting university can be a really exciting and really nerve-wracking time. There are so many questions you might have before you start. How do you know what to pack? How do you make friends? How do you study? Is it really going to be the best time of your life?!

You might be just about to start university in the next week or two, or simply feel like indulging in the nostalgia of those first few weeks. Either way, join Sharp Scratch panel members new and old as we come together to discuss the sorts of things we were worried about or looking forward to before we started university. 


Check us out on social media:
Twitter: twitter.com/BMJStudent
Instagram: www.instagram.com/bmj_student/
Facebook: www.facebook.com/BMJStudent/


This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Starting university can be a really exciting and …</itunes:subtitle>
      <description>Starting university can be a really exciting and really nerve-wracking time. There are so many questions you might have before you start. How do you know what to pack? How do you make friends? How do you study? Is it really going to be the best time of your life?!

You might be just about to start university in the next week or two, or simply feel like indulging in the nostalgia of those first few weeks. Either way, join Sharp Scratch panel members new and old as we come together to discuss the sorts of things we were worried about or looking forward to before we started university. 


Check us out on social media:
Twitter: twitter.com/BMJStudent
Instagram: www.instagram.com/bmj_student/
Facebook: www.facebook.com/BMJStudent/


This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="44731662" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1342285408-bmjpodcasts-startinguniversity.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1305009310</guid>
      <title>Status epilepticus</title>
      <pubDate>Mon, 12 Sep 2022 08:30:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/status-ep</link>
      <itunes:duration>00:28:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Status epilepticus is a serious medical emergency. Fortunately, it is relatively rare but when it does occur it can cause a range of serious complications including focal neurological deficits, cognitive dysfunction, and behavioural problems. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast on status epilepticus, Kieran Walsh talks to Dr. Rajiv Mohanraj, Consultant Neurologist and Honorary Senior Lecturer at the Manchester Centre for Clinical Neurosciences

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Status epilepticus is a serious medical emergency…</itunes:subtitle>
      <description>Status epilepticus is a serious medical emergency. Fortunately, it is relatively rare but when it does occur it can cause a range of serious complications including focal neurological deficits, cognitive dysfunction, and behavioural problems. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast on status epilepticus, Kieran Walsh talks to Dr. Rajiv Mohanraj, Consultant Neurologist and Honorary Senior Lecturer at the Manchester Centre for Clinical Neurosciences

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="34290976" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1305009310-bmjpodcasts-status-ep.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1342431418</guid>
      <title>Gastroparesis Month with Richard McCallum</title>
      <pubDate>Mon, 12 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/gastroparesis-month-with-richard-mccallum</link>
      <itunes:duration>00:30:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this conversation with John Dickinson, MD, PhD, University of Nebraska Medical Center and Social Media Editor for Journal of Investigative Medicine, JIM editor, Dr. Richard McCallum, provides an overview of the incidence, symptoms, diagnosis and management of gastroparesis. This podcast is especially relevant for primary care physicians, gastroenterologists, and GI researchers. Gastroparesis is a common disorder frequently tied with diabetes but has vague symptoms that can be misdiagnosed. Dr. McCallum walks us through common diagnostic approaches and discusses promising new therapies to reduce the symptom burden.</itunes:summary>
      <itunes:subtitle>In this conversation with John Dickinson, MD, PhD…</itunes:subtitle>
      <description>In this conversation with John Dickinson, MD, PhD, University of Nebraska Medical Center and Social Media Editor for Journal of Investigative Medicine, JIM editor, Dr. Richard McCallum, provides an overview of the incidence, symptoms, diagnosis and management of gastroparesis. This podcast is especially relevant for primary care physicians, gastroenterologists, and GI researchers. Gastroparesis is a common disorder frequently tied with diabetes but has vague symptoms that can be misdiagnosed. Dr. McCallum walks us through common diagnostic approaches and discusses promising new therapies to reduce the symptom burden.</description>
      <enclosure length="29576962" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1342431418-bmjpodcasts-gastroparesis-month-with-richard-mccallum.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-jtXKAod92prTuYKW-AogISw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1340686810</guid>
      <title>ATHENA-MONO Trial with Bradley J. Monk</title>
      <pubDate>Mon, 12 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/athena-mono-trial-with-bradley-j-monk</link>
      <itunes:duration>00:43:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor Bradley J. Monk to discuss the ATHENA-MONO clinical trial. Prof. Monk is an international thought leader and clinical trialist who has developed and advocated for maintenance treatment in newly diagnosed advanced and recurrent ovarian cancer. ATHENA-MONO represents his fifth positive randomized phase 3 trial studying maintenance treatment and adds confidence to this efficacious and tolerable paradigm changing opportunity for all patients regardless of the molecular genotype (allcomers).

Highlights:
- Maintenance therapy is now the global standard of care in patients with advanced or recurrent epithelial ovarian cancer. This can include a PAPP inhibitor, bevacizumab, or the combination.
- Maintenance treatment is efficacious in all molecular subgroups and is tolerable without an impairment in the quality of life.
- Payers acknowledge the value of maintenance treatment as do consensus guidelines.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor Bradley J. Monk to discuss the ATHENA-MONO clinical trial. Prof. Monk is an international thought leader and clinical trialist who has developed and advocated for maintenance treatment in newly diagnosed advanced and recurrent ovarian cancer. ATHENA-MONO represents his fifth positive randomized phase 3 trial studying maintenance treatment and adds confidence to this efficacious and tolerable paradigm changing opportunity for all patients regardless of the molecular genotype (allcomers).

Highlights:
- Maintenance therapy is now the global standard of care in patients with advanced or recurrent epithelial ovarian cancer. This can include a PAPP inhibitor, bevacizumab, or the combination.
- Maintenance treatment is efficacious in all molecular subgroups and is tolerable without an impairment in the quality of life.
- Payers acknowledge the value of maintenance treatment as do consensus guidelines.</description>
      <enclosure length="41207725" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1340686810-bmjpodcasts-athena-mono-trial-with-bradley-j-monk.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1339871149</guid>
      <title>Management of Helicobacter pylori infection — the Maastricht VI/Florence Consensus Report</title>
      <pubDate>Fri, 09 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/maastricht-hpylori-consensus-report</link>
      <itunes:duration>00:12:41</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Peter Malfertheiner, Gastroenterologist, who is senior Professor of Medicine at the Ludwig Maximilian University of Munich, Munich, Germany, on the paper 'Management of Helicobacter pylori infection—the Maastricht VI/Florence Consensus Report' published in paper copy in Gut in September 2022 and online at: https://gut.bmj.com/content/71/9/1724
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Peter Malfertheiner, Gastroenterologist, who is senior Professor of Medicine at the Ludwig Maximilian University of Munich, Munich, Germany, on the paper 'Management of Helicobacter pylori infection—the Maastricht VI/Florence Consensus Report' published in paper copy in Gut in September 2022 and online at: https://gut.bmj.com/content/71/9/1724
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="12188942" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1339871149-bmjpodcasts-maastricht-hpylori-consensus-report.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1339299394</guid>
      <title>Nationwide rAVM discharge incidence is inversely correlated with uAVM intervention rate</title>
      <pubDate>Thu, 08 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/nationwide-ravm-discharge-incidence-is-inversely-correlated-with-uavm-intervention-rate</link>
      <itunes:duration>00:20:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The 2013 ARUBA trial concluded that medical management alone is superior to medical management with interventional therapy for patients with unruptured brain arteriovenous malformations. A study was conducted to analyze AVM treatment and epidemiologic response to the ARUBA trial. Following ARUBA, there has been a stark decrease in interventions for uAVMs. Nationwide rAVM discharge incidence is inversely correlated with uAVM intervention rate. Less uAVM interventions may lead to a substantial increase in AVM rupture incidence.
In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque speaks with Dr. Evan Luther(1) and Dr. Robert Starke(2) about their paper "Unruptured arteriovenous malformation intervention rate is inversely correlated with ruptured AVM discharge incidence" - https://jnis.bmj.com/content/12/suppl_1/a163. 
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!
This episode was produced by Leticia Amorim and edited by Brian O'Toole.
(1) Neurological Surgery, University of Miami, Miami, Florida, USA
(2) Department of Neurosurgery &amp; Radiology, Miller School of Medicine, University of Miami, Miami, Florida, USA</itunes:summary>
      <itunes:subtitle>The 2013 ARUBA trial concluded that medical manag…</itunes:subtitle>
      <description>The 2013 ARUBA trial concluded that medical management alone is superior to medical management with interventional therapy for patients with unruptured brain arteriovenous malformations. A study was conducted to analyze AVM treatment and epidemiologic response to the ARUBA trial. Following ARUBA, there has been a stark decrease in interventions for uAVMs. Nationwide rAVM discharge incidence is inversely correlated with uAVM intervention rate. Less uAVM interventions may lead to a substantial increase in AVM rupture incidence.
In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque speaks with Dr. Evan Luther(1) and Dr. Robert Starke(2) about their paper "Unruptured arteriovenous malformation intervention rate is inversely correlated with ruptured AVM discharge incidence" - https://jnis.bmj.com/content/12/suppl_1/a163. 
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!
This episode was produced by Leticia Amorim and edited by Brian O'Toole.
(1) Neurological Surgery, University of Miami, Miami, Florida, USA
(2) Department of Neurosurgery &amp; Radiology, Miller School of Medicine, University of Miami, Miami, Florida, USA</description>
      <enclosure length="20031528" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1339299394-bmjpodcasts-nationwide-ravm-discharge-incidence-is-inversely-correlated-with-uavm-intervention-rate.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1338655657</guid>
      <title>SLN Mapping in Endometrial Hyperplasia with Devon Abt</title>
      <pubDate>Tue, 06 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sln-mapping-in-endometrial-hyperplasia-with-devon-abt</link>
      <itunes:duration>00:28:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Devon Abt to discuss SLN mapping in endometrial hyperplasia. Devon is a fourth-year Resident in Obstetrics &amp; Gynecology at Beth Israel Deaconess Medical Center/Harvard Medical School currently applying into Gynecologic Oncology fellowship.
Highlights:
 - Fewer than 30% of patients with preoperative diagnosis of endometrial intraepithelial neoplasia had concurrent endometrial cancer on final pathology.
Endometrial stripe ≥20mm was associated with 2 times the risk of concurrent endometrial cancer.
 - Routine SLND in all patients with preoperative diagnosis of endometrial intraepithelial neoplasia is not cost-effective and would result in overtreatment.
 - Endometrial stripe may be a criterion for selectively using a sentinel lymph node algorithm in patients with preoperative diagnosis of endometrial intraepithelial neoplasia who are poor candidates for lymphadenectomy or at institutions where frozen section is not available or reliable.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Devon Abt to discuss SLN mapping in endometrial hyperplasia. Devon is a fourth-year Resident in Obstetrics &amp; Gynecology at Beth Israel Deaconess Medical Center/Harvard Medical School currently applying into Gynecologic Oncology fellowship.
Highlights:
 - Fewer than 30% of patients with preoperative diagnosis of endometrial intraepithelial neoplasia had concurrent endometrial cancer on final pathology.
Endometrial stripe ≥20mm was associated with 2 times the risk of concurrent endometrial cancer.
 - Routine SLND in all patients with preoperative diagnosis of endometrial intraepithelial neoplasia is not cost-effective and would result in overtreatment.
 - Endometrial stripe may be a criterion for selectively using a sentinel lymph node algorithm in patients with preoperative diagnosis of endometrial intraepithelial neoplasia who are poor candidates for lymphadenectomy or at institutions where frozen section is not available or reliable.</description>
      <enclosure length="27093367" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1338655657-bmjpodcasts-sln-mapping-in-endometrial-hyperplasia-with-devon-abt.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8sMw0i8ynG3AWhRS-Zx3ugg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1336205944</guid>
      <title>Bullying in UK cardiology: a systemic problem requiring systemic solutions</title>
      <pubDate>Tue, 06 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/bullying-in-uk-cardiology-a-systemic-problem-requiring-systemic-solutions</link>
      <itunes:duration>00:20:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by BJCA President Dr Fielder Camm from Oxford, UK. They discuss his recent publication in Heart concerning bullying of trainees in UK cardiology and what we can all do to improve things. 
If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by BJCA President Dr Fielder Camm from Oxford, UK. They discuss his recent publication in Heart concerning bullying of trainees in UK cardiology and what we can all do to improve things. 
If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2</description>
      <enclosure length="48417941" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1336205944-bmjpodcasts-bullying-in-uk-cardiology-a-systemic-problem-requiring-systemic-solutions.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1338199453</guid>
      <title>Series 1 wrap up</title>
      <pubDate>Mon, 05 Sep 2022 17:54:06 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/series-1-wrap-up</link>
      <itunes:duration>00:41:08</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This is our last episode of series 1 of Doctor Informed, and with it we're coming full circle. Clara will be talking to our first two guests, Mary Dixon-Woods and Bill Kirkup, having now heard from all of our other experts over this series. 

In this first series, we've learned about speaking out, team work, compassionate leadership  - all the things that are needed to help clinicians challenge the status quo,  So in this episode, we'll be asking Mary how much she thinks things have changed, and Bill how he manages a career challenging the healthcare system.

Our guests

Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

For links to the work that Mary talked about visit https://www.thisinstitute.cam.ac.uk/

Bill Kirkup is a clinician turned investigator - he led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel</itunes:summary>
      <itunes:subtitle>This is our last episode of series 1 of Doctor In…</itunes:subtitle>
      <description>This is our last episode of series 1 of Doctor Informed, and with it we're coming full circle. Clara will be talking to our first two guests, Mary Dixon-Woods and Bill Kirkup, having now heard from all of our other experts over this series. 

In this first series, we've learned about speaking out, team work, compassionate leadership  - all the things that are needed to help clinicians challenge the status quo,  So in this episode, we'll be asking Mary how much she thinks things have changed, and Bill how he manages a career challenging the healthcare system.

Our guests

Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

For links to the work that Mary talked about visit https://www.thisinstitute.cam.ac.uk/

Bill Kirkup is a clinician turned investigator - he led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel</description>
      <enclosure length="59177537" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1338199453-bmjpodcasts-series-1-wrap-up.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-LDABgfwgLaPwCB02-DIJolA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1336335646</guid>
      <title>Sweetness and pain - ADC's Archimedes September 2022</title>
      <pubDate>Fri, 02 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adc-archimedes-september-2022</link>
      <itunes:duration>00:10:26</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We want to make you think and consider in this podcast, so we’re wondering if you know if honey can be helpful after tonsillectomies - to reduce pain (https://adc.bmj.com/content/107/9/845.1). And when we are wondering about that, we might already be considering the challenges in assessing subjective outcomes (https://adc.bmj.com/content/107/9/845.2)… and beyond that, getting involved with your own 'Archi' [adc.bmj.com/pages/authors/#archimedes]
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>We want to make you think and consider in this po…</itunes:subtitle>
      <description>We want to make you think and consider in this podcast, so we’re wondering if you know if honey can be helpful after tonsillectomies - to reduce pain (https://adc.bmj.com/content/107/9/845.1). And when we are wondering about that, we might already be considering the challenges in assessing subjective outcomes (https://adc.bmj.com/content/107/9/845.2)… and beyond that, getting involved with your own 'Archi' [adc.bmj.com/pages/authors/#archimedes]
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="10029765" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1336335646-bmjpodcasts-adc-archimedes-september-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1336317916</guid>
      <title>Hip joint imaging findings in football players and their relevance in injury management EP#514</title>
      <pubDate>Fri, 02 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/hip-joint-imaging-findings-in-football-players-and-their-relevance-in-injury-management-ep514</link>
      <itunes:duration>00:18:40</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Joshua Heerey chats on this podcast to BJSM’s Dr. Liam West about hip joint imaging. Josh gives us a sneak peek into the findings from the “Femoroacetabular impingement &amp; hip OsteoathRitis Cohort (FORCe) study &amp; how they may help clinicians manage their patients with hip and groin pain. The podcast is heavily based around clinical scenarios that are commonly faced in the clinic or sports team settings. 

Dr Heerey is a physiotherapist and Hip Osteoarthritis Research and Development Lead at La Trobe University’s Sport and Exercise Medicine Research Centre in Melbourne, Australia. Dr Heerey obtained his PhD in 2021, with his research programme focusing on understanding the relationship between hip joint imaging findings and pain, and risk factors for development of early hip osteoarthritis in football players. He has published numerous articles examining the diagnosis and treatment of intra-articular hip conditions and is a current member of the International Hip-Related Pain Research Network and Young Athlete’s Hip Research Collaboration, which are multi-disciplinary international research teams created to improve the care of people living with hip and groin conditions. 
Dr Heerey works clinically at Lifecare Prahran Sports Medicine Clinic. He has a particular interest in the management of longstanding hip and groin conditions


Relevant links:
- Heerey et al. What is the prevalence of imaging-defined intra-articular hip pathologies in people with and without pain? A systematic review and meta-analysis. Br J Sports Med. 2018;52(9):581-93. http://dx.doi.org/10.1136/bjsports-2017-098264 
- Heerey et al. What is the prevalence of hip intra-articular pathologies and osteoarthritis in active athletes with hip and groin pain compared with those without? A systematic review and meta-analysis. Sports Med. 2019;49:951-972.  https://doi.org/10.1007/s40279-019-01092-y 
 - Heerey et al. Prevalence of early hip OA features in high- impact athletes. The femoroacetabular impingement and hip osteoarthritis cohort (FORCe) study. Osteoarthritis Cartilage. 2021; 29(3): 323-334. https://doi.org/10.1016/j.joca.2020.12.013 
- Heerey et al. The size and prevalence of bony hip morphology do not differ between football players with and without hip and/or groin pain: Findings from the FORCe cohort. J Orthop Sports Phys Ther. 2021; 51(3): 115-125. https://www.jospt.org/doi/10.2519/jospt.2021.9622 
- Heerey et al. Cam morphology is associated with MRI-defined cartilage defects and labral tears: a case–control study of 237 young adult football players with and without hip and groin pain. BMJ Open Sport &amp; Exercise Medicine 2021;7:e001199. http://dx.doi.org/10.1136/bmjsem-2021-001199</itunes:summary>
      <itunes:subtitle>Dr. Joshua Heerey chats on this podcast to BJSM’s…</itunes:subtitle>
      <description>Dr. Joshua Heerey chats on this podcast to BJSM’s Dr. Liam West about hip joint imaging. Josh gives us a sneak peek into the findings from the “Femoroacetabular impingement &amp; hip OsteoathRitis Cohort (FORCe) study &amp; how they may help clinicians manage their patients with hip and groin pain. The podcast is heavily based around clinical scenarios that are commonly faced in the clinic or sports team settings. 

Dr Heerey is a physiotherapist and Hip Osteoarthritis Research and Development Lead at La Trobe University’s Sport and Exercise Medicine Research Centre in Melbourne, Australia. Dr Heerey obtained his PhD in 2021, with his research programme focusing on understanding the relationship between hip joint imaging findings and pain, and risk factors for development of early hip osteoarthritis in football players. He has published numerous articles examining the diagnosis and treatment of intra-articular hip conditions and is a current member of the International Hip-Related Pain Research Network and Young Athlete’s Hip Research Collaboration, which are multi-disciplinary international research teams created to improve the care of people living with hip and groin conditions. 
Dr Heerey works clinically at Lifecare Prahran Sports Medicine Clinic. He has a particular interest in the management of longstanding hip and groin conditions


Relevant links:
- Heerey et al. What is the prevalence of imaging-defined intra-articular hip pathologies in people with and without pain? A systematic review and meta-analysis. Br J Sports Med. 2018;52(9):581-93. http://dx.doi.org/10.1136/bjsports-2017-098264 
- Heerey et al. What is the prevalence of hip intra-articular pathologies and osteoarthritis in active athletes with hip and groin pain compared with those without? A systematic review and meta-analysis. Sports Med. 2019;49:951-972.  https://doi.org/10.1007/s40279-019-01092-y 
 - Heerey et al. Prevalence of early hip OA features in high- impact athletes. The femoroacetabular impingement and hip osteoarthritis cohort (FORCe) study. Osteoarthritis Cartilage. 2021; 29(3): 323-334. https://doi.org/10.1016/j.joca.2020.12.013 
- Heerey et al. The size and prevalence of bony hip morphology do not differ between football players with and without hip and/or groin pain: Findings from the FORCe cohort. J Orthop Sports Phys Ther. 2021; 51(3): 115-125. https://www.jospt.org/doi/10.2519/jospt.2021.9622 
- Heerey et al. Cam morphology is associated with MRI-defined cartilage defects and labral tears: a case–control study of 237 young adult football players with and without hip and groin pain. BMJ Open Sport &amp; Exercise Medicine 2021;7:e001199. http://dx.doi.org/10.1136/bmjsem-2021-001199</description>
      <enclosure length="44832391" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1336317916-bmjpodcasts-hip-joint-imaging-findings-in-football-players-and-their-relevance-in-injury-management-ep514.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1334894095</guid>
      <title>Primary Survey - the highlights of August 2022</title>
      <pubDate>Fri, 02 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-august-2022</link>
      <itunes:duration>00:36:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Sarah Edwards, Social Media Editor of EMJ, and Rick Body, Deputy Editor of EMJ, take you through the best of the Emergency Medicine Journal in August 2022, covering topics from COVID-19 to triage to community Emergency Medicine to complications of emergency intubation in children and survival rates for out of hospital cardiac arrest.
Read the highlights: https://emj.bmj.com/content/39/8/567, and the complete issue: https://emj.bmj.com/content/39/8.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</itunes:summary>
      <itunes:subtitle>Sarah Edwards, Social Media Editor of EMJ, and Ri…</itunes:subtitle>
      <description>Sarah Edwards, Social Media Editor of EMJ, and Rick Body, Deputy Editor of EMJ, take you through the best of the Emergency Medicine Journal in August 2022, covering topics from COVID-19 to triage to community Emergency Medicine to complications of emergency intubation in children and survival rates for out of hospital cardiac arrest.
Read the highlights: https://emj.bmj.com/content/39/8/567, and the complete issue: https://emj.bmj.com/content/39/8.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</description>
      <enclosure length="35276590" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1334894095-bmjpodcasts-emj-august-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1334892631</guid>
      <title>Iron deficiency anaemia: pathophysiology, assessment, practical management</title>
      <pubDate>Fri, 02 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/iron-deficiency-anaemia-pathophysiology-assessment-practical-management</link>
      <itunes:duration>00:22:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This is the second in a new series of BMJ Open Gastroenterology interviews, in which we will be covering high-profile publications in conjunction with the lead authors of the papers. 
In this episode we are focusing on a paper entitled ‘Iron deficiency anaemia: pathophysiology, assessment, practical management’ published online in January 2022 (https://bmjopengastro.bmj.com/content/9/1/e000759). Dr James Ashton, Social Media Editor of BMJOG, interviews the authors Dr. Aditi Kumar(1) and Prof. Matthew Brookes(2). This paper is currently our most read article online and covers practical tips for diagnosis, management and additional investigations for this very common problem.
Related blog post: https://blogs.bmj.com/bmjopengastro/2022/01/25/a-cutting-edge-review-iron-deficiency-anaemia-pathophysiology-assessment-practical-management/
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.
(1) Gastroenterology trainee at The Royal Wolverhampton NHS Trust
(2) Consultant gastroenterologist and lead of gastroenterology clinical research program at Wolverhampton, Professor of gastroenterology at the University of Wolverhampton</itunes:summary>
      <itunes:subtitle>This is the second in a new series of BMJ Open Ga…</itunes:subtitle>
      <description>This is the second in a new series of BMJ Open Gastroenterology interviews, in which we will be covering high-profile publications in conjunction with the lead authors of the papers. 
In this episode we are focusing on a paper entitled ‘Iron deficiency anaemia: pathophysiology, assessment, practical management’ published online in January 2022 (https://bmjopengastro.bmj.com/content/9/1/e000759). Dr James Ashton, Social Media Editor of BMJOG, interviews the authors Dr. Aditi Kumar(1) and Prof. Matthew Brookes(2). This paper is currently our most read article online and covers practical tips for diagnosis, management and additional investigations for this very common problem.
Related blog post: https://blogs.bmj.com/bmjopengastro/2022/01/25/a-cutting-edge-review-iron-deficiency-anaemia-pathophysiology-assessment-practical-management/
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.
(1) Gastroenterology trainee at The Royal Wolverhampton NHS Trust
(2) Consultant gastroenterologist and lead of gastroenterology clinical research program at Wolverhampton, Professor of gastroenterology at the University of Wolverhampton</description>
      <enclosure length="21950797" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1334892631-bmjpodcasts-iron-deficiency-anaemia-pathophysiology-assessment-practical-management.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8Hpqx4SiPtynOzgC-7ijsKA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1335627082</guid>
      <title>Concerns about a colleague</title>
      <pubDate>Thu, 01 Sep 2022 13:40:12 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/concerns-about-a-colleague</link>
      <itunes:duration>00:42:15</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Medicine is a team sport. We work with multi-disciplinary teams to deliver patient care. However, there may be times when you will work with a colleague who worries you professionally. You may find it difficult to address this unprofessional behaviour, especially as a junior member of the team. In this episode, we’ll be talking about when this becomes enough to act and what you can do about it.

Expert guests:
Prof Charlotte Rees (@charlreessidhu on Twitter) is the Head of School of Health Sciences, College of Health, Medicine &amp; Wellbeing at the University of Newcastle, NSW, Australia.
Prof Lynn Monrouxe (@LynnMonrouxe on Twitter) is a Professor and Academic Lead of Health Professions Education Research at The University of Sydney.
They are the co-authors of the book, Healthcare Professionalism: Improving Practice through Reflections on Workplace Dilemmas.

Check us out on social media:
Twitter: twitter.com/BMJStudent
Instagram: www.instagram.com/bmj_student/
Facebook: www.facebook.com/BMJStudent/

Thank you to Louise Griffin, final year med student at the University of Birmingham and Clegg Scholar 2022, who proposed this idea to be a Sharp Scratch episode.

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Medicine is a team sport. We work with multi-disc…</itunes:subtitle>
      <description>Medicine is a team sport. We work with multi-disciplinary teams to deliver patient care. However, there may be times when you will work with a colleague who worries you professionally. You may find it difficult to address this unprofessional behaviour, especially as a junior member of the team. In this episode, we’ll be talking about when this becomes enough to act and what you can do about it.

Expert guests:
Prof Charlotte Rees (@charlreessidhu on Twitter) is the Head of School of Health Sciences, College of Health, Medicine &amp; Wellbeing at the University of Newcastle, NSW, Australia.
Prof Lynn Monrouxe (@LynnMonrouxe on Twitter) is a Professor and Academic Lead of Health Professions Education Research at The University of Sydney.
They are the co-authors of the book, Healthcare Professionalism: Improving Practice through Reflections on Workplace Dilemmas.

Check us out on social media:
Twitter: twitter.com/BMJStudent
Instagram: www.instagram.com/bmj_student/
Facebook: www.facebook.com/BMJStudent/

Thank you to Louise Griffin, final year med student at the University of Birmingham and Clegg Scholar 2022, who proposed this idea to be a Sharp Scratch episode.

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="40562432" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1335627082-bmjpodcasts-concerns-about-a-colleague.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1335114043</guid>
      <title>Professor David Hemenway: a public health career in "a brand new field", and five books</title>
      <pubDate>Thu, 01 Sep 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/injury-prevention-professor-david-hemenway</link>
      <itunes:duration>00:33:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>David Hemenway, PhD, is Professor of Health Policy, and the Director of the Harvard Injury Control Research Center.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>David Hemenway, PhD, is Professor of Health Polic…</itunes:subtitle>
      <description>David Hemenway, PhD, is Professor of Health Policy, and the Director of the Harvard Injury Control Research Center.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="32222980" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1335114043-bmjpodcasts-injury-prevention-professor-david-hemenway.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-lBNYPWMk19NnXlDd-TWVzcQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1298086903</guid>
      <title>New-onset atrial fibrillation</title>
      <pubDate>Mon, 29 Aug 2022 08:30:08 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/new-onset-atrial-fibrillation</link>
      <itunes:duration>00:25:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Atrial fibrillation is the most common sustained heart rhythm disorder in adults worldwide. The prevalence is between 2% and 4%. If left untreated, atrial fibrillation is a significant risk factor for stroke, myocardial infarction and congestive cardiac failure. So it is important that we get diagnosis and management of this condition right.  In this BMJ Best Practice podcast on new-onset atrial fibrillation, Kieran Walsh talks to Bharat Kantharia, Clinical Professor of Medicine, Icahn School of Medicine at Mount Sinai, New York.

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Atrial fibrillation is the most common sustained …</itunes:subtitle>
      <description>Atrial fibrillation is the most common sustained heart rhythm disorder in adults worldwide. The prevalence is between 2% and 4%. If left untreated, atrial fibrillation is a significant risk factor for stroke, myocardial infarction and congestive cardiac failure. So it is important that we get diagnosis and management of this condition right.  In this BMJ Best Practice podcast on new-onset atrial fibrillation, Kieran Walsh talks to Bharat Kantharia, Clinical Professor of Medicine, Icahn School of Medicine at Mount Sinai, New York.

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="30282016" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1298086903-bmjpodcasts-new-onset-atrial-fibrillation.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1321585708</guid>
      <title>Preventing anal cancer in people with HIV: learnings from the ANCHOR study</title>
      <pubDate>Mon, 29 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sti-anchor-study</link>
      <itunes:duration>00:20:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, we interview Professor Joel Palefsky about the ANCHOR study. Sexually Transmitted Infections' Editorial Fellow, Dr Ming Lee, speaks to the journal Editor in Chief, Professor Anna Maria Geretti, and Professor Palefsky, chief investigator of the randomised controlled trial, about the study which investigated treatment of anal high-grade squamous intraepithelial lesions (HSIL) to prevent progression to anal cancer. 
The study was stopped early following an interim analysis showing a clear benefit in reducing the risk of progression to anal cancer by 57 %, and the findings were recently published in the New England Journal of Medicine. Professor Palefsky also discusses how screening for anal cancer could be improved.
Related link about the ANCHOR study: https://www.nejm.org/doi/10.1056/NEJMoa2201048?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed</itunes:summary>
      <itunes:subtitle>In this podcast, we interview Professor Joel Pale…</itunes:subtitle>
      <description>In this podcast, we interview Professor Joel Palefsky about the ANCHOR study. Sexually Transmitted Infections' Editorial Fellow, Dr Ming Lee, speaks to the journal Editor in Chief, Professor Anna Maria Geretti, and Professor Palefsky, chief investigator of the randomised controlled trial, about the study which investigated treatment of anal high-grade squamous intraepithelial lesions (HSIL) to prevent progression to anal cancer. 
The study was stopped early following an interim analysis showing a clear benefit in reducing the risk of progression to anal cancer by 57 %, and the findings were recently published in the New England Journal of Medicine. Professor Palefsky also discusses how screening for anal cancer could be improved.
Related link about the ANCHOR study: https://www.nejm.org/doi/10.1056/NEJMoa2201048?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed</description>
      <enclosure length="20095058" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1321585708-bmjpodcasts-sti-anchor-study.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QsRTwnBAaqDmx3t3-PmDMzA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1322114251</guid>
      <title>IJGC EiC Summer Podcasts: Parp Inhibitors: Treatment and Adverse Events with Ainhoa Madariaga</title>
      <pubDate>Mon, 29 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ijgc-eic-summer-podcasts-parp-inhibitors-treatment-and-adverse-events-with-ainhoa-madariaga</link>
      <itunes:duration>00:25:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ainhoa Madariaga to discuss parp inhibitor treatments and adverse events. Dr. Madariaga's article "Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events" (ijgc.bmj.com/content/early/2020…8/ijgc-2020-001288), was the Lead Article in the July 2020 issue of IJGC. Dr. Madariaga is a medical oncologist working as a clinical research fellow in the gynecology and drug development program at Princess Margaret Cancer Centre. Her clinical and academic areas of interest are gynecologic cancers and early phase clinical trial design, such as development of drug-repurposing studies, cancer treatment adverse event and patient reported outcomes assessment.

Original release date: July 6, 2021</itunes:summary>
      <itunes:subtitle>In this rebroadcasted episode of the IJGC podcast…</itunes:subtitle>
      <description>In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ainhoa Madariaga to discuss parp inhibitor treatments and adverse events. Dr. Madariaga's article "Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events" (ijgc.bmj.com/content/early/2020…8/ijgc-2020-001288), was the Lead Article in the July 2020 issue of IJGC. Dr. Madariaga is a medical oncologist working as a clinical research fellow in the gynecology and drug development program at Princess Margaret Cancer Centre. Her clinical and academic areas of interest are gynecologic cancers and early phase clinical trial design, such as development of drug-repurposing studies, cancer treatment adverse event and patient reported outcomes assessment.

Original release date: July 6, 2021</description>
      <enclosure length="24077791" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1322114251-bmjpodcasts-ijgc-eic-summer-podcasts-parp-inhibitors-treatment-and-adverse-events-with-ainhoa-madariaga.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1329631858</guid>
      <title>Episode 6: Neuraxial &amp; General Anesthesia for TJA Show Similar Rates of Perioperative Complications</title>
      <pubDate>Mon, 29 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-6-neuraxial-general-anesthesia-for-tja-show-similar-rates-of-perioperative-complications</link>
      <itunes:duration>00:29:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The impact of the type of anesthesia on perioperative outcomes has been the subject of much debate. Observational data suggests that neuraxial anesthesia may provide benefits over general anesthesia, especially in the orthopedic population; however, it remains unclear if these benefits can be materialized in all subpopulations. In this month’s RAPM Focus, Executive Editor Stavros Memtsoudis, MD, PhD, interviews Edward Yap, MD, the first author of “Neuraxial and general anesthesia for outpatient total joint arthroplasty result in similarly low rates of major perioperative complications: a multicentered cohort study,” first published online in January 2022 (https://rapm.bmj.com/content/47/5/294). The study used introspective data from cases performed in 21 centers in the Kaiser Permanente Northern California system between 2017-2019, with the primary goal to compare perioperative outcomes between procedures performed with neuraxial anesthesia and general anesthesia.

Dr. Yap is a senior physician and anesthesiologist with the Kaiser Permanente South San Francisco Medical Group and a volunteer assistant professor with the University of California San Francisco.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</itunes:summary>
      <itunes:subtitle>The impact of the type of anesthesia on periopera…</itunes:subtitle>
      <description>The impact of the type of anesthesia on perioperative outcomes has been the subject of much debate. Observational data suggests that neuraxial anesthesia may provide benefits over general anesthesia, especially in the orthopedic population; however, it remains unclear if these benefits can be materialized in all subpopulations. In this month’s RAPM Focus, Executive Editor Stavros Memtsoudis, MD, PhD, interviews Edward Yap, MD, the first author of “Neuraxial and general anesthesia for outpatient total joint arthroplasty result in similarly low rates of major perioperative complications: a multicentered cohort study,” first published online in January 2022 (https://rapm.bmj.com/content/47/5/294). The study used introspective data from cases performed in 21 centers in the Kaiser Permanente Northern California system between 2017-2019, with the primary goal to compare perioperative outcomes between procedures performed with neuraxial anesthesia and general anesthesia.

Dr. Yap is a senior physician and anesthesiologist with the Kaiser Permanente South San Francisco Medical Group and a volunteer assistant professor with the University of California San Francisco.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</description>
      <enclosure length="70836572" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1329631858-bmjpodcasts-episode-6-neuraxial-general-anesthesia-for-tja-show-similar-rates-of-perioperative-complications.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zz7gWPu5CVbo7hEl-LPlCNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1330532464</guid>
      <title>Talk Evidence - a new way of understanding antidepressant effectiveness</title>
      <pubDate>Wed, 24 Aug 2022 17:44:03 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-a-new-way-of-understanding-antidepressant-effectiveness</link>
      <itunes:duration>00:42:18</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this week's episode, Joe Ross, professor of medicine at Yale, and The BMJ's US research editor, and Juan Franco, researcher at Heinrich-Heine-Universität and editor in chief of BMJ EBM are in the hot-seat.

They will discuss new research on the effectiveness of antidepressants - based on all the individual patient data submitted to the FDA between 1979 and now. 

We'll take a look at a study of industry sponsorship of cost effectiveness analysis, and seeing similar patters of publication bias to RCTs.

And finally we'll be talking about new research on the ongoing, and emergent pandemics - covid and monkeypox.

Reading listResponse to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis
https://www.bmj.com/content/378/bmj-2021-067606)
 
Using individual participant data to improve network meta-analysis projects
https://ebm.bmj.com/content/early/2022/08/10/bmjebm-2022-111931 
 
Industry sponsorship bias in cost effectiveness analysis: registry based analysis
https://www.bmj.com/content/377/bmj-2021-069573
 
Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak https://www.bmj.com/content/378/bmj-2022-072410
 
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada:
https://www.bmj.com/content/378/bmj-2022-071502</itunes:summary>
      <itunes:subtitle>In this week's episode, Joe Ross, professor of me…</itunes:subtitle>
      <description>In this week's episode, Joe Ross, professor of medicine at Yale, and The BMJ's US research editor, and Juan Franco, researcher at Heinrich-Heine-Universität and editor in chief of BMJ EBM are in the hot-seat.

They will discuss new research on the effectiveness of antidepressants - based on all the individual patient data submitted to the FDA between 1979 and now. 

We'll take a look at a study of industry sponsorship of cost effectiveness analysis, and seeing similar patters of publication bias to RCTs.

And finally we'll be talking about new research on the ongoing, and emergent pandemics - covid and monkeypox.

Reading listResponse to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis
https://www.bmj.com/content/378/bmj-2021-067606)
 
Using individual participant data to improve network meta-analysis projects
https://ebm.bmj.com/content/early/2022/08/10/bmjebm-2022-111931 
 
Industry sponsorship bias in cost effectiveness analysis: registry based analysis
https://www.bmj.com/content/377/bmj-2021-069573
 
Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak https://www.bmj.com/content/378/bmj-2022-072410
 
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada:
https://www.bmj.com/content/378/bmj-2022-071502</description>
      <enclosure length="40623541" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1330532464-bmjpodcasts-talk-evidence-a-new-way-of-understanding-antidepressant-effectiveness.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2yobq1Hjl6r87WmD-zdjn1Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1330432630</guid>
      <title>Retention with Pamela Curtis and GP trainees</title>
      <pubDate>Wed, 24 Aug 2022 14:19:51 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/retention-with-pamela-curtis-and-gp-trainees</link>
      <itunes:duration>00:38:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Despite the Conservation party manifesto for the 2019 general election promising to deliver 6,000 additional full-time equivalent GPs, worryingly, the NHS lost 717 FTE GPs between March 2019 and March 2022, and the Health and Social Care Committee’s July 2022 report on workforce was scathing about the Government’s failure to act decisively on the chronic staff shortages across healthcare in the UK. This week, we speak to more colleagues from the RCGP conference: first, we talk to Pamela Curtis about the challenges of returning to general practice after a break; secondly, we speak to a group of GP trainees about their innovative platform, The Big GP Consultation, and hear their thoughts on shaping the future of general practice.


Our guests:

Pamela Curtis is a salaried GP working at NHS Bristol, North Somerset and South Gloucestershire ICB.

Veena Aggarwal, Devina Maru, Liam Loftus and Rachel Weaver are all GP trainees, and are part of the team for The Big GP Consultation.

Further reading:

House of Commons Health and Social Care Committee. Workforce: recruitment, training and retention in health and social care. 2022. https://committees.parliament.uk/publications/23246/documents/169640/default/

The Big GP Consultation. https://thebiggpconsultation.co.uk/</itunes:summary>
      <itunes:subtitle>Despite the Conservation party manifesto for the …</itunes:subtitle>
      <description>Despite the Conservation party manifesto for the 2019 general election promising to deliver 6,000 additional full-time equivalent GPs, worryingly, the NHS lost 717 FTE GPs between March 2019 and March 2022, and the Health and Social Care Committee’s July 2022 report on workforce was scathing about the Government’s failure to act decisively on the chronic staff shortages across healthcare in the UK. This week, we speak to more colleagues from the RCGP conference: first, we talk to Pamela Curtis about the challenges of returning to general practice after a break; secondly, we speak to a group of GP trainees about their innovative platform, The Big GP Consultation, and hear their thoughts on shaping the future of general practice.


Our guests:

Pamela Curtis is a salaried GP working at NHS Bristol, North Somerset and South Gloucestershire ICB.

Veena Aggarwal, Devina Maru, Liam Loftus and Rachel Weaver are all GP trainees, and are part of the team for The Big GP Consultation.

Further reading:

House of Commons Health and Social Care Committee. Workforce: recruitment, training and retention in health and social care. 2022. https://committees.parliament.uk/publications/23246/documents/169640/default/

The Big GP Consultation. https://thebiggpconsultation.co.uk/</description>
      <enclosure length="36950516" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1330432630-bmjpodcasts-retention-with-pamela-curtis-and-gp-trainees.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1328540500</guid>
      <title>September 2022 - healthcare costs, gout, metformin and B12, more on COI and carbetocin</title>
      <pubDate>Wed, 24 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-september-2022</link>
      <itunes:duration>00:26:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September 2022 issue of DTB. They discuss a new national guideline on the management of gout (https://dtb.bmj.com/content/60/9/130). They highlight a safety update on the risk of vitamin B12 deficiency with metformin (https://dtb.bmj.com/content/60/9/131) and provide an overview of a study that analysed the way countries across Europe report payments made by pharmaceutical companies to healthcare professionals (https://dtb.bmj.com/content/60/9/135). They end the podcast with a discussion on the evidence for carbetocin in the prevention of postpartum haemorrhage (https://dtb.bmj.com/content/60/9/136). 
The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September 2022 issue of DTB. They discuss a new national guideline on the management of gout (https://dtb.bmj.com/content/60/9/130). They highlight a safety update on the risk of vitamin B12 deficiency with metformin (https://dtb.bmj.com/content/60/9/131) and provide an overview of a study that analysed the way countries across Europe report payments made by pharmaceutical companies to healthcare professionals (https://dtb.bmj.com/content/60/9/135). They end the podcast with a discussion on the evidence for carbetocin in the prevention of postpartum haemorrhage (https://dtb.bmj.com/content/60/9/136). 
The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="63585588" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1328540500-bmjpodcasts-dtb-september-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1322098237</guid>
      <title>IJGC EiC Summer Podcasts: ESGO-ESTRO-ESP Endometrial Cancer Guidelines with Nicole Concin</title>
      <pubDate>Mon, 22 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ijgc-eic-summer-podcasts-esgo-estro-esp-endometrial-cancer-guidelines-with-nicole-concin</link>
      <itunes:duration>00:43:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Nicole Concin to discuss the ESGO-ESTRO-ESP Endometrial Cancer Guidelines.

Original release date: January 4, 2021</itunes:summary>
      <itunes:subtitle>In this rebroadcasted episode of the IJGC podcast…</itunes:subtitle>
      <description>In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Nicole Concin to discuss the ESGO-ESTRO-ESP Endometrial Cancer Guidelines.

Original release date: January 4, 2021</description>
      <enclosure length="41693517" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1322098237-bmjpodcasts-ijgc-eic-summer-podcasts-esgo-estro-esp-endometrial-cancer-guidelines-with-nicole-concin.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1327235080</guid>
      <title>Primary Survey - the highlights of July 2022</title>
      <pubDate>Mon, 22 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/primary-survey-the-highlights-of-july-2022</link>
      <itunes:duration>00:42:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Sarah Edwards, Social Media Editor of EMJ, and Rick Body, Deputy Editor of EMJ, take you through the best of the Emergency Medicine Journal in July 2022. 
They cover some important topics including ED crowding, telephone triage, unrecognised endobroncheal intubation, acute coronary syndromes and pre-hospital trauma.
Read the highlights: https://emj.bmj.com/content/39/7/491
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</itunes:summary>
      <itunes:subtitle>Sarah Edwards, Social Media Editor of EMJ, and Ri…</itunes:subtitle>
      <description>Sarah Edwards, Social Media Editor of EMJ, and Rick Body, Deputy Editor of EMJ, take you through the best of the Emergency Medicine Journal in July 2022. 
They cover some important topics including ED crowding, telephone triage, unrecognised endobroncheal intubation, acute coronary syndromes and pre-hospital trauma.
Read the highlights: https://emj.bmj.com/content/39/7/491
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</description>
      <enclosure length="40845896" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1327235080-bmjpodcasts-primary-survey-the-highlights-of-july-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1326763207</guid>
      <title>Kyoto international consensus report on the gastro-oesophageal junction</title>
      <pubDate>Fri, 19 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/kyoto-international-consensus-report-on-the-gastro-oesophageal-junction</link>
      <itunes:duration>00:12:23</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Sugano, Department of Medicine, Jichi Medical University, Tochigi, Japan, about the paper 'Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction'. The article is published in paper copy in Gut in August 2022, and available online: https://gut.bmj.com/content/71/8/1488.
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Sugano, Department of Medicine, Jichi Medical University, Tochigi, Japan, about the paper 'Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction'. The article is published in paper copy in Gut in August 2022, and available online: https://gut.bmj.com/content/71/8/1488.
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="11903058" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1326763207-bmjpodcasts-kyoto-international-consensus-report-on-the-gastro-oesophageal-junction.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1323904552</guid>
      <title>Orthoses for Neurological Ankles</title>
      <pubDate>Thu, 18 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/orthoses-for-neurological-ankles</link>
      <itunes:duration>00:31:40</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Amy Ross Russell(1), interviews Dr. Stephen Kirker(2) about his recent paper detailing the use of appropriate orthoses for patients with weakness or abnormal posture of their lower leg, and they discuss the sorts of problems that can be helped in neurological practice and the range of devices commonly used.
Read the latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/4/311) and the August print issue of the journal.
The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-august-2022-issue
(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Rehab Medicine Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053).
The Practical Neurology podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</itunes:summary>
      <itunes:subtitle>Dr. Amy Ross Russell(1), interviews Dr. Stephen K…</itunes:subtitle>
      <description>Dr. Amy Ross Russell(1), interviews Dr. Stephen Kirker(2) about his recent paper detailing the use of appropriate orthoses for patients with weakness or abnormal posture of their lower leg, and they discuss the sorts of problems that can be helped in neurological practice and the range of devices commonly used.
Read the latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/4/311) and the August print issue of the journal.
The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-august-2022-issue
(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Rehab Medicine Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053).
The Practical Neurology podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</description>
      <enclosure length="30408201" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1323904552-bmjpodcasts-orthoses-for-neurological-ankles.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-M6LzgU5ITLVzC4tt-0v3b6Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1326524620</guid>
      <title>Atoms: the highlights from the ADC September 2022</title>
      <pubDate>Thu, 18 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-adc-september-2022</link>
      <itunes:duration>00:16:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the August 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/9/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the August 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/9/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="32444521" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1326524620-bmjpodcasts-atoms-adc-september-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1323003766</guid>
      <title>Body Talk: “Corporeal Pedagogies”</title>
      <pubDate>Thu, 18 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/body-talk-corporeal-pedagogies</link>
      <itunes:duration>00:27:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this month's podcast, Brandy Schillace talks to Dr Sally Waite and Dr Olivia Turner, of Newcastle University. They discuss "corporeal pedagogy", a form of learning and teaching that suspends conventional modes of Western education, particularly within a university setting, to facilitate embodied and haptic learning and production of knowledge.
A blog post containing the transcript of this podcast is available here: https://blogs.bmj.com/medical-humanities/2022/08/18/body-talk-corporeal-pedagogies-with-dr-sally-waite-and-dr-olivia-turner. 
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>In this month's podcast, Brandy Schillace talks t…</itunes:subtitle>
      <description>In this month's podcast, Brandy Schillace talks to Dr Sally Waite and Dr Olivia Turner, of Newcastle University. They discuss "corporeal pedagogy", a form of learning and teaching that suspends conventional modes of Western education, particularly within a university setting, to facilitate embodied and haptic learning and production of knowledge.
A blog post containing the transcript of this podcast is available here: https://blogs.bmj.com/medical-humanities/2022/08/18/body-talk-corporeal-pedagogies-with-dr-sally-waite-and-dr-olivia-turner. 
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="53158173" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1323003766-bmjpodcasts-body-talk-corporeal-pedagogies.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-35rzDteJIBP6iGmy-ch0M3g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1325159881</guid>
      <title>Mark Beattie's UpFront August 2022: Moving forward post-pandemic - BSG Live 2022</title>
      <pubDate>Tue, 16 Aug 2022 14:03:26 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mark-beatties-upfront-august-2022-moving-forward-post-pandemic-bsg-live-2022</link>
      <itunes:duration>00:14:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Please listen to and enjoy the Editor-in-Chief Mark Beattie's highlights from the special edition of Frontline Gastroenterology put together to celebrate BSG Live 2022, with the overarching theme "Moving forward post-pandemic". The content reflects the breadth and strength of our specialty with first-class reviews written by speakers from and linked to content at the meeting.
Read the UpFront of the August 2022 issue of Frontline Gastroenterology: https://fg.bmj.com/content/13/e1/e1
The full issue is now online: https://fg.bmj.com/content/13/e1
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</itunes:summary>
      <itunes:subtitle>Please listen to and enjoy the Editor-in-Chief Ma…</itunes:subtitle>
      <description>Please listen to and enjoy the Editor-in-Chief Mark Beattie's highlights from the special edition of Frontline Gastroenterology put together to celebrate BSG Live 2022, with the overarching theme "Moving forward post-pandemic". The content reflects the breadth and strength of our specialty with first-class reviews written by speakers from and linked to content at the meeting.
Read the UpFront of the August 2022 issue of Frontline Gastroenterology: https://fg.bmj.com/content/13/e1/e1
The full issue is now online: https://fg.bmj.com/content/13/e1
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</description>
      <enclosure length="13505514" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1325159881-bmjpodcasts-mark-beatties-upfront-august-2022-moving-forward-post-pandemic-bsg-live-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-o1BkZCOWh4Cf1N4Z-IOMxDQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1300215751</guid>
      <title>Acute pancreatitis</title>
      <pubDate>Mon, 15 Aug 2022 08:30:06 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/acute-pancreatitis</link>
      <itunes:duration>00:19:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Acute pancreatitis: an update on diagnosis and management 
Acute pancreatitis is a common and serious condition. The incidence of acute pancreatitis in the UK is about 50 per 100,000 per year. And it can cause a range of complications including acute renal failure, pancreatic abscess and of course chronic pancreatitis. So it is important that we get diagnosis and management of this condition right. In this BMJ Best Practice podcast on acute pancreatitis, Kieran Walsh talks to 

Professor Scott Tenner, Clinical Professor of Medicine, State University of New York.  ST is an author of references cited in the BMJ Best Practice topic on acute pancreatitis. He declares that he has no other competing interests. 

BMJ Relevant topic link - https://bestpractice.bmj.com/topics/en-gb/3000118

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Acute pancreatitis: an update on diagnosis and ma…</itunes:subtitle>
      <description>Acute pancreatitis: an update on diagnosis and management 
Acute pancreatitis is a common and serious condition. The incidence of acute pancreatitis in the UK is about 50 per 100,000 per year. And it can cause a range of complications including acute renal failure, pancreatic abscess and of course chronic pancreatitis. So it is important that we get diagnosis and management of this condition right. In this BMJ Best Practice podcast on acute pancreatitis, Kieran Walsh talks to 

Professor Scott Tenner, Clinical Professor of Medicine, State University of New York.  ST is an author of references cited in the BMJ Best Practice topic on acute pancreatitis. He declares that he has no other competing interests. 

BMJ Relevant topic link - https://bestpractice.bmj.com/topics/en-gb/3000118

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="23490976" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1300215751-bmjpodcasts-acute-pancreatitis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1322091382</guid>
      <title>IJGC EiC Summer Podcasts: Updates on Role of HIPEC in Ovarian Cancer with Oliver Zivanovic</title>
      <pubDate>Mon, 15 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ijgc-eic-summer-podcasts-updates-on-role-of-hipec-in-ovarian-cancer-with-oliver-zivanovic</link>
      <itunes:duration>00:47:39</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Oliver Zivanovic to discuss updates on role of HIPEC in ovarian cancer. Dr. Zivanovic is a Gynecologic Cancer Surgeon at Memorial Sloan Kettering Cancer Center, with the goal to advance the early detection and treatment of women with gynecologic cancers. His special interests include the treatment of patients with advanced stage ovarian cancer and electronic patient-reported symptom monitoring after cancer surgery.

Original release date: August 30, 2021</itunes:summary>
      <itunes:subtitle>In this rebroadcasted episode of the IJGC podcast…</itunes:subtitle>
      <description>In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Oliver Zivanovic to discuss updates on role of HIPEC in ovarian cancer. Dr. Zivanovic is a Gynecologic Cancer Surgeon at Memorial Sloan Kettering Cancer Center, with the goal to advance the early detection and treatment of women with gynecologic cancers. His special interests include the treatment of patients with advanced stage ovarian cancer and electronic patient-reported symptom monitoring after cancer surgery.

Original release date: August 30, 2021</description>
      <enclosure length="45748139" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1322091382-bmjpodcasts-ijgc-eic-summer-podcasts-updates-on-role-of-hipec-in-ovarian-cancer-with-oliver-zivanovic.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1322837650</guid>
      <title>Publication to the pitch – we all have a role. Professor Benita Olivier. EP# 513</title>
      <pubDate>Fri, 12 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/publication-to-the-pitch-we-all-have-a-role-professor-benita-olivier-ep-513</link>
      <itunes:duration>00:25:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast we host Professor Benita Olivier (Twitter @BenitaOlivier). Benita is a lecturer in musculoskeletal physiotherapy at the University of the Witwatersrand and is the Director of the Wits Cricket Research Hub. Benita provides great practical tips for clinicians and researchers to create time and increase access to evidence-based information to bridge the gap between publication and the pitch. We also discuss some of the emerging research in African athletes, and what we can learn from Kenyan endurance runners.  
  
Wits Cricket Research Hub https://www.youtube.com/channel/UCIenu_8XdRB7ttG3lGMLcMw 
Facebook: @witscricketresearchhub https://www.facebook.com/witscricketresearchhub 
Instagram: @witscricketresearchhub https://www.instagram.com/witscricketresearchhub/ 
Twitter: @WitsCricketRH https://twitter.com/WitsCricketRH 
LinkedIn: WITS Cricket Research Hub https://www.linkedin.com/company/wits-cricket-research-hub/ 
   
Knowledge and adherence towards evidence-based sports Physiotherapy standards among physiotherapists in Kenya https://www.ijmhr.org/IntJPhysiotherRes/IJPR.2020.171 
  
A prevalence of running-related injuries among professional endurance runners in the Rift Valley, Kenya https://journals.assaf.org.za/index.php/sajsm/article/view/10690 
  
Musculoskeletal predictors of non-contact injury in cricketers e Few and far between? A longitudinal cohort study https://linkinghub.elsevier.com/retrieve/pii/S1466853X1830021X</itunes:summary>
      <itunes:subtitle>In this podcast we host Professor Benita Olivier …</itunes:subtitle>
      <description>In this podcast we host Professor Benita Olivier (Twitter @BenitaOlivier). Benita is a lecturer in musculoskeletal physiotherapy at the University of the Witwatersrand and is the Director of the Wits Cricket Research Hub. Benita provides great practical tips for clinicians and researchers to create time and increase access to evidence-based information to bridge the gap between publication and the pitch. We also discuss some of the emerging research in African athletes, and what we can learn from Kenyan endurance runners.  
  
Wits Cricket Research Hub https://www.youtube.com/channel/UCIenu_8XdRB7ttG3lGMLcMw 
Facebook: @witscricketresearchhub https://www.facebook.com/witscricketresearchhub 
Instagram: @witscricketresearchhub https://www.instagram.com/witscricketresearchhub/ 
Twitter: @WitsCricketRH https://twitter.com/WitsCricketRH 
LinkedIn: WITS Cricket Research Hub https://www.linkedin.com/company/wits-cricket-research-hub/ 
   
Knowledge and adherence towards evidence-based sports Physiotherapy standards among physiotherapists in Kenya https://www.ijmhr.org/IntJPhysiotherRes/IJPR.2020.171 
  
A prevalence of running-related injuries among professional endurance runners in the Rift Valley, Kenya https://journals.assaf.org.za/index.php/sajsm/article/view/10690 
  
Musculoskeletal predictors of non-contact injury in cricketers e Few and far between? A longitudinal cohort study https://linkinghub.elsevier.com/retrieve/pii/S1466853X1830021X</description>
      <enclosure length="62111868" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1322837650-bmjpodcasts-publication-to-the-pitch-we-all-have-a-role-professor-benita-olivier-ep-513.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1320849517</guid>
      <title>Rotating shift patterns putting safe care delivery at risk</title>
      <pubDate>Wed, 10 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/rotating-shift-patterns-safe-care-delivery-at-risk</link>
      <itunes:duration>00:12:45</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In today's podcast, we discuss the results of an observational study that showed
reduced alertness during working hours among eight-hour rotating-shift nurses.
Evidence-Based Nursing Associate Editor, Kerry Gaskin, interviews Vittoria Sorice and Emma Russell, both from Chesterfield Royal Hospital NHS Foundation Trust, UK.
Their paper is available on the EBN website (https://ebn.bmj.com/content/early/2022/04/06/ebnurs-2022-103518)and is a commentary on: Min A, Hong HC, Son S, et al, Alertness during working hours among eight-hour rotating-shift nurses: an observational study. J Nurs Scholar 2021;75. doi:10.1111/JNU.12743
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In today's podcast, we discuss the results of an …</itunes:subtitle>
      <description>In today's podcast, we discuss the results of an observational study that showed
reduced alertness during working hours among eight-hour rotating-shift nurses.
Evidence-Based Nursing Associate Editor, Kerry Gaskin, interviews Vittoria Sorice and Emma Russell, both from Chesterfield Royal Hospital NHS Foundation Trust, UK.
Their paper is available on the EBN website (https://ebn.bmj.com/content/early/2022/04/06/ebnurs-2022-103518)and is a commentary on: Min A, Hong HC, Son S, et al, Alertness during working hours among eight-hour rotating-shift nurses: an observational study. J Nurs Scholar 2021;75. doi:10.1111/JNU.12743
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.</description>
      <enclosure length="12241605" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1320849517-bmjpodcasts-rotating-shift-patterns-safe-care-delivery-at-risk.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XWHwP663TNF7c5jR-ys6wWw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1320617917</guid>
      <title>Reflecting on a crisis</title>
      <pubDate>Tue, 09 Aug 2022 09:52:09 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reflecting-on-a-crisis</link>
      <itunes:duration>00:53:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Previous Doctor Informed episodes have discussed how to prevent patient safety issues from occurring, but sometimes situations are beyond anyone's control - like COVID.

It can be hard to look back, especially if difficult decisions and compromises were made, including ones we did not completely agree with, or if there could be criticism of the way we responded. We ask how individual doctors, teams, and organisations could respond to and recover from major problems?

In this episode, we're joined by Annelieke Driessen, a THIS Institute fellow and medical anthropologist. She is a research fellow at the University of Oxford and honorary assistant professor in medical anthropology at the London School of Hygiene and Tropical Medicine, who has spent hours listening to and understanding patient experiences of ICU during the pandemic. We'll also hear from Dominque Allwood, Chief Medical Officer at UCL Partners, and Director of Population Health at Imperial College Healthcare NHS Trust, who focuses on creating positive change in healthcare.

 
The research Annelieke Driessen discussed, and the full versions of the patient interviews that are included in the podcast are available at https://healthtalk.org/Experiences-of-Covid-19-and-Intensive-Care/overview</itunes:summary>
      <itunes:subtitle>Previous Doctor Informed episodes have discussed …</itunes:subtitle>
      <description>Previous Doctor Informed episodes have discussed how to prevent patient safety issues from occurring, but sometimes situations are beyond anyone's control - like COVID.

It can be hard to look back, especially if difficult decisions and compromises were made, including ones we did not completely agree with, or if there could be criticism of the way we responded. We ask how individual doctors, teams, and organisations could respond to and recover from major problems?

In this episode, we're joined by Annelieke Driessen, a THIS Institute fellow and medical anthropologist. She is a research fellow at the University of Oxford and honorary assistant professor in medical anthropology at the London School of Hygiene and Tropical Medicine, who has spent hours listening to and understanding patient experiences of ICU during the pandemic. We'll also hear from Dominque Allwood, Chief Medical Officer at UCL Partners, and Director of Population Health at Imperial College Healthcare NHS Trust, who focuses on creating positive change in healthcare.

 
The research Annelieke Driessen discussed, and the full versions of the patient interviews that are included in the podcast are available at https://healthtalk.org/Experiences-of-Covid-19-and-Intensive-Care/overview</description>
      <enclosure length="51715342" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1320617917-bmjpodcasts-reflecting-on-a-crisis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-LDABgfwgLaPwCB02-DIJolA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1316486593</guid>
      <title>IJGC EiC Summer Podcasts: ConCerv Trial with Kathleen Schmeler</title>
      <pubDate>Mon, 08 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ijgc-editor-in-chief-summer-podcasts-concerv-trial-with-kathleen-schmeler</link>
      <itunes:duration>00:48:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Kathleen Schmeler to discuss the ConCerv Trial. Dr. Schmeler is the lead author of “ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer,” which was the Lead Article of IJGC’s October 2021 issue. Dr. Schmeler is a Professor in Gynecologic Oncology at The University of Texas MD Anderson Cancer Center. She provides care to women with gynecologic malignancies including surgery, chemotherapy and preventive services. Dr. Schmeler is also the Executive Director of Global Oncology for the MD Anderson Cancer Network. Her research interest is in cervical cancer prevention and treatment, particularly for resource-constrained countries and medically underserved communities in the US.

Original release date: October 4, 2021

Highlights:
- The ConCerv trial is the first prospective study of conservative surgery in women with low-risk cervical cancer. It included 14 sites in 9 countries.
- Findings from the ConCerv Trial offer prospective data supporting a more conservative approach to low-risk patients, sparing them the early and late morbidity associated with radical procedures.
- It will also allow for safer cervical cancer surgery in low- and middle-income countries, where the burden of cervical cancer is highest.
- In our study, conservative surgery was associated with a 3.5% recurrence rate in women with low-risk cervical cancer. In addition, the rate of positive lymph nodes was 5%, with lymph node assessment recommended in this low-risk population.
- Further study is needed to determine long term outcomes and optimal pathologic criteria for conservative surgery.</itunes:summary>
      <itunes:subtitle>In this rebroadcasted episode of the IJGC podcast…</itunes:subtitle>
      <description>In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Kathleen Schmeler to discuss the ConCerv Trial. Dr. Schmeler is the lead author of “ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer,” which was the Lead Article of IJGC’s October 2021 issue. Dr. Schmeler is a Professor in Gynecologic Oncology at The University of Texas MD Anderson Cancer Center. She provides care to women with gynecologic malignancies including surgery, chemotherapy and preventive services. Dr. Schmeler is also the Executive Director of Global Oncology for the MD Anderson Cancer Network. Her research interest is in cervical cancer prevention and treatment, particularly for resource-constrained countries and medically underserved communities in the US.

Original release date: October 4, 2021

Highlights:
- The ConCerv trial is the first prospective study of conservative surgery in women with low-risk cervical cancer. It included 14 sites in 9 countries.
- Findings from the ConCerv Trial offer prospective data supporting a more conservative approach to low-risk patients, sparing them the early and late morbidity associated with radical procedures.
- It will also allow for safer cervical cancer surgery in low- and middle-income countries, where the burden of cervical cancer is highest.
- In our study, conservative surgery was associated with a 3.5% recurrence rate in women with low-risk cervical cancer. In addition, the rate of positive lymph nodes was 5%, with lymph node assessment recommended in this low-risk population.
- Further study is needed to determine long term outcomes and optimal pathologic criteria for conservative surgery.</description>
      <enclosure length="46146872" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1316486593-bmjpodcasts-ijgc-editor-in-chief-summer-podcasts-concerv-trial-with-kathleen-schmeler.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1318429033</guid>
      <title>Exercise for Post-Menopausal Women with Dr. NiCole Keith. EP#512</title>
      <pubDate>Fri, 05 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/exercise-for-post-menopausal-women-with-dr-nicole-keith-ep512</link>
      <itunes:duration>00:19:11</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Jacob Wessels, MD is joined by sports medicine researcher and past president of the American College of Sports Medicine, Dr. NiCole Keith, PhD to discuss the topic of Exercise for Post-Menopausal Women.
 
Dr. NiCole Keith (T: @nicolekeithphd) is a Professor from the Department of Kinesiology and associate dean of faculty affairs in the School of Health &amp; Human Sciences at Indiana University-Purdue University Indianapolis. Her research interests include physical activity and health equity. In addition to serving as the current president of the ACSM she has previously served as the vice president of membership, communication, and policy and serves on both the Exercise is Medicine and American Fitness Index advisory boards.
 
In this 20 -minute conversation Dr. Keith addresses the following topics:
·        Discussing the different stages of menopause and the importance of physical activity during these stages 
·        Creating effective exercise prescriptions, including the best physical activity recommendations and strategies
·        The best types of exercises for post-menopausal women and several alternatives, based on potential health and risk factors
·        Addressing health disparities between genders and communities, and making sure individuals can safely engage in physical activity</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM Sports Medcast (T: @…</itunes:subtitle>
      <description>On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Jacob Wessels, MD is joined by sports medicine researcher and past president of the American College of Sports Medicine, Dr. NiCole Keith, PhD to discuss the topic of Exercise for Post-Menopausal Women.
 
Dr. NiCole Keith (T: @nicolekeithphd) is a Professor from the Department of Kinesiology and associate dean of faculty affairs in the School of Health &amp; Human Sciences at Indiana University-Purdue University Indianapolis. Her research interests include physical activity and health equity. In addition to serving as the current president of the ACSM she has previously served as the vice president of membership, communication, and policy and serves on both the Exercise is Medicine and American Fitness Index advisory boards.
 
In this 20 -minute conversation Dr. Keith addresses the following topics:
·        Discussing the different stages of menopause and the importance of physical activity during these stages 
·        Creating effective exercise prescriptions, including the best physical activity recommendations and strategies
·        The best types of exercises for post-menopausal women and several alternatives, based on potential health and risk factors
·        Addressing health disparities between genders and communities, and making sure individuals can safely engage in physical activity</description>
      <enclosure length="12027121" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1318429033-bmjpodcasts-exercise-for-post-menopausal-women-with-dr-nicole-keith-ep512.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1312728334</guid>
      <title>Epidemiology of paediatric injuries in Nepal: evidence from emergency departments</title>
      <pubDate>Thu, 04 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/epidemiology-of-paediatric-injuries-in-nepal-evidence-from-emergency-department-injury-surveillance</link>
      <itunes:duration>00:28:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month, Dr. Rachel Agbeko, Senior Editor of ADC, is joined by Prof. Julie Mytton(1) and Prof. Sunil Joshi(2) to discuss their new model of injury surveillance in Nepalese emergency departments, the trends in injuries affecting children, and the implications of these.
Read the paper 'Epidemiology of paediatric injuries in Nepal: evidence from emergency department injury surveillance' on the ADC website -
https://adc.bmj.com/content/106/11/1050.
The ADC Spotlight podcast is the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. This series is produced by Letícia Amorim and edited by Brian O'Toole.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

(1) Professor of Public Health at University of the West of England, Bristol, UK
(2)Professor at Dep. Community Medicine, Director of Nepal Injury Research Centre, Nepal</itunes:summary>
      <itunes:subtitle>This month, Dr. Rachel Agbeko, Senior Editor of A…</itunes:subtitle>
      <description>This month, Dr. Rachel Agbeko, Senior Editor of ADC, is joined by Prof. Julie Mytton(1) and Prof. Sunil Joshi(2) to discuss their new model of injury surveillance in Nepalese emergency departments, the trends in injuries affecting children, and the implications of these.
Read the paper 'Epidemiology of paediatric injuries in Nepal: evidence from emergency department injury surveillance' on the ADC website -
https://adc.bmj.com/content/106/11/1050.
The ADC Spotlight podcast is the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. This series is produced by Letícia Amorim and edited by Brian O'Toole.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

(1) Professor of Public Health at University of the West of England, Bristol, UK
(2)Professor at Dep. Community Medicine, Director of Nepal Injury Research Centre, Nepal</description>
      <enclosure length="27788433" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1312728334-bmjpodcasts-epidemiology-of-paediatric-injuries-in-nepal-evidence-from-emergency-department-injury-surveillance.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-MRWRroZ1Uz3oKq7p-pEKt2w-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1316606299</guid>
      <title>Research at the interface, with Professor Flaura Winston, paediatrician</title>
      <pubDate>Thu, 04 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/research-at-the-interface-with-paediatrician-professor-flora-winston</link>
      <itunes:duration>00:33:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month, we explore the career of Professor Flaura Winston, Scientific Director of the Center for Injury Research and Prevention at Children's Hospital of Philadelphia, and Distinguished Chair in the Department of Pediatrics.
Dr Winston is a board-certified pediatrician, a doctorally-trained engineer, and a public health researcher, who conducts research at the interface of child and adolescent health, injury, engineering, and behavioral science.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>This month, we explore the career of Professor Fl…</itunes:subtitle>
      <description>This month, we explore the career of Professor Flaura Winston, Scientific Director of the Center for Injury Research and Prevention at Children's Hospital of Philadelphia, and Distinguished Chair in the Department of Pediatrics.
Dr Winston is a board-certified pediatrician, a doctorally-trained engineer, and a public health researcher, who conducts research at the interface of child and adolescent health, injury, engineering, and behavioral science.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="32216292" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1316606299-bmjpodcasts-research-at-the-interface-with-paediatrician-professor-flora-winston.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-97PYlC3idubTCbxz-1rv9FQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1316356006</guid>
      <title>Mesenchymal stromal cells: a potential new SLE treatment option?</title>
      <pubDate>Wed, 03 Aug 2022 05:00:22 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mesenchymal-stromal-cells-a-potential-new-sle-treatment-option</link>
      <itunes:duration>00:17:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Duane Peters from the Lupus Foundation of America interviews Dr Gary Gilkeson from the Medical University of South Carolina about a phase I trial into the use of mesenchymal stromal cells (MSC) in refractory lupus patients in the USA, following impressive results of clinical improvement resulting from this therapy in China. 
The trial indicated that infusions of MSCs derived from the umbilical cord are safe and may be effective in treating mild to moderate systemic lupus erythematosus, with minimal adverse effects. 
Access the article: http://dx.doi.org/10.1136/lupus-2022-000704</itunes:summary>
      <itunes:subtitle>Duane Peters from the Lupus Foundation of America…</itunes:subtitle>
      <description>Duane Peters from the Lupus Foundation of America interviews Dr Gary Gilkeson from the Medical University of South Carolina about a phase I trial into the use of mesenchymal stromal cells (MSC) in refractory lupus patients in the USA, following impressive results of clinical improvement resulting from this therapy in China. 
The trial indicated that infusions of MSCs derived from the umbilical cord are safe and may be effective in treating mild to moderate systemic lupus erythematosus, with minimal adverse effects. 
Access the article: http://dx.doi.org/10.1136/lupus-2022-000704</description>
      <enclosure length="15501079" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1316356006-bmjpodcasts-mesenchymal-stromal-cells-a-potential-new-sle-treatment-option.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-nYLdZcs1mGbveYvA-nRXRyQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1317184630</guid>
      <title>Mark Beattie's UpFront July 2022</title>
      <pubDate>Wed, 03 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/fg-upfront-july-2022</link>
      <itunes:duration>00:09:45</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The highlights of this edition brought to you by the Editor-in-Chief of Frontline Gastroenterology Mark Beattie.
Read the UpFront of the July 2022 issue of Frontline Gastroenterology: https://fg.bmj.com/content/13/4/271
The full issue is now online: https://fg.bmj.com/content/13/4
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</itunes:summary>
      <itunes:subtitle>The highlights of this edition brought to you by …</itunes:subtitle>
      <description>The highlights of this edition brought to you by the Editor-in-Chief of Frontline Gastroenterology Mark Beattie.
Read the UpFront of the July 2022 issue of Frontline Gastroenterology: https://fg.bmj.com/content/13/4/271
The full issue is now online: https://fg.bmj.com/content/13/4
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</description>
      <enclosure length="9365210" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1317184630-bmjpodcasts-fg-upfront-july-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-TluQJ5qhs1L1WwdB-PBLAjg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1315640518</guid>
      <title>Continuity with Martin Marshall and Emma Gladwinfield</title>
      <pubDate>Mon, 01 Aug 2022 09:27:57 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/continuity-with-martin-marshall-and-emma-gladwinfield</link>
      <itunes:duration>00:44:12</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this week’s episode, we share our experiences of attending the recent RCGP Annual Conference, and our thoughts on the topics that were covered in the talks at this year’s event. We talk to RCGP Chair, Martin Marshall, about continuity of care, which he states is one of the defining features of general practice. Evidence has shown that continuity of care is associated with better health outcomes for patients, but how can doctors convince politicians and policymakers of the benefits of it? We also speak to Emma Gladwinfield, a GP in Rossendale, about how connecting with schools, churches and community centres is helping to build relationships with patients and deliver care in her local community.


Our guests: 

Martin Marshall is the Chair of the RCGP, a GP in Newham, East London, and Professor of Healthcare Improvement at UCL.

Emma Gladwinfield is a GP in Rossendale, East Lancashire.


Further reading:

‘Tackling the crisis in primary care’. doi:10.1136/bmj.o1485. https://www.bmj.com/content/377/bmj.o1485</itunes:summary>
      <itunes:subtitle>In this week’s episode, we share our experiences …</itunes:subtitle>
      <description>In this week’s episode, we share our experiences of attending the recent RCGP Annual Conference, and our thoughts on the topics that were covered in the talks at this year’s event. We talk to RCGP Chair, Martin Marshall, about continuity of care, which he states is one of the defining features of general practice. Evidence has shown that continuity of care is associated with better health outcomes for patients, but how can doctors convince politicians and policymakers of the benefits of it? We also speak to Emma Gladwinfield, a GP in Rossendale, about how connecting with schools, churches and community centres is helping to build relationships with patients and deliver care in her local community.


Our guests: 

Martin Marshall is the Chair of the RCGP, a GP in Newham, East London, and Professor of Healthcare Improvement at UCL.

Emma Gladwinfield is a GP in Rossendale, East Lancashire.


Further reading:

‘Tackling the crisis in primary care’. doi:10.1136/bmj.o1485. https://www.bmj.com/content/377/bmj.o1485</description>
      <enclosure length="42443336" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1315640518-bmjpodcasts-continuity-with-martin-marshall-and-emma-gladwinfield.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Tqy8mWi9bDQ02wgc-1sMbPg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1298094766</guid>
      <title>COPD - an update on diagnosis and management</title>
      <pubDate>Mon, 01 Aug 2022 08:30:02 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/copd-2022</link>
      <itunes:duration>00:23:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>COPD or chronic obstructive pulmonary disease is common. The pooled global prevalence is 15% in men and 9% in women. The expanding epidemic of smoking and the ageing of the population means that its prevalence is increasing. And COPD is a serious disease. It is associated with recurrent pneumonia, cor pulmonale, and respiratory failure. In this BMJ Best Practice podcast, Kieran Walsh talks to Dr. Hanna Sandelowsky, GP, Head of Unit at the Academic Primary Healthcare Centre, and Senior Researcher at Karolinska Institutet in Sweden.

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>COPD or chronic obstructive pulmonary disease is …</itunes:subtitle>
      <description>COPD or chronic obstructive pulmonary disease is common. The pooled global prevalence is 15% in men and 9% in women. The expanding epidemic of smoking and the ageing of the population means that its prevalence is increasing. And COPD is a serious disease. It is associated with recurrent pneumonia, cor pulmonale, and respiratory failure. In this BMJ Best Practice podcast, Kieran Walsh talks to Dr. Hanna Sandelowsky, GP, Head of Unit at the Academic Primary Healthcare Centre, and Senior Researcher at Karolinska Institutet in Sweden.

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="28475776" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1298094766-bmjpodcasts-copd-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1312754509</guid>
      <title>Chemotherapy Response Score in Ovarian Cancer with Alejandra Martinez</title>
      <pubDate>Mon, 01 Aug 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/chemotherapy-response-score-in-ovarian-cancer-with-alejandra-martinez</link>
      <itunes:duration>00:32:47</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor Alejandra Martinez to discuss the Chemotherapy Response Score (CRS) in ovarian cancer. Prof. Martinez has been the Deputy Head of the Surgical Oncology Department at Toulouse University Cancer Center (Institut Universitaire du Cancer de Toulouse) since 2016. She has served as the Director of the ESGO fellowship program of the IUCTO since 2017 and as a professor in oncology since 2021.
 
Highlights:
- CRS is an easy and reproductible biomarker that can help to stratify a patient's treatment.
- CRS 1-2 is associated with higher tumor load, more extensive surgical procedures, residual tumor after cytoreduction, and early relapse.
- Pathology response measured by the CRS is associated with disease-free and overall survival in patients with stage IIIC/IV treated with neoadjuvant chemotherapy irrespective of the number of cycles.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor Alejandra Martinez to discuss the Chemotherapy Response Score (CRS) in ovarian cancer. Prof. Martinez has been the Deputy Head of the Surgical Oncology Department at Toulouse University Cancer Center (Institut Universitaire du Cancer de Toulouse) since 2016. She has served as the Director of the ESGO fellowship program of the IUCTO since 2017 and as a professor in oncology since 2021.
 
Highlights:
- CRS is an easy and reproductible biomarker that can help to stratify a patient's treatment.
- CRS 1-2 is associated with higher tumor load, more extensive surgical procedures, residual tumor after cytoreduction, and early relapse.
- Pathology response measured by the CRS is associated with disease-free and overall survival in patients with stage IIIC/IV treated with neoadjuvant chemotherapy irrespective of the number of cycles.</description>
      <enclosure length="31305344" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1312754509-bmjpodcasts-chemotherapy-response-score-in-ovarian-cancer-with-alejandra-martinez.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1315224307</guid>
      <title>Talk Evidence - shoulders, knees, and woes</title>
      <pubDate>Sun, 31 Jul 2022 15:42:08 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-shoulders-knees-and-woes</link>
      <itunes:duration>00:37:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode, Juan Franco, editor in chief of BMJ EBM, and Helen Macdonald, The BMJ's research integrity editor, sit down to discuss what's new in the world of evidence.

Firstly, last week they went to the first EBM Live conference for two years - and report back on what happened when the evidence community got back together.

We have two research papers looking at knees and shoulders, and finding out about the balance of risks and benefits.

In covid news, we're still finding new symptoms associated with infection, 2.5 years after the pandemic started. We'll also hear how complex it is to research vaccine efficacy now.

Reading list:
Smell and taste dysfunction after covid-19 https://www.bmj.com/content/378/bmj.o1653

Serious adverse event rates and reoperation after arthroscopic shoulder surgery
https://www.bmj.com/content/378/bmj-2021-069901

Viscosupplementation for knee osteoarthritis
https://www.bmj.com/content/378/bmj-2022-069722

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
https://www.bmj.com/content/378/bmj-2022-071249</itunes:summary>
      <itunes:subtitle>In this episode, Juan Franco, editor in chief of …</itunes:subtitle>
      <description>In this episode, Juan Franco, editor in chief of BMJ EBM, and Helen Macdonald, The BMJ's research integrity editor, sit down to discuss what's new in the world of evidence.

Firstly, last week they went to the first EBM Live conference for two years - and report back on what happened when the evidence community got back together.

We have two research papers looking at knees and shoulders, and finding out about the balance of risks and benefits.

In covid news, we're still finding new symptoms associated with infection, 2.5 years after the pandemic started. We'll also hear how complex it is to research vaccine efficacy now.

Reading list:
Smell and taste dysfunction after covid-19 https://www.bmj.com/content/378/bmj.o1653

Serious adverse event rates and reoperation after arthroscopic shoulder surgery
https://www.bmj.com/content/378/bmj-2021-069901

Viscosupplementation for knee osteoarthritis
https://www.bmj.com/content/378/bmj-2022-069722

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
https://www.bmj.com/content/378/bmj-2022-071249</description>
      <enclosure length="36239986" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1315224307-bmjpodcasts-talk-evidence-shoulders-knees-and-woes.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2yobq1Hjl6r87WmD-zdjn1Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1312007305</guid>
      <title>Understanding and managing psychological disorders in patients with inflammatory bowel disease</title>
      <pubDate>Fri, 29 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/understanding-and-managing-psychological-disorders-in-patients-with-inflammatory-bowel-disease</link>
      <itunes:duration>00:15:42</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Associate and Social Media Editor of FG and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Bel Kok who is a Consultant Gastroenterologist in the Department of Gastroenterology, Royal London Hospital, Barts and The London NHS Trust, London, UK on the paper 'Understanding and managing psychological disorders in patients with inflammatory bowel disease: a practical guide' published in paper copy in Frontline Gastroenterology in May 2022 and on the website: https://fg.bmj.com/content/early/2022/05/23/flgastro-2022-102094.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Associate and Social Media Edito…</itunes:subtitle>
      <description>Dr Philip Smith, Associate and Social Media Editor of FG and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Bel Kok who is a Consultant Gastroenterologist in the Department of Gastroenterology, Royal London Hospital, Barts and The London NHS Trust, London, UK on the paper 'Understanding and managing psychological disorders in patients with inflammatory bowel disease: a practical guide' published in paper copy in Frontline Gastroenterology in May 2022 and on the website: https://fg.bmj.com/content/early/2022/05/23/flgastro-2022-102094.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="15083728" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1312007305-bmjpodcasts-understanding-and-managing-psychological-disorders-in-patients-with-inflammatory-bowel-disease.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1311204877</guid>
      <title>August 2022 - COI, STOMP/STAMP, BP deprescribing, amiodarone and bempedoic acid</title>
      <pubDate>Thu, 28 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-august-2022</link>
      <itunes:duration>00:32:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the August 2022 issue of DTB. They discuss progress in reducing use of psychotropic medications in adults and children with a learning disability, autism or both (https://dtb.bmj.com/content/60/8/114). They also provide an overview of a study that assessed the effect of deprescribing antihypertensive medication in older people (https://dtb.bmj.com/content/60/8/118) and talk about a national safety alert relating to amiodarone (https://dtb.bmj.com/content/60/8/116). They end the podcast with a discussion on the evidence for the lipid-lowering drug bempedoic acid and its effect on reducing low-density lipoprotein-cholesterol and the lack of evidence on clinical outcomes (https://dtb.bmj.com/content/60/8/120). 
The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the August 2022 issue of DTB. They discuss progress in reducing use of psychotropic medications in adults and children with a learning disability, autism or both (https://dtb.bmj.com/content/60/8/114). They also provide an overview of a study that assessed the effect of deprescribing antihypertensive medication in older people (https://dtb.bmj.com/content/60/8/118) and talk about a national safety alert relating to amiodarone (https://dtb.bmj.com/content/60/8/116). They end the podcast with a discussion on the evidence for the lipid-lowering drug bempedoic acid and its effect on reducing low-density lipoprotein-cholesterol and the lack of evidence on clinical outcomes (https://dtb.bmj.com/content/60/8/120). 
The contact address for the DTB team is dtb@bmj.com.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="76987964" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1311204877-bmjpodcasts-dtb-august-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1312202611</guid>
      <title>Why bother? - Archimedes August 2022</title>
      <pubDate>Tue, 26 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/why-bother-archimedes-august-2022</link>
      <itunes:duration>00:07:42</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Last month we gave you a sneaky audio advanced peek into traumatic cardiac arrest - https://adc.bmj.com/content/107/7/695.1 - and so this month we are encouraging you to take a step back and think about why on earth we are doing this difficult, demanding, and intellectually brain stretching stuff of critically appraising clinical research studies - https://adc.bmj.com/content/107/8/772.1 - and beyond that, getting involved and creating some Archi’s yourself  - adc.bmj.com/pages/authors/#archimedes.
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Last month we gave you a sneaky audio advanced pe…</itunes:subtitle>
      <description>Last month we gave you a sneaky audio advanced peek into traumatic cardiac arrest - https://adc.bmj.com/content/107/7/695.1 - and so this month we are encouraging you to take a step back and think about why on earth we are doing this difficult, demanding, and intellectually brain stretching stuff of critically appraising clinical research studies - https://adc.bmj.com/content/107/8/772.1 - and beyond that, getting involved and creating some Archi’s yourself  - adc.bmj.com/pages/authors/#archimedes.
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="15187621" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1312202611-bmjpodcasts-why-bother-archimedes-august-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1309626169</guid>
      <title>Can we use mathematics to reduce aortic stenosis waiting lists?</title>
      <pubDate>Tue, 26 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/can-we-use-mathematics-to-reduce-aortic-stenosis-waiting-lists</link>
      <itunes:duration>00:20:23</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Ramesh Nadarajah from the University of Leeds. They discuss their recent paper on Covid-bloated waiting lists and whether modelling can help to improve the situation for patients with aortic stenosis. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://bmjopen.bmj.com/content/12/6/e059309</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Ramesh Nadarajah from the University of Leeds. They discuss their recent paper on Covid-bloated waiting lists and whether modelling can help to improve the situation for patients with aortic stenosis. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://bmjopen.bmj.com/content/12/6/e059309</description>
      <enclosure length="48909668" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1309626169-bmjpodcasts-can-we-use-mathematics-to-reduce-aortic-stenosis-waiting-lists.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1309806385</guid>
      <title>Updates on Overall Survival PARP Inhibitors</title>
      <pubDate>Mon, 25 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/updates-on-overall-survival-parp-inhibitors</link>
      <itunes:duration>00:35:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Robert Coleman and Shannon Westin to discuss updates on overall survival PARP inhibitors. Robert L. Coleman, MD, is a gynecologic oncologist is Houston Texas and serves as SVP and Chief Scientific Officer for US Oncology Research. His primary research interests are in drug development for gynecological cancers and clinical trial management; he has authored more than 350 peer-reviewed publications. Dr. Shannon Westin focuses on developmental therapeutics and the use of biomarkers to predict response and recurrence in gynecologic malignancies. She currently serves as the Director of Early Drug Development and Phase I trials in her department and is a Co-Director of the Ovarian Cancer Moonshot. She is currently the PI or co-PI for greater than 30 novel treatment trials in gynecologic malignancies.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Robert Coleman and Shannon Westin to discuss updates on overall survival PARP inhibitors. Robert L. Coleman, MD, is a gynecologic oncologist is Houston Texas and serves as SVP and Chief Scientific Officer for US Oncology Research. His primary research interests are in drug development for gynecological cancers and clinical trial management; he has authored more than 350 peer-reviewed publications. Dr. Shannon Westin focuses on developmental therapeutics and the use of biomarkers to predict response and recurrence in gynecologic malignancies. She currently serves as the Director of Early Drug Development and Phase I trials in her department and is a Co-Director of the Ovarian Cancer Moonshot. She is currently the PI or co-PI for greater than 30 novel treatment trials in gynecologic malignancies.</description>
      <enclosure length="33936194" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1309806385-bmjpodcasts-updates-on-overall-survival-parp-inhibitors.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1308430699</guid>
      <title>Episode 5: Buprenorphine Management in the Perioperative Period: Review and Recommendations</title>
      <pubDate>Mon, 25 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-5-buprenorphine-management-in-the-perioperative-period-review-and-recommendations</link>
      <itunes:duration>00:35:47</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Buprenorphine is an incredibly safe and effective drug as both an analgesic as well as a front-line therapy for the treatment of an opioid use disorder (OUD). However, decisions around the management of this drug in the perioperative period have generated substantial confusion and anxiety amongst patients, policymakers, and healthcare providers. In this month’s “RAPM Focus,” Editor-in-Chief Brian Sites, MD, interviews Lynn Kohan, MD, the senior author of “Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel,” first published in August 2021 (https://rapm.bmj.com/content/46/10/840). This multi-center and multi-disciplinary project establishes expert recommendations for the perioperative management of patients with OUD and brings clarity to many of these questions.

Dr. Kohan is an associate professor of anesthesiology and pain medicine at the University of Virginia (UVA) Pain Management Center. She did her anesthesiology residency at Georgetown University and her pain fellowship at UVA. She has served as the chronic pain fellowship director for the past several years and was recently appointed division chief of pan medicine. She is actively involved with ASRA Pain Medicine, serving as the chair of the membership committee. In addition, she holds leadership positions in the area of education, serving as the president-elect of the Association of Pain Program Directors, council member of the Society of Academic Associations of Anesthesiology and Perioperative Medicine, and the chair of the fellowship committee at the American Academy of Pain Medicine. 

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</itunes:summary>
      <itunes:subtitle>Buprenorphine is an incredibly safe and effective…</itunes:subtitle>
      <description>Buprenorphine is an incredibly safe and effective drug as both an analgesic as well as a front-line therapy for the treatment of an opioid use disorder (OUD). However, decisions around the management of this drug in the perioperative period have generated substantial confusion and anxiety amongst patients, policymakers, and healthcare providers. In this month’s “RAPM Focus,” Editor-in-Chief Brian Sites, MD, interviews Lynn Kohan, MD, the senior author of “Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel,” first published in August 2021 (https://rapm.bmj.com/content/46/10/840). This multi-center and multi-disciplinary project establishes expert recommendations for the perioperative management of patients with OUD and brings clarity to many of these questions.

Dr. Kohan is an associate professor of anesthesiology and pain medicine at the University of Virginia (UVA) Pain Management Center. She did her anesthesiology residency at Georgetown University and her pain fellowship at UVA. She has served as the chronic pain fellowship director for the past several years and was recently appointed division chief of pan medicine. She is actively involved with ASRA Pain Medicine, serving as the chair of the membership committee. In addition, she holds leadership positions in the area of education, serving as the president-elect of the Association of Pain Program Directors, council member of the Society of Academic Associations of Anesthesiology and Perioperative Medicine, and the chair of the fellowship committee at the American Academy of Pain Medicine. 

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</description>
      <enclosure length="85812752" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1308430699-bmjpodcasts-episode-5-buprenorphine-management-in-the-perioperative-period-review-and-recommendations.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zz7gWPu5CVbo7hEl-LPlCNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1309486270</guid>
      <title>Prescribed personalities</title>
      <pubDate>Fri, 22 Jul 2022 06:00:22 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/prescribed-personalities</link>
      <itunes:duration>00:45:30</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Have you ever felt like you had to dial up an aspect of your personality in order to fit in on placement? When going on placement, there may be times when you feel like ‘the odd one out’. But do you have to fit in? Are there benefits in being different?

Does medical training shape us into doctors with identical tone and manner and does this bode well with patients?

In this episode, the Sharp Scratch team recounts experiences of displaying different sides of their personality at work, the positives of working with people of different personalities, and the importance of being your true authentic self. 

Expert guest:
Miss Clara Munro (@ClaraEMunro on Twitter)is a General Surgical Trainee in the North East of England and was the Editorial Registrar at the BMJ.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Have you ever felt like you had to dial up an asp…</itunes:subtitle>
      <description>Have you ever felt like you had to dial up an aspect of your personality in order to fit in on placement? When going on placement, there may be times when you feel like ‘the odd one out’. But do you have to fit in? Are there benefits in being different?

Does medical training shape us into doctors with identical tone and manner and does this bode well with patients?

In this episode, the Sharp Scratch team recounts experiences of displaying different sides of their personality at work, the positives of working with people of different personalities, and the importance of being your true authentic self. 

Expert guest:
Miss Clara Munro (@ClaraEMunro on Twitter)is a General Surgical Trainee in the North East of England and was the Editorial Registrar at the BMJ.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="43680896" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1309486270-bmjpodcasts-prescribed-personalities.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-m4GjR7IuHyQoFNOi-c09P1g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1307305744</guid>
      <title>A faecal microbiota signature with high specificity for pancreatic cancer</title>
      <pubDate>Fri, 22 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/a-faecal-microbiota-signature-with-high-specificity-for-pancreatic-cancer</link>
      <itunes:duration>00:06:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Professor Peer Bork, Director of the Heidelberg site of the European Molecular Biology Laboratory Heidelberg, Baden, Germany on the paper 'A faecal microbiota signature with high specificity for pancreatic cancer' published in paper copy in Gut in July 2022, and available online: https://gut.bmj.com/content/71/7/1359
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Professor Peer Bork, Director of the Heidelberg site of the European Molecular Biology Laboratory Heidelberg, Baden, Germany on the paper 'A faecal microbiota signature with high specificity for pancreatic cancer' published in paper copy in Gut in July 2022, and available online: https://gut.bmj.com/content/71/7/1359
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="6573243" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1307305744-bmjpodcasts-a-faecal-microbiota-signature-with-high-specificity-for-pancreatic-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1309808113</guid>
      <title>AIS Female Performance &amp; Health Initiative with Dr. Rachel Harris EP#511</title>
      <pubDate>Fri, 22 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ais-female-performance-health-initiative-with-dr-rachel-harris-ep511</link>
      <itunes:duration>00:19:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The Women in Sport Congress, happening in Melbourne 17-19 August 2022, is looking to start conversations on how we can optimise women’s performance programmes and overall health within a sporting context. Dr. Rachel Harris is a Sport &amp; Exercise Medicine Physician based in Perth, Australia, who is the project lead for the AIS Female Performance &amp; Health Imitative (FPHI) and is co-organising the Women in Sport Congress. During the podcast she discusses strategies we need to employ to keep women and girls engaged in physical activity with some bonus content on tips to get involved in Para-Sport! 
 
Links 
https://www.ais.gov.au/fphi 
https://womeninsportcongress.org.au/</itunes:summary>
      <itunes:subtitle>The Women in Sport Congress, happening in Melbour…</itunes:subtitle>
      <description>The Women in Sport Congress, happening in Melbourne 17-19 August 2022, is looking to start conversations on how we can optimise women’s performance programmes and overall health within a sporting context. Dr. Rachel Harris is a Sport &amp; Exercise Medicine Physician based in Perth, Australia, who is the project lead for the AIS Female Performance &amp; Health Imitative (FPHI) and is co-organising the Women in Sport Congress. During the podcast she discusses strategies we need to employ to keep women and girls engaged in physical activity with some bonus content on tips to get involved in Para-Sport! 
 
Links 
https://www.ais.gov.au/fphi 
https://womeninsportcongress.org.au/</description>
      <enclosure length="47904391" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1309808113-bmjpodcasts-ais-female-performance-health-initiative-with-dr-rachel-harris-ep511.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1308020665</guid>
      <title>Posthumanism and the LivingBodiesObject Project</title>
      <pubDate>Thu, 21 Jul 2022 04:00:22 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/posthumanism-and-the-livingbodiesobject-project</link>
      <itunes:duration>00:37:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>LivingBodiesObjects is a 3-year project funded by the Wellcome Trust designed to test and extend the boundaries of Medical Humanities research. Today we talk to Stuart Murray and Amelia DeFalco, University of Leeds, about the value of de-centering structures and opening diversity.
Link to the blog post with more information about the project, and transcription of the podcast: 
https://blogs.bmj.com/medical-humanities/2022/07/21/posthumanism-and-the-livingbodiesobject-project
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>LivingBodiesObjects is a 3-year project funded by…</itunes:subtitle>
      <description>LivingBodiesObjects is a 3-year project funded by the Wellcome Trust designed to test and extend the boundaries of Medical Humanities research. Today we talk to Stuart Murray and Amelia DeFalco, University of Leeds, about the value of de-centering structures and opening diversity.
Link to the blog post with more information about the project, and transcription of the podcast: 
https://blogs.bmj.com/medical-humanities/2022/07/21/posthumanism-and-the-livingbodiesobject-project
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="71828114" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1308020665-bmjpodcasts-posthumanism-and-the-livingbodiesobject-project.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-35rzDteJIBP6iGmy-ch0M3g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1305722548</guid>
      <title>Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study</title>
      <pubDate>Wed, 20 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/jak-inhibitors-oral-surveillance-study</link>
      <itunes:duration>00:17:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, Dr. Javier Rodríguez-Carrio (1) talks to Dr. Tue Kragstrup (2) about the recent safety data on JAK inhibitors emerged after the ORAL Surveillance study. They discuss what is the current situation, the potential strategies to escape a ‘static’ situation, by managing uncertainty in the context of balancing risks, patient preferences and shared-decision process.
Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002236
(1) Javier Rodríguez-Carrio (University of Oviedo) (@javierrcarrio); (2) Tue Wenzel Kragstrup (University of Aarhus) (@KragstrupTW)</itunes:summary>
      <itunes:subtitle>In this podcast, Dr. Javier Rodríguez-Carrio (1) …</itunes:subtitle>
      <description>In this podcast, Dr. Javier Rodríguez-Carrio (1) talks to Dr. Tue Kragstrup (2) about the recent safety data on JAK inhibitors emerged after the ORAL Surveillance study. They discuss what is the current situation, the potential strategies to escape a ‘static’ situation, by managing uncertainty in the context of balancing risks, patient preferences and shared-decision process.
Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002236
(1) Javier Rodríguez-Carrio (University of Oviedo) (@javierrcarrio); (2) Tue Wenzel Kragstrup (University of Aarhus) (@KragstrupTW)</description>
      <enclosure length="16474278" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1305722548-bmjpodcasts-jak-inhibitors-oral-surveillance-study.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-xsyoYtEZKvN4aP9w-fnLRPA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1306933633</guid>
      <title>Atoms: the highlights from the ADC August 2022</title>
      <pubDate>Tue, 19 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-august-2022</link>
      <itunes:duration>00:13:30</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the August 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/8/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr. Nick Brown, and Senior Editor of ADC, Dr. Rachel Agbeko, bring you the monthly Atoms - the highlights of the August 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/8/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="12966346" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1306933633-bmjpodcasts-atoms-the-highlights-from-the-adc-august-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-kLlv8zTGLsUJHKA6-oCDiuQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1307238208</guid>
      <title>Diabetes in Ukraine - supporting NCDs in a conflict zone</title>
      <pubDate>Mon, 18 Jul 2022 11:13:13 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ukraine-supporting-ncds-conflict</link>
      <itunes:duration>00:42:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>As the Russian invasion of Ukraine continues, living under the uncertainty has become the new normal for thousands of patients with diabetes who are dependant on insulin.

Supporting patients with non-communicable disease is the reality of all disaster situations now, and that added layer of complexity makes coordinating responses even harder.

In this podcast, we'll hear how people with diabetes are being supported in Ukraine, and what is being done to improve things, despite the continued fighting.

Our guests;
Iryna Vlasenko, Vice President of the International Diabetes Federation
Slim Slama, unit head for NCD management at the WHO
Yaroslav Diakunchak, family physician in Brovary, Kyiv.</itunes:summary>
      <itunes:subtitle>As the Russian invasion of Ukraine continues, liv…</itunes:subtitle>
      <description>As the Russian invasion of Ukraine continues, living under the uncertainty has become the new normal for thousands of patients with diabetes who are dependant on insulin.

Supporting patients with non-communicable disease is the reality of all disaster situations now, and that added layer of complexity makes coordinating responses even harder.

In this podcast, we'll hear how people with diabetes are being supported in Ukraine, and what is being done to improve things, despite the continued fighting.

Our guests;
Iryna Vlasenko, Vice President of the International Diabetes Federation
Slim Slama, unit head for NCD management at the WHO
Yaroslav Diakunchak, family physician in Brovary, Kyiv.</description>
      <enclosure length="61057661" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1307238208-bmjpodcasts-ukraine-supporting-ncds-conflict.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XDKA1oGZA6yXXCn9-WYgrrw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1298090479</guid>
      <title>TIA - an update on diagnosis and management</title>
      <pubDate>Mon, 18 Jul 2022 08:30:02 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/tia</link>
      <itunes:duration>00:20:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Transient ischemic attacks are common - in the UK, the US and around the world. And they are important – mainly because of the high risk of stroke following a TIA. The risk of stroke is high in the first 7 days. So it is important to get on with diagnosis, investigations, and management as soon as possible.  In this BMJ Best Practice podcast, Kieran Walsh talks to Dr Jennifer Simpson, Vascular Neurologist and Associate Professor in the Department of Neurology at the University of Colorado.

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Transient ischemic attacks are common - in the UK…</itunes:subtitle>
      <description>Transient ischemic attacks are common - in the UK, the US and around the world. And they are important – mainly because of the high risk of stroke following a TIA. The risk of stroke is high in the first 7 days. So it is important to get on with diagnosis, investigations, and management as soon as possible.  In this BMJ Best Practice podcast, Kieran Walsh talks to Dr Jennifer Simpson, Vascular Neurologist and Associate Professor in the Department of Neurology at the University of Colorado.

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="25152736" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1298090479-bmjpodcasts-tia.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-tIvTnxA86rapVDSy-SBqWzw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1303232938</guid>
      <title>Editors Highlights of the August 2022 issue</title>
      <pubDate>Mon, 18 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-august-2022-issue</link>
      <itunes:duration>00:38:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the August 2022 issue of the journal.
Read more on the PN website: https://pn.bmj.com/content/22/4/261
The full issue here: https://pn.bmj.com/content/22/4
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</itunes:summary>
      <itunes:subtitle>Practical Neurology Editors Phil Smith and Gerain…</itunes:subtitle>
      <description>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the August 2022 issue of the journal.
Read more on the PN website: https://pn.bmj.com/content/22/4/261
The full issue here: https://pn.bmj.com/content/22/4
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.
Thank you for listening.</description>
      <enclosure length="36937977" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1303232938-bmjpodcasts-editors-highlights-of-the-august-2022-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1307144521</guid>
      <title>Opportunistic Salpingectomy to Prevent Ovarian Cancer with Dr. Gillian Hanley</title>
      <pubDate>Mon, 18 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/opportunistic-salpingectomy-to-prevent-ovarian-cancer-with-dr-gillian-hanley</link>
      <itunes:duration>00:41:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gillian Hanley to discuss opportunistic salpingectomy for the prevention of ovarian cancer. Gillian Hanley, PhD, is an Associate Professor in the department of Obstetrics &amp; Gynaecology at the University of British Columbia and a Canada Research Chair in Population-based Gynecologic and Perinatal outcomes. She does health services research in gynecology, primarily in the area of ovarian cancer prevention.

 

Highlights:

1. Opportunistic salpingectomy, the removal of fallopian tubes during a hysterectomy with ovarian preservation or instead of tubal ligation, has been recommended as ovarian cancer prevention following evidence that the fallopian tube is the tissue of origin for most high grade serous ovarian cancers.
2. We recently published the first data comparing observed to expected numbers of serous and epithelial ovarian cancers following opportunistic salpingectomy done for the purposes of ovarian cancer prevention in British Columbia, Canada.
3.Our data strongly suggest that opportunistic salpingectomy is effective in preventing serous ovarian cancers. There were 0 serous cancers in the opportunistic salpingectomy, and if they had been arising at the same rate as in the control groups (hysterectomy alone and tubal ligation), we would have expected 5.3. 0 is below the low end of the 95% confidence interval.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gillian Hanley to discuss opportunistic salpingectomy for the prevention of ovarian cancer. Gillian Hanley, PhD, is an Associate Professor in the department of Obstetrics &amp; Gynaecology at the University of British Columbia and a Canada Research Chair in Population-based Gynecologic and Perinatal outcomes. She does health services research in gynecology, primarily in the area of ovarian cancer prevention.

 

Highlights:

1. Opportunistic salpingectomy, the removal of fallopian tubes during a hysterectomy with ovarian preservation or instead of tubal ligation, has been recommended as ovarian cancer prevention following evidence that the fallopian tube is the tissue of origin for most high grade serous ovarian cancers.
2. We recently published the first data comparing observed to expected numbers of serous and epithelial ovarian cancers following opportunistic salpingectomy done for the purposes of ovarian cancer prevention in British Columbia, Canada.
3.Our data strongly suggest that opportunistic salpingectomy is effective in preventing serous ovarian cancers. There were 0 serous cancers in the opportunistic salpingectomy, and if they had been arising at the same rate as in the control groups (hysterectomy alone and tubal ligation), we would have expected 5.3. 0 is below the low end of the 95% confidence interval.</description>
      <enclosure length="39625995" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1307144521-bmjpodcasts-opportunistic-salpingectomy-to-prevent-ovarian-cancer-with-dr-gillian-hanley.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-JZ2jYmCyDLqEXWgi-GazJMQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1303997662</guid>
      <title>Archimedes July 2022: Broken hearts and trying to fix them</title>
      <pubDate>Wed, 13 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/archimedes-july-2022</link>
      <itunes:duration>00:17:12</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We are faced in paediatrics with some very, very difficult situations. Where our humanity and medical training come to the fore - in working with families dealing with the cliff edge of their child’s mortality - is where we need to put the same emotional and intellectual effort we would want if the tables were turned. At these times, knowing our advice is based on the  best available evidence may have even greater importance.
This month we address this in two different fields of care. The ED, and traumatic cardiac arrest [https://adc.bmj.com/content/107/7/695.1] and in the neonatal intensive care, with a resistant intracardiac thrombosis [https://adc.bmj.com/content/early/2022/05/10/archdischild-2022-323789]. We also spend a few moments pleading with you not to be beguiled by the power of p [https://adc.bmj.com/content/107/7/695.2]… and while less clinical, that’s as important. 
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>We are faced in paediatrics with some very, very …</itunes:subtitle>
      <description>We are faced in paediatrics with some very, very difficult situations. Where our humanity and medical training come to the fore - in working with families dealing with the cliff edge of their child’s mortality - is where we need to put the same emotional and intellectual effort we would want if the tables were turned. At these times, knowing our advice is based on the  best available evidence may have even greater importance.
This month we address this in two different fields of care. The ED, and traumatic cardiac arrest [https://adc.bmj.com/content/107/7/695.1] and in the neonatal intensive care, with a resistant intracardiac thrombosis [https://adc.bmj.com/content/early/2022/05/10/archdischild-2022-323789]. We also spend a few moments pleading with you not to be beguiled by the power of p [https://adc.bmj.com/content/107/7/695.2]… and while less clinical, that’s as important. 
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="16525269" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1303997662-bmjpodcasts-archimedes-july-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1300941007</guid>
      <title>Evaluation of the causes of sex disparity in heart failure trials</title>
      <pubDate>Tue, 12 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/evaluation-of-the-causes-of-sex-disparity-in-heart-failure-trials</link>
      <itunes:duration>00:14:30</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Holly Morgan from London. They discuss her paper about why fewer women than men are enrolled in heart failure trials. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/04/14/heartjnl-2021-320696</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Holly Morgan from London. They discuss her paper about why fewer women than men are enrolled in heart failure trials. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/04/14/heartjnl-2021-320696</description>
      <enclosure length="34816093" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1300941007-bmjpodcasts-evaluation-of-the-causes-of-sex-disparity-in-heart-failure-trials.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1303180945</guid>
      <title>Adverse drug reactions with Anders Holt and Corine Ekhart</title>
      <pubDate>Mon, 11 Jul 2022 09:31:52 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adverse-drug-reactions-with-anders-holt-and-corine-ekhart</link>
      <itunes:duration>00:42:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>As more and more pharmaceutical products come onto the market, there are so many potential drug interactions, and adverse reactions, to bear in mind during a consultation in primary care. In this week’s episode, we speak to Anders Holt, the author of a recent research paper looking at co-prescribing nitrates and sildenafil, which is surprisingly common, and adverse events associated with this. We also discuss the neuropsychiatric side effects of montelukast with Corine Ekhart, and talk about the challenges of striking the right balance between highlighting a rare but important side effect and causing the patient anxiety about taking the medication.


Our guests:

Anders Holt is a PhD candidate at Copenhagen University Hospital, Denmark.

Corine Ekhart is a pharmacist at the Netherlands Pharmacovigilance Centre Lareb in 's-Hertogenbosch, the Netherlands.


Further reading:

‘Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study’. doi:10.7326/M21-3445 https://www.acpjournals.org/doi/10.7326/M21-3445

‘Neuropsychiatric reactions with the use of montelukast’. doi:10.1136/bmj-2021-067554 

https://www.bmj.com/content/376/bmj-2021-067554</itunes:summary>
      <itunes:subtitle>As more and more pharmaceutical products come ont…</itunes:subtitle>
      <description>As more and more pharmaceutical products come onto the market, there are so many potential drug interactions, and adverse reactions, to bear in mind during a consultation in primary care. In this week’s episode, we speak to Anders Holt, the author of a recent research paper looking at co-prescribing nitrates and sildenafil, which is surprisingly common, and adverse events associated with this. We also discuss the neuropsychiatric side effects of montelukast with Corine Ekhart, and talk about the challenges of striking the right balance between highlighting a rare but important side effect and causing the patient anxiety about taking the medication.


Our guests:

Anders Holt is a PhD candidate at Copenhagen University Hospital, Denmark.

Corine Ekhart is a pharmacist at the Netherlands Pharmacovigilance Centre Lareb in 's-Hertogenbosch, the Netherlands.


Further reading:

‘Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study’. doi:10.7326/M21-3445 https://www.acpjournals.org/doi/10.7326/M21-3445

‘Neuropsychiatric reactions with the use of montelukast’. doi:10.1136/bmj-2021-067554 

https://www.bmj.com/content/376/bmj-2021-067554</description>
      <enclosure length="51265222" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1303180945-bmjpodcasts-adverse-drug-reactions-with-anders-holt-and-corine-ekhart.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Tqy8mWi9bDQ02wgc-1sMbPg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1296611305</guid>
      <title>Imiquimod vs Surgery RCT in Vulvar VIN</title>
      <pubDate>Mon, 11 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/imiquimod-vs-surgery-rct-in-vulvar-vin</link>
      <itunes:duration>00:27:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gerda Trutnovsky to discuss the use of imiquimod versus surgery for the treatment of vHSIL. Dr. Trutnovsky studied at the University of Graz/Austria and the University of Sydney/Australia. She works as an associate professor in the Department of Obstetrics and Gynecology at the Medical University of Graz/Austria, with a special interest in vulvar disease.

Highlights:
This was the first prospective trial of imiquimod versus surgery for the treatment of vulvar high grade squamous intraepithelial lesions (vHSIL).
Complete clinical response at 6 months was observed in 80% of patients using imiquimod per-protocol, compared to 79% in women who had one surgical intervention.
Imiquimod was used in a slowly escalating dosage scheme up to 3 times a week and reduced in case of side effects – local toxicity was mostly mild to moderate.
Imiquimod is a safe, effective and well accepted alternative to surgery and can be considered a first-line treatment option.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Gerda Trutnovsky to discuss the use of imiquimod versus surgery for the treatment of vHSIL. Dr. Trutnovsky studied at the University of Graz/Austria and the University of Sydney/Australia. She works as an associate professor in the Department of Obstetrics and Gynecology at the Medical University of Graz/Austria, with a special interest in vulvar disease.

Highlights:
This was the first prospective trial of imiquimod versus surgery for the treatment of vulvar high grade squamous intraepithelial lesions (vHSIL).
Complete clinical response at 6 months was observed in 80% of patients using imiquimod per-protocol, compared to 79% in women who had one surgical intervention.
Imiquimod was used in a slowly escalating dosage scheme up to 3 times a week and reduced in case of side effects – local toxicity was mostly mild to moderate.
Imiquimod is a safe, effective and well accepted alternative to surgery and can be considered a first-line treatment option.</description>
      <enclosure length="26614661" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1296611305-bmjpodcasts-imiquimod-vs-surgery-rct-in-vulvar-vin.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1303179487</guid>
      <title>Reviewing the June issue with Katherine Hicks-Courant and Christina Uwins</title>
      <pubDate>Mon, 11 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reviewing-the-june-issue-with-katherine-hicks-courant-and-christina-uwins</link>
      <itunes:duration>00:16:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC Podcast, Editorial Fellows Katherine Hicks-Courant and Christina Uwins discuss the contents of the June issue of IJGC.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC Podcast, Editorial Fe…</itunes:subtitle>
      <description>In this episode of the IJGC Podcast, Editorial Fellows Katherine Hicks-Courant and Christina Uwins discuss the contents of the June issue of IJGC.</description>
      <enclosure length="38466626" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1303179487-bmjpodcasts-reviewing-the-june-issue-with-katherine-hicks-courant-and-christina-uwins.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1303163926</guid>
      <title>An Overview of the NIH LRP with Dr. Sara Myers</title>
      <pubDate>Mon, 11 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/an-overview-of-the-nih-lrp-with-dr-sara-myers</link>
      <itunes:duration>00:25:45</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this conversation with John Dickenson, MD, PhD, University of Nebraska Medical Center and Social Media Editor for Journal of Investigative Medicine, Sara Myers, PhD, University of Nebraska Omaha, provides an overview of the NIH loan repayment program (LRP) program, including eligibility, the application process, renew options, and keys to successful application. Student loan debt has been a big topic in the news recently and certainly a factor for trainees and junior faculty thinking about pursuing an academic career. This timely topic is relevant to those JIM podcast listeners who are trainees or junior facility members in academic careers who may have student loan debts. 



Dr. Sara Myers is the D.B. and Paula Varner Professor in the department of Biomechanics at the University of Nebraska at Omaha. She is also the Assistant Vice Chancellor at the Office of Research and Creative Activity. Her lab focuses on the biophysical forces that influence human disease  such as neuromuscular disease and peripheral vascular diseases. She has been well funded including NIH and VA funding with 45 manuscripts.</itunes:summary>
      <itunes:subtitle>In this conversation with John Dickenson, MD, PhD…</itunes:subtitle>
      <description>In this conversation with John Dickenson, MD, PhD, University of Nebraska Medical Center and Social Media Editor for Journal of Investigative Medicine, Sara Myers, PhD, University of Nebraska Omaha, provides an overview of the NIH loan repayment program (LRP) program, including eligibility, the application process, renew options, and keys to successful application. Student loan debt has been a big topic in the news recently and certainly a factor for trainees and junior faculty thinking about pursuing an academic career. This timely topic is relevant to those JIM podcast listeners who are trainees or junior facility members in academic careers who may have student loan debts. 



Dr. Sara Myers is the D.B. and Paula Varner Professor in the department of Biomechanics at the University of Nebraska at Omaha. She is also the Assistant Vice Chancellor at the Office of Research and Creative Activity. Her lab focuses on the biophysical forces that influence human disease  such as neuromuscular disease and peripheral vascular diseases. She has been well funded including NIH and VA funding with 45 manuscripts.</description>
      <enclosure length="24602610" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1303163926-bmjpodcasts-an-overview-of-the-nih-lrp-with-dr-sara-myers.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-70kbmOy2s1YSSQsi-LEZ2sw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1301399959</guid>
      <title>Understanding your payslip (special segment)</title>
      <pubDate>Fri, 08 Jul 2022 06:00:28 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/understanding-your-payslip-special-segment</link>
      <itunes:duration>00:08:18</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This is a special segment from the Sharp Scratch episode - what med school didn’t teach you about money. 

Have you received your first payslip and not sure whether you have been paid correctly? Listen to this short clip where the doctors behind Medics Money will guide you through the key things to check on your payslip and decipher tax codes in under 10 minutes. 

If you would like to hear more about how to claim tax rebate, information about income protection and relocation costs, head over to episode 78, titled 'what med school didn’t teach you about money' to find more.

Expert guests:
Dr Tommy Perkins and Dr Ed Cantello are GPs and co-founders of Medics Money.

Useful links that Dr Perkins and Dr Cantelo recommend:
•Free Ebook www.medicsmoney.co.uk/ebook/
•10 top tips for junior doctors podcast www.medicsmoney.co.uk/ep-5-10-financ…unior-doctors/
•Tax code guide - www.medicsmoney.co.uk/is-your-doctor…-code-correct/
•Tax rebate guide - www.medicsmoney.co.uk/free-guide/

Check us out on social media:
Twitter: twitter.com/BMJStudent
Instagram: www.instagram.com/bmj_student/
Facebook: www.facebook.com/BMJStudent/

This episode does not represent any form of financial, legal or accounting advice and tax allowances and rates are subject to change.</itunes:summary>
      <itunes:subtitle>This is a special segment from the Sharp Scratch …</itunes:subtitle>
      <description>This is a special segment from the Sharp Scratch episode - what med school didn’t teach you about money. 

Have you received your first payslip and not sure whether you have been paid correctly? Listen to this short clip where the doctors behind Medics Money will guide you through the key things to check on your payslip and decipher tax codes in under 10 minutes. 

If you would like to hear more about how to claim tax rebate, information about income protection and relocation costs, head over to episode 78, titled 'what med school didn’t teach you about money' to find more.

Expert guests:
Dr Tommy Perkins and Dr Ed Cantello are GPs and co-founders of Medics Money.

Useful links that Dr Perkins and Dr Cantelo recommend:
•Free Ebook www.medicsmoney.co.uk/ebook/
•10 top tips for junior doctors podcast www.medicsmoney.co.uk/ep-5-10-financ…unior-doctors/
•Tax code guide - www.medicsmoney.co.uk/is-your-doctor…-code-correct/
•Tax rebate guide - www.medicsmoney.co.uk/free-guide/

Check us out on social media:
Twitter: twitter.com/BMJStudent
Instagram: www.instagram.com/bmj_student/
Facebook: www.facebook.com/BMJStudent/

This episode does not represent any form of financial, legal or accounting advice and tax allowances and rates are subject to change.</description>
      <enclosure length="7977344" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1301399959-bmjpodcasts-understanding-your-payslip-special-segment.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-m4GjR7IuHyQoFNOi-c09P1g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1301396749</guid>
      <title>What med school didn't teach you about money w/ Medics Money</title>
      <pubDate>Fri, 08 Jul 2022 06:00:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/what-med-school-didnt-teach-you-about-money</link>
      <itunes:duration>00:47:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>At med school, we are trained to interpret blood tests but not much (if at all) on how to interpret your payslip.

Financial literacy doesn’t feature much in our medical curriculum but it’s an important life skill to have: from interpreting your payslip to claiming tax rebate on your postgrad exams fees. 

In this episode, the doctors behind Medics Money share their experiences regarding costs that newly qualified doctors will have to consider after med school, some money saving tips for junior docs and things to look out for when you’re interpreting a payslip.

Topics covered:
•Things to look out for on your payslip
•What should you do when you notice you haven’t been paid correctly
•Sick pay
•Claiming tax rebate on costs of training
•Relocation costs


Expert guests:
Dr Tommy Perkins and Dr Ed Cantello are GPs and co-founders of Medics Money. 

Useful links that Dr Perkins and Dr Cantelo recommend: 
•Free Ebook https://www.medicsmoney.co.uk/ebook/
•10 top tips for junior doctors podcast https://www.medicsmoney.co.uk/ep-5-10-financial-tips-for-junior-doctors/
•Tax code guide - https://www.medicsmoney.co.uk/is-your-doctors-tax-code-correct/
•Tax rebate guide - https://www.medicsmoney.co.uk/free-guide/

 
Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.

This episode does not represent any form of financial, legal or accounting advice and tax allowances and rates are subject to change.</itunes:summary>
      <itunes:subtitle>At med school, we are trained to interpret blood …</itunes:subtitle>
      <description>At med school, we are trained to interpret blood tests but not much (if at all) on how to interpret your payslip.

Financial literacy doesn’t feature much in our medical curriculum but it’s an important life skill to have: from interpreting your payslip to claiming tax rebate on your postgrad exams fees. 

In this episode, the doctors behind Medics Money share their experiences regarding costs that newly qualified doctors will have to consider after med school, some money saving tips for junior docs and things to look out for when you’re interpreting a payslip.

Topics covered:
•Things to look out for on your payslip
•What should you do when you notice you haven’t been paid correctly
•Sick pay
•Claiming tax rebate on costs of training
•Relocation costs


Expert guests:
Dr Tommy Perkins and Dr Ed Cantello are GPs and co-founders of Medics Money. 

Useful links that Dr Perkins and Dr Cantelo recommend: 
•Free Ebook https://www.medicsmoney.co.uk/ebook/
•10 top tips for junior doctors podcast https://www.medicsmoney.co.uk/ep-5-10-financial-tips-for-junior-doctors/
•Tax code guide - https://www.medicsmoney.co.uk/is-your-doctors-tax-code-correct/
•Tax rebate guide - https://www.medicsmoney.co.uk/free-guide/

 
Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.

This episode does not represent any form of financial, legal or accounting advice and tax allowances and rates are subject to change.</description>
      <enclosure length="45625088" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1301396749-bmjpodcasts-what-med-school-didnt-teach-you-about-money.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-m4GjR7IuHyQoFNOi-c09P1g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1300706644</guid>
      <title>Global Health Humanities, a June Special Issue</title>
      <pubDate>Thu, 07 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/global-health-humanities-a-june-special-issue</link>
      <itunes:duration>00:28:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-chief of Medical Humanities, Brandy Schillace, interviews Narin Hassan and Jessica Howell about their innovative and interdisciplinary approach to health humanities.
Narin Hassan is Associate Professor and Director of Global Media and Cultures (MS-GMC) in the School of Literature, Media, and Communication at Georgia Tech. Jessica Howell is Professor of English and Associate Director of the Glasscock Center for Humanities Research at Texas A&amp;M University. 
Read the blog with the transcription of this podcast: https://blogs.bmj.com/medical-humanities/2022/07/07/global-health-humanities-a-june-special-issue
The special issue is available: https://mh.bmj.com/content/48/2
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>Editor-in-chief of Medical Humanities, Brandy Sch…</itunes:subtitle>
      <description>Editor-in-chief of Medical Humanities, Brandy Schillace, interviews Narin Hassan and Jessica Howell about their innovative and interdisciplinary approach to health humanities.
Narin Hassan is Associate Professor and Director of Global Media and Cultures (MS-GMC) in the School of Literature, Media, and Communication at Georgia Tech. Jessica Howell is Professor of English and Associate Director of the Glasscock Center for Humanities Research at Texas A&amp;M University. 
Read the blog with the transcription of this podcast: https://blogs.bmj.com/medical-humanities/2022/07/07/global-health-humanities-a-june-special-issue
The special issue is available: https://mh.bmj.com/content/48/2
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="55236159" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1300706644-bmjpodcasts-global-health-humanities-a-june-special-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-35rzDteJIBP6iGmy-ch0M3g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1300682443</guid>
      <title>“If you don’t have a mentor, go and get them!”, Dr Mark Rosenberg's 40 years in Injury Prevention</title>
      <pubDate>Thu, 07 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ip-july-2022</link>
      <itunes:duration>00:39:17</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In a very personal interview, Dr Mark Rosenberg, who has been at the centre of injury prevention for more than a generation, tells Dr Rod McClure​, about his path in a career that was not always understood.
"We were given an old bathroom in the sub-sub-basement of a minor building and a lot of people in public health thought that's just where we belonged." 
Mark L. Rosenberg was president and CEO of the Task Force for Global Health, and has also worked at the Centers for Disease Control and Prevention (CDC) for 20 years, where he was instrumental in founding the National Center for Injury Prevention and Control (NCIPC).
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>In a very personal interview, Dr Mark Rosenberg, …</itunes:subtitle>
      <description>In a very personal interview, Dr Mark Rosenberg, who has been at the centre of injury prevention for more than a generation, tells Dr Rod McClure​, about his path in a career that was not always understood.
"We were given an old bathroom in the sub-sub-basement of a minor building and a lot of people in public health thought that's just where we belonged." 
Mark L. Rosenberg was president and CEO of the Task Force for Global Health, and has also worked at the Centers for Disease Control and Prevention (CDC) for 20 years, where he was instrumental in founding the National Center for Injury Prevention and Control (NCIPC).
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="37727502" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1300682443-bmjpodcasts-ip-july-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-lBNYPWMk19NnXlDd-TWVzcQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1300617970</guid>
      <title>July: brain injuries; (mal)nutrition; disability; and drug reactions</title>
      <pubDate>Wed, 06 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/july-2022-adc-atoms</link>
      <itunes:duration>00:21:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the July 2022 issue. 
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/7/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the July 2022 issue. 
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/7/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="21058036" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1300617970-bmjpodcasts-july-2022-adc-atoms.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1299384388</guid>
      <title>HTLV2022: 20th International Conference on Human Retrovirology</title>
      <pubDate>Wed, 06 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/htlv2022-20th-international-conference-on-human-retrovirology</link>
      <itunes:duration>00:17:39</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Thank you for joining us for the HTLV2022 Conference review. Dr Fabiola Martin speaks to Joanna Curteis, the Australian patient representative, Dr Carolina Rosadas, researcher associate at National Centre for Human Retrovirology, Imperial College London, who specialises in HTLV-1 vertical transmission and Prof Damian Purcell. Damian's research group investigates the HIV-1 and HTLV-1 human retroviruses that cause AIDS and leukaemia/inflammatory pathogenesis respectively at Doherty Institute, Melbourne. We also discuss the Global Call to Action towards the elimination of HTLV-1 and an important message from the World Health Organisation delivered by Dr Meg Doherty.
Related blog post: https://blogs.bmj.com/sti/2022/07/06/ichr-2022/
Related links:
https://www.htlvnet.com 
https://www.htlvaware.com 
HTLV Channel https://www.youtube.com/channel/UCI6aLSTtk7chXMeybJ92Fhw 
Follow @HTLVChannel 
National Centre for Human Retrovirology http://www.htlv.eu/ 
WHO HTLV technical report https://apps.who.int/iris/handle/10665/339773</itunes:summary>
      <itunes:subtitle>Thank you for joining us for the HTLV2022 Confere…</itunes:subtitle>
      <description>Thank you for joining us for the HTLV2022 Conference review. Dr Fabiola Martin speaks to Joanna Curteis, the Australian patient representative, Dr Carolina Rosadas, researcher associate at National Centre for Human Retrovirology, Imperial College London, who specialises in HTLV-1 vertical transmission and Prof Damian Purcell. Damian's research group investigates the HIV-1 and HTLV-1 human retroviruses that cause AIDS and leukaemia/inflammatory pathogenesis respectively at Doherty Institute, Melbourne. We also discuss the Global Call to Action towards the elimination of HTLV-1 and an important message from the World Health Organisation delivered by Dr Meg Doherty.
Related blog post: https://blogs.bmj.com/sti/2022/07/06/ichr-2022/
Related links:
https://www.htlvnet.com 
https://www.htlvaware.com 
HTLV Channel https://www.youtube.com/channel/UCI6aLSTtk7chXMeybJ92Fhw 
Follow @HTLVChannel 
National Centre for Human Retrovirology http://www.htlv.eu/ 
WHO HTLV technical report https://apps.who.int/iris/handle/10665/339773</description>
      <enclosure length="16955349" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1299384388-bmjpodcasts-htlv2022-20th-international-conference-on-human-retrovirology.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-pAPNWIdcqzhbf4vB-70N7zw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1275683272</guid>
      <title>Using patient registries to estimate SLE incidence rate in the USA</title>
      <pubDate>Wed, 06 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/using-patient-registries-to-estimate-sle-incidence-rate-in-the-usa</link>
      <itunes:duration>00:16:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Duane Peters from the Lupus Foundation of America interviews Dr Peter Izmirly from New York University and Dr Elizabeth Ferucci from the Alaska Native Tribal Health Consortium, both in the USA. 

They discuss the establishment of a network of population-based lupus patient registries in the USA and how these have been used to estimate the incidence rate of systemic lupus erythematosus using standardised data stratified by sex, race and ethnicity.

Access the article: https://lupus.bmj.com/content/8/1/e000614</itunes:summary>
      <itunes:subtitle>Duane Peters from the Lupus Foundation of America…</itunes:subtitle>
      <description>Duane Peters from the Lupus Foundation of America interviews Dr Peter Izmirly from New York University and Dr Elizabeth Ferucci from the Alaska Native Tribal Health Consortium, both in the USA. 

They discuss the establishment of a network of population-based lupus patient registries in the USA and how these have been used to estimate the incidence rate of systemic lupus erythematosus using standardised data stratified by sex, race and ethnicity.

Access the article: https://lupus.bmj.com/content/8/1/e000614</description>
      <enclosure length="13757575" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1275683272-bmjpodcasts-using-patient-registries-to-estimate-sle-incidence-rate-in-the-usa.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zOfBZ6joPLX9GdP1-jqUXQg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1291041922</guid>
      <title>Ankylosing spondylitis</title>
      <pubDate>Mon, 04 Jul 2022 08:30:27 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ankylosing-spondylitis-1</link>
      <itunes:duration>00:14:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Axial spondyloarthritis is a chronic progressive inflammatory arthropathy, which ultimately may lead to radiographical changes in the spine and sacroiliac joints. This radiographical stage is known as ankylosing spondylitis.

Inflammatory back pain is the hallmark clinical feature. This is defined as back pain that is of insidious onset, is worse in the morning, and improves with exercise.

In this podcast, Markku Kauppi, Professor of Rheumatology, Helsinki University, gives a clinical overview of the condition.

For more on ankylosing spondylitis, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/366

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Axial spondyloarthritis is a chronic progressive …</itunes:subtitle>
      <description>Axial spondyloarthritis is a chronic progressive inflammatory arthropathy, which ultimately may lead to radiographical changes in the spine and sacroiliac joints. This radiographical stage is known as ankylosing spondylitis.

Inflammatory back pain is the hallmark clinical feature. This is defined as back pain that is of insidious onset, is worse in the morning, and improves with exercise.

In this podcast, Markku Kauppi, Professor of Rheumatology, Helsinki University, gives a clinical overview of the condition.

For more on ankylosing spondylitis, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/366

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="17702176" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1291041922-bmjpodcasts-ankylosing-spondylitis-1.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ujs7lai7EfGopsDJ-npDHtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1295924617</guid>
      <title>Surgical Staging Advanced Cervical Cancer</title>
      <pubDate>Mon, 04 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/surgical-staging-advanced-cervical-cancer</link>
      <itunes:duration>00:30:30</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Dimitrios Nasioudis. Dr. Nasioudis is a Gynecologic Oncology Fellow at the University of Pennsylvania. His current research focuses on translational therapeutics and population-based research.

Highlights:
The utility of surgical staging for patients with locally advanced cervical cancer has not been established.
While PET-CT is the most sensitive imaging modality to detect para-aortic metastases, the false negative rate can be as high as 20%.
In the United States, surgical staging for locally advanced cervical cancer is rarely performed with a decreasing utilization.
The impact of surgical staging on the oncologic outcomes is not clear.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Dimitrios Nasioudis. Dr. Nasioudis is a Gynecologic Oncology Fellow at the University of Pennsylvania. His current research focuses on translational therapeutics and population-based research.

Highlights:
The utility of surgical staging for patients with locally advanced cervical cancer has not been established.
While PET-CT is the most sensitive imaging modality to detect para-aortic metastases, the false negative rate can be as high as 20%.
In the United States, surgical staging for locally advanced cervical cancer is rarely performed with a decreasing utilization.
The impact of surgical staging on the oncologic outcomes is not clear.</description>
      <enclosure length="29290160" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1295924617-bmjpodcasts-surgical-staging-advanced-cervical-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1297861009</guid>
      <title>Applying Sport Psychology to Improve Clinical Performance with Dr Helen Church. EP #510</title>
      <pubDate>Fri, 01 Jul 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/applying-sport-psychology-to-improve-clinical-performance-with-dr-helen-church-ep-510</link>
      <itunes:duration>00:30:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This BJSM podcast discusses how health care professionals can learn from the sports psychology world. Noting the similarities between athletes and health care professionals Dr Helen Church has put together a new PERFORM (Performance Enhancing Routine for Optimisation of Readiness using Metacognition) framework, using Performance Enhancing Routines to improve clinical performance. She provides practical advice on how you and your practise can benefit from simple sport psychology measures giving some fantastic examples for inspiration.
Dr Helen Church is a GP trainee and academic clinical lecturer at the University of Nottingham, working as a clinical assistant professor in medical education. This podcast is hosted by Dr Shona Kohlhardt.

Links to useful papers further discussing sports psychology in clinical performance:
1.  Using Insights From Sports Psychology to Improve Recently Qualified Doctors’ Self-Efficacy While Managing Acutely Unwell Patients (Church et al., 2021) https://journals.lww.com/academicmedicine/Fulltext/2021/05000/Using_Insights_From_Sports_Psychology_to_Improve.41.aspx
 
2. Applying sport psychology in health professions education: A systematic review of performance mental skills training (Sandars et al., 2021)
https://www.tandfonline.com/doi/full/10.1080/0142159X.2021.196643 
 
3. Applying sport psychology to improve clinical performance (Church et al., 2017)
 https://www.tandfonline.com/doi/full/10.1080/0142159X.2017.135953 
 
4. What can medical educators learn from the Rio 2016 Olympic Games? (Church et al., 2017)
https://www.tandfonline.com/doi/full/10.1080/0142159X.2016.127040</itunes:summary>
      <itunes:subtitle>This BJSM podcast discusses how health care profe…</itunes:subtitle>
      <description>This BJSM podcast discusses how health care professionals can learn from the sports psychology world. Noting the similarities between athletes and health care professionals Dr Helen Church has put together a new PERFORM (Performance Enhancing Routine for Optimisation of Readiness using Metacognition) framework, using Performance Enhancing Routines to improve clinical performance. She provides practical advice on how you and your practise can benefit from simple sport psychology measures giving some fantastic examples for inspiration.
Dr Helen Church is a GP trainee and academic clinical lecturer at the University of Nottingham, working as a clinical assistant professor in medical education. This podcast is hosted by Dr Shona Kohlhardt.

Links to useful papers further discussing sports psychology in clinical performance:
1.  Using Insights From Sports Psychology to Improve Recently Qualified Doctors’ Self-Efficacy While Managing Acutely Unwell Patients (Church et al., 2021) https://journals.lww.com/academicmedicine/Fulltext/2021/05000/Using_Insights_From_Sports_Psychology_to_Improve.41.aspx
 
2. Applying sport psychology in health professions education: A systematic review of performance mental skills training (Sandars et al., 2021)
https://www.tandfonline.com/doi/full/10.1080/0142159X.2021.196643 
 
3. Applying sport psychology to improve clinical performance (Church et al., 2017)
 https://www.tandfonline.com/doi/full/10.1080/0142159X.2017.135953 
 
4. What can medical educators learn from the Rio 2016 Olympic Games? (Church et al., 2017)
https://www.tandfonline.com/doi/full/10.1080/0142159X.2016.127040</description>
      <enclosure length="74256717" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1297861009-bmjpodcasts-applying-sport-psychology-to-improve-clinical-performance-with-dr-helen-church-ep-510.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1295440486</guid>
      <title>Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of brain tumors</title>
      <pubDate>Thu, 30 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/perfusion-guided-endovascular-super-selective-intra-arterial-infusion-for-treatment-of-brain-tumors</link>
      <itunes:duration>00:22:47</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Survival for glioblastoma remains very poor despite decades of research, with a 5-year survival of only 5%. Technological improvements that have revolutionized treatment of ischemic stroke and brain aneurysms have great potential in providing more precise and selective delivery of cancer therapeutic agents to brain tumors.
In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque speaks with Dr. Stephen Chen (1)and Dr. Peter Kan (2) about their paper "Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors". The paper describes a technique using perfusion guidance to enhance the precision of endovascular super-selective intra-arterial (ESIA) infusions of mesenchymal stem cells loaded with Delta-24 in the treatment of glioblastoma. This technique enhances targeted super-selective delivery of therapeutic agents for brain tumors.
Paper available online (https://jnis.bmj.com/content/14/6/533) and in June print issue of JNIS. 
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!
This episode was produced by Leticia Amorim and edited by Brian O'Toole.
(1) Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA 
(2) Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA</itunes:summary>
      <itunes:subtitle>Survival for glioblastoma remains very poor despi…</itunes:subtitle>
      <description>Survival for glioblastoma remains very poor despite decades of research, with a 5-year survival of only 5%. Technological improvements that have revolutionized treatment of ischemic stroke and brain aneurysms have great potential in providing more precise and selective delivery of cancer therapeutic agents to brain tumors.
In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque speaks with Dr. Stephen Chen (1)and Dr. Peter Kan (2) about their paper "Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors". The paper describes a technique using perfusion guidance to enhance the precision of endovascular super-selective intra-arterial (ESIA) infusions of mesenchymal stem cells loaded with Delta-24 in the treatment of glioblastoma. This technique enhances targeted super-selective delivery of therapeutic agents for brain tumors.
Paper available online (https://jnis.bmj.com/content/14/6/533) and in June print issue of JNIS. 
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!
This episode was produced by Leticia Amorim and edited by Brian O'Toole.
(1) Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA 
(2) Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA</description>
      <enclosure length="21882670" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1295440486-bmjpodcasts-perfusion-guided-endovascular-super-selective-intra-arterial-infusion-for-treatment-of-brain-tumors.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1296660997</guid>
      <title>ADC Fetal and Neonatal’s Fantoms. Highlights from the March 2022 issue</title>
      <pubDate>Wed, 29 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adc-fetal-and-neonatals-fantoms-highlights-from-the-march-2022-issue</link>
      <itunes:duration>00:14:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the March 2022 issue. The Fantoms article: https://fn.bmj.com/content/107/2/115
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>ADC Fetal and Neonatal’s Associate Editor, Jonath…</itunes:subtitle>
      <description>ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the March 2022 issue. The Fantoms article: https://fn.bmj.com/content/107/2/115
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="14344776" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1296660997-bmjpodcasts-adc-fetal-and-neonatals-fantoms-highlights-from-the-march-2022-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-jmEMFkxseIi7iRCf-Nwmt9w-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1295624746</guid>
      <title>July 2022 - an e-letter, estradiol, APPGs, inclisiran and nitrofurantoin</title>
      <pubDate>Wed, 29 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-july-2022</link>
      <itunes:duration>00:29:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the July 2022 issue of DTB. They discuss the proposed reclassification of estradiol vaginal tablets from Prescription Only Medicine to a Pharmacy medicine (https://dtb.bmj.com/content/60/7/98) and review a study that assessed pharmaceutical industry funding of All Party Parliamentary Groups (https://dtb.bmj.com/content/60/7/100). They talk about the evidence for the lipid-lowering drug inclisiran and its effect on reducing low-density lipoprotein-cholesterol and the lack of evidence on clinical outcomes (https://dtb.bmj.com/content/60/7/102). The editors also highlight a case report of acute lung toxicity caused by nitrofurantoin (https://dtb.bmj.com/content/60/7/108).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the July 2022 issue of DTB. They discuss the proposed reclassification of estradiol vaginal tablets from Prescription Only Medicine to a Pharmacy medicine (https://dtb.bmj.com/content/60/7/98) and review a study that assessed pharmaceutical industry funding of All Party Parliamentary Groups (https://dtb.bmj.com/content/60/7/100). They talk about the evidence for the lipid-lowering drug inclisiran and its effect on reducing low-density lipoprotein-cholesterol and the lack of evidence on clinical outcomes (https://dtb.bmj.com/content/60/7/102). The editors also highlight a case report of acute lung toxicity caused by nitrofurantoin (https://dtb.bmj.com/content/60/7/108).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="70151784" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1295624746-bmjpodcasts-dtb-july-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1292598658</guid>
      <title>Sleepiness and cardiovascular risk</title>
      <pubDate>Tue, 28 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sleepiness-and-cardiovascular-risk</link>
      <itunes:duration>00:17:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Virend Somers from The Mayo Clinic. They discuss the connections between sleepiness and cardiovascular risk. 
If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/early/2022/01/30/heartjnl-2021-319596</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Virend Somers from The Mayo Clinic. They discuss the connections between sleepiness and cardiovascular risk. 
If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/early/2022/01/30/heartjnl-2021-319596</description>
      <enclosure length="42818902" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1292598658-bmjpodcasts-sleepiness-and-cardiovascular-risk.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1297082368</guid>
      <title>Consensus Statement on Pre-Invasive Vulvar Disease with Mario Preti</title>
      <pubDate>Mon, 27 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/consensus-statement-on-pre-invasive-vulvar-disease-with-mario-preti</link>
      <itunes:duration>00:37:19</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Mario Preti to discuss the ESGO, ISSVD, ECSVD, and EFC consensus statements on pre-invasive vulvar lesions. Dr. Preti received his Specialization in Gynecology and Obstetrics and Specialization in Medical Oncology at the University of Torino. He is Associate Professor at the Department of Surgical Sciences, University of Torino, Italy, and the Immediate Past President of the ISSVD (International Society for the Study of Vulvo-vaginal disease). Dr. Preti is the author of 4 books on vulvo-vaginal diseases, and as of June 2022, he has published 108 papers indexed in Scopus/Pubmed, with 2,014 citations and an H-index of 23.

Highlights:
Epidemiological data show no decrease in vulvar invasive cancer incidence. This means that accurate diagnosis and treatment of pre-invasive vulvar disease must be improved: these are among the ESGO-ISSVD-ECSVD aims.
The two carcinogenic pathways of vulvar squamous neoplasia recognize as precursors two vulvar intraepithelial neoplasia (VIN): HPV-associated squamous intraepithelial lesions (High Grade VIN) and HPV-independent VIN (mainly differentiated VIN). These precursors have different clinical approach, treatment and oncological risk. Their histologic features can be subtle, and the histological diagnosis may be further complicated by coexisting conditions.
For differentiated VIN, an excisional procedure must always be adopted. Medical treatment (imiquimod or cidofovir) and ablative treatment can be considered for high grade VIN to preserve anatomy and function. These conservative approaches must be preceded by representative biopsies to exclude invasive disease.
Follow up should be modulated according to the risk of recurrence (type of lesion, patient age and immunological conditions, other associated lower genital tract lesions).
Pre-invasive vulvar lesions deserve specific attention because they affect not only functionality and body image, but also psychosexual factors.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Mario Preti to discuss the ESGO, ISSVD, ECSVD, and EFC consensus statements on pre-invasive vulvar lesions. Dr. Preti received his Specialization in Gynecology and Obstetrics and Specialization in Medical Oncology at the University of Torino. He is Associate Professor at the Department of Surgical Sciences, University of Torino, Italy, and the Immediate Past President of the ISSVD (International Society for the Study of Vulvo-vaginal disease). Dr. Preti is the author of 4 books on vulvo-vaginal diseases, and as of June 2022, he has published 108 papers indexed in Scopus/Pubmed, with 2,014 citations and an H-index of 23.

Highlights:
Epidemiological data show no decrease in vulvar invasive cancer incidence. This means that accurate diagnosis and treatment of pre-invasive vulvar disease must be improved: these are among the ESGO-ISSVD-ECSVD aims.
The two carcinogenic pathways of vulvar squamous neoplasia recognize as precursors two vulvar intraepithelial neoplasia (VIN): HPV-associated squamous intraepithelial lesions (High Grade VIN) and HPV-independent VIN (mainly differentiated VIN). These precursors have different clinical approach, treatment and oncological risk. Their histologic features can be subtle, and the histological diagnosis may be further complicated by coexisting conditions.
For differentiated VIN, an excisional procedure must always be adopted. Medical treatment (imiquimod or cidofovir) and ablative treatment can be considered for high grade VIN to preserve anatomy and function. These conservative approaches must be preceded by representative biopsies to exclude invasive disease.
Follow up should be modulated according to the risk of recurrence (type of lesion, patient age and immunological conditions, other associated lower genital tract lesions).
Pre-invasive vulvar lesions deserve specific attention because they affect not only functionality and body image, but also psychosexual factors.</description>
      <enclosure length="35824534" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1297082368-bmjpodcasts-consensus-statement-on-pre-invasive-vulvar-disease-with-mario-preti.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1291590973</guid>
      <title>Episode 4: Recent Cannabis Use and Nightly Sleep Duration in Adults</title>
      <pubDate>Mon, 27 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-4-recent-cannabis-use-and-nightly-sleep-duration-in-adults</link>
      <itunes:duration>00:33:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>There is much political, professional, and cultural debate around the impact that cannabinoids, good or bad, have on health and wellbeing. This month’s “RAPM Focus,” evaluates the relationship between cannabis use and sleep patterns among adult Americans. Editor-in-Chief Brian Sites, MD, interviews authors Calvin Diep, MD, and Karim Ladha, MD, on the paper “Recent cannabis use and nightly sleep duration in adults: a population analysis of the NHANES from 2005 to 2018,” first published in December 2021 (https://rapm.bmj.com/content/47/2/100). The study used observational data from the National Health and Nutrition Examination Survey (NHANES) and examined whether recent use of cannabinoids impacted on incidence of too little sleep or too much sleep.

Dr. Diap is a second-year resident in the Department of Anesthesiology and Pain Medicine at the University of Toronto. He is also enrolled in the clinician investigator program and will be starting his graduate studies at the Institute of Health Policy Management at the University of Toronto. His research interests lie in using clinician epidemiological methods to study patient-centered outcomes in the perioperative period, such as pain and disability, as well as opioid and cannabinoid use patterns at population levels.

Dr. Ladha is a clinician scientist and staff anesthesiologist at St. Michael’s Hospital at the University of Toronto. He received his medical degree from the Johns Hopkins University School of Medicine. He then completed his anesthesia training at the Massachusetts General Hospital and obtained a master’s degree in clinical epidemiology from the Harvard School of Public Health. His research uses mixed methodologies to obtain a multi-faceted view of pain and recovery after surgery, including retrospective analyses of administrative databases and prospective observational studies in multi-center randomized controlled trials.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</itunes:summary>
      <itunes:subtitle>There is much political, professional, and cultur…</itunes:subtitle>
      <description>There is much political, professional, and cultural debate around the impact that cannabinoids, good or bad, have on health and wellbeing. This month’s “RAPM Focus,” evaluates the relationship between cannabis use and sleep patterns among adult Americans. Editor-in-Chief Brian Sites, MD, interviews authors Calvin Diep, MD, and Karim Ladha, MD, on the paper “Recent cannabis use and nightly sleep duration in adults: a population analysis of the NHANES from 2005 to 2018,” first published in December 2021 (https://rapm.bmj.com/content/47/2/100). The study used observational data from the National Health and Nutrition Examination Survey (NHANES) and examined whether recent use of cannabinoids impacted on incidence of too little sleep or too much sleep.

Dr. Diap is a second-year resident in the Department of Anesthesiology and Pain Medicine at the University of Toronto. He is also enrolled in the clinician investigator program and will be starting his graduate studies at the Institute of Health Policy Management at the University of Toronto. His research interests lie in using clinician epidemiological methods to study patient-centered outcomes in the perioperative period, such as pain and disability, as well as opioid and cannabinoid use patterns at population levels.

Dr. Ladha is a clinician scientist and staff anesthesiologist at St. Michael’s Hospital at the University of Toronto. He received his medical degree from the Johns Hopkins University School of Medicine. He then completed his anesthesia training at the Massachusetts General Hospital and obtained a master’s degree in clinical epidemiology from the Harvard School of Public Health. His research uses mixed methodologies to obtain a multi-faceted view of pain and recovery after surgery, including retrospective analyses of administrative databases and prospective observational studies in multi-center randomized controlled trials.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.</description>
      <enclosure length="79786784" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1291590973-bmjpodcasts-episode-4-recent-cannabis-use-and-nightly-sleep-duration-in-adults.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-36rEAsdbqSkJRswY-u6sWGg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1293075460</guid>
      <title>Do doctors do what they preach</title>
      <pubDate>Fri, 24 Jun 2022 06:00:23 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/do-doctors-do-what-they-preach</link>
      <itunes:duration>00:45:27</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>At medical school, we learn about the importance of healthy health behaviours and promote them to patients at consultations. But do you always do what you preach? 

In this episode, we chatted about the importance of self-care, admitting to the inability to be infallible, and whether your health habits would affect the way you counsel your patients.
 
Expert guest:
Professor Erica Frank (erica.frank@ubc.ca) is a Professor at the Faculty of Medicine at the University of British Columbia; she is also the Founder of NextGenU.org.

Articles mentioned in the episode:
• Alcohol consumption and alcohol counselling behaviour among US medical students: cohort study - https://www.bmj.com/content/337/bmj.a2155 
• Experiences of belittlement and harassment and their correlates among medical students in the United States: longitudinal survey - https://www.bmj.com/content/333/7570/682 
 
Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>At medical school, we learn about the importance …</itunes:subtitle>
      <description>At medical school, we learn about the importance of healthy health behaviours and promote them to patients at consultations. But do you always do what you preach? 

In this episode, we chatted about the importance of self-care, admitting to the inability to be infallible, and whether your health habits would affect the way you counsel your patients.
 
Expert guest:
Professor Erica Frank (erica.frank@ubc.ca) is a Professor at the Faculty of Medicine at the University of British Columbia; she is also the Founder of NextGenU.org.

Articles mentioned in the episode:
• Alcohol consumption and alcohol counselling behaviour among US medical students: cohort study - https://www.bmj.com/content/337/bmj.a2155 
• Experiences of belittlement and harassment and their correlates among medical students in the United States: longitudinal survey - https://www.bmj.com/content/333/7570/682 
 
Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="43642496" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1293075460-bmjpodcasts-do-doctors-do-what-they-preach.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-m4GjR7IuHyQoFNOi-c09P1g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1291062979</guid>
      <title>PICaSSO Histologic Remission Index in ulcerative colitis: a novel simplified histological score</title>
      <pubDate>Fri, 24 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/picasso-histologic-remission-index-in-ulcerative-colitis-a-novel-simplified-histological-score</link>
      <itunes:duration>00:10:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Dr Marietta Iacucci, Associate Professor in Gastroenterology, Institute of Immunology and Immunotherapy, University of Birmingham and Consultant Gastroenterologist, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, on the paper "‘PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" published in paper copy in Gut in May 2022, and available online: https://gut.bmj.com/content/71/5/889
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Dr Marietta Iacucci, Associate Professor in Gastroenterology, Institute of Immunology and Immunotherapy, University of Birmingham and Consultant Gastroenterologist, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, on the paper "‘PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system" published in paper copy in Gut in May 2022, and available online: https://gut.bmj.com/content/71/5/889
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="10127150" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1291062979-bmjpodcasts-picasso-histologic-remission-index-in-ulcerative-colitis-a-novel-simplified-histological-score.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1293495937</guid>
      <title>Is telehealth here to stay? Dr Allison Ezzat on patient and clinician pandemic experiences. EP #509</title>
      <pubDate>Fri, 24 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/is-telehealth-here-to-stay-dr-allison-ezzat-on-patient-and-clinician-pandemic-experiences-ep-509</link>
      <itunes:duration>00:25:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>One of the silver linings of COVID-19 pandemic is the increased adoption of telehealth in allied health and sports medicine services for people with musculoskeletal conditions. In this podcast we talk to Dr Allison Ezzat about the experiences and attitudes of patients and clinicians in using telehealth. Allison has led the creation of a telehealth toolkit for patients and clinicians and discusses the future of telehealth. Allison is a Canadian physiotherapist, and a current post-doctoral research fellow at La Trobe University, Australia. 
“It's second best”: A mixed-methods evaluation of the experiences and attitudes of people with musculoskeletal pain towards physiotherapist delivered telehealth during COVID-19 pandemic - https://www.sciencedirect.com/science/article/pii/S2468781221001843?via%3Dihub
Canadian Physiotherapists Integrate Virtual Care during the COVID-19 Pandemic https://utpjournals.press/doi/10.3138/ptc-2022-0092 
“Much better than I thought it was going to be - telehealth delivered group-based education and exercise was perceived as acceptable among people with knee osteoarthritis” https://www.sciencedirect.com/science/article/pii/S2665913122000395
Telehealth toolkit for clinicians:  https://telehealth.trekeducation.org/</itunes:summary>
      <itunes:subtitle>One of the silver linings of COVID-19 pandemic is…</itunes:subtitle>
      <description>One of the silver linings of COVID-19 pandemic is the increased adoption of telehealth in allied health and sports medicine services for people with musculoskeletal conditions. In this podcast we talk to Dr Allison Ezzat about the experiences and attitudes of patients and clinicians in using telehealth. Allison has led the creation of a telehealth toolkit for patients and clinicians and discusses the future of telehealth. Allison is a Canadian physiotherapist, and a current post-doctoral research fellow at La Trobe University, Australia. 
“It's second best”: A mixed-methods evaluation of the experiences and attitudes of people with musculoskeletal pain towards physiotherapist delivered telehealth during COVID-19 pandemic - https://www.sciencedirect.com/science/article/pii/S2468781221001843?via%3Dihub
Canadian Physiotherapists Integrate Virtual Care during the COVID-19 Pandemic https://utpjournals.press/doi/10.3138/ptc-2022-0092 
“Much better than I thought it was going to be - telehealth delivered group-based education and exercise was perceived as acceptable among people with knee osteoarthritis” https://www.sciencedirect.com/science/article/pii/S2665913122000395
Telehealth toolkit for clinicians:  https://telehealth.trekeducation.org/</description>
      <enclosure length="60000129" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1293495937-bmjpodcasts-is-telehealth-here-to-stay-dr-allison-ezzat-on-patient-and-clinician-pandemic-experiences-ep-509.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1291662211</guid>
      <title>Bradford Tales Authentically and Poetically Portrayed in Film by Clio Barnard</title>
      <pubDate>Thu, 23 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/bradford-tales-film-by-clio-barnard</link>
      <itunes:duration>00:35:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Clio Barnard is multi-award winning British Film writer, director and producer. In this conversation with Medical Humanities' film and media correspondent,  Khalid Ali, she revisits her 'Bradford Film Trilogy'; 'The Arbor' (2010), 'The Selfish Giant' (2013), and 'Ali &amp; Ava' (2021). 
The uniqueness and diversity of Bradford community portrayed as a love story between two unlikely characters made 'Ali and Ava' a film celebrating love, friendship, forgiveness, and hope.
Read more about Clio Barnard's work - including a transcript of the podcast on our blog: https://blogs.bmj.com/medical-humanities/2022/06/23/bradford-tales-authentically-and-poetically-portrayed-in-film-by-clio-barnard.
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>Clio Barnard is multi-award winning British Film …</itunes:subtitle>
      <description>Clio Barnard is multi-award winning British Film writer, director and producer. In this conversation with Medical Humanities' film and media correspondent,  Khalid Ali, she revisits her 'Bradford Film Trilogy'; 'The Arbor' (2010), 'The Selfish Giant' (2013), and 'Ali &amp; Ava' (2021). 
The uniqueness and diversity of Bradford community portrayed as a love story between two unlikely characters made 'Ali and Ava' a film celebrating love, friendship, forgiveness, and hope.
Read more about Clio Barnard's work - including a transcript of the podcast on our blog: https://blogs.bmj.com/medical-humanities/2022/06/23/bradford-tales-authentically-and-poetically-portrayed-in-film-by-clio-barnard.
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="69455857" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1291662211-bmjpodcasts-bradford-tales-film-by-clio-barnard.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-35rzDteJIBP6iGmy-ch0M3g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1291445881</guid>
      <title>Posterior reversible encephalopathy syndrome (PRES): diagnosis and management</title>
      <pubDate>Tue, 21 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/posterior-reversible-encephalopathy-syndrome-pres-diagnosis-and-management</link>
      <itunes:duration>00:30:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr. Amy Ross Russell(1), interviews Assoc. Prof. Todd Hardy(2) and Dr. James Triplett(3), about their recent paper detailing the clinical approach to diagnosis and management of Posterior Reversible Encephalopathy Syndrome (PRES).

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/3/183) and the June print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-june-2022-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Staff Specialist Neurologist at Concord Hospital, Clinical Associate Professor in Medicine at the University of Sydney, Australia
(3) Staff Specialist Neurologist and Neurophysiologist, Concord Hospital, Sydney, Australia

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</itunes:summary>
      <itunes:subtitle>Dr. Amy Ross Russell(1), interviews Assoc. Prof. …</itunes:subtitle>
      <description>Dr. Amy Ross Russell(1), interviews Assoc. Prof. Todd Hardy(2) and Dr. James Triplett(3), about their recent paper detailing the clinical approach to diagnosis and management of Posterior Reversible Encephalopathy Syndrome (PRES).

Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/3/183) and the June print issue of the journal.

The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-june-2022-issue?in=bmjpodcasts/sets/pn-podcast

(1) Neurology, University Hospital Southampton NHS Foundation Trust, UK
(2) Staff Specialist Neurologist at Concord Hospital, Clinical Associate Professor in Medicine at the University of Sydney, Australia
(3) Staff Specialist Neurologist and Neurophysiologist, Concord Hospital, Sydney, Australia

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.</description>
      <enclosure length="29132172" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1291445881-bmjpodcasts-posterior-reversible-encephalopathy-syndrome-pres-diagnosis-and-management.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1291555279</guid>
      <title>Reflections on my presidency and the future of AFMR with Samrat Das, MD</title>
      <pubDate>Tue, 21 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reflections-on-my-presidency-and-the-future-of-afmr-with-samrat-das-md</link>
      <itunes:duration>00:31:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief Dr. Richard McCallum and Associate Professor of Pediatrics and the Director of Pediatric Undergraduate Medical Education at Duke University School of Medicine, Dr. Samrat Das, discuss what it has been like to be the president of the American Federation of Medical Research (AFMR) over the last year. Join us as we honor Dr. Das during his final days as president of AFMR. Dr. Das discusses advice for future presidents and his own future career plans. We are very grateful for all the work Dr. Das has done for AFMR, and we wish him the very best in his future endeavors.</itunes:summary>
      <itunes:subtitle>Editor-in-Chief Dr. Richard McCallum and Associat…</itunes:subtitle>
      <description>Editor-in-Chief Dr. Richard McCallum and Associate Professor of Pediatrics and the Director of Pediatric Undergraduate Medical Education at Duke University School of Medicine, Dr. Samrat Das, discuss what it has been like to be the president of the American Federation of Medical Research (AFMR) over the last year. Join us as we honor Dr. Das during his final days as president of AFMR. Dr. Das discusses advice for future presidents and his own future career plans. We are very grateful for all the work Dr. Das has done for AFMR, and we wish him the very best in his future endeavors.</description>
      <enclosure length="30176362" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1291555279-bmjpodcasts-reflections-on-my-presidency-and-the-future-of-afmr-with-samrat-das-md.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-70kbmOy2s1YSSQsi-LEZ2sw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1290949009</guid>
      <title>Working in the NHS with Long Covid: three nurses’ stories</title>
      <pubDate>Tue, 21 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/being-a-nurse-living-with-long-covid</link>
      <itunes:duration>00:51:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Living with Long Covid is a different experience for each person, and can have significant ramifications for their personal lives and careers. 
In this last podcast of a series about Long Covid, Dr Alison Twycross, Editor in Chief of Evidence-Based Nursing, hears from Alison Love(1), Lynn Biggerstaff(2) and Sue Campion(3). 
The EBN podcast series of three episodes on Long Covid is produced by Letícia Amorim and edited by Brian O'Toole.
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.
(1) Staff Nurse in ICU; (2) Ward Sister, Community Hospital, elderly rehabilitation ward; (3) Paediatric Nurse, Southampton Children’s Hospital.</itunes:summary>
      <itunes:subtitle>Living with Long Covid is a different experience …</itunes:subtitle>
      <description>Living with Long Covid is a different experience for each person, and can have significant ramifications for their personal lives and careers. 
In this last podcast of a series about Long Covid, Dr Alison Twycross, Editor in Chief of Evidence-Based Nursing, hears from Alison Love(1), Lynn Biggerstaff(2) and Sue Campion(3). 
The EBN podcast series of three episodes on Long Covid is produced by Letícia Amorim and edited by Brian O'Toole.
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.
(1) Staff Nurse in ICU; (2) Ward Sister, Community Hospital, elderly rehabilitation ward; (3) Paediatric Nurse, Southampton Children’s Hospital.</description>
      <enclosure length="48976874" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1290949009-bmjpodcasts-being-a-nurse-living-with-long-covid.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-9MuvMYDwJ6tCn2cy-tR5pVA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1286926687</guid>
      <title>Mark Beattie's UpFront May 2022</title>
      <pubDate>Mon, 20 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mark-beatties-upfront-may-2022</link>
      <itunes:duration>00:08:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The highlights of the latest edition of the journal brought to you by the Editor-in-Chief of Frontline Gastroenterology Mark Beattie.
Read the UpFront of the May 2022 issue of Frontline Gastroenterology: https://fg.bmj.com/content/13/3/183
The full issue is now online: https://fg.bmj.com/content/13/3
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</itunes:summary>
      <itunes:subtitle>The highlights of the latest edition of the journ…</itunes:subtitle>
      <description>The highlights of the latest edition of the journal brought to you by the Editor-in-Chief of Frontline Gastroenterology Mark Beattie.
Read the UpFront of the May 2022 issue of Frontline Gastroenterology: https://fg.bmj.com/content/13/3/183
The full issue is now online: https://fg.bmj.com/content/13/3
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</description>
      <enclosure length="8384260" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1286926687-bmjpodcasts-mark-beatties-upfront-may-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1288717141</guid>
      <title>Fertility preservation for young people with cancer</title>
      <pubDate>Mon, 20 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/fertility-preservation-for-young-people-with-cancer</link>
      <itunes:duration>00:20:48</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month, Dr Rachel Agbeko, Senior Editor of ADC, is joined by paediatric oncologist Dr Amanda Friend(1) to discuss the methods employed for fertility preservation for children of various ages and sexes who are undergoing cancer treatment.
Read the paper 'Inconsistencies in fertility preservation for young people with cancer in the UK' for free for one month on the ADC website: https://adc.bmj.com/content/107/3/265 and in March's issue.
The ADC Spotlight podcast is the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. This series is produced by Letícia Amorim and edited by Brian O'Toole.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832
(1) Leeds Institute of Medical Research, University of Leeds, and Paediatric and Adolescent Oncology, Leeds Teaching Hospitals NHS Trust, UK</itunes:summary>
      <itunes:subtitle>This month, Dr Rachel Agbeko, Senior Editor of AD…</itunes:subtitle>
      <description>This month, Dr Rachel Agbeko, Senior Editor of ADC, is joined by paediatric oncologist Dr Amanda Friend(1) to discuss the methods employed for fertility preservation for children of various ages and sexes who are undergoing cancer treatment.
Read the paper 'Inconsistencies in fertility preservation for young people with cancer in the UK' for free for one month on the ADC website: https://adc.bmj.com/content/107/3/265 and in March's issue.
The ADC Spotlight podcast is the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. This series is produced by Letícia Amorim and edited by Brian O'Toole.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832
(1) Leeds Institute of Medical Research, University of Leeds, and Paediatric and Adolescent Oncology, Leeds Teaching Hospitals NHS Trust, UK</description>
      <enclosure length="19977194" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1288717141-bmjpodcasts-fertility-preservation-for-young-people-with-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-MRWRroZ1Uz3oKq7p-pEKt2w-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1289136877</guid>
      <title>Mentor's Podcast: Andreas Obermair</title>
      <pubDate>Mon, 20 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mentors-podcast-andreas-obermair</link>
      <itunes:duration>01:00:02</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Andreas Obermair. Dr. Obermair is a gynecological oncologist in Brisbane, Australia, promoting surgery with proven better patient outcomes.

 

Highlights:

- Facing and dealing with adversity in life
- Goals for making gynecological oncology safer, less invasive, and smarter; ensuring that patients are not scared of treatment; and increasing the effectiveness of treatment
- Exploring novel options of therapy and seeking strategies for newer treatments. Only if we are not satisfied with what we do today can we hope to achieve a better outcome tomorrow.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Andreas Obermair. Dr. Obermair is a gynecological oncologist in Brisbane, Australia, promoting surgery with proven better patient outcomes.

 

Highlights:

- Facing and dealing with adversity in life
- Goals for making gynecological oncology safer, less invasive, and smarter; ensuring that patients are not scared of treatment; and increasing the effectiveness of treatment
- Exploring novel options of therapy and seeking strategies for newer treatments. Only if we are not satisfied with what we do today can we hope to achieve a better outcome tomorrow.</description>
      <enclosure length="57644511" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1289136877-bmjpodcasts-mentors-podcast-andreas-obermair.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-JZ2jYmCyDLqEXWgi-GazJMQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1289462392</guid>
      <title>Talk Evidence - political persuasion and mortality, too much medicine</title>
      <pubDate>Fri, 17 Jun 2022 16:45:27 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-political-persuasion-and-mortality-too-much-medicine</link>
      <itunes:duration>00:41:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this week's episode, Helen Macdonald is joined by Joseph Ross, US research editor for The BMJ, and Juan Franco, editor of BMJ EBM.

They begin by discussing a review of obesity interventions in primary care, and Joe wonders if GPs are really the best people to tackle the issue.
https://www.bmj.com/content/377/bmj-2021-069719 

Cervical screening in the UK now includes HPV testing, and they look at research which examines whether this could mean longer periods between screening tests.
https://www.bmj.com/content/377/bmj-2021-068776 

They all enjoy a new State of the Art Review into Revascularization in stable coronary artery disease.
https://www.bmj.com/content/377/bmj-2021-067085

Juan and Joe look at a review into combinations of covid-19 vaccinations - and wonder whether we'll ever see more trials to fit into this meta-analysis. 
https://www.bmj.com/content/377/bmj-2022-069989

Finally, they find out how your political persuasion has affected mortality in the US, with new research that links Republican and Democrat voters with differential changes in mortality.
https://www.bmj.com/content/377/bmj-2021-069308</itunes:summary>
      <itunes:subtitle>In this week's episode, Helen Macdonald is joined…</itunes:subtitle>
      <description>In this week's episode, Helen Macdonald is joined by Joseph Ross, US research editor for The BMJ, and Juan Franco, editor of BMJ EBM.

They begin by discussing a review of obesity interventions in primary care, and Joe wonders if GPs are really the best people to tackle the issue.
https://www.bmj.com/content/377/bmj-2021-069719 

Cervical screening in the UK now includes HPV testing, and they look at research which examines whether this could mean longer periods between screening tests.
https://www.bmj.com/content/377/bmj-2021-068776 

They all enjoy a new State of the Art Review into Revascularization in stable coronary artery disease.
https://www.bmj.com/content/377/bmj-2021-067085

Juan and Joe look at a review into combinations of covid-19 vaccinations - and wonder whether we'll ever see more trials to fit into this meta-analysis. 
https://www.bmj.com/content/377/bmj-2022-069989

Finally, they find out how your political persuasion has affected mortality in the US, with new research that links Republican and Democrat voters with differential changes in mortality.
https://www.bmj.com/content/377/bmj-2021-069308</description>
      <enclosure length="39454510" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1289462392-bmjpodcasts-talk-evidence-political-persuasion-and-mortality-too-much-medicine.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-hDmmaOiPBa29QvOy-nMLtow-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1289174035</guid>
      <title>Brain Health – a key concept for all working in sport. EP# 508</title>
      <pubDate>Fri, 17 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/brain-health-a-key-concept-for-all-working-in-sport-ep-508</link>
      <itunes:duration>00:19:40</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, we are joined by Dr James Robson and Professor Craig Ritchie to discuss all things ‘brain health’. We discuss what is meant by this term, why it is important, and what some of the steps people can take to optimise their brain health.

Related resources:

Lancet Commission https://www.thelancet.com/article/S0140-6736(20)30367-6/fulltext

Sport and Exercise for Brain Health MOOC https://www.futurelearn.com/admin/courses/sport-and-exercise-for-brain-health/1</itunes:summary>
      <itunes:subtitle>In this podcast, we are joined by Dr James Robson…</itunes:subtitle>
      <description>In this podcast, we are joined by Dr James Robson and Professor Craig Ritchie to discuss all things ‘brain health’. We discuss what is meant by this term, why it is important, and what some of the steps people can take to optimise their brain health.

Related resources:

Lancet Commission https://www.thelancet.com/article/S0140-6736(20)30367-6/fulltext

Sport and Exercise for Brain Health MOOC https://www.futurelearn.com/admin/courses/sport-and-exercise-for-brain-health/1</description>
      <enclosure length="47232521" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1289174035-bmjpodcasts-brain-health-a-key-concept-for-all-working-in-sport-ep-508.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1284005410</guid>
      <title>CPET testing in heart failure - a masterclass with Dr. Buber from Seattle</title>
      <pubDate>Tue, 14 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/cpet-testing-in-heart-failure-a-masterclass-with-dr-buber-from-seattle</link>
      <itunes:duration>00:27:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr. James Rudd, is joined by Dr. Buber from Seattle. They discuss all aspects of CPET testing for heart failure and many other indications. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/early/2022/04/10/heartjnl-2021-319617</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr. James Rudd, is joined by Dr. Buber from Seattle. They discuss all aspects of CPET testing for heart failure and many other indications. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/early/2022/04/10/heartjnl-2021-319617</description>
      <enclosure length="64784726" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1284005410-bmjpodcasts-cpet-testing-in-heart-failure-a-masterclass-with-dr-buber-from-seattle.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1286536777</guid>
      <title>Violence against GPs  with Adam Janjua, Marcela Schilderman, and Anita Bignell</title>
      <pubDate>Mon, 13 Jun 2022 12:59:50 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/violence-against-gps</link>
      <itunes:duration>00:52:30</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A recent investigation, by The BMJ, showed a worrying increase in incidence of violence, directed to wards GPs, and reported to the police. In this episode of Deep Breath in, Tom and Jenny are joined by Gareth Iacobucci, assistant news editor for The BMJ who broke the story.

They'll hear from a GP affected, and get some advice on preventing violence, and deescalation, from two mental health experts, who deal with the most agitated patients. 

Our guests:
Adam Janjua, a GP in Fleetwood, Lancashire.
Marcela Schilderman, a consultant psychiatrist at South London and the Maudsley NHS Foundation Trust 
and Anita Bignell, a mental health nurse, at South London and the Maudsley NHS Foundation Trust

Reading list
Violent incidents at GP surgeries double in five years, BMJ investigation finds
https://www.bmj.com/content/377/bmj.o1333</itunes:summary>
      <itunes:subtitle>A recent investigation, by The BMJ, showed a worr…</itunes:subtitle>
      <description>A recent investigation, by The BMJ, showed a worrying increase in incidence of violence, directed to wards GPs, and reported to the police. In this episode of Deep Breath in, Tom and Jenny are joined by Gareth Iacobucci, assistant news editor for The BMJ who broke the story.

They'll hear from a GP affected, and get some advice on preventing violence, and deescalation, from two mental health experts, who deal with the most agitated patients. 

Our guests:
Adam Janjua, a GP in Fleetwood, Lancashire.
Marcela Schilderman, a consultant psychiatrist at South London and the Maudsley NHS Foundation Trust 
and Anita Bignell, a mental health nurse, at South London and the Maudsley NHS Foundation Trust

Reading list
Violent incidents at GP surgeries double in five years, BMJ investigation finds
https://www.bmj.com/content/377/bmj.o1333</description>
      <enclosure length="50416325" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1286536777-bmjpodcasts-violence-against-gps.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Tqy8mWi9bDQ02wgc-1sMbPg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1287119164</guid>
      <title>Fertility-sparing Neoadjuvant Chemotherapy in &gt;4cm Cervical Cancer with Dr. David Viveros-Carreño</title>
      <pubDate>Mon, 13 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/fertility-sparing-neoadjuvant-chemotherapy-in-4cm-cervical-cancer-with-dr-david-viveros-carreno-1</link>
      <itunes:duration>00:29:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Viveros-Carreño. Dr. Viveros-Carreño is a Gynecologic Oncologist at Instituto Nacional de Cancerología, Clínica Universitaria Colombia and Clínica Los Nogales in Bogotá, Colombia.

Highlights:
- Fertility-sparing surgery after neoadjuvant chemotherapy in cervical cancer &gt;4 cm is feasible, but the evidence is limited and should be considered as an experimental intervention.
- A complete pathological response occurred in 56% of patients.
- At least one pregnancy was achieved in 67% of cases and 60% were pre-term deliveries.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Viveros-Carreño. Dr. Viveros-Carreño is a Gynecologic Oncologist at Instituto Nacional de Cancerología, Clínica Universitaria Colombia and Clínica Los Nogales in Bogotá, Colombia.

Highlights:
- Fertility-sparing surgery after neoadjuvant chemotherapy in cervical cancer &gt;4 cm is feasible, but the evidence is limited and should be considered as an experimental intervention.
- A complete pathological response occurred in 56% of patients.
- At least one pregnancy was achieved in 67% of cases and 60% were pre-term deliveries.</description>
      <enclosure length="28204302" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1287119164-bmjpodcasts-fertility-sparing-neoadjuvant-chemotherapy-in-4cm-cervical-cancer-with-dr-david-viveros-carreno-1.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1284272251</guid>
      <title>Handguns, structural racism, and an intersectional framework: 3 student papers</title>
      <pubDate>Thu, 09 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ip-podcast-june-2022</link>
      <itunes:duration>00:29:47</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month we chat with three students recently awarded for their papers at the SAVIR injury conference in the USA.
Stephen Oliphant is a Doctoral Candidate, School of Criminal Justice, Michigan State University; Kelsey Conrick is a Doctoral Student, School of Social Work, University of Washington; and Mudia Uzzi is a Doctoral Candidate, Health Policy Research Scholar at Robert Wood Johnson Foundation, Department of Health, Behavior and Society Johns Hopkins University.
Read these and the other Abstracts from the SAVIR conference on the Injury Prevention website: 
"Do handgun purchase waiting periods save lives? Evidence from a synthetic control approach" - https://injuryprevention.bmj.com/content/28/Suppl_1/A6.2

"Modeling the association of structural racism with disparities in firearm homicide victimization" - https://injuryprevention.bmj.com/content/28/Suppl_1/A23.1

 "Investigating violence disparities through an intersectional lens: using additive interaction approaches to explore the relationship of redlining and racialized economic segregation on non-fatal shootings in Baltimore city, Maryland" - https://injuryprevention.bmj.com/content/28/Suppl_1/A57.2.

Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>This month we chat with three students recently a…</itunes:subtitle>
      <description>This month we chat with three students recently awarded for their papers at the SAVIR injury conference in the USA.
Stephen Oliphant is a Doctoral Candidate, School of Criminal Justice, Michigan State University; Kelsey Conrick is a Doctoral Student, School of Social Work, University of Washington; and Mudia Uzzi is a Doctoral Candidate, Health Policy Research Scholar at Robert Wood Johnson Foundation, Department of Health, Behavior and Society Johns Hopkins University.
Read these and the other Abstracts from the SAVIR conference on the Injury Prevention website: 
"Do handgun purchase waiting periods save lives? Evidence from a synthetic control approach" - https://injuryprevention.bmj.com/content/28/Suppl_1/A6.2

"Modeling the association of structural racism with disparities in firearm homicide victimization" - https://injuryprevention.bmj.com/content/28/Suppl_1/A23.1

 "Investigating violence disparities through an intersectional lens: using additive interaction approaches to explore the relationship of redlining and racialized economic segregation on non-fatal shootings in Baltimore city, Maryland" - https://injuryprevention.bmj.com/content/28/Suppl_1/A57.2.

Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="28601781" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1284272251-bmjpodcasts-ip-podcast-june-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-lBNYPWMk19NnXlDd-TWVzcQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1282140646</guid>
      <title>Next-generation sequencing of bile cell-free DNA for early detection of malignant biliary strictures</title>
      <pubDate>Tue, 07 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/next-generation-sequencing-of-bile-cell-free-dna-for-early-detection-of-malignant-biliary-strictures</link>
      <itunes:duration>00:10:02</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Dr Maria Arechederra, young researcher at the Hepatology Program in the Center for Applied Medical Research (CIMA) from the University of Navarra in Pamplona, Spain, on the paper "Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures" which is published in paper copy in Gut in June 2022, and available online: https://gut.bmj.com/content/71/6/1141
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Dr Maria Arechederra, young researcher at the Hepatology Program in the Center for Applied Medical Research (CIMA) from the University of Navarra in Pamplona, Spain, on the paper "Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures" which is published in paper copy in Gut in June 2022, and available online: https://gut.bmj.com/content/71/6/1141
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="9634794" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1282140646-bmjpodcasts-next-generation-sequencing-of-bile-cell-free-dna-for-early-detection-of-malignant-biliary-strictures.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1279286620</guid>
      <title>Air pollution associated with higher risk of developing autoimmune diseases</title>
      <pubDate>Mon, 06 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/air-pollution-associated-with-higher-risk-of-developing-autoimmune-diseases</link>
      <itunes:duration>00:18:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, RMD Open's Social Media Advisor, Dr. Paul Studenic, speaks to Dr. Giovanni Adami, from Universita degli Studi di Verona, Italy, about his population-based cohort study evaluating air pollution-associated risk of developing an immune-mediated disease. By using an Italian-wide patient-dataset, initially designed for fracture risk assessment in women in combination with data for air-quality control stations across Italy, he presents results indicating that long-term exposure to air pollution coincides with a higher risk of developing autoimmune diseases.
Read it on the RMD Open website: https://rmdopen.bmj.com/content/8/1/e002055</itunes:summary>
      <itunes:subtitle>In this podcast, RMD Open's Social Media Advisor,…</itunes:subtitle>
      <description>In this podcast, RMD Open's Social Media Advisor, Dr. Paul Studenic, speaks to Dr. Giovanni Adami, from Universita degli Studi di Verona, Italy, about his population-based cohort study evaluating air pollution-associated risk of developing an immune-mediated disease. By using an Italian-wide patient-dataset, initially designed for fracture risk assessment in women in combination with data for air-quality control stations across Italy, he presents results indicating that long-term exposure to air pollution coincides with a higher risk of developing autoimmune diseases.
Read it on the RMD Open website: https://rmdopen.bmj.com/content/8/1/e002055</description>
      <enclosure length="17985200" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1279286620-bmjpodcasts-air-pollution-associated-with-higher-risk-of-developing-autoimmune-diseases.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-xsyoYtEZKvN4aP9w-fnLRPA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1279209400</guid>
      <title>End of Life Care in Gynecologic Oncology</title>
      <pubDate>Mon, 06 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/end-of-life-care-in-gynecologic-oncology</link>
      <itunes:duration>00:34:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Katherine Hicks-Courant, MD, MSHP. Dr. Hicks-Courant is a fellow in the Division of Gynecologic Oncology at the University of Pennsylvania. She studies the intersection of gynecologic oncology, palliative care and oncology care delivery systems.
 
Highlights:

Having a gynecologic rather than a medical oncologist was associated with lower rates of high-intensity end-of-life care.
Having a gynecologic oncologist rather than a medical oncologist was associated with higher rates of invasive procedures.
Having a gynecologic oncologist rather than a medical oncologist was associated with higher Medicare spending.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Katherine Hicks-Courant, MD, MSHP. Dr. Hicks-Courant is a fellow in the Division of Gynecologic Oncology at the University of Pennsylvania. She studies the intersection of gynecologic oncology, palliative care and oncology care delivery systems.
 
Highlights:

Having a gynecologic rather than a medical oncologist was associated with lower rates of high-intensity end-of-life care.
Having a gynecologic oncologist rather than a medical oncologist was associated with higher rates of invasive procedures.
Having a gynecologic oncologist rather than a medical oncologist was associated with higher Medicare spending.</description>
      <enclosure length="33100276" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1279209400-bmjpodcasts-end-of-life-care-in-gynecologic-oncology.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1275678604</guid>
      <title>Defining remission in systemic lupus erythematosus</title>
      <pubDate>Wed, 01 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/defining-remission-in-systemic-lupus-erythematosus</link>
      <itunes:duration>00:19:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Duane Peters from the Lupus Foundation of America interviews Professor Ronald van Vollenhoven from the Amsterdam University Medical Centers in the Netherlands and Dr Cynthia Aranow from the Feinstein Institute for Medical Research in New York, USA. 

They discuss the efforts of the DORIS international task force to agree on a single definition of remission in systemic lupus erythematosus, which they hope will ensure that clinicians, patients and researchers in the field are all working towards the same outcome. 

Access the article: https://lupus.bmj.com/content/8/1/e000538</itunes:summary>
      <itunes:subtitle>Duane Peters from the Lupus Foundation of America…</itunes:subtitle>
      <description>Duane Peters from the Lupus Foundation of America interviews Professor Ronald van Vollenhoven from the Amsterdam University Medical Centers in the Netherlands and Dr Cynthia Aranow from the Feinstein Institute for Medical Research in New York, USA. 

They discuss the efforts of the DORIS international task force to agree on a single definition of remission in systemic lupus erythematosus, which they hope will ensure that clinicians, patients and researchers in the field are all working towards the same outcome. 

Access the article: https://lupus.bmj.com/content/8/1/e000538</description>
      <enclosure length="16630202" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1275678604-bmjpodcasts-defining-remission-in-systemic-lupus-erythematosus.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zOfBZ6joPLX9GdP1-jqUXQg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1269325504</guid>
      <title>Enteropathies with villous atrophy but negative coeliac serology in adults: current issues</title>
      <pubDate>Wed, 01 Jun 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/enteropathies-with-villous-atrophy-but-negative-coeliac-serology-in-adults-current-issues</link>
      <itunes:duration>00:22:21</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This is the first in a new series of BMJ Open Gastroenterology interviews, in which we will be covering high-profile publications in conjunction with the lead authors of the papers. 
In this quarter’s podcast, we will be discussing a review article entitled ‘Enteropathies with villous atrophy but negative coeliac serology in adults: current issues’ published online in November 2021 (https://bmjopengastro.bmj.com/content/8/1/e000630).
Dr James Ashton (Social Media Editor of BMJOG) interviews Dr. Annalisa Schiepatti, researcher at the University of Pavia, Italy, and a junior consultant at the Gastroenterology Unit of Maugeri Insitute in Pavia.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</itunes:summary>
      <itunes:subtitle>This is the first in a new series of BMJ Open Gas…</itunes:subtitle>
      <description>This is the first in a new series of BMJ Open Gastroenterology interviews, in which we will be covering high-profile publications in conjunction with the lead authors of the papers. 
In this quarter’s podcast, we will be discussing a review article entitled ‘Enteropathies with villous atrophy but negative coeliac serology in adults: current issues’ published online in November 2021 (https://bmjopengastro.bmj.com/content/8/1/e000630).
Dr James Ashton (Social Media Editor of BMJOG) interviews Dr. Annalisa Schiepatti, researcher at the University of Pavia, Italy, and a junior consultant at the Gastroenterology Unit of Maugeri Insitute in Pavia.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</description>
      <enclosure length="21460113" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1269325504-bmjpodcasts-enteropathies-with-villous-atrophy-but-negative-coeliac-serology-in-adults-current-issues.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8Hpqx4SiPtynOzgC-7ijsKA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1275323350</guid>
      <title>June 2022 - a complaint, primary care spirometry, paracetamol and frailty, serotonin syndrome</title>
      <pubDate>Tue, 31 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-june-2022</link>
      <itunes:duration>00:20:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the June 2022 issue of DTB. They discuss the impact that the cessation of spirometry services in primary care has had on diagnosing obstructive lung disease (https://dtb.bmj.com/content/60/6/82). They highlight two separate patient safety incident reports from the Healthcare Safety Investigation Branch - confusion over the prescribed dose of oral morphine solution and the harm caused by a standard therapeutic dose of paracetamol in a frail older person (https://dtb.bmj.com/content/60/6/84). The editors also talk about an article on serotonin syndrome (https://dtb.bmj.com/content/60/6/88).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.
Read the June issue: https://dtb.bmj.com/content/60/6</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the June 2022 issue of DTB. They discuss the impact that the cessation of spirometry services in primary care has had on diagnosing obstructive lung disease (https://dtb.bmj.com/content/60/6/82). They highlight two separate patient safety incident reports from the Healthcare Safety Investigation Branch - confusion over the prescribed dose of oral morphine solution and the harm caused by a standard therapeutic dose of paracetamol in a frail older person (https://dtb.bmj.com/content/60/6/84). The editors also talk about an article on serotonin syndrome (https://dtb.bmj.com/content/60/6/88).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.
Read the June issue: https://dtb.bmj.com/content/60/6</description>
      <enclosure length="50210894" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1275323350-bmjpodcasts-dtb-june-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1276102435</guid>
      <title>Aortopathy in Pregnancy</title>
      <pubDate>Tue, 31 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/aortopathy-in-pregnancy</link>
      <itunes:duration>00:25:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Dr Andrew Perry is joined by Dr. Stephanie Curtis, a physician at the Bristol Royal Infirmary who specializes in caring for women who are pregnant and have co-morbid aortopathy. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/02/09/heartjnl-2021-319828</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Dr Andrew P…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Dr Andrew Perry is joined by Dr. Stephanie Curtis, a physician at the Bristol Royal Infirmary who specializes in caring for women who are pregnant and have co-morbid aortopathy. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/02/09/heartjnl-2021-319828</description>
      <enclosure length="62297368" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1276102435-bmjpodcasts-aortopathy-in-pregnancy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1277938258</guid>
      <title>"But it’s always been done that way"</title>
      <pubDate>Mon, 30 May 2022 16:30:15 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/but-its-aways-been-done-that-way</link>
      <itunes:duration>00:50:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In Doctor Informed, we've been hearing a lot about the problems of healthcare, but we also want to talk about solutions. Whatever we're going to do to fix healthcare, whether that's bullying, or burnout, or patient safety - it's going to require change. And change is hard.

 

In this episode Clara Munro is joined by Graham Martin, director of research at THIS Institute. They discuss the dreaded phrase "But it's always been done this way", and why failing is the path to success, and the true importance of listening.

 

Our guests;

Penny Pereira, Q managing director at the Health Foundation. Q helps promote improvement within the health and care system, encouraging and supporting a wide range of people to effectively lead improvement. https://www.health.org.uk/about-the-health-foundation/our-people/q-and-q-labs-team

Moira Durbridge, director of safety and risk at University Hospitals of Leicester NHS Trust. Moira trained as a nurse, and continues to work clinically, as well as her role in leading her Trust's change.</itunes:summary>
      <itunes:subtitle>In Doctor Informed, we've been hearing a lot abou…</itunes:subtitle>
      <description>In Doctor Informed, we've been hearing a lot about the problems of healthcare, but we also want to talk about solutions. Whatever we're going to do to fix healthcare, whether that's bullying, or burnout, or patient safety - it's going to require change. And change is hard.

 

In this episode Clara Munro is joined by Graham Martin, director of research at THIS Institute. They discuss the dreaded phrase "But it's always been done this way", and why failing is the path to success, and the true importance of listening.

 

Our guests;

Penny Pereira, Q managing director at the Health Foundation. Q helps promote improvement within the health and care system, encouraging and supporting a wide range of people to effectively lead improvement. https://www.health.org.uk/about-the-health-foundation/our-people/q-and-q-labs-team

Moira Durbridge, director of safety and risk at University Hospitals of Leicester NHS Trust. Moira trained as a nurse, and continues to work clinically, as well as her role in leading her Trust's change.</description>
      <enclosure length="48692661" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1277938258-bmjpodcasts-but-its-aways-been-done-that-way.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-LDABgfwgLaPwCB02-DIJolA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1277719222</guid>
      <title>Milk allergies with Nicola Brathwaite</title>
      <pubDate>Mon, 30 May 2022 09:47:25 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/milk-allergies-with-nicola-brathwaite</link>
      <itunes:duration>00:47:08</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Consultations about suspected cow’s milk protein allergies are quite common in primary care, but these allergies can be a challenge to diagnose, particularly as symptoms can manifest in many different ways, and testing can be complicated. We talk to Dr. Nicola Brathwaite about the diagnosis and management of cow’s milk protein allergies in infants, and our discussion includes how to navigate consultations with parents who may be distressed and fraught with anxiety over their baby’s symptoms, and how best to manage the reintroduction of milk back into the diet.


Our guest:

Nicola Brathwaite is a paediatric allergy consultant at King's College Hospital, London. She completed her specialist training in Paediatrics and Paediatric Allergy in Cape Town, South Africa.</itunes:summary>
      <itunes:subtitle>Consultations about suspected cow’s milk protein …</itunes:subtitle>
      <description>Consultations about suspected cow’s milk protein allergies are quite common in primary care, but these allergies can be a challenge to diagnose, particularly as symptoms can manifest in many different ways, and testing can be complicated. We talk to Dr. Nicola Brathwaite about the diagnosis and management of cow’s milk protein allergies in infants, and our discussion includes how to navigate consultations with parents who may be distressed and fraught with anxiety over their baby’s symptoms, and how best to manage the reintroduction of milk back into the diet.


Our guest:

Nicola Brathwaite is a paediatric allergy consultant at King's College Hospital, London. She completed her specialist training in Paediatrics and Paediatric Allergy in Cape Town, South Africa.</description>
      <enclosure length="45258291" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1277719222-bmjpodcasts-milk-allergies-with-nicola-brathwaite.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1279201375</guid>
      <title>Conservative Management of Cervical Cancer with Rene Pareja</title>
      <pubDate>Mon, 30 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/conservative-management-of-cervical-cancer-with-rene-pareja</link>
      <itunes:duration>00:30:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Rene Pareja to discuss conservative management of cervical cancer. Dr. Pareja is a gynecologist-oncologist at Astorga Oncology Clinic in Medellín and the National Cancer Institute in Bogotá, Colombia. He is a reviewer for more than 20 specialty journals, an Associate Editor for IJGC, a member of the Editorial Board of Gynecology Oncology, and a member of the board of directors of the International Gynecological Cancer Society (IGCS). Additionally, he is a member of FIGO committee on Women's Cancer. Dr. Pareja is the author of nine book chapters and more than 70 publications in peer-reviewed journals, and at IGCS 2021 he received an award for Community Advancement in Resource-Limited Settings.

 
Highlights:

1. Fertility preserving options have to be offered to all women wishing to preserve their fertility potential, that fulfil the ECOG status, histological, and imaging criteria.

2. It is recommended to have an evaluation by human reproduction specialized teams in order to rule out any potential impairment before the surgery. 

3. The relapse rate for vaginal radical trachelectomy, abdominal radical trachelectomy and simple trachelectomy/conization are around 4-5%.

4. The highest live birth rates are seen in patients undergoing conization + lymph node assessment (over 88%).

5. Vaginal radical trachelectomy and minimally invasive radical trachelectomy, with preservation of ascendent branch of uterine artery, are contraindicated in women with tumors &gt; 2 cm, due to the high rate of relapse (over 20%).</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Rene Pareja to discuss conservative management of cervical cancer. Dr. Pareja is a gynecologist-oncologist at Astorga Oncology Clinic in Medellín and the National Cancer Institute in Bogotá, Colombia. He is a reviewer for more than 20 specialty journals, an Associate Editor for IJGC, a member of the Editorial Board of Gynecology Oncology, and a member of the board of directors of the International Gynecological Cancer Society (IGCS). Additionally, he is a member of FIGO committee on Women's Cancer. Dr. Pareja is the author of nine book chapters and more than 70 publications in peer-reviewed journals, and at IGCS 2021 he received an award for Community Advancement in Resource-Limited Settings.

 
Highlights:

1. Fertility preserving options have to be offered to all women wishing to preserve their fertility potential, that fulfil the ECOG status, histological, and imaging criteria.

2. It is recommended to have an evaluation by human reproduction specialized teams in order to rule out any potential impairment before the surgery. 

3. The relapse rate for vaginal radical trachelectomy, abdominal radical trachelectomy and simple trachelectomy/conization are around 4-5%.

4. The highest live birth rates are seen in patients undergoing conization + lymph node assessment (over 88%).

5. Vaginal radical trachelectomy and minimally invasive radical trachelectomy, with preservation of ascendent branch of uterine artery, are contraindicated in women with tumors &gt; 2 cm, due to the high rate of relapse (over 20%).</description>
      <enclosure length="29729017" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1279201375-bmjpodcasts-conservative-management-of-cervical-cancer-with-rene-pareja.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1269939943</guid>
      <title>Episode 3: Percutaneous Cryoneurolysis of the LFCN for Analgesia Following Skin Grafting.</title>
      <pubDate>Mon, 30 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-3-percutaneous-cryoneurolysis-of-the-lfcn-for-analgesia-following-skin-grafting</link>
      <itunes:duration>00:27:40</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month’s “RAPM Focus” highlights a small study conducted by a team out of the University of California San Diego, designed to determine if percutaneous cryoneurolysis of the lateral femoral cutaneous nerve is feasible and shows potential for future study in management of burn patients. Dr. John J. Finneran is the first author of “Percutaneous cryoneurolysis of the lateral femoral cutaneous nerve for analgesia following skin grafting: a randomized, controlled pilot study,” published first in August 2021 and subsequently in the January 2022 print edition (https://rapm.bmj.com/content/47/1/60). 

As Dr. Finneran reported in the paper, peripheral nerve blocks may be used for postoperative analgesia following split thickness skin graft, and the lateral femoral cutaneous nerve is “an 
optimal target, since it innervates the lateral thigh and has no motor component.” However, because local anesthetic nerve blocks are limited in their duration, this study looked at the use of ultrasound-guided percutaneous cyroneurolysis for extended analgesic effect. The results were promising, with the patients who were randomized to the cryoneurolysis group having lower average and maximum pain scores, less need for opioid analgesics, and fewer reports of sleep disturbances during the first two nights after surgery. Listen in as Dr. Finneran describes the study, the procedure, and future research objectives.

Dr. Finneran is a Health Sciences clinical associate professor and associate residency program director in the Department of Anesthesiology at the University of California San Diego, as well as clinical director for Regional Anesthesiology at UC San Diego Medical Center – Hillcrest.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.


@RAPM_Online</itunes:summary>
      <itunes:subtitle>This month’s “RAPM Focus” highlights a small stud…</itunes:subtitle>
      <description>This month’s “RAPM Focus” highlights a small study conducted by a team out of the University of California San Diego, designed to determine if percutaneous cryoneurolysis of the lateral femoral cutaneous nerve is feasible and shows potential for future study in management of burn patients. Dr. John J. Finneran is the first author of “Percutaneous cryoneurolysis of the lateral femoral cutaneous nerve for analgesia following skin grafting: a randomized, controlled pilot study,” published first in August 2021 and subsequently in the January 2022 print edition (https://rapm.bmj.com/content/47/1/60). 

As Dr. Finneran reported in the paper, peripheral nerve blocks may be used for postoperative analgesia following split thickness skin graft, and the lateral femoral cutaneous nerve is “an 
optimal target, since it innervates the lateral thigh and has no motor component.” However, because local anesthetic nerve blocks are limited in their duration, this study looked at the use of ultrasound-guided percutaneous cyroneurolysis for extended analgesic effect. The results were promising, with the patients who were randomized to the cryoneurolysis group having lower average and maximum pain scores, less need for opioid analgesics, and fewer reports of sleep disturbances during the first two nights after surgery. Listen in as Dr. Finneran describes the study, the procedure, and future research objectives.

Dr. Finneran is a Health Sciences clinical associate professor and associate residency program director in the Department of Anesthesiology at the University of California San Diego, as well as clinical director for Regional Anesthesiology at UC San Diego Medical Center – Hillcrest.

*The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.


@RAPM_Online</description>
      <enclosure length="66361988" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1269939943-bmjpodcasts-episode-3-percutaneous-cryoneurolysis-of-the-lfcn-for-analgesia-following-skin-grafting.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-36rEAsdbqSkJRswY-u6sWGg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1276101832</guid>
      <title>What is Archimedes? Pause for thought…</title>
      <pubDate>Fri, 27 May 2022 09:34:42 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/what-is-archimedes-pause-for-thought</link>
      <itunes:duration>00:11:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month we have an interlude in our rush to ask, acquire, appraise and apply the next quality evidence available to our clinically greedy hands, and spend five minutes going over the process of creating an Archimedes. Dr. Bob Philips, Social Media, and Archimedes Editor take you through what you might expect … what might be asked of you … and how to give the fruits of your intellectual inquiry stand the best chance of hitting print (and this podcast).
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>This month we have an interlude in our rush to as…</itunes:subtitle>
      <description>This month we have an interlude in our rush to ask, acquire, appraise and apply the next quality evidence available to our clinically greedy hands, and spend five minutes going over the process of creating an Archimedes. Dr. Bob Philips, Social Media, and Archimedes Editor take you through what you might expect … what might be asked of you … and how to give the fruits of your intellectual inquiry stand the best chance of hitting print (and this podcast).
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="10645419" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1276101832-bmjpodcasts-what-is-archimedes-pause-for-thought.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1275793948</guid>
      <title>Too much medicine</title>
      <pubDate>Fri, 27 May 2022 06:00:30 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/too-much-medicine</link>
      <itunes:duration>00:46:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>“Do no harm” is a mantra that is drummed into medical students from day 1 of medical school. Most of us have gone into medicine as we believe medicine to be a force of good. However, too much medicine is capable of causing harm to patients and generating unnecessary waste.


In this episode, we spoke about overdiagnosis, communicating risks and benefits with patients, and why you shouldn't take that free lunch sponsored by drug companies.


Recommended reading: 
•Preventing overdiagnosis: how to stop harming the healthy. Link: https://www.bmj.com/content/344/bmj.e3502
•Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement. Link: https://www.bmj.com/content/326/7400/1189


Expert guest:
Dr Martin Brunet (@docmartin68 on Twitter) is a GP and a GP trainer at Guildford. He is also the author of The GP Consultation Reimagined: A Tale of Two Houses.


Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/

 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>“Do no harm” is a mantra that is drummed into med…</itunes:subtitle>
      <description>“Do no harm” is a mantra that is drummed into medical students from day 1 of medical school. Most of us have gone into medicine as we believe medicine to be a force of good. However, too much medicine is capable of causing harm to patients and generating unnecessary waste.


In this episode, we spoke about overdiagnosis, communicating risks and benefits with patients, and why you shouldn't take that free lunch sponsored by drug companies.


Recommended reading: 
•Preventing overdiagnosis: how to stop harming the healthy. Link: https://www.bmj.com/content/344/bmj.e3502
•Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement. Link: https://www.bmj.com/content/326/7400/1189


Expert guest:
Dr Martin Brunet (@docmartin68 on Twitter) is a GP and a GP trainer at Guildford. He is also the author of The GP Consultation Reimagined: A Tale of Two Houses.


Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/

 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="44612096" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1275793948-bmjpodcasts-too-much-medicine.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1275561556</guid>
      <title>Assess, ask, reassure, and refer!  Cancer exercise toolkit and tips with Dr Amy Dennett. EP #507</title>
      <pubDate>Fri, 27 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/assess-ask-reassure-and-refer-cancer-exercise-toolkit-and-tips-with-dr-amy-dennett-ep-507</link>
      <itunes:duration>00:30:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this BJSM Podcast Dr Amy Dennett is hosted by Dr Brooke Patterson. Historically people with cancer have been told to rest, and patients and practitioners are often hesitant to get started with physical activity. Amy provides some great practical tips and resources - to support people with cancer exercise safely, safety and precautions, and tips for healthcare services and providers who want to get started with cancer exercise groups. Amy provides a huge array of resources available for healthcare services and clinicians.  
 
Cancer exercise toolkit: https://cancerexercisetoolkit.trekeducation.org/
Cancer exercise toolkit paper: https://cancer.jmir.org/2022/2/e34903/authors 
Treatment protocols https://www.eviq.org.au/  
International registry and handouts on exercise and cancer https://www.exerciseismedicine.org/eim-in-action/moving-through-cancer/ 
Patient and clinician resources https://www.petermac.org/cancersurvivorship</itunes:summary>
      <itunes:subtitle>In this BJSM Podcast Dr Amy Dennett is hosted by …</itunes:subtitle>
      <description>In this BJSM Podcast Dr Amy Dennett is hosted by Dr Brooke Patterson. Historically people with cancer have been told to rest, and patients and practitioners are often hesitant to get started with physical activity. Amy provides some great practical tips and resources - to support people with cancer exercise safely, safety and precautions, and tips for healthcare services and providers who want to get started with cancer exercise groups. Amy provides a huge array of resources available for healthcare services and clinicians.  
 
Cancer exercise toolkit: https://cancerexercisetoolkit.trekeducation.org/
Cancer exercise toolkit paper: https://cancer.jmir.org/2022/2/e34903/authors 
Treatment protocols https://www.eviq.org.au/  
International registry and handouts on exercise and cancer https://www.exerciseismedicine.org/eim-in-action/moving-through-cancer/ 
Patient and clinician resources https://www.petermac.org/cancersurvivorship</description>
      <enclosure length="73728000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1275561556-bmjpodcasts-assess-ask-reassure-and-refer-cancer-exercise-toolkit-and-tips-with-dr-amy-dennett-ep-507.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1248885001</guid>
      <title>Ischaemic stroke</title>
      <pubDate>Thu, 26 May 2022 11:32:56 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ischaemic-stroke</link>
      <itunes:duration>00:25:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Ischaemic stroke is a leading cause of morbidity and mortality.

The World Health Organization defines stroke as “a clinical syndrome consisting of rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin”.

David Wang, Professor of Neurology, Barrow Neurological Institute, Phoenix, Arizona, gives us a clinical overview of the condition.

For more on ischaemic stroke, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/3000114

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Ischaemic stroke is a leading cause of morbidity …</itunes:subtitle>
      <description>Ischaemic stroke is a leading cause of morbidity and mortality.

The World Health Organization defines stroke as “a clinical syndrome consisting of rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin”.

David Wang, Professor of Neurology, Barrow Neurological Institute, Phoenix, Arizona, gives us a clinical overview of the condition.

For more on ischaemic stroke, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/3000114

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="24879951" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1248885001-bmjpodcasts-ischaemic-stroke.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ujs7lai7EfGopsDJ-npDHtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1271875720</guid>
      <title>Primary Survey - the highlights of May 2022</title>
      <pubDate>Thu, 26 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/primary-survey-the-highlights-of-may-2022</link>
      <itunes:duration>00:36:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month we have a feast of studies looking at cardiac arrest. Want to know if one-handed CPR is any good for multi-tasking pre-hospital responders? You'll find out if you listen. Want to know if pre-hospital ECMO should be a thing for elite athletes at major events? We cover that too. Want to know if machine learning is about to revolutionise our practice and solve all our crowding problems? It's all here. And more. Take a listen and keep yourself at the cutting edge!
Read the highlights: https://emj.bmj.com/content/39/5/343
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</itunes:summary>
      <itunes:subtitle>This month we have a feast of studies looking at …</itunes:subtitle>
      <description>This month we have a feast of studies looking at cardiac arrest. Want to know if one-handed CPR is any good for multi-tasking pre-hospital responders? You'll find out if you listen. Want to know if pre-hospital ECMO should be a thing for elite athletes at major events? We cover that too. Want to know if machine learning is about to revolutionise our practice and solve all our crowding problems? It's all here. And more. Take a listen and keep yourself at the cutting edge!
Read the highlights: https://emj.bmj.com/content/39/5/343
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</description>
      <enclosure length="34974823" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1271875720-bmjpodcasts-primary-survey-the-highlights-of-may-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1273752073</guid>
      <title>Talk Evidence - evidence in Roe vs Wade, MI treatment variation, and tribal methodologies</title>
      <pubDate>Mon, 23 May 2022 16:44:38 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-may-2022</link>
      <itunes:duration>00:46:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Helen Macdonald, The BMJ's research integrity editor is back with another episode, and this week is joined by Joe Ross, professor of medicine and public health at Yale, and US research editor for The BMJ, and Juan Franco, editor in chief of BMJ EBM, and Professor at the  Instituto Universitario Hospital Italiano de Buenos Aires

In this episode they discuss;

The US supreme court looks set to overturn Roe v Wade, creating a patchwork of abortion provision across the U.S.  We consider the role which evidence might play in documenting how health is affected by that decision, and whether medical evidence is being used at all in the debate.

We'll give you a quick update on treatment for Covid-19

We know that trials are needed for new treatments, but in the face of an exponentially growing amount of observational data, is it time for a shift in that certainty? Joe tells us about his research into whether trials and observational studies of three drugs in covid produce the same answer? 

And finally, treatment variation - it's one of the things that helped kick-start the EBM revolution, but there's still much to learn. Juan describes some new research which examines how countries stack up when you compare their handling of and outcomes of a common condition such as a myocardial infarction.

Reading list;

Navigating Loss of Abortion Services — A Large Academic Medical Center Prepares for the Overturn of Roe v. Wade
https://www.nejm.org/doi/full/10.1056/NEJMp2206246.

A living WHO guideline on drugs for covid-19
https://www.bmj.com/content/370/bmj.m3379

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19
https://www.bmj.com/content/377/bmj-2021-069400

Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries
https://www.bmj.com/content/377/bmj-2021-069164</itunes:summary>
      <itunes:subtitle>Helen Macdonald, The BMJ's research integrity edi…</itunes:subtitle>
      <description>Helen Macdonald, The BMJ's research integrity editor is back with another episode, and this week is joined by Joe Ross, professor of medicine and public health at Yale, and US research editor for The BMJ, and Juan Franco, editor in chief of BMJ EBM, and Professor at the  Instituto Universitario Hospital Italiano de Buenos Aires

In this episode they discuss;

The US supreme court looks set to overturn Roe v Wade, creating a patchwork of abortion provision across the U.S.  We consider the role which evidence might play in documenting how health is affected by that decision, and whether medical evidence is being used at all in the debate.

We'll give you a quick update on treatment for Covid-19

We know that trials are needed for new treatments, but in the face of an exponentially growing amount of observational data, is it time for a shift in that certainty? Joe tells us about his research into whether trials and observational studies of three drugs in covid produce the same answer? 

And finally, treatment variation - it's one of the things that helped kick-start the EBM revolution, but there's still much to learn. Juan describes some new research which examines how countries stack up when you compare their handling of and outcomes of a common condition such as a myocardial infarction.

Reading list;

Navigating Loss of Abortion Services — A Large Academic Medical Center Prepares for the Overturn of Roe v. Wade
https://www.nejm.org/doi/full/10.1056/NEJMp2206246.

A living WHO guideline on drugs for covid-19
https://www.bmj.com/content/370/bmj.m3379

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19
https://www.bmj.com/content/377/bmj-2021-069400

Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries
https://www.bmj.com/content/377/bmj-2021-069164</description>
      <enclosure length="44480887" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1273752073-bmjpodcasts-talk-evidence-may-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2yobq1Hjl6r87WmD-zdjn1Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1274336875</guid>
      <title>SOLO1-The 5-year Follow Up Data with Dr. Susana Banerjee</title>
      <pubDate>Mon, 23 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/solo1-the-5-year-follow-up-data-with-dr-susana-banerjee</link>
      <itunes:duration>00:34:36</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Susana Banerjee to discuss SOLO1. Dr. Banerjee is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit. She is also Reader in Women’s Cancers at the Institute of Cancer Research. Dr Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers.

 

Highlights:
- This report is the longest follow-up period for a PARP inhibitor in the newly diagnosed advanced ovarian cancer.
- The present analysis shows a PFS benefit that is sustained for several years following completion of 2 years of maintenance olaparib.
- PFS benefit was consistent irrespective of higher or lower clinical risk or BRCA1 or BRCA2 mutation.
- SOLO1 is the first to report longer-term follow-up for safety in patients with newly diagnosed ovarian cancer receiving a PARPi as maintenance treatment.
- The safety profile for patients in the maintenance olaparib remained consistent with that reported previously, with no new safety signals. Importantly, no additional cases of MDS or AML were reported.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Susana Banerjee to discuss SOLO1. Dr. Banerjee is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit. She is also Reader in Women’s Cancers at the Institute of Cancer Research. Dr Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers.

 

Highlights:
- This report is the longest follow-up period for a PARP inhibitor in the newly diagnosed advanced ovarian cancer.
- The present analysis shows a PFS benefit that is sustained for several years following completion of 2 years of maintenance olaparib.
- PFS benefit was consistent irrespective of higher or lower clinical risk or BRCA1 or BRCA2 mutation.
- SOLO1 is the first to report longer-term follow-up for safety in patients with newly diagnosed ovarian cancer receiving a PARPi as maintenance treatment.
- The safety profile for patients in the maintenance olaparib remained consistent with that reported previously, with no new safety signals. Importantly, no additional cases of MDS or AML were reported.</description>
      <enclosure length="20973204" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1274336875-bmjpodcasts-solo1-the-5-year-follow-up-data-with-dr-susana-banerjee.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1272050599</guid>
      <title>June: challenging assumptions</title>
      <pubDate>Fri, 20 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-june-2022</link>
      <itunes:duration>00:11:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the June 2022 issue. 
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/6/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the June 2022 issue. 
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/6/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="11127326" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1272050599-bmjpodcasts-atoms-june-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1270285570</guid>
      <title>Comparing treatment outcomes of intracranial bifurcation aneurysms locations using the WEB device</title>
      <pubDate>Fri, 20 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/comparing-treatment-outcomes-of-intracranial-bifurcation-aneurysms-locations-using-the-web-device</link>
      <itunes:duration>00:26:19</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The Woven EndoBridge (WEB) device has FDA approval for treatment of wide-necked intracranial bifurcation aneurysms. It has been shown to result in adequate occlusion in bifurcation aneurysms overall, but its usefulness in the individual bifurcation locations has been evaluated separately only in few case series, which were limited by small sample sizes.
In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, interviews Dr. Nimer Adeeb (1)and Dr. Adam Dmytriw (2) on their paper "Comparing treatment outcomes of various intracranial bifurcation aneurysms locations using the Woven EndoBridge (WEB) device".
Paper available online: https://jnis.bmj.com/content/early/2022/04/27/neurintsurg-2022-018694
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!
This episode was edited by Brian O'Toole.
(1) Departments of Neurosurgery and Neurointerventional Surgery, Louisiana State University Health Sciences Center
(2)Neuroendovascular Program, Massachusetts General Hospital, Harvard University</itunes:summary>
      <itunes:subtitle>The Woven EndoBridge (WEB) device has FDA approva…</itunes:subtitle>
      <description>The Woven EndoBridge (WEB) device has FDA approval for treatment of wide-necked intracranial bifurcation aneurysms. It has been shown to result in adequate occlusion in bifurcation aneurysms overall, but its usefulness in the individual bifurcation locations has been evaluated separately only in few case series, which were limited by small sample sizes.
In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, interviews Dr. Nimer Adeeb (1)and Dr. Adam Dmytriw (2) on their paper "Comparing treatment outcomes of various intracranial bifurcation aneurysms locations using the Woven EndoBridge (WEB) device".
Paper available online: https://jnis.bmj.com/content/early/2022/04/27/neurintsurg-2022-018694
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767
Thank you for listening!
This episode was edited by Brian O'Toole.
(1) Departments of Neurosurgery and Neurointerventional Surgery, Louisiana State University Health Sciences Center
(2)Neuroendovascular Program, Massachusetts General Hospital, Harvard University</description>
      <enclosure length="25271483" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1270285570-bmjpodcasts-comparing-treatment-outcomes-of-intracranial-bifurcation-aneurysms-locations-using-the-web-device.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1265941711</guid>
      <title>Editors Highlights of the June 2022 issue</title>
      <pubDate>Wed, 18 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-june-2022-issue</link>
      <itunes:duration>00:38:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the June 2022 issue of the journal.
Read more on the PN website: https://pn.bmj.com/content/22/3/175
The full issue here: https://pn.bmj.com/content/22/3
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
Thank you for listening.</itunes:summary>
      <itunes:subtitle>Practical Neurology Editors Phil Smith and Gerain…</itunes:subtitle>
      <description>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the June 2022 issue of the journal.
Read more on the PN website: https://pn.bmj.com/content/22/3/175
The full issue here: https://pn.bmj.com/content/22/3
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 
Thank you for listening.</description>
      <enclosure length="36804648" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1265941711-bmjpodcasts-editors-highlights-of-the-june-2022-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1266231745</guid>
      <title>Sustainable return to nursing with Long Covid, advice from the experts</title>
      <pubDate>Tue, 17 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/long-covid-return-to-work-with-dr-clare-rayner-and-kirsty-stanley</link>
      <itunes:duration>00:49:02</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Returning to work as a nurse with Long Covid is thwart with difficulties in part due to its relapsing-remitting nature. Many nurses with Long Covid experience post-exertional malaise and symptom exacerbation if they push themselves and this may trigger a major relapse. This means that a return to work needs to be planned carefully. 
In this second podcast of a series about Long Covid, Dr Alison Twycross, Editor in Chief of Evidence-Based Nursing, speaks to two freelance consultants from Long Covid Work: Dr Clare Rayner, a consultant occupational physician, and Kirsty Stanley, Director, Occupational Therapist &amp; Writer at Occupation4Life Ltd, about best practice in this context. They provide guidance for both employers and employees. Alison, Clare and Kirsty are also members of the Long Covid Support Employment Group. More information on the Long Covid Nurses and Midwives UK website: http://www.lcnmuk.co.uk/
The EBN podcast series on Long Covid is produced by Letícia Amorim and edited by Brian O'Toole.
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.
The first episode of this three-episode series: https://soundcloud.com/bmjpodcasts/long-covid-what-we-know-so-far-with-dr-elaine-maxwell?in=bmjpodcasts/sets/ebn-podcast&amp;utm_source=clipboard&amp;utm_medium=text&amp;utm_campaign=social_sharing</itunes:summary>
      <itunes:subtitle>Returning to work as a nurse with Long Covid is t…</itunes:subtitle>
      <description>Returning to work as a nurse with Long Covid is thwart with difficulties in part due to its relapsing-remitting nature. Many nurses with Long Covid experience post-exertional malaise and symptom exacerbation if they push themselves and this may trigger a major relapse. This means that a return to work needs to be planned carefully. 
In this second podcast of a series about Long Covid, Dr Alison Twycross, Editor in Chief of Evidence-Based Nursing, speaks to two freelance consultants from Long Covid Work: Dr Clare Rayner, a consultant occupational physician, and Kirsty Stanley, Director, Occupational Therapist &amp; Writer at Occupation4Life Ltd, about best practice in this context. They provide guidance for both employers and employees. Alison, Clare and Kirsty are also members of the Long Covid Support Employment Group. More information on the Long Covid Nurses and Midwives UK website: http://www.lcnmuk.co.uk/
The EBN podcast series on Long Covid is produced by Letícia Amorim and edited by Brian O'Toole.
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.
The first episode of this three-episode series: https://soundcloud.com/bmjpodcasts/long-covid-what-we-know-so-far-with-dr-elaine-maxwell?in=bmjpodcasts/sets/ebn-podcast&amp;utm_source=clipboard&amp;utm_medium=text&amp;utm_campaign=social_sharing</description>
      <enclosure length="47084772" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1266231745-bmjpodcasts-long-covid-return-to-work-with-dr-clare-rayner-and-kirsty-stanley.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-9MuvMYDwJ6tCn2cy-tR5pVA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1267415584</guid>
      <title>Physician judgement vs risk scores - are we as good as we think?</title>
      <pubDate>Tue, 17 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/physician-judgement-vs-risk-scores-are-we-as-good-as-we-think</link>
      <itunes:duration>00:18:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Christopher Fordyce from the University of British Columbia. They discuss how good physicians are at judging the nature of chest pain. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/108/11/860</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Christopher Fordyce from the University of British Columbia. They discuss how good physicians are at judging the nature of chest pain. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/108/11/860</description>
      <enclosure length="44348915" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1267415584-bmjpodcasts-physician-judgement-vs-risk-scores-are-we-as-good-as-we-think.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1270592575</guid>
      <title>The ALICE Trial with Glauco Baiocchi Neto</title>
      <pubDate>Mon, 16 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-alice-trial-with-glauco-baiocchi-neto</link>
      <itunes:duration>00:33:39</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Glauco Baiocchi. Dr. Baiocchi is the Director of the Department of Gynecologic Oncology at the AC Camargo Cancer Center in Sao Paulo, Brazil.

Highlights:

-SLN biopsy has emerged as an accurate method for lymph node staging in endometrial cancer.
-Prospective studies aimed to analyze the performance of SLN biopsy in staging endometrial cancer rather than oncological outcomes.
-ALICE trial aims to confirm that SLN mapping without systematic node dissection does not negatively impact oncological outcomes.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Glauco Baiocchi. Dr. Baiocchi is the Director of the Department of Gynecologic Oncology at the AC Camargo Cancer Center in Sao Paulo, Brazil.

Highlights:

-SLN biopsy has emerged as an accurate method for lymph node staging in endometrial cancer.
-Prospective studies aimed to analyze the performance of SLN biopsy in staging endometrial cancer rather than oncological outcomes.
-ALICE trial aims to confirm that SLN mapping without systematic node dissection does not negatively impact oncological outcomes.</description>
      <enclosure length="32132889" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1270592575-bmjpodcasts-the-alice-trial-with-glauco-baiocchi-neto.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1267770541</guid>
      <title>Parosmia with Emily Woodroofe and Claire Hopkins</title>
      <pubDate>Sat, 14 May 2022 03:00:03 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/parosmia-with-emily-woodroofe-and-claire-hopkins</link>
      <itunes:duration>00:42:03</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Parosmia – a distorted sense of smell, and a delayed post-covid symptom – affects approximately 50% of people who experienced loss of smell during their initial covid infection, and it is currently attracting a lot of media attention. We hear from Emily Woodroofe, a third year medical student, about what it’s like to have parosmia, before we speak to Professor Claire Hopkins about what GPs need to know about it, and how they can best support their patients who are experiencing what can be a distressing symptom.


Our guests:

Emily Woodroofe is a third year medical student at Barts and The London School of Medicine and Dentistry.

Claire Hopkins is an ENT consultant, and professor of Rhinology at Guy’s and St. Thomas’ NHS foundation Trust.


Further reading:

‘Parosmia—a common consequence of covid-19’ https://www.bmj.com/content/377/bmj-2021-069860</itunes:summary>
      <itunes:subtitle>Parosmia – a distorted sense of smell, and a dela…</itunes:subtitle>
      <description>Parosmia – a distorted sense of smell, and a delayed post-covid symptom – affects approximately 50% of people who experienced loss of smell during their initial covid infection, and it is currently attracting a lot of media attention. We hear from Emily Woodroofe, a third year medical student, about what it’s like to have parosmia, before we speak to Professor Claire Hopkins about what GPs need to know about it, and how they can best support their patients who are experiencing what can be a distressing symptom.


Our guests:

Emily Woodroofe is a third year medical student at Barts and The London School of Medicine and Dentistry.

Claire Hopkins is an ENT consultant, and professor of Rhinology at Guy’s and St. Thomas’ NHS foundation Trust.


Further reading:

‘Parosmia—a common consequence of covid-19’ https://www.bmj.com/content/377/bmj-2021-069860</description>
      <enclosure length="40377363" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1267770541-bmjpodcasts-parosmia-with-emily-woodroofe-and-claire-hopkins.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1267784563</guid>
      <title>Get political, for health's sake</title>
      <pubDate>Fri, 13 May 2022 17:53:32 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/get-political-for-healths-sake</link>
      <itunes:duration>00:37:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The influence of public health on politics, at least at the beginning of the pandemic, had never been stronger - but now it seems as hard to persuade politicians to pay attention as ever, yet political will is essential in making different sectors work together to create a healthier world.

In this podcast, The BMJ's editor in chief, Kamran Abbasi is joined by Shyama Kuruvilla, senior strategic adviser at World Health Organization, and Kent Buse, director of the global healthier societies program at The George Institute for Global Health.

They discuss examples of where multisectoral working has managed to bridge the gaps between sectors, and how healthcare needs to get political to make that success more widespread.

This is part of the collection "The world we want: Actions towards a sustainable, fairer and healthier society" - https://www.bmj.com/pmac-2022</itunes:summary>
      <itunes:subtitle>The influence of public health on politics, at le…</itunes:subtitle>
      <description>The influence of public health on politics, at least at the beginning of the pandemic, had never been stronger - but now it seems as hard to persuade politicians to pay attention as ever, yet political will is essential in making different sectors work together to create a healthier world.

In this podcast, The BMJ's editor in chief, Kamran Abbasi is joined by Shyama Kuruvilla, senior strategic adviser at World Health Organization, and Kent Buse, director of the global healthier societies program at The George Institute for Global Health.

They discuss examples of where multisectoral working has managed to bridge the gaps between sectors, and how healthcare needs to get political to make that success more widespread.

This is part of the collection "The world we want: Actions towards a sustainable, fairer and healthier society" - https://www.bmj.com/pmac-2022</description>
      <enclosure length="54484926" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1267784563-bmjpodcasts-get-political-for-healths-sake.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XDKA1oGZA6yXXCn9-WYgrrw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1267165939</guid>
      <title>Funding medical school</title>
      <pubDate>Fri, 13 May 2022 06:00:33 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/funding-medical-school</link>
      <itunes:duration>00:48:54</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Along with the general public, medical students are feeling the cost-of-living crunch. How are medical students faring with the increasing cost of living?

In this episode, medical students from outside of the studio send in their perspectives on how they are making ends meet, balancing medical school and part-time work and navigating the student funding system.

Thank you to Michaela Vernon, Elle Gordon, Alex Twist, Trisha Suji, Ruth Carter and Eilidh Garrett who contributed to this episode.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Along with the general public, medical students a…</itunes:subtitle>
      <description>Along with the general public, medical students are feeling the cost-of-living crunch. How are medical students faring with the increasing cost of living?

In this episode, medical students from outside of the studio send in their perspectives on how they are making ends meet, balancing medical school and part-time work and navigating the student funding system.

Thank you to Michaela Vernon, Elle Gordon, Alex Twist, Trisha Suji, Ruth Carter and Eilidh Garrett who contributed to this episode.

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="46946816" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1267165939-bmjpodcasts-funding-medical-school.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-lXnS4avtuj3eRF85-BgETDQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1267523446</guid>
      <title>The latest trends in doping science and testing with Dr Matt Fedoruk. Ep #506</title>
      <pubDate>Fri, 13 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-latest-trends-in-doping-science-and-testing-with-dr-matt-fedoruk-ep-506</link>
      <itunes:duration>00:26:54</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM (T: @TheAMSSM) Sports Medcast, host Dr. Krystian Bigosinski, is joined by Dr. Matt Fedoruk, PhD, who works as the Chief Science Officer leading the Science &amp; Research team at the U.S. Anti-Doping Agency (@usantidoping).
Dr. Fedoruk served as a Featured National Speaker in the Doping in Sport session during the 2022 AMSSM Annual Meeting. In this conversation, he discusses some of the latest trends in doping science and testing and address the following topics:
·       His experience as a USADA Officer during the 2022 Olympic and Paralympics Games in China, and the new testing measures that were recently put in place.
·       How does WADA’s Athlete Biological Passport work, and what has its impact been on anti-doping?
·       How does he view orthobiologic treatments, such as PRP and stem cell therapies, through the lens of anti-doping?
·       Are gene doping technologies realistic from a physiological standpoint, or it is still the stuff of science fiction?
·       How does USADA balance respect for athlete autonomy and privacy, while also performing meaningful doping control?
·       How should sports medicine providers proceed when encountering athletes who might be coerced into doping programs?
·       How should physicians approach care of recreational athletes when it comes to the risks and benefits of substances that may be performance-enhancers, such as testosterone?
·       How does he approach being a fan of sport while working at USADA, where he often sees the best of worst of sport?</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM (T: @TheAMSSM) Sport…</itunes:subtitle>
      <description>On this episode of the AMSSM (T: @TheAMSSM) Sports Medcast, host Dr. Krystian Bigosinski, is joined by Dr. Matt Fedoruk, PhD, who works as the Chief Science Officer leading the Science &amp; Research team at the U.S. Anti-Doping Agency (@usantidoping).
Dr. Fedoruk served as a Featured National Speaker in the Doping in Sport session during the 2022 AMSSM Annual Meeting. In this conversation, he discusses some of the latest trends in doping science and testing and address the following topics:
·       His experience as a USADA Officer during the 2022 Olympic and Paralympics Games in China, and the new testing measures that were recently put in place.
·       How does WADA’s Athlete Biological Passport work, and what has its impact been on anti-doping?
·       How does he view orthobiologic treatments, such as PRP and stem cell therapies, through the lens of anti-doping?
·       Are gene doping technologies realistic from a physiological standpoint, or it is still the stuff of science fiction?
·       How does USADA balance respect for athlete autonomy and privacy, while also performing meaningful doping control?
·       How should sports medicine providers proceed when encountering athletes who might be coerced into doping programs?
·       How should physicians approach care of recreational athletes when it comes to the risks and benefits of substances that may be performance-enhancers, such as testosterone?
·       How does he approach being a fan of sport while working at USADA, where he often sees the best of worst of sport?</description>
      <enclosure length="18748164" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1267523446-bmjpodcasts-the-latest-trends-in-doping-science-and-testing-with-dr-matt-fedoruk-ep-506.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1265700046</guid>
      <title>Finding a bed, what does medical law have to do with it?</title>
      <pubDate>Thu, 12 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/medical-law-beds-for-children</link>
      <itunes:duration>00:18:46</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Welcome back to the ADC Spotlight podcast, the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. 

This month, Dr Rachel Agbeko, Senior Editor of ADC, is joined by Mr Robert Wheeler, paediatric and neonatal surgeon and honorary senior lecturer in medical law (1) to discuss the shortage of clinical provision, and the placements for children requiring assessment and treatment for mental illness. 

Read the paper 'Providing beds for children' for free for one month on the ADC website: https://adc.bmj.com/content/107/2/114 and on the February's issue.
More from the author about clinical law and ethics: https://blogs.bmj.com/medical-ethics/2022/05/01/law-ethics-basic-science/

The ADC Spotlight series is produced by Letícia Amorim and edited by Brian O'Toole.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

(1) Consultant Paediatric &amp; Neonatal Surgeon at the Wessex Regional Centre for Paediatric Surgery, University Hospital Southampton NHS Foundation Trust, UK.</itunes:summary>
      <itunes:subtitle>Welcome back to the ADC Spotlight podcast, the Ar…</itunes:subtitle>
      <description>Welcome back to the ADC Spotlight podcast, the Archives of Disease in Childhood podcast covering areas that don’t usually get much attention or might be taken for granted in children's health. 

This month, Dr Rachel Agbeko, Senior Editor of ADC, is joined by Mr Robert Wheeler, paediatric and neonatal surgeon and honorary senior lecturer in medical law (1) to discuss the shortage of clinical provision, and the placements for children requiring assessment and treatment for mental illness. 

Read the paper 'Providing beds for children' for free for one month on the ADC website: https://adc.bmj.com/content/107/2/114 and on the February's issue.
More from the author about clinical law and ethics: https://blogs.bmj.com/medical-ethics/2022/05/01/law-ethics-basic-science/

The ADC Spotlight series is produced by Letícia Amorim and edited by Brian O'Toole.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

(1) Consultant Paediatric &amp; Neonatal Surgeon at the Wessex Regional Centre for Paediatric Surgery, University Hospital Southampton NHS Foundation Trust, UK.</description>
      <enclosure length="18027832" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1265700046-bmjpodcasts-medical-law-beds-for-children.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ocBdboMiPzhq9ZRT-whMReA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1264958908</guid>
      <title>Mentor's Podcast: Jalid Sehouli</title>
      <pubDate>Mon, 09 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mentors-podcast-jalid-sehouli</link>
      <itunes:duration>01:10:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jalid Sehouli. Dr. Sehouli is director of the department of gynecology with center of oncological surgery at Charité Medical University in Berlin. He founded the first certified ovarian cancer center in 2007, published more than 500 articles, and is a teacher and a writer of several belletristic books.
 
Highlights:
Gynecology should be always holistic, interdisciplinary, and multi-professional.
Research in gynecology relies on teamwork, and international collaboration is essential.
The most relevant drug in medicine is communication!</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jalid Sehouli. Dr. Sehouli is director of the department of gynecology with center of oncological surgery at Charité Medical University in Berlin. He founded the first certified ovarian cancer center in 2007, published more than 500 articles, and is a teacher and a writer of several belletristic books.
 
Highlights:
Gynecology should be always holistic, interdisciplinary, and multi-professional.
Research in gynecology relies on teamwork, and international collaboration is essential.
The most relevant drug in medicine is communication!</description>
      <enclosure length="67400984" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1264958908-bmjpodcasts-mentors-podcast-jalid-sehouli.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1263266659</guid>
      <title>Menopause therapy and greater trochanteric pain syndrome with Racheal Cowan and Jill Cook. EP #505</title>
      <pubDate>Fri, 06 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/menopause-therapy-and-greater-trochanteric-pain-syndrome-with-racheal-cowan-and-jill-cook-ep-505</link>
      <itunes:duration>00:25:27</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast we are joined by Rachael Cowan and Professor Jill Cook. They provide an update on the evidence for management of greater trochanteric pain syndrome (GTPS) and discuss the results of a recent clinical trial evaluating the effect of menopausal hormone therapy, exercise, and education on tendon pain and function in post-menopausal women with GTPS. On the eve of retirement, Jill provides an opinion on what the next big breakthroughs in tendinopathy research should be!  
 
Cowan et al. 2021
https://journals.sagepub.com/doi/full/10.1177/03635465211061142
 
Ganderton et al. 2018
https://www.liebertpub.com/doi/abs/10.1089/jwh.2017.6729
 
Mellor et al. 2018
https://www.bmj.com/content/361/bmj.k1662.long</itunes:summary>
      <itunes:subtitle>In this podcast we are joined by Rachael Cowan an…</itunes:subtitle>
      <description>In this podcast we are joined by Rachael Cowan and Professor Jill Cook. They provide an update on the evidence for management of greater trochanteric pain syndrome (GTPS) and discuss the results of a recent clinical trial evaluating the effect of menopausal hormone therapy, exercise, and education on tendon pain and function in post-menopausal women with GTPS. On the eve of retirement, Jill provides an opinion on what the next big breakthroughs in tendinopathy research should be!  
 
Cowan et al. 2021
https://journals.sagepub.com/doi/full/10.1177/03635465211061142
 
Ganderton et al. 2018
https://www.liebertpub.com/doi/abs/10.1089/jwh.2017.6729
 
Mellor et al. 2018
https://www.bmj.com/content/361/bmj.k1662.long</description>
      <enclosure length="61080000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1263266659-bmjpodcasts-menopause-therapy-and-greater-trochanteric-pain-syndrome-with-racheal-cowan-and-jill-cook-ep-505.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1263249085</guid>
      <title>Irritable Bowel Syndrome</title>
      <pubDate>Fri, 06 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/irritable-bowel-syndrome</link>
      <itunes:duration>00:27:24</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief Dr. Richard McCallum and Assistant Professor of Medicine at Mayo Clinic School of Medicine, Dr. Lucinda Harris, discuss stress and IBS, antibiotic treatment options, and new findings regarding IBS in females and military service members. Dr. Harris is also a consultant at the Division of Gastroenterology and Hepatology at Mayo Clinic Scottsdale and is a current member of the Gastroenterology Fellowship committee. Her special clinical and research interests include IBS, gastroparesis, chronic constipation, and pelvic floor disorders as well as celiac disease and autonomic disorders.</itunes:summary>
      <itunes:subtitle>Editor-in-Chief Dr. Richard McCallum and Assistan…</itunes:subtitle>
      <description>Editor-in-Chief Dr. Richard McCallum and Assistant Professor of Medicine at Mayo Clinic School of Medicine, Dr. Lucinda Harris, discuss stress and IBS, antibiotic treatment options, and new findings regarding IBS in females and military service members. Dr. Harris is also a consultant at the Division of Gastroenterology and Hepatology at Mayo Clinic Scottsdale and is a current member of the Gastroenterology Fellowship committee. Her special clinical and research interests include IBS, gastroparesis, chronic constipation, and pelvic floor disorders as well as celiac disease and autonomic disorders.</description>
      <enclosure length="26172104" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1263249085-bmjpodcasts-irritable-bowel-syndrome.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I5sr8jKXxhTu5ll7-JWOUwA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1261642681</guid>
      <title>Growing ​"a broad field​"​: research and practice​. The SAVIR conference</title>
      <pubDate>Thu, 05 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/growing-a-broad-field-research-and-practice-the-savir-conference</link>
      <itunes:duration>00:24:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this conversation with two members of the scientific committee of the recently held conference of​ the Society for Advancement of Violence and Injury Research​ (SAVIR)​, we focus on ways of growing the field of Injury Prevention and ​include ​new generations of emerging professionals.
​Editor-in-Chief of Injury Prevention, Rod McClure​, interviews Rosemary Nabaweesi, Associate Professor in the Center for Health Policy at the School of Graduate Studies and Research, Meharry Medical College, Tennessee, and Elizabeth E. O’Neal, Postdoctoral Research Fellow - College of Liberal Arts and Sciences at the University of Iowa.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>In this conversation with two members of the scie…</itunes:subtitle>
      <description>In this conversation with two members of the scientific committee of the recently held conference of​ the Society for Advancement of Violence and Injury Research​ (SAVIR)​, we focus on ways of growing the field of Injury Prevention and ​include ​new generations of emerging professionals.
​Editor-in-Chief of Injury Prevention, Rod McClure​, interviews Rosemary Nabaweesi, Associate Professor in the Center for Health Policy at the School of Graduate Studies and Research, Meharry Medical College, Tennessee, and Elizabeth E. O’Neal, Postdoctoral Research Fellow - College of Liberal Arts and Sciences at the University of Iowa.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="23114813" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1261642681-bmjpodcasts-growing-a-broad-field-research-and-practice-the-savir-conference.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-97PYlC3idubTCbxz-1rv9FQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1258455340</guid>
      <title>What's the relationship between self-efficacy and quality of life in SLE patients?</title>
      <pubDate>Wed, 04 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/whats-the-relationship-between-self-efficacy-and-quality-of-life-in-sle-patients</link>
      <itunes:duration>00:20:19</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Duane Peters from the Lupus Foundation of America talks to Dr Cristina Drenkard from Emory University and Dr Teresa Brady from Clarity Consulting and Communications, both based in Atlanta, USA. 

They discuss their paper on the relationship between levels of self-efficacy and health behaviours and outcomes in black women with SLE. Their study specifically evaluated the associations between age, educational level and depression in SLE patients and the degree of pain and fatigue they experienced. These findings may help predict who might benefit most from self-efficacy-enhancing interventions to improve quality of life.

Access the article: https://lupus.bmj.com/content/9/1/e000566</itunes:summary>
      <itunes:subtitle>Duane Peters from the Lupus Foundation of America…</itunes:subtitle>
      <description>Duane Peters from the Lupus Foundation of America talks to Dr Cristina Drenkard from Emory University and Dr Teresa Brady from Clarity Consulting and Communications, both based in Atlanta, USA. 

They discuss their paper on the relationship between levels of self-efficacy and health behaviours and outcomes in black women with SLE. Their study specifically evaluated the associations between age, educational level and depression in SLE patients and the degree of pain and fatigue they experienced. These findings may help predict who might benefit most from self-efficacy-enhancing interventions to improve quality of life.

Access the article: https://lupus.bmj.com/content/9/1/e000566</description>
      <enclosure length="16114091" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1258455340-bmjpodcasts-whats-the-relationship-between-self-efficacy-and-quality-of-life-in-sle-patients.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zOfBZ6joPLX9GdP1-jqUXQg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1245423343</guid>
      <title>Essential tremor</title>
      <pubDate>Tue, 03 May 2022 09:16:49 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/essential-tremor</link>
      <itunes:duration>00:14:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Essential tremor is characterised by a progressive tremor of the upper extremities, present in posture and action, without other neurological signs or symptoms.

The prevalence and incidence increases with age, but the condition can appear in early adulthood in those who have a family history.

Sheng-Han Kuo, Assistant Professor of Neurology, Columbia University, New York, gives us an overview of the condition.

For more on essential tremor, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/1089

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Essential tremor is characterised by a progressiv…</itunes:subtitle>
      <description>Essential tremor is characterised by a progressive tremor of the upper extremities, present in posture and action, without other neurological signs or symptoms.

The prevalence and incidence increases with age, but the condition can appear in early adulthood in those who have a family history.

Sheng-Han Kuo, Assistant Professor of Neurology, Columbia University, New York, gives us an overview of the condition.

For more on essential tremor, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/1089

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="14338709" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1245423343-bmjpodcasts-essential-tremor.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ujs7lai7EfGopsDJ-npDHtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1257554803</guid>
      <title>ADC Fetal and Neonatal’s Fantoms. Highlights from the January 2022 issue</title>
      <pubDate>Tue, 03 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adc-fetal-and-neonatals-fantoms-highlights-from-the-january-202-issue</link>
      <itunes:duration>00:17:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the January 2022 issue. The Fantoms article: https://fn.bmj.com/content/107/1/1

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>ADC Fetal and Neonatal’s Associate Editor, Jonath…</itunes:subtitle>
      <description>ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the January 2022 issue. The Fantoms article: https://fn.bmj.com/content/107/1/1

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="16441259" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1257554803-bmjpodcasts-adc-fetal-and-neonatals-fantoms-highlights-from-the-january-202-issue.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-PDk0heSRM2lHslN5-fy94mA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1259081821</guid>
      <title>A comprehensive review on heart failure with preserved ejection fraction (HFpEF)</title>
      <pubDate>Tue, 03 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/a-comprehensive-review-on-heart-failure-with-preserved-ejection-fraction-hfpef</link>
      <itunes:duration>00:24:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Harriette Van Spall, Department of Medicine, McMaster University, Canada. They discuss her paper "Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management". If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/early/2022/01/11/heartjnl-2021-319605</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Harriette Van Spall, Department of Medicine, McMaster University, Canada. They discuss her paper "Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management". If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/early/2022/01/11/heartjnl-2021-319605</description>
      <enclosure length="58770180" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1259081821-bmjpodcasts-a-comprehensive-review-on-heart-failure-with-preserved-ejection-fraction-hfpef.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1258660531</guid>
      <title>Gender Imbalance in Authorship in Gynecologic Oncology</title>
      <pubDate>Mon, 02 May 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/gender-imbalance-in-authorship-in-gynecologic-oncology</link>
      <itunes:duration>00:24:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Sarah Mah to discuss the gender imbalance in authorship in gynecologic oncology. Sarah Mah is a Gynecologic Oncology fellow at McMaster University who received her MSc in Quality Improvement and Patient Safety through the University of Toronto Institute of Health Policy, Management and Evaluation and completed residency at the University of British Columbia. Her research interests are in quality improvement with an equity and sustainability lens, knowledge translation, and cancer prevention.

Highlights:
Women now account for 55-70% of practicing Gynecologic Oncologists and &gt;80% of Gynecologic Oncology fellows in the United States and Canada.
Rates of female first authorship in Gynecologic Oncology journals are rising in proportion, but rates of female senior authorship lag behind, with male authors still overrepresented.
Women remain underrepresented as members of Editorial Boards of Gynecologic Oncology journals, particularly in leadership positions.
While the COVID-19 pandemic has not yet impacted the proportion of female authors, we discuss reasons for why this could be of future concern and the importance of ongoing surveillance.
We discuss some of the literature regarding gender inequity in academia and publishing and explore possible strategies for improvement.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Sarah Mah to discuss the gender imbalance in authorship in gynecologic oncology. Sarah Mah is a Gynecologic Oncology fellow at McMaster University who received her MSc in Quality Improvement and Patient Safety through the University of Toronto Institute of Health Policy, Management and Evaluation and completed residency at the University of British Columbia. Her research interests are in quality improvement with an equity and sustainability lens, knowledge translation, and cancer prevention.

Highlights:
Women now account for 55-70% of practicing Gynecologic Oncologists and &gt;80% of Gynecologic Oncology fellows in the United States and Canada.
Rates of female first authorship in Gynecologic Oncology journals are rising in proportion, but rates of female senior authorship lag behind, with male authors still overrepresented.
Women remain underrepresented as members of Editorial Boards of Gynecologic Oncology journals, particularly in leadership positions.
While the COVID-19 pandemic has not yet impacted the proportion of female authors, we discuss reasons for why this could be of future concern and the importance of ongoing surveillance.
We discuss some of the literature regarding gender inequity in academia and publishing and explore possible strategies for improvement.</description>
      <enclosure length="23069259" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1258660531-bmjpodcasts-gender-imbalance-in-authorship-in-gynecologic-oncology.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1259830897</guid>
      <title>Deep Breath In - what's in store for general practice in the UK</title>
      <pubDate>Sat, 30 Apr 2022 10:11:30 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/deep-breath-in-whats-in-store-for-general-practice-in-the-uk</link>
      <itunes:duration>00:43:45</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This is a special episode of our podcast for GP's, Deep Breath In, where we tackle the everyday challenges of being a GP.

With the focus on covid, and the pressure on hospitals, it may be easy to overlook what’s happening in general practice in the UK - but changes are afoot. Our new health secretary Sajid Javid doesn’t seem to like our long standing GP practice arrangement, NHS England has imposed new weekend working arrangements on the already stretched service, and the workforce pressures continue.

In this episode of Deep Breath In, our GP panel of Tom Nolan, Navjoyt Ladher, and Jenny Rasanathan are joined by Gareth Iacobucci, The BMJ’s assistant news editor, to give them the lowdown on what’s happening around primary care, who some of the key players are, and what his predictions for 2022.

You can find Deep Breath In on all major podcast apps
https://www.bmj.com/podcasts/deepbreathin</itunes:summary>
      <itunes:subtitle>This is a special episode of our podcast for GP's…</itunes:subtitle>
      <description>This is a special episode of our podcast for GP's, Deep Breath In, where we tackle the everyday challenges of being a GP.

With the focus on covid, and the pressure on hospitals, it may be easy to overlook what’s happening in general practice in the UK - but changes are afoot. Our new health secretary Sajid Javid doesn’t seem to like our long standing GP practice arrangement, NHS England has imposed new weekend working arrangements on the already stretched service, and the workforce pressures continue.

In this episode of Deep Breath In, our GP panel of Tom Nolan, Navjoyt Ladher, and Jenny Rasanathan are joined by Gareth Iacobucci, The BMJ’s assistant news editor, to give them the lowdown on what’s happening around primary care, who some of the key players are, and what his predictions for 2022.

You can find Deep Breath In on all major podcast apps
https://www.bmj.com/podcasts/deepbreathin</description>
      <enclosure length="42011584" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1259830897-bmjpodcasts-deep-breath-in-whats-in-store-for-general-practice-in-the-uk.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1259829364</guid>
      <title>What's in store for general practice in the UK</title>
      <pubDate>Sat, 30 Apr 2022 10:08:03 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/whats-in-store-for-general-practice-in-the-uk</link>
      <itunes:duration>00:43:18</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>With the focus on covid, and the pressure on hospitals, it may be easy to overlook what’s happening in general practice in the UK - but changes are afoot. Our new health secretary Sajid Javid doesn’t seem to like our long standing GP practice arrangement, NHS England has imposed new weekend working arrangements on the already stretched service, and the workforce pressures continue.

In this episode of Deep Breath In, our GP panel of Tom Nolan, Navjoyt Ladher, and Jenny Rasanathan are joined by Gareth Iacobucci, The BMJ’s assistant news editor, to give them the lowdown on what’s happening around primary care, who some of the key players are, and what his predictions for 2022.</itunes:summary>
      <itunes:subtitle>With the focus on covid, and the pressure on hosp…</itunes:subtitle>
      <description>With the focus on covid, and the pressure on hospitals, it may be easy to overlook what’s happening in general practice in the UK - but changes are afoot. Our new health secretary Sajid Javid doesn’t seem to like our long standing GP practice arrangement, NHS England has imposed new weekend working arrangements on the already stretched service, and the workforce pressures continue.

In this episode of Deep Breath In, our GP panel of Tom Nolan, Navjoyt Ladher, and Jenny Rasanathan are joined by Gareth Iacobucci, The BMJ’s assistant news editor, to give them the lowdown on what’s happening around primary care, who some of the key players are, and what his predictions for 2022.</description>
      <enclosure length="41580250" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1259829364-bmjpodcasts-whats-in-store-for-general-practice-in-the-uk.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1258770421</guid>
      <title>See it, say it, sorted?</title>
      <pubDate>Fri, 29 Apr 2022 06:01:21 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/see-it-say-it-sorted</link>
      <itunes:duration>00:39:57</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>If you see something that doesn’t look right when going on placement, do you feel comfortable raising a concern? In this episode, we discuss the topic of raising concerns and the considerations that med students and junior doctors may have when it comes to speaking up.
 
Expert guest:
Dr Natasha Malik (@1natasha_malik on Twitter) is a portfolio GP who works with Health Education England, UCL medical school and Imperial medical school.

Top tip:
“In moments of uncertainty, the first thing to do is to find those pillars of support and talk to people about it, because that increases confidence. It also allows you to find out information about where to go next.”
 
Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>If you see something that doesn’t look right when…</itunes:subtitle>
      <description>If you see something that doesn’t look right when going on placement, do you feel comfortable raising a concern? In this episode, we discuss the topic of raising concerns and the considerations that med students and junior doctors may have when it comes to speaking up.
 
Expert guest:
Dr Natasha Malik (@1natasha_malik on Twitter) is a portfolio GP who works with Health Education England, UCL medical school and Imperial medical school.

Top tip:
“In moments of uncertainty, the first thing to do is to find those pillars of support and talk to people about it, because that increases confidence. It also allows you to find out information about where to go next.”
 
Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="38361344" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1258770421-bmjpodcasts-see-it-say-it-sorted.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1258120252</guid>
      <title>Primary Survey -  the highlights of April 2022 in 30 minutes!</title>
      <pubDate>Fri, 29 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-220422-april-2022-primary-survey-rick-body-sarah-edwards</link>
      <itunes:duration>00:29:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Rick Body, Deputy Editor of EMJ, and Sarah Edwards, Social Media Editor of EMJ, talk through the very best of the Emergency Medicine Journal with most of the papers we published in April 2022. We cover everything from sepsis and qSOFA scoring to how to manage traumatic pneumothoraces and how to recognise cervical spine injuries. We even look at the problem we have with convenience sampling in Emergency Medicine clinical research studies. Do we need to make big changes? Have a listen and find out!
Read the highlights: https://emj.bmj.com/content/39/4/269
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</itunes:summary>
      <itunes:subtitle>Rick Body, Deputy Editor of EMJ, and Sarah Edward…</itunes:subtitle>
      <description>Rick Body, Deputy Editor of EMJ, and Sarah Edwards, Social Media Editor of EMJ, talk through the very best of the Emergency Medicine Journal with most of the papers we published in April 2022. We cover everything from sepsis and qSOFA scoring to how to manage traumatic pneumothoraces and how to recognise cervical spine injuries. We even look at the problem we have with convenience sampling in Emergency Medicine clinical research studies. Do we need to make big changes? Have a listen and find out!
Read the highlights: https://emj.bmj.com/content/39/4/269
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).</description>
      <enclosure length="28006190" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1258120252-bmjpodcasts-emj-220422-april-2022-primary-survey-rick-body-sarah-edwards.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1258671796</guid>
      <title>Episode 2: Reviving the medical lecture: practical tips for delivering effective lectures</title>
      <pubDate>Thu, 28 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-2-reviving-the-medical-lecture-practical-tips-for-delivering-effective-lectures</link>
      <itunes:duration>00:31:08</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month’s “RAPM Focus” looks at evidence-based practices to improve the creation and delivery of medical education lectures. Editor-in-Chief Brian Sites, MD, interviews Monica W. Harbell, MD, first author of the paper “Reviving the medical lecture: practical tips for delivering effective lectures,” published in the March 2022 issue of Regional Anesthesia &amp; Pain Medicine (https://rapm.bmj.com/content/47/5/331).

In the paper, Dr. Harbell and coauthor Dr. Patricia S. O’Sullivan outline nine specific tips for effective presentations including the importance of learning objectives, content organization, effective visuals, simple slide design, and others. They also provide tips to keep your audience interested and engaged, particularly in an increasingly virtual world. 

Dr. Harbell is an assistant professor in the Department of Anesthesiology and Perioperative medicine at the Mayo Clinic in Arizona and the associate program director for the Mayo Clinic Arizona Anesthesiology residency. She is the chair of the American Society of Anesthesiologists (ASA) Committee on Patient Safety and Education and a member of the ASA committee on practice parameters.</itunes:summary>
      <itunes:subtitle>This month’s “RAPM Focus” looks at evidence-based…</itunes:subtitle>
      <description>This month’s “RAPM Focus” looks at evidence-based practices to improve the creation and delivery of medical education lectures. Editor-in-Chief Brian Sites, MD, interviews Monica W. Harbell, MD, first author of the paper “Reviving the medical lecture: practical tips for delivering effective lectures,” published in the March 2022 issue of Regional Anesthesia &amp; Pain Medicine (https://rapm.bmj.com/content/47/5/331).

In the paper, Dr. Harbell and coauthor Dr. Patricia S. O’Sullivan outline nine specific tips for effective presentations including the importance of learning objectives, content organization, effective visuals, simple slide design, and others. They also provide tips to keep your audience interested and engaged, particularly in an increasingly virtual world. 

Dr. Harbell is an assistant professor in the Department of Anesthesiology and Perioperative medicine at the Mayo Clinic in Arizona and the associate program director for the Mayo Clinic Arizona Anesthesiology residency. She is the chair of the American Society of Anesthesiologists (ASA) Committee on Patient Safety and Education and a member of the ASA committee on practice parameters.</description>
      <enclosure length="74691020" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1258671796-bmjpodcasts-episode-2-reviving-the-medical-lecture-practical-tips-for-delivering-effective-lectures.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-WQMXS6WaWqrBOudd-zuJTcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1257123214</guid>
      <title>May 2022 - an apology, international drug bulletins, mirtazapine and oral antivirals for covid-19</title>
      <pubDate>Wed, 27 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-may-2022</link>
      <itunes:duration>00:20:48</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the May 2022 issue of DTB. They talk about drug bulletins across the world and the role of the International Society of Drug Bulletins in supporting bulletins and ensuring that they are intellectually and financially independent (https://dtb.bmj.com/content/60/5/66). They review a study that assessed the use of mirtazapine for treating agitation in people with dementia (https://dtb.bmj.com/content/60/5/68). The editors also discuss the evidence behind two new oral antivirals that have been licensed for the treatment of covid-19 (https://dtb.bmj.com/content/60/5/73).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the May 2022 issue of DTB. They talk about drug bulletins across the world and the role of the International Society of Drug Bulletins in supporting bulletins and ensuring that they are intellectually and financially independent (https://dtb.bmj.com/content/60/5/66). They review a study that assessed the use of mirtazapine for treating agitation in people with dementia (https://dtb.bmj.com/content/60/5/68). The editors also discuss the evidence behind two new oral antivirals that have been licensed for the treatment of covid-19 (https://dtb.bmj.com/content/60/5/73).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="49929974" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1257123214-bmjpodcasts-dtb-may-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1257333070</guid>
      <title>Archimedes May 2022: Micro Magic</title>
      <pubDate>Tue, 26 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/archimedes-may-2022</link>
      <itunes:duration>00:14:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>This month we go all buggy, thinking about how we can use EU-level regulatory frameworks to help us act in our clinical lives (https://adc.bmj.com/content/107/5/507.2). We also address the persuasive power of an accelerated BCG reaction in children… fort noted by Koch of Koch’s Postulates in rodents (https://adc.bmj.com/content/107/5/507.1), and ask a partially useful question that might save many hours and many many stabs - are CVC concentrations of tobramycin good enough to judge how to dose in children? (https://adc.bmj.com/content/107/5/512).
Please do tell us what you think of the podcast or the section, and if you’re revisiting the Journey to the West in TV form, on any of the socials.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>This month we go all buggy, thinking about how we…</itunes:subtitle>
      <description>This month we go all buggy, thinking about how we can use EU-level regulatory frameworks to help us act in our clinical lives (https://adc.bmj.com/content/107/5/507.2). We also address the persuasive power of an accelerated BCG reaction in children… fort noted by Koch of Koch’s Postulates in rodents (https://adc.bmj.com/content/107/5/507.1), and ask a partially useful question that might save many hours and many many stabs - are CVC concentrations of tobramycin good enough to judge how to dose in children? (https://adc.bmj.com/content/107/5/512).
Please do tell us what you think of the podcast or the section, and if you’re revisiting the Journey to the West in TV form, on any of the socials.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="14009990" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1257333070-bmjpodcasts-archimedes-may-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1254945541</guid>
      <title>Secondary Cytoreductive Surgery in Ovarian Cancer</title>
      <pubDate>Mon, 25 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/secondary-cytoreductive-surgery-in-ovarian-cancer</link>
      <itunes:duration>00:44:12</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Robert Bristow, Prof. Christina Fotopoulou, and Dr. Myong Cheol Lim to discuss Secondary Cytoreductive Surgery in Ovarian Cancer. Dr. Bristow is Professor and Chair of the Department of Obstetrics and Gynecology at the University of California, Irvine School of Medicine. His clinical expertise and research interests focus on the surgical management of advanced-stage and recurrent ovarian cancer. Prof. Christina Fotopoulou has served as the Chair of Gynaecological Cancer Surgery at the Department of Surgery and Cancer at Imperial College London, UK. She has served as an elected ESGO council member and Chair of the ESGO guidelines committee. Dr. Myong Cheol Lim is a gynecologic oncologist, working for National Cancer Center Korea. He is fully dedicated to clinical research, including cytoreductive surgery and HIPEC for the management of ovarian cancer.
 
Highlights:
- This large meta-analysis on the value of secondary debulking showed that both complete as well as optimal cytoreductive surgery for ovarian cancer relapse significantly increased patients' overall survival.
- Median overall survival of a patients cohort increased by 9% and 7% when the complete and optimal cytoreductive rates increased by 10%, respectively, even after adjusting of other well established prognostic factors.
- Patients with ovarian cancer relapse should be evaluated for their eligibility for secondary debulking surgery in an effort to improve their survival.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Robert Bristow, Prof. Christina Fotopoulou, and Dr. Myong Cheol Lim to discuss Secondary Cytoreductive Surgery in Ovarian Cancer. Dr. Bristow is Professor and Chair of the Department of Obstetrics and Gynecology at the University of California, Irvine School of Medicine. His clinical expertise and research interests focus on the surgical management of advanced-stage and recurrent ovarian cancer. Prof. Christina Fotopoulou has served as the Chair of Gynaecological Cancer Surgery at the Department of Surgery and Cancer at Imperial College London, UK. She has served as an elected ESGO council member and Chair of the ESGO guidelines committee. Dr. Myong Cheol Lim is a gynecologic oncologist, working for National Cancer Center Korea. He is fully dedicated to clinical research, including cytoreductive surgery and HIPEC for the management of ovarian cancer.
 
Highlights:
- This large meta-analysis on the value of secondary debulking showed that both complete as well as optimal cytoreductive surgery for ovarian cancer relapse significantly increased patients' overall survival.
- Median overall survival of a patients cohort increased by 9% and 7% when the complete and optimal cytoreductive rates increased by 10%, respectively, even after adjusting of other well established prognostic factors.
- Patients with ovarian cancer relapse should be evaluated for their eligibility for secondary debulking surgery in an effort to improve their survival.</description>
      <enclosure length="42214005" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1254945541-bmjpodcasts-secondary-cytoreductive-surgery-in-ovarian-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1254951247</guid>
      <title>Creativity and wellbeing</title>
      <pubDate>Fri, 22 Apr 2022 12:14:31 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/creativity-and-wellbeing</link>
      <itunes:duration>00:35:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Paula Redmond, clinical psychologist who supports healthcare workers experiencing burnout and other difficulties related to their job. Before this, she worked for the NHS until she experienced bullying, and a lack of support from her organisation, which made her strike out on her own.

In this wellbeing podcast, she describes the way in which her experience of bullying affected her, and how she used the creative process to help her move on. 

She and Cat Chatfield discuss what creativity actually is, and why small projects can be just as useful as big complex ones - depending upon what you need at the time.

Futher reading:
a Blog series on bullying in healthcare: https://drpaularedmond.com/category/bullying_in_healthcare/page/2/
a mindful embroidery craftivism project ("Do no harm but take no shit") https://drpaularedmond.com/donoharm/</itunes:summary>
      <itunes:subtitle>Paula Redmond, clinical psychologist who supports…</itunes:subtitle>
      <description>Paula Redmond, clinical psychologist who supports healthcare workers experiencing burnout and other difficulties related to their job. Before this, she worked for the NHS until she experienced bullying, and a lack of support from her organisation, which made her strike out on her own.

In this wellbeing podcast, she describes the way in which her experience of bullying affected her, and how she used the creative process to help her move on. 

She and Cat Chatfield discuss what creativity actually is, and why small projects can be just as useful as big complex ones - depending upon what you need at the time.

Futher reading:
a Blog series on bullying in healthcare: https://drpaularedmond.com/category/bullying_in_healthcare/page/2/
a mindful embroidery craftivism project ("Do no harm but take no shit") https://drpaularedmond.com/donoharm/</description>
      <enclosure length="34489154" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1254951247-bmjpodcasts-creativity-and-wellbeing.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ECy0ukKsSbm89IFB-iNu7yw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1254942247</guid>
      <title>Why you should join us for #BJSMLive2022, with Dr Fiona Wilson. EP# 504</title>
      <pubDate>Fri, 22 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/why-you-should-join-us-for-bjsmlive2022-with-dr-fiona-wilson-ep-504</link>
      <itunes:duration>00:17:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast with co-chair of the inaugural BJSM Live event on 25th May 2022, we chat about the event itself and some of the efforts to make it as diverse and inclusive as possible.

For tickets, please check out http://bjsmlive.bmj.com/</itunes:summary>
      <itunes:subtitle>In this podcast with co-chair of the inaugural BJ…</itunes:subtitle>
      <description>In this podcast with co-chair of the inaugural BJSM Live event on 25th May 2022, we chat about the event itself and some of the efforts to make it as diverse and inclusive as possible.

For tickets, please check out http://bjsmlive.bmj.com/</description>
      <enclosure length="41088000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1254942247-bmjpodcasts-why-you-should-join-us-for-bjsmlive2022-with-dr-fiona-wilson-ep-504.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1253166547</guid>
      <title>The BCS Centenary - the past, present and future of British Cardiology</title>
      <pubDate>Thu, 21 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-bcs-centenary-the-past-present-and-future-of-british-cardiology</link>
      <itunes:duration>00:27:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by past British Cardiovascular Society president, Dr Iain Simpson, and BCS archivist and cardiologist Dr Caroline Coats. They discuss the formation of the BCS, its more recent history and some of the world-leading advances that British cardiology has made over the last 100 years. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/108/10/761
Read the special issue: https://heart.bmj.com/content/108/10.</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by past British Cardiovascular Society president, Dr Iain Simpson, and BCS archivist and cardiologist Dr Caroline Coats. They discuss the formation of the BCS, its more recent history and some of the world-leading advances that British cardiology has made over the last 100 years. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/108/10/761
Read the special issue: https://heart.bmj.com/content/108/10.</description>
      <enclosure length="65442388" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1253166547-bmjpodcasts-the-bcs-centenary-the-past-present-and-future-of-british-cardiology.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1253624302</guid>
      <title>May: Overcoming the barriers, treatment of pneumonia, cystic fibrosis and refugees</title>
      <pubDate>Wed, 20 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adc-atoms-may-2022</link>
      <itunes:duration>00:17:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the May 2022 issue. 
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/5/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the May 2022 issue. 
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/5/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="17255861" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1253624302-bmjpodcasts-adc-atoms-may-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1248550009</guid>
      <title>Autoinflammatory syndromes in neurology: when our first line of defence misbehaves</title>
      <pubDate>Tue, 19 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/autoinflammatory-syndromes-in-neurology-when-our-first-line-of-defence-misbehaves</link>
      <itunes:duration>00:39:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Amy Ross Russell, Neurology, University Hospital Southampton NHS Foundation Trust, interviews Dr William Diprose, Dept. of Neurology, Auckland City Hospital and Dept. of Medicine, Faculty of Medicine and Health Science, University of Auckland, New Zealand; Dr Anthony Jordan, Dept. of Clinical Immunology and Allergy, Auckland City Hospital, NZ; and Dr Neil Anderson, Dept. of Neurology, Auckland City Hospital, NZ about their recent paper reviewing the neurological features of specific autoinflammatory syndromes.


Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/2/145) and the April print issue of the journal.


The paper is also discussed by Practical Neurology editors, Dr Phil Smith and Dr Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/pn-april-2022-highlights?in=bmjpodcasts/sets/pn-podcast


Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). Thank you for listening.</itunes:summary>
      <itunes:subtitle>Dr Amy Ross Russell, Neurology, University Hospit…</itunes:subtitle>
      <description>Dr Amy Ross Russell, Neurology, University Hospital Southampton NHS Foundation Trust, interviews Dr William Diprose, Dept. of Neurology, Auckland City Hospital and Dept. of Medicine, Faculty of Medicine and Health Science, University of Auckland, New Zealand; Dr Anthony Jordan, Dept. of Clinical Immunology and Allergy, Auckland City Hospital, NZ; and Dr Neil Anderson, Dept. of Neurology, Auckland City Hospital, NZ about their recent paper reviewing the neurological features of specific autoinflammatory syndromes.


Read this latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/2/145) and the April print issue of the journal.


The paper is also discussed by Practical Neurology editors, Dr Phil Smith and Dr Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/pn-april-2022-highlights?in=bmjpodcasts/sets/pn-podcast


Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). Thank you for listening.</description>
      <enclosure length="37606294" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1248550009-bmjpodcasts-autoinflammatory-syndromes-in-neurology-when-our-first-line-of-defence-misbehaves.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1253003134</guid>
      <title>The PARCER Trial with Supriya Chopra</title>
      <pubDate>Mon, 18 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-parcer-trial-with-supriya-chopra</link>
      <itunes:duration>00:40:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Supriya Chopra. Dr. Chopra is a Professor in Radiation Oncology at ACTREC, Tata Memorial Centre and Principal Investigator of the PARCER trial. Her research focus is to improve outcomes of cervical cancer through use of advanced radiation techniques in patients undergoing RT for both primary and recurrent metastatic cervical cancer. She also co-leads multi-institutional molecular translational research programme (BIOEMBRACE) for cervix cancer.

HIGHLIGHTS:
- Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy (IG-IMRT) with three-dimensional conformal radiation therapy (3D-CRT) in women with cervical cancer undergoing postoperative radiation.
- IG-IMRT results in reduced toxicity with no difference in disease outcomes in cervical cancer. 
- The 3-year cumulative incidence of grade ≥ 2 late GI toxicity in the IG-IMRT and 3D-CRT arms were 21.1% versus 42.4%.
- The cumulative incidence of grade ≥ 2 any late toxicity was 28.1% versus 48.9%.
- Patients reported reduced diarrhea (P = .04), improved appetite (P = .008), and lesser bowel symptoms (P = .002) with IG-IMRT. 
- The 3-year pelvic relapse-free survival and disease-free survival in the IG-IMRT versus the 3D-CRT arm were 81.8% versus 84% and 76.9% versus 81.2%, respectively.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Supriya Chopra. Dr. Chopra is a Professor in Radiation Oncology at ACTREC, Tata Memorial Centre and Principal Investigator of the PARCER trial. Her research focus is to improve outcomes of cervical cancer through use of advanced radiation techniques in patients undergoing RT for both primary and recurrent metastatic cervical cancer. She also co-leads multi-institutional molecular translational research programme (BIOEMBRACE) for cervix cancer.

HIGHLIGHTS:
- Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy (IG-IMRT) with three-dimensional conformal radiation therapy (3D-CRT) in women with cervical cancer undergoing postoperative radiation.
- IG-IMRT results in reduced toxicity with no difference in disease outcomes in cervical cancer. 
- The 3-year cumulative incidence of grade ≥ 2 late GI toxicity in the IG-IMRT and 3D-CRT arms were 21.1% versus 42.4%.
- The cumulative incidence of grade ≥ 2 any late toxicity was 28.1% versus 48.9%.
- Patients reported reduced diarrhea (P = .04), improved appetite (P = .008), and lesser bowel symptoms (P = .002) with IG-IMRT. 
- The 3-year pelvic relapse-free survival and disease-free survival in the IG-IMRT versus the 3D-CRT arm were 81.8% versus 84% and 76.9% versus 81.2%, respectively.</description>
      <enclosure length="38616501" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1253003134-bmjpodcasts-the-parcer-trial-with-supriya-chopra.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1250831437</guid>
      <title>Quality improvement and wellbeing are inextricably linked</title>
      <pubDate>Fri, 15 Apr 2022 16:55:56 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/quality-improvement-and-wellbeing-are-inextricably-linked</link>
      <itunes:duration>00:28:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Over the course of the last few years, the BMJ has published a series of articles in our Quality Improvement series - aiming to give those new to improvement science a good grasp of how to think about changing things in healthcare.

Then covid-19 came along, and it seemed like all of healthcare was now aimed at just surviving in the face of the pandemic, and all thoughts of quality improvement projects went out the window... But did they?

Cat Chatfield, is joined by Will Warburton, former director of quality improvement at the Health Foundation, and advisor on the series.

To read all of the open access articles mentioned in the discussion, visit https://www.bmj.com/quality-improvement</itunes:summary>
      <itunes:subtitle>Over the course of the last few years, the BMJ ha…</itunes:subtitle>
      <description>Over the course of the last few years, the BMJ has published a series of articles in our Quality Improvement series - aiming to give those new to improvement science a good grasp of how to think about changing things in healthcare.

Then covid-19 came along, and it seemed like all of healthcare was now aimed at just surviving in the face of the pandemic, and all thoughts of quality improvement projects went out the window... But did they?

Cat Chatfield, is joined by Will Warburton, former director of quality improvement at the Health Foundation, and advisor on the series.

To read all of the open access articles mentioned in the discussion, visit https://www.bmj.com/quality-improvement</description>
      <enclosure length="26958784" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1250831437-bmjpodcasts-quality-improvement-and-wellbeing-are-inextricably-linked.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XDKA1oGZA6yXXCn9-WYgrrw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1250204353</guid>
      <title>The role of medical students in activism</title>
      <pubDate>Fri, 15 Apr 2022 06:00:54 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-role-of-medical-students-in-activism</link>
      <itunes:duration>00:41:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>As medical students progress through medical school, some students are becoming dissatisfied by the lack of attention to socially relevant healthcare issues in the conventional curriculum, and begin to understand that some of the frustrations we encounter at work arise from political decisions. These issues have prompted medical students to voice their concerns and advocate for change.

In this episode, we will be talking about activism, how to get involved and what you can do to push for change.

Topics:
• What makes an activist?
• There is a role for everyone in activism
• Things to bear in mind when considering civil disobedience


Expert guest:
Dr Rita Issa (@DrRitaIssa on Twitter) is a GP, public health academic, and activist. The groups that she’s helped (co)founded or worked with include Doctors for Extinction Rebellion, Docs Not Cops and Medact.
 
Shout out to the following student-activists:
Mikaela Loach (@mikaelaloach on Twitter)
Rhiannon Osborne (@rhiannon_osborn on Twitter)
Amit Singh (@amit_ankhi on Twitter) 
Marina Politis (@marinadpol on Twitter)

Interested in getting involved? Here are some organisations that you can check out:
Health for Green New Deal - https://www.medact.org/project/health-for-a-green-new-deal/ 
Student for Global Health -  https://studentsforglobalhealth.org/ 
Doctors for Extinction Rebellion - https://www.doctorsforxr.com/  
Docs not Cops http://www.docsnotcops.co.uk/ 


Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>As medical students progress through medical scho…</itunes:subtitle>
      <description>As medical students progress through medical school, some students are becoming dissatisfied by the lack of attention to socially relevant healthcare issues in the conventional curriculum, and begin to understand that some of the frustrations we encounter at work arise from political decisions. These issues have prompted medical students to voice their concerns and advocate for change.

In this episode, we will be talking about activism, how to get involved and what you can do to push for change.

Topics:
• What makes an activist?
• There is a role for everyone in activism
• Things to bear in mind when considering civil disobedience


Expert guest:
Dr Rita Issa (@DrRitaIssa on Twitter) is a GP, public health academic, and activist. The groups that she’s helped (co)founded or worked with include Doctors for Extinction Rebellion, Docs Not Cops and Medact.
 
Shout out to the following student-activists:
Mikaela Loach (@mikaelaloach on Twitter)
Rhiannon Osborne (@rhiannon_osborn on Twitter)
Amit Singh (@amit_ankhi on Twitter) 
Marina Politis (@marinadpol on Twitter)

Interested in getting involved? Here are some organisations that you can check out:
Health for Green New Deal - https://www.medact.org/project/health-for-a-green-new-deal/ 
Student for Global Health -  https://studentsforglobalhealth.org/ 
Doctors for Extinction Rebellion - https://www.doctorsforxr.com/  
Docs not Cops http://www.docsnotcops.co.uk/ 


Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="39617408" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1250204353-bmjpodcasts-the-role-of-medical-students-in-activism.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1250103190</guid>
      <title>Elite athletes and pregnancy - the latest evidence and guidance with Dr Margie Davenport Ep #503</title>
      <pubDate>Fri, 15 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/elite-athletes-and-pregnancy-the-latest-evidence-and-guidance-with-dr-margie-davenport-ep-503</link>
      <itunes:duration>00:23:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this week’s BJSM podcast, we are joined by Assistant Professor Margie Davenport, to talk about the latest evidence and experience around exercising and competing as an elite athlete whilst pregnant.

We discuss why this is such an important issue as well as some of the myths or misconceptions that exist in this space. Dr Davenport also provides a range of practical tips for team physicians, scientists and therapists to consider when it comes to advising athletes on planning pregnancies, training whilst pregnant, and shaping support networks and systems to support athletes that want to start a family?

Here is the key paper and some other notable resources discussed in the podcast:

Pushing for change: a qualitative study of the experiences of elite athletes during pregnancy https://bjsm.bmj.com/content/56/8/452 
Why can’t I exercise during pregnancy? Time to revisit medical ‘absolute’ and ‘relative’ contraindications: systematic review of evidence of harm and a call to action https://bjsm.bmj.com/content/54/23/1395
 
Get Active Questionnaire for pregnancy checklist https://csep.ca/2021/05/27/get-active-questionnaire-for-pregnancy/</itunes:summary>
      <itunes:subtitle>On this week’s BJSM podcast, we are joined by Ass…</itunes:subtitle>
      <description>On this week’s BJSM podcast, we are joined by Assistant Professor Margie Davenport, to talk about the latest evidence and experience around exercising and competing as an elite athlete whilst pregnant.

We discuss why this is such an important issue as well as some of the myths or misconceptions that exist in this space. Dr Davenport also provides a range of practical tips for team physicians, scientists and therapists to consider when it comes to advising athletes on planning pregnancies, training whilst pregnant, and shaping support networks and systems to support athletes that want to start a family?

Here is the key paper and some other notable resources discussed in the podcast:

Pushing for change: a qualitative study of the experiences of elite athletes during pregnancy https://bjsm.bmj.com/content/56/8/452 
Why can’t I exercise during pregnancy? Time to revisit medical ‘absolute’ and ‘relative’ contraindications: systematic review of evidence of harm and a call to action https://bjsm.bmj.com/content/54/23/1395
 
Get Active Questionnaire for pregnancy checklist https://csep.ca/2021/05/27/get-active-questionnaire-for-pregnancy/</description>
      <enclosure length="56352000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1250103190-bmjpodcasts-elite-athletes-and-pregnancy-the-latest-evidence-and-guidance-with-dr-margie-davenport-ep-503.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1248921523</guid>
      <title>Sex differences in endovascular thrombectomy outcomes in large vessel occlusion</title>
      <pubDate>Wed, 13 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/sex-differences-in-endovascular-thrombectomy-outcomes-in-large-vessel-occlusion</link>
      <itunes:duration>00:26:06</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Sex disparities in acute ischemic stroke outcomes are well reported with IV thrombolysis. Despite several studies, there is still a lack of consensus on whether endovascular thrombectomy (EVT) outcomes differ between men and women.
In this podcast, we discuss the Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) study, in which women had similar discharge outcomes as men following EVT, in a propensity-matched cohort, but the improvement from discharge to 90 days was significantly worse in women, suggesting the influence of post-discharge factors. 
JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, interviews Johanna Fifi (Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York) and Amrou Sarraj (Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio). 
Paper available online: https://jnis.bmj.com/content/early/2022/02/28/neurintsurg-2021-018348. 
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767.
Thank you for listening!</itunes:summary>
      <itunes:subtitle>Sex disparities in acute ischemic stroke outcomes…</itunes:subtitle>
      <description>Sex disparities in acute ischemic stroke outcomes are well reported with IV thrombolysis. Despite several studies, there is still a lack of consensus on whether endovascular thrombectomy (EVT) outcomes differ between men and women.
In this podcast, we discuss the Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) study, in which women had similar discharge outcomes as men following EVT, in a propensity-matched cohort, but the improvement from discharge to 90 days was significantly worse in women, suggesting the influence of post-discharge factors. 
JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, interviews Johanna Fifi (Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York) and Amrou Sarraj (Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio). 
Paper available online: https://jnis.bmj.com/content/early/2022/02/28/neurintsurg-2021-018348. 
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767.
Thank you for listening!</description>
      <enclosure length="25061249" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1248921523-bmjpodcasts-sex-differences-in-endovascular-thrombectomy-outcomes-in-large-vessel-occlusion.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1241975755</guid>
      <title>Updates and New Options in Advanced Ovarian Cancer</title>
      <pubDate>Mon, 11 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/updates-and-new-options-in-advanced-ovarian-cancer</link>
      <itunes:duration>00:26:37</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Katherine Kurnit. Dr. Kurnit is an Assistant Professor at the University of Chicago in the section of Gynecologic Oncology. Her research interests include developmental therapeutics and early phase clinical trials for patients with gynecologic cancers.

Highlights:
Although surgical practices have changed over time, there is still much debate and no consistent consensus about timing or the use of new therapies such as HIPEC.
More options for upfront maintenance therapy are now available for ovarian cancer patients.
We need new treatment approaches for patients with platinum-resistant ovarian cancer.
Finding ways to ensure ovarian cancer care is safe, feasible, and cost-effective in many different settings (nationally and internationally) will be important.
New strategies for screening and prevention are sorely needed</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Katherine Kurnit. Dr. Kurnit is an Assistant Professor at the University of Chicago in the section of Gynecologic Oncology. Her research interests include developmental therapeutics and early phase clinical trials for patients with gynecologic cancers.

Highlights:
Although surgical practices have changed over time, there is still much debate and no consistent consensus about timing or the use of new therapies such as HIPEC.
More options for upfront maintenance therapy are now available for ovarian cancer patients.
We need new treatment approaches for patients with platinum-resistant ovarian cancer.
Finding ways to ensure ovarian cancer care is safe, feasible, and cost-effective in many different settings (nationally and internationally) will be important.
New strategies for screening and prevention are sorely needed</description>
      <enclosure length="25558621" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1241975755-bmjpodcasts-updates-and-new-options-in-advanced-ovarian-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1246559224</guid>
      <title>Challenges of Exercise and Physical Activity in Minorities with Dr. Meredith Turner. Ep #502</title>
      <pubDate>Fri, 08 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/challenges-of-exercise-and-physical-activity-in-minorities-with-dr-meredith-turner-eep-502</link>
      <itunes:duration>00:13:15</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM (T: @TheAMSSM) Sports Medcast, host Dr. Jacob Wessels, MD, is joined by Dr. Meredith Turner, MD, who is one of the speakers in the Race and Sport session during the 2022 AMSSM Annual Meeting.

In this conversation, Dr. Turner discusses her upcoming presentation in Austin, TX, on the Challenges of Exercise and Physical Activity in Minorities and address the following topics:
·       The definition of minority populations and how she first got interested in this topic
·       Identifying some of the primary barriers that minorities encounter regarding physical activity in their communities
·       How socioeconomic barriers that contribute to these health disparities in minorities
·       Ways that sports medicine professionals and healthcare providers can help recognize and address these factors in their communities

Resources:
Oliver, E. J., Dodd-Reynolds, C., Kasim, A., &amp; Vallis, D. (2021). Inequalities and Inclusion in Exercise Referral Schemes: A Mixed-Method Multi-Scheme Analysis. International journal of environmental research and public health, 18(6), 3033. https://doi.org/10.3390/ijerph18063033
https://pubmed.ncbi.nlm.nih.gov/33809451/

Hawes, A. M., Smith, G. S., McGinty, E., Bell, C., Bower, K., LaVeist, T. A., Gaskin, D. J., &amp; Thorpe, R. J., Jr (2019). Disentangling Race, Poverty, and Place in Disparities in Physical Activity. International journal of environmental research and public health, 16(7), 1193. https://doi.org/10.3390/ijerph16071193
https://pubmed.ncbi.nlm.nih.gov/30987098/

Physical activity deserts: What they are and how to reduce them with Dr. NiCole Keith. Ep #468 https://soundcloud.com/bmjpodcasts/physical-activity-deserts-what-they-are-and-how-to-reduce-them-with-dr-nicole-keith-ep-468</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM (T: @TheAMSSM) Sport…</itunes:subtitle>
      <description>On this episode of the AMSSM (T: @TheAMSSM) Sports Medcast, host Dr. Jacob Wessels, MD, is joined by Dr. Meredith Turner, MD, who is one of the speakers in the Race and Sport session during the 2022 AMSSM Annual Meeting.

In this conversation, Dr. Turner discusses her upcoming presentation in Austin, TX, on the Challenges of Exercise and Physical Activity in Minorities and address the following topics:
·       The definition of minority populations and how she first got interested in this topic
·       Identifying some of the primary barriers that minorities encounter regarding physical activity in their communities
·       How socioeconomic barriers that contribute to these health disparities in minorities
·       Ways that sports medicine professionals and healthcare providers can help recognize and address these factors in their communities

Resources:
Oliver, E. J., Dodd-Reynolds, C., Kasim, A., &amp; Vallis, D. (2021). Inequalities and Inclusion in Exercise Referral Schemes: A Mixed-Method Multi-Scheme Analysis. International journal of environmental research and public health, 18(6), 3033. https://doi.org/10.3390/ijerph18063033
https://pubmed.ncbi.nlm.nih.gov/33809451/

Hawes, A. M., Smith, G. S., McGinty, E., Bell, C., Bower, K., LaVeist, T. A., Gaskin, D. J., &amp; Thorpe, R. J., Jr (2019). Disentangling Race, Poverty, and Place in Disparities in Physical Activity. International journal of environmental research and public health, 16(7), 1193. https://doi.org/10.3390/ijerph16071193
https://pubmed.ncbi.nlm.nih.gov/30987098/

Physical activity deserts: What they are and how to reduce them with Dr. NiCole Keith. Ep #468 https://soundcloud.com/bmjpodcasts/physical-activity-deserts-what-they-are-and-how-to-reduce-them-with-dr-nicole-keith-ep-468</description>
      <enclosure length="9004624" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1246559224-bmjpodcasts-challenges-of-exercise-and-physical-activity-in-minorities-with-dr-meredith-turner-eep-502.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1246546636</guid>
      <title>Long Covid: what we know so far, with Dr Elaine Maxwell</title>
      <pubDate>Fri, 08 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/long-covid-what-we-know-so-far-with-dr-elaine-maxwell</link>
      <itunes:duration>00:24:41</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In the first of a series of three episodes about Long Covid, Dr Roberta Heale, Associate Editor of Evidence-Based Nursing, speaks to Dr Elaine Maxwell, Nurse and author of two National Institute for Health Research reviews on evidence on Long Covid. They discuss the variance in reported Long Covid statistics, the impact of vaccinations, symptoms, and research efforts.
The EBN podcast series on Long Covid is produced by Letícia Amorim and edited by Brian O'Toole.
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.
To read more about this subject, follow the links:
https://evidence.nihr.ac.uk/themedreview/living-with-covid19/
https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/</itunes:summary>
      <itunes:subtitle>In the first of a series of three episodes about …</itunes:subtitle>
      <description>In the first of a series of three episodes about Long Covid, Dr Roberta Heale, Associate Editor of Evidence-Based Nursing, speaks to Dr Elaine Maxwell, Nurse and author of two National Institute for Health Research reviews on evidence on Long Covid. They discuss the variance in reported Long Covid statistics, the impact of vaccinations, symptoms, and research efforts.
The EBN podcast series on Long Covid is produced by Letícia Amorim and edited by Brian O'Toole.
Please subscribe to the Evidence-Based Nursing podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the Evidence-Based Nursing podcast iTunes page (https://podcasts.apple.com/gb/podcast/ebn-podcast/id942927408). Thank you for listening.
To read more about this subject, follow the links:
https://evidence.nihr.ac.uk/themedreview/living-with-covid19/
https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/</description>
      <enclosure length="23704554" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1246546636-bmjpodcasts-long-covid-what-we-know-so-far-with-dr-elaine-maxwell.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XWHwP663TNF7c5jR-ys6wWw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1245592306</guid>
      <title>From Canada to Sweden. Effective roadside barriers, plus electric cars: opportunities vs safety cost</title>
      <pubDate>Thu, 07 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ip-podcast-april-2022-robert-thomson</link>
      <itunes:duration>00:28:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>"Someone has to make a bold experiment once in a while". This month, we talk to Professor Robert Thomson, Mechanics and Maritime Sciences, Chalmers University of Technology, Gothenburg, Sweden. The discussion begins with PhD work on roadside barriers and ends with a discussion about commitment to grand visions, preventing injuries and saving lives. "Here's what you can do if your government and your society gets on board". The conversation, lead by Editor-in-Chief of Injury Prevention Rod McClure, also covers the unintended safety costs of electrification of modern vehicles. There remains a world of opportunity for the safety engineer.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>"Someone has to make a bold experiment once in a …</itunes:subtitle>
      <description>"Someone has to make a bold experiment once in a while". This month, we talk to Professor Robert Thomson, Mechanics and Maritime Sciences, Chalmers University of Technology, Gothenburg, Sweden. The discussion begins with PhD work on roadside barriers and ends with a discussion about commitment to grand visions, preventing injuries and saving lives. "Here's what you can do if your government and your society gets on board". The conversation, lead by Editor-in-Chief of Injury Prevention Rod McClure, also covers the unintended safety costs of electrification of modern vehicles. There remains a world of opportunity for the safety engineer.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="27788015" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1245592306-bmjpodcasts-ip-podcast-april-2022-robert-thomson.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-97PYlC3idubTCbxz-1rv9FQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1245129286</guid>
      <title>Challenging but achievable: reaching Low Lupus Disease Activity State (LLDAS) in childhood-onset SLE</title>
      <pubDate>Wed, 06 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/challenging-but-achievable-reaching-low-lupus-disease-activity-state-lldas-in-childhood-onset-sle</link>
      <itunes:duration>00:20:12</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Duane Peters from the Lupus Foundation of America talks to Dr Sylvia Kamphuis and Dr Javad Wahadat from the Erasmus Medical Center in Rotterdam in the Netherlands about aiming for a Low Lupus Disease Activity State (LLDAS) in children with systemic lupus erythematosus (SLE). They outline the difference between LLDAS and clinical remission (CR), and discuss how LLDAS may be a more achievable target for patients than CR that nevertheless still brings significant clinical benefits in terms of decreasing damage accrual and improving health-related quality of life.

Access the paper here: https://lupus.bmj.com/content/8/1/e000571</itunes:summary>
      <itunes:subtitle>Duane Peters from the Lupus Foundation of America…</itunes:subtitle>
      <description>Duane Peters from the Lupus Foundation of America talks to Dr Sylvia Kamphuis and Dr Javad Wahadat from the Erasmus Medical Center in Rotterdam in the Netherlands about aiming for a Low Lupus Disease Activity State (LLDAS) in children with systemic lupus erythematosus (SLE). They outline the difference between LLDAS and clinical remission (CR), and discuss how LLDAS may be a more achievable target for patients than CR that nevertheless still brings significant clinical benefits in terms of decreasing damage accrual and improving health-related quality of life.

Access the paper here: https://lupus.bmj.com/content/8/1/e000571</description>
      <enclosure length="17088982" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1245129286-bmjpodcasts-challenging-but-achievable-reaching-low-lupus-disease-activity-state-lldas-in-childhood-onset-sle.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zOfBZ6joPLX9GdP1-jqUXQg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1244112691</guid>
      <title>Mycoplasma Genitalium: Easy to detect, hard to treat</title>
      <pubDate>Wed, 06 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mycoplasma-genitalium-easy-to-detect-hard-to-treat</link>
      <itunes:duration>00:20:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, we focus on the bacterial genitourinary pathogen Mycoplasma genitalium (MGEN). We have known this pathogen for a long-time but only in recent years we have been testing and treating more frequently for this bacteria. In this conversation with Dr Fabiola Martin, STI's Podcast editor, Dr Emma Sweeney, Prof Catriona Bradshaw and Prof Nicola Low provide a clinical and research update on MGEN. Dr Emma Sweeney is a Postdoctoral researcher, The University of Queensland Centre for Clinical Research, Brisbane, Australia. Prof Catriona Bradshaw is a Clinician researcher based at Melbourne Sexual Health Centre, Melbourne, Australia. Prof Nicola Low is an Infectious disease epidemiologist, leading the Sexual and Reproductive Health Research Group at the Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Read the blog post: https://blogs.bmj.com/sti/2022/04/06/mgen/
Some relevant papers published by STI: 
Adverse pregnancy and perinatal outcomes, 2022, Frenzer C, Egli-Gany D, Vallely L, et al. https://sti.bmj.com/content/early/2022/03/28/sextrans-2021-055352 
Prevalence in different populations, 2018, Baumann L, Cina M, Egli-Gany D, et al. https://sti.bmj.com/content/94/4/255 
Persistence, concordance, complications in non-pregnant people, 2019, Cina M, Baumann L, Egli-Gany D, et al. https://sti.bmj.com/content/95/5/328</itunes:summary>
      <itunes:subtitle>In this podcast, we focus on the bacterial genito…</itunes:subtitle>
      <description>In this podcast, we focus on the bacterial genitourinary pathogen Mycoplasma genitalium (MGEN). We have known this pathogen for a long-time but only in recent years we have been testing and treating more frequently for this bacteria. In this conversation with Dr Fabiola Martin, STI's Podcast editor, Dr Emma Sweeney, Prof Catriona Bradshaw and Prof Nicola Low provide a clinical and research update on MGEN. Dr Emma Sweeney is a Postdoctoral researcher, The University of Queensland Centre for Clinical Research, Brisbane, Australia. Prof Catriona Bradshaw is a Clinician researcher based at Melbourne Sexual Health Centre, Melbourne, Australia. Prof Nicola Low is an Infectious disease epidemiologist, leading the Sexual and Reproductive Health Research Group at the Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Read the blog post: https://blogs.bmj.com/sti/2022/04/06/mgen/
Some relevant papers published by STI: 
Adverse pregnancy and perinatal outcomes, 2022, Frenzer C, Egli-Gany D, Vallely L, et al. https://sti.bmj.com/content/early/2022/03/28/sextrans-2021-055352 
Prevalence in different populations, 2018, Baumann L, Cina M, Egli-Gany D, et al. https://sti.bmj.com/content/94/4/255 
Persistence, concordance, complications in non-pregnant people, 2019, Cina M, Baumann L, Egli-Gany D, et al. https://sti.bmj.com/content/95/5/328</description>
      <enclosure length="19613987" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1244112691-bmjpodcasts-mycoplasma-genitalium-easy-to-detect-hard-to-treat.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QsRTwnBAaqDmx3t3-PmDMzA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1243944166</guid>
      <title>Doctor Informed - Medicine's me too moments</title>
      <pubDate>Mon, 04 Apr 2022 10:19:01 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/doctor-informed-medicines-me-too-moments</link>
      <itunes:duration>00:42:41</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode we’re going to be talking about misogyny in surgery, recent revelations about sexual harassment in the theatre have emerged - but these behaviours have been endemic for a while, even as the profession seemed to ignore them.

Joining Clara Munro is Baroness Helena Kenned, the author of a recent report into diversity in medicine, who, as a barrister, has long worked on discrimination cases.

The reports mentioned in the episode are from the Royal College of Surgeons;

https://www.rcseng.ac.uk/about-the-rcs/about-our-mission/diversity-review-2021/</itunes:summary>
      <itunes:subtitle>In this episode we’re going to be talking about m…</itunes:subtitle>
      <description>In this episode we’re going to be talking about misogyny in surgery, recent revelations about sexual harassment in the theatre have emerged - but these behaviours have been endemic for a while, even as the profession seemed to ignore them.

Joining Clara Munro is Baroness Helena Kenned, the author of a recent report into diversity in medicine, who, as a barrister, has long worked on discrimination cases.

The reports mentioned in the episode are from the Royal College of Surgeons;

https://www.rcseng.ac.uk/about-the-rcs/about-our-mission/diversity-review-2021/</description>
      <enclosure length="40987584" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1243944166-bmjpodcasts-doctor-informed-medicines-me-too-moments.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iv1zjTJkVfROtFcB-2RBqcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1241330704</guid>
      <title>ERAS and MIS for Same-Day Discharge</title>
      <pubDate>Mon, 04 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/eras-and-mis-for-same-day-discharge</link>
      <itunes:duration>00:41:22</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Genevieve Bouchard-Fortier. Dr. Bouchard-Fortier is an assistant professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Toronto and a member of the Division of Gynecologic Oncology at the University Health Network/Sinai Health Systems. Her research is focused on improving the quality of care of gynecologic oncology patients as well as developing quality metrics to measure outcomes.

Highlights:

• We implemented a perioperative program to increase same day discharge rate after minimally invasive hysterectomy from 30% to 75% in gynecologic oncology patients.

• ERAS principles significantly improved the same day discharge rate while maintaining a low complication rate.

• Longer surgery, timing of surgery, and narcotic use were significantly associated with overnight admission.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Genevieve Bouchard-Fortier. Dr. Bouchard-Fortier is an assistant professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Toronto and a member of the Division of Gynecologic Oncology at the University Health Network/Sinai Health Systems. Her research is focused on improving the quality of care of gynecologic oncology patients as well as developing quality metrics to measure outcomes.

Highlights:

• We implemented a perioperative program to increase same day discharge rate after minimally invasive hysterectomy from 30% to 75% in gynecologic oncology patients.

• ERAS principles significantly improved the same day discharge rate while maintaining a low complication rate.

• Longer surgery, timing of surgery, and narcotic use were significantly associated with overnight admission.</description>
      <enclosure length="39505306" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1241330704-bmjpodcasts-eras-and-mis-for-same-day-discharge.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1243870789</guid>
      <title>Archimedes April 2022: Quality babies</title>
      <pubDate>Mon, 04 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/archimedes-april-2022</link>
      <itunes:duration>00:12:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Croaking and wheezing and slightly exhausted… not the average neonatologist but Archimedes this month is brought to you from post-natal palaces and 'post-nasal drip'.
We start thinking about how best to communicate a post-natal diagnosis of Down syndrome(https://adc.bmj.com/content/107/4/409.1), which is prefaced by some thoughts on what it means to undertake a ‘good’ qualitative study(https://adc.bmj.com/content/107/4/409.2). We have more on this on our blog site, in this series: https://blogs.bmj.com/adc/category/qualitative/
We then dive down from the wards into the NICU where we wonder how to shift the clogged secretions of a grot-filled lung, and someone suggests DNAse, which sounds a lot like magic, but magic that can be evidence-based(https://adc.bmj.com/content/107/4/411).
When you’ve had a listen tell us what you think, and submit your own following the instructions on the website and you too could be hearing all about yourself croaked Archi or in active conversation too.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Croaking and wheezing and slightly exhausted… not…</itunes:subtitle>
      <description>Croaking and wheezing and slightly exhausted… not the average neonatologist but Archimedes this month is brought to you from post-natal palaces and 'post-nasal drip'.
We start thinking about how best to communicate a post-natal diagnosis of Down syndrome(https://adc.bmj.com/content/107/4/409.1), which is prefaced by some thoughts on what it means to undertake a ‘good’ qualitative study(https://adc.bmj.com/content/107/4/409.2). We have more on this on our blog site, in this series: https://blogs.bmj.com/adc/category/qualitative/
We then dive down from the wards into the NICU where we wonder how to shift the clogged secretions of a grot-filled lung, and someone suggests DNAse, which sounds a lot like magic, but magic that can be evidence-based(https://adc.bmj.com/content/107/4/411).
When you’ve had a listen tell us what you think, and submit your own following the instructions on the website and you too could be hearing all about yourself croaked Archi or in active conversation too.
Please listen to our regular podcasts and subscribe to Apple Podcasts, Google Podcasts, Stitcher, and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="12355708" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1243870789-bmjpodcasts-archimedes-april-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1242238132</guid>
      <title>Patient Confidential - is it okay to recount patients’ stories</title>
      <pubDate>Fri, 01 Apr 2022 06:00:43 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/patient-confidential-is-it-okay-to-recount-patients-stories</link>
      <itunes:duration>00:39:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>As healthcare professionals, we meet people from all walks of life and collect stories along the way — stories of illness and convalescence. When we hear interesting stories, there can be an urge to share them. When something bad happens, you may want to talk and offload it onto your friends and family. 

As we know, patient confidentiality is a core value in medicine. So what is permissible to share? Is there a way to share these stories while respecting the ethical boundaries?

In this episode, the Sharp Scratch team explores the ethical considerations involved in talking and writing about patients, and discusses the popular literature genre of medical memoirs. 

Expert guest: Dr Matt Phillips is a sexual health consultant and a honorary clinical professor in genitourinary medicine and ethics at the University of Central Lancashire.

Recommended reading: 
The ethics of medical memoirs. Link: https://www.bmj.com/content/367/bmj.l6270 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>As healthcare professionals, we meet people from …</itunes:subtitle>
      <description>As healthcare professionals, we meet people from all walks of life and collect stories along the way — stories of illness and convalescence. When we hear interesting stories, there can be an urge to share them. When something bad happens, you may want to talk and offload it onto your friends and family. 

As we know, patient confidentiality is a core value in medicine. So what is permissible to share? Is there a way to share these stories while respecting the ethical boundaries?

In this episode, the Sharp Scratch team explores the ethical considerations involved in talking and writing about patients, and discusses the popular literature genre of medical memoirs. 

Expert guest: Dr Matt Phillips is a sexual health consultant and a honorary clinical professor in genitourinary medicine and ethics at the University of Central Lancashire.

Recommended reading: 
The ethics of medical memoirs. Link: https://www.bmj.com/content/367/bmj.l6270 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="37509632" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1242238132-bmjpodcasts-patient-confidential-is-it-okay-to-recount-patients-stories.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1242525793</guid>
      <title>Post-COVID Syndrome in Athletes. With Dr Monica Verduzco-Gutierrez. Ep #501</title>
      <pubDate>Fri, 01 Apr 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/post-covid-syndrome-in-athletes-with-dr-monica-verduzco-gutierrez-ep-501</link>
      <itunes:duration>00:16:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On this episode of the AMSSM CRN Spotlight Podcast (T: @TheAMSSM) host Dr. Jeremy Schroeder, DO, is joined by Dr. Monica Verduzco-Gutierrez (T: @MVGutierrezMD), who is serving as the AAPM&amp;R Exchange Lecture Speaker during the 2022 AMSSM Annual Meeting.
In this conversation, Dr. Verduzco-Gutierrez discusses her upcoming presentation in Austin, TX, on Post-COVID Syndrome in Athletes and address the following topics:
•	Defining Post-COVID Syndrome and its many potential impacts
•	How and why she developed a Post-COVID Recovery Clinic
•	Her contributions to multi-disciplinary collaborative consensus guidance statements for patients with PASC
•	How she generally approaches treating patients with Post-COVID Syndrome
•	The differences in rates and severity in Post-COVID Syndrome in athletes compared with other populations
•	Her advice for aspiring researchers in sport and exercise science
Resources:
Models of Care for Postacute COVID-19 Clinics: Experiences and a Practical Framework for Outpatient Physiatry Settings (https://pubmed.ncbi.nlm.nih.gov/34793373/)
Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)(https://onlinelibrary.wiley.com/doi/10.1002/pmrj.12744)
Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients (https://onlinelibrary.wiley.com/doi/full/10.1002/pmrj.12684)</itunes:summary>
      <itunes:subtitle>On this episode of the AMSSM CRN Spotlight Podcas…</itunes:subtitle>
      <description>On this episode of the AMSSM CRN Spotlight Podcast (T: @TheAMSSM) host Dr. Jeremy Schroeder, DO, is joined by Dr. Monica Verduzco-Gutierrez (T: @MVGutierrezMD), who is serving as the AAPM&amp;R Exchange Lecture Speaker during the 2022 AMSSM Annual Meeting.
In this conversation, Dr. Verduzco-Gutierrez discusses her upcoming presentation in Austin, TX, on Post-COVID Syndrome in Athletes and address the following topics:
•	Defining Post-COVID Syndrome and its many potential impacts
•	How and why she developed a Post-COVID Recovery Clinic
•	Her contributions to multi-disciplinary collaborative consensus guidance statements for patients with PASC
•	How she generally approaches treating patients with Post-COVID Syndrome
•	The differences in rates and severity in Post-COVID Syndrome in athletes compared with other populations
•	Her advice for aspiring researchers in sport and exercise science
Resources:
Models of Care for Postacute COVID-19 Clinics: Experiences and a Practical Framework for Outpatient Physiatry Settings (https://pubmed.ncbi.nlm.nih.gov/34793373/)
Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)(https://onlinelibrary.wiley.com/doi/10.1002/pmrj.12744)
Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients (https://onlinelibrary.wiley.com/doi/full/10.1002/pmrj.12684)</description>
      <enclosure length="11615794" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1242525793-bmjpodcasts-post-covid-syndrome-in-athletes-with-dr-monica-verduzco-gutierrez-ep-501.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1241587921</guid>
      <title>Endoscopic full-thickness plication for the treatment of PPI-dependent GERD</title>
      <pubDate>Thu, 31 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/endoscopic-full-thickness-plication-for-the-treatment-of-ppi-dependent-gerd</link>
      <itunes:duration>00:07:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Rakesh Kalapala, Senior Consultant Gastroenterologist &amp; Therapeutic Endoscopist, Head of GI Motility Lab, Director of Endoscopy at the Center for Obesity &amp; Metabolic Therapy, Member of the International Bariatric and Metabolic Endoscopy Committee, Asian Institute of Gastroenterology Hospitals, Hyderabad, India on the paper 'Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial' which is published in paper copy in Gut in April 2022, and is available here: https://gut.bmj.com/content/71/4/686

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Rakesh Kalapala, Senior Consultant Gastroenterologist &amp; Therapeutic Endoscopist, Head of GI Motility Lab, Director of Endoscopy at the Center for Obesity &amp; Metabolic Therapy, Member of the International Bariatric and Metabolic Endoscopy Committee, Asian Institute of Gastroenterology Hospitals, Hyderabad, India on the paper 'Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial' which is published in paper copy in Gut in April 2022, and is available here: https://gut.bmj.com/content/71/4/686

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="6727888" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1241587921-bmjpodcasts-endoscopic-full-thickness-plication-for-the-treatment-of-ppi-dependent-gerd.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1236538288</guid>
      <title>DTB turns 60! Plus: conflicts of interest, harms from nitrofurantoin and hypertension in pregnancy</title>
      <pubDate>Thu, 31 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-april-2022</link>
      <itunes:duration>00:28:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the April 2022 issue of DTB. They talk about DTB's 60th anniversary, the importance of independent scrutiny of new medicines and the need to question how medicines are licensed and used (https://dtb.bmj.com/content/60/4/50). They highlight the benefits of a comprehensive national register of conflicts of interest and discuss a study that compared a quadpill containing low doses of four antihypertensive agents with a standard dose of irbesartan (https://dtb.bmj.com/content/60/4/56). They also review a study that assessed clinicians' awareness of the harms from long-term use of nitrofurantoin (https://dtb.bmj.com/content/60/4/59) and provide an overview of an article on managing hypertension in pregnancy (https://dtb.bmj.com/content/60/4/60). The editors also look back at the very first issue of DTB that was published on 20th April 1962 (https://dtb.bmj.com/content/s1-1/1).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the April 2022 issue of DTB. They talk about DTB's 60th anniversary, the importance of independent scrutiny of new medicines and the need to question how medicines are licensed and used (https://dtb.bmj.com/content/60/4/50). They highlight the benefits of a comprehensive national register of conflicts of interest and discuss a study that compared a quadpill containing low doses of four antihypertensive agents with a standard dose of irbesartan (https://dtb.bmj.com/content/60/4/56). They also review a study that assessed clinicians' awareness of the harms from long-term use of nitrofurantoin (https://dtb.bmj.com/content/60/4/59) and provide an overview of an article on managing hypertension in pregnancy (https://dtb.bmj.com/content/60/4/60). The editors also look back at the very first issue of DTB that was published on 20th April 1962 (https://dtb.bmj.com/content/s1-1/1).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="68526145" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1236538288-bmjpodcasts-dtb-april-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1241471788</guid>
      <title>Covid vaccine safety, Methenamine hippurate, and intersectionality</title>
      <pubDate>Wed, 30 Mar 2022 18:08:53 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/covid-vaccine-safety-methenamine-hippurate-and-intersectionality</link>
      <itunes:duration>00:37:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of Talk Evidence, Helen Macdonald, the BMJ’s research integrity editor is joined by Joe Ross, US research editor, and Juan Franco, editor in chief of BMJEBM, to talk about all things evidence.

Joe gives us an update about covid, including new research on safety of the vaccine  Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events
https://www.bmj.com/content/376/bmj-2021-068373

Juan updates us on a potential new prophylactic for recurrent UTIs, Methenamine hippurate, which could be an alternative to antibiotics.
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women
https://www.bmj.com/content/376/bmj-2021-0068229

Helen tells us about some research which evaluates the way in which intersecting identities combine to make students experience of medical school more difficult.
Marginalized identities, mistreatment, discrimination, and burnout among US medical students
https://www.bmj.com/content/376/bmj-2021-065984</itunes:summary>
      <itunes:subtitle>In this episode of Talk Evidence, Helen Macdonald…</itunes:subtitle>
      <description>In this episode of Talk Evidence, Helen Macdonald, the BMJ’s research integrity editor is joined by Joe Ross, US research editor, and Juan Franco, editor in chief of BMJEBM, to talk about all things evidence.

Joe gives us an update about covid, including new research on safety of the vaccine  Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events
https://www.bmj.com/content/376/bmj-2021-068373

Juan updates us on a potential new prophylactic for recurrent UTIs, Methenamine hippurate, which could be an alternative to antibiotics.
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women
https://www.bmj.com/content/376/bmj-2021-0068229

Helen tells us about some research which evaluates the way in which intersecting identities combine to make students experience of medical school more difficult.
Marginalized identities, mistreatment, discrimination, and burnout among US medical students
https://www.bmj.com/content/376/bmj-2021-065984</description>
      <enclosure length="36059009" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1241471788-bmjpodcasts-covid-vaccine-safety-methenamine-hippurate-and-intersectionality.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2yobq1Hjl6r87WmD-zdjn1Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1241298403</guid>
      <title>First episode: Factors associated with treatment outcomes for low back pain injections</title>
      <pubDate>Wed, 30 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/rapm-focus-podcast-episode-1</link>
      <itunes:duration>00:28:43</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In the first episode of RAPM Focus, Editor-in-Chief Brian Sites, MD, interviews Stephen P. Cohen, MD, first author of the paper “Multicenter study evaluating factors associated with treatment outcome for low back pain injections”. This prospective study looked at 346 patients receiving one of three procedures: epidural steroid injection for sciatica, sacroiliac joint injections for axial low back pain, and facet interventions for axial low back pain. The study was designed to evaluate associations among more than two dozen demographic, clinical, and technical factors on treatment outcomes. Results found that patients with lower baseline pain scores, depressive symptomatology, and obesity experienced smaller pain reductions. Smoking and sleep deprivation were also associated with poorer outcomes. 
Dr. Cohen is a professor of anesthesiology and critical care medicine, neurology, physical medicine &amp; rehabilitation and psychiatry and behavioral sciences at the Johns Hopkins School of Medicine and Uniformed Services University of the Health Sciences in Baltimore, MD. He is also chief of pain medicine and director of the Blaustein Pain Treatment Center at Johns Hopkins and director of pain research at Walter Reed National Military Medical Center.
@RAPM_Online</itunes:summary>
      <itunes:subtitle>In the first episode of RAPM Focus, Editor-in-Chi…</itunes:subtitle>
      <description>In the first episode of RAPM Focus, Editor-in-Chief Brian Sites, MD, interviews Stephen P. Cohen, MD, first author of the paper “Multicenter study evaluating factors associated with treatment outcome for low back pain injections”. This prospective study looked at 346 patients receiving one of three procedures: epidural steroid injection for sciatica, sacroiliac joint injections for axial low back pain, and facet interventions for axial low back pain. The study was designed to evaluate associations among more than two dozen demographic, clinical, and technical factors on treatment outcomes. Results found that patients with lower baseline pain scores, depressive symptomatology, and obesity experienced smaller pain reductions. Smoking and sleep deprivation were also associated with poorer outcomes. 
Dr. Cohen is a professor of anesthesiology and critical care medicine, neurology, physical medicine &amp; rehabilitation and psychiatry and behavioral sciences at the Johns Hopkins School of Medicine and Uniformed Services University of the Health Sciences in Baltimore, MD. He is also chief of pain medicine and director of the Blaustein Pain Treatment Center at Johns Hopkins and director of pain research at Walter Reed National Military Medical Center.
@RAPM_Online</description>
      <enclosure length="68936355" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1241298403-bmjpodcasts-rapm-focus-podcast-episode-1.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-36rEAsdbqSkJRswY-u6sWGg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1241226265</guid>
      <title>Colon Cancer Awareness</title>
      <pubDate>Wed, 30 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/colon-cancer-awareness</link>
      <itunes:duration>00:33:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In honor of Colon Cancer Awareness Month, Editor-in-Chief Dr. Richard McCallum and Dr. Ihsan Al Bayati, Assistant Professor of Gastroenterology at TTUHSC Paul L. Foster School of Medicine, discuss different screening modalities for colon cancer, risk factors for colon cancer, Lynch syndrome, treatment, staging, and prognosis for colorectal cancer.</itunes:summary>
      <itunes:subtitle>In honor of Colon Cancer Awareness Month, Editor-…</itunes:subtitle>
      <description>In honor of Colon Cancer Awareness Month, Editor-in-Chief Dr. Richard McCallum and Dr. Ihsan Al Bayati, Assistant Professor of Gastroenterology at TTUHSC Paul L. Foster School of Medicine, discuss different screening modalities for colon cancer, risk factors for colon cancer, Lynch syndrome, treatment, staging, and prognosis for colorectal cancer.</description>
      <enclosure length="32214878" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1241226265-bmjpodcasts-colon-cancer-awareness.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-7o9sX2h0NbNPksAK-4Bz28w-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1237043920</guid>
      <title>Searching for genetic causes of cardiomyopathy</title>
      <pubDate>Tue, 29 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/searching-for-genetic-causes-of-cardiomyopathy</link>
      <itunes:duration>00:23:19</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Social Media Intern, Dr Andrew Perry is joined by Dr. Gasnat Shaboodien, a researcher at the University of Cape Town who studies the genetics of cardiovascular disease.

If you enjoy the show, please subscribe to the podcast. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2. It helps us reach new listeners!

Link to published paper: https://heart.bmj.com/content/early/2022/02/08/heartjnl-2021-320424</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Social Medi…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Social Media Intern, Dr Andrew Perry is joined by Dr. Gasnat Shaboodien, a researcher at the University of Cape Town who studies the genetics of cardiovascular disease.

If you enjoy the show, please subscribe to the podcast. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2. It helps us reach new listeners!

Link to published paper: https://heart.bmj.com/content/early/2022/02/08/heartjnl-2021-320424</description>
      <enclosure length="55937812" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1237043920-bmjpodcasts-searching-for-genetic-causes-of-cardiomyopathy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1240083703</guid>
      <title>April 2022: consequences of armed conflicts for children; and several meanings of ‘growth’</title>
      <pubDate>Mon, 28 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/april-2022-adc-atoms</link>
      <itunes:duration>00:19:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the April 2022 issue. They start this month by addressing the consequences of wars on children in light of the latest war in Ukraine.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/4/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the April 2022 issue. They start this month by addressing the consequences of wars on children in light of the latest war in Ukraine.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/4/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="18793951" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1240083703-bmjpodcasts-april-2022-adc-atoms.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1240025431</guid>
      <title>GOG 281: Use of Trametinib in Low-Grade Serous Cancer</title>
      <pubDate>Mon, 28 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/gog-281-use-of-trametinib-in-low-grade-serous-cancer</link>
      <itunes:duration>00:41:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David M. Gershenson to discuss the use of trametinib in low-grade serous cancer. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research of rare ovarian cancers.


Highlights:
Trametinib represents a new standard for the treatment of recurrent low-grade serous carcinoma of the ovary/peritoneum.
The findings of GOG 281 suggest that women whose tumor harbors a MAPK mutation (KRAS, NRAS, BRAF) may have a greater probability of response to trametinib, but the results are hypothesis-generating, and further studies are needed. Importantly, trametinib should not be withheld from a woman whose tumor lacks MAPK mutations.
Based on the findings of GOG 281 and preclinical studies, future trials will include combinations of a MEK inhibitor plus endocrine therapy and novel agents targeting the MAPK signaling pathway or, more specifically, RAS.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David M. Gershenson to discuss the use of trametinib in low-grade serous cancer. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research of rare ovarian cancers.


Highlights:
Trametinib represents a new standard for the treatment of recurrent low-grade serous carcinoma of the ovary/peritoneum.
The findings of GOG 281 suggest that women whose tumor harbors a MAPK mutation (KRAS, NRAS, BRAF) may have a greater probability of response to trametinib, but the results are hypothesis-generating, and further studies are needed. Importantly, trametinib should not be withheld from a woman whose tumor lacks MAPK mutations.
Based on the findings of GOG 281 and preclinical studies, future trials will include combinations of a MEK inhibitor plus endocrine therapy and novel agents targeting the MAPK signaling pathway or, more specifically, RAS.</description>
      <enclosure length="23531940" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1240025431-bmjpodcasts-gog-281-use-of-trametinib-in-low-grade-serous-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1238587084</guid>
      <title>Episode 500 – The past, present and future of BJSM</title>
      <pubDate>Fri, 25 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/episode-500-the-past-present-and-future-of-bjsm</link>
      <itunes:duration>00:27:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In BJSM’s 500th episode, we are joined by two of the current editors, Professor Jonathan Drezner and Dr Joanna Kemp, to look ahead as well as back at the specialty in general. We discuss hot topics, the direction in which the specialty as well as the journal is heading, and we get some top tips for early career researchers and clinicians too.</itunes:summary>
      <itunes:subtitle>In BJSM’s 500th episode, we are joined by two of …</itunes:subtitle>
      <description>In BJSM’s 500th episode, we are joined by two of the current editors, Professor Jonathan Drezner and Dr Joanna Kemp, to look ahead as well as back at the specialty in general. We discuss hot topics, the direction in which the specialty as well as the journal is heading, and we get some top tips for early career researchers and clinicians too.</description>
      <enclosure length="65088000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1238587084-bmjpodcasts-episode-500-the-past-present-and-future-of-bjsm.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1237911220</guid>
      <title>Wellbeing - hot food on a night shift</title>
      <pubDate>Thu, 24 Mar 2022 12:46:54 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/wellbeing-hot-food-on-a-night-shift</link>
      <itunes:duration>00:22:54</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The issue of food on nightshifts is a perennial grumble in the NHS, and though it might seem trivial, what does it say of an organisation if they demand their staff work when they're hungry, and what is the onward implication for that on patient care?

To discuss all of these issues, we're joined by Neely Mozawala, a community specialist diabetes podiatrist, and Sahlia Saliha Mahmood-Ahmed, a gastroenterologist who have started the #24hrhotfoodfortheNHS campaign.</itunes:summary>
      <itunes:subtitle>The issue of food on nightshifts is a perennial g…</itunes:subtitle>
      <description>The issue of food on nightshifts is a perennial grumble in the NHS, and though it might seem trivial, what does it say of an organisation if they demand their staff work when they're hungry, and what is the onward implication for that on patient care?

To discuss all of these issues, we're joined by Neely Mozawala, a community specialist diabetes podiatrist, and Sahlia Saliha Mahmood-Ahmed, a gastroenterologist who have started the #24hrhotfoodfortheNHS campaign.</description>
      <enclosure length="21992175" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1237911220-bmjpodcasts-wellbeing-hot-food-on-a-night-shift.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XDKA1oGZA6yXXCn9-WYgrrw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1237890436</guid>
      <title>Great Explanations</title>
      <pubDate>Thu, 24 Mar 2022 12:01:05 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/great-explanations</link>
      <itunes:duration>00:49:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We see patients all the time who ,more than any drug or cure, just want an explanation for their symptoms, to understand why they feel the way they do.

But giving an explanation isn't necessarily straightforward, we're unsure  of the diagnosis, we might worry about how the explanation might be received, or a 10 minute appointment just isn't time to go into all the details.

In today's episode, we've enlisted the help of consultation skills expert, Roger Neighbour, and hear how important a great explanation is from The BMJ patient editor Amy Price.

Our guests:

Roger Neighbour is a retired GP and a former president of the Royal College of GPs. He has written the books on consultations skills, and teaches courses on how to put those skills into practice.

Amy Price is a patient, a researcher editor for The BMJ's patient and public partnership, and a senior research scientist at Stanford School of Medicine.</itunes:summary>
      <itunes:subtitle>We see patients all the time who ,more than any d…</itunes:subtitle>
      <description>We see patients all the time who ,more than any drug or cure, just want an explanation for their symptoms, to understand why they feel the way they do.

But giving an explanation isn't necessarily straightforward, we're unsure  of the diagnosis, we might worry about how the explanation might be received, or a 10 minute appointment just isn't time to go into all the details.

In today's episode, we've enlisted the help of consultation skills expert, Roger Neighbour, and hear how important a great explanation is from The BMJ patient editor Amy Price.

Our guests:

Roger Neighbour is a retired GP and a former president of the Royal College of GPs. He has written the books on consultations skills, and teaches courses on how to put those skills into practice.

Amy Price is a patient, a researcher editor for The BMJ's patient and public partnership, and a senior research scientist at Stanford School of Medicine.</description>
      <enclosure length="47509001" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1237890436-bmjpodcasts-great-explanations.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1229254354</guid>
      <title>Asthma In adults</title>
      <pubDate>Tue, 22 Mar 2022 10:35:11 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/asthma-in-adults</link>
      <itunes:duration>00:21:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Patients with asthma present with recurrent episodes of shortness of breath, chest tightness, wheezing, or coughing.

Examination typically demonstrates an expiratory wheeze; however, in severe asthma there is poor air entry and the chest is silent.

Lauren Eggert, Clinical Assistant Professor,  Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, gives us a clinical overview of the condition.

For more on asthma, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/44

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Patients with asthma present with recurrent episo…</itunes:subtitle>
      <description>Patients with asthma present with recurrent episodes of shortness of breath, chest tightness, wheezing, or coughing.

Examination typically demonstrates an expiratory wheeze; however, in severe asthma there is poor air entry and the chest is silent.

Lauren Eggert, Clinical Assistant Professor,  Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, gives us a clinical overview of the condition.

For more on asthma, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/44

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="20313009" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1229254354-bmjpodcasts-asthma-in-adults.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ujs7lai7EfGopsDJ-npDHtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1236195229</guid>
      <title>Mark Beattie's UpFront March 2022</title>
      <pubDate>Mon, 21 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mark-beatties-upfront-march-2022</link>
      <itunes:duration>00:09:08</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The highlights of this edition brought to you by the Editor-in-Chief of Frontline Gastroenterology Mark Beattie.
Read the UpFront of the March 2022 issue of Frontline Gastroenterology: https://fg.bmj.com/content/13/2/93
The full issue is now online: https://fg.bmj.com/content/13/2
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</itunes:summary>
      <itunes:subtitle>The highlights of this edition brought to you by …</itunes:subtitle>
      <description>The highlights of this edition brought to you by the Editor-in-Chief of Frontline Gastroenterology Mark Beattie.
Read the UpFront of the March 2022 issue of Frontline Gastroenterology: https://fg.bmj.com/content/13/2/93
The full issue is now online: https://fg.bmj.com/content/13/2
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify.</description>
      <enclosure length="8777559" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1236195229-bmjpodcasts-mark-beatties-upfront-march-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1236038239</guid>
      <title>Mentor's Podcast: Rene Pareja</title>
      <pubDate>Mon, 21 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/mentors-podcast-rene-pareja</link>
      <itunes:duration>00:53:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Rene Pareja, a gynecologist-oncologist at Astorga Oncology Clinic in Medellín and the National Cancer Institute in Bogotá, Colombia. Dr. Pareja is a reviewer for more than 20 specialty journals, an Associate Editor for IJGC, and a member of the board of directors of the International Gynecological Cancer Society (IGCS). He is the author of nine book chapters and more than 70 publications in peer-reviewed journals, and at IGCS 2021 he received an award for Community Advancement in Resource-Limited Settings.
 
Highlights:
Tips for expertise in minimally invasive surgery: (1) learn from an experienced mentor, (2) train all the time, (3) get a formal course, (4) record your surgeries.
The crucial components to do surgery related research: Start to review papers, write protocols/systematic reviews, and try to work the most and tirelessly on an original project.
A successful person is someone who has failed several times.
Secrets and tips on life and professional career.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Rene Pareja, a gynecologist-oncologist at Astorga Oncology Clinic in Medellín and the National Cancer Institute in Bogotá, Colombia. Dr. Pareja is a reviewer for more than 20 specialty journals, an Associate Editor for IJGC, and a member of the board of directors of the International Gynecological Cancer Society (IGCS). He is the author of nine book chapters and more than 70 publications in peer-reviewed journals, and at IGCS 2021 he received an award for Community Advancement in Resource-Limited Settings.
 
Highlights:
Tips for expertise in minimally invasive surgery: (1) learn from an experienced mentor, (2) train all the time, (3) get a formal course, (4) record your surgeries.
The crucial components to do surgery related research: Start to review papers, write protocols/systematic reviews, and try to work the most and tirelessly on an original project.
A successful person is someone who has failed several times.
Secrets and tips on life and professional career.</description>
      <enclosure length="29588796" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1236038239-bmjpodcasts-mentors-podcast-rene-pareja.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1233945886</guid>
      <title>The clinical guideline will see you now</title>
      <pubDate>Fri, 18 Mar 2022 07:00:43 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-clinical-guideline-will-see-you-now</link>
      <itunes:duration>00:43:01</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Medical students are taught about and examined a lot on clinical guidelines. What is best for patients overall, as recommended in guidelines, may not be appropriate for individuals. Blanket recommendations, rather than a menu of options or recommendations for shared decision making, ignore patients' preferences.

So what do guidelines mean in practice? When do we deviate from them when your clinical acumen is telling you that guidelines may not be the best fit?

Expert guest: Dr Liam Loftus is a GP trainee and a National Medical Director’s Clinical Fellow who has worked with the Personalised Care Institute.

Recommended reading:

How can tomorrow’s doctors be more caring? A phenomenological investigation. Link: onlinelibrary.wiley.com/doi/10.1111/medu.13684

Potential benefits, limitations, and harms of clinical guidelines. Link: www.bmj.com/content/318/7182/527

Check us out on social media:
Twitter: twitter.com/BMJStudent
Instagram: www.instagram.com/bmj_student/
Facebook: www.facebook.com/BMJStudent/

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Medical students are taught about and examined a …</itunes:subtitle>
      <description>Medical students are taught about and examined a lot on clinical guidelines. What is best for patients overall, as recommended in guidelines, may not be appropriate for individuals. Blanket recommendations, rather than a menu of options or recommendations for shared decision making, ignore patients' preferences.

So what do guidelines mean in practice? When do we deviate from them when your clinical acumen is telling you that guidelines may not be the best fit?

Expert guest: Dr Liam Loftus is a GP trainee and a National Medical Director’s Clinical Fellow who has worked with the Personalised Care Institute.

Recommended reading:

How can tomorrow’s doctors be more caring? A phenomenological investigation. Link: onlinelibrary.wiley.com/doi/10.1111/medu.13684

Potential benefits, limitations, and harms of clinical guidelines. Link: www.bmj.com/content/318/7182/527

Check us out on social media:
Twitter: twitter.com/BMJStudent
Instagram: www.instagram.com/bmj_student/
Facebook: www.facebook.com/BMJStudent/

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="41295488" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1233945886-bmjpodcasts-the-clinical-guideline-will-see-you-now.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1229318140</guid>
      <title>Editors Highlights of the April 2022 issue</title>
      <pubDate>Fri, 18 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/pn-april-2022-highlights</link>
      <itunes:duration>00:39:23</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the April 2022 issue of the journal.
Read more on the PN website: https://pn.bmj.com/content/22/2/93
The full issue here: https://pn.bmj.com/content/22/2
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.

If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

Thank you for listening.</itunes:summary>
      <itunes:subtitle>Practical Neurology Editors Phil Smith and Gerain…</itunes:subtitle>
      <description>Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the April 2022 issue of the journal.
Read more on the PN website: https://pn.bmj.com/content/22/2/93
The full issue here: https://pn.bmj.com/content/22/2
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.

If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). 

Thank you for listening.</description>
      <enclosure length="37813602" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1229318140-bmjpodcasts-pn-april-2022-highlights.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1233924085</guid>
      <title>Everyone’s going to make a mistake</title>
      <pubDate>Thu, 17 Mar 2022 14:01:52 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/everyones-going-to-make-a-mistake</link>
      <itunes:duration>00:51:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Medicine is complex, and as a doctor you won't always do the right thing - but you can prepare yourself for when mistakes happen, both emotionally and logistically.

In this episode of Doctor Informed, Clara Munro is joined by Susanna Stamford, a patient who was on the receiving end of a mistake, which catalysed her interest in patient safety. We're also joined by Anthea Martin, from Medical Protection, who dispels some myths about saying sorry. Ayisha Ashmore returns to the pod to digest the lessons from our experts.

Futher reading:
The video that Susanna mentioned is available to watch on youtube
bitly.com/ManagingAdverseEvents</itunes:summary>
      <itunes:subtitle>Medicine is complex, and as a doctor you won't al…</itunes:subtitle>
      <description>Medicine is complex, and as a doctor you won't always do the right thing - but you can prepare yourself for when mistakes happen, both emotionally and logistically.

In this episode of Doctor Informed, Clara Munro is joined by Susanna Stamford, a patient who was on the receiving end of a mistake, which catalysed her interest in patient safety. We're also joined by Anthea Martin, from Medical Protection, who dispels some myths about saying sorry. Ayisha Ashmore returns to the pod to digest the lessons from our experts.

Futher reading:
The video that Susanna mentioned is available to watch on youtube
bitly.com/ManagingAdverseEvents</description>
      <enclosure length="49483440" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1233924085-bmjpodcasts-everyones-going-to-make-a-mistake.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iv1zjTJkVfROtFcB-2RBqcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1230404227</guid>
      <title>LivingBodiesObjects: Changing the way we research</title>
      <pubDate>Thu, 17 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/livingbodiesobjects-changing-the-way-we-research</link>
      <itunes:duration>00:32:39</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>LivingBodiesObjects is a 3-year project funded by the Wellcome Trust designed to test and extend the boundaries of Medical Humanities research.
Editor-in-chief of Medical Humanities, Brandy Schillace, interviews Stuart Murray, Professor of Contemporary Literatures and Film and Director of the Centre of Medical Humanities at the University of Leeds, in the UK.
Read the blog with the transcription of this podcast here: https://blogs.bmj.com/medical-humanities/2022/03/17/livingbodiesobjects-with-stuart-murray.
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>LivingBodiesObjects is a 3-year project funded by…</itunes:subtitle>
      <description>LivingBodiesObjects is a 3-year project funded by the Wellcome Trust designed to test and extend the boundaries of Medical Humanities research.
Editor-in-chief of Medical Humanities, Brandy Schillace, interviews Stuart Murray, Professor of Contemporary Literatures and Film and Director of the Centre of Medical Humanities at the University of Leeds, in the UK.
Read the blog with the transcription of this podcast here: https://blogs.bmj.com/medical-humanities/2022/03/17/livingbodiesobjects-with-stuart-murray.
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="63459912" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1230404227-bmjpodcasts-livingbodiesobjects-changing-the-way-we-research.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-35rzDteJIBP6iGmy-ch0M3g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1230916612</guid>
      <title>Care of the patient after valve intervention</title>
      <pubDate>Mon, 14 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/care-of-the-patient-after-valve-intervention</link>
      <itunes:duration>00:16:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Lynne Millar from Bart's Hospital in London. They discuss her review paper - "Care of the patient after valve intervention". If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/01/10/heartjnl-2021-319767</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Lynne Millar from Bart's Hospital in London. They discuss her review paper - "Care of the patient after valve intervention". If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/early/2022/01/10/heartjnl-2021-319767</description>
      <enclosure length="39571642" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1230916612-bmjpodcasts-care-of-the-patient-after-valve-intervention.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1229843170</guid>
      <title>Neoadjuvant vs Primary Surgery: A NCDB Study with Alex Melamed</title>
      <pubDate>Mon, 14 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/neoadjuvant-vs-primary-surgery-a-ncdb-study-with-alex-melamed</link>
      <itunes:duration>00:39:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Alex Melamed to discuss neoadjuvant versus primary surgery. Alex Melamed is a gynecologist oncologist and a health services researcher at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Columbia Irving Medical Center.

Highlights:
- The emergence of evidence supporting non-inferiority of neoadjuvant chemotherapy (NACT) compared with primary surgery for advance ovarian cancer led to increased utilization of NACT.
- However, while some cancer programs in the U.S. doubled their use of NACT, others continued to use this approach infrequently.
- The differential adoption of NACT by cancer programs can be viewed, and analyzed, as a natural experiment using a difference-in-differences study design.
- Compared with programs that continued to use NACT infrequently, high users of NACT had similar improvements in median survival, with greater reductions in 6-month and 12-month mortality.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Alex Melamed to discuss neoadjuvant versus primary surgery. Alex Melamed is a gynecologist oncologist and a health services researcher at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Columbia Irving Medical Center.

Highlights:
- The emergence of evidence supporting non-inferiority of neoadjuvant chemotherapy (NACT) compared with primary surgery for advance ovarian cancer led to increased utilization of NACT.
- However, while some cancer programs in the U.S. doubled their use of NACT, others continued to use this approach infrequently.
- The differential adoption of NACT by cancer programs can be viewed, and analyzed, as a natural experiment using a difference-in-differences study design.
- Compared with programs that continued to use NACT infrequently, high users of NACT had similar improvements in median survival, with greater reductions in 6-month and 12-month mortality.</description>
      <enclosure length="37523956" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1229843170-bmjpodcasts-neoadjuvant-vs-primary-surgery-a-ncdb-study-with-alex-melamed.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1230619906</guid>
      <title>Solving retention to support workforce recovery</title>
      <pubDate>Fri, 11 Mar 2022 18:21:23 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-bmj-nuffield-trust-roundtable-2022-solving-retention-to-support-workforce-recovery</link>
      <itunes:duration>00:58:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>The covid-19 pandemic has stretched healthcare staff like never before. As part of the 2022 Nuffield Trust summit, The BMJ hosted a roundtable discussion looking at why workers leave the NHS and how staff wellbeing and retention can be improved. 

Joining us to discuss are:
Kamran Abbasi, editor in chief, The BMJ
Billy Palmer, senior fellow, Nuffield Trust
Lucina Rolewicz, researcher, Nuffield Trust
Mark Britnell, global healthcare expert and senior partner, KPMG International
Neil Greenburg, consultant occupational and forensic psychiatrist, King's College London's centre for military health research
Rose Penfold, National Institute for Clinical Research academic clinical fellow in geriatrics
Rammya Mathew, GP and quality improvement lead for Islington GP Federation
Partha Kar, diabetes consultant and NHS England's national advisor for diabetes
Danny Mortimer, chief executive of NHS Employers

The Nuffield Trust report, "The Long Goodbye" which was discussed in this roundtable is available here - https://www.nuffieldtrust.org.uk/resource/the-long-goodbye-exploring-rates-of-staff-leaving-the-nhs-and-social-care</itunes:summary>
      <itunes:subtitle>The covid-19 pandemic has stretched healthcare st…</itunes:subtitle>
      <description>The covid-19 pandemic has stretched healthcare staff like never before. As part of the 2022 Nuffield Trust summit, The BMJ hosted a roundtable discussion looking at why workers leave the NHS and how staff wellbeing and retention can be improved. 

Joining us to discuss are:
Kamran Abbasi, editor in chief, The BMJ
Billy Palmer, senior fellow, Nuffield Trust
Lucina Rolewicz, researcher, Nuffield Trust
Mark Britnell, global healthcare expert and senior partner, KPMG International
Neil Greenburg, consultant occupational and forensic psychiatrist, King's College London's centre for military health research
Rose Penfold, National Institute for Clinical Research academic clinical fellow in geriatrics
Rammya Mathew, GP and quality improvement lead for Islington GP Federation
Partha Kar, diabetes consultant and NHS England's national advisor for diabetes
Danny Mortimer, chief executive of NHS Employers

The Nuffield Trust report, "The Long Goodbye" which was discussed in this roundtable is available here - https://www.nuffieldtrust.org.uk/resource/the-long-goodbye-exploring-rates-of-staff-leaving-the-nhs-and-social-care</description>
      <enclosure length="84659315" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1230619906-bmjpodcasts-the-bmj-nuffield-trust-roundtable-2022-solving-retention-to-support-workforce-recovery.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XDKA1oGZA6yXXCn9-WYgrrw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1228625344</guid>
      <title>Primary Survey -  the highlights of March 2022, including MUST READ papers on ED exit block</title>
      <pubDate>Thu, 10 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/primary-survey-the-highlights-of-march-2022</link>
      <itunes:duration>00:31:53</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Rick Body, Deputy Editor of EMJ, and Sarah Edwards, Social Media Editor of EMJ, talk through the highlights of the March 2022 edition of the EMJ. We've picked out some of the hottest, most controversial papers from this month's episodes and we're privileged to have the thoughts of the EMJ Editor in Chief, Ellen Weber. 
We'll discuss hot issues from the association between exit block and mortality, the 4-hour target, the prognostic importance of admitting patients to outlying wards, decision aids for traumatic brain injury and to predict hospital admission [is doctor better than computer at deciding who needs admission?] and lung ultrasound for COVID-19.
Read the highlights: https://emj.bmj.com/content/39/3/165
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>Rick Body, Deputy Editor of EMJ, and Sarah Edward…</itunes:subtitle>
      <description>Rick Body, Deputy Editor of EMJ, and Sarah Edwards, Social Media Editor of EMJ, talk through the highlights of the March 2022 edition of the EMJ. We've picked out some of the hottest, most controversial papers from this month's episodes and we're privileged to have the thoughts of the EMJ Editor in Chief, Ellen Weber. 
We'll discuss hot issues from the association between exit block and mortality, the 4-hour target, the prognostic importance of admitting patients to outlying wards, decision aids for traumatic brain injury and to predict hospital admission [is doctor better than computer at deciding who needs admission?] and lung ultrasound for COVID-19.
Read the highlights: https://emj.bmj.com/content/39/3/165
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="30613419" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1228625344-bmjpodcasts-primary-survey-the-highlights-of-march-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3uyF294iaNeaFz4G-UPl8OA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1222460452</guid>
      <title>Bacterial meningitis</title>
      <pubDate>Wed, 09 Mar 2022 16:18:33 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/bacterial-meningitis</link>
      <itunes:duration>00:22:25</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Bacterial meningitis represents a life-threatening inflammation of the meninges.

Elisabeth Adderson, Associate Member, St. Jude Faculty, Director, Pediatric Infectious Diseases Fellowship Program, St. Jude Children's Research Hospital, Memphis, gives an overview of the condition.

For more on bacterial meningitis, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/3000104

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Bacterial meningitis represents a life-threatenin…</itunes:subtitle>
      <description>Bacterial meningitis represents a life-threatening inflammation of the meninges.

Elisabeth Adderson, Associate Member, St. Jude Faculty, Director, Pediatric Infectious Diseases Fellowship Program, St. Jude Children's Research Hospital, Memphis, gives an overview of the condition.

For more on bacterial meningitis, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/3000104

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="21572417" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1222460452-bmjpodcasts-bacterial-meningitis.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ujs7lai7EfGopsDJ-npDHtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1228009927</guid>
      <title>Rural healthcare in a pandemic</title>
      <pubDate>Mon, 07 Mar 2022 15:09:10 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/rural-healthcare-in-a-pandemic</link>
      <itunes:duration>00:27:37</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the podcast we’re going to be talking about rural healthcare - and specifically the difficulties that distance, demographics, and funding have introduced into the world’s covid-19 response.

Rural regions made vulnerable by limited healthcare infrastructure, lower rates of vaccination, and opposition to government policies are the new frontlines in the pandemic, but support systems have not adjusted to the growing rural needs for health education, testing, vaccination, and treatment. 

Michael Forster Rothbart, Kata Karáth, and Lungelo Ndhlovu report from the US, Ecuador, and Zimbabwe</itunes:summary>
      <itunes:subtitle>In this episode of the podcast we’re going to be …</itunes:subtitle>
      <description>In this episode of the podcast we’re going to be talking about rural healthcare - and specifically the difficulties that distance, demographics, and funding have introduced into the world’s covid-19 response.

Rural regions made vulnerable by limited healthcare infrastructure, lower rates of vaccination, and opposition to government policies are the new frontlines in the pandemic, but support systems have not adjusted to the growing rural needs for health education, testing, vaccination, and treatment. 

Michael Forster Rothbart, Kata Karáth, and Lungelo Ndhlovu report from the US, Ecuador, and Zimbabwe</description>
      <enclosure length="39728847" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1228009927-bmjpodcasts-rural-healthcare-in-a-pandemic.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XDKA1oGZA6yXXCn9-WYgrrw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1227924688</guid>
      <title>Diagnostic excellence with Hardeep Singh, Denise Connor, and Gurpreet Dhaliwal</title>
      <pubDate>Mon, 07 Mar 2022 12:43:02 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/diagnostic-excellence-with-hardeep-singh-denise-connor-and-gurpreet-dhaliwal</link>
      <itunes:duration>00:52:40</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Diagnosis is a complex categorisation task driven by mental models  that reside in long term memory. Through education and experience, clinicians form scripts that encapsulate their knowledge of specific conditions and develop diagnostic schemas that structure their approach to a specific health problem. 

This cognitive process also intersects with systems, teamwork, and social factors that can enhance or reduce diagnostic accuracy.

In this podcast, we hear about five techniques that can help with the accuracy of those mental models, and mitigate against some of the external factors which may reduce diagnostic accuracy.

Our guests;

Hardeep Singh trained as a GP before moving to becoming a general internist and professor of patient safety research at Michael E DeBakey Veterans Affairs Medical Center and Baylor College of Medicine Houston.

Denise Connor is an associate professor of medicine at University of California San Francisco and a practicing internist at San Francisco Veterans Affairs Medical Center.

Gurpreet Dhaliwal is a general internist at the San Francisco Veterans Affairs Medical Center, and a clinician educator.</itunes:summary>
      <itunes:subtitle>Diagnosis is a complex categorisation task driven…</itunes:subtitle>
      <description>Diagnosis is a complex categorisation task driven by mental models  that reside in long term memory. Through education and experience, clinicians form scripts that encapsulate their knowledge of specific conditions and develop diagnostic schemas that structure their approach to a specific health problem. 

This cognitive process also intersects with systems, teamwork, and social factors that can enhance or reduce diagnostic accuracy.

In this podcast, we hear about five techniques that can help with the accuracy of those mental models, and mitigate against some of the external factors which may reduce diagnostic accuracy.

Our guests;

Hardeep Singh trained as a GP before moving to becoming a general internist and professor of patient safety research at Michael E DeBakey Veterans Affairs Medical Center and Baylor College of Medicine Houston.

Denise Connor is an associate professor of medicine at University of California San Francisco and a practicing internist at San Francisco Veterans Affairs Medical Center.

Gurpreet Dhaliwal is a general internist at the San Francisco Veterans Affairs Medical Center, and a clinician educator.</description>
      <enclosure length="75762625" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1227924688-bmjpodcasts-diagnostic-excellence-with-hardeep-singh-denise-connor-and-gurpreet-dhaliwal.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1227863371</guid>
      <title>IJGC Special Issue 2022: Radiation Oncology</title>
      <pubDate>Mon, 07 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ijgc-special-issue-2022-radiation-oncology</link>
      <itunes:duration>00:42:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gaffney, Dr. Carien Creutzberg, and Dr. Anuja Jhingran to discuss this month's special issue on radiation oncology. Dr. Gaffney, MD, PhD, Senior Director of Clinical Research, is Professor and Vice-Chair of the University of Utah (U of U) Department of Radiation Oncology. Dr. Gaffney is a distinguished clinician and a long-standing leader in clinical research, and he is also a past president of the American Brachytherapy Society. Dr. Carien Creutzberg is Professor of Radiation Oncology at Leiden University Medical Center, the Netherlands. She specializes in research and treatment of gynecological cancers and has been initiator and principal investigator of the four PORTEC trials and the TransPORTEC consortium. She is current chair of the GCIG Endometrial Cancer Committee and past Council member of ESGO and IGCS. Dr. Anuja Jhingran is a Professor of Radiation Oncology in the Section of Gynecology at The University of Texas MD Anderson Cancer Center. She is the present treasure/secretary for IGCS. She is highly active in GCSC, GCIC, ASCO, and SGO. Her passion is to improve treatment for all women with gynecological cancer throughout the world and she does this through mentoring physicians in underserved regions throughout world.

Highlights:
Stereotactic body radiation therapy (SBRT) is useful in gynecological cancers.
Brachytherapy improves survival in cervix cancer.
Image guidance in radiation oncology decreases morbidity.
Patients with small volume disease and long disease-free interval may be good candidates for SBRT.
Immunotherapy can be combined with radiation therapy.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gaffney, Dr. Carien Creutzberg, and Dr. Anuja Jhingran to discuss this month's special issue on radiation oncology. Dr. Gaffney, MD, PhD, Senior Director of Clinical Research, is Professor and Vice-Chair of the University of Utah (U of U) Department of Radiation Oncology. Dr. Gaffney is a distinguished clinician and a long-standing leader in clinical research, and he is also a past president of the American Brachytherapy Society. Dr. Carien Creutzberg is Professor of Radiation Oncology at Leiden University Medical Center, the Netherlands. She specializes in research and treatment of gynecological cancers and has been initiator and principal investigator of the four PORTEC trials and the TransPORTEC consortium. She is current chair of the GCIG Endometrial Cancer Committee and past Council member of ESGO and IGCS. Dr. Anuja Jhingran is a Professor of Radiation Oncology in the Section of Gynecology at The University of Texas MD Anderson Cancer Center. She is the present treasure/secretary for IGCS. She is highly active in GCSC, GCIC, ASCO, and SGO. Her passion is to improve treatment for all women with gynecological cancer throughout the world and she does this through mentoring physicians in underserved regions throughout world.

Highlights:
Stereotactic body radiation therapy (SBRT) is useful in gynecological cancers.
Brachytherapy improves survival in cervix cancer.
Image guidance in radiation oncology decreases morbidity.
Patients with small volume disease and long disease-free interval may be good candidates for SBRT.
Immunotherapy can be combined with radiation therapy.</description>
      <enclosure length="40119456" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1227863371-bmjpodcasts-ijgc-special-issue-2022-radiation-oncology.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1226183242</guid>
      <title>There is no pill for homelessness</title>
      <pubDate>Fri, 04 Mar 2022 09:22:42 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/there-is-no-pill-for-homelessness</link>
      <itunes:duration>00:43:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>There is often a debate about whether medicine is an art or a science. Our medical curriculum tends to favour the science bit, with pathophysiology of diseases and treatment algorithms dominating our learning agenda. Social determinants of health also have equal importance in influencing one’s health, but are we taught enough to address this? 



Timestamps:
0:00 - 3:15 Intro
3:16 - 7:19  How much do you get taught about social determinants of health at medical school
7:20 - 12:00 Do we apply what we learn in medical training about social determinants on health in actual clinical practice? 
12:01 - 14:29 There is no easy one-size-fits-all managing social determinants of health
14:30 - 18:53 How do you adapt management plans according to the patient’s circumstances?
18:54 - 21:15 A medical student who has experienced homelessness before shares her insight
21:16 - 24:26 Importance of diversifying the demographic of medical students
24:27 - 28:10  The importance of empathy, compassion and being non-judgemental
29:20 - 34:20 Doctors make up the system that patients have to go through, and we can make the experience pleasant for patients
34:21 - 35:18 Vote for Lily as the next prime minister!
35:19 - 36:44 What medical students can do to address social determinants of health outside of medical capacity
36:45- 39:47 What you can do to learn more about social determinants of health in and outside of medical school
39:48 - 43:38 Final remarks


Expert guest:
Dr Andrew Moscrop (@andrewmoscrop on Twitter) is a GP working in a health centre for people who are homeless in Oxford and a researcher in social determinants of health. 


Thank you to Maz Sadler who contributed to this episode.


Recommended reading: 
If social determinants of health are so important, shouldn’t we ask patients about them? https://www.bmj.com/content/371/bmj.m4150 

*We’re looking for new panel members!*

Are you a:
✅ Medical student
✅ Listener of Sharp Scratch
✅ Keen on representing the voice of medical students?

In the past, the panel only consisted of medical students studying in the UK. However, remote recording meant that we can extend this opportunity to medical students in other countries. If you’re interested, please apply via the link below. We look forward to hearing from you!

Apply here: https://forms.gle/QocryfkG137cWTb88

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>There is often a debate about whether medicine is…</itunes:subtitle>
      <description>There is often a debate about whether medicine is an art or a science. Our medical curriculum tends to favour the science bit, with pathophysiology of diseases and treatment algorithms dominating our learning agenda. Social determinants of health also have equal importance in influencing one’s health, but are we taught enough to address this? 



Timestamps:
0:00 - 3:15 Intro
3:16 - 7:19  How much do you get taught about social determinants of health at medical school
7:20 - 12:00 Do we apply what we learn in medical training about social determinants on health in actual clinical practice? 
12:01 - 14:29 There is no easy one-size-fits-all managing social determinants of health
14:30 - 18:53 How do you adapt management plans according to the patient’s circumstances?
18:54 - 21:15 A medical student who has experienced homelessness before shares her insight
21:16 - 24:26 Importance of diversifying the demographic of medical students
24:27 - 28:10  The importance of empathy, compassion and being non-judgemental
29:20 - 34:20 Doctors make up the system that patients have to go through, and we can make the experience pleasant for patients
34:21 - 35:18 Vote for Lily as the next prime minister!
35:19 - 36:44 What medical students can do to address social determinants of health outside of medical capacity
36:45- 39:47 What you can do to learn more about social determinants of health in and outside of medical school
39:48 - 43:38 Final remarks


Expert guest:
Dr Andrew Moscrop (@andrewmoscrop on Twitter) is a GP working in a health centre for people who are homeless in Oxford and a researcher in social determinants of health. 


Thank you to Maz Sadler who contributed to this episode.


Recommended reading: 
If social determinants of health are so important, shouldn’t we ask patients about them? https://www.bmj.com/content/371/bmj.m4150 

*We’re looking for new panel members!*

Are you a:
✅ Medical student
✅ Listener of Sharp Scratch
✅ Keen on representing the voice of medical students?

In the past, the panel only consisted of medical students studying in the UK. However, remote recording meant that we can extend this opportunity to medical students in other countries. If you’re interested, please apply via the link below. We look forward to hearing from you!

Apply here: https://forms.gle/QocryfkG137cWTb88

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="62218726" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1226183242-bmjpodcasts-there-is-no-pill-for-homelessness.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1226229946</guid>
      <title>Knowledge translation – moving away from ‘what’, to ‘how’ and ‘why’ with Dr Sheree Bekker. EP #499</title>
      <pubDate>Fri, 04 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/knowledge-translation-moving-away-from-what-to-how-and-why-with-dr-sheree-bekker-ep-499</link>
      <itunes:duration>00:20:24</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>On the podcast this week, we are thrilled to be joined by Associate Professor at the Centre for Health, Injury and Illness Prevention in Sport at the University of Bath, Dr Sheree Bekker.

We have all heard the term ‘knowledge translation’, but do we really know why it is important, what this process actually involves, and how can we all start embracing it in our professional lives?

Dr Bekker is a leader in this area, and we are thrilled that she has joined us to record the first in this ‘knowledge translation’ podcast series. You can find some of the resources that are mentioned in this podcast in the links below:

Dr Bekker’s twitter handle https://twitter.com/shereebekker

Dr Bekker’s #viral twitter thread https://twitter.com/shereebekker/status/1369972461014499331?lang=hi

Anterior cruciate ligament injury: towards a gendered environmental approach https://bjsm.bmj.com/content/55/17/984  

We hope you enjoyed this podcast. Get in touch with us via social media if you have any feedback or suggestions for future guests.</itunes:summary>
      <itunes:subtitle>On the podcast this week, we are thrilled to be j…</itunes:subtitle>
      <description>On the podcast this week, we are thrilled to be joined by Associate Professor at the Centre for Health, Injury and Illness Prevention in Sport at the University of Bath, Dr Sheree Bekker.

We have all heard the term ‘knowledge translation’, but do we really know why it is important, what this process actually involves, and how can we all start embracing it in our professional lives?

Dr Bekker is a leader in this area, and we are thrilled that she has joined us to record the first in this ‘knowledge translation’ podcast series. You can find some of the resources that are mentioned in this podcast in the links below:

Dr Bekker’s twitter handle https://twitter.com/shereebekker

Dr Bekker’s #viral twitter thread https://twitter.com/shereebekker/status/1369972461014499331?lang=hi

Anterior cruciate ligament injury: towards a gendered environmental approach https://bjsm.bmj.com/content/55/17/984  

We hope you enjoyed this podcast. Get in touch with us via social media if you have any feedback or suggestions for future guests.</description>
      <enclosure length="48960000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1226229946-bmjpodcasts-knowledge-translation-moving-away-from-what-to-how-and-why-with-dr-sheree-bekker-ep-499.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1222405282</guid>
      <title>Golem Girl: Disability and Embodiment with Riva Lehrer</title>
      <pubDate>Fri, 04 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/golem-girl-disability-and-embodiment-with-riva-lehrer</link>
      <itunes:duration>00:29:58</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>We are excited to present Riva Lehrer, artist and author, and her book GOLEM GIRL, about disability, embodiment, joy, and becoming herself.
Read the blog with the transcription of this podcast here: https://blogs.bmj.com/medical-humanities/2023/03/04/podcast-with-riva-lehrer-author-of-golem-girl-a-memoir.
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</itunes:summary>
      <itunes:subtitle>We are excited to present Riva Lehrer, artist and…</itunes:subtitle>
      <description>We are excited to present Riva Lehrer, artist and author, and her book GOLEM GIRL, about disability, embodiment, joy, and becoming herself.
Read the blog with the transcription of this podcast here: https://blogs.bmj.com/medical-humanities/2023/03/04/podcast-with-riva-lehrer-author-of-golem-girl-a-memoir.
Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!</description>
      <enclosure length="57973130" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1222405282-bmjpodcasts-golem-girl-disability-and-embodiment-with-riva-lehrer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-UB9QqPLjXdSwMri7-tvh8XA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1225696405</guid>
      <title>JIM Update by the Editor-in-Chief</title>
      <pubDate>Thu, 03 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/jim-update-by-the-editor-in-chief</link>
      <itunes:duration>00:17:49</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief Dr. Richard McCallum shares the latest details about JIM’s progress during 2021. Additionally, Dr. McCallum discusses readers’ perspectives about the journal and what we can hope to see this upcoming year from JIM.</itunes:summary>
      <itunes:subtitle>Editor-in-Chief Dr. Richard McCallum shares the l…</itunes:subtitle>
      <description>Editor-in-Chief Dr. Richard McCallum shares the latest details about JIM’s progress during 2021. Additionally, Dr. McCallum discusses readers’ perspectives about the journal and what we can hope to see this upcoming year from JIM.</description>
      <enclosure length="17024520" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1225696405-bmjpodcasts-jim-update-by-the-editor-in-chief.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2Nm6HxUap6J89tyj-lOHSWg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1225693135</guid>
      <title>Thyroid Month: Review of Thyroid Disorders</title>
      <pubDate>Thu, 03 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/thyroid-month-review-of-thyroid-disorders</link>
      <itunes:duration>00:27:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the JIM podcast, Editor-in-Chief Dr. Richard McCallum, speaks with Dr. Tamis Bright, the Chief of the Division of Endocrinology at Texas Tech El Paso. Last year on this podcast series, she discussed hypothyroidism. She now returns to discuss the effects, screening tools, and treatment modalities for hyperthyroidism.

Dr. Tamis Bright, MD, is a Clinical Endocrinologist and Associate Professor at Texas Tech Health Sciences Paul L. Foster School of Medicine in El Paso, Texas. Additionally, she is known as an Endocrinology, Diabetes, and Metabolism specialist. Dr. Bright has more experience with Thyroid Disorders than other specialists in her area. She is affiliated with University Medical Center of El Paso, where she treats a wide variety of patients. Dr. Bright received her medical degree from Loyola University Chicago Stritch School of Medicine and has been in practice for more than 20 years.</itunes:summary>
      <itunes:subtitle>In this episode of the JIM podcast, Editor-in-Chi…</itunes:subtitle>
      <description>In this episode of the JIM podcast, Editor-in-Chief Dr. Richard McCallum, speaks with Dr. Tamis Bright, the Chief of the Division of Endocrinology at Texas Tech El Paso. Last year on this podcast series, she discussed hypothyroidism. She now returns to discuss the effects, screening tools, and treatment modalities for hyperthyroidism.

Dr. Tamis Bright, MD, is a Clinical Endocrinologist and Associate Professor at Texas Tech Health Sciences Paul L. Foster School of Medicine in El Paso, Texas. Additionally, she is known as an Endocrinology, Diabetes, and Metabolism specialist. Dr. Bright has more experience with Thyroid Disorders than other specialists in her area. She is affiliated with University Medical Center of El Paso, where she treats a wide variety of patients. Dr. Bright received her medical degree from Loyola University Chicago Stritch School of Medicine and has been in practice for more than 20 years.</description>
      <enclosure length="26396697" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1225693135-bmjpodcasts-thyroid-month-review-of-thyroid-disorders.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Zaobd7TgjLNGvmXC-fCQHSA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1224562594</guid>
      <title>Rumination Syndrome, the effortless regurgitation in humans</title>
      <pubDate>Thu, 03 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/rumination-syndrome</link>
      <itunes:duration>00:15:54</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Rumination in humans is a disorder of the gut-brain interaction affecting three percent of people worldwide. It's characterised by recurrent regurgitation without associated retching or significant nause​a. B​ehavioural therapies are proved to be effective​, with the potential to be successful at the primary care level.
Dr Aditi Kumar, trainee associate editor of Frontline Gastroenterology and specialist gastroenterology registrar in the West Midlands, UK, interviews Dr Ben Disney, a Consultant Gastroenterologist at University Hospitals Coventry and Warwickshire NHS Trust, with a specialist interest on disorders of the gut-brain interaction. Also present is Dr Dipesh Vasant, a Consultant Gastroenterology and Honorary Senior Lecturer at the University of Manchester, with a specialist interest in neurogastroenterology and motility disorders. This Frontline Gastroenterology podcast discusses the recently published paper in January 2022: “Rumination Syndrome: pathophysiology, diagnosis and practical assessment” - https://fg.bmj.com/content/early/2022/01/10/flgastro-2021-101856.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</itunes:summary>
      <itunes:subtitle>Rumination in humans is a disorder of the gut-bra…</itunes:subtitle>
      <description>Rumination in humans is a disorder of the gut-brain interaction affecting three percent of people worldwide. It's characterised by recurrent regurgitation without associated retching or significant nause​a. B​ehavioural therapies are proved to be effective​, with the potential to be successful at the primary care level.
Dr Aditi Kumar, trainee associate editor of Frontline Gastroenterology and specialist gastroenterology registrar in the West Midlands, UK, interviews Dr Ben Disney, a Consultant Gastroenterologist at University Hospitals Coventry and Warwickshire NHS Trust, with a specialist interest on disorders of the gut-brain interaction. Also present is Dr Dipesh Vasant, a Consultant Gastroenterology and Honorary Senior Lecturer at the University of Manchester, with a specialist interest in neurogastroenterology and motility disorders. This Frontline Gastroenterology podcast discusses the recently published paper in January 2022: “Rumination Syndrome: pathophysiology, diagnosis and practical assessment” - https://fg.bmj.com/content/early/2022/01/10/flgastro-2021-101856.
Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229</description>
      <enclosure length="15279750" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1224562594-bmjpodcasts-rumination-syndrome.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-wtq5M8RfhOiyVmCI-nVJpNQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1224462529</guid>
      <title>Changing the perception: diversity and representation within academic Injury Prevention</title>
      <pubDate>Thu, 03 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/diversity-and-representation-within-academic-injury-prevention</link>
      <itunes:duration>00:23:44</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, we walk in the shoes of two PhD scholars starting out on their careers in violence and injury prevention research. 
Jennifer L. Thompson, MPH, and Lauren Malthaner, MPH, University of Texas, School of Public Health, describe their personal and diverse aspects of the experience they bring to their Doctoral studies. They talk about how their experiences shape their aspirations. They talk of the experience of pandemic learning and provide demonstration of how deep reflection and frank articulation of insights are such important drivers of necessary change.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>In this podcast, we walk in the shoes of two PhD …</itunes:subtitle>
      <description>In this podcast, we walk in the shoes of two PhD scholars starting out on their careers in violence and injury prevention research. 
Jennifer L. Thompson, MPH, and Lauren Malthaner, MPH, University of Texas, School of Public Health, describe their personal and diverse aspects of the experience they bring to their Doctoral studies. They talk about how their experiences shape their aspirations. They talk of the experience of pandemic learning and provide demonstration of how deep reflection and frank articulation of insights are such important drivers of necessary change.
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="22786297" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1224462529-bmjpodcasts-diversity-and-representation-within-academic-injury-prevention.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-97PYlC3idubTCbxz-1rv9FQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1225028245</guid>
      <title>Archimedes March 2022: Tubes and technology</title>
      <pubDate>Wed, 02 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/archimedes-march-2022-tubes-and-technology</link>
      <itunes:duration>00:11:34</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A bit like aircraft, intubating and extubating are the awkward and skill-requiring parts of a ventilator journey. Well, not so much the tube removal itself, but the choice of when to do it. And we’ve got a topic report which asks if the ubiquitous ultrasound could help us with that decision: (https://adc.bmj.com/content/107/3/303.1). As for popping a tube in, how do you know it’s in the right place? Slide that probe over - at least in neonates - and see if you can see the tip located properly (https://adc.bmj.com/content/107/3/305).
So while we’re thinking about tubes and ways of working, perhaps we need to consider just how do we test such ‘craft’ interventions? Well… have a listen and while the whole answer won’t be revealed … some starter thoughts might be (https://adc.bmj.com/content/107/3/303.2).
Tie down your garden furniture, hold onto your fence posts, and tell us what you think, and submit your own following the instructions on the website and you too could be hearing all about yourself spoken by Archi.
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>A bit like aircraft, intubating and extubating ar…</itunes:subtitle>
      <description>A bit like aircraft, intubating and extubating are the awkward and skill-requiring parts of a ventilator journey. Well, not so much the tube removal itself, but the choice of when to do it. And we’ve got a topic report which asks if the ubiquitous ultrasound could help us with that decision: (https://adc.bmj.com/content/107/3/303.1). As for popping a tube in, how do you know it’s in the right place? Slide that probe over - at least in neonates - and see if you can see the tip located properly (https://adc.bmj.com/content/107/3/305).
So while we’re thinking about tubes and ways of working, perhaps we need to consider just how do we test such ‘craft’ interventions? Well… have a listen and while the whole answer won’t be revealed … some starter thoughts might be (https://adc.bmj.com/content/107/3/303.2).
Tie down your garden furniture, hold onto your fence posts, and tell us what you think, and submit your own following the instructions on the website and you too could be hearing all about yourself spoken by Archi.
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="11110190" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1225028245-bmjpodcasts-archimedes-march-2022-tubes-and-technology.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1223908558</guid>
      <title>Dysosmobacter welbionis, a new human commensal bacterium preventing diet-induced obesity</title>
      <pubDate>Wed, 02 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dysosmobacter-welbionis-a-new-human-commensal-bacterium-preventing-diet-induced-obesity</link>
      <itunes:duration>00:11:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Patrice Cani, Louvain Drug Research Institute, WELBIO, Metabolism and Nutrition, UCLouvain, Brussels, Belgium and Emilie Moens de Hase a PhD student in the same institution. 
This Gut podcast is focused on the paper "Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice" which is published in paper copy in Gut in March 2022, and is available here: https://gut.bmj.com/content/71/3/534
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Patrice Cani, Louvain Drug Research Institute, WELBIO, Metabolism and Nutrition, UCLouvain, Brussels, Belgium and Emilie Moens de Hase a PhD student in the same institution. 
This Gut podcast is focused on the paper "Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice" which is published in paper copy in Gut in March 2022, and is available here: https://gut.bmj.com/content/71/3/534
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="11180407" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1223908558-bmjpodcasts-dysosmobacter-welbionis-a-new-human-commensal-bacterium-preventing-diet-induced-obesity.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1221617311</guid>
      <title>Could a high fiber diet positively impact the gut microbiome of SLE patients?</title>
      <pubDate>Wed, 02 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/could-a-high-fiber-diet-positively-impact-the-gut-microbiome-of-sle-patients</link>
      <itunes:duration>00:15:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Duane Peters from the Lupus Foundation of America interviews Professor Iryna Kulyk from Indiana University in the USA and Professor Martin Kriegel from the University of Münster in Germany and Yale University in the USA. They discuss their study, presented at the Lupus 21st Century conference in September 2021, on the influence of the consumption of resistant starch (a type of dietary fiber) on the composition of the gut microbiota of lupus patients.

Access the abstract here: https://lupus.bmj.com/content/8/Suppl_2/A63.2.abstract</itunes:summary>
      <itunes:subtitle>Duane Peters from the Lupus Foundation of America…</itunes:subtitle>
      <description>Duane Peters from the Lupus Foundation of America interviews Professor Iryna Kulyk from Indiana University in the USA and Professor Martin Kriegel from the University of Münster in Germany and Yale University in the USA. They discuss their study, presented at the Lupus 21st Century conference in September 2021, on the influence of the consumption of resistant starch (a type of dietary fiber) on the composition of the gut microbiota of lupus patients.

Access the abstract here: https://lupus.bmj.com/content/8/Suppl_2/A63.2.abstract</description>
      <enclosure length="13449653" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1221617311-bmjpodcasts-could-a-high-fiber-diet-positively-impact-the-gut-microbiome-of-sle-patients.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zOfBZ6joPLX9GdP1-jqUXQg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1221556639</guid>
      <title>How natural language processing (NLP) can improve cardiology care</title>
      <pubDate>Tue, 01 Mar 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/how-natural-language-processing-nlp-can-improve-cardiology-care</link>
      <itunes:duration>00:18:02</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Meghan Reading Turchioe from Weill Cornell Medicine in New York. They discuss a systematic review of the use of natural language processing in cardiology, and how it might improve patient care. If you enjoy the show, please leave us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 or wherever you get your podcasts.
Link to published paper: https://heart.bmj.com/content/early/2021/10/27/heartjnl-2021-319769</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Meghan Reading Turchioe from Weill Cornell Medicine in New York. They discuss a systematic review of the use of natural language processing in cardiology, and how it might improve patient care. If you enjoy the show, please leave us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 or wherever you get your podcasts.
Link to published paper: https://heart.bmj.com/content/early/2021/10/27/heartjnl-2021-319769</description>
      <enclosure length="43293436" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1221556639-bmjpodcasts-how-natural-language-processing-nlp-can-improve-cardiology-care.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1224343021</guid>
      <title>Tisotumab vedotin (TV) in Advanced or Recurrent Cervical Cancer</title>
      <pubDate>Mon, 28 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/tisotumab-vedotin-tv-in-advanced-or-recurrent-cervical-cancer</link>
      <itunes:duration>00:40:49</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Robert Coleman to discuss TV in Advanced or Recurrent Cervical Cancer.

HIGHLIGHTS:
Drug development in cervix cancer has undergone a renaissance in recent years with the identification of novel antibody drug conjugates (ADC) and immunotherapy measurably impacting patient survivorship.
Tisotumab vedotin (TV) is an ADC targeting tumor expression of tissue factor delivering the cytotoxic warhead MMAE.
InnovaTV 204/ GOG-3023/ENGOT-cx6 is a single arm phase II trial of TV in patients with recurrent/metastatic previously treatment cervix cancer who had measurable disease seeking assessment of objective response by independent radiological review, duration of response and safety.
101 assessable patients were enrolled demonstrating a ORR of 24%, with median duration of response of 8.3 months.
The regimen was well tolerated with the most common treatment-related adverse events being alopecia, epistaxis, nausea, conjunctivitis, fatigue, and dry eye. A rigorous eye care plan can mitigate high grade ocular toxicity.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Robert Coleman to discuss TV in Advanced or Recurrent Cervical Cancer.

HIGHLIGHTS:
Drug development in cervix cancer has undergone a renaissance in recent years with the identification of novel antibody drug conjugates (ADC) and immunotherapy measurably impacting patient survivorship.
Tisotumab vedotin (TV) is an ADC targeting tumor expression of tissue factor delivering the cytotoxic warhead MMAE.
InnovaTV 204/ GOG-3023/ENGOT-cx6 is a single arm phase II trial of TV in patients with recurrent/metastatic previously treatment cervix cancer who had measurable disease seeking assessment of objective response by independent radiological review, duration of response and safety.
101 assessable patients were enrolled demonstrating a ORR of 24%, with median duration of response of 8.3 months.
The regimen was well tolerated with the most common treatment-related adverse events being alopecia, epistaxis, nausea, conjunctivitis, fatigue, and dry eye. A rigorous eye care plan can mitigate high grade ocular toxicity.</description>
      <enclosure length="39194957" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1224343021-bmjpodcasts-tisotumab-vedotin-tv-in-advanced-or-recurrent-cervical-cancer.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1222338700</guid>
      <title>The blame game</title>
      <pubDate>Fri, 25 Feb 2022 13:29:57 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-blame-game</link>
      <itunes:duration>00:51:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In previous episodes of Doctor Informed, we've talked about the importance of speaking out, but the culture in your organisation might not always make that easy, especially if you feel something has gone wrong and you might be blamed for it. 

Blame culture, no blame culture, just culture - there are many terms which are used to describe the environment in which individuals and teams work, the feel within a team and an organisation. In this episode we'll explore what they mean, why blame can be detrimental to patient safety, and give some tips on how to investigate problems without throwing blame around.

Our guests in this episode;

Joselle Wright - Deputy Director of Midwifery, Gynaecology and Sexual Health at Walsall Healthcare NHS Trust

Susanna Stanford, who became involved in patient safety after experience of a spinal anaesthetic failing during a c-section in 2010. She is an ambassador for the Clinical Human Factors Group.</itunes:summary>
      <itunes:subtitle>In previous episodes of Doctor Informed, we've ta…</itunes:subtitle>
      <description>In previous episodes of Doctor Informed, we've talked about the importance of speaking out, but the culture in your organisation might not always make that easy, especially if you feel something has gone wrong and you might be blamed for it. 

Blame culture, no blame culture, just culture - there are many terms which are used to describe the environment in which individuals and teams work, the feel within a team and an organisation. In this episode we'll explore what they mean, why blame can be detrimental to patient safety, and give some tips on how to investigate problems without throwing blame around.

Our guests in this episode;

Joselle Wright - Deputy Director of Midwifery, Gynaecology and Sexual Health at Walsall Healthcare NHS Trust

Susanna Stanford, who became involved in patient safety after experience of a spinal anaesthetic failing during a c-section in 2010. She is an ambassador for the Clinical Human Factors Group.</description>
      <enclosure length="49763473" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1222338700-bmjpodcasts-the-blame-game.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-LDABgfwgLaPwCB02-DIJolA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1222292575</guid>
      <title>Bringing the 6Rs to life – a patient perspective of return to sport post-partum. Ep #498</title>
      <pubDate>Fri, 25 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/bringing-the-6rs-to-life-a-patient-perspective-of-return-to-sport-post-partum-ep-498</link>
      <itunes:duration>00:34:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast Grainne Donnelly, Associate Prof Izzy Moore and Dr Brooke Patterson speak with Steph about her experience returning to sport post-partum using the 6Rs framework (https://pubmed.ncbi.nlm.nih.gov/34836883/).

Listen to Part 1 first: https://soundcloud.com/bmjpodcasts/bjsm-11022022-ep-497?in=bmjpodcasts/sets/bjsm-1&amp;utm_source=clipboard&amp;utm_medium=text&amp;utm_campaign=social_sharing  where Izzy and Grainne discuss the framework and the role of a musculoskeletal clinician.

Return to running BJSM infographic - https://bjsm.bmj.com/content/54/18/1114</itunes:summary>
      <itunes:subtitle>In this podcast Grainne Donnelly, Associate Prof …</itunes:subtitle>
      <description>In this podcast Grainne Donnelly, Associate Prof Izzy Moore and Dr Brooke Patterson speak with Steph about her experience returning to sport post-partum using the 6Rs framework (https://pubmed.ncbi.nlm.nih.gov/34836883/).

Listen to Part 1 first: https://soundcloud.com/bmjpodcasts/bjsm-11022022-ep-497?in=bmjpodcasts/sets/bjsm-1&amp;utm_source=clipboard&amp;utm_medium=text&amp;utm_campaign=social_sharing  where Izzy and Grainne discuss the framework and the role of a musculoskeletal clinician.

Return to running BJSM infographic - https://bjsm.bmj.com/content/54/18/1114</description>
      <enclosure length="83136000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1222292575-bmjpodcasts-bringing-the-6rs-to-life-a-patient-perspective-of-return-to-sport-post-partum-ep-498.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1212398074</guid>
      <title>NATSAL-COVID: Britain's National Surveys of Sexual Attitudes and Lifestyles</title>
      <pubDate>Wed, 23 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/natsal-covid-britains-national-surveys-of-sexual-attitudes-and-lifestyles</link>
      <itunes:duration>00:17:13</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Today we focus on NATSAL and NATSAL COVID. These are Britain’s National Surveys of Sexual Attitudes and Lifestyles. 
NATSAL has been undertaken every 10 years since 1990 and is a key data source for sexual and reproductive health policy development. However, the COVID-19 pandemic disrupted many aspects of sexual lifestyles, prompting the initiation of the NATSAL-COVID study with the aim of understanding the impact of COVID-19 on sexual behaviour and service use. 
Professor Cath Mercer and Professor Nigel Field join us to discuss the results of this study. 
All the findings relate to the first four months of lockdown in Britain, which started in March 2020.
Related blog: https://blogs.bmj.com/sti/2022/02/23/natsal-covid-sex-love-and-lockdown/
Relevant Natsal-COVID papers:
 - STI paper on sexual behaviour during the pandemic: https://sti.bmj.com/content/early/2021/12/14/sextrans-2021-055210
 - Paper in Lancet PH on sexual health services: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00253-X
 - Paper in BMJ Open on sex outside of the household: https://bmjopen.bmj.com/content/12/2/e055284
 - Natsal-COVID wave 1 method paper: https://wellcomeopenresearch.org/articles/6-209</itunes:summary>
      <itunes:subtitle>Today we focus on NATSAL and NATSAL COVID. These …</itunes:subtitle>
      <description>Today we focus on NATSAL and NATSAL COVID. These are Britain’s National Surveys of Sexual Attitudes and Lifestyles. 
NATSAL has been undertaken every 10 years since 1990 and is a key data source for sexual and reproductive health policy development. However, the COVID-19 pandemic disrupted many aspects of sexual lifestyles, prompting the initiation of the NATSAL-COVID study with the aim of understanding the impact of COVID-19 on sexual behaviour and service use. 
Professor Cath Mercer and Professor Nigel Field join us to discuss the results of this study. 
All the findings relate to the first four months of lockdown in Britain, which started in March 2020.
Related blog: https://blogs.bmj.com/sti/2022/02/23/natsal-covid-sex-love-and-lockdown/
Relevant Natsal-COVID papers:
 - STI paper on sexual behaviour during the pandemic: https://sti.bmj.com/content/early/2021/12/14/sextrans-2021-055210
 - Paper in Lancet PH on sexual health services: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00253-X
 - Paper in BMJ Open on sex outside of the household: https://bmjopen.bmj.com/content/12/2/e055284
 - Natsal-COVID wave 1 method paper: https://wellcomeopenresearch.org/articles/6-209</description>
      <enclosure length="16530284" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1212398074-bmjpodcasts-natsal-covid-britains-national-surveys-of-sexual-attitudes-and-lifestyles.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-pAPNWIdcqzhbf4vB-70N7zw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1220594347</guid>
      <title>March 2022 - Paracetamol and blood pressure, greener inhalers, harms from medicines and naldemedine</title>
      <pubDate>Wed, 23 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-march-2022</link>
      <itunes:duration>00:22:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the March 2022 issue of DTB. They talk about paracetamol and its effect on blood pressure and discuss progress on moving to inhalers that have less of an impact on the environment (https://dtb.bmj.com/content/60/3/34). The editors review a study that examined harms from medicines (https://dtb.bmj.com/content/60/3/37) and discuss the use of naldemedine in the management of opioid-induced constipation (https://dtb.bmj.com/content/60/3/39).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the March 2022 issue of DTB. They talk about paracetamol and its effect on blood pressure and discuss progress on moving to inhalers that have less of an impact on the environment (https://dtb.bmj.com/content/60/3/34). The editors review a study that examined harms from medicines (https://dtb.bmj.com/content/60/3/37) and discuss the use of naldemedine in the management of opioid-induced constipation (https://dtb.bmj.com/content/60/3/39).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="21449246" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1220594347-bmjpodcasts-dtb-march-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1209339166</guid>
      <title>Type 1 diabetes</title>
      <pubDate>Mon, 21 Feb 2022 14:45:12 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/type-1-diabetes</link>
      <itunes:duration>00:23:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Type 1 diabetes mellitus is a metabolic disorder characterised by hyperglycaemia due to absolute insulin deficiency. The condition develops due to destruction of pancreatic beta cells, mostly by immune-mediated mechanisms.

In this podcast, Rajesh Garg, Professor of Medicine, University of Miami Miller School of Medicine, gives us an overview of the condition.

For more on type 1 diabetes, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/25

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Type 1 diabetes mellitus is a metabolic disorder …</itunes:subtitle>
      <description>Type 1 diabetes mellitus is a metabolic disorder characterised by hyperglycaemia due to absolute insulin deficiency. The condition develops due to destruction of pancreatic beta cells, mostly by immune-mediated mechanisms.

In this podcast, Rajesh Garg, Professor of Medicine, University of Miami Miller School of Medicine, gives us an overview of the condition.

For more on type 1 diabetes, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/25

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="22628170" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1209339166-bmjpodcasts-type-1-diabetes.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ujs7lai7EfGopsDJ-npDHtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1219891618</guid>
      <title>The FeMMe Trial with Drs. Andreas Obermair and Monika Janda</title>
      <pubDate>Mon, 21 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ijgc-21feb22-obermair-janda-the-femme-trial</link>
      <itunes:duration>00:48:38</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Andreas Obermair and Monika Janda to discuss the FeMMe trial.

Highlights:
feMMe was a randomised phase 2 trial testing LNG-IUD alone or in combination with a weight loss intervention or metformin for endometrial hyperplasia with atypia or stage 1 endometrial cancer.
Overall complete pathological response at 6 month was 61%.
Women with endometrial hyperplasia with atypia responded much better than women with endometrial cancer.
Weight loss achieved was moderate and BMI was not associated with response – more work on weight loss interventions needed.
Metformin did not improve response – more biomarker research is needed to understand who will respond to LNG-IUD or not.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Andreas Obermair and Monika Janda to discuss the FeMMe trial.

Highlights:
feMMe was a randomised phase 2 trial testing LNG-IUD alone or in combination with a weight loss intervention or metformin for endometrial hyperplasia with atypia or stage 1 endometrial cancer.
Overall complete pathological response at 6 month was 61%.
Women with endometrial hyperplasia with atypia responded much better than women with endometrial cancer.
Weight loss achieved was moderate and BMI was not associated with response – more work on weight loss interventions needed.
Metformin did not improve response – more biomarker research is needed to understand who will respond to LNG-IUD or not.</description>
      <enclosure length="46698996" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1219891618-bmjpodcasts-ijgc-21feb22-obermair-janda-the-femme-trial.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1217715262</guid>
      <title>Paraneoplastic neurological syndromes: a practical approach to diagnosis and management</title>
      <pubDate>Mon, 21 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/paraneoplastic-neurological-syndromes-a-practical-approach-to-diagnosis-and-management</link>
      <itunes:duration>00:34:23</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Amy Ross Russell, Neurology, University Hospital Southampton NHS Foundation Trust, interviews Dr Sophie Binks and Professor Sarosh Irani, from the Oxford Autoimmune Neurology Group, about their recent paper about a practical approach to diagnosis and management of paraneoplastic neurological syndromes.
Read the latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/1/19) and the February print issue of the journal.
The paper is also discussed by Practical Neurology editors, Dr Phil Smith and Dr Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-february-2022-issue?in=bmjpodcasts/sets/pn-podcast
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). Thank you for listening.</itunes:summary>
      <itunes:subtitle>Dr Amy Ross Russell, Neurology, University Hospit…</itunes:subtitle>
      <description>Dr Amy Ross Russell, Neurology, University Hospital Southampton NHS Foundation Trust, interviews Dr Sophie Binks and Professor Sarosh Irani, from the Oxford Autoimmune Neurology Group, about their recent paper about a practical approach to diagnosis and management of paraneoplastic neurological syndromes.
Read the latest Editor’s Choice paper on the Practical Neurology website (https://pn.bmj.com/content/22/1/19) and the February print issue of the journal.
The paper is also discussed by Practical Neurology editors, Dr Phil Smith and Dr Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-february-2022-issue?in=bmjpodcasts/sets/pn-podcast
Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. 
If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). Thank you for listening.</description>
      <enclosure length="33022118" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1217715262-bmjpodcasts-paraneoplastic-neurological-syndromes-a-practical-approach-to-diagnosis-and-management.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3PXFe9VkrCHYhpPb-2Y0wdw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1218259516</guid>
      <title>Ramadan with Ammad Mahmood and Sahira Dar</title>
      <pubDate>Fri, 18 Feb 2022 15:12:56 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/ramadan-with-ammad-mahmood-and-sahira-dar</link>
      <itunes:duration>00:44:10</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>As Ramadan draws near, clinicians may be approached by their Muslim patients to discuss managing their health conditions during the month of fasting. How should someone with a chronic condition, such as diabetes or epilepsy, time their medications during this period? Can a person who’s pregnant or breastfeeding partake in fasting? What alternative options are available to someone whose health needs make participating fully in fasting too risky? 

In this week’s episode, we discuss the many questions doctors and patients may have around this topic with Ammad Mahmood and Sahira Dar, authors of a recently published article in The BMJ on advising patients with existing conditions about fasting during Ramadan, and talk about the importance of individualised advice and shared decision making.

Our guests:
Ammad Mahmood is a neurological trainee, currently undertaking a PHD in stroke imaging at the University of Glasgow.
Sahira Dar is a GP, practising in Glasgow, with special interests in lifestyle medicine and mental health issues.

Further reading:
‘Advising patients with existing conditions about fasting during Ramadan’ by Ammad Mahmood, Sahira Dar et al. https://www.bmj.com/content/376/bmj-2020-063613</itunes:summary>
      <itunes:subtitle>As Ramadan draws near, clinicians may be approach…</itunes:subtitle>
      <description>As Ramadan draws near, clinicians may be approached by their Muslim patients to discuss managing their health conditions during the month of fasting. How should someone with a chronic condition, such as diabetes or epilepsy, time their medications during this period? Can a person who’s pregnant or breastfeeding partake in fasting? What alternative options are available to someone whose health needs make participating fully in fasting too risky? 

In this week’s episode, we discuss the many questions doctors and patients may have around this topic with Ammad Mahmood and Sahira Dar, authors of a recently published article in The BMJ on advising patients with existing conditions about fasting during Ramadan, and talk about the importance of individualised advice and shared decision making.

Our guests:
Ammad Mahmood is a neurological trainee, currently undertaking a PHD in stroke imaging at the University of Glasgow.
Sahira Dar is a GP, practising in Glasgow, with special interests in lifestyle medicine and mental health issues.

Further reading:
‘Advising patients with existing conditions about fasting during Ramadan’ by Ammad Mahmood, Sahira Dar et al. https://www.bmj.com/content/376/bmj-2020-063613</description>
      <enclosure length="42410317" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1218259516-bmjpodcasts-ramadan-with-ammad-mahmood-and-sahira-dar.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1217801248</guid>
      <title>Can you learn empathy?</title>
      <pubDate>Fri, 18 Feb 2022 07:00:34 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/can-you-learn-empathy</link>
      <itunes:duration>00:43:52</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Empathy is one of the essential qualities of a good doctor. One way this is assessed at medical school is the use of objective structured clinical examination (OSCE) stations. The use of OSCEs in medical schools is controversial -  it can be used to simulate clinical examination and test students’ ability to express empathy while some perceive OSCEs as an artificial and narrow understanding of clinical medicine. 

Topics:
• How do medical students’ experiences of empathy change during their medical education?
• What factors do medical students describe as influencing their empathy during medical school?
• Should and can empathy be assessed?
• Importance of empathy in the patient-doctor relationship


Expert guest:
Dr David Jeffrey is a retired palliative doctor and former academic mentor at Dundee medical school involved in student support. He also did a PhD exploring empathy in medical students.


Recommended reading: 
• I never asked to be ICE’d - https://www.bmj.com/content/354/bmj.i3729 
• Communication skills and the problem with fake patients - https://www.bmj.com/content/357/sbmj.j974?sso= 


*We’re looking for new panel members!*


Are you a:
✅ Medical student
✅ Listener of Sharp Scratch
✅ Keen on representing the voice of medical students?


In the past, the panel only consisted of medical students studying in the UK. However, remote recording meant that we can extend this opportunity to medical students in other countries. If you’re interested, please apply via the link below. We look forward to hearing from you!


Apply here: https://forms.gle/QocryfkG137cWTb88


Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Empathy is one of the essential qualities of a go…</itunes:subtitle>
      <description>Empathy is one of the essential qualities of a good doctor. One way this is assessed at medical school is the use of objective structured clinical examination (OSCE) stations. The use of OSCEs in medical schools is controversial -  it can be used to simulate clinical examination and test students’ ability to express empathy while some perceive OSCEs as an artificial and narrow understanding of clinical medicine. 

Topics:
• How do medical students’ experiences of empathy change during their medical education?
• What factors do medical students describe as influencing their empathy during medical school?
• Should and can empathy be assessed?
• Importance of empathy in the patient-doctor relationship


Expert guest:
Dr David Jeffrey is a retired palliative doctor and former academic mentor at Dundee medical school involved in student support. He also did a PhD exploring empathy in medical students.


Recommended reading: 
• I never asked to be ICE’d - https://www.bmj.com/content/354/bmj.i3729 
• Communication skills and the problem with fake patients - https://www.bmj.com/content/357/sbmj.j974?sso= 


*We’re looking for new panel members!*


Are you a:
✅ Medical student
✅ Listener of Sharp Scratch
✅ Keen on representing the voice of medical students?


In the past, the panel only consisted of medical students studying in the UK. However, remote recording meant that we can extend this opportunity to medical students in other countries. If you’re interested, please apply via the link below. We look forward to hearing from you!


Apply here: https://forms.gle/QocryfkG137cWTb88


Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="42111872" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1217801248-bmjpodcasts-can-you-learn-empathy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1215722410</guid>
      <title>March: toxic environments - the lethality of racism, lead, Zika virus, and fertility after cancer</title>
      <pubDate>Thu, 17 Feb 2022 11:24:22 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/adc-atoms-march-2022-issue-highlights</link>
      <itunes:duration>00:17:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the March 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/3/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the March 2022 issue.
Read it on the Archives of Disease in Childhood website: https://adc.bmj.com/content/107/3/i
Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</description>
      <enclosure length="17214483" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1215722410-bmjpodcasts-adc-atoms-march-2022-issue-highlights.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1216561060</guid>
      <title>ESO-ESMINT expedited recommendation on intravenous thrombolysis before mechanical thrombectomy</title>
      <pubDate>Thu, 17 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/eso-esmint-thrombolysis-before-mechanical-thrombectomy</link>
      <itunes:duration>00:24:16</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In the latest podcast, we discuss the joint expedited recommendations from the European Stroke Organisation (ESO) and the European Society for Minimally Invasive Neurological Therapy (ESMINT) on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion.
JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, interviews Dr. Guillaume Turc, Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Université de Paris, and co-chair of the module working group. 
Paper available here: https://jnis.bmj.com/content/14/3/209. 
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767.
Thank you for listening!</itunes:summary>
      <itunes:subtitle>In the latest podcast, we discuss the joint exped…</itunes:subtitle>
      <description>In the latest podcast, we discuss the joint expedited recommendations from the European Stroke Organisation (ESO) and the European Society for Minimally Invasive Neurological Therapy (ESMINT) on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion.
JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, interviews Dr. Guillaume Turc, Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Université de Paris, and co-chair of the module working group. 
Paper available here: https://jnis.bmj.com/content/14/3/209. 
Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767.
Thank you for listening!</description>
      <enclosure length="23299969" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1216561060-bmjpodcasts-eso-esmint-thrombolysis-before-mechanical-thrombectomy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-VebiywaEzucPGWY7-sj12ng-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1213819336</guid>
      <title>Single Cell Transcriptomics with Dr. Alan Daugherty, Editor-in-Chief of ATVB</title>
      <pubDate>Tue, 15 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/single-cell-transcriptomics-with-dr-alan-daugherty-editor-in-chief-of-atvb</link>
      <itunes:duration>00:16:28</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Intern, Dr. Andrew Perry, is joined by Dr. Alan Daugherty, from the University of Kentucky, and Editor-in-Chief of the Arteriosclerosis, Thrombosis, and Vascular Biology journal. They discuss the latest developments in transcriptomics and how they might be used to understand the causes of vascular disease.
If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Intern, Dr. Andrew Perry, is joined by Dr. Alan Daugherty, from the University of Kentucky, and Editor-in-Chief of the Arteriosclerosis, Thrombosis, and Vascular Biology journal. They discuss the latest developments in transcriptomics and how they might be used to understand the causes of vascular disease.
If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2</description>
      <enclosure length="39529321" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1213819336-bmjpodcasts-single-cell-transcriptomics-with-dr-alan-daugherty-editor-in-chief-of-atvb.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1211662609</guid>
      <title>Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin</title>
      <pubDate>Mon, 14 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/innate-lymphoid-cells-link-tgfb-and-fibrotic-pathways-in-ssc-skin</link>
      <itunes:duration>00:21:40</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, Dr. Truchetet discusses her work on the role of innate lymphoid cells in the fibrotic processes in systemic sclerosis (SSc) patients. The group of Dr. Truchetet found that ILC2 are crucial mediators of skin fibrosis in SSc and that combined treatment of patients with TGFb inhibitors and IL-10 might be an attractive new therapeutic approach in SSc. 
Read the full paper on the ARD website: https://ard.bmj.com/content/80/12/1594
Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page (https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059).</itunes:summary>
      <itunes:subtitle>In this podcast, Dr. Truchetet discusses her work…</itunes:subtitle>
      <description>In this podcast, Dr. Truchetet discusses her work on the role of innate lymphoid cells in the fibrotic processes in systemic sclerosis (SSc) patients. The group of Dr. Truchetet found that ILC2 are crucial mediators of skin fibrosis in SSc and that combined treatment of patients with TGFb inhibitors and IL-10 might be an attractive new therapeutic approach in SSc. 
Read the full paper on the ARD website: https://ard.bmj.com/content/80/12/1594
Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page (https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059).</description>
      <enclosure length="20813948" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1211662609-bmjpodcasts-innate-lymphoid-cells-link-tgfb-and-fibrotic-pathways-in-ssc-skin.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-Q8IztkyICEJ9DhxU-zNgWPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1212189658</guid>
      <title>Legends in Gynecologic Oncology: David Gershenson</title>
      <pubDate>Mon, 14 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/legends-in-gynecologic-oncology-david-gershenson</link>
      <itunes:duration>00:29:30</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. David M. Gershenson to discuss legends in gynecologic oncology. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research or rare ovarian cancers.

 

Highlights:
Mentoring is an essential component of a successful career in gynecologic oncology, and every trainee should seek a mentor early in their fellowship.
Strive to achieve the optimal work/life balance to avoid burnout over the course of your career.
The subspecialty of gynecologic oncology has been consistently gratifying for me during the past 40+ years. It provides young trainees with a myriad of wonderful opportunities and career choices.
I strongly recommend having a 5-year plan to optimize success in your professional career.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. David M. Gershenson to discuss legends in gynecologic oncology. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research or rare ovarian cancers.

 

Highlights:
Mentoring is an essential component of a successful career in gynecologic oncology, and every trainee should seek a mentor early in their fellowship.
Strive to achieve the optimal work/life balance to avoid burnout over the course of your career.
The subspecialty of gynecologic oncology has been consistently gratifying for me during the past 40+ years. It provides young trainees with a myriad of wonderful opportunities and career choices.
I strongly recommend having a 5-year plan to optimize success in your professional career.</description>
      <enclosure length="28325092" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1212189658-bmjpodcasts-legends-in-gynecologic-oncology-david-gershenson.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1213960426</guid>
      <title>Be the difference that makes the difference for pregnant and post-partum women. EP #497</title>
      <pubDate>Fri, 11 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/bjsm-11022022-ep-497</link>
      <itunes:duration>00:31:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Associate Professor Izzy Moore and Grainne Donnelly discuss running during and after pregnancy and provide practical tips and great resources for clinicians treating pregnant and post-partum women. How can you ask about pelvic health? What is the role of a musculoskeletal clinician? How can we ensure less women suffer in silence? 

Original research: Multidisciplinary, biopsychosocial factors contributing to return to running and running related stress urinary incontinence in postpartum women https://bjsm.bmj.com/content/55/22/1286.info

Editorial: Multidisciplinary, biopsychosocial factors contributing to return to running and running related stress urinary incontinence in postpartum women:  https://pubmed.ncbi.nlm.nih.gov/34836883/

2019 return to running guideline https://doi.org/10.1016/j.physio.2020.03.276

Return to running BJSM infographic  - https://bjsm.bmj.com/content/54/18/1114

Run ready post-partum BJSM blogs
https://blogs.bmj.com/bjsm/2019/05/20/ready-steadygo-ensuring-postnatal-women-are-run-ready/ and https://blogs.bmj.com/bjsm/2021/08/22/return-to-running-following-childbirth-when-the-principles-of-sports-medicine-and-pelvic-health-collide/
 
Pelvic health impact questionnaire https://pubmed.ncbi.nlm.nih.gov/16021067/
Canadian guidelines - https://bjsm.bmj.com/content/52/21/1339

Clinical commentary considering the whole system readiness for running post-partum https://journals.lww.com/jwhpt/Abstract/2022/01000/Beyond_the_Musculoskeletal_System__Considering.7.aspx</itunes:summary>
      <itunes:subtitle>Associate Professor Izzy Moore and Grainne Donnel…</itunes:subtitle>
      <description>Associate Professor Izzy Moore and Grainne Donnelly discuss running during and after pregnancy and provide practical tips and great resources for clinicians treating pregnant and post-partum women. How can you ask about pelvic health? What is the role of a musculoskeletal clinician? How can we ensure less women suffer in silence? 

Original research: Multidisciplinary, biopsychosocial factors contributing to return to running and running related stress urinary incontinence in postpartum women https://bjsm.bmj.com/content/55/22/1286.info

Editorial: Multidisciplinary, biopsychosocial factors contributing to return to running and running related stress urinary incontinence in postpartum women:  https://pubmed.ncbi.nlm.nih.gov/34836883/

2019 return to running guideline https://doi.org/10.1016/j.physio.2020.03.276

Return to running BJSM infographic  - https://bjsm.bmj.com/content/54/18/1114

Run ready post-partum BJSM blogs
https://blogs.bmj.com/bjsm/2019/05/20/ready-steadygo-ensuring-postnatal-women-are-run-ready/ and https://blogs.bmj.com/bjsm/2021/08/22/return-to-running-following-childbirth-when-the-principles-of-sports-medicine-and-pelvic-health-collide/
 
Pelvic health impact questionnaire https://pubmed.ncbi.nlm.nih.gov/16021067/
Canadian guidelines - https://bjsm.bmj.com/content/52/21/1339

Clinical commentary considering the whole system readiness for running post-partum https://journals.lww.com/jwhpt/Abstract/2022/01000/Beyond_the_Musculoskeletal_System__Considering.7.aspx</description>
      <enclosure length="30663574" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1213960426-bmjpodcasts-bjsm-11022022-ep-497.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1213937524</guid>
      <title>Reviewing the February Issue with Felix Boria (Spanish version)</title>
      <pubDate>Fri, 11 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reviewing-the-february-issue-with-felix-boria-spanish-version</link>
      <itunes:duration>00:16:56</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC Podcast, Editorial Fellow Felix Boria discusses the contents of the February issue of IJGC in Spanish.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC Podcast, Editorial Fe…</itunes:subtitle>
      <description>In this episode of the IJGC Podcast, Editorial Fellow Felix Boria discusses the contents of the February issue of IJGC in Spanish.</description>
      <enclosure length="16256521" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1213937524-bmjpodcasts-reviewing-the-february-issue-with-felix-boria-spanish-version.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1213933852</guid>
      <title>Reviewing the February Issue with Floriane Jochum and Natalie Medley (English version)</title>
      <pubDate>Fri, 11 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reviewing-the-february-issue-with-floriane-jochum-and-natalie-medley-english-version</link>
      <itunes:duration>00:16:21</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC Podcast, Editorial Fellows Floriane Jochum and Natalie Medley discuss the contents of the February issue of IJGC in English.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC Podcast, Editorial Fe…</itunes:subtitle>
      <description>In this episode of the IJGC Podcast, Editorial Fellows Floriane Jochum and Natalie Medley discuss the contents of the February issue of IJGC in English.</description>
      <enclosure length="15698546" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1213933852-bmjpodcasts-reviewing-the-february-issue-with-floriane-jochum-and-natalie-medley-english-version.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1212654868</guid>
      <title>Vaccine mandate's unintended consequences</title>
      <pubDate>Wed, 09 Feb 2022 12:24:13 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/vaccine-mandates-unintended-consequences</link>
      <itunes:duration>00:40:23</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>There was a proposed vaccine mandate for NHS staff in the UK (now abandoned) but in other countries mandates continue, but are they without harm, and do we have evidence about how effective they are?

In this episode, we'll be discussing how a proposed vaccine mandate would have affected GP practices in the UK, particularly when it comes to the demographics of staff who have not accepted the vaccine. 

We'll also be discussing direct and indirect evidence which might have helped us assess the efficacy of a mandate.

Our guests;
Steve Mowle is a GP in South London, and honorary treasurer, of the Royal College of General Practice.
Juan Franco is a GP at the Hospital Italiano de Buenos Aires, Argentina, and Vice-Chair of the Research Department at the Instituto Universitario Hospital Italiano (IUHI), where he is also Director of the Cochrane Associate Centre.</itunes:summary>
      <itunes:subtitle>There was a proposed vaccine mandate for NHS staf…</itunes:subtitle>
      <description>There was a proposed vaccine mandate for NHS staff in the UK (now abandoned) but in other countries mandates continue, but are they without harm, and do we have evidence about how effective they are?

In this episode, we'll be discussing how a proposed vaccine mandate would have affected GP practices in the UK, particularly when it comes to the demographics of staff who have not accepted the vaccine. 

We'll also be discussing direct and indirect evidence which might have helped us assess the efficacy of a mandate.

Our guests;
Steve Mowle is a GP in South London, and honorary treasurer, of the Royal College of General Practice.
Juan Franco is a GP at the Hospital Italiano de Buenos Aires, Argentina, and Vice-Chair of the Research Department at the Instituto Universitario Hospital Italiano (IUHI), where he is also Director of the Cochrane Associate Centre.</description>
      <enclosure length="38780759" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1212654868-bmjpodcasts-vaccine-mandates-unintended-consequences.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1205356942</guid>
      <title>Generalised anxiety disorder</title>
      <pubDate>Mon, 07 Feb 2022 10:37:22 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/generalised-anxiety-disorder</link>
      <itunes:duration>00:12:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Generalised anxiety disorder (GAD) is a common condition defined as chronic, excessive worry for at least six months that causes distress or impairment.

Christopher Gale, Research Director and Consultant Psychiatrist, Southern District Health Board, New Zealand gives a clinical overview of the condition.

For more on GAD, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/120

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</itunes:summary>
      <itunes:subtitle>Generalised anxiety disorder (GAD) is a common co…</itunes:subtitle>
      <description>Generalised anxiety disorder (GAD) is a common condition defined as chronic, excessive worry for at least six months that causes distress or impairment.

Christopher Gale, Research Director and Consultant Psychiatrist, Southern District Health Board, New Zealand gives a clinical overview of the condition.

For more on GAD, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/120

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</description>
      <enclosure length="11681815" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1205356942-bmjpodcasts-generalised-anxiety-disorder.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-ujs7lai7EfGopsDJ-npDHtw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1211234977</guid>
      <title>What you weren't told about working as a junior doctor</title>
      <pubDate>Mon, 07 Feb 2022 09:10:33 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/what-you-werent-told-about-working-as-a-junior-doctor</link>
      <itunes:duration>00:47:35</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>When going on placement, you are probably more interested in gaining experience in the clinical environment and less interested in how frequently doctors can take breaks. 
 
Doctors’ working conditions may seem irrelevant as a medical student but they are closely associated with work satisfaction and wellbeing. In this episode, the Sharp Scratch panel discussed doctors’ working conditions and how it impacts our day-to-day work.


Expert guest:
Dr Kevin Teoh (@kevinteohrh on Twitter) is a Chartered Psychologist and the Executive Officer for the European Academy of Occupational Health Psychology. 


Thank you to Dr Saliha Mahmood Ahmed (@salihacooks on Twitter) and Neely Mozawala (@NeelyMozawala on Twitter) who contributed to this episode. 


*We’re looking for new panel members!*

Are you a:
✅ Medical student
✅ Listener of Sharp Scratch
✅ Keen on representing the voice of medical students?

In the past, the panel only consisted of medical students studying in the UK. However, remote recording means that we can extend this opportunity to medical students in other countries. If you’re interested, please apply via the link below. We look forward to hearing from you!

Apply here: https://forms.gle/QocryfkG137cWTb88




Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>When going on placement, you are probably more in…</itunes:subtitle>
      <description>When going on placement, you are probably more interested in gaining experience in the clinical environment and less interested in how frequently doctors can take breaks. 
 
Doctors’ working conditions may seem irrelevant as a medical student but they are closely associated with work satisfaction and wellbeing. In this episode, the Sharp Scratch panel discussed doctors’ working conditions and how it impacts our day-to-day work.


Expert guest:
Dr Kevin Teoh (@kevinteohrh on Twitter) is a Chartered Psychologist and the Executive Officer for the European Academy of Occupational Health Psychology. 


Thank you to Dr Saliha Mahmood Ahmed (@salihacooks on Twitter) and Neely Mozawala (@NeelyMozawala on Twitter) who contributed to this episode. 


*We’re looking for new panel members!*

Are you a:
✅ Medical student
✅ Listener of Sharp Scratch
✅ Keen on representing the voice of medical students?

In the past, the panel only consisted of medical students studying in the UK. However, remote recording means that we can extend this opportunity to medical students in other countries. If you’re interested, please apply via the link below. We look forward to hearing from you!

Apply here: https://forms.gle/QocryfkG137cWTb88




Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 
This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="45689216" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1211234977-bmjpodcasts-what-you-werent-told-about-working-as-a-junior-doctor.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1209733276</guid>
      <title>SUCCOR: Cone Before Radical Hysterectomy</title>
      <pubDate>Mon, 07 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/succor-cone-before-radical-hysterectomy</link>
      <itunes:duration>00:34:59</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Enrique Chacón and Luis Chiva to discuss the possible protective role of conization.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Enrique Chacón and Luis Chiva to discuss the possible protective role of conization.</description>
      <enclosure length="33589706" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1209733276-bmjpodcasts-succor-cone-before-radical-hysterectomy.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1207243522</guid>
      <title>Better asthma control, half of the carbon footprint with climate-friendly inhalers</title>
      <pubDate>Mon, 07 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/asthma-eco-friendly-inhalers</link>
      <itunes:duration>00:07:31</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, is joined by Professor Ashley Woodcock, Manchester Academic Health Sciences Centre, The University of Manchester, UK, to discuss the paper "Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis."
This paper was a secondary analysis of the Salford Lung Study in Asthma. In a real world study SLS asthma showed that a once daily combination treatment in a dry powder inhaler improved asthma control over one year, versus usual treatment. This secondary analysis looked at the impact on carbon footprint for those patients switching from a pressurised MDI to DPI treatment.</itunes:summary>
      <itunes:subtitle>In this podcast, Rachael Moses, Multimedia Editor…</itunes:subtitle>
      <description>In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, is joined by Professor Ashley Woodcock, Manchester Academic Health Sciences Centre, The University of Manchester, UK, to discuss the paper "Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis."
This paper was a secondary analysis of the Salford Lung Study in Asthma. In a real world study SLS asthma showed that a once daily combination treatment in a dry powder inhaler improved asthma control over one year, versus usual treatment. This secondary analysis looked at the impact on carbon footprint for those patients switching from a pressurised MDI to DPI treatment.</description>
      <enclosure length="7231946" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1207243522-bmjpodcasts-asthma-eco-friendly-inhalers.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-mheS8iihgySIVMX0-q9UGJQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1209874909</guid>
      <title>Learning to listen</title>
      <pubDate>Fri, 04 Feb 2022 17:35:10 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/learning-to-listen</link>
      <itunes:duration>00:47:24</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In previous episodes of Doctor Informed, we've talked about the importance of speaking out, and how to do that better, but as you progress through your medical career, you will become the person to whom those with problems will turn. 

In this episode we will explore listening. As a senior clinician, how can you make the space in your work to be a good listener, when what you hear might not be what you want to hear?

Our guests;
Megan Reitz is a professor of Leadership and Dialogue at Hult Business School.
John Higgins is research director at The Right Conversation.

Reading
Speaking truth to power: why leaders cannot hear what they need to hear 
https://bmjleader.bmj.com/content/5/4/270</itunes:summary>
      <itunes:subtitle>In previous episodes of Doctor Informed, we've ta…</itunes:subtitle>
      <description>In previous episodes of Doctor Informed, we've talked about the importance of speaking out, and how to do that better, but as you progress through your medical career, you will become the person to whom those with problems will turn. 

In this episode we will explore listening. As a senior clinician, how can you make the space in your work to be a good listener, when what you hear might not be what you want to hear?

Our guests;
Megan Reitz is a professor of Leadership and Dialogue at Hult Business School.
John Higgins is research director at The Right Conversation.

Reading
Speaking truth to power: why leaders cannot hear what they need to hear 
https://bmjleader.bmj.com/content/5/4/270</description>
      <enclosure length="45504469" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1209874909-bmjpodcasts-learning-to-listen.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-iv1zjTJkVfROtFcB-2RBqcA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1209649087</guid>
      <title>Peripheral Nerve Hydrodissection: A minimally invasive approach with Dr. Garry Ho. EP# 496</title>
      <pubDate>Fri, 04 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/peripheral-nerve-hydrodissection-a-minimally-invasive-approach-with-dr-garry-ho-ep-496</link>
      <itunes:duration>00:21:18</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>What is peripheral nerve hydrodissection and what conditions can it potentially treat? What is the data behind it’s practice? Has one injectate proven to be more efficacious than the others? 

On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Devin McFadden, MD is joined by family medicine and sports medicine physicians Dr. Garry Ho. 

Dr. Garry Ho is an Associate Professor from the Department of Family Medicine at the Virginia Commonwealth University School of Medicine, University of Vriginia School of Medicine, and the Georgetown University School of Medicine and has worked closely with athletes from several professional and collegiate organizations including the Washington Football Team, the D.C. Divas, the Washington Glory, the US Military Academy at West Point and the US Naval Academy in Annapolis.

In this 20 minute conversation Dr. Ho addresses the following topics:
The definition of hydrodissection and theory behind its use?
The current data supporting this procedure with respect to injectate utilized and anatomic location targeted.
A discussion of the training required to become competent in this practice, and methods for assessing proficiency in learners?

2022 AMSSM Annual Meeting Information: https://annualmeeting.amssm.org

Lam KHS, Hung CY, Chiang YP, Onishi K, Su DCJ, Clark TB, Reeves KD. Ultrasound-Guided Nerve Hydrodissection for Pain Management: Rationale, Methods, Current Literature, and Theoretical Mechanisms. J Pain Res. 2020;13:1957-1968

https://www.dovepress.com/ultrasound-guided-nerve-hydrodissection-for-pain-management-rationale--peer-reviewed-fulltext-article-JPR

Cass, Shane P. DO Ultrasound-Guided Nerve Hydrodissection, Current Sports Medicine Reports: January/February 2016 - Volume 15 - Issue 1 - p 20-22 

https://journals.lww.com/acsm-csmr/Fulltext/2016/01000/Ultrasound_Guided_Nerve_Hydrodissection__What_is.10.aspx</itunes:summary>
      <itunes:subtitle>What is peripheral nerve hydrodissection and what…</itunes:subtitle>
      <description>What is peripheral nerve hydrodissection and what conditions can it potentially treat? What is the data behind it’s practice? Has one injectate proven to be more efficacious than the others? 

On this episode of the AMSSM Sports Medcast (T: @TheAMSSM) host Dr. Devin McFadden, MD is joined by family medicine and sports medicine physicians Dr. Garry Ho. 

Dr. Garry Ho is an Associate Professor from the Department of Family Medicine at the Virginia Commonwealth University School of Medicine, University of Vriginia School of Medicine, and the Georgetown University School of Medicine and has worked closely with athletes from several professional and collegiate organizations including the Washington Football Team, the D.C. Divas, the Washington Glory, the US Military Academy at West Point and the US Naval Academy in Annapolis.

In this 20 minute conversation Dr. Ho addresses the following topics:
The definition of hydrodissection and theory behind its use?
The current data supporting this procedure with respect to injectate utilized and anatomic location targeted.
A discussion of the training required to become competent in this practice, and methods for assessing proficiency in learners?

2022 AMSSM Annual Meeting Information: https://annualmeeting.amssm.org

Lam KHS, Hung CY, Chiang YP, Onishi K, Su DCJ, Clark TB, Reeves KD. Ultrasound-Guided Nerve Hydrodissection for Pain Management: Rationale, Methods, Current Literature, and Theoretical Mechanisms. J Pain Res. 2020;13:1957-1968

https://www.dovepress.com/ultrasound-guided-nerve-hydrodissection-for-pain-management-rationale--peer-reviewed-fulltext-article-JPR

Cass, Shane P. DO Ultrasound-Guided Nerve Hydrodissection, Current Sports Medicine Reports: January/February 2016 - Volume 15 - Issue 1 - p 20-22 

https://journals.lww.com/acsm-csmr/Fulltext/2016/01000/Ultrasound_Guided_Nerve_Hydrodissection__What_is.10.aspx</description>
      <enclosure length="14835062" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1209649087-bmjpodcasts-peripheral-nerve-hydrodissection-a-minimally-invasive-approach-with-dr-garry-ho-ep-496.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1209153208</guid>
      <title>Reviewing the February Issue with Irina Tsibulak (Russian version)</title>
      <pubDate>Thu, 03 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reviewing-the-february-issue-with-irina-tsibulak-russian-version-1</link>
      <itunes:duration>00:16:32</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC Podcast, former Edito…</itunes:subtitle>
      <description>In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.</description>
      <enclosure length="21779985" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1209153208-bmjpodcasts-reviewing-the-february-issue-with-irina-tsibulak-russian-version-1.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1205095042</guid>
      <title>Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Pg-LPS</title>
      <pubDate>Thu, 03 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/gut-microbiota-modulates-copd-pathogenesis-role-of-anti-inflammatory-pg-lps</link>
      <itunes:duration>00:11:36</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Lu from the Department of Respiratory Care, College of Medicine, Fu Jen Catholic University, Taiwan, and Drs Lai and Dr Lin from the Department of Medical Biotechnology and Laboratory Science, and Microbiota Research Center, College of Medicine, Chang Gung University, Taiwan. 
The Gut podcast is focused on the paper "Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide", which is published in paper copy in Gut in February 2022, and is available here: https://gut.bmj.com/content/71/2/309
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</itunes:summary>
      <itunes:subtitle>Dr Philip Smith, Digital and Education Editor of …</itunes:subtitle>
      <description>Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Lu from the Department of Respiratory Care, College of Medicine, Fu Jen Catholic University, Taiwan, and Drs Lai and Dr Lin from the Department of Medical Biotechnology and Laboratory Science, and Microbiota Research Center, College of Medicine, Chang Gung University, Taiwan. 
The Gut podcast is focused on the paper "Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide", which is published in paper copy in Gut in February 2022, and is available here: https://gut.bmj.com/content/71/2/309
Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).</description>
      <enclosure length="11138611" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1205095042-bmjpodcasts-gut-microbiota-modulates-copd-pathogenesis-role-of-anti-inflammatory-pg-lps.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-QHyh9NzyYH7qYviX-A4EYPQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1208647591</guid>
      <title>"I like being a big fish in a small pond", an epidemiologist in an unconventional field</title>
      <pubDate>Thu, 03 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/an-epidemiologist-in-an-unconventional-field</link>
      <itunes:duration>00:23:14</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Dr Rebecca Spicer, Impact Research, LLC, PhD, MPH, is an epidemiologist working among engineers to make cars safer. A change of path in her career that is allowing her to see her "work make a difference". In this conversation with Dr Rod McClure, she advises career-seekers to "look beyond what's normal".
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</itunes:summary>
      <itunes:subtitle>Dr Rebecca Spicer, Impact Research, LLC, PhD, MPH…</itunes:subtitle>
      <description>Dr Rebecca Spicer, Impact Research, LLC, PhD, MPH, is an epidemiologist working among engineers to make cars safer. A change of path in her career that is allowing her to see her "work make a difference". In this conversation with Dr Rod McClure, she advises career-seekers to "look beyond what's normal".
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!</description>
      <enclosure length="22315257" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1208647591-bmjpodcasts-an-epidemiologist-in-an-unconventional-field.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-97PYlC3idubTCbxz-1rv9FQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1204685971</guid>
      <title>A new biomarker for cognitive dysfunction in SLE?</title>
      <pubDate>Wed, 02 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/a-new-biomarker-for-cognitive-dysfunction-in-sle</link>
      <itunes:duration>00:16:00</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Duane Peters from the Lupus Foundation of America interviews Dr Erik Anderson and Dr Meggan Mackay from the Feinstein Institutes for Medical Research in New York in the USA. They discuss their study into imbalances in quinolinic acid and kynurenic acid levels in the brain in SLE patients, and propose that the ratio between these two metabolites could be used as a new biomarker or therapeutic target for cognitive dysfunction.

Access the paper here: https://lupus.bmj.com/content/8/1/e000559</itunes:summary>
      <itunes:subtitle>Duane Peters from the Lupus Foundation of America…</itunes:subtitle>
      <description>Duane Peters from the Lupus Foundation of America interviews Dr Erik Anderson and Dr Meggan Mackay from the Feinstein Institutes for Medical Research in New York in the USA. They discuss their study into imbalances in quinolinic acid and kynurenic acid levels in the brain in SLE patients, and propose that the ratio between these two metabolites could be used as a new biomarker or therapeutic target for cognitive dysfunction.

Access the paper here: https://lupus.bmj.com/content/8/1/e000559</description>
      <enclosure length="13556149" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1204685971-bmjpodcasts-a-new-biomarker-for-cognitive-dysfunction-in-sle.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zOfBZ6joPLX9GdP1-jqUXQg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1204485802</guid>
      <title>Anticoagulant prescribing for atrial fibrillation and risk of incident dementia</title>
      <pubDate>Tue, 01 Feb 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/anticoagulant-prescribing-for-atrial-fibrillation-and-risk-of-incident-dementia</link>
      <itunes:duration>00:16:55</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Charlotte Warren-Gash and Dr Sharon Cadogan  from the London School of Hygiene &amp; Tropical Medicine, London, UK. They discuss their study that demonstrated that prescribing DOACs rather than warfarin was associated with lower incident rates of dementia and mild cognitive impairment.
If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/107/23/1898.abstract</itunes:summary>
      <itunes:subtitle>In this episode of the Heart podcast, Digital Med…</itunes:subtitle>
      <description>In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Charlotte Warren-Gash and Dr Sharon Cadogan  from the London School of Hygiene &amp; Tropical Medicine, London, UK. They discuss their study that demonstrated that prescribing DOACs rather than warfarin was associated with lower incident rates of dementia and mild cognitive impairment.
If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper: https://heart.bmj.com/content/107/23/1898.abstract</description>
      <enclosure length="40593517" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1204485802-bmjpodcasts-anticoagulant-prescribing-for-atrial-fibrillation-and-risk-of-incident-dementia.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-W3trd8WssVywCmGb-ZyOogQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1207195192</guid>
      <title>Reviewing the January Issue with Irina Tsibulak (Russian version)</title>
      <pubDate>Mon, 31 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/reviewing-the-january-issue-with-irina-tsibulak-russian-version</link>
      <itunes:duration>00:14:09</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC Podcast, former Edito…</itunes:subtitle>
      <description>In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.</description>
      <enclosure length="18332232" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1207195192-bmjpodcasts-reviewing-the-january-issue-with-irina-tsibulak-russian-version.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1204725367</guid>
      <title>ESGO Quality Indicators in Endometrial Cancer with Nicole Concin</title>
      <pubDate>Mon, 31 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/esgo-quality-indicators-in-endometrial-cancer-with-nicole-concin</link>
      <itunes:duration>00:45:33</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss the article European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma.  Dr. Concin is a gynaecological oncologist, ESGO president, Co-Chair of ENGOT Early Drug Development Network, and Professor at Medical University of Innsbruck, Innsbruck Austria &amp; Kliniken Essen-Mitte, Essen, Germany.
Related Link: https://ijgc.bmj.com/content/31/12/1508</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss the article European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma.  Dr. Concin is a gynaecological oncologist, ESGO president, Co-Chair of ENGOT Early Drug Development Network, and Professor at Medical University of Innsbruck, Innsbruck Austria &amp; Kliniken Essen-Mitte, Essen, Germany.
Related Link: https://ijgc.bmj.com/content/31/12/1508</description>
      <enclosure length="43734830" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1204725367-bmjpodcasts-esgo-quality-indicators-in-endometrial-cancer-with-nicole-concin.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1205560120</guid>
      <title>Talk Evidence - isolation periods, openness, and environmental impacts</title>
      <pubDate>Fri, 28 Jan 2022 17:35:44 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/talk-evidence-isolation-periods-openness-and-environmental-impacts</link>
      <itunes:duration>00:35:07</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In the first Talk Evidence of 2022, we'll be asking about the evidence for isolation - now that isolation periods are being reduced, or even stopped in the event of a negative lateral flow test, we'll find out what data that's based on, and if it's appropriate. 

Vaccinations and treatments for covid-19 have been the one major success story of the pandemic, but that doesn't mean we should abandon the principles of openness and transparency when it comes to scrutinising the data - we'll hear what access to the data which underlies regulatory approval could do now.

Finally, the impacts of climate change were set out in a WHO report in November last year - and recent weather seems to underline their conclusions. We'll discuss new evidence linking the environment and health, and ask what clinicians can do with that.

Reading list:
Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods
https://www.medrxiv.org/content/10.1101/2021.12.23.21268326v1.full.pdf

Covid-19 vaccines and treatments: we must have raw data, now
https://www.bmj.com/content/376/bmj.o102

WHO report: Climate change and health
https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health

Ambient heat and risks of emergency department visits among adults in the United States: time stratified case crossover study
https://www.bmj.com/content/375/bmj-2021-065653

Residential exposure to transportation noise in Denmark and incidence of dementia: national cohort study
https://www.bmj.com/content/374/bmj.n1954

Long term exposure to low level air pollution and mortality in eight European cohorts within the ELAPSE project: pooled analysis
https://www.bmj.com/content/374/bmj.n1904</itunes:summary>
      <itunes:subtitle>In the first Talk Evidence of 2022, we'll be aski…</itunes:subtitle>
      <description>In the first Talk Evidence of 2022, we'll be asking about the evidence for isolation - now that isolation periods are being reduced, or even stopped in the event of a negative lateral flow test, we'll find out what data that's based on, and if it's appropriate. 

Vaccinations and treatments for covid-19 have been the one major success story of the pandemic, but that doesn't mean we should abandon the principles of openness and transparency when it comes to scrutinising the data - we'll hear what access to the data which underlies regulatory approval could do now.

Finally, the impacts of climate change were set out in a WHO report in November last year - and recent weather seems to underline their conclusions. We'll discuss new evidence linking the environment and health, and ask what clinicians can do with that.

Reading list:
Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods
https://www.medrxiv.org/content/10.1101/2021.12.23.21268326v1.full.pdf

Covid-19 vaccines and treatments: we must have raw data, now
https://www.bmj.com/content/376/bmj.o102

WHO report: Climate change and health
https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health

Ambient heat and risks of emergency department visits among adults in the United States: time stratified case crossover study
https://www.bmj.com/content/375/bmj-2021-065653

Residential exposure to transportation noise in Denmark and incidence of dementia: national cohort study
https://www.bmj.com/content/374/bmj.n1954

Long term exposure to low level air pollution and mortality in eight European cohorts within the ELAPSE project: pooled analysis
https://www.bmj.com/content/374/bmj.n1904</description>
      <enclosure length="33715094" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1205560120-bmjpodcasts-talk-evidence-isolation-periods-openness-and-environmental-impacts.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-2yobq1Hjl6r87WmD-zdjn1Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1205364184</guid>
      <title>To jab or not to jab? Responsible use of orthobiologics and regenerative therapies. EP #495</title>
      <pubDate>Fri, 28 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/to-jab-or-not-to-jab-responsible-use-of-orthobiologics-and-regenerative-therapies-ep-495</link>
      <itunes:duration>00:29:05</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode host Dr Brooke Patterson, is joined by Associate Professor Shane Shapiro, to discuss the responsible use of orthobiologics and regenerative therapies in sports medicine. Professor Shapiro provides clinicians with practical considerations and tips for communicating with patients who may be considering the use of orthobiologics.
 
Links
American Medical Society for Sports Medicine Position Statement: Principles for the Responsible Use of Regenerative Medicine in Sports Medicine https://journals.lww.com/cjsportsmed/Fulltext/2021/11000/American_Medical_Society_for_Sports_Medicine.10.aspx

Editorial - highlights from the American Medical Society for Sports Medicine position statement on responsible use of regenerative medicine and orthobiologics in sports medicine https://bjsm.bmj.com/content/early/2021/10/21/bjsports-2021-104887</itunes:summary>
      <itunes:subtitle>In this episode host Dr Brooke Patterson, is join…</itunes:subtitle>
      <description>In this episode host Dr Brooke Patterson, is joined by Associate Professor Shane Shapiro, to discuss the responsible use of orthobiologics and regenerative therapies in sports medicine. Professor Shapiro provides clinicians with practical considerations and tips for communicating with patients who may be considering the use of orthobiologics.
 
Links
American Medical Society for Sports Medicine Position Statement: Principles for the Responsible Use of Regenerative Medicine in Sports Medicine https://journals.lww.com/cjsportsmed/Fulltext/2021/11000/American_Medical_Society_for_Sports_Medicine.10.aspx

Editorial - highlights from the American Medical Society for Sports Medicine position statement on responsible use of regenerative medicine and orthobiologics in sports medicine https://bjsm.bmj.com/content/early/2021/10/21/bjsports-2021-104887</description>
      <enclosure length="69816000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1205364184-bmjpodcasts-to-jab-or-not-to-jab-responsible-use-of-orthobiologics-and-regenerative-therapies-ep-495.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1199913271</guid>
      <title>Primary Survey - the February 2022 issue in just over 30 minutes!</title>
      <pubDate>Thu, 27 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/emj-february-2022-primary-survey</link>
      <itunes:duration>00:33:18</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Rick Body, Deputy Editor of EMJ, and Sarah Edwards, Social Media Editor of EMJ, talk through the highlights of the February edition of the Emergency Medicine Journal.
Read the highlights: https://emj.bmj.com/content/39/2/85.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</itunes:summary>
      <itunes:subtitle>Rick Body, Deputy Editor of EMJ, and Sarah Edward…</itunes:subtitle>
      <description>Rick Body, Deputy Editor of EMJ, and Sarah Edwards, Social Media Editor of EMJ, talk through the highlights of the February edition of the Emergency Medicine Journal.
Read the highlights: https://emj.bmj.com/content/39/2/85.
You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244). 
Thank you for listening!</description>
      <enclosure length="31984325" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1199913271-bmjpodcasts-emj-february-2022-primary-survey.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-1YdbMWDWihTePtKu-RUocJA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1203116944</guid>
      <title>Overprescribing, overuse of short-acting beta agonists, inflammatory bowel disease in pregnancy</title>
      <pubDate>Thu, 27 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/dtb-february-2022</link>
      <itunes:duration>00:21:36</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the February 2022 issue of DTB. They talk about some of the details from a national report on overprescribing and discuss its implications (https://dtb.bmj.com/content/60/2/18). The editors review a study that highlighted overprescribing of short-acting beta agonists in people with asthma (https://dtb.bmj.com/content/60/2/21). They also discuss an article on prescribing for women of childbearing age who have inflammatory bowel disease and managing medicines during pregnancy (https://dtb.bmj.com/content/60/2/24).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</itunes:summary>
      <itunes:subtitle>In this podcast, James Cave (Editor-in-Chief) and…</itunes:subtitle>
      <description>In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the February 2022 issue of DTB. They talk about some of the details from a national report on overprescribing and discuss its implications (https://dtb.bmj.com/content/60/2/18). The editors review a study that highlighted overprescribing of short-acting beta agonists in people with asthma (https://dtb.bmj.com/content/60/2/21). They also discuss an article on prescribing for women of childbearing age who have inflammatory bowel disease and managing medicines during pregnancy (https://dtb.bmj.com/content/60/2/24).
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.</description>
      <enclosure length="51860124" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1203116944-bmjpodcasts-dtb-february-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-w7U97fpJrekl77MI-mGwN0g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1203538783</guid>
      <title>How can a patient sue for their conception?</title>
      <pubDate>Tue, 25 Jan 2022 18:16:41 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/how-can-a-patient-sue-for-their-conception</link>
      <itunes:duration>00:46:29</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>A recent case against a GP in England has worried the profession - does the fact that a patient, born with a neural tube defect, successfully sued their mother's GP open up the floodgates for litigation? How will that effect the way that you practice?

In this episode we're joined by Claire Dyer, The BMJ's legal correspondent, who explains how that case unfolded.

We also have a clinical update on childhood constipation, and the authors of a recent article in The BMJ give their tips on getting kids to drink movicol.

Show jumper wins case against mother’s GP for “wrongful conception” that resulted in her disability
https://www.bmj.com/content/375/bmj.n2999

Childhood constipation
https://www.bmj.com/content/375/bmj-2021-065046</itunes:summary>
      <itunes:subtitle>A recent case against a GP in England has worried…</itunes:subtitle>
      <description>A recent case against a GP in England has worried the profession - does the fact that a patient, born with a neural tube defect, successfully sued their mother's GP open up the floodgates for litigation? How will that effect the way that you practice?

In this episode we're joined by Claire Dyer, The BMJ's legal correspondent, who explains how that case unfolded.

We also have a clinical update on childhood constipation, and the authors of a recent article in The BMJ give their tips on getting kids to drink movicol.

Show jumper wins case against mother’s GP for “wrongful conception” that resulted in her disability
https://www.bmj.com/content/375/bmj.n2999

Childhood constipation
https://www.bmj.com/content/375/bmj-2021-065046</description>
      <enclosure length="44631770" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1203538783-bmjpodcasts-how-can-a-patient-sue-for-their-conception.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zGlnMquMkSi0Y6oH-ZmbfmA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1201037296</guid>
      <title>The DESKTOP III Trial with Philipp Harter</title>
      <pubDate>Mon, 24 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/the-desktop-iii-trial-with-philipp-harter</link>
      <itunes:duration>00:41:03</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Prof. Philipp Harter to discuss The DESKTOP III Trial.  Prof. Harter is the director of the Department of Gynecology &amp; Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany, and the chair of the AGO Study Group. 
Highlights:
-Role of surgery for relapsed ovarian cancer is under debate
-DESKTOP III has shown a significant benefit regarding PFS and OS by secondary cytoreduction
-The data, interpretation and clinical consequences are discussed".</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Prof. Philipp Harter to discuss The DESKTOP III Trial.  Prof. Harter is the director of the Department of Gynecology &amp; Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany, and the chair of the AGO Study Group. 
Highlights:
-Role of surgery for relapsed ovarian cancer is under debate
-DESKTOP III has shown a significant benefit regarding PFS and OS by secondary cytoreduction
-The data, interpretation and clinical consequences are discussed".</description>
      <enclosure length="39419819" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1201037296-bmjpodcasts-the-desktop-iii-trial-with-philipp-harter.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-8sMw0i8ynG3AWhRS-Zx3ugg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1200802450</guid>
      <title>Why is it so hard to speak out about patient safety?</title>
      <pubDate>Fri, 21 Jan 2022 16:40:05 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/why-is-it-so-hard-to-speak-out-about-patient-safety</link>
      <itunes:duration>00:37:20</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In the previous episodes of Doctor Informed, we've heard why it's so important to talk about patient safety concerns, and some of the mechanisms that allow hospital staff to raise them, but knowing why and how doesn't always make it easier to speak out. 

In this episode we're exploring the concept of a voiceable concern – identifying what counts as a concern, and what counts as an occasion for voice by an individual, is not a straightforward matter of applying objective criteria- for example how do you tell if you're witnessing poor practice, or just something that lies outside your area of understanding? Or how do you know if the common practice in this particular ward is actually an outlier when looking at other hospitals?

Our guests this week;
Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

Zoe Fritz is a consultant in acute medicine at Cambridge University Hospitals NHS Foundation Trust, she is also a Wellcome Fellow in society and ethics at THIS Institute, investigating how we communicate and record uncertainty around diagnosis.

Reading:
https://pubmed.ncbi.nlm.nih.gov/34978470/

www.bmj.com/podcasts/doctorinformed/
https://www.thisinstitute.cam.ac.uk/podcast/</itunes:summary>
      <itunes:subtitle>In the previous episodes of Doctor Informed, we'v…</itunes:subtitle>
      <description>In the previous episodes of Doctor Informed, we've heard why it's so important to talk about patient safety concerns, and some of the mechanisms that allow hospital staff to raise them, but knowing why and how doesn't always make it easier to speak out. 

In this episode we're exploring the concept of a voiceable concern – identifying what counts as a concern, and what counts as an occasion for voice by an individual, is not a straightforward matter of applying objective criteria- for example how do you tell if you're witnessing poor practice, or just something that lies outside your area of understanding? Or how do you know if the common practice in this particular ward is actually an outlier when looking at other hospitals?

Our guests this week;
Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

Zoe Fritz is a consultant in acute medicine at Cambridge University Hospitals NHS Foundation Trust, she is also a Wellcome Fellow in society and ethics at THIS Institute, investigating how we communicate and record uncertainty around diagnosis.

Reading:
https://pubmed.ncbi.nlm.nih.gov/34978470/

www.bmj.com/podcasts/doctorinformed/
https://www.thisinstitute.cam.ac.uk/podcast/</description>
      <enclosure length="35842506" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1200802450-bmjpodcasts-why-is-it-so-hard-to-speak-out-about-patient-safety.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-LDABgfwgLaPwCB02-DIJolA-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1200546424</guid>
      <title>Publish or perish?</title>
      <pubDate>Fri, 21 Jan 2022 07:00:24 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/publish-or-perish</link>
      <itunes:duration>00:45:37</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Publications, presentations, citations - these are trophies that you can flash proudly on your CV. However, what medical students may underestimate, is the long hours required reading papers, processing data and revising manuscripts. While academic medicine can be rewarding and intellectually stimulating, it is not the only way to become a successful clinician, and it definitely isn’t the be-all and end-all. 


Topics:
•What do editors look for in manuscripts?
•The importance of having a mentor in academia
•Navigating author guidelines
•Pre-print platforms
•How does one get into publishing?
•How do I get better at writing? 
•What do researchers look for when medical students reach out to them? 
•Predatory journals


Expert guest:
Dr Joseph Ross (@jsross119 on Twitter) is a Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management) at the Yale School of Medicine. He is also the co-founder of the preprint service for medicine and health sciences - medRxiv. 
 

Check out Edward Christopher’s piece on predatory journals: https://blogs.bmj.com/bmj/2019/10/08/edward-christopher-how-can-medical-students-avoid-predatory-journals/ 
 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</itunes:summary>
      <itunes:subtitle>Publications, presentations, citations - these ar…</itunes:subtitle>
      <description>Publications, presentations, citations - these are trophies that you can flash proudly on your CV. However, what medical students may underestimate, is the long hours required reading papers, processing data and revising manuscripts. While academic medicine can be rewarding and intellectually stimulating, it is not the only way to become a successful clinician, and it definitely isn’t the be-all and end-all. 


Topics:
•What do editors look for in manuscripts?
•The importance of having a mentor in academia
•Navigating author guidelines
•Pre-print platforms
•How does one get into publishing?
•How do I get better at writing? 
•What do researchers look for when medical students reach out to them? 
•Predatory journals


Expert guest:
Dr Joseph Ross (@jsross119 on Twitter) is a Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management) at the Yale School of Medicine. He is also the co-founder of the preprint service for medicine and health sciences - medRxiv. 
 

Check out Edward Christopher’s piece on predatory journals: https://blogs.bmj.com/bmj/2019/10/08/edward-christopher-how-can-medical-students-avoid-predatory-journals/ 
 

Check us out on social media:
Twitter: https://twitter.com/BMJStudent
Instagram: https://www.instagram.com/bmj_student/
Facebook: https://www.facebook.com/BMJStudent/
 

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.</description>
      <enclosure length="43798400" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1200546424-bmjpodcasts-publish-or-perish.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-3xgLqaofAJr2ExN6-RSSs0Q-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1205223637</guid>
      <title>Archimedes Feb 2022: Sniffles, coughs, wheezes and wonderings</title>
      <pubDate>Fri, 21 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/archimedes-feb-2022-sniffles-coughs-wheezes-and-wonderings</link>
      <itunes:duration>00:10:12</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>When we ask our PICO questions, how often do we think about what we’re not asking … and when should we revise them? That’s the core of this little piece which encourages us to think about thinking a bit - https://adc.bmj.com/content/107/2/193.2.
Far less profound, and far more helpful, is the question of if twins (and triplets and higher orders) are at greater risk of RSV just by being doublets (which really should be what we call them) - https://adc.bmj.com/content/107/2/193.1. And almost as useful is if you can stop a child with annoying sniffles having annoying sniffles when all else fails by splashing them with monteleukast - https://adc.bmj.com/content/107/2/197.
So for now, kick back in the snow, tell us what you think, and submit your own following the instructions on the website and you too could be hearing all about yourself spoken by Archi.</itunes:summary>
      <itunes:subtitle>When we ask our PICO questions, how often do we t…</itunes:subtitle>
      <description>When we ask our PICO questions, how often do we think about what we’re not asking … and when should we revise them? That’s the core of this little piece which encourages us to think about thinking a bit - https://adc.bmj.com/content/107/2/193.2.
Far less profound, and far more helpful, is the question of if twins (and triplets and higher orders) are at greater risk of RSV just by being doublets (which really should be what we call them) - https://adc.bmj.com/content/107/2/193.1. And almost as useful is if you can stop a child with annoying sniffles having annoying sniffles when all else fails by splashing them with monteleukast - https://adc.bmj.com/content/107/2/197.
So for now, kick back in the snow, tell us what you think, and submit your own following the instructions on the website and you too could be hearing all about yourself spoken by Archi.</description>
      <enclosure length="9800723" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1205223637-bmjpodcasts-archimedes-feb-2022-sniffles-coughs-wheezes-and-wonderings.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1200888034</guid>
      <title>Loneliness, friendship and love in the office space</title>
      <pubDate>Fri, 21 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/loneliness-friendship-and-love-in-the-office-space</link>
      <itunes:duration>00:32:40</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>J. Rick Castañeda is a writer, director and producer (https://www.imdb.com/name/nm1479268/?ref_=tt_ov_dr). His works have been around the world to festivals in London, Canada, Japan, and Romania, as well as festivals in the US such as SXSW. He made over 30 short films, earning recognition from YouTube, Crackle, and Funny or Die. 
Rick uses humour to explore stress, anxiety and disenfranchisement in the office space. In this podcast, Rick reflects on his childhood and time spent as an office worker, and how these experiences inspired his creative writing and film career. He stresses the importance of portraying human beings from different backgrounds in his films to encourage a dialogue between cultures.
Related links:
https://blogs.bmj.com/medical-humanities/2022/01/21/loneliness-friendship-and-love-in-the-office-space
https://blogs.bmj.com/medical-humanities/2019/07/30/christina-lee-mindlessness-book-review/ 
https://blogs.bmj.com/medical-humanities/2016/12/14/film-review-dear-zindagi/ 
https://blogs.bmj.com/medical-humanities/2016/07/13/film-review-notes-on-blindness/</itunes:summary>
      <itunes:subtitle>J. Rick Castañeda is a writer, director and produ…</itunes:subtitle>
      <description>J. Rick Castañeda is a writer, director and producer (https://www.imdb.com/name/nm1479268/?ref_=tt_ov_dr). His works have been around the world to festivals in London, Canada, Japan, and Romania, as well as festivals in the US such as SXSW. He made over 30 short films, earning recognition from YouTube, Crackle, and Funny or Die. 
Rick uses humour to explore stress, anxiety and disenfranchisement in the office space. In this podcast, Rick reflects on his childhood and time spent as an office worker, and how these experiences inspired his creative writing and film career. He stresses the importance of portraying human beings from different backgrounds in his films to encourage a dialogue between cultures.
Related links:
https://blogs.bmj.com/medical-humanities/2022/01/21/loneliness-friendship-and-love-in-the-office-space
https://blogs.bmj.com/medical-humanities/2019/07/30/christina-lee-mindlessness-book-review/ 
https://blogs.bmj.com/medical-humanities/2016/12/14/film-review-dear-zindagi/ 
https://blogs.bmj.com/medical-humanities/2016/07/13/film-review-notes-on-blindness/</description>
      <enclosure length="63428735" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1200888034-bmjpodcasts-loneliness-friendship-and-love-in-the-office-space.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-35rzDteJIBP6iGmy-ch0M3g-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1200894898</guid>
      <title>A call to action for a more systematic approach to respiratory health. EP# 494</title>
      <pubDate>Fri, 21 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/a-call-to-action-for-a-more-systematic-approach-to-respiratory-health-ep-494</link>
      <itunes:duration>00:20:19</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this podcast with Dr James Hull and Dr Maarit Valtonen, we take a deep dive into a topic that affects athletes around the globe.

We cover:
•	The extent of the issue
•	A recommended approach to evaluating athletes
•	The value of point-of-case testing
•	Return to sport

For some further resources, the below links  may well be useful

Papers:
https://bjsm.bmj.com/content/early/2021/11/17/bjsports-2021-104719
https://bjsm.bmj.com/content/53/17/1093 
https://bjsm.bmj.com/content/55/20/1144</itunes:summary>
      <itunes:subtitle>In this podcast with Dr James Hull and Dr Maarit …</itunes:subtitle>
      <description>In this podcast with Dr James Hull and Dr Maarit Valtonen, we take a deep dive into a topic that affects athletes around the globe.

We cover:
•	The extent of the issue
•	A recommended approach to evaluating athletes
•	The value of point-of-case testing
•	Return to sport

For some further resources, the below links  may well be useful

Papers:
https://bjsm.bmj.com/content/early/2021/11/17/bjsports-2021-104719
https://bjsm.bmj.com/content/53/17/1093 
https://bjsm.bmj.com/content/55/20/1144</description>
      <enclosure length="48768000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1200894898-bmjpodcasts-a-call-to-action-for-a-more-systematic-approach-to-respiratory-health-ep-494.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-L9pGvEFaXvUsfXd4-MNDtaw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1199245363</guid>
      <title>Dr Nick Brown and Dr Rachel Agbeko discuss the February issue</title>
      <pubDate>Fri, 21 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/atoms-the-highlights-from-the-adc-february-2022</link>
      <itunes:duration>00:15:50</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the February 2022 issue.
Read it on the Archives of Disease in Childhood website:
https://adc.bmj.com/content/107/2/i</itunes:summary>
      <itunes:subtitle>Editor-in-Chief of the Archives of Disease in Chi…</itunes:subtitle>
      <description>Editor-in-Chief of the Archives of Disease in Childhood, Dr Nick Brown, and Senior Editor, Dr Rachel Agbeko, bring you the Atoms - the highlights of the February 2022 issue.
Read it on the Archives of Disease in Childhood website:
https://adc.bmj.com/content/107/2/i</description>
      <enclosure length="15203682" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1199245363-bmjpodcasts-atoms-the-highlights-from-the-adc-february-2022.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-I65FhC4BIVHhf5Uz-j9iSMw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1196487001</guid>
      <title>IRTA: Open vs MIS Radical Trachelectomy with Gloria Salvo and Rene Pareja</title>
      <pubDate>Mon, 17 Jan 2022 11:00:18 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/irta-open-vs-mis-radical-trachelectomy-with-gloria-salvo-and-rene-pareja</link>
      <itunes:duration>00:40:04</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Gloria Salvo and Dr. Rene Pareja to discuss IRTA: Open vs MIS Radical Trachelectomy.  Dr. Salvo was trained as a gynecologist in Hospital Italiano de Buenos Aires, Argentina and works as a Clinical Reviewer/Data Abstractor of the Neuroendocrine Cervical Tumor Registry (NeCTuR) at MD Anderson Cancer Center.   She has published several articles in cervical cancer including sentinel lymph node mapping and fertility-sparing surgery, neuroendocrine cervical carcinomas, and is the first author of the IRTA Study.

Highlights
-In this multicenter retrospective study, we found no difference in the 4.5-year DFS rates between open radical trachelectomy and minimally invasive radical trachelectomy in patients with tumors up to 2 cm, even after adjusting for potential confounding variables because of unbalanced groups.
-There was no difference in the OS rates or recurrence rates between the open surgery and MIS groups.
-Risk factors for relapse were more common in the open surgery group, but oncologic outcomes were similar for the open and minimally invasive approaches.</itunes:summary>
      <itunes:subtitle>In this episode of the IJGC podcast, Editor-in-Ch…</itunes:subtitle>
      <description>In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Gloria Salvo and Dr. Rene Pareja to discuss IRTA: Open vs MIS Radical Trachelectomy.  Dr. Salvo was trained as a gynecologist in Hospital Italiano de Buenos Aires, Argentina and works as a Clinical Reviewer/Data Abstractor of the Neuroendocrine Cervical Tumor Registry (NeCTuR) at MD Anderson Cancer Center.   She has published several articles in cervical cancer including sentinel lymph node mapping and fertility-sparing surgery, neuroendocrine cervical carcinomas, and is the first author of the IRTA Study.

Highlights
-In this multicenter retrospective study, we found no difference in the 4.5-year DFS rates between open radical trachelectomy and minimally invasive radical trachelectomy in patients with tumors up to 2 cm, even after adjusting for potential confounding variables because of unbalanced groups.
-There was no difference in the OS rates or recurrence rates between the open surgery and MIS groups.
-Risk factors for relapse were more common in the open surgery group, but oncologic outcomes were similar for the open and minimally invasive approaches.</description>
      <enclosure length="38468544" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1196487001-bmjpodcasts-irta-open-vs-mis-radical-trachelectomy-with-gloria-salvo-and-rene-pareja.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-zfTW0aMHilyayry0-VaxSrQ-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1197009703</guid>
      <title>US Assistant Secretary of Health, Rachel Levine</title>
      <pubDate>Sat, 15 Jan 2022 13:03:12 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/us-assistant-secretary-of-health-rachel-levine</link>
      <itunes:duration>00:24:39</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>Rachel Levine Trained as a paediatrician, before becoming firstly the state of Pennsylvania's Physician General, then its Health Secretary.

During president Joe Biden's administration, she was nominated to become the U.S.'s assistant secretary of health. That lead to her becoming a four-star admiral in the U.S. Public Health Service Commissioned Corps, and thus the  first openly transgender four-star officer in the US.

In this podcast, we discussed the pandemic - but also wider problems affecting Americans' health, notably climate change, inequality and the opioid crisis. We also discuss the health and care of LGBT+ people, in the U.S, and around the world.

This interview was recorded on the 16th of December 2021.</itunes:summary>
      <itunes:subtitle>Rachel Levine Trained as a paediatrician, before …</itunes:subtitle>
      <description>Rachel Levine Trained as a paediatrician, before becoming firstly the state of Pennsylvania's Physician General, then its Health Secretary.

During president Joe Biden's administration, she was nominated to become the U.S.'s assistant secretary of health. That lead to her becoming a four-star admiral in the U.S. Public Health Service Commissioned Corps, and thus the  first openly transgender four-star officer in the US.

In this podcast, we discussed the pandemic - but also wider problems affecting Americans' health, notably climate change, inequality and the opioid crisis. We also discuss the health and care of LGBT+ people, in the U.S, and around the world.

This interview was recorded on the 16th of December 2021.</description>
      <enclosure length="23666101" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1197009703-bmjpodcasts-us-assistant-secretary-of-health-rachel-levine.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-XDKA1oGZA6yXXCn9-WYgrrw-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item><item>
      <guid isPermaLink="false">tag:soundcloud,2010:tracks/1196532334</guid>
      <title>Achilles tendinopathy masterclass pt 2, with Dr Adam Weir and Assoc Prof Robert-Jan de Vos. EP #493</title>
      <pubDate>Fri, 14 Jan 2022 00:00:00 +0000</pubDate>
      <link>https://soundcloud.com/bmjpodcasts/achilles-tendinopathy-masterclass-pt-2-with-dr-adam-weir-and-prof-robert-jan-de-vos-ep-493</link>
      <itunes:duration>00:28:51</itunes:duration>
      <itunes:author>BMJ Group</itunes:author>
      <itunes:explicit>no</itunes:explicit>
      <itunes:summary>In part 2 of this podcast series Dr Adam Weir talks to Associate Professor Robert-Jan de Vos about the recently published Dutch multidisciplinary guideline on Achilles tendinopathy. They give a clinically focused overview that all practitioners will find invaluable.

They discuss:
Conservative treatment
The role of surgery
Prognosis
Secondary prevention
 
Links
https://soundcloud.com/bmjpodcasts/sets/bjsm-1?si=ed9b271d1d7140ca81ecfbb201ec42ae&amp;utm_source=clipboard&amp;utm_medium=text&amp;utm_campaign=social_sharing
https://bjsm.bmj.com/content/55/20/1125</itunes:summary>
      <itunes:subtitle>In part 2 of this podcast series Dr Adam Weir tal…</itunes:subtitle>
      <description>In part 2 of this podcast series Dr Adam Weir talks to Associate Professor Robert-Jan de Vos about the recently published Dutch multidisciplinary guideline on Achilles tendinopathy. They give a clinically focused overview that all practitioners will find invaluable.

They discuss:
Conservative treatment
The role of surgery
Prognosis
Secondary prevention
 
Links
https://soundcloud.com/bmjpodcasts/sets/bjsm-1?si=ed9b271d1d7140ca81ecfbb201ec42ae&amp;utm_source=clipboard&amp;utm_medium=text&amp;utm_campaign=social_sharing
https://bjsm.bmj.com/content/55/20/1125</description>
      <enclosure length="69264000" type="audio/mpeg" url="https://dts.podtrac.com/redirect.mp3/feeds.soundcloud.com/stream/1196532334-bmjpodcasts-achilles-tendinopathy-masterclass-pt-2-with-dr-adam-weir-and-prof-robert-jan-de-vos-ep-493.mp3"/>
      <itunes:image href="https://i1.sndcdn.com/artworks-AlsN4MiGnYdEQ7Fb-dT2oYg-t3000x3000.jpg"/>
    <author>podcasts.admin@bmj.com (BMJ Group)</author></item>
      </channel>
    </rss>